PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Oesterhelt, F; Oesterhelt, D; Pfeiffer, M; Engel, A; Gaub, HE; Muller, DJ				Oesterhelt, F; Oesterhelt, D; Pfeiffer, M; Engel, A; Gaub, HE; Muller, DJ			Unfolding pathways of individual bacteriorhodopsins	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPE; PROTEIN-COUPLED RECEPTORS; SCANNING PROBE MICROSCOPY; PROTON PUMPS; RESOLUTION; MEMBRANES; MECHANISM; MOLECULES; MODEL; DNA	Atomic force microscopy and single-molecule force spectroscopy were combined to image and manipulate purple membrane patches from Halobacterium salinarum. Individual bacteriorhodopsin molecules were first localized and then extracted from the membrane; the remaining vacancies were imaged again. Anchoring forces between 100 and 200 piconewtons for the different helices were found. Upon extraction, the helices were found to unfold. The force spectra revealed the individuality of the unfolding pathways. Helices G and F as well as helices E and D always unfolded pairwise, whereas helices B and C occasionally unfolded one after the other. Experiments with cleaved Loops revealed the origin of the individuality: stabilization of helix B by neighboring helices.	Univ Munich, CeNS, D-80799 Munich, Germany; Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Basel, Bioctr, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Munich; University of Munich; Max Planck Society; University of Basel; Max Planck Society	Gaub, HE (corresponding author), Univ Munich, CeNS, Arnalienstr 54, D-80799 Munich, Germany.		Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665				BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; Engel A, 1999, CURR BIOL, V9, pR133, DOI 10.1016/S0960-9822(99)80081-5; Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; EVANS E, 1999, J PHYS-CONDENS MAT, V11, P1; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Hargrave PA, 1991, CURR OPIN STRUC BIOL, V1, P575, DOI 10.1016/S0959-440X(05)80080-6; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HEYMANN JB, IN PRESS STRUCTURE; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; Lanyi JK, 1997, J BIOL CHEM, V272, P31209, DOI 10.1074/jbc.272.50.31209; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Oesterhelt D, 1974, Methods Enzymol, V31, P667; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Pfeiffer M, 1999, J MOL BIOL, V287, P163, DOI 10.1006/jmbi.1998.2593; PFEIFFER M, 2000, THESIS L MAXIMILIANS; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; SHAO ZF, 1995, Q REV BIOPHYS, V28, P195, DOI 10.1017/S0033583500003061; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zhang YY, 1996, BIOPHYS J, V71, P2168, DOI 10.1016/S0006-3495(96)79418-3	48	576	598	11	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					143	146		10.1126/science.288.5463.143	http://dx.doi.org/10.1126/science.288.5463.143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753119				2022-12-01	WOS:000086387700053
J	Smoger, SH; Felice, TL; Kloecker, GH				Smoger, SH; Felice, TL; Kloecker, GH			Urinary incontinence among male veterans receiving care in primary care clinics	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; PREVALENCE; COMMUNITY; HEALTH; SEEKING; ADULTS; WOMEN	Background: Male urinary incontinence is not a well-investigated subject. Objective: To determine the prevalence and consequences of incontinence in men. Design: Cross-sectional survey. Setting: 3 primary care clinics in a Kentucky Veterans Affairs facility. Patients: 840 men with a mean age of 59.8 years (range, 25 to 93 years). Measurements: Written survey on patient demographic information and continence, including the Incontinence Impact Questionnaire. Results: Among all study patients, 32.3% reported incontinence within the past 12 months and 13.8% (43% of those who were incontinent) reported at least weekly episodes. Age did not correlate with frequency or amount of urine loss. Frequency correlated with emotional health, social relationships, physical activity, and travel. Greater amounts of lost urine had a stronger effect on emotional health, social relationships, and travel. Among men with incontinence, only 32% had discussed incontinence with their medical provider but 75% desired evaluation and treatment. Conclusions: Urinary incontinence is common among male veterans and affects all age groups. Although incontinence often has unfavorable consequences on quality of life and although men with incontinence desired treatment, they seldom discussed the problem with medical providers. Systematic screening of men for urinary incontinence may be necessary.	Univ Louisville, Div Gen Internal Med, Louisville, KY 40292 USA; Vet Affairs Med Ctr, Louisville, KY USA	University of Louisville; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smoger, SH (corresponding author), Univ Louisville, Div Gen Internal Med, 530 S Jackson St, Louisville, KY 40292 USA.	shsmog01@med.louisville.edu						*AG HLTH CAR POL R, 1996, AHCPR PUBL; ARMSTRONG EP, 1998, VET HLTH SYST J  OCT, P37; BURGIO KL, 1994, J AM GERIATR SOC, V42, P208, DOI 10.1111/j.1532-5415.1994.tb04954.x; DIOKNO AC, 1986, J UROLOGY, V136, P1022; DuBeau CE, 1998, J AM GERIATR SOC, V46, P683, DOI 10.1111/j.1532-5415.1998.tb03801.x; HERR HW, 1994, J UROLOGY, V151, P652, DOI 10.1016/S0022-5347(17)35038-3; HERZOG AR, 1990, J AM GERIATR SOC, V38, P273, DOI 10.1111/j.1532-5415.1990.tb03504.x; Hunskaar Steinar, 1993, Scandinavian Journal of Primary Health Care, V11, P193, DOI 10.3109/02813439308994829; Johnson TM, 1998, J AM GERIATR SOC, V46, P693, DOI 10.1111/j.1532-5415.1998.tb03802.x; LAGACE EA, 1993, J FAM PRACTICE, V36, P610; NIH, 1990, J AM GERIATR SOC, V38, P265; Nygaard IE, 1996, J AM GERIATR SOC, V44, P1049, DOI 10.1111/j.1532-5415.1996.tb02936.x; OUSLANDER JG, 1990, GERONTOLOGIST, V30, P369, DOI 10.1093/geront/30.3.369; OUSLANDER JG, 1982, JAMA-J AM MED ASSOC, V248, P1194, DOI 10.1001/jama.248.10.1194; Payne CK, 1998, UROLOGY, V51, P3, DOI 10.1016/S0090-4295(98)90001-2; Roberts RO, 1998, J AM GERIATR SOC, V46, P467, DOI 10.1111/j.1532-5415.1998.tb02468.x; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243; WETLE T, 1995, J AM GERIATR SOC, V43, P349, DOI 10.1111/j.1532-5415.1995.tb05806.x	20	17	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2000	132	7					547	551		10.7326/0003-4819-132-7-200004040-00006	http://dx.doi.org/10.7326/0003-4819-132-7-200004040-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298FU	10744591				2022-12-01	WOS:000086129300005
J	Wimmer, EA; Carleton, A; Harjes, P; Turner, T; Desplan, C				Wimmer, EA; Carleton, A; Harjes, P; Turner, T; Desplan, C			bicoid-independent formation of thoracic segments in Drosophila	SCIENCE			English	Article							GENE HUNCHBACK; BODY PATTERN; DIFFERENTIAL REGULATION; RNA-BINDING; EMBRYO; EXPRESSION; GRADIENT; PROTEIN; ANTERIOR; MORPHOGEN	The maternal determinant Bicoid (Bcd) represents the paradigm of a morphogen that provides positional information for pattern formation. However, as bicoid seems to be a recently acquired gene in flies, the question was raised as to how embryonic patterning is achieved in organisms with more ancestral modes of development. Because the phylogenetically conserved Hunchback (Hb) protein had previously been shown to act as a morphogen in abdominal patterning, we asked which functions of Bcd could be performed by Hb. By reestablishing a proposed ancient regulatory circuitry in which maternal Hb controls zygotic hunchback expression, we show that Hb is able to form thoracic segments in the absence of Bcd.	NYU, Dept Biol, New York, NY 10003 USA; Univ Bayreuth, Lehrstuhl Genet, D-95447 Bayreuth, Germany	New York University; University of Bayreuth	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.		Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159; Wimmer, Ernst A./0000-0002-2480-2804; Desplan, Claude/0000-0002-6914-1413				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; CURTIS D, 1995, DEVELOPMENT, V121, P1899; DRAPER B, 1996, CELL, V82, P205; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Gao Q, 1998, DEVELOPMENT, V125, P4185; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HULSKAMP M, 1994, GENETICS, V138, P125; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Janody F, 2000, DEVELOPMENT, V127, P1573; Kosman D, 1997, DEVELOPMENT, V124, P1343; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; LUKOWITZ W, 1994, MECH DEVELOP, V45, P105, DOI 10.1016/0925-4773(94)90024-8; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Niessing D, 2000, MOL CELL, V5, P395, DOI 10.1016/S1097-2765(00)80434-7; PATEL NH, COMMUNICATION; Raff R. A., 1996, SHAPE LIFE; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; SANDER K, 1994, DEVELOPMENT S, V120, P187; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SCHRODER R, 1993, ROUX ARCH DEV BIOL, V203, P34, DOI 10.1007/BF00539888; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SOMMER R, 1991, DEVELOPMENT, V113, P419; SOMMER RJ, 1992, P NATL ACAD SCI USA, V89, P10782, DOI 10.1073/pnas.89.22.10782; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; STJOHNSTON D, 1992, CELL, V68, P201; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; WIMMER E, UNPUB; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; Wolff C, 1995, DEVELOPMENT, V121, P4227; Wolff C, 1998, DEVELOPMENT, V125, P3645; XU X, 1994, DEVELOPMENT, V120, P277	49	67	67	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2476	2479		10.1126/science.287.5462.2476	http://dx.doi.org/10.1126/science.287.5462.2476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741965				2022-12-01	WOS:000086202200042
J	Parkhill, J; Achtman, M; James, KD; Bentley, SD; Churcher, C; Klee, SR; Morelli, G; Basham, D; Brown, D; Chillingworth, T; Davies, RM; Davis, P; Devlin, K; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Leather, S; Moule, S; Mungall, K; Quail, MA; Rajandream, MA; Rutherford, KM; Simmonds, M; Skelton, J; Whitehead, S; Spratt, BG; Barrell, BG				Parkhill, J; Achtman, M; James, KD; Bentley, SD; Churcher, C; Klee, SR; Morelli, G; Basham, D; Brown, D; Chillingworth, T; Davies, RM; Davis, P; Devlin, K; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Leather, S; Moule, S; Mungall, K; Quail, MA; Rajandream, MA; Rutherford, KM; Simmonds, M; Skelton, J; Whitehead, S; Spratt, BG; Barrell, BG			Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491	NATURE			English	Article							PILIN ANTIGENIC VARIATION; OUTER-MEMBRANE PROTEIN; MOLECULAR CHARACTERIZATION; VARIABLE EXPRESSION; GONORRHOEAE; GENE; RECOMBINATION; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS	Neisseria meningitidis causes bacterial meningitis and is therefore responsible for considerable morbidity and mortality in both the developed and the developing world. Meningococci are opportunistic pathogens that colonize the nasopharynges and oropharynges of asymptomatic carriers. For reasons that are still mostly unknown, they occasionally gain access to the blood, and subsequently to the cerebrospinal fluid, to cause septicaemia and meningitis. N. meningitidis strains are divided into a number of serogroups on the basis of the immunochemistry of their capsular polysaccharides; serogroup A strains are responsible for major epidemics and pandemics of meningococcal disease, and therefore most of the morbidity and mortality associated with this disease. Here we have determined the complete genome sequence of a serogroup A strain of Neisseria meningitidis, Z2491 (ref. 1). The sequence is 2,184,406 base pairs in length, with an overall G+C content of 51.8%, and contains 2,121 predicted coding sequences. The most notable feature of the genome is the presence of many hundreds of repetitive elements, ranging from short repeats, positioned either singly or in large multiple arrays, to insertion sequences and gene duplications of one kilobase or more. Many of these repeats appear to be involved in genome fluidity and antigenic variation in this important human pathogen.	Sanger Ctr, Cambridge CB10 1SA, England; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England	Wellcome Trust Sanger Institute; Max Planck Society; University of Oxford	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		Spratt, Brian G/A-1676-2009; Rutherford, Kim/Y-7995-2018; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020	Rutherford, Kim/0000-0001-6277-726X; Parkhill, Julian/0000-0002-7069-5958; Davies, Robert/0000-0002-9983-1378; Davis, Paul/0000-0001-5545-0824; Achtman, Mark/0000-0001-6815-0070				Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; DOMENIGHINI M, 1990, MOL MICROBIOL, V4, P787, DOI 10.1111/j.1365-2958.1990.tb00649.x; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HowellAdams B, 1996, MOL MICROBIOL, V22, P509, DOI 10.1046/j.1365-2958.1996.00128.x; KLEE SR, IN PRESS INFECT IMMU; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Pettersson A, 1998, MOL MICROBIOL, V27, P599, DOI 10.1046/j.1365-2958.1998.00707.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Smith NH, 1999, MOL BIOL EVOL, V16, P773, DOI 10.1093/oxfordjournals.molbev.a026162; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Swartley JS, 1998, J BACTERIOL, V180, P1533, DOI 10.1128/JB.180.6.1533-1539.1998; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; VONDERHAAR RA, 1994, J BACTERIOL, V176, P6207, DOI 10.1128/jb.176.20.6207-6213.1994; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; ZHOU JJ, 1992, MOL MICROBIOL, V6, P2135, DOI 10.1111/j.1365-2958.1992.tb01387.x	30	573	1193	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					502	506		10.1038/35006655	http://dx.doi.org/10.1038/35006655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761919				2022-12-01	WOS:000086257700050
J	Tharun, S; He, WH; Mayes, AE; Lennertz, P; Beggs, JD; Parker, R				Tharun, S; He, WH; Mayes, AE; Lennertz, P; Beggs, JD; Parker, R			Yeast Sm-like proteins function in mRNA decapping and decay	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; DEADENYLATION; DEGRADATION; TURNOVER; U6	One of the main mechanisms of messenger RNA degradation in eukaryotes occurs by deadenylation-dependent decapping which leads to 5'-to-3' decay(1,2). A family of Sm-like (Lsm) proteins has been identified, members of which contain the 'Sm' sequence motif, form a complex with U6 small nuclear RNA and are required for pre-mRNA splicing(3-9). Here we show that mutations in seven yeast Lsm proteins (Lsm1-Lsm7) also lead to inhibition of mRNA decapping. In addition, the Lsm1-Lsm7 proteins coimmunoprecipitate with the mRNA decapping enzyme (Dcp1), a decapping activator (Pat1/Mrt1) and with mRNA. This indicates that the Lsm proteins may promote decapping by interactions with the mRNA and the decapping machinery. In addition, the Lsm complex that functions in mRNA decay appears to be distinct from the U6-associated Lsm complex, indicating that Lsm proteins form specific complexes that affect different aspects of mRNA metabolism.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Unilever Res Colworth, Sharnbrook MK44 1LQ, Beds, England	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University of Edinburgh; Unilever	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu	, jbeggs/N-9551-2019; Beggs, Jean/H-4861-2011	Beggs, Jean/0000-0002-8179-6519				Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; FROMONTRACINE M, UNPUB P NATL ACAD SC; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He WH, 1999, METHODS, V17, P3, DOI 10.1006/meth.1998.0701; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Tharun S, 1999, GENETICS, V151, P1273; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791	23	329	345	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					515	518		10.1038/35006676	http://dx.doi.org/10.1038/35006676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761922	Green Published			2022-12-01	WOS:000086257700053
J	Berlyne, G; Barnes, N				Berlyne, G; Barnes, N			No role for NO in asthma?	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; INHIBITION; AIR		London Chest Hosp, Dept Resp Med, London E2 9JX, England	University of London; Queen Mary University London	Berlyne, G (corresponding author), London Chest Hosp, Dept Resp Med, London E2 9JX, England.							de Gouw HWFM, 1999, THORAX, V54, P1033, DOI 10.1136/thx.54.11.1033; Hamad AM, 1999, EUR RESPIR J, V14, P702, DOI 10.1034/j.1399-3003.1999.14c34.x; KHARITONOV SA, 1995, EUR RESPIR J, V8, P295, DOI 10.1183/09031936.95.08020295; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P454, DOI 10.1164/ajrccm.153.1.8542158; Kharitonov SA, 1996, EUR RESPIR J, V9, P196, DOI 10.1183/09031936.96.09020196; Lim S, 1999, AM J RESP CRIT CARE, V159, P22, DOI 10.1164/ajrccm.159.1.9706006; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Silkoff PE, 1999, AM J RESP CRIT CARE, V159, P940, DOI 10.1164/ajrccm.159.3.9805044; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Taylor DA, 1998, AM J RESP CRIT CARE, V158, P99, DOI 10.1164/ajrccm.158.1.9709091; Taylor DA, 1998, THORAX, V53, P483, DOI 10.1136/thx.53.6.483; van Rensen ELJ, 1999, THORAX, V54, P403, DOI 10.1136/thx.54.5.403; Yates DH, 1996, EUR RESPIR J, V9, P1130, DOI 10.1183/09031936.96.09061130	13	16	19	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1029	1030		10.1016/S0140-6736(00)02027-4	http://dx.doi.org/10.1016/S0140-6736(00)02027-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744082				2022-12-01	WOS:000086380800003
J	Hakala, M; Niemela, RK				Hakala, M; Niemela, RK			Does autonomic nervous impairment have a role in pathophysiology of Sjogren's syndrome	LANCET			English	Editorial Material							AUTOANTIBODIES; PROGRESSION		Univ Oulu, Dept Internal Med, Div Rheumatol, FIN-90220 Oulu, Finland	University of Oulu	Hakala, M (corresponding author), Univ Oulu, Dept Internal Med, Div Rheumatol, FIN-90220 Oulu, Finland.							Andonopoulos AP, 1998, J RHEUMATOL, V25, P2385; Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151; Barendregt PJ, 1999, ANN RHEUM DIS, V58, P746, DOI 10.1136/ard.58.12.746; Fox R I, 1999, Curr Opin Rheumatol, V11, P364, DOI 10.1097/00002281-199909000-00007; JONSSON R, 1993, BRIT J RHEUMATOL, V32, P578; KAUTZNER J, 1995, HEART RATE VARIABILI, P165; Kovacs L, 2000, ANN RHEUM DIS, V59, P48, DOI 10.1136/ard.59.1.48; Mandl T, 1997, SCAND J RHEUMATOL, V26, P253, DOI 10.3109/03009749709105312; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Tenovuo J, 1994, TXB CLIN CARIOLOGY, P17; Tornwall J, 1997, LANCET, V349, P1814, DOI 10.1016/S0140-6736(05)61694-7; Zoukhri D, 1998, CLIN IMMUNOL IMMUNOP, V89, P126, DOI 10.1006/clin.1998.4597	12	13	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1032	1033		10.1016/S0140-6736(00)02030-4	http://dx.doi.org/10.1016/S0140-6736(00)02030-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744085				2022-12-01	WOS:000086380800006
J	Yanovski, JA; Yanovski, SZ; Sovik, KN; Nguyen, TT; O'Neil, PM; Sebring, NG				Yanovski, JA; Yanovski, SZ; Sovik, KN; Nguyen, TT; O'Neil, PM; Sebring, NG			A prospective study of holiday weight gain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; SEASONAL AFFECTIVE-DISORDER; UNITED-STATES; SMOKING CESSATION; US ADULTS; WOMEN; OVERWEIGHT; PREVALENCE; AGE; OBESITY	Background: It is commonly asserted that the average American gains 5 lb (2.3 kg) or more over the holiday period between Thanksgiving and New Year's Day, yet few data support this statement. Methods: To estimate actual holiday-related weight variation, we measured body weight in a convenience sample of 195 adults. The subjects were weighed four times at intervals of six to eight weeks, so that weight change was determined for three periods: preholiday (from late September or early October to mid-November), holiday (from mid-November to early or mid-January), and postholiday (from early or mid-January to late February or early March). A final measurement of body weight was obtained in 165 subjects the following September or October. Data on other vital signs and self-reported health measures were obtained from the patients in order to mask the main outcome of interest. Results: The mean (+/-SD) weight increased significantly during the holiday period (gain, 0.37+/-1.52 kg; P<0.001), but not during the preholiday period (gain, 0.18+/-1.49 kg; P=0.09) or the postholiday period (loss, 0.07+/-1.14 kg; P=0.36). As compared with their weight in late September or early October, the study subjects had an average net weight gain of 0.48+/-2.22 kg in late February or March (P=0.003). Between February or March and the next September or early October, there was no significant additional change in weight (gain, 0.21 kg+/-2.3 kg; P=0.13) for the 165 participants who returned for follow-up. Conclusions: The average holiday weight gain is less than commonly asserted. Since this gain is not reversed during the spring or summer months, the net 0.48-kg weight gain in the fall and winter probably contributes to the increase in body weight that frequently occurs during adulthood. (N Engl J Med 2000;342:861-7.) (C)2000, Massachusetts Medical Society.	NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; NIDDKD, Div Nutr Res Coordinat, NIH, Bethesda, MD 20892 USA; NIH, Warren G Magnuson Clin Ctr, Dept Nutr, Bethesda, MD 20892 USA; Med Univ S Carolina, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; Medical University of South Carolina	Yanovski, JA (corresponding author), NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bldg 10,Rm 10N262,10 Ctr Dr,MSC 1862, Bethesda, MD 20892 USA.			O'Neil, Patrick/0000-0002-0388-4046; Yanovski, Jack/0000-0001-8542-1637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD000641, ZIA HD000641-14] Funding Source: Medline; NICHD NIH HHS [Z01 HD-00641] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON I, 1992, INT J OBESITY, V16, P1013; Baker RC, 1998, HEALTH PSYCHOL, V17, P367, DOI 10.1037/0278-6133.17.4.367; BALLARDBARBASH R, 1990, CANCER RES, V50, P2152; Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; CARLEY T, 1997, EXERCISE TIPS REDUCE; *CNN INT, 1995, AV AM GAINS 7 10 POU; COLDITZ GA, 1990, AM J CLIN NUTR, V51, P1100, DOI 10.1093/ajcn/51.6.1100; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; GOLDBOURT U, 1991, ISRAEL J MED SCI, V27, P264; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Jeffery RW, 1997, INT J OBESITY, V21, P457, DOI 10.1038/sj.ijo.0800431; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; MOE K, 1996, KEEPING HOLIDAY POUN; NAJJAR M, 1987, VITAL HLTH STAT, V11; NASH W, 1997, RICH HOLIDAY FOOD LE, P3; Nurse G T, 1968, Cent Afr J Med, V14, P122; *OH U, 1997, PART HEART RIGHT APP; PANTERBRICK C, 1995, J BIOSOC SCI, V27, P215, DOI 10.1017/S0021932000022719; PAWSON IG, 1982, SOC SCI MED, V16, P183, DOI 10.1016/0277-9536(82)90021-1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROOKUS MA, 1987, HUM BIOL, V59, P599; ROSENTHAL NE, 1987, ANN NY ACAD SCI, V499, P216, DOI 10.1111/j.1749-6632.1987.tb36213.x; Sahyoun NR, 1999, AM J PUBLIC HEALTH, V89, P391, DOI 10.2105/AJPH.89.3.391; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; SHAH M, 1991, INT J OBESITY, V15, P499; Shimamoto H, 1998, JPN J PHYS FIT SPORT, V47, P509, DOI 10.7600/jspfsm1949.47.509; SILVERSTEIN LJ, 1996, J AM DIET ASSOC, V96, pA30; SMITH N, 1999, HOLIDAY WEIGHT GAIN; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; *TEX MED ASS, 1998, HOL EAT; THOMPSON C, 1988, J AFFECT DISORDERS, V14, P257, DOI 10.1016/0165-0327(88)90043-2; VANLIERE MJ, 1994, BRIT J NUTR, V72, P479, DOI 10.1079/BJN19940049; VANSTAVEREN WA, 1986, INT J OBESITY, V10, P133; WESCOTT WL, 1998, SURVIVAL STRATEGIES; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1994, INT J OBESITY, V18, P561; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; WING RR, 1991, ARCH INTERN MED, V151, P97, DOI 10.1001/archinte.151.1.97; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; ZAHORSKAMARKIEWICZ B, 1980, INT J OBESITY, V4, P139; 1998, OBES RES, V6, P464	45	227	231	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2000	342	12					861	867		10.1056/NEJM200003233421206	http://dx.doi.org/10.1056/NEJM200003233421206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296FU	10727591	Green Accepted			2022-12-01	WOS:000086014100006
J	Jackson, R				Jackson, R			Updated New Zealand cardiovascular disease risk-benefit prediction guide	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Community Hlth, Auckland, New Zealand	University of Auckland	Jackson, R (corresponding author), Univ Auckland, Dept Community Hlth, Auckland, New Zealand.	rt.jackson@auckland.ac.nz		Jackson, Rod/0000-0001-5914-6934				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; National Health Committee, 1995, GUID MAN MILDL RAIS; Shepherd J, 1996, LANCET, V348, P1339	7	177	180	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					709	710		10.1136/bmj.320.7236.709	http://dx.doi.org/10.1136/bmj.320.7236.709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710588	Green Published			2022-12-01	WOS:000085895300029
J	Tanaka, H; Arakawa, H; Yamaguchi, T; Shiraishi, K; Fukuda, S; Matsui, K; Takei, Y; Nakamura, Y				Tanaka, H; Arakawa, H; Yamaguchi, T; Shiraishi, K; Fukuda, S; Matsui, K; Takei, Y; Nakamura, Y			A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage	NATURE			English	Article							WILD-TYPE P53; SMALL-SUBUNIT; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; UV IRRADIATION; PROTEIN; EXPRESSION; REPAIR; SENSITIVITY; AGENTS	The p53 gene is frequently inactivated in human cancers. Here we have isolated a p53-inducible gene, p53R2,by using differential display to examine messenger RNAs in a cancer-derived human cell line carrying a highly regulated wild-type p53 expression system. p53R2 contains a p53-binding sequence in intron 1 and encodes a 351-amino-acid peptide with striking similarity to the ribonucleotide reductase small subunit(R2), which is important in DNA synthesis during cell division. Expression of p53R2, but not R2, was induced by ultraviolet and gamma-irradiation and adriamycin treatment in a wild-type p53-dependent manner. Induction of p53R2 in p53-deficient cells caused G2/M arrest and prevented cells from death in response to adriamycin, Inhibition of endogenous p53R2 expression in cells that have an intact p53-dependent DNA damage checkpoint reduced ribonucleotide reductase activity, DNA repair and cell survival after exposure to various genotoxins. Our results indicate that p53R2 encodes a ribonucleotide reductase that is directly involved in the p53 checkpoint for repair of damaged DNA, The discovery of p53R2 clarifies a relationship between a ribonucleotide reductase activity involved in repair of damaged DNA and tumour suppression by p53.	Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Ceraline J, 1998, INT J CANCER, V75, P432, DOI 10.1002/(SICI)1097-0215(19980130)75:3<432::AID-IJC17>3.0.CO;2-A; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; ERIKSSON S, 1981, J BIOL CHEM, V256, P9436; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Furuhata T, 1996, ONCOGENE, V13, P1965; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; HARPER JW, 1993, CELL, V75, P805; Hawkins DS, 1996, CANCER RES, V56, P892; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; KASTAN MB, 1991, CANCER RES, V51, P6304; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.3.CO;2-3; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; REDDY GPV, 1982, J BIOL CHEM, V257, P2526; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Smith ML, 1997, P NATL ACAD SCI USA, V94, P12255, DOI 10.1073/pnas.94.23.12255; Takei Y, 1998, GENE CHROMOSOME CANC, V23, P1; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Urano T, 1997, CANCER RES, V57, P3281; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	41	725	746	1	56	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					42	49		10.1038/35003506	http://dx.doi.org/10.1038/35003506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716435				2022-12-01	WOS:000085775100038
J	Sandin, RH; Enlund, G; Samuelsson, P; Lennmarken, C				Sandin, RH; Enlund, G; Samuelsson, P; Lennmarken, C			Awareness during anaesthesia: a prospective case study	LANCET			English	Article							GENERAL-ANESTHESIA; RECALL; PROPOFOL	Background Patients who are given general anaesthesia are not guaranteed to remain unconscious during surgery. Knowledge about the effectiveness of current protective measures is scarce, as is our understanding of patients' responses to this complication. We did a prospective case study to assess conscious awareness during anaesthesia. Methods 11 785 patients who had undergone general anaesthesia were interviewed for awareness on three occasions: before they left the post-anaesthesia care unit, and 1-3 days and 7-14 days after the operation. Findings We identified 18 cases of awareness and one case of inadvertent muscle blockade that had occurred before unconsciousness. Incidence of awareness was 0.18% in cases in which neuromuscular blocking drugs were used, and 0.10% in the absence of such drugs. 17 cases of awareness were identified at the final interview, but no more than 11 would have been detected if an interview had been done only when the patients left the post-anaesthesia care unit. Four non-paralysed patients recalled intraoperative events, but none had anxiety during wakefulness or had delayed neurotic symptoms. This finding contrasts with anaesthesia with muscle relaxants, during which 11 of 14 patients had pain, anxiety, or delayed neurotic symptoms, After repeated discussion and information, the delayed neurotic symptoms resolved within 3 weeks in all patients. Analysis of individual cases suggests that a reduced incidence of recall of intraoperative events would not be achieved by monitoring of end-tidal anaesthetic gas concentration or by more frequent use of benzodiazepines. Interpretation The inability to prevent awareness by conventional measures may advocate monitoring of cerebral activity by neurophysiological techniques. However, the sensitivity of such techniques is not known, and in the light of our findings, at least 861 patients would need to be monitored to avoid one patient from suffering due to awareness during relaxant anaesthesia.	Lanssjukhuset, Dept Anaesthesia & Intens Care, S-39185 Kalmar, Sweden; Vrinnevisjukhuset, Dept Anaesthesia & Intens Care, Norrkoping, Sweden		Sandin, RH (corresponding author), Lanssjukhuset, Dept Anaesthesia & Intens Care, S-39185 Kalmar, Sweden.	rolfs@ltkalmar.se	garcia, waynice np/K-3914-2015					BRICE DD, 1970, BRIT J ANAESTH, V42, P535, DOI 10.1093/bja/42.6.535; Klafta JM, 1996, ANESTH ANALG, V83, P1314, DOI 10.1097/00000539-199612000-00031; LIU WHD, 1991, ANAESTHESIA, V46, P435, DOI 10.1111/j.1365-2044.1991.tb11677.x; Myles PS, 2000, BRIT J ANAESTH, V84, P6, DOI 10.1093/oxfordjournals.bja.a013383; Nordstrom O, 1996, BRIT J ANAESTH, V76, P699, DOI 10.1093/bja/76.5.699; Nordstrom O, 1997, ACTA ANAESTH SCAND, V41, P978, DOI 10.1111/j.1399-6576.1997.tb04823.x; Pomfrett CJD, 1999, BRIT J ANAESTH, V82, P659, DOI 10.1093/bja/82.5.659; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; Ranta SOV, 1998, ANESTH ANALG, V86, P1084, DOI 10.1097/00000539-199805000-00035	9	417	449	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					707	711		10.1016/S0140-6736(99)11010-9	http://dx.doi.org/10.1016/S0140-6736(99)11010-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703802				2022-12-01	WOS:000085615600012
J	Meng, XJ; Lindahl, M; Hyvonen, ME; Parvinen, M; de Rooij, DG; Hess, MW; Raatikainen-Ahokas, A; Sainio, K; Rauvala, H; Lakso, M; Pichel, JG; Westphal, H; Saarma, M; Sariola, H				Meng, XJ; Lindahl, M; Hyvonen, ME; Parvinen, M; de Rooij, DG; Hess, MW; Raatikainen-Ahokas, A; Sainio, K; Rauvala, H; Lakso, M; Pichel, JG; Westphal, H; Saarma, M; Sariola, H			Regulation of cell fate decision of undifferentiated spermatogonia by GDNF	SCIENCE			English	Article							ENTERIC NERVOUS-SYSTEM; ACID RECEPTOR-ALPHA; MICE LACKING GDNF; NEUROTROPHIC FACTOR; IN-VIVO; MOTOR-NEURONS; EXPRESSION; TESTIS; SPERMATOGENESIS; MOUSE	The molecular control of self-renewal and differentiation of stem cells has remained enigmatic. Transgenic Loss-of-function and overexpression models now show that the dosage of glial cell Line-derived neurotrophic factor (GDNF), produced by Sertoli cells, regulates cell fate decisions of undifferentiated spermatogonial cells that include the stem cells for spermatogenesis. Gene-targeted mice with one GDNF-null allele show depletion of stem cell reserves, whereas mice overexpressing GDNF show accumulation of undifferentiated spermatogonia. They are unable to respond properly to differentiation signals and undergo apoptosis upon retinoic acid treatment. Nonmetastatic testicular tumors are regularly formed in older GDNF-overexpressing mice. Thus, GDNF contributes to paracrine regulation of spermatogonial self-renewal and differentiation.	Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Dev Biol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Mol Neurobiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Transgen Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland; Univ Turku, Dept Anat, FIN-20520 Turku, Finland; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Hosp Merida, Unidad Invest, Badajoz 06800, Spain; NICHHD, Bethesda, MD 20892 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Turku; Utrecht University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sariola, H (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Res Program Dev Biol, POB 56,Viikinkaari 9, FIN-00014 Helsinki, Finland.		Pichel, Jose G/AAF-2255-2019; Lindahl, Maria/AHE-1252-2022; de Rooij, D.G./AAW-1195-2021; Hess, Michael/AAE-1985-2019	Pichel, Jose G/0000-0001-8580-0952; Hess, Michael/0000-0002-5154-3553; Lindahl, Maria/0000-0002-5674-8830; Rauvala, Heikki/0000-0001-7809-9811; de Rooij, Dirk/0000-0003-3932-4419				Akmal KM, 1998, ENDOCRINOLOGY, V139, P1239, DOI 10.1210/en.139.3.1239; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; CLERMONT Y, 1963, AM J ANAT, V112, P35, DOI 10.1002/aja.1001120103; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Hu J, 1999, ENDOCRINOLOGY, V140, P3416, DOI 10.1210/en.140.8.3416; HUCKINS C, 1971, ANAT REC, V169, P533, DOI 10.1002/ar.1091690306; Kokaia Z, 1999, EUR J NEUROSCI, V11, P1202, DOI 10.1046/j.1460-9568.1999.00513.x; KOSHIMIZU U, 1995, MOL REPROD DEV, V40, P221, DOI 10.1002/mrd.1080400211; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Meistrich M.L., 1993, CELL MOL BIOL TESTIS, p266?295; MENG XK, UNPUB; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Parvinen M, 1997, HISTOCHEM CELL BIOL, V108, P77, DOI 10.1007/s004180050148; PELLETIER RM, 1992, MICROSC RES TECHNIQ, V20, P3, DOI 10.1002/jemt.1070200104; PESCOVITZ OH, 1994, TRENDS ENDOCRIN MET, V5, P126, DOI 10.1016/1043-2760(94)90094-9; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sainio K, 1997, DEVELOPMENT, V124, P4077; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1756; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	39	978	1077	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1489	1493		10.1126/science.287.5457.1489	http://dx.doi.org/10.1126/science.287.5457.1489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688798				2022-12-01	WOS:000085531600052
J	Young, FE				Young, FE			A time for restraint	SCIENCE			English	Editorial Material								The debate on the use of human embryos for research will be one of the more important issues of the 21st century. Unlike recombinant DNA technology, embryonic stem cell research most probably will result in the destruction of living embryos. Many people consider this research immoral, illegal, and unnecessary. Therefore, it is imperative to proceed cautiously. Federal funding of research using human embryos or pluripotent cells derived from them would be inappropriate until further resolution of the ethical issues has been achieved.	Fourth Presbyterian Church, Reformed Theol Seminary, Bethesda, MD 20816 USA		Young, FE (corresponding author), Fourth Presbyterian Church, Reformed Theol Seminary, 5500 River Rd, Bethesda, MD 20816 USA.							CAMPBELL CS, 1997, CLONING HUMAN BEINGS, V2, pD3; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; FORSYTHE CD, 1998, VALPARAISO U LAW REV, V32, P491; Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kuhn HG, 1999, BIOESSAYS, V21, P625, DOI 10.1002/(SICI)1521-1878(199908)21:8<625::AID-BIES1>3.0.CO;2-6; Lanza RP, 1999, SCIENCE, V283, P1849; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; *NBAC, 1999, EX SUMM ETH ISS HUM; ROBERTSON JA, 1978, SOUTHERN CALIF LAW R, V51, P1203; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; 1986, FED REG, V51, P23302	12	37	46	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1424	1424		10.1126/science.287.5457.1424	http://dx.doi.org/10.1126/science.287.5457.1424			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688779				2022-12-01	WOS:000085531600033
J	Naeem, S; Hahn, DR; Schuurman, G				Naeem, S; Hahn, DR; Schuurman, G			Producer-decomposer co-dependency influences biodiversity effects	NATURE			English	Article							ECOSYSTEM PROCESSES; PLANT; DIVERSITY; NITROGEN; PRODUCTIVITY; BIOMASS; CARBON	Producers, such as plants and algae, acquire nutrients from inorganic sources that are supplied primarily by decomposers whereas decomposers, mostly fungi and bacteria, acquire carbon from organic sources that are supplied primarily by producers. This producer-decomposer co-dependency is important in governing ecosystem processes(1-4), which implies that the impacts of declining biodiversity on ecosystem functioning(5-7) should be strongly infuenced by this process. Here we show, by simultaneously manipulating producer (green algal) and decomposer (heterotrophic bacterial) diversity in freshwater microcosms, that algal biomass production varies considerably among microcosms (0.0-0.67 mg ml(-1)), but that neither algal nor bacterial diversity by itself can explain this variation. Instead, production is a joint function of both algal and bacterial diversity. Furthermore, the range in algal production in microscosms in which bacterial diversity was manipulated was nearly double (1.82 times) that of microcosms in which bacterial diversity was not manipulated. Measures of organic carbon use by bacteria in these microcosms indicate that carbon usage is the mechanism responsible for these results. Because both producer(8) and microbial diversity(9) respond to disturbance and habitat modification, the main causes of biodiversity loss(8), these results suggest that ecosystem response to changing biodiversity is likely to be more complex than other studies(5-7) have shown.	Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Naeem, S (corresponding author), Univ Washington, Dept Zool, 24 Kincaid Hall,Boc 351800, Seattle, WA 98195 USA.							Allsopp D., 1995, MICROBIAL DIVERSITY; BERMAN T, 1974, MAR BIOL, V28, P305, DOI 10.1007/BF00388498; Berman-Frank I, 1999, BIOSCIENCE, V49, P29, DOI 10.2307/1313491; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Griffiths BS, 1997, MICROBIAL COMMUNITIES, P1; HARTE J, 1993, AM NAT, V141, P839; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; JONES AK, 1982, MICROBIAL INTERACTIO, P189; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Mulder CPH, 1999, ECOL LETT, V2, P237; Naeem S, 1998, ECOLOGY, V79, P2603, DOI 10.1890/0012-9658(1998)079[2603:CSRAAB]2.0.CO;2; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; PRITCHARD PH, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P161; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Smalla K, 1998, APPL ENVIRON MICROB, V64, P1220; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wetzel R.G., 2013, LIMNOLOGICAL ANAL; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WOOD A M, 1990, Marine Microbial Food Webs, V4, P103; ZAK DR, 1990, BIOGEOCHEMISTRY, V11, P111, DOI 10.1007/BF00002062; ZAK DR, 1991, OECOLOGIA, V88, P189, DOI 10.1007/BF00320810	30	165	179	2	98	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					762	764		10.1038/35001568	http://dx.doi.org/10.1038/35001568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693803				2022-12-01	WOS:000085423100050
J	Mi, J; Law, C; Zhang, KL; Osmond, C; Stein, C; Barker, D				Mi, J; Law, C; Zhang, KL; Osmond, C; Stein, C; Barker, D			Effects of infant birthweight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China	ANNALS OF INTERNAL MEDICINE			English	Article						body mass index; pregnancy; birth weight; insulin resistance	DEPENDENT DIABETES-MELLITUS; BLOOD-PRESSURE; GLUCOSE-TOLERANCE; BIRTH-WEIGHT; NUTRITIONAL-STATUS; SERUM-CHOLESTEROL; HEART-DISEASE; FETAL; POPULATION; GROWTH	Background: Reduced birthweight is associated with increased risk for the insulin resistance syndrome. Part of this risk is hypothesized to originate from undernutrition in utero. The prevalence of the insulin resistance syndrome increases in countries that undergo the transition from chronic malnutrition to adequate nutrition, when postnatal nutrition improves more rapidly than prenatal nutrition. Objective: To determine whether the components of the insulin resistance syndrome are associated with reduced fetal growth and maternal undernutrition. Design: A nonconcurrent, prospective study of men and women whose mothers' heights and weights were recorded during pregnancy. Setting: Beijing, China. Participants: 627 men and women (mean age, 45 years) whose mothers' obstetric records were preserved. Measurements: Adult offspring's blood pressure, plasma glucose levels, insulin levels, and lipid concentrations during an oral glucose tolerance test. The main explanatory measurements were mothers' body mass index during pregnancy and offspring's birthweight and adult size. Results: After adjustment for sex and current body mass index, low birthweight was associated with elevated plasma glucose levels, insulin levels, triglyceride concentrations, and blood pressure. For every l-kg increase in birthweight, systolic blood pressure decreased by 2.9 mm Hg (95% CI, 0.3 to 5.4 mm Hg) and the 2-hour plasma glucose level decreased by 5.1%(CI, 0.7% to 9.3%). Low maternal body mass index in early and late pregnancy was associated with elevated levels of plasma glucose, insulin, and triglycerides in adult offspring but was not associated with elevated blood pressure. Conclusions: Risk for the insulin resistance syndrome may be partially established through low maternal body mass before pregnancy and consequent fetal undernutrition. This risk is independent of that associated with adult obesity. In developing countries such as China, improved nutrition in girls and young women may offer long-term benefits to offspring.	Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Peking Union Med Coll, Beijing, Peoples R China	University of Southampton; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Mi, J (corresponding author), Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Law, Catherine/A-1353-2009	Law, Catherine/0000-0002-1777-9386; Osmond, Clive/0000-0002-9054-4655				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ALLAIN CC, 1974, CLIN CHEM, V20, P470; ALPHA B, 1992, EUR J CLIN CHEM CLIN, V30, P27; Barker D.J.P., 1998, MOTHERS BABIES HLTH; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Clark PM, 1998, OBSTET GYNECOL, V91, P103, DOI 10.1016/S0029-7844(97)00581-4; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; FOSSATI P, 1982, CLIN CHEM, V28, P2077; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GODFREY KM, 1994, BRIT J OBSTET GYNAEC, V101, P398, DOI 10.1111/j.1471-0528.1994.tb11911.x; Gregory J., 1990, DIETARY NUTR SURVEY; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; James WPT, 1997, NUTR REV, V55, pS31, DOI 10.1111/j.1753-4887.1997.tb06097.x; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Laor A, 1997, BRIT MED J, V315, P449, DOI 10.1136/bmj.315.7106.449; Law CM, 1996, J HYPERTENS, V14, P935; LAW CM, 1991, ARCH DIS CHILD, V66, P1291, DOI 10.1136/adc.66.11.1291; LAW CM, 1995, DIABETIC MED, V12, P24, DOI 10.1111/j.1464-5491.1995.tb02057.x; LEE C C, 1948, Chin Med J, V66, P153; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NI T. G., 1949, Chinese Medical Journal, V87, P677; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Ramachandran A, 1997, DIABETOLOGIA, V40, P232, DOI 10.1007/s001250050668; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Taylor SJC, 1998, BRIT MED J, V317, P680, DOI 10.1136/bmj.317.7159.680; UTTLEY K. H., 1940, CHINESE MED JOUR, V58, P582; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/BF00403383; Whincup PH, 1997, DIABETOLOGIA, V40, P319, DOI 10.1007/s001250050681; Zimmet PZ, 1997, J DIABETES COMPLICAT, V11, P60, DOI 10.1016/S1056-8727(96)00090-6	36	210	234	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2000	132	4					253	+		10.7326/0003-4819-132-4-200002150-00002	http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285CY	10681279				2022-12-01	WOS:000085372900001
J	Perez, GI; Trbovich, AM; Gosden, RG; Tilly, JL				Perez, GI; Trbovich, AM; Gosden, RG; Tilly, JL			Reproductive biology - Mitochondria and the death of oocytes	NATURE			English	Article							APOPTOSIS; OVARY		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Univ Leeds, Leeds Gen Infirm, Ctr Reprod Growth & Dev, Leeds LS2 9NS, W Yorkshire, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Leeds General Infirmary; University of Leeds	Perez, GI (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, VBK137E-GYN, Boston, MA 02114 USA.		Perez, Gloria I/GMX-1286-2022					BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BEAUMONT HM, 1962, PROC R SOC SER B-BIO, V155, P557, DOI 10.1098/rspb.1962.0019; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; FORABOSCO A, 1991, ANAT RECORD, V231, P201, DOI 10.1002/ar.1092310208; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; PIKO L, 1976, DEV BIOL, V49, P1, DOI 10.1016/0012-1606(76)90253-0; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; TILLY JL, 1999, MOL BIOL REPROD MED, P79	14	126	140	1	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					500	501		10.1038/35000651	http://dx.doi.org/10.1038/35000651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676949				2022-12-01	WOS:000085227300035
J	Bae, S; Kurtz, RC				Bae, S; Kurtz, RC			Strategy after diagnosis of pancreatic dysplasia	LANCET			English	Editorial Material							HEREDITARY PANCREATITIS; CANCER		Mem Sloan Kettering Canc Ctr, Serv Gastroenterol & Nutr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Kurtz, RC (corresponding author), Mem Sloan Kettering Canc Ctr, Serv Gastroenterol & Nutr, 1275 York Ave, New York, NY 10021 USA.							Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Finch MD, 1997, DIGESTION, V58, P564, DOI 10.1159/000201502; Flanders TY, 1996, J MED GENET, V33, P889, DOI 10.1136/jmg.33.11.889; GRUBAN RH, 1993, AM J PATHOL, V143, P545; LEE JG, 1995, GASTROINTEST ENDOSC, V42, P317, DOI 10.1016/S0016-5107(95)70129-X; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; Lynch HT, 1996, SEMIN ONCOL, V23, P251; Markowitz AJ, 1999, GASTROENTEROLOGY, V116, pA458; Tada M, 1996, GASTROENTEROLOGY, V110, P227, DOI 10.1053/gast.1996.v110.pm8536861	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2000	355	9198					85	86		10.1016/S0140-6736(99)00354-2	http://dx.doi.org/10.1016/S0140-6736(99)00354-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288HT	10675163				2022-12-01	WOS:000085557200007
J	Nieto, FJ; Young, TB; Lind, BK; Shahar, E; Samet, JM; Redline, S; D'Agostino, RB; Newman, AB; Lebowitz, MD; Pickering, TG				Nieto, FJ; Young, TB; Lind, BK; Shahar, E; Samet, JM; Redline, S; D'Agostino, RB; Newman, AB; Lebowitz, MD; Pickering, TG		Sleep Heart Hlth Study	Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; BLOOD-PRESSURE; SYSTEMIC HYPERTENSION; RISK-FACTORS; RELATIVE RISK; PREVALENCE; POPULATION; MORTALITY; HEALTH; MEN	Context Sleep-disordered breathing (SDB) and sleep apnea have been linked to hypertension in previous studies, but most of these studies used surrogate information to define SDB (eg, snoring) and were based on small clinic populations, or both. Objective To assess the association between SDB and hypertension in a large cohort of middle-aged and older persons. Design and Setting Cross-sectional analyses of participants in the Sleep Heart Health Study, a community-based multicenter study conducted between November 1995 and January 1998. Participants A total of 6132 subjects recruited from ongoing population-based studies (aged greater than or equal to 40 years; 52.8% female). Main Outcome Measures Apnea-hypopnea index (AHI, the average number of apneas plus hypopneas per hour of sleep, with hypopnea defined as a greater than or equal to 30% reduction in airflow or thoracoabdominal excursion accompanied by a greater than or equal to 4% drop in oxyhemoglobin saturation), obtained by unattended home polysomnography. Other measures include arousal index; percentage of sleep time below 90% oxygen saturation; history of snoring; and presence of hypertension, defined as resting blood pressure of at least 140/90 mm Hg or use of antihypertensive medication. Results Mean systolic and diastolic blood pressure and prevalence of hypertension increased significantly with increasing SDB measures, although some of this association was explained by body mass index (BMI). After adjusting for demographics and anthropometric variables (including BMI, neck circumference, and waist-to-hip ratio), as well as for alcohol intake and smoking, the odds ratio for hypertension, comparing the highest category of AHI (greater than or equal to 30 per hour) with the lowest category (<1.5 per hour), was 1.37 (95% confidence interval [CI], 1.03-1.83; P for trend=.005). The corresponding estimate comparing the highest and lowest categories of percentage of sleep time below 90% oxygen saturation (greater than or equal to 12% vs <0.05%) was 1.46 (95% CI, 1.12-1.88; P for trend <.001). In stratified analyses, associations of hypertension with either measure of SDB were seen in both sexes, older and younger ages, all ethnic groups, and among normal-weight and overweight individuals. Weaker and nonsignificant associations were observed for the arousal index or self-reported history of habitual snoring. Conclusion Our findings from the largest cross-sectional study to date indicate that SDB is associated with systemic hypertension in middle-aged and older individuals of different sexes and ethnic backgrounds.	Johns Hopkins Univ, Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Wisconsin, Madison, WI USA; Univ Minnesota, Minneapolis, MN USA; Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Clin Epidemiol, Cleveland, OH 44106 USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA USA; Univ Arizona, Coll Med, Resp Sci Ctr, Tucson, AZ USA; Cornell Univ, New York Cornell Med Ctr, Ctr Cardiovasc, New York, NY USA	Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Arizona; Cornell University	Nieto, FJ (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, 615 N Wolfe St,Room W6009, Baltimore, MD 21205 USA.		Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053940, U01HL053938, U01HL053931] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01HL53940, U01HL53931, U01HL53938] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASKENASY JJM, 1995, ISRAEL J MED SCI, V31, P561; Bartel PR, 1995, AM J HYPERTENS, V8, P1200, DOI 10.1016/0895-7061(95)00387-8; BLIWISE DL, 1988, AM J PUBLIC HEALTH, V78, P544, DOI 10.2105/AJPH.78.5.544; BONNET MH, 1992, SLEEP, V15, P526; BONSIGNORE MR, 1994, EUR RESPIR J, V7, P786, DOI 10.1183/09031936.94.07040786; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; FLETCHER EC, 1985, ANN INTERN MED, V103, P190, DOI 10.7326/0003-4819-103-2-190; FREEMAN J, 1980, AM J EPIDEMIOL, V112, P707, DOI 10.1093/oxfordjournals.aje.a113043; GISLASON T, 1987, ACTA MED SCAND, V222, P415; GISLASON T, 1993, CHEST, V103, P1147, DOI 10.1378/chest.103.4.1147; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Hastie TJ, 1990, GEN ADDITIVE MODELS; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; HLA KM, 1994, ANN INTERN MED, V120, P382, DOI 10.7326/0003-4819-120-5-199403010-00005; HOFFSTEIN V, 1991, AM J MED, V91, P190, DOI 10.1016/0002-9343(91)90014-O; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; KALES A, 1984, LANCET, V2, P1005; LAVIE P, 1993, CHEST, V103, P717, DOI 10.1378/chest.103.3.717; LAVIE P, 1984, ARCH INTERN MED, V144, P2025, DOI 10.1001/archinte.144.10.2025; LEVINSON PD, 1991, ARCH INTERN MED, V151, P455, DOI 10.1001/archinte.151.3.455; Lindberg E, 1998, EUR RESPIR J, V11, P884, DOI 10.1183/09031936.98.11040884; Martorell R., 1988, ANTHROPOMETRIC STAND, P41; *MATHS INC, 1993, S PLUS 2000 GUID STA, V1; MILLMAN RP, 1991, CHEST, V99, P861, DOI 10.1378/chest.99.4.861; *NAT HIGH BLOOD PR, 1993, NAT I HLTH PUBL; NORTON PG, 1985, BRIT MED J, V291, P630, DOI 10.1136/bmj.291.6496.630; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Quan SF, 1997, SLEEP, V20, P1077; Redline S, 1997, SLEEP, V20, P1209, DOI 10.1093/sleep/20.12.1209; Redline S, 1998, SLEEP, V21, P759; Schlesselman J.J., 1982, CASE CONTROL STUDIES; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; *SHHS RES GROP, 1996, SLEEP HEART HLTH STU; SILVERBERG DS, 1995, ISRAEL J MED SCI, V31, P527; Stradling J, 1997, SLEEP, V20, P789, DOI 10.1093/sleep/20.9.789a; STRADLING JR, 1990, BRIT MED J, V300, P75, DOI 10.1136/bmj.300.6717.75; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; SUZUKI M, 1993, SLEEP, V16, P545, DOI 10.1093/sleep/16.6.545; Szklo M., 2000, EPIDEMIOLOGY BASICS; WALLER PC, 1989, LANCET, V1, P143; Whitney CW, 1998, SLEEP, V21, P749, DOI 10.1093/sleep/21.7.749; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245; WILCOX I, 1993, SLEEP, V16, P539, DOI 10.1093/sleep/16.6.539; WILLIAMS AJ, 1985, AM J CARDIOL, V55, P1019, DOI 10.1016/0002-9149(85)90738-6; Worsnop CJ, 1998, AM J RESP CRIT CARE, V157, P111, DOI 10.1164/ajrccm.157.1.9609063; Wright J, 1997, BRIT MED J, V314, P851; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 1996, SLEEP, V19, pS202, DOI 10.1093/sleep/19.suppl_10.S202; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhao LP, 1996, AM J EPIDEMIOL, V144, P598	54	2244	2369	2	107	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2000	283	14					1829	1836		10.1001/jama.283.14.1829	http://dx.doi.org/10.1001/jama.283.14.1829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300HY	10770144	Bronze			2022-12-01	WOS:000086248600028
J	Landray, MJ; Lehman, R; Arnold, I				Landray, MJ; Lehman, R; Arnold, I			Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study	BRITISH MEDICAL JOURNAL			English	Article									Hightown Surg, Banbury OX18 9DB, Oxon, England; Univ Birmingham, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Oxford Radcliffe Hosp NHS Trust, Horton Hosp, Dept Med, Banbury OX16 9AL, Oxon, England	University of Birmingham; Oxford University Hospitals NHS Foundation Trust	Lehman, R (corresponding author), Hightown Surg, Banbury OX18 9DB, Oxon, England.			Landray, Martin/0000-0001-6646-827X				Hoes A. W., 1998, European Heart Journal, V19, pL2; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Struthers AD, 1999, EUR HEART J, V20, P712; WHEELDON NM, 1993, Q J MED, V86, P17	4	63	64	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					985	986		10.1136/bmj.320.7240.985	http://dx.doi.org/10.1136/bmj.320.7240.985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303XP	10753153	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000086453100028
J	Gavaghan, H				Gavaghan, H			Companies of all sizes are prospecting for proteins	NATURE			English	Editorial Material																		Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Kell DB, 2000, TRENDS BIOTECHNOL, V18, P93, DOI 10.1016/S0167-7799(99)01407-9; 2000, NATURE, V403, P815; 1999, NATURE, V402, P715	6	3	3	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					684	+		10.1038/35007267	http://dx.doi.org/10.1038/35007267			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766256				2022-12-01	WOS:000086400100069
J	Bath, PHW; Lees, KR				Bath, PHW; Lees, KR			ABC of arterial and venous disease - Acute stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Nottingham, Nottingham NG7 2RD, England; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland	University of Nottingham; University of Glasgow	Bath, PHW (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.							Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Bath PMW, 1997, INT J CLIN PRACT, V51, P504; LEES KR, 1998, LANCET S3, V352, P28; *ROYAL COLL PHYS, 1994, STROK AUD PACK	4	34	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					920	923		10.1136/bmj.320.7239.920	http://dx.doi.org/10.1136/bmj.320.7239.920			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10742005	Green Published			2022-12-01	WOS:000086337100032
J	Williams, TJ; Pepitone, ME; Christensen, SE; Cooke, BM; Huberman, AD; Breedlove, NJ; Breedlove, TJ; Jordan, CL; Breedlove, SM				Williams, TJ; Pepitone, ME; Christensen, SE; Cooke, BM; Huberman, AD; Breedlove, NJ; Breedlove, TJ; Jordan, CL; Breedlove, SM			Finger-length ratios and sexual orientation	NATURE			English	Article									Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Neurosci Endocrinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Williams, TJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall,MC 1650, Berkeley, CA 94720 USA.		Cooke, Bradley/E-4568-2013	Cooke, Bradley/0000-0003-0989-9684; Breedlove, S. Marc/0000-0003-4359-4315				BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Blanchard R, 1997, Annu Rev Sex Res, V8, P27; Bogaert AF, 1999, ARCH SEX BEHAV, V28, P213, DOI 10.1023/A:1018780108597; Bogaert AF, 1997, BEHAV NEUROSCI, V111, P1395, DOI 10.1037/0735-7044.111.6.1395; Breedlove SM, 1999, BRAIN BEHAV EVOLUT, V54, P8, DOI 10.1159/000006607; BRODIE HK, 1974, AM J PSYCHIAT, V131, P82, DOI 10.1176/ajp.131.1.82; GORMAN MR, 1994, PERSPECT BIOL MED, V38, P61; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; JAMES WH, 1987, HUM BIOL, V59, P721; Manning JT, 1999, NATURE, V399, P214, DOI 10.1038/20341; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; MAYERBAHLBURG HFL, 1984, PROGR BRAIN RES, V61, P375; McFadden D, 1998, P NATL ACAD SCI USA, V95, P2709, DOI 10.1073/pnas.95.5.2709; MCFADDEN D, IN PRESS J ASS RES O	14	314	336	4	82	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					455	456		10.1038/35006555	http://dx.doi.org/10.1038/35006555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761903				2022-12-01	WOS:000086257700034
J	Yasutomo, K; Doyle, C; Miele, L; Germain, RN				Yasutomo, K; Doyle, C; Miele, L; Germain, RN			The duration of antigen receptor signalling determines CD4(+) versus CD8(+) T-cell lineage fate	NATURE			English	Article							CLASS-II INTERACTION; TRANSGENIC MICE; TYROSINE KINASE; THYMOCYTES; COMMITMENT; DIFFERENTIATION; SPECIFICITY; EXPRESSION; ACTIVATION; MECHANISM	Signals elicited by binding of the T-cell antigen receptor and the CD4/CD8 co-receptor to major histocompatibility complex (MHC) molecules control the generation of CD4(+) (helper) or CD8(+) (cytotoxic) T cells from thymic precursors that initially express both co-receptor proteins'. These precursors have unique, clonally distributed T-cell receptors with unpredictable specificity for the self-MHC molecules involved in this differentiation process', However, the mature T cells that emerge express only the CD4 (MHC class II-binding) or CD8 (MHC class I-binding) co-receptor that complements the MHC class-specificity of the T-cell receptor. How this matching of co-receptor-defined lineage and T-cell-receptor specificity is achieved remains unknown(1,3,4), as does whether signalling by the T-cell receptors, co-receptors and/ or general cell-fate regulators such as Notch-1 (refs 5, 6) contributes to initial lineage choice, to subsequent differentiation processes or to both. Here we show that the CD4 versus CD8 lineage fate of immature thymocytes is controlled by the co-receptor-influenced duration of initial T-cell receptor-dependent signalling. Notch-1 does not appear to be essential for this fate determination, but it is selectively required for CD8(+) T-cell maturation after commitment directed by T-cell receptors, This indicates that the signals constraining CD4 versus CD8 lineage decisions are distinct from those that support subsequent differentiation events such as silencing of co-receptor loci.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Canc Immunol Program, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Loyola University Chicago	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.		Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Yasutomo, Koji/0000-0003-0411-2037; Miele, Lucio/0000-0002-5853-7287	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000757] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Basson MA, 1998, J EXP MED, V187, P1249; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bommhardt U, 1999, J IMMUNOL, V163, P715; CHAN TYK, 1995, PHARMACOEPIDEM DR S, V4, P165; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; INABA M, 1991, J EXP MED, V173, P549, DOI 10.1084/jem.173.3.549; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Riberdy JM, 1998, P NATL ACAD SCI USA, V95, P4493, DOI 10.1073/pnas.95.8.4493; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	30	198	206	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					506	510		10.1038/35006664	http://dx.doi.org/10.1038/35006664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761920				2022-12-01	WOS:000086257700051
J	Adams, MD; Celniker, SE; Holt, RA; Evans, CA; Gocayne, JD; Amanatides, PG; Scherer, SE; Li, PW; Hoskins, RA; Galle, RF; George, RA; Lewis, SE; Richards, S; Ashburner, M; Henderson, SN; Sutton, GG; Wortman, JR; Yandell, MD; Zhang, Q; Chen, LX; Brandon, RC; Rogers, YHC; Blazej, RG; Champe, M; Pfeiffer, BD; Wan, KH; Doyle, C; Baxter, EG; Helt, G; Nelson, CR; Miklos, GLG; Abril, JF; Agbayani, A; An, HJ; Andrews-Pfannkoch, C; Baldwin, D; Ballew, RM; Basu, A; Baxendale, J; Bayraktaroglu, L; Beasley, EM; Beeson, KY; Benos, PV; Berman, BP; Bhandari, D; Bolshakov, S; Borkova, D; Botchan, MR; Bouck, J; Brokstein, P; Brottier, P; Burtis, KC; Busam, DA; Butler, H; Cadieu, E; Center, A; Chandra, I; Cherry, JM; Cawley, S; Dahlke, C; Davenport, LB; Davies, A; de Pablos, B; Delcher, A; Deng, ZM; Mays, AD; Dew, I; Dietz, SM; Dodson, K; Doup, LE; Downes, M; Dugan-Rocha, S; Dunkov, BC; Dunn, P; Durbin, KJ; Evangelista, CC; Ferraz, C; Ferriera, S; Fleischmann, W; Fosler, C; Gabrielian, AE; Garg, NS; Gelbart, WM; Glasser, K; Glodek, A; Gong, FC; Gorrell, JH; Gu, ZP; Guan, P; Harris, M; Harris, NL; Harvey, D; Heiman, TJ; Hernandez, JR; Houck, J; Hostin, D; Houston, DA; Howland, TJ; Wei, MH; Ibegwam, C; Jalali, M; Kalush, F; Karpen, GH; Ke, ZX; Kennison, JA; Ketchum, KA; Kimmel, BE; Kodira, CD; Kraft, C; Kravitz, S; Kulp, D; Lai, ZW; Lasko, P; Lei, YD; Levitsky, AA; Li, JY; Li, ZY; Liang, Y; Lin, XY; Liu, XJ; Mattei, B; McIntosh, TC; McLeod, MP; McPherson, D; Merkulov, G; Milshina, NV; Mobarry, C; Morris, J; Moshrefi, A; Mount, SM; Moy, M; Murphy, B; Murphy, L; Muzny, DM; Nelson, DL; Nelson, DR; Nelson, KA; Nixon, K; Nusskern, DR; Pacleb, JM; Palazzolo, M; Pittman, GS; Pan, S; Pollard, J; Puri, V; Reese, MG; Reinert, K; Remington, K; Saunders, RDC; Scheeler, F; Shen, H; Shue, BC; Siden-Kiamos, I; Simpson, M; Skupski, MP; Smith, T; Spier, E; Spradling, AC; Stapleton, M; Strong, R; Sun, E; Svirskas, R; Tector, C; Turner, R; Venter, E; Wang, AHH; Wang, X; Wang, ZY; Wassarman, DA; Weinstock, GM; Weissenbach, J; Williams, SM; Woodage, T; Worley, KC; Wu, D; Yang, S; Yao, QA; Ye, J; Yeh, RF; Zaveri, JS; Zhan, M; Zhang, GG; Zhao, Q; Zheng, LS; Zheng, XQH; Zhong, FN; Zhong, WY; Zhou, XJ; Zhu, SP; Zhu, XH; Smith, HO; Gibbs, RA; Myers, EW; Rubin, GM; Venter, JC				Adams, MD; Celniker, SE; Holt, RA; Evans, CA; Gocayne, JD; Amanatides, PG; Scherer, SE; Li, PW; Hoskins, RA; Galle, RF; George, RA; Lewis, SE; Richards, S; Ashburner, M; Henderson, SN; Sutton, GG; Wortman, JR; Yandell, MD; Zhang, Q; Chen, LX; Brandon, RC; Rogers, YHC; Blazej, RG; Champe, M; Pfeiffer, BD; Wan, KH; Doyle, C; Baxter, EG; Helt, G; Nelson, CR; Miklos, GLG; Abril, JF; Agbayani, A; An, HJ; Andrews-Pfannkoch, C; Baldwin, D; Ballew, RM; Basu, A; Baxendale, J; Bayraktaroglu, L; Beasley, EM; Beeson, KY; Benos, PV; Berman, BP; Bhandari, D; Bolshakov, S; Borkova, D; Botchan, MR; Bouck, J; Brokstein, P; Brottier, P; Burtis, KC; Busam, DA; Butler, H; Cadieu, E; Center, A; Chandra, I; Cherry, JM; Cawley, S; Dahlke, C; Davenport, LB; Davies, A; de Pablos, B; Delcher, A; Deng, ZM; Mays, AD; Dew, I; Dietz, SM; Dodson, K; Doup, LE; Downes, M; Dugan-Rocha, S; Dunkov, BC; Dunn, P; Durbin, KJ; Evangelista, CC; Ferraz, C; Ferriera, S; Fleischmann, W; Fosler, C; Gabrielian, AE; Garg, NS; Gelbart, WM; Glasser, K; Glodek, A; Gong, FC; Gorrell, JH; Gu, ZP; Guan, P; Harris, M; Harris, NL; Harvey, D; Heiman, TJ; Hernandez, JR; Houck, J; Hostin, D; Houston, DA; Howland, TJ; Wei, MH; Ibegwam, C; Jalali, M; Kalush, F; Karpen, GH; Ke, ZX; Kennison, JA; Ketchum, KA; Kimmel, BE; Kodira, CD; Kraft, C; Kravitz, S; Kulp, D; Lai, ZW; Lasko, P; Lei, YD; Levitsky, AA; Li, JY; Li, ZY; Liang, Y; Lin, XY; Liu, XJ; Mattei, B; McIntosh, TC; McLeod, MP; McPherson, D; Merkulov, G; Milshina, NV; Mobarry, C; Morris, J; Moshrefi, A; Mount, SM; Moy, M; Murphy, B; Murphy, L; Muzny, DM; Nelson, DL; Nelson, DR; Nelson, KA; Nixon, K; Nusskern, DR; Pacleb, JM; Palazzolo, M; Pittman, GS; Pan, S; Pollard, J; Puri, V; Reese, MG; Reinert, K; Remington, K; Saunders, RDC; Scheeler, F; Shen, H; Shue, BC; Siden-Kiamos, I; Simpson, M; Skupski, MP; Smith, T; Spier, E; Spradling, AC; Stapleton, M; Strong, R; Sun, E; Svirskas, R; Tector, C; Turner, R; Venter, E; Wang, AHH; Wang, X; Wang, ZY; Wassarman, DA; Weinstock, GM; Weissenbach, J; Williams, SM; Woodage, T; Worley, KC; Wu, D; Yang, S; Yao, QA; Ye, J; Yeh, RF; Zaveri, JS; Zhan, M; Zhang, GG; Zhao, Q; Zheng, LS; Zheng, XQH; Zhong, FN; Zhong, WY; Zhou, XJ; Zhu, SP; Zhu, XH; Smith, HO; Gibbs, RA; Myers, EW; Rubin, GM; Venter, JC			The genome sequence of Drosophila melanogaster	SCIENCE			English	Review							DNA-REPLICATION; CHROMOSOME DYNAMICS; GENE-EXPRESSION; HETEROCHROMATIN; PROTEINS; FAMILY; PREDICTION; CHROMATIN	The fly Drosophila melanogaster is one of the most intensively studied organisms in biology and serves as a model system for the investigation of many developmental and cellular processes common to higher eukaryotes, including humans. We have determined the nucleotide sequence of nearly all of the similar to 120-megabase euchromatic portion of the Drosophila genome using a whole-genome shotgun sequencing strategy supported by extensive clone-based sequence and a high-quality bacterial artificial chromosome physical map. Efforts are under way to close the remaining gaps; however, the sequence is of sufficient accuracy and Contiguity to be declared substantially complete and to support an initial analysis of genome structure and preliminary gene annotation and interpretation. The genome encodes similar to 13,600 genes, somewhat fewer than the smaller Caenorhabditis elegans genome, but with comparable functional diversity.	Celera Genom, Rockville, MD 20850 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, BDGP, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, BDGP, Berkeley, CA 94720 USA; European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; Neomorph Inc, Berkeley, CA 94710 USA; Genetixxpress Pty Ltd, Sydney, NSW 2108, Australia; IMIM UPF, Dept Med Informat, Barcelona 08003, Spain; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; EMBL, EDGP, Heidelberg, Germany; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94710 USA; Genoscope, F-91000 Evry, France; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95618 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Rennes 2, Fac Med, Sch Med, EDGP,CNRS,UPR 41, F-35043 Rennes, France; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, EDGP, E-28049 Madrid, Spain; Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA; Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; Univ Montpellier, Sch Med, EDGP, Inst Genet Humaine,CNRS,CRBM, F-34396 Montpellier 5, France; NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Inst Genom Res, Rockville, MD 20850 USA; Sanger Ctr, EDGP, Cambridge CB10 1SA, England; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA; Univ Dundee, Dept Anat & Physiol, EDGP, Dundee DD1 4HN, Scotland; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; Carnegie Inst Sci, HHM Embryol, Baltimore, MD 21210 USA; Motorola Biochip Syst, Tempe, AZ 85284 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Berkeley, Howard Hughes Med Inst, BDGP, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Baylor College of Medicine; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Harvard University; Washington University (WUSTL); Foundation for Research & Technology - Hellas (FORTH); European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; University of California System; University of California Davis; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite Rennes 2; Stanford University; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Salk Institute; University of Arizona; University of Arizona; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); McGill University; University System of Maryland; University of Maryland College Park; J. Craig Venter Institute; Wellcome Trust Sanger Institute; University of Tennessee System; University of Tennessee Health Science Center; University of Dundee; Open University - UK; Carnegie Institution for Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; University of California System; University of California Berkeley	Adams, MD (corresponding author), Celera Genom, 45 W Gude Dr, Rockville, MD 20850 USA.		Holt, Robert A/C-3303-2009; Ferrando, Josep F Abril/B-3877-2014; Weinstock, George M/C-6314-2013; Berman, Benjamin P/D-5942-2014; BERMAN, BENJAMIN/AAT-3720-2021; Lasko, Paul/C-6761-2014; Reinert, Knut/V-3327-2019	Holt, Robert A/0000-0002-7259-1247; Ferrando, Josep F Abril/0000-0001-7793-589X; Weinstock, George M/0000-0002-2997-4592; Berman, Benjamin P/0000-0002-2099-9005; BERMAN, BENJAMIN/0000-0002-2099-9005; Lasko, Paul/0000-0002-4037-3501; Reinert, Knut/0000-0003-3078-8129; Deslattes Mays, Anne/0000-0001-7951-3439; Svirskas, Robert/0000-0001-8374-6008; Kulp, David/0000-0001-6540-0222; Wortman, Jennifer/0000-0002-8713-1227; Benos, Panayiotis/0000-0003-3172-3132; Lewis, Suzanna/0000-0002-8343-612X; Murphy, Lee/0000-0001-6467-7449; Worley, Kim/0000-0002-0282-1000; Harris, Michael/0000-0001-8789-0912; Mount, Steve/0000-0003-2748-8205; Rubin, Gerald/0000-0001-8762-8703; Burtis, Kenneth/0000-0002-9644-3265; Cherry, J. Michael/0000-0001-9163-5180	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [P50-HG00750] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000750] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABRIL JF, IN PRESS BIOINFORMAT; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson B, 1996, BIOTECHNIQUES, V20, P1022; Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Ashburner M, 1999, GENETICS, V153, P179; Belotserkovskaya R, 1999, CRIT REV EUKAR GENE, V9, P221, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.70; Biessmann H, 1997, CHROMOSOMA, V106, P63, DOI 10.1007/s004120050225; BRIZUELA BJ, 1994, GENETICS, V137, P803; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge C. B., 1999, RNA WORLD; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Craig JM, 1999, EXP CELL RES, V246, P249, DOI 10.1006/excr.1998.4278; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Dunkov BC, 1999, DNA CELL BIOL, V18, P937, DOI 10.1089/104454999314791; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Feger G, 1999, GENE, V227, P149, DOI 10.1016/S0378-1119(98)00596-4; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Flores C, 1999, P NATL ACAD SCI USA, V96, P2964, DOI 10.1073/pnas.96.6.2964; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Fraser CM, 1997, ELECTROPHORESIS, V18, P1207, DOI 10.1002/elps.1150180803; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hartenstein K, 1997, GENETICS, V147, P1755; HARTL DL, 1992, TRENDS GENET, V8, P70, DOI 10.1016/0168-9525(92)90353-6; HENIKOFF S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P1; Hirano T, 1998, CURR OPIN CELL BIOL, V10, P317, DOI 10.1016/S0955-0674(98)80006-9; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; HUANG X, 1995, GENOMICS, V46, P37; Jankowska-Anyszka M, 1998, J BIOL CHEM, V273, P10538, DOI 10.1074/jbc.273.17.10538; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jessberger R, 1998, CURR OPIN GENET DEV, V8, P254, DOI 10.1016/S0959-437X(98)80149-4; KENNARD ML, 1995, EMBO J, V14, P4178, DOI 10.1002/j.1460-2075.1995.tb00091.x; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Kusano K, 1999, GENETICS, V151, P1027; Lambert A, 1998, REPROD NUTR DEV, V38, P69, DOI 10.1051/rnd:19980106; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; LEVIS RW, 1993, MOL GEN GENET, V236, P440, DOI 10.1007/BF00277145; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LOCKE J, UNPUB; LOHE AR, 1993, GENETICS, V134, P1149; Maleszka R, 1997, MICROBIOL-UK, V143, P1781, DOI 10.1099/00221287-143-6-1781; MIKLOS GLG, 1988, P NATL ACAD SCI USA, V85, P2051, DOI 10.1073/pnas.85.7.2051; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; PETER AHG, UNPUB; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; REESE MG, IN PRESS GENOME RES; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Saffery R, 1999, CHROMOSOME RES, V7, P261, DOI 10.1023/A:1009222729850; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Sekelsky JJ, 1999, NUCLEIC ACIDS RES, V27, P3762, DOI 10.1093/nar/27.18.3762; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P185, DOI 10.1016/S0091-679X(08)60913-9; Spradling AC, 1999, GENETICS, V153, P135; Strunnikov AV, 1998, TRENDS CELL BIOL, V8, P454, DOI 10.1016/S0962-8924(98)01370-1; TEARLE RG, 1989, GENETICS, V122, P595; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; YAMAMOTO MT, 1990, GENETICS, V125, P821; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	82	4471	8370	14	971	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2185	2195		10.1126/science.287.5461.2185	http://dx.doi.org/10.1126/science.287.5461.2185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731132				2022-12-01	WOS:000086049100033
J	Syntichaki, P; Topalidou, I; Thireos, G				Syntichaki, P; Topalidou, I; Thireos, G			The Gcn5 bromodomain co-ordinates nucleosome remodelling	NATURE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; YEAST PHO5 PROMOTER; ADA-COMPLEX; IN-VIVO; CHROMATIN; TRANSCRIPTION; SAGA	The access of transcription factors to eukaryotic promoters often requires modification of their chromatin structure, which is accomplished by the action of two general classes of multiprotein complexes(1). One class contains histone acetyltransferases (HATs), such as Gcn5 in the SAGA complex(2), which acetylate nucleosomal histones. The second dass contains ATPases, such as Swi2 in the Swi/Snf complex(3), which provide the energy for nucleosome remodelling. In several promoters these two complexes cooperate but their functional linkage is unknown(4-8). A protein module that is present in, all, nuclear HATs, the bromodomain, could provide such a link(9). The recently reported in vitro binding of a HAT bromodomain with acetylated lysines within H3 and H4 aminoterminal peptides(10) indicates that this interaction may constitute a targeting step for events that follow histone acetylation. Here we use a suitable promoter to show that bromodomain residues essential for acetyl-lysine binding are not required in vivo for Gcn5-mediated histone acetylation but are fundamental for the subsequent Swi2-dependent nucleosome remodelling and consequent transcriptional activation. We show that the Gcn5 bromodomain stabilizes the Swi/Snf complex on this promoter.	FORTH, Inst Mol Biol & Biotechnol, Heraklion 71110, Crete, Greece; Univ Crete, Dept Biol, Heraklion 71409, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Thireos, G (corresponding author), FORTH, Inst Mol Biol & Biotechnol, POB 1527, Heraklion 71110, Crete, Greece.		Topalidou, Irini/ABG-2833-2020; Syntichaki, Popi/ABA-7218-2020	Syntichaki, Popi/0000-0001-9536-8905				ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Roberts SM, 1997, GENETICS, V147, P451; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Syntichaki P, 1998, J BIOL CHEM, V273, P24414, DOI 10.1074/jbc.273.38.24414; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640	26	163	165	3	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					414	417		10.1038/35006136	http://dx.doi.org/10.1038/35006136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746732				2022-12-01	WOS:000086119000057
J	Triendl, R				Triendl, R			Japan's cloning ban will still allow stem cell experiments	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					321	321		10.1038/35006223	http://dx.doi.org/10.1038/35006223			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10766599	Bronze			2022-12-01	WOS:000086119000006
J	Tropepe, V; Coles, BLK; Chiasson, BJ; Horsford, DJ; Elia, AJ; McInnes, RR; van der Kooy, D				Tropepe, V; Coles, BLK; Chiasson, BJ; Horsford, DJ; Elia, AJ; McInnes, RR; van der Kooy, D			Retinal stem cells in the adult mammalian eye	SCIENCE			English	Article							PIGMENT EPITHELIUM; HOMEOBOX GENE; IN-VITRO; PHOTORECEPTOR DIFFERENTIATION; PROGENITOR PROLIFERATION; NERVOUS-SYSTEM; NEURAL RETINA; RAT RETINA; GROWTH; FOREBRAIN	The mature mammalian retina is thought to lack regenerative capacity. Here, we report the identification of a stem cell in the adult mouse eye, which represents a possible substrate for retinal regeneration. Single pigmented ciliary margin cells clonally proliferate in vitro to form sphere colonies of cells that can differentiate into retinal-specific cell types, including rod photoreceptors, bipolar neurons, and Muller glia. Adult retinal stem cells are localized to the pigmented ciliary margin and not to the central and peripheral retinal pigmented epithelium, indicating that these cells may be homologous to those found in the eye germinal zone of other nonmammalian vertebrates.	Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Genet Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	van der Kooy, D (corresponding author), Univ Toronto, Dept Anat & Cell Biol, Med Sci Bldg 1105,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.							BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BODENSTEIN L, 1987, DEV BIOL, V121, P192, DOI 10.1016/0012-1606(87)90152-7; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1997, J NEUROSCI, V17, P5046; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOLLYFIELD JG, 1972, J COMP NEUROL, V144, P373, DOI 10.1002/cne.901440308; Ilia M, 1996, DEV BRAIN RES, V95, P176; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; KONYUKHOV BV, 1975, DEV BIOL, V45, P1, DOI 10.1016/0012-1606(75)90235-3; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levine EM, 1997, J NEUROSCI, V17, P6277; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morshead C. M., 1998, Society for Neuroscience Abstracts, V24, P1528; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Pittack C, 1997, DEVELOPMENT, V124, P805; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; REH TA, 1987, DEV BIOL, V122, P471, DOI 10.1016/0012-1606(87)90311-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; STRANZNICKY C, 1971, J EMBRYOL EXP MORPH, V27, P67; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; TRUSLOVE GM, 1962, J EMBRYOL EXP MORPH, V10, P652; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K	42	820	914	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2032	2036		10.1126/science.287.5460.2032	http://dx.doi.org/10.1126/science.287.5460.2032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720333				2022-12-01	WOS:000085902800067
J	Barnett, HJM; Gunton, RV; Eliasziw, M; Fleming, L; Sharpe, B; Gates, P; Meldrum, H				Barnett, HJM; Gunton, RV; Eliasziw, M; Fleming, L; Sharpe, B; Gates, P; Meldrum, H			Causes and severity of ischemic stroke in patients with internal carotid artery stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR THROMBI; NONVALVULAR ATRIAL-FIBRILLATION; DATA-BANK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; MYOCARDIAL-INFARCTION; CEREBRAL INFARCTION; LACUNAR INFARCTS; NATURAL-HISTORY; CARDIAC SOURCES; CLINICAL RISK	Context Therapeutic trials generally have not distinguished outcomes of stroke according to cause. Objective To determine whether stroke and subsequent disability was of large-artery, lacunar, or cardioembolic origin in patients with different degrees of symptomatic and asymptomatic carotid stenosis. Design Observational study of prospective data collected from the North American Symptomatic Carotid Endarterectomy Trial between 1987 and 1997. Setting and Patients A total of 2885 patients from 106 sites in the United States and abroad (median age, 67 years; 70% male) who had symptomatic internal carotid artery stenosis. Main Outcome Measure Risk of stroke from each of the 3 causes at 5 years by territory and degree of stenosis. Results During an average follow-up of 5 years, 749 patients had 1039 strokes, including 112 of cardioembolic, 211 of lacunar, 698 of large-artery, 17 of primary intracerebral hemorrhage, and 1 of subarachnoid hemorrhage origin. The 5-year risk of first stroke after entry into the trial in any territory was 2.6% of cardioembolic cause, 6.9% of lacunar cause, and 19.7% of large-artery cause. The proportion of cardioembolic strokes in the territory of the symptomatic artery was 12.0% and 6.9% in 60% to 69% and 70% to 99% arterial stenosis, respectively; large-artery strokes predominated (78.4%) at 70% to 99% arterial stenosis. With 70% to 99% arterial stenosis, the proportion of strokes of cardioembolic and lacunar origin was 43.5% and 21.6% in asymptomatic and symptomatic arteries, respectively. A total of 67.6% of cardioembolic, 16.7% of lacunar, and 33.0% of large-artery strokes in the territory of the asymptomatic artery were disabling or fatal. Conclusions Our data suggest that approximately 20% and 45% of strokes in the territory of symptomatic and asymptomatic carotid arteries with 70% to 99% stenosis, respectively, are unrelated to carotid stenosis. The cause of subsequent strokes in similar types of patients should be considered when making treatment decisions involving carotid endarterectomy for patients with asymptomatic carotid stenosis, since lacunar and cardioembolic strokes cannot be prevented by endarterectomy.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Geelong Hosp, Dept Neurosci, Geelong, Vic, Australia; Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Geelong Hospital; University of Melbourne	Barnett, HJM (corresponding author), John P Robarts Res Inst, POB 5015,100 Perth Dr, London, ON N6A 5K8, Canada.				NINDS NIH HHS [R01-NS-24456] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; Arboix A, 1997, ACTA NEUROL SCAND, V96, P407; ARBOIX A, 1990, STROKE, V21, P842, DOI 10.1161/01.STR.21.6.842; ASINGER RW, 1989, ARCH NEUROL-CHICAGO, V46, P727; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P855, DOI 10.1212/WNL.41.6.855; Bousser MG, 1997, LANCET, V349, P1564, DOI 10.1016/S0140-6736(97)22022-2; BRICKNER ME, 1994, AM J CARDIOL, V74, P391, DOI 10.1016/0002-9149(94)90409-X; Brickner ME, 1996, AM J MED, V100, P465; CAIRNS JA, 1992, CHEST, V102, pS456, DOI 10.1378/chest.102.4_Supplement.456S; CAPLAN LR, 1988, NEUROLOGY, V38, P791, DOI 10.1212/WNL.38.5.791; CHAN K, 1996, CAN J CARDIOL, V12, pE121; CLAVIER I, 1994, STROKE, V25, P2005, DOI 10.1161/01.STR.25.10.2005; Davis BR, 1998, STROKE, V29, P1333, DOI 10.1161/01.STR.29.7.1333; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; HART RG, 1986, ARCH NEUROL-CHICAGO, V43, P71; HUMPHREY PRD, 1985, POSTGRAD MED J, V61, P1039, DOI 10.1136/pgmj.61.722.1039; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; KEREN A, 1990, J AM COLL CARDIOL, V15, P790, DOI 10.1016/0735-1097(90)90275-T; KITTNER SJ, 1992, NEUROLOGY, V42, P299, DOI 10.1212/WNL.42.2.299; KITTNER SJ, 1990, NEUROLOGY, V40, P281, DOI 10.1212/WNL.40.2.281; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; MAST H, 1994, STROKE, V25, P776, DOI 10.1161/01.STR.25.4.776; QI A, 1996, CAN J CARDIOL, V12, pE98; Rauh G, 1996, STROKE, V27, P691, DOI 10.1161/01.STR.27.4.691; ROSENTHAL MS, 1992, INT J CARDIOL, V37, P277, DOI 10.1016/0167-5273(92)90256-3; ROTHROCK JF, 1993, ARCH INTERN MED, V153, P619, DOI 10.1001/archinte.153.5.619; SANDERCOCK PAG, 1989, BRIT MED J, V298, P75, DOI 10.1136/bmj.298.6666.75; STRATTON JR, 1988, CIRCULATION, V78, P1388, DOI 10.1161/01.CIR.78.6.1388; STRATTON JR, 1987, CIRCULATION, V75, P1004, DOI 10.1161/01.CIR.75.5.1004; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Yamamoto H, 1998, J NEUROL NEUROSUR PS, V64, P771, DOI 10.1136/jnnp.64.6.771; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; ZABALGOITIA M, 1990, CIRCULATION, V82, P109	44	172	184	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1429	1436		10.1001/jama.283.11.1429	http://dx.doi.org/10.1001/jama.283.11.1429			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732932				2022-12-01	WOS:000085696700027
J	Howe, DT; Gornall, R; Wellesley, D; Boyle, T; Barber, J				Howe, DT; Gornall, R; Wellesley, D; Boyle, T; Barber, J			Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans	BRITISH MEDICAL JOURNAL			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SERUM ALPHA-FETOPROTEIN; UNCONJUGATED ESTRIOL; HCG; EXPERIENCES; ENGLAND; PROGRAM; WALES	Objective To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning. Design Retrospective six year survey. Setting Maternity units of a district general hospital. Subjects Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998. Main outcome measures All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy. Results 31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, foul in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95%, confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies. Conclusions The overall detection rate was considerably higher than assumed ill demonstration projects for serum screening: As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.	Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Salisbury Dist Hosp, Cytogenet Lab, Salisbury SP2 8BJ, Wilts, England; Princess Anne Hosp, Wessex Maternal & Fetal Med Unit, Southampton SO16 5YA, Hants, England	Salisbury District Hospital; Salisbury District Hospital	Howe, DT (corresponding author), Princess Anne Hosp, Wessex Maternal & Fetal Med Unit, Southampton SO16 5YA, Hants, England.							ADAMS MM, 1981, JAMA-J AM MED ASSOC, V246, P758, DOI 10.1001/jama.246.7.758; BECKHUIS J, 1993, THESIS GRONINGEN U G; BURTON BK, 1993, AM J OBSTET GYNECOL, V169, P526, DOI 10.1016/0002-9378(93)90613-N; Cans C, 1998, PRENATAL DIAG, V18, P683, DOI 10.1002/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO;2-G; CHENG EY, 1993, OBSTET GYNECOL, V81, P72; Crossley J A, 1994, J Med Screen, V1, P180; CUCKLE H, 1991, PRENATAL DIAG, V11, P29, DOI 10.1002/pd.1970110106; DAVIES T, 1991, BRIT MED J, V303, P312; DAWSON AJ, 1993, BRIT J OBSTET GYNAEC, V100, P875, DOI 10.1111/j.1471-0528.1993.tb14326.x; GOODBURN SF, 1994, PRENATAL DIAG, V14, P391, DOI 10.1002/pd.1970140509; GREEN JM, 1994, BRIT MED J, V309, P769, DOI 10.1136/bmj.309.6957.769; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; KEATINGE RM, 1991, BRIT MED J, V303, P54, DOI 10.1136/bmj.303.6793.54-d; KELLNER LH, 1995, AM J OBSTET GYNECOL, V172, P831, DOI 10.1016/0002-9378(95)90007-1; Lam YH, 1998, PRENATAL DIAG, V18, P585, DOI 10.1002/(SICI)1097-0223(199806)18:6<585::AID-PD305>3.0.CO;2-R; MACRI JN, 1994, PRENATAL DIAG, V14, P97, DOI 10.1002/pd.1970140204; MANCINI G, 1994, INT J CLIN LAB RES, V24, P49, DOI 10.1007/BF02592410; McDuffie R S Jr, 1996, J Matern Fetal Med, V5, P70; MOONEY RA, 1994, OBSTET GYNECOL, V84, P298; NYBERG DA, 1990, OBSTET GYNECOL, V76, P370; Pandya PP, 1995, BRIT J OBSTET GYNAEC, V102, P957, DOI 10.1111/j.1471-0528.1995.tb10902.x; Pescia G, 1993, Rev Med Suisse Romande, V113, P277; PHILLIPS OP, 1992, OBSTET GYNECOL, V80, P353; Piggott M, 1994, J Med Screen, V1, P45; Royal College of Obstetricians and Gynaecologists, 1993, REP WORK PART BIOCH, P19; Sadler M, 1997, BRIT J OBSTET GYNAEC, V104, P176, DOI 10.1111/j.1471-0528.1997.tb11040.x; Salonen R, 1997, ACTA OBSTET GYN SCAN, V76, P817, DOI 10.3109/00016349709024358; SHELDON T, 1991, BRIT MED J, V303, P55, DOI 10.1136/bmj.303.6793.55-a; SMITH DK, 1994, BRIT MED J, V309, P776, DOI 10.1136/bmj.309.6957.776; SPENCER K, 1993, BRIT MED J, V307, P764, DOI 10.1136/bmj.307.6907.764; STATHAM H, 1993, BRIT MED J, V307, P174, DOI 10.1136/bmj.307.6897.174; Valerio D, 1996, Minerva Ginecol, V48, P169; van Rijn M, 1998, Ned Tijdschr Geneeskd, V142, P409; Wald NJ, 1996, BRIT J OBSTET GYNAEC, V103, P407, DOI 10.1111/j.1471-0528.1996.tb09765.x; WALD NJ, 1992, BMJ-BRIT MED J, V305, P391, DOI 10.1136/bmj.305.6850.391; WELLESLEY D, 1999, ANN REPORT WESSEX AN	36	39	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					606	610		10.1136/bmj.320.7235.606	http://dx.doi.org/10.1136/bmj.320.7235.606			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698877	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000085742600023
J	Henney, JE				Henney, JE			Celecoxib indicated for FAP	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-01	WOS:000085424100007
J	Dornhorst, A; Frost, G				Dornhorst, A; Frost, G			Jelly-beans, only a colourful distraction from gestational glucose-challenge tests	LANCET			English	Editorial Material							TOLERANCE		Hammersmith Hosp, Imperial Coll Sch Med, Dept Metab Med, London W12 0NN, England; Hammersmith Hosp, Imperial Coll Sch Med, Dept Nutr & Dietet, London W12 0NN, England	Imperial College London; Imperial College London	Dornhorst, A (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Dept Metab Med, London W12 0NN, England.							*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS74; HANSON U, 1993, AM J PERINAT, V10, P330, DOI 10.1055/s-2007-994754; Jarrett RJ, 1997, BMJ-BRIT MED J, V315, P736, DOI 10.1136/bmj.315.7110.736; JARRETT RJ, 1993, BMJ-BRIT MED J, V306, P37, DOI 10.1136/bmj.306.6869.37; Lamar ME, 1999, AM J OBSTET GYNECOL, V181, P1154, DOI 10.1016/S0002-9378(99)70099-2; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; Pettitt D.J., 1985, DIABETES, V34, P119, DOI DOI 10.2337/DIAB.34.2.S119; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; WALKINSHAW SA, 1999, COCHRANE LIB; WALKINSHAW SA, 2000, COCHRANE LIB	10	7	7	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					674	674		10.1016/S0140-6736(00)90025-4	http://dx.doi.org/10.1016/S0140-6736(00)90025-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703798				2022-12-01	WOS:000085615600007
J	Vinje, WE; Gallant, JL				Vinje, WE; Gallant, JL			Sparse coding and decorrelation in primary visual cortex during natural vision	SCIENCE			English	Article							RECEPTIVE-FIELD; STRIATE CORTEX; CORTICAL DYNAMICS; RESPONSES; SCENES; NORMALIZATION; INTEGRATION; MECHANISMS; PATTERNS; NEURONS	Theoretical studies suggest that primary visual cortex (area V1) uses a sparse code to efficiently represent natural scenes. This issue was investigated by recording from V1 neurons in awake behaving macaques during both free viewing of natural scenes and conditions simulating natural vision. Stimulation of the nonclassical receptive field increases the selectivity and sparseness of individual V1 neurons, increases the sparseness of the population response distribution, and strongly decorrelates the responses of neuron pairs. These effects are due to both excitatory and suppressive modulation of the classical receptive field by the nonclassical receptive field and do not depend critically on the spatiotemporal structure of the stimuli. During natural vision, the classical and nonclassical receptive fields function together to form a sparse representation of the visual world. This sparse code may be computationally efficient for both early vision and higher visual processing.	Univ Calif Berkeley, Program Neurosci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Program Neurosci, Berkeley, CA 94720 USA.		Gallant, Jack L/C-4426-2011					ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P153; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; Barlow H.B., 1961, SENSORY COMMUNICATIO; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Carandini M, 1997, J NEUROSCI, V17, P8621; Conner CE, 1997, J NEUROSCI, V17, P3201; Dan Y, 1996, J NEUROSCI, V16, P3351; DAUGMAN JG, 1989, IEEE T BIO-MED ENG, V36, P107, DOI 10.1109/10.16456; DILORENZO PM, 1989, J NEUROPHYSIOL, V62, P823, DOI 10.1152/jn.1989.62.4.823; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FOLDIAK P, 1995, HDB BRAIN THEORY NEU, P895; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Lewicki MS, 1998, ADV NEUR IN, V10, P815; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SIMONCELLI EP, 1998, ADV NEURAL INFORMATI, V11; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; Walker GA, 1999, J NEUROSCI, V19, P10536; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	34	825	849	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1273	1276		10.1126/science.287.5456.1273	http://dx.doi.org/10.1126/science.287.5456.1273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678835				2022-12-01	WOS:000085444700052
J	Finette, BA; Homans, AC; Albertini, RJ				Finette, BA; Homans, AC; Albertini, RJ			Emergence of genetic instability in children treated for leukemia	SCIENCE			English	Article							T-LYMPHOCYTES; HPRT LOCUS; MUTATIONS; CANCER; POPULATION; EXPOSURE; DELETION; MUTATORS; P53	T cells from patients who had received chemotherapy for B-lineage acute lymphocytic Leukemia were studied to determine whether genetic instability, a principal characteristic of cancer cells, can also occur in nonmalignant cells. Consistent with expectations for a genetic instability phenotype, multiple mutations were detected in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) reporter gene in independently isolated mutant T cells expressing identical rearranged T cell receptor beta (TCR beta) gene hypervariable regions. These results indicate that cancer treatment can lead to genetic instability in nonmalignant cells in some individuals. They also suggest a mechanistic paradigm for the induction of second malignancies and drug resistance.	Univ Vermont, Dept Pediat, Burlington, VT 05405 USA; Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; Univ Vermont, Vermont Canc Ctr, Burlington, VT 05405 USA; Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Finette, BA (corresponding author), Univ Vermont, Dept Pediat, Med Alumni Bldg, Burlington, VT 05405 USA.	finette@salus.med.uvm.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD035309] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K01CA077737, P30CA022435] Funding Source: NIH RePORTER; NCI NIH HHS [1K01CA77737, P30CA22435] Funding Source: Medline; NICHD NIH HHS [1R29HD35309] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albertini RJ, 1998, MUTAT RES-FUND MOL M, V400, P381, DOI 10.1016/S0027-5107(98)00063-3; BRANDA RF, 1991, CANCER RES, V51, P6603; Cariello NF, 1998, NUCLEIC ACIDS RES, V26, P198, DOI 10.1093/nar/26.1.198; Finette BA, 1998, NAT MED, V4, P1144, DOI 10.1038/2640; FINETTE BA, 1994, MUTAT RES, V308, P223, DOI 10.1016/0027-5107(94)90157-0; FUSCOE JC, 1991, CANCER RES, V51, P6001; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; HIROTA H, 1994, MUTAT RES-DNA REPAIR, V315, P95, DOI 10.1016/0921-8777(94)90010-8; Hunt CR, 1998, CANCER RES, V58, P3986; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KOSHI S, 1998, MUTAT RES, V422, P213; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Orr-Weaver TL, 1998, NATURE, V392, P223, DOI 10.1038/32520; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Strauss BS, 1998, SEMIN CANCER BIOL, V8, P431, DOI 10.1006/scbi.1998.0092; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wickremasinghe RG, 1999, BLOOD, V93, P3587, DOI 10.1182/blood.V93.11.3587.411k46_3587_3600	23	45	46	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					514	517		10.1126/science.288.5465.514	http://dx.doi.org/10.1126/science.288.5465.514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775110				2022-12-01	WOS:000086626000045
J	Maiorano, D; Moreau, J; Mechali, M				Maiorano, D; Moreau, J; Mechali, M			XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis	NATURE			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; CELL-CYCLE; LICENSING SYSTEM; MCM PROTEINS; CDC6 PROTEIN; S-PHASE; CHROMATIN; INITIATION; EXTRACTS	In eukaryotic cells, chromosomal DNA replication begins with the formation of pre-replication complexes at replication origins. Formation and maintenance of pre-replication complexes is dependent upon CDC6 (ref. 1), a protein which allows assembly of MCM2-7 proteins(2-4), which are putative replicative helicases(5). The functional assembly of MCM proteins into chromatin corresponds to replication licensing. Removal of these proteins from chromatin in S phase is crucial in origins firing regulation(6). We have identified a protein that is required for the assembly of prereplication complexes, in a screen for maternally expressed genes in Xenopus. This factor (XCDT1) is a relative of fission yeast cdt1, a protein proposed to function in DNA replication(7), and is the first to be identified in vertebrates. Here we show, using Xenopus in vitro systems, that XCDT1 is required for chromosomal DNA replication. XCDT1 associates with pre-replicative chromatin in a manner dependent on ORC protein and is removed from chromatin at the time of initiation of DNA synthesis. Immunodepletion and reconstitution experiments show that XCDT1 is required to load MCM2-7 proteins onto pre-replicative chromatin. These findings indicate that XCDT1 is an essential component of the system that regulates origins firing during S phase.	CNRS, Inst Human Genet, F-34396 Montpellier 5, France; Univ Paris 07, Inst Jacques Monod, Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Cite	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 5, France.	mechali@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017	Maiorano, Domenico/0000-0003-4229-5903				ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MAIORANO D, IN PRESS J BIOL CHEM; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Menut S, 1999, ADV MOLEC BIOL, P196; MOREAU J, 1995, MOL REPROD DEV, V41, P1, DOI 10.1002/mrd.1080410102; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Rowles A, 1999, J CELL SCI, V112, P2011; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x	25	289	291	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					622	625		10.1038/35007104	http://dx.doi.org/10.1038/35007104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766247				2022-12-01	WOS:000086400100058
J	Quinn, TC; Wawer, MJ; Sewankambo, N; Serwadda, D; Li, CJ; Wabwire-Mangen, F; Meehan, MO; Lutalo, T; Gray, RH				Quinn, TC; Wawer, MJ; Sewankambo, N; Serwadda, D; Li, CJ; Wabwire-Mangen, F; Meehan, MO; Lutalo, T; Gray, RH		Rakai Project Study Grp	Viral load and heterosexual transmission of human immunodeficiency virus type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 RNA LEVELS; TRANSFUSION RECIPIENTS; SEXUAL TRANSMISSION; SEMEN; MEN; REDUCTION; BLOOD; RISK	Background and Methods: We examined the influence of viral load in relation to other risk factors for the heterosexual transmission of human immunodeficiency virus type 1 (HIV-1). In a community-based study of 15,127 persons in a rural district of Uganda, we identified 415 couples in which one partner was HIV-1-positive and one was initially HIV-1-negative and followed them prospectively for up to 30 months. The incidence of HIV-1 infection per 100 person-years among the initially seronegative partners was examined in relation to behavioral and biologic variables. Results: The male partner was HIV-1-positive in 228 couples, and the female partner was HIV-1-positive in 187 couples. Ninety of the 415 initially HIV-1-negative partners seroconverted (incidence, 11.8 per 100 person-years). The rate of male-to-female transmission was not significantly different from the rate of female-to-male transmission (12.0 per 100 person-years vs. 11.6 per 100 person-years). The incidence of seroconversion was highest among the partners who were 15 to 19 years of age (15.3 per 100 person-years). The incidence was 16.7 per 100 person-years among 137 uncircumcised male partners, whereas there were no seroconversions among the 50 circumcised male partners (P<0.001). The mean serum HIV-1 RNA level was significantly higher among HIV-1-positive subjects whose partners seroconverted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 copies per milliliter, P=0.01). There were no instances of transmission among the 51 subjects with serum HIV-1 RNA levels of less than 1500 copies per milliliter; there was a significant dose-response relation of increased transmission with increasing viral load. In multivariate analyses of log-transformed HIV-1 RNA levels, each log increment in the viral load was associated with a rate ratio of 2.45 for seroconversion (95 percent confidence interval, 1.85 to 3.26). Conclusions: The viral load is the chief predictor of the risk of heterosexual transmission of HIV-1, and transmission is rare among persons with levels of less than 1500 copies of HIV-1 RNA per milliliter. (N Engl J Med 2000;342:921-9.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, Bethesda, MD 20892 USA; Columbia Univ, New York, NY USA; Makerere Univ, Fac Med, Kampala, Uganda	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Makerere University	Quinn, TC (corresponding author), Johns Hopkins Univ, Div Infect Dis, 720 Rutland Ave,Ross 1159, Baltimore, MD 21205 USA.		Quinn, Thomas/A-2494-2010	Sewankambo, Nelson/0000-0001-9362-053X	NIAID NIH HHS [R01 AI34826S, R01 AI34826B] Funding Source: Medline; NICHD NIH HHS [5P30HD06826] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, Z01AI000358, ZIAAI000361, ZIAAI000358, R01AI034826] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AIDS CONTR PROGR, 1992, HIV TEST POL, P1; ARMITAGE P, 1977, STAT METHODS MED RES; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CAMERON DW, 1989, LANCET, V2, P403; *CDCP, 1998, HIV AIDS SURV REP, V10; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fiscus SA, 1998, AIDS RES HUM RETROV, V14, pS27; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 1998, NEW ENGL J MED, V339, P1846, DOI 10.1056/NEJM199812173392510; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; Hoffman TL, 1997, J INFECT DIS, V176, P1093, DOI 10.1086/516519; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; Lee TH, 1996, J ACQ IMMUN DEF SYND, V12, P427, DOI 10.1097/00042560-199608010-00015; Mayaux MJ, 1997, J INFECT DIS, V175, P172, DOI 10.1093/infdis/175.1.172; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Mock PA, 1999, AIDS, V13, P407, DOI 10.1097/00002030-199902250-00014; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Nelson KE, 1999, J INFECT DIS, V180, P337, DOI 10.1086/314882; Nelson KE, 1999, J INFECT DIS, V180, P1756; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Quinn, 1996, LANCET, V348, P276; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Ragni MV, 1998, J ACQ IMMUN DEF SYND, V17, P42, DOI 10.1097/00042560-199801010-00006; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Royce RA, 1997, NEW ENGL J MED, V337, P799; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SHIBOSKI SC, 1999, J ACQ IMMUN DEF SYND, V19, P527; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; *STAT DEP, 1996, UG DEM HLTH SURV 199, P48; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; *UNAIDS JOINT UN P, 1999, AIDS EP UPD; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; *WHO, 1985, WEEKL EP REC, V60, P342; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	50	2265	2310	1	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2000	342	13					921	929		10.1056/NEJM200003303421303	http://dx.doi.org/10.1056/NEJM200003303421303			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DC	10738050				2022-12-01	WOS:000086179700003
J	Korinek, WS; Copeland, MJ; Chaudhuri, A; Chant, J				Korinek, WS; Copeland, MJ; Chaudhuri, A; Chant, J			Molecular linkage underlying microtubule orientation toward cortical sites in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR MIGRATION; MITOTIC SPINDLE; PROTEIN; IDENTIFICATION; TUBULIN; BINDING; KINESIN; GENE	Selective microtubule orientation-toward spatially defined cortical sites is critical to polarized cellular processes as diverse as axon outgrowth and T cell cytotoxicity. In yeast, oriented cytoplasmic microtubules align the mitotic spindle between mother and bud. The cortical marker protein Kar9 Localizes to the bud tip and is required for the orientation of microtubules toward this region. Here, we show that Kar9 directs microtubule orientation by acting through Bim1, a conserved microtubule-binding protein. Bim1 homolog EB1 was originally identified through its interaction with adenomatous polyposis coil (APC) tumor suppressor, raising the possibility that an APC-EB1 linkage orients microtubules in higher cells.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Chant, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	chant@fas.harvard.edu		Korinek, William/0000-0002-6293-1623	NIGMS NIH HHS [GM07620-20, GM49782, GM07620-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049782] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; James P, 1996, GENETICS, V144, P1425; Kaiser C., 1994, METHODS YEAST GENETI; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KORINEK WS, UNPUB; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Miller, 1972, EXPT MOL GENETICS; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; Stearns T, 1997, J CELL BIOL, V138, P957, DOI 10.1083/jcb.138.5.957; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993	26	179	180	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2257	2259		10.1126/science.287.5461.2257	http://dx.doi.org/10.1126/science.287.5461.2257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731146				2022-12-01	WOS:000086049100049
J	Misura, KMS; Scheller, RH; Weis, WI				Misura, KMS; Scheller, RH; Weis, WI			Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex	NATURE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SYNAPTIC VESICLE DOCKING; N-TERMINAL DOMAIN; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; SEC1 HOMOLOG; SYNTAXIN; FUSION; ROP; SPECIFICITY	Syntaxin 1a and neuronal Sec1 (nSec1) form an evolutionarily conserved heterodimer that is essential for vesicle trafficking and membrane fusion. The crystal structure of the nSec1-syntaxin la complex, determined at 2.6 Angstrom resolution, reveals that major conformational rearrangements occur in syntaxin relative to both the core SNARE complex and isolated syntaxin. We identify regions of the two proteins that seem to determine the binding specificity of particular Sec1 proteins for syntaxin isoforms, which is likely to be important for the fidelity of membrane trafficking. The structure also indicates mechanisms that might couple the action of upstream effector proteins to conformational changes in syntaxin la and nSec1 that lead to core complex formation and membrane fusion.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Fairchild Bldg,299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rowe J, 1999, J CELL SCI, V112, P1865; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TERWILLIGER TC, 1997, SOLVE AUTOMATED CRYS; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Webb GC, 1997, GENETICS, V147, P467; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	49	587	606	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					355	362		10.1038/35006120	http://dx.doi.org/10.1038/35006120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746715				2022-12-01	WOS:000086119000040
J	Ferner, RE; Aronson, JK				Ferner, RE; Aronson, JK			Medication errors, worse than a crime	LANCET			English	Editorial Material									City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX1 2JD, England	University of Birmingham; Radcliffe Infirmary; University of Oxford	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England.			Ferner, Robin/0000-0003-3769-1346				Ashraf H, 2000, LANCET, V355, P471, DOI 10.1016/S0140-6736(00)82021-8; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Ferner RE, 1999, BRIT J CLIN PHARMACO, V47, P581; FERNER RE, 1999, SIDE EFFECTS DRUGS A, P22; Firth-Cozens J, 1993, MED ACCIDENTS, P131; Kohn L.T., 2000, ERR IS HUMAN BUILDIN; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; Reason J., 1990, HUMAN ERROR, DOI 10.1017/cbo9781139062367; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; TEAHON K, 1993, BRIT MED J, V307, P605, DOI 10.1136/bmj.307.6904.605; Walley T, 1997, BRIT J CLIN PHARMACO, V44, P171, DOI 10.1046/j.1365-2125.1997.00668.x	11	46	48	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					947	948		10.1016/S0140-6736(00)99025-1	http://dx.doi.org/10.1016/S0140-6736(00)99025-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YH	10768430				2022-12-01	WOS:000086054000006
J	Sander, C				Sander, C			Genomic medicine and the future of health care	SCIENCE			English	Article								Genomic technologies and computational advances are Leading to an information revolution in biology and medicine. Simulations of molecular processes in cells and predictions of drug effects in humans will advance pharmaceutical research and speed up clinical trials. Computational prognostics and diagnostics that combine clinical data with genotyping and molecular profiling may soon cause fundamental changes in the practice of health care.	Millennium Pharmaceut & Millennium Predict Med, Cambridge, MA 02139 USA; MIT, Ctr Genome Res, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Massachusetts Institute of Technology (MIT)	Sander, C (corresponding author), Millennium Pharmaceut & Millennium Predict Med, 640 Mem Dr, Cambridge, MA 02139 USA.							Abbott A, 1999, NATURE, V402, P219, DOI 10.1038/46111; Arkin A, 1998, GENETICS, V149, P1633; BRAZMA A, COMMUNICATION; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Clark DE, 2000, DRUG DISCOV TODAY, V5, P49, DOI 10.1016/S1359-6446(99)01451-8; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; MUIR CS, COMMUNICATION; Schaff J, 1999, Pac Symp Biocomput, P228; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Service RF, 1999, SCIENCE, V284, P80; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WEINSTEIN JN, 1999, NAT GENET, V23, P81; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X	17	119	156	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1977	1978		10.1126/science.287.5460.1977	http://dx.doi.org/10.1126/science.287.5460.1977			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755952				2022-12-01	WOS:000085902800050
J	Pagola, S; Stephens, PW; Bohle, DS; Kosar, AD; Madsen, SK				Pagola, S; Stephens, PW; Bohle, DS; Kosar, AD; Madsen, SK			The structure of malaria pigment beta-haematin	NATURE			English	Article							FALCIPARUM HEMOGLOBIN DEGRADATION; PLASMODIUM-FALCIPARUM; HEME POLYMERIZATION; POWDER DIFFRACTION; IRON ENVIRONMENT; HEMATIN; CHLOROQUINE; MECHANISM; TROPHOZOITES; INHIBITION	Despite the worldwide public health impact of malaria, neither the mechanism by which the Plasmodium parasite detoxifies and sequesters haem, nor the action of current antimalarial drugs is well understood. The haem groups released from the digestion of the haemoglobin of infected red blood cells are aggregated into an insoluble material called haemozoin or malaria pigment. Synthetic beta-haematin (Fe-III-protoporphyrin-IX)(2) is chemically(1,2). spectroscopically(2,3) and crystallographically(4) identical to haemozoin and is believed to consist of strands of Fe-III-porphyrin units, linked into a polymer by propionate oxygen-iron bonds. Here we report the crystal structure of beta-haematin determined using simulated annealing techniques to analyse powder diffraction data obtained with synchrotron radiation. The molecules are linked into dimers through reciprocal iron-carboxylate bonds to one of the propionic side chains of each porphyrin, and the dimers form chains linked by hydrogen bonds in the crystal. This result has implications for understanding the action of current antimalarial drugs and possibly for the design of new therapeutic agents.	SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Univ Wyoming, Dept Chem, Laramie, WY 82071 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Wyoming	Stephens, PW (corresponding author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.			PAGOLA, SILVINA/0000-0003-2083-7599				Adams PA, 1996, J INORG BIOCHEM, V63, P69, DOI 10.1016/0162-0134(95)00212-X; Andreev YG, 1998, J CHEM SOC DALTON, P4071, DOI 10.1039/a805437a; BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; BOHLE DS, 1993, BIOCHEM BIOPH RES CO, V193, P504, DOI 10.1006/bbrc.1993.1652; Bohle DS, 1998, J AM CHEM SOC, V120, P8255, DOI 10.1021/ja980962u; BOHLE DS, 1994, ACS SYM SER, V572, P497; BOMINAAR EL, 1992, INORG CHEM, V31, P1845, DOI 10.1021/ic00036a023; David WIF, 1998, CHEM COMMUN, P931, DOI 10.1039/a800855h; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; Egan TJ, 1999, J INORG BIOCHEM, V73, P101, DOI 10.1016/S0162-0134(98)10095-8; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1996, MOL BIOCHEM PARASIT, V83, P189, DOI 10.1016/S0166-6851(96)02772-7; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; KOENIG DF, 1965, ACTA CRYSTALLOGR, V18, P663, DOI 10.1107/S0365110X65001536; LARSON AC, 1987, LAUR86748 LOS AL LAB; LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; LEMBERG R, 1949, HAEMATIN COMPOUNDS B; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; RIDLEY RG, 1995, NATURE, V378, P138, DOI 10.1038/378138b0; Scheidt W.R., 1987, METAL COMPLEXES TETR, V64, P1, DOI DOI 10.1007/BFB0036789; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784	30	704	728	0	100	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					307	310		10.1038/35005132	http://dx.doi.org/10.1038/35005132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749217				2022-12-01	WOS:000086022200055
J	Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW				Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW			Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; THERAPY; EVENTS	Objective To examine the accuracy of a new version of the Sheffield table designed to aid decisions on lipids screening and detect thresholds for risk of coronary heart disease needed to implement current guidelines for primary prevention of cardiovascular disease. Design Comparison of decisions made on the basis of the table with absolute risk of coronary heart disease or cardiovascular disease calculated by the Framingham risk function. The decisions related to statin treatment when corollary risk is greater than or equal to 30% over 10 years; aspirin treatment when the risk is greater than or equal to 15% over 10 years; and die treatment of mild hypertension when the cardiovascular risk is greater than or equal to 20% over 10 years. Setting The table is designed for use in general practice Subjects Random sample of 1000 people aged 35-64 years from the 1995 Scottish health survey Main outcome measures Sensitivity, specificity, and positive and negative predictive values of the table. Results 13% of people had a coronary risk of greater than or equal to 15%, and 2.2% a risk of greater than or equal to 30%, over 10 years. 22% had mild hypertension (systolic blood pressure 140-159 mm Hg). The table indicated lipids screening for everyone with a coronary risk of greater than or equal to 15% over 10 years, for 95% of people with a ratio of total cholesterol to high density lipoprotein cholesterol of greater than or equal to 8.0, but for < 50% with a coronary risk of < 5% over 10 years. Sensitivity and specificity were 97% and 95% respectively for a coronary risk of greater than or equal to 15% over 10 years; 82% and 99% for a coronary risk of greater than or equal to 30% over 10 years; and 88% and 90% for a cardiovascular risk of greater than or equal to 20% over 10 years in mild hypertension. Conclusion The table identifies all high risk people for lipids screening, reduces screening of low risk people by more than half, and ensures that treatments are prescribed appropriately to those at high risk, while avoiding inappropriate treatment of people at low risk	Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Ramsay, LE (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	d.colley@sheffield.ac.uk		Yeo, Wilfred/0000-0001-9554-5203				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Boissel JP, 1998, JAMA-J AM MED ASSOC, V280, P1949, DOI 10.1001/jama.280.22.1949; Chalmers J, 1999, J HYPERTENS, V17, P151; COLLINS R, 1992, TXB HYPERTENSION, P1156; *COR SERV COMM, 1995, MIN HLTH GUID MAN MI; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; HAQ IU, 1995, LANCET, V346, P1467, DOI 10.1016/S0140-6736(95)92477-9; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Haq IU, 1996, CLIN SCI, V91, P773; Haq IU, 1999, QJM-INT J MED, V92, P379, DOI 10.1093/qjmed/92.7.379; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; *JOINT HLTH SURV U, 1995, SCOTT HLTH SURV; *JOINT NAT COMM PR, 1998, ARCH INTERN MED, V157, P2413; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1333; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Ramsay LE, 1998, AM J HYPERTENS, V11, p79S, DOI 10.1016/S0895-7061(98)00063-6; *STANDM ED ADV COM, 1997, US STAT; SYTKOWSKI PA, 1997, CIRCULATION S1, V96, P437; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, HEART, V80, pS1; Wood D, 1998, EUR HEART J, V19, P1434	24	128	134	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					671	676		10.1136/bmj.320.7236.671	http://dx.doi.org/10.1136/bmj.320.7236.671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710573	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000085895300017
J	Lee, JS; Collins, KM; Brown, AL; Lee, CH; Chung, JH				Lee, JS; Collins, KM; Brown, AL; Lee, CH; Chung, JH			hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response	NATURE			English	Article							CELL-CYCLE; OVARIAN-CANCER; S-PHASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GENE; TRANSCRIPTION; BREAST; YEAST; ATM	Mutations in the BRCA1 (ref. 1) tumour suppressor gene are found in almost all of the families with inherited breast and ovarian cancers and about half of the families with only breast cancer(2,3). Although the biochemical function of BRCA1 is not well understood, it is important for DNA damage repair(4-7) and cell-cycle checkpoints(8-10). BRCA1 exists in nuclear foci but is hyperphosphorylated and disperses after DNA damage(11,12). It is not known whether BRCA1 phosphorylation and dispersion and its function in DNA damage response are related. In yeast the DNA damage response and the replication-block checkpoint are mediated partly through the Cds1 kinase family(13-20). Here we report that the human Cds1 kinase (hCds1/Chk2)(21-23) regulates BRCA1 function after DNA damage by phosphorylating serine 988 of BRCA1. We show that hCds1 and BRCA1 interact and colocalize within discrete nuclear foci but separate after gamma irradiation. Phosphorylation of BRCA1 at serine 988 is required for the release of BRCA1 from hCds1. This phosphorylation is also important for the ability of BRCA1 to restore survival after DNA damage in the BRCA1-mutated cell line HCC1937.	NHLBI, Lab Mol Hematol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chung, JH (corresponding author), NHLBI, Lab Mol Hematol, NIH, Bldg 10, Bethesda, MD 20892 USA.							Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; BODDY MN, 1998, NATURE, V395, P507; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; EASTON DF, 1993, AM J HUM GENET, V52, P678; Feunteun J, 1996, BBA-REV CANCER, V1242, P177, DOI 10.1016/0304-419X(95)00016-9; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Larson JS, 1997, CANCER RES, V57, P3351; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	29	438	456	0	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					201	204		10.1038/35004614	http://dx.doi.org/10.1038/35004614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724175				2022-12-01	WOS:000085870900056
J	Abe, Y; Shodai, T; Muto, T; Mihara, K; Torii, H; Nishikawa, S; Endo, T; Kohda, D				Abe, Y; Shodai, T; Muto, T; Mihara, K; Torii, H; Nishikawa, S; Endo, T; Kohda, D			Structural basis of presequence recognition by the mitochondrial protein import receptor Tom20	CELL			English	Article							NUCLEAR MAGNETIC-RESONANCE; OUTER-MEMBRANE; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; C-13/N-15-ENRICHED PROTEINS; PREPROTEIN TRANSLOCASE; C-13 MAGNETIZATION; BINDING DOMAIN; ACID CHAIN; NMR	Most mitochondrial proteins are synthesized in the cytosol as precursor proteins with a cleavable N-terminal presequence and are imported into mitochondria. We report here the NMR structure of a general import receptor, rat Tom20, in a complex with a presenquence peptide derived from rat aldehyde dehydrogenase, The cytosolic domain of Tom20 forms an all alpha-helical structure with a groove to accommodate the presequence peptide. The bound presequence forms an amphiphilic helical structure with hydrophobic leucines aligned on one side to interact with a hydrophobic patch in the Tom20 groove. Although the positive charges of the presequence are essential for import ability, presequence binding to Tom20 is mediated mainly by hydrophobic rather than ionic interactions.	Nagoya Univ, Fac Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Biomol Engn Res Inst, Dept Biol Struct, Osaka 5650874, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128512, Japan	Nagoya University; Kyushu University	Kohda, D (corresponding author), Nagoya Univ, Fac Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.		Abe, Yoshito/D-8370-2012; Kohda, Daisuke/I-4990-2019; Abe, Yoshito/AAH-6141-2021	Abe, Yoshito/0000-0002-0016-8490; Kohda, Daisuke/0000-0001-8234-3776; Abe, Yoshito/0000-0002-0016-8490				BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOPING IS, 1995, FEBS LETT, V373, P45; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HAUCKE V, 1995, J BIOL CHEM, V270, P5565, DOI 10.1074/jbc.270.10.5565; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Komiya T, 1997, EMBO J, V16, P4267, DOI 10.1093/emboj/16.14.4267; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lill R, 1996, TRENDS CELL BIOL, V6, P56, DOI 10.1016/0962-8924(96)81015-4; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; LITHGOW T, 1995, TRENDS BIOCHEM SCI, V20, P98, DOI 10.1016/S0968-0004(00)88972-0; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NAKAI T, 1993, J BIOMOL NMR, V3, P19; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Pfanner N, 1997, ANNU REV CELL DEV BI, V13, P25, DOI 10.1146/annurev.cellbio.13.1.25; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, J BIOL CHEM, V263, P4509; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1997, NATURE, V388, P121, DOI 10.1038/40510; Schleiff E, 1998, BIOCHEMISTRY-US, V37, P13052, DOI 10.1021/bi980746y; Schleiff E, 1997, J BIOL CHEM, V272, P17784, DOI 10.1074/jbc.272.28.17784; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Yano M, 1998, J BIOL CHEM, V273, P26844, DOI 10.1074/jbc.273.41.26844; [No title captured]	52	413	422	3	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					551	560		10.1016/S0092-8674(00)80691-1	http://dx.doi.org/10.1016/S0092-8674(00)80691-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721992	Bronze			2022-12-01	WOS:000085700000008
J	Whitmore, D; Foulkes, NS; Sassone-Corsi, P				Whitmore, D; Foulkes, NS; Sassone-Corsi, P			Light acts directly on organs and cells in culture to set the vertebrate circadian clock	NATURE			English	Article							DROSOPHILA; ZEBRAFISH; GENE; ENTRAINMENT; EXPRESSION	The expression of dock genes in vertebrates is widespread and not restricted to classical dock structures(1,2). The expression of the Clock gene in zebrafish shows a strong circadian oscillation in many tissues in vivo and in culture, showing that endogenous oscillators exist in peripheral organs(3). A defining feature of circadian clocks is that they can be set or entrained to local time, usually by the environmental light-dark cycle(4,5). An important question is whether peripheral oscillators are entrained to local time by signals from central pacemakers such as the eyes or are themselves directly light-responsive. Here we show that the peripheral organ docks of zebrafish are set by light-dark cycles in culture. We also show that a zebrafish-derived cell line contains a circadian oscillator, which is also directly light entrained.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbour, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	paolosc@titus.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011; Foulkes, Nicholas S/K-7003-2013	Foulkes, Nicholas S/0000-0002-1794-9891; Whitmore, David/0000-0003-2420-8220				Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; ASCHOFF J, 1986, Journal of Biological Rhythms, V1, P91, DOI 10.1177/074873048600100201; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARRETT RK, 1995, J NEUROSCI, V15, P5681; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CERMAKIAN N, IN PRESS P NATL ACAD, V97; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Earnest DJ, 1999, J NEUROBIOL, V39, P1, DOI 10.1002/(SICI)1097-4695(199904)39:1<1::AID-NEU1>3.0.CO;2-F; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; PEPPELENBOSCH MP, 1995, EXP CELL RES, V218, P183, DOI 10.1006/excr.1995.1146; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 1998, CURR OPIN NEUROBIOL, V8, P635, DOI 10.1016/S0959-4388(98)80092-5; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	29	345	350	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					87	91		10.1038/35003589	http://dx.doi.org/10.1038/35003589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716448				2022-12-01	WOS:000085775100051
J	Collett, T				Collett, T			Behavior - Measuring beelines to food	SCIENCE			English	Editorial Material									Univ Sussex, Sch Biol Sci, Sussex Ctr Neurosci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Collett, T (corresponding author), Univ Sussex, Sch Biol Sci, Sussex Ctr Neurosci, Biol Bldg, Brighton BN1 9QG, E Sussex, England.							BRANINGER HD, 1957, Z VERGL PHYSIOL, V40, P264; Esch HE, 1996, J EXP BIOL, V199, P155; RONACHER B, IN PRESS J EXP BIOL; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; von Frisch K., 1967, DANCE LANGUAGE ORIEN	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					817	818		10.1126/science.287.5454.817	http://dx.doi.org/10.1126/science.287.5454.817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691558				2022-12-01	WOS:000085136400034
J	An, WF; Bowlby, MR; Betty, M; Cao, J; Ling, HP; Mendoza, G; Hinson, JW; Mattsson, KI; Strassle, BW; Trimmer, JS; Rhodes, KJ				An, WF; Bowlby, MR; Betty, M; Cao, J; Ling, HP; Mendoza, G; Hinson, JW; Mattsson, KI; Strassle, BW; Trimmer, JS; Rhodes, KJ			Modulation of A-type potassium channels by a family of calcium sensors	NATURE			English	Article							K+ CHANNEL; SUBTHRESHOLD POTENTIALS; PYRAMIDAL NEURONS; BINDING PROTEIN; MAMMALIAN BRAIN; ASSOCIATION; DENDRITES; SUBUNITS; SYSTEM	In the brain and heart, rapidly inactivating (A-type) voltage-gated potassium (Kv) currents operate at subthreshold membrane potentials to control the excitability of neurons and cardiac myocytes(1,2). Although pore-forming alpha-subunits of the Kv4, or Shal-related, channel family form A-type currents in heterologous cells(3), these differ significantly from native A-type currents. Here we describe three Kv channel-interacting proteins (KChIPs) that bind to the cytoplasmic amino termini of Kv4 alpha-subunits. We find that expression of KChIP and Kv4 together reconstitutes several features of native A-type currents by modulating the density, inactivation kinetics and rate of recovery from inactivation of Kv4 channels in heterologous cells. All three KChIPs co-localize and co-immunoprecipitate with brain Kv4 alpha-subunits, and are thus integral components of native Kv4 channel complexes. The KChIPs have four EF-hand-like domains and bind calcium ions. As the activity and density of neuronal A-type currents tightly control responses to excitatory synaptic inputs, these KChIPs may regulate A-type currents, and hence neuronal excitability, in response to changes in intracellular calcium.	Wyeth Ayerst Res, Div Neurosci, Princeton, NJ 08543 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Pfizer; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Rhodes, KJ (corresponding author), Wyeth Ayerst Res, Div Neurosci, Princeton, NJ 08543 USA.							BAIROCH A, 1990, FEBS LETT, V269, P454, DOI 10.1016/0014-5793(90)81214-9; BOWLBY MR, 1995, J NEUROPHYSIOL, V73, P2221, DOI 10.1152/jn.1995.73.6.2221; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Linse Sara, 1995, V30, P89; NEF P, 1996, GUIDEBOOK CALCIUM BI, P94; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Song WJ, 1998, J NEUROSCI, V18, P3124; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	22	782	810	1	38	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					553	556		10.1038/35000592	http://dx.doi.org/10.1038/35000592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676964				2022-12-01	WOS:000085227300052
J	Barton, JH				Barton, JH			Financing of vaccines	LANCET			English	Editorial Material									Stanford Univ, Sch Law, Stanford, CA 94305 USA	Stanford University	Barton, JH (corresponding author), Stanford Univ, Sch Law, Stanford, CA 94305 USA.							Bloom BR, 1998, NAT MED, V4, P480, DOI 10.1038/nm0598supp-480; *CONS GROUP INT AG, 1998, CONS GROUP INT AGR R; *GLOB PROGR VACC, 1996, STAT WORLDS VACC IMM; Keohane Robert O., 1996, I ENV AID PITFALLS P; Mahoney RT, 1999, VACCINE, V17, P646, DOI 10.1016/S0264-410X(98)00246-1; Miller LH, 1998, NAT MED, V4, P520, DOI 10.1038/nm0598supp-520; MURASKIN W, 1995, WAR HEPATITIS B; SACHS J, 1999, ECONOMIST       0814, P17; *WORLD BANK, 1998, HLTH NUTR POP SECT S, P61; *WORLD BANK, 1993, WORLD DEV REP	10	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1269	1270		10.1016/S0140-6736(00)02100-0	http://dx.doi.org/10.1016/S0140-6736(00)02100-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770320				2022-12-01	WOS:000086448000041
J	Sheffield, C				Sheffield, C			The new laureate speaks - The response of this year's Nobelist in full	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					549	549		10.1038/35007161	http://dx.doi.org/10.1038/35007161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766219	Bronze			2022-12-01	WOS:000086400100028
J	Leydon, GM; Boulton, M; Moynihan, C; Jones, A; Mossman, J; Boudioni, M; McPherson, K				Leydon, GM; Boulton, M; Moynihan, C; Jones, A; Mossman, J; Boudioni, M; McPherson, K			Cancer patients' information needs and information seeking behaviour: in depth interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREFERENCES	Objectives To explore why cancer patients do riot want or seek information about their condition beyond that volunteered by their physicians at times during their illness. Design Qualitative study based on in-depth interviews. Setting Outpatient oncology clinics at a London cancer centre. Participants 17 patients with cancer diagnosed in previous 6 months. Main outcome measures Analysis of patients narratives to identify key themes and categories. Results While all patients wanted basic information on diagnosis and treatment, not all wanted further information at all stages of their illness. Three overarching attitudes to their management of cancel limited patients' desire for and subsequent efforts to obtain further information: faith, hope, and charity: Faith in their doctor's medical expertise precluded the need for patients to seek further information themselves. Hope was essential for patients to carry on with life as normal and could be maintained through silence and avoiding information, especially too detailed or "unsafe" information. Charity to fellow patients, especially those seen as more needy than themselves, was expressed in the recognition that scarce resources-including information and explanations-had to be shared and meant that limited Information was accepted as inevitable. Conclusions Cancer patients' attitudes to cancer. and their strategies for coping with their illness can constrain their wish for information and their, efforts to obtain it. In developing recommendations, the government's cancer information strategy should attend to variations in patients' desires for information and the reasons for them.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc & Publ Hlth Unit, London WC1E 7HT, England; Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England; Inst Canc Res, Sutton SM2 5PT, Surrey, England; Royal Marsden NHS Trust, Sutton SM2 5PT, Surrey, England; Royal Free Hosp, Sch Med, London NW3 2QG, England; CancerBACUP, London EC2A 3JR, England	University of London; London School of Hygiene & Tropical Medicine; Oxford Brookes University; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Leydon, GM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc & Publ Hlth Unit, London WC1E 7HT, England.	g.leydon@Ishtm.ac.uk	Leydon, Geraldine M/C-4968-2011; BOULTON, Mary/X-9056-2019	BOULTON, Mary/0000-0002-2247-8318; Leydon, Geraldine Marie/0000-0001-5986-3300				Boudioni M, 1999, BRIT J CANCER, V79, P138, DOI 10.1038/sj.bjc.6690023; Boudioni M, 1998, BRIT MED J, V317, P1016, DOI 10.1136/bmj.317.7164.1016; BUTOW P, 1994, BRIT J CANCER, V71, P1115; Byrne P., 1976, DOCTORS TALKING PATI; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; Coulter A, 1998, BMJ-BRIT MED J, V317, P225, DOI 10.1136/bmj.317.7153.225; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; FORD S, 1995, SOC SCI MED, P1; HARRISON J, 1995, SOC SCI MED, V41, P1255, DOI 10.1016/0277-9536(94)00411-L; HOUTS P, 1991, J CANCER EDUC, V6, P225; INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604; LUPTON D, 1996, HLTH SOCIOLOGY EMOTI, P157; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; National Cancer Alliance, 1996, PAT CTR CANC SERV WH; Orne M T, 1968, Int J Psychiatry, V5, P403; Parsons T., 1951, SOCIAL SYSTEM; Pinder R., 1990, MANAGEMENT CHRONIC I; RITCHIE J, 1994, ANAL QUALITATIVE DAT, P172; Silverman D., 2020, INTERPRETING QUALITA, V6th ed.; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; WongWylie G, 1997, QUAL HEALTH RES, V7, P32, DOI 10.1177/104973239700700103	23	570	577	5	86	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					909	913		10.1136/bmj.320.7239.909	http://dx.doi.org/10.1136/bmj.320.7239.909			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	301YA	10742000	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000086337100025
J	Chapman, B				Chapman, B			Necessity for afferent activity to maintain eye-specific segregation in ferret lateral geniculate nucleus	SCIENCE			English	Article							TETRODOTOXIN; INFUSION	In the adult mammal, retinal ganglion cell axon arbors are restricted to eye-specific Layers in the lateral geniculate nucleus. Blocking neuronal activity early in development prevents this segregation from occurring. To test whether activity is also required to maintain eye-specific segregation, ganglion cell activity was blocked after segregation was established. This caused desegregation, so that both eyes' axons became concentrated in lumina A, normally occupied only by contralateral afferents. These results show that an activity-dependent process is necessary for maintaining eye-specific segregation and suggest that activity-independent cues may favor Lamina A as the target for arborization of afferents from both eyes.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.				NATIONAL EYE INSTITUTE [R01EY011369] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11369, R01 EY011369-11, R01 EY011369] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chapman B, 2000, J NEUROSCI, V20, P1922; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; GUILLERY RW, 1985, J NEUROSCI, V5, P1370; HUTCHINS JB, 1990, J COMP NEUROL, V298, P113, DOI 10.1002/cne.902980109; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MORGAN J, 1993, VISUAL NEUROSCI, V10, P303, DOI 10.1017/S0952523800003709; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SRETAVAN DW, 1986, J NEUROSCI, V6, P990; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; WONG WC, COMMUNICATION; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	15	90	97	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2479	2482		10.1126/science.287.5462.2479	http://dx.doi.org/10.1126/science.287.5462.2479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741966	Green Accepted			2022-12-01	WOS:000086202200043
J	Pienitz, R; Vincent, WF				Pienitz, R; Vincent, WF			Effect of climate change relative to ozone depletion on UV exposure in subarctic lakes	NATURE			English	Article							ULTRAVIOLET-RADIATION; NORTHWEST-TERRITORIES; BOREAL FOREST; B PENETRATION; VEGETATION; TREELINE; CANADA; ACIDIFICATION; YELLOWKNIFE	The effect of stratospheric ozone depletion on increases in ambient levels of solar ultraviolet (UV) radiation in high-latitude regions' has raised concerns about the response of northern ecosystems to environmental change. The concentration of coloured dissolved organic material, which is derived from terrestrial vegetation and acts as a screen for ultraviolet radiation, is low in high-latitude lakes(2). The underwater light environment in these lakes is therefore likely to be sensitive to small variations in the supply of this material, in addition to the effects of ozone depletion(2-5). Here we use fossil diatom assemblages in combination with bio-optical models to estimate the magnitude of past variations in the underwater light regime of a lake at the boreal tree line. We find large shifts in underwater UV-B, UV-A and photosynthetically available radiation associated with changes in the input of coloured dissolved organic material into subarctic lakes during the Holocene. The inferred changes in biological exposure to UV radiation were at least two orders of magnitude greater than those associated with moderate (30%) ozone depletion. Our findings indicate that freshwater ecosystems at present located across vegetation gradients will experience significant shifts in underwater spectral irradiance through the effects of climate change on catchment vegetation and the export of coloured dissolved organic material.	Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	Laval University	Pienitz, R (corresponding author), Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada.	reinhard.pienitz@cen.ulaval.ca; warwick.vincent@bio.ulaval.ca	Vincent, Warwick/AAH-6152-2019; Vincent, Warwick F/C-9522-2009	Vincent, Warwick/0000-0001-9055-1938; 				Battarbee RW, 1997, HYDROBIOLOGIA, V348, P69, DOI 10.1023/A:1003085116632; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; ENGSTROM DR, 1987, CAN J FISH AQUAT SCI, V44, P1306, DOI 10.1139/f87-154; Fallu MA, 1999, ECOSCIENCE, V6, P603, DOI 10.1080/11956860.1999.11682553; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; FREDERICK JE, 1988, SCIENCE, V241, P438, DOI 10.1126/science.241.4864.438; Hansen G, 1999, J GEOPHYS RES-ATMOS, V104, P1837, DOI 10.1029/1998JD100021; *INT ARCT SCI COMM, 1995, EFF INCR ULTR RAD AR, V2; IPCC,, 1996, CLIMATE CHANGE 1995; Korsman T., 1994, Holocene, V4, P132, DOI 10.1177/095968369400400203; Laurion I, 1997, PHOTOCHEM PHOTOBIOL, V65, P107; Leavitt PR, 1997, NATURE, V388, P457, DOI 10.1038/41296; MACDONALD GM, 1993, NATURE, V361, P243, DOI 10.1038/361243a0; MacDonald GM, 1998, ANN ASSOC AM GEOGR, V88, P183, DOI 10.1111/1467-8306.00090; MOSER KA, 1990, QUATERNARY RES, V34, P227, DOI 10.1016/0033-5894(90)90033-H; Pielke RA, 1995, J GEOPHYS RES-ATMOS, V100, P25755, DOI 10.1029/95JD02418; Pienitz R, 1999, ARCT ANTARCT ALP RES, V31, P82, DOI 10.2307/1552625; PIENITZ R, 1993, HYDROBIOLOGIA, V269, P391, DOI 10.1007/BF00028037; PLENITZ R, 1997, CAN J FISH AQUAT SCI, V54, P347; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SMITH TM, 1992, ADV ECOL RES, V22, P93, DOI 10.1016/S0065-2504(08)60134-8; URBAN NR, 1989, WATER RESOUR RES, V25, P1619, DOI 10.1029/WR025i007p01619; Vincent WF, 1996, GEOSCI CAN, V23, P231; Vincent WF, 1998, ANN GLACIOL, V27, P691; Vinebrooke RD, 1996, LIMNOL OCEANOGR, V41, P1035, DOI 10.4319/lo.1996.41.5.1035; Williamson CE, 1996, LIMNOL OCEANOGR, V41, P1024, DOI 10.4319/lo.1996.41.5.1024; Wolfe BB, 1996, J PALEOLIMNOL, V15, P171; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0	29	155	161	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					484	487		10.1038/35006616	http://dx.doi.org/10.1038/35006616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761913				2022-12-01	WOS:000086257700044
J	Ridker, PM; Hennekens, CH; Buring, JE; Rifai, N				Ridker, PM; Hennekens, CH; Buring, JE; Rifai, N			C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; AVERAGE CHOLESTEROL LEVELS; SEVERE UNSTABLE ANGINA; APPARENTLY HEALTHY-MEN; MYOCARDIAL-INFARCTION; RISK; EVENTS; ATHEROSCLEROSIS; PRAVASTATIN; PREVENTION	Background: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. Methods: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and several lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. Results: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), low-density lipoprotein (LDL) cholesterol (2.4), apolipoprotein B-100 (3.4), high-density lipoprotein (HDL) cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). Conclusions: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying women at risk for cardiovascular events. (N Engl J Med 2000;342:836-43.) (C)2000, Massachusetts Medical Society.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 75 Francis St, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755, R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA47988] Funding Source: Medline; NHLBI NIH HHS [HL43851, HL58755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Liuzzo G, 1998, CIRCULATION, V98, P2370, DOI 10.1161/01.CIR.98.22.2370; Macy EM, 1997, CLIN CHEM, V43, P52; Maseri A, 1997, NEW ENGL J MED, V336, P1014, DOI 10.1056/NEJM199704033361409; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1999, JAMA-J AM MED ASSOC, V281, P1817, DOI 10.1001/jama.281.19.1817; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; RIDKER PM, IN PRESS CIRCULATION; Rifai N, 1999, CLIN CHEM, V45, P2136; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Toss H, 1997, CIRCULATION, V96, P4204; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; *WHO, 1971, ISCH HEART DIS REG R	33	4451	4727	3	387	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2000	342	12					836	843		10.1056/NEJM200003233421202	http://dx.doi.org/10.1056/NEJM200003233421202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296FU	10733371				2022-12-01	WOS:000086014100002
J	Goshima, G; Yanagida, M				Goshima, G; Yanagida, M			Establishing biorientation occurs with precocious separation of the sister kinetochores, but not the arms, in the early spindle of budding yeast	CELL			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; CENTROMERE; PROTEIN; CHROMOSOMES; ANAPHASE; MITOSIS	Sister kinetochores are bioriented toward the spindle poles in higher eukaryotic prometaphase before chromosome segregation. We show that, in budding yeast, the sister kinetochores are separated in the very early spindle, while the sister arms remain associated. Biorientation of the separated kinetochores is achieved already after replication. Mtw1p, a homolog of fission yeast Mis12 required for biorientation, locates at the centromeres in an Ndc10p-dependent manner. Mtw1p and the sequences 1.8 and 3.8 kb from CEN3 and CEN15, respectively, behave like the precociously separated kinetochores, whereas the sequences 23 and 35 kb distant from CEN3 and CEN5 previously used as the centromere markers behave like a part of the arm. Mtw1p and Ndc10p are identically located except for additional spindle localization of Ndc10p. A model explaining small centromeres and early spindle formation in budding yeast is proposed.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, CREST Res Proj, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University; Kyoto University; Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yanagida@kozo.biophys.kyoto-u.ac.jp						ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Allshire RC, 1997, CURR OPIN GENET DEV, V7, P264, DOI 10.1016/S0959-437X(97)80137-2; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; Chibana H, 1996, GENES CELLS, V1, P727, DOI 10.1111/j.1365-2443.1996.tb00013.x; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Gorbsky GJ, 1997, BIOESSAYS, V19, P193, DOI 10.1002/bies.950190303; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; HAGAN IM, 1988, J CELL SCI, V89, P343; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; IMIGER S, 1995, CELL, V81, P269; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; MASUDA H, 1992, J CELL BIOL, V117, P1055, DOI 10.1083/jcb.117.5.1055; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pereira G, 1997, J CELL SCI, V110, P295; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Waters JC, 1996, J CELL SCI, V109, P2823; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; WOODS A, 1989, J CELL SCI, V93, P491	46	252	255	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					619	633		10.1016/S0092-8674(00)80699-6	http://dx.doi.org/10.1016/S0092-8674(00)80699-6			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761928	Bronze			2022-12-01	WOS:000085983800005
J	Lieu, TA; Ray, GT; Black, SB; Butler, JC; Klein, JO; Breiman, RF; Miller, MA; Shinefield, HR				Lieu, TA; Ray, GT; Black, SB; Butler, JC; Klein, JO; Breiman, RF; Miller, MA; Shinefield, HR			Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE OTITIS-MEDIA; UNITED-STATES; BACTERIAL-MENINGITIS; IMMUNIZATION; INFECTIONS; EPIDEMIOLOGY; PREVENTION; EFFICACY; PROGRAM	Context Pneumococcal conjugate vaccine for infants has recently been found effective against meningitis, bacteremia, pneumonia, and otitis media. Objective Tc,evaluate the projected health and economic impact: of pneumococcal conjugate vaccination of healthy US infants and young children. Design Cost-effectiveness analysis based on data from the Northern California Kaiser Permanente randomized trial and other published and unpublished sources. Setting and Patients A hypothetical US birth cohort of 3.8 million infants, Interventions Hypothetical comparisons of routine vaccination of healthy infants, requiring 4 doses of pneumococcal conjugate vaccine (at 2, 4, 6, and 12-15 months), and catch-up vaccination of children aged 2 to 4.9 years requiring 1 dose, with children receiving no intervention. Main Outcome Measures Cost per life-year saved and cost per-episode of meningitis, bacteremia, pneumonia, and otitis media prevented. Results Vaccination of healthy infants would prevent more than 12 000 cases of meningitis and bacteremia, 53 000 cases of pneumonia, 1 million episodes of otitis media, and 116 deaths due to pneumococcal infection. Before accounting for vaccine costs, the vaccination program would save $342 million in medical and $415 million in work-loss and other costs from averted pneumococcal disease. Vaccination of healthy infants would result in net savings for society if the vaccine cost less than $46 per dose, and net savings for the health care payer if the vaccine cost less than $18 pet dose. At the manufacturer's list price of $58 per dose, infant vaccination would cost society $80 000 per life-year saved or $160 per otitis media episode prevented (other estimated costs would be $3200 per pneumonia case prevented, $15 000 for bacteremia, and $280 000 for meningitis). The cost-effectiveness of an additional program to administer 1 dose of vaccine to children aged 2 to 4.9 years would vary depending on the children's ages, relative risks of pneumococcal disease, and vaccine cost Conclusions Pneumococcal conjugate vaccination of healthy US infants has the potential to be cost-effective, To achieve cost savings, its cost would need to be lower than the manufacturer's list price. In addition to tangible costs, the vaccine should be appraised based on the less tangible value of preventing mortality and morbidity from pneumococcal disease.	Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Kaiser Permanente, Div Res, Vaccine Study Ctr, Oakland, CA USA; Boston Univ, Med Ctr, Boston City Hosp, Dept Pediat, Boston, MA USA; Natl Ctr Infect Dis, Arctic Invest Program, Anchorage, AK USA; Ctr Dis Control & Prevent, Natl Vaccine Program Off, Atlanta, GA USA; Childrens Vaccine Initiat, Geneva, Switzerland	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Kaiser Permanente; Boston Medical Center; Boston University; Centers for Disease Control & Prevention - USA	Lieu, TA (corresponding author), Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.	tracy_lieu@hphc.org						Alsarraf R, 1998, ANN OTO RHINOL LARYN, V107, P120, DOI 10.1177/000348949810700207; *AM MED ASS, 1998, PHYS MED GUID; Black S, 1999, PEDIATR RES, V45, p157A, DOI 10.1203/00006450-199904020-00932; BLACK S, 1998, CONT PEDIAT S    NOV, P12; BLACK S, IN PRESS PEDIAT INFE; BLUESTONE CD, 1995, OTITIS MEDIA INFANTS, P229; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; *BUR LAB STAT, 1999, CONS PRIC IND ALL UR; BUTLER JC, 1995, J INFECT DIS, V171, P885, DOI 10.1093/infdis/171.4.885; BYMS PJ, 1997, ARCH PEDIAT ADOLESC, V151, P407; CAPRA AM, IN PRESS PEDIAT INFE; CASPER LM, 1999, WHOS MINDING OUR PRE; *CDCP, 1997, VITAL HLTH STAT, V23, P69; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P829; Centers for Disease Control and Prevention, 2000, ACT BACT COR SURV AB; COCHI SL, 1988, AM J DIS CHILD, V142, P499, DOI 10.1001/archpedi.1988.02150050037025; Eskola J, 1999, PEDIATR INFECT DIS J, V18, P543, DOI 10.1097/00006454-199906000-00015; Fiore AE, 1999, EMERG INFECT DIS, V5, P828, DOI 10.3201/eid0506.990616; Freed GL, 1996, ARCH PEDIAT ADOL MED, V150, P421, DOI 10.1001/archpedi.1996.02170290087014; Gold MR., 1996, COST EFFECTIVENESS H; GRABOWSKY M, 1991, J INFECT DIS, V164, P1237, DOI 10.1093/infdis/164.6.1237; HADDIX A, 1994, PRACTICAL GUIDE PREV; HALL MJ, 1998, ADV DATA VITAL HLTH, V300, P8; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; HARDY AM, 1991, VITAL HLTH STAT, V10, P10; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; Kaplan SL, 1998, PEDIATRICS, V102, P538, DOI 10.1542/peds.102.3.538; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; LIEU TA, 1994, JAMA-J AM MED ASSOC, V271, P375, DOI 10.1001/jama.271.5.375; LIEU TA, 1994, JAMA-J AM MED ASSOC, V217, P375; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; MAKELA PH, 1981, REV INFECT DIS, V3, pS124; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Miller MA, 1996, JAMA-J AM MED ASSOC, V276, P967, DOI 10.1001/jama.276.12.967; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; Nieminen T, 1999, PEDIATR INFECT DIS J, V18, P764, DOI 10.1097/00006454-199909000-00005; Obaro S, 1998, LANCET, V351, P1284, DOI 10.1016/S0140-6736(05)79345-4; Oh PI, 1996, CLIN THER, V18, P160, DOI 10.1016/S0149-2918(96)80188-3; POMEROY SL, 1990, NEW ENGL J MED, V323, P1651, DOI 10.1056/NEJM199012133232402; *PRACT MAN INF COR, 1999, MED FEES US; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Severens JL, 1997, AM J OTOL, V18, P714; Shinefield HR, 1999, PEDIATR INFECT DIS J, V18, P757, DOI 10.1097/00006454-199909000-00004; Sorum PC, 1999, MED DECIS MAKING, V19, P27, DOI 10.1177/0272989X9901900104; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thompson D, 1999, PEDIATR INFECT DIS J, V18, P239, DOI 10.1097/00006454-199903000-00006; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; WAITZMAN NJ, 1996, COST BIRTH DEFECTS; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752; 1998, FED REG, V63, P40954	54	202	204	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1460	1468		10.1001/jama.283.11.1460	http://dx.doi.org/10.1001/jama.283.11.1460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732936				2022-12-01	WOS:000085696700031
J	Clyne, PJ; Warr, CG; Carlson, JR				Clyne, PJ; Warr, CG; Carlson, JR			Candidate taste receptors in Drosophila	SCIENCE			English	Article							POX-NEURO; GENE POXN; MELANOGASTER; ORGANS; BEHAVIOR	Little is known about the molecular mechanisms of taste perception in animals, particularly the initial events of taste signaling. A large and diverse family of seven transmembrane domain proteins was identified from the Drosophila genome database with a computer algorithm that identifies proteins on the basis of structure. Eighteen of 19 genes examined were expressed in the Drosophila labellum, a gustatory organ of the proboscis. Expression was not detected in a variety of other tissues. The genes were not expressed in the labellum of a Drosophila mutant, pox-neuro(70), in which taste neurons are eliminated. Tissue specificity of expression of these genes, along with their structural similarity, supports the possibility that the family encodes a Large and divergent family of taste receptors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.			Warr, Coral/0000-0002-5289-3950	NIDCD NIH HHS [DC-02174] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHAPMAN RF, 1991, J EXP BIOL, V158, P241; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DETHIER VG, 1955, Q REV BIOL, V30, P348, DOI 10.1086/401030; Dethier VG, 1976, HUNGRY FLY; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; PERIN MS, 1991, J BIOL CHEM, V266, P615; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; SHIRAISHI A, 1970, J GEN PHYSIOL, V56, P768, DOI 10.1085/jgp.56.6.768; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	20	438	490	9	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1830	1834		10.1126/science.287.5459.1830	http://dx.doi.org/10.1126/science.287.5459.1830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710312				2022-12-01	WOS:000085775300044
J	Blackwood, D				Blackwood, D			P300, a state and a trait marker in schizophrenia	LANCET			English	Editorial Material							SUBCOMPONENT ABNORMALITIES		Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Blackwood, D (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.							Adler LE, 1999, BIOL PSYCHIAT, V46, P8, DOI 10.1016/S0006-3223(99)00085-2; Almasy L, 1999, AM J MED GENET, V88, P383; Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Blackwood DHR, 1999, BRIT J PSYCHIAT, V175, P357, DOI 10.1192/bjp.175.4.357; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, pP357; Ford JM, 1999, BIOL PSYCHIAT, V46, P94, DOI 10.1016/S0006-3223(98)00290-X; Frodl-Bauch T, 1999, BIOL PSYCHIAT, V45, P116, DOI 10.1016/S0006-3223(98)00108-5; Higashima M, 1998, BIOL PSYCHIAT, V44, P115, DOI 10.1016/S0006-3223(97)00359-4; O'Donnell BF, 1999, PSYCHOPHYSIOLOGY, V36, P388, DOI 10.1017/S0048577299971688; ROTH WT, 1972, ARCH GEN PSYCHIAT, V27, P466; Salisbury DF, 1998, ARCH GEN PSYCHIAT, V55, P173, DOI 10.1001/archpsyc.55.2.173; Turetsky B, 1998, BIOL PSYCHIAT, V43, P31, DOI 10.1016/S0006-3223(97)00261-8; Turetsky BI, 1998, BIOL PSYCHIAT, V43, P84, DOI 10.1016/S0006-3223(97)00258-8; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Weir N, 1998, SCHIZOPHR RES, V31, P151, DOI 10.1016/S0920-9964(98)00017-6; Weisbrod M, 1999, BIOL PSYCHIAT, V46, P721, DOI 10.1016/S0006-3223(99)00022-0	16	50	52	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					771	772		10.1016/S0140-6736(99)00261-5	http://dx.doi.org/10.1016/S0140-6736(99)00261-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711922				2022-12-01	WOS:000085766900006
J	Schlichting, I; Berendzen, J; Chu, K; Stock, AM; Maves, SA; Benson, DE; Sweet, BM; Ringe, D; Petsko, GA; Sligar, SG				Schlichting, I; Berendzen, J; Chu, K; Stock, AM; Maves, SA; Benson, DE; Sweet, BM; Ringe, D; Petsko, GA; Sligar, SG			The catalytic pathway of cytochrome P450cam at atomic resolution	SCIENCE			English	Article							PEROXIDASE COMPOUND-I; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; C PEROXIDASE; CRYSTALLOGRAPHY; HYDROXYLATION; P-450CAM; INTERMEDIATE; SPECTROSCOPY	Members of the cytochrome P450 superfamily catalyze the addition of molecular oxygen to nonactivated hydrocarbons at physiological temperature-a reaction that requires high temperature to proceed in the absence of a catalyst. Structures were obtained for three intermediates in the hydroxylation reaction of camphor by P450cam with trapping techniques and cryocrystallography. The structure of the ferrous dioxygen adduct of P450cam was determined with 0.91 angstrom wavelength x-rays; irradiation with 1.5 angstrom x-rays results in breakdown of the dioxygen molecule to an intermediate that would be consistent with an oxyferryl species. The structures show conformational changes in several important residues and reveal a network of bound water molecules that may provide the protons needed for the reaction.	Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; Los Alamos Natl Lab, Biophys Grp, Los Alamos, NM 87545 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; Rutgers State University New Brunswick; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Brookhaven National Laboratory; Brandeis University	Schlichting, I (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	ilme.schlichting@mpi-dortmund.mpg.de	Petsko, Gregory/AAO-7962-2020; Schlichting, Ilme/I-1339-2013	Stock, Ann/0000-0002-0446-8079; Berendzen, Joel/0000-0002-9454-9074	NIGMS NIH HHS [GM31756, GM33775] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031756, R01GM033775, R01GM031756] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKENS J, 1994, J AM CHEM SOC, V116, P1143, DOI 10.1021/ja00082a051; Benson DE, 1997, BIOCHEMISTRY-US, V36, P5104, DOI 10.1021/bi963170q; Borman S, 1999, CHEM ENG NEWS, V77, P31, DOI 10.1021/cen-v077n049.p031; BREWER CB, 1986, ARCH BIOCHEM BIOPHYS, V249, P515, DOI 10.1016/0003-9861(86)90029-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, X PLOR SYSTEM CRYSTA; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; CHANCE B, 1980, FEBS LETT, V112, P178, DOI 10.1016/0014-5793(80)80174-8; Contzen J, 1999, BIOCHEMISTRY-US, V38, P16253, DOI 10.1021/bi991759u; DAVYDOV R, 1991, FEBS LETT, V295, P113, DOI 10.1016/0014-5793(91)81398-R; DAWSON JH, 1986, J AM CHEM SOC, V108, P8114, DOI 10.1021/ja00285a052; DEWITT JG, 1991, J AM CHEM SOC, V113, P9219, DOI 10.1021/ja00024a031; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; GERBER NC, 1994, J BIOL CHEM, V269, P4260; GERBER NC, 1992, J AM CHEM SOC, V114, P8742, DOI 10.1021/ja00048a081; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; Groves John T., 1995, P3; GROVES JT, 1984, J AM CHEM SOC, V106, P2177, DOI 10.1021/ja00319a044; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAJDU J, 1993, ANNU REV BIOPH BIOM, V22, P467, DOI 10.1146/annurev.bb.22.060193.002343; Harris D, 1998, J AM CHEM SOC, V120, P4308, DOI 10.1021/ja974110q; Harris DL, 1996, J AM CHEM SOC, V118, P6377, DOI 10.1021/ja954101m; HEDEGAARD J, 1965, J BIOL CHEM, V240, P4038; Honeychurch MJ, 1999, FEBS LETT, V451, P351, DOI 10.1016/S0014-5793(99)00610-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KIMATA Y, 1995, BIOCHEM BIOPH RES CO, V208, P96, DOI 10.1006/bbrc.1995.1310; KOBAYASHI K, 1990, BIOCHIM BIOPHYS ACTA, V1037, P297, DOI 10.1016/0167-4838(90)90028-E; KUBOTA M, 1991, J BIOCHEM-TOKYO, V110, P232, DOI 10.1093/oxfordjournals.jbchem.a123562; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LIPSCOMB JD, 1976, J BIOL CHEM, V251, P1116; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILLER VP, 1992, J BIOL CHEM, V267, P8936; Mueller Ernest J., 1995, P83; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEWCOMB M, IN PRESS J AM CHEM S; Ortiz deMontellano PR, 1995, CYTOCHROME P450 STRU; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; PETSKO GA, 1992, PHILOS T ROY SOC A, V340, P323, DOI 10.1098/rsta.1992.0070; PORTER TD, 1991, J BIOL CHEM, V266, P13469; POULOS TL, 1982, J BIOL CHEM, V257, P427; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; RAAG R, 1989, BIOCHEMISTRY-US, V28, P7586, DOI 10.1021/bi00445a013; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RINGE D, 1992, PHILOS T R SOC A, V340, P273, DOI 10.1098/rsta.1992.0066; Schlichting I, 1997, METHOD ENZYMOL, V277, P467, DOI 10.1016/S0076-6879(97)77026-5; SCHLICHTING I, UNPUB; SHARROCK M, 1976, BIOCHIM BIOPHYS ACTA, V420, P8, DOI 10.1016/0005-2795(76)90340-8; SHIMADA H, 1994, CYTOCHROME P450, P299; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; SLIGAR SG, 1974, BIOCHEM BIOPH RES CO, V61, P290, DOI 10.1016/0006-291X(74)90565-8; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stoddard BL, 1996, PHARMACOL THERAPEUT, V70, P215, DOI 10.1016/0163-7258(96)00058-7; TYSON CA, 1972, J BIOL CHEM, V247, P5777; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; WATANABE R, 1995, INT J RADIAT BIOL, V68, P113, DOI 10.1080/09553009514551011; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531	66	1122	1136	7	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1615	1622		10.1126/science.287.5458.1615	http://dx.doi.org/10.1126/science.287.5458.1615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698731				2022-12-01	WOS:000085628200028
J	Hariharan, S; Johnson, CP; Bresnahan, BA; Taranto, SE; McIntosh, MJ; Stablein, D				Hariharan, S; Johnson, CP; Bresnahan, BA; Taranto, SE; McIntosh, MJ; Stablein, D			Improved graft survival after renal transplantation in the United States, 1988 to 1996.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Transplantation	MAY 15-19, 1999	CHICAGO, ILLINOIS	Amer Soc Transplantat			ALLOGRAFT SURVIVAL; ACUTE REJECTION; CYCLOSPORINE ERA; RISK-FACTORS; RECIPIENTS; PREDICTORS; IMPACT; RACE	Background: The introduction of cyclosporine has resulted in improvement in the short-term outcome of renal transplantation, but its effect on the long-term survival of kidney transplants is not known. Methods: We analyzed the influence of demographic characteristics (age, sex, and race), transplant-related variables (living or cadaveric donor, panel-reactive antibody titer, extent of HLA matching, and cold-ischemia time), and post-transplantation variables (presence or absence of acute rejection, delayed graft function, and therapy with mycophenolate mofetil and tacrolimus) on graft survival for all 93,934 renal transplantations performed in the United States between 1988 and 1996. A regression analysis adjusted for these variables was used to estimate the risk of graft failure within the first year and more than one year after transplantation. Results: From 1988 to 1996, the one-year survival rate for grafts from living donors increased from 88.8 to 93.9 percent, and the rate for cadaveric grafts increased from 75.7 to 87.7 percent. The half-life for grafts from living donors increased steadily from 12.7 to 21.6 years, and that for cadaveric grafts increased from 7.9 to 13.8 years. After censoring of data for patients who died with functioning grafts, the half-life for grafts from living donors increased from 16.9 years to 35.9 years, and that for cadaveric grafts increased from 11.0 years to 19.5 years. The average yearly reduction in the relative hazard of graft failure after one year was 4.2 percent for all recipients (P<0.001), 0.4 percent for those who had acute rejection (P=0.57), and 6.3 percent for those who did not have acute rejection (P<0.001). Conclusions: Since 1988, there has been a substantial increase in short-term and long-term survival of kidney grafts from both living and cadaveric donors. (N Engl J Med 2000;342:605-12.) (C)2000, Massachusetts Medical Society.	Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Div Transplant Surg, Milwaukee, WI 53226 USA; United Network Organ Sharing, Richmond, VA USA; EMMES Corp, Potomac, MD USA	Medical College of Wisconsin; Medical College of Wisconsin; United Network for Organ Sharing; Emmes Corporation	Hariharan, S (corresponding author), Med Coll Wisconsin, Div Nephrol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.				NIAID NIH HHS [N01-AI-25132] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025132] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER JW, 1994, TRANSPLANTATION, V57, P871, DOI 10.1097/00007890-199403270-00018; ALMOND PS, 1993, TRANSPLANTATION, V55, P752, DOI 10.1097/00007890-199304000-00013; BURKE JF, 1994, NEW ENGL J MED, V331, P358, DOI 10.1056/NEJM199408113310604; Cho S, 1999, AM J KIDNEY DIS, V34, P296; COLE E, 1995, CLIN TRANSPLANT, V9, P282; Cosio FG, 1997, TRANSPLANTATION, V63, P1611, DOI 10.1097/00007890-199706150-00013; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; Hariharan S, 1996, CLIN TRANSPLANT, V10, P186; Hariharan S, 1997, TRANSPLANTATION, V64, P1748, DOI 10.1097/00007890-199712270-00022; HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235; Hariharan S, 1996, CLIN TRANSPLANT, V10, P538; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; Jindal RM, 1999, NEPHRON, V83, P13, DOI 10.1159/000045468; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASISKE BL, 1991, NEW ENGL J MED, V324, P302, DOI 10.1056/NEJM199101313240505; KERMAN RH, 1991, TRANSPLANTATION, V51, P338, DOI 10.1097/00007890-199102000-00013; MERION RM, 1984, NEW ENGL J MED, V310, P148, DOI 10.1056/NEJM198401193100303; MORRIS PJ, 1994, BRIT J SURG, V81, P635, DOI 10.1002/bjs.1800810503; PAUL LC, 1995, KIDNEY INT, V47, P1491, DOI 10.1038/ki.1995.211; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; RUSH DN, 1995, TRANSPLANTATION, V59, P511; SCHROEDER TJ, 1995, TRANSPLANT P, V27, P837; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; SUMRANI N, 1993, TRANSPLANT P, V25, P2259; Tejani A, 1996, J AM SOC NEPHROL, V7, P550; Tejani A, 1996, TRANSPLANTATION, V61, P1054, DOI 10.1097/00007890-199604150-00011; TESI RJ, 1993, CLIN TRANSPLANT, V7, P345; THIEL G, 1994, TRANSPLANT P, V26, P2493; *USRDS, 1998, NIH PUBL, P39; Valente JF, 1997, CLIN TRANSPLANT, V11, P231	31	1495	1578	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					605	612		10.1056/NEJM200003023420901	http://dx.doi.org/10.1056/NEJM200003023420901			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699159	Bronze			2022-12-01	WOS:000085575500001
J	Vielle-Calzada, JP; Baskar, R; Grossniklaus, U				Vielle-Calzada, JP; Baskar, R; Grossniklaus, U			Delayed activation of the paternal genome during seed development	NATURE			English	Article							ARABIDOPSIS-THALIANA; PATTERN-FORMATION; GENE; EMBRYO; EMBRYOGENESIS; PROTEIN; GNOM; TRAP	Little is known about the timing of the maternal-to-zygotic transition during seed development in flowering plants. Because plant embryos can develop from somatic cells or microspores(1), maternal contributions are not considered to be crucial in early embryogensis(2). Early-acting embryo-lethal mutants in Arabidopsis, including emb30/gnom which affects the first zygotic division(3,4) have fuelled the perception that both maternal and paternal genomes are active immediately after fertilization. Here we show that none of the paternally inherited alleles of 20 loci that we tested is expressed during early seed development in Arabidopsis. For genes that are expressed at later stages, the paternally inherited allele becomes active three to four days after fertilization. The genes that we tested are involved in various processes and distributed throughout the genome, indicating that most, if not all, of the paternal genome may be initially silenced. Our findings are corroborated by genetic studies showing that emb30/gnom has a maternal-effect phenotype that is paternally rescuable in addition to its zygotic lethality. Thus, contrary to previous interpretations, early embryo and endosperm development are mainly under maternal control.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Grossniklaus, U (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Grossniklaus, Ueli/E-9995-2016; Grossniklaus, Ueli/A-2736-2012	Grossniklaus, Ueli/0000-0002-0522-8974; Ramamurthy, Baskar/0000-0001-5705-9976; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490				BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0; Berger F, 1999, CURR OPIN PLANT BIOL, V2, P28, DOI 10.1016/S1369-5266(99)80006-5; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P351; Buglia G, 1999, CHROMOSOME RES, V7, P71, DOI 10.1023/A:1009231529635; Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/s004380050121; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; HOWELL SH, 1999, MOL GENETICS PLANT D; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MAYER U, 1993, DEVELOPMENT, V117, P149; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; Meinke DW, 1994, ARABIDOPSIS THALIANA, P253; Moore JM, 1997, COLD SPRING HARB SYM, V62, P35, DOI 10.1101/SQB.1997.062.01.007; Mordhorst AP, 1997, CRIT REV PLANT SCI, V16, P535, DOI 10.1080/713608156; Newman-Smith ED, 1998, CURR OPIN GENET DEV, V8, P472, DOI 10.1016/S0959-437X(98)80120-2; NUR U, 1990, DEVELOPMENT S, V1, P29; Oakeley EJ, 1997, P NATL ACAD SCI USA, V94, P11721, DOI 10.1073/pnas.94.21.11721; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; SPRINGER PS, 1995, SCIENCE, V268, P877, DOI 10.1126/science.7754372; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; UEDA K, 1995, DEV BIOL, V169, P210, DOI 10.1006/dbio.1995.1138; VAN WENT J. L., 1984, EMBRYOLOGY ANGIOSPER, P273, DOI [10.1007/978-3-642-69302-1_6, DOI 10.1007/978-3-642-69302-1_6]; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3; Xu HL, 1999, PLANT MOL BIOL, V39, P607, DOI 10.1023/A:1006162120037; ZALOKAR M, 1976, DEV BIOL, V49, P425, DOI 10.1016/0012-1606(76)90185-8; ZIMMERMAN JL, 1991, NEW BIOL, V3, P641	29	239	257	2	34	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					91	94		10.1038/35003595	http://dx.doi.org/10.1038/35003595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716449				2022-12-01	WOS:000085775100052
J	Tunstall-Pedoe, H; Vanuzzo, D; Hobbs, M; Mahonen, M; Cepaitis, Z; Kuulasmaa, K; Keil, U				Tunstall-Pedoe, H; Vanuzzo, D; Hobbs, M; Mahonen, M; Cepaitis, Z; Kuulasmaa, K; Keil, U		WHO MONICA Project	Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIALS; UNSTABLE ANGINA; CASE-FATALITY; REINFARCTION; MANAGEMENT; GUIDELINES; PREVENTION; DECLINE; FAILURE	Background The revolution in coronary care in the mid-1980s to mid-1990s corresponded with monitoring of coronary heart disease (CHD) in 31 populations of the WHO MONICA Project. We studied the impact of this revolution on coronary endpoints. Methods Case fatality, coronary-event rates, and CHD mortality were monitored in men and women aged 35-64 years in two separate 3-4-year periods. In each period, we recorded percentage use of eight treatments: coronary-artery reperfusion before, thrombolytics during, and beta-blockers, antiplatelet drugs, and angiotensin-converting-enzyme (ACE) inhibitors before and during non-fatal myocardial infarction. Values were averaged to produce treatment scores. We correlated changes across populations, and regressed changes in coronary endpoints on changes in treatment scores. Findings Treatment changes correlated positively with each other but inversely with change in coronary endpoints. By regression, for the common average treatment change of 20, case fatality fell by 19% (95% CI 12-26) in men and 16% (5-27) in women; coronary-event rates fell by 25% (16-35) and 23% (7-39); and CHD mortality rates fell by 42% (31-53) and 34% (17-50). The regression model explained an estimated 61% and 41% of variance for men and women in trends for case fatality, 52% and 30% for coronary-event rates, and 72% and 56% for CHD mortality. Interpretation Changes in coronary care and secondary prevention were strongly linked with declining coronary endpoints. Scores and benefits followed a geographical east-to-west gradient. The apparent effects of the treatment might be exaggerated by other changes in economically successful populations, so their specificity needs further assessment.	Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, MONICA Qual Control Ctr Event Registrat, Dundee DD1 9SY, Scotland; Ctr Malattie Cardiovasc, ASS4 Medio Friuli, Udine, Italy; Univ Western Australia, Dept Publ Hlth, Perth, WA 6009, Australia; Natl Publ Hlth Inst, KTL, MONICA Data Ctr, Dept Epidemiol & Hlth Promot, Helsinki, Finland; Univ Munster, Dept Epidemiol & Social Med, D-4400 Munster, Germany	University of Dundee; University of Western Australia; Finland National Institute for Health & Welfare; University of Munster	Tunstall-Pedoe, H (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Cardiovasc Epidemiol Unit, MONICA Qual Control Ctr Event Registrat, Dundee DD1 9SY, Scotland.	h.tunstallpedoe@dundee.ac.uk	Zikic, Milorad/Q-6630-2019	Paluzie, Guillermo/0000-0002-5808-6041; Kuulasmaa, Kari/0000-0003-2165-1411				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1986, LANCET, V2, P57; *ANT TRIAL COLL, 1988, BMJ-BRIT MED J, V196, P320; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; Chambless L, 1997, CIRCULATION, V96, P3849; COLLINS R, 1995, LANCET, V345, P669; DEVITA C, 1994, LANCET, V343, P1115; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; FRYE RL, 1982, CIRCULATION, V65, P111; Fuller WayneA., 2009, MEASUREMENT ERROR MO, V305; FURBERG CD, 1985, AM J CARDIOL, V55, P1110, DOI 10.1016/0002-9149(85)90756-8; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; HELD PH, 1989, BMJ-BRIT MED J, V299, P1187, DOI 10.1136/bmj.299.6709.1187; HJALMARSON A, 1981, LANCET, V2, P823; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; KUULASMAA K, 1997, B INT STAT I, P295; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; NORRIS RM, 1969, LANCET, V1, P274; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; PEDERSEN TR, 1994, LANCET, V344, P1383; PEEL AAF, 1962, BRIT HEART J, V24, P745; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259	39	346	360	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 26	2000	355	9205					688	700		10.1016/S0140-6736(99)11181-4	http://dx.doi.org/10.1016/S0140-6736(99)11181-4			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703800				2022-12-01	WOS:000085615600010
J	Antson, AA; Burns, JE; Moroz, OV; Scott, DJ; Sanders, CM; Bronstein, IB; Dodson, GG; Wilson, KS; Maitland, NJ				Antson, AA; Burns, JE; Moroz, OV; Scott, DJ; Sanders, CM; Bronstein, IB; Dodson, GG; Wilson, KS; Maitland, NJ			Structure of the intact transactivation domain of the human papillomavirus E2 protein	NATURE			English	Article							DNA-BINDING DOMAIN; FUNCTIONAL INTERACTION; AMINO-ACIDS; REPLICATION; ACTIVATION; DIMERS	Papillomaviruses cause warts and proliferative lesions in skin and other epithelia. In a minority of papillomavirus types ('high risk'. including human papillomaviruses 16, 18, 31, 33, 45 and 56), further transformation of the wart lesions can produce tumours'. The papillomavirus E2 protein controls primary transcription and replication of the viral genome(2). Both activities are governed by a similar to 200 amino-acid amino-terminal module (E2NT) which is connected to a DNA-binding carboxy-terminal module by a flexible linker. Here we describe the crystal structure of the complete E2NT module from human papillomavirus 16. The E2NT module forms a dimer both in the crystal and in solution. Amino acids that are necessary for transactivation are located at the dimer interface, indicating that the dimer structure may be important in the interactions of E2NT with viral and cellular transcription factors. We propose that dimer formation may contribute to the stabilization of DNA loops(3) which may serve to relocate distal DNA-binding transcription factors to the site of human papillomavirus transcription initiation.	Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5DD, N Yorkshire, England; Natl Inst Med Res, London NW7 1AA, England	University of York - UK; University of York - UK; MRC National Institute for Medical Research	Wilson, KS (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.		Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Maitland, Norman/0000-0003-1607-9035; Scott, David/0000-0002-6726-2078; Moroz, Olga/0000-0002-0354-6119; Wilson, Keith/0000-0002-3581-2194; Burns, Julie/0000-0003-1238-8826				Abroi A, 1996, J VIROL, V70, P6169, DOI 10.1128/JVI.70.9.6169-6179.1996; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; Brokaw JL, 1996, J VIROL, V70, P23, DOI 10.1128/JVI.70.1.23-29.1996; Burns JE, 1998, ACTA CRYSTALLOGR D, V54, P1471, DOI 10.1107/S0907444998010889; Chao SF, 1999, BIOCHEMISTRY-US, V38, P4586, DOI 10.1021/bi982616v; COLLETTI V, 1994, SKULL BASE SURG, V4, P1, DOI 10.1055/s-2008-1058981; Cooper CS, 1998, VIROLOGY, V241, P312, DOI 10.1006/viro.1997.8941; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050; GAUTHIER JM, 1991, NEW BIOL, V3, P498; Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; KNIGHT JD, 1991, P NATL ACAD SCI USA, V88, P3204, DOI 10.1073/pnas.88.8.3204; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1; MCBRIDE AA, 1997, HUMAN PAPILLOMAVIRUS, P54; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; Mok YK, 1996, PROTEIN SCI, V5, P310; OLDFIELD TJ, 1994, P CCP4 STUD WEEK 1 M, P15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sengchanthalangsy LL, 1999, J MOL BIOL, V289, P1029, DOI 10.1006/jmbi.1999.2823; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998; zur Hausen H, 1994, Curr Top Microbiol Immunol, V186, P131	29	88	93	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					805	809		10.1038/35001638	http://dx.doi.org/10.1038/35001638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693813				2022-12-01	WOS:000085423100060
J	Brazma, A; Robinson, A; Cameron, G; Ashburner, M				Brazma, A; Robinson, A; Cameron, G; Ashburner, M			One-stop shop for microarray data - Is a universal, public DNA-microarray database a realistic goal?	NATURE			English	Editorial Material									European Bioinformat Inst, Wellcome Trust Genome, Cambridge CB10 1SD, England	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Brazma, A (corresponding author), European Bioinformat Inst, Wellcome Trust Genome, Campus, Cambridge CB10 1SD, England.	brazma@ebi.ac.uk		Brazma, Alvis/0000-0001-5988-7409				*CHIPP FOR, 1999, NATURE GENET S, V21; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Kaiser J, 1999, SCIENCE, V284, P410; Pennisi E, 1999, SCIENCE, V286, P449, DOI 10.1126/science.286.5439.449; 1999, NATURE GENET, V22, P211	5	101	106	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					699	700		10.1038/35001676	http://dx.doi.org/10.1038/35001676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693778				2022-12-01	WOS:000085423100020
J	Kitov, PI; Sadowska, JM; Mulvey, G; Armstrong, GD; Ling, H; Pannu, NS; Read, RJ; Bundle, DR				Kitov, PI; Sadowska, JM; Mulvey, G; Armstrong, GD; Ling, H; Pannu, NS; Read, RJ; Bundle, DR			Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands	NATURE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; RECEPTOR; BINDING; IDENTIFICATION; PATHOGENESIS; GLYCOSIDES; TYPE-1; MICE	The diseases caused by Shiga and cholera toxins account for the loss of millions of lives each year(1). Both belong to the clinically significant subset of bacterial AB(5) toxins consisting of an enzymatically active A subunit that gains entry to susceptible mammalian cells after oligosaccharide recognition by the B-5 homopentamer(2,3), Therapies might target the obligatory oligosaccharide-toxin recognition event(4), but the low intrinsic affinity of carbohydrate-protein interactions hampers the development of low-molecular-weight inhibitors(5). The toxins circumvent low affinity by binding simultaneously to five or more cell-surface carbohydrates(6), Here we demonstrate the use of the crystal structure of the B-5 subunit Of Escherichia coli O157:H7 Shiga-like toxin I (SLT-I) in complex with an analogue of its carbohydrate receptor(6) to design an oligovalent, water-soluble carbohydrate ligand (named STARFISH), with subnanomolar inhibitory activity. The in vitro inhibitory activity is 1-10-million-fold higher than that of univalent ligands and is by far the highest molar activity of any inhibitor yet reported for Shiga-like toxins I and II. Crystallography of the STARFISH/Shiga-like toxin I complex explains this activity. Two trisaccharide receptors at the tips of each of five spacer arms simultaneously engage all five B subunits of two toxin molecules.	Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England	University of Alberta; University of Alberta; University of Alberta; University of Cambridge	Bundle, DR (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.		Ling, Hong/E-3729-2010; Read, Randy J/L-1418-2013; Kitov, Pavel/J-3714-2014	Read, Randy J/0000-0001-8273-0047; 				ARMSTRONG GD, 1991, J INFECT DIS, V164, P1160, DOI 10.1093/infdis/164.6.1160; ARONSON M, 1979, J INFECT DIS, V139, P329, DOI 10.1093/infdis/139.3.329; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; BOYD B, 1989, NEPHRON, V51, P207, DOI 10.1159/000185286; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CIMOLAI N, 1990, J PEDIATR-US, V116, P589, DOI 10.1016/S0022-3476(05)81609-9; DEGRANDIS S, 1987, J BACTERIOL, V169, P4313, DOI 10.1128/jb.169.9.4313-4319.1987; Dubber M, 1998, CARBOHYD RES, V310, P35, DOI 10.1016/S0008-6215(98)00155-4; FUCHS G, 1986, INFECT IMMUN, V53, P372, DOI 10.1128/IAI.53.2.372-377.1986; HOLMGREN J, 1992, GASTROENTEROL CLIN N, V21, P283; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kitov PI, 1998, CARBOHYD RES, V307, P361, DOI 10.1016/S0008-6215(98)00053-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Mulvey G, 1998, J MICROBIOL METH, V32, P247, DOI 10.1016/S0167-7012(98)00028-1; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Read RJ, 1997, METHOD ENZYMOL, V277, P110, DOI 10.1016/S0076-6879(97)77009-5; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993	30	729	756	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					669	672		10.1038/35001095	http://dx.doi.org/10.1038/35001095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688205				2022-12-01	WOS:000085288200057
J	Mayer, W; Niveleau, A; Walter, J; Fundele, R; Haaf, T				Mayer, W; Niveleau, A; Walter, J; Fundele, R; Haaf, T			Embryogenesis - Demethylation of the zygotic paternal genome	NATURE			English	Article							DNA-REPLICATION; PREIMPLANTATION DEVELOPMENT; MOUSE EMBRYOS; METHYLATION		Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Grenoble 1, Mol & Struct Virol Unit, F-38706 La Tronche, France	Max Planck Society; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)								Adenot PG, 1997, DEVELOPMENT, V124, P4615; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; HOWLETT SK, 1986, ROUX ARCH DEV BIOL, V195, P499, DOI 10.1007/BF00375890; MONK M, 1987, DEVELOPMENT, V99, P371; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; SCHEER U, 1987, EUR J CELL BIOL, V43, P358; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	10	1011	1066	0	91	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					501	502		10.1038/35000656	http://dx.doi.org/10.1038/35000656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676950				2022-12-01	WOS:000085227300037
J	Ong, KKL; Ahmed, ML; Emmett, PM; Preece, MA; Dunger, DB				Ong, KKL; Ahmed, ML; Emmett, PM; Preece, MA; Dunger, DB		Avon Longitudinal Study Pregnancy	Association between postnatal catch-up growth and obesity in childhood: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PREGNANT-WOMEN; WEIGHT-GAIN; SOUTH-WEST; POPULATION; CHILDREN; INFANTS; ENGLAND; BIRTH; DIET	Objective To identify predictors of postnatal catch-up growth from birth to two years and its relation to size and obesity at five years. Design Regional prospective cohort study. Setting Avon longitudinal study of pregnancy and childhood, United Kingdom. Subjects 848 full term singletons from a 10% random sample of the Avon longitudinal study of pregnancy and childhood. Main outcome measures Maternal birth weight, prepregnancy weight pregnancy weight gain, height, smoking, and parity, and paternal height, Weight and length of infants at birth, two years, and five years expressed as standard deviation (SD) scores fr om the UK reference scores for 1990, Percentage fat mass and total fat mass (estimated from skinfolds) and waist circumference at five years. Results Size at birth was representative of die national reference. Overall, 30.7% (260 of 848) of infants showed a gain in SD score for weight greater than 0.67 SD scores between zero and two years, indicating clinically significant catch-up growth. These children had lower weight, length, and ponderal index at birth than other children, and were more often from primiparous pregnancies. They also had taller fathers than other children, and their mothers had lower birth weights and were more likely to smoke during pregnancy. Children who showed catch-up growth between zero and two years were heavier, taller, and fatter (body mass index, percentage body fat, and waist circumference) at five years than other children. Conclusions Tn this contemporary well nourished cohort, catch-up growth was predicted by factors relating to intrauterine restraint of fetal growth. Children who showed catch-up growth between zero and two years were fatter and had more central fat distribution at five years than other children. Mechanisms that signal and regulate early catch-up growth in the postnatal period may influence associations between small size at birth and risks for disease in adulthood.	Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1N 1AH, England	University of Oxford; University of Bristol; University of London; University College London	Dunger, DB (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.		Emmett, Pauline/AAL-6815-2021	Dunger, Professor David/0000-0002-2566-9304; Emmett, Pauline/0000-0003-1076-4779; Golding, Jean/0000-0003-2826-3307	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; OBRIEN PM, 1999, P 36 ROYAL COLL OBST; Ong KKL, 1999, J CLIN ENDOCR METAB, V84, P1145, DOI 10.1210/jc.84.3.1145; OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281; OUNSTED M, 1975, LANCET, V1, P1393, DOI 10.1016/S0140-6736(75)92605-7; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Siri W E, 1993, Nutrition, V9, P480; Tanner J. M., 1994, Acta Medica Auxologica (Milan), V26, P7; Tanner J. M., 1986, HUMAN GROWTH, P167; TANNER JM, 1956, ARCH DIS CHILD, V31, P372, DOI 10.1136/adc.31.159.372; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; 1999, AVON LONGITUDINAL ST	25	1180	1243	0	68	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					967	971		10.1136/bmj.320.7240.967	http://dx.doi.org/10.1136/bmj.320.7240.967			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303XP	10753147	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000086453100020
J	Bianchi, E; Denti, S; Granata, A; Bossi, G; Geginat, J; Villa, A; Rogge, L; Pardi, R				Bianchi, E; Denti, S; Granata, A; Bossi, G; Geginat, J; Villa, A; Rogge, L; Pardi, R			Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity	NATURE			English	Article							COMPLEX; KINASE; CYTOSKELETAL; REQUIRES; SUBUNIT; SIGNALS	Integrin adhesion receptors transduce signals that control complex cell functions which require the regulation of gene expression, such as proliferation, differentiation and survival(1). Their intracellular domain has no catalytic function, indicating that interaction with other transducing molecules is crucial for integrin-mediated signalling. Here we have identified a protein that interacts with the cytoplasmic domain of the beta 2 subunit of the alpha L/beta 2 integrin LFA-1. This protein is JAB1 (Jun activation domain-binding protein 1), a coactivator of the c-Jun transcription factor(2). We found that JAB1 is present both in the nucleus and in the cytoplasm of cells and that a fraction of JAB1 colocalizes with LFA-1 at the cell membrane. LFA-1 engagement is followed by an increase of the nuclear pool of JAB1, paralleled by enhanced binding of c-Jun-containing AP-1 complexes to their DNA consensus site and increased transactivation of an AP-1-dependent promoter. We suggest that signalling through the LFA-1 integrin may affect c-Jun-driven transcription by regulating JAB1 nuclear localization. This represents a new pathway for integrin-dependent modulation of gene expression.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Milan Bicocca, Fac Med, MIA, I-20052 Monza, Italy; Roche Milano Ric, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Oxford; University of Milano-Bicocca; Roche Holding; Vita-Salute San Raffaele University	Bianchi, E (corresponding author), San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy.		Rogge, Lars/GYJ-6142-2022; Villa, Antonello/B-4781-2012; Geginat, Jens/AAA-5818-2019	Geginat, Jens/0000-0003-4813-0384; Villa, Antonello/0000-0002-3820-8072; Rogge, Lars/0000-0003-1262-9204	Telethon [E.0492] Funding Source: Medline	Telethon(Fondazione Telethon)		Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Geginat J, 1999, J IMMUNOL, V162, P5085; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; PARDI R, 1995, J IMMUNOL, V155, P1252; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7	21	180	188	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					617	+		10.1038/35007098	http://dx.doi.org/10.1038/35007098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766246				2022-12-01	WOS:000086400100057
J	Fuentes-Prior, P; Iwanaga, Y; Huber, R; Pagila, R; Rumennik, G; Seto, M; Morser, J; Light, DR; Bode, W				Fuentes-Prior, P; Iwanaga, Y; Huber, R; Pagila, R; Rumennik, G; Seto, M; Morser, J; Light, DR; Bode, W			Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex	NATURE			English	Article							RAY CRYSTAL-STRUCTURE; FACTOR-LIKE DOMAINS; EGF-LIKE DOMAIN; PROTEIN-C; MOLECULAR MECHANISMS; COFACTOR ACTIVITY; BINDING-SITE; COAGULATION; ACTIVATION; SURFACE	The serine proteinase alpha-thrombin causes blood clotting through proteolytic cleavage of fibrinogen and protease-activated receptors and amplifies its own generation by activating the essential clotting factors V and VIII1, Thrombomodulin(2), a transmembrane thrombin receptor with six contiguous epidermal growth factor-like domains (TME1-6), profoundly alters the substrate specificity of thrombin from pro- to anticoagulant by activating protein C (see, for example, reference 2). Activated protein C then deactivates the coagulation cascade by degrading activated factors V and VIII2. The thrombin-thrombomodulin complex inhibits fibrinolysis by activating the procarboxypeptidase thrombin-activatable fibrinolysis inhibitor(3). Here we present the 2.3 Angstrom crystal structure of human alpha-thrombin bound to the smallest thrombomodulin fragment required for full protein-C co-factor activity, TME456. The Y-shaped thrombomodulin fragment binds to thrombin's anion-binding exosite-I, preventing binding of procoagulant substrates. Thrombomodulin binding does not seem to induce marked allosteric structural rearrangements at the thrombin active site. Rather, docking of a protein C model to thrombin-TME456 indicates that TME45 may bind substrates in such a manner that their zymogen-activation cleavage sites are presented optimally to the unaltered thrombin active site.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Berlex Biosci, Richmond, CA 94804 USA	Max Planck Society	Fuentes-Prior, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.	fuentes@biochem.mpg.de; bode@biochem.mpg.de		Fuentes-Prior, Pablo/0000-0002-6618-3204				ADLER M, 1995, J BIOL CHEM, V270, P23366, DOI 10.1074/jbc.270.40.23366; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Benitez BAS, 1997, J MOL BIOL, V273, P913, DOI 10.1006/jmbi.1997.1356; BODE W, 1992, PROTEIN SCI, V1, P426; BRUNGER GJ, 1993, XPLOR VERSION 3 1 SY; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CLARKE JH, 1993, J BIOL CHEM, V268, P6309; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; GRINNELL BW, 1994, BIOCHEM J, V303, P929, DOI 10.1042/bj3030929; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; HOGG PJ, 1992, J BIOL CHEM, V267, P703; Knobe KE, 1999, PROTEINS, V35, P218, DOI 10.1002/(SICI)1097-0134(19990501)35:2<218::AID-PROT8>3.0.CO;2-2; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Light DR, 1999, EUR J BIOCHEM, V262, P522, DOI 10.1046/j.1432-1327.1999.00398.x; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P13547, DOI 10.1021/bi00250a006; MEININGER DP, 1995, PROTEIN SCI, V4, P1683, DOI 10.1002/pro.5560040904; MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042; NAGASHIMA M, 1993, J BIOL CHEM, V268, P2888; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; VINCENOT A, 1995, FEBS LETT, V367, P153, DOI 10.1016/0014-5793(95)00552-K; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485; YE J, 1991, J BIOL CHEM, V266, P23016; ZUSHI M, 1991, J BIOL CHEM, V266, P19886	37	259	288	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					518	525		10.1038/35006683	http://dx.doi.org/10.1038/35006683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761923				2022-12-01	WOS:000086257700054
J	Harms, KE; Wright, SJ; Calderon, O; Hernandez, A; Herre, EA				Harms, KE; Wright, SJ; Calderon, O; Hernandez, A; Herre, EA			Pervasive density-dependent recruitment enhances seedling diversity in a tropical forest	NATURE			English	Article							JANZEN-CONNELL MODEL; NEOTROPICAL FOREST; TREE; SPECIFICITY; HERBIVORY; SURVIVAL; DISTANCE	Negative density-dependent recruitment of seedlings, that is, seeds of a given species are less likely to become established seedlings if the density of that species is high, has been proposed to be an important mechanism contributing to the extraordinary diversity of tropical tree communities(1-3) because it can potentially prevent any particular species from usurping all available space, either in close proximity to seed sources or at relatively larger spatial scales(1-18). However, density-dependent recruitment does not necessarily enhance community diversity(14). Furthermore, although density-dependent effects have been found at some life stages in some species(3-13), no study has shown that density-dependent recruitment affects community diversity(14,15). Here we report the results of observations in a lowland, moist forest in the Republic of Panama in which the species identities of 386,027 seeds that arrived at 200 seed traps were compared with the species identities of 13,068 seedlings that recruited into adjacent plots over a 4-year period. Across the 200 sites, recruit seedling diversity was significantly higher than seed diversity. Part of this difference was explained by interspecies differences in average recruitment success. Even after accounting for these differences, however, negative density-dependent recruitment contributes significantly to the increase in diversity from Seeds to seedling recruits.	Smithsonian Trop Res Inst, Balboa, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Wright, SJ (corresponding author), Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama.	wrightj@tivoli.si.edu	Wright, Stuart Joseph/M-3311-2013	Wright, Stuart Joseph/0000-0003-4260-5676				[Anonymous], 1991, PLANT ANIMAL INTERAC; AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; CONNELL J H, 1971, P298; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; HAMMERSTEIN B, 1995, CD-ROM PROF, V8, P76; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; HOWE HF, 1990, J TROP ECOL, V6, P259, DOI 10.1017/S0266467400004508; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; HUBBELL SP, 1980, OIKOS, V35, P214, DOI 10.2307/3544429; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Leigh E.G., 1999, TROPICAL FOREST ECOL; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 1999, P ROY SOC B-BIOL SCI, V266, P1445, DOI 10.1098/rspb.1999.0799; Wright SJ, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P449; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.1890/0012-9658(1999)080[1632:TENOSO]2.0.CO;2	27	719	807	4	276	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					493	495		10.1038/35006630	http://dx.doi.org/10.1038/35006630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761916				2022-12-01	WOS:000086257700047
J	Brenner, S				Brenner, S			Genomics - The end of the beginning	SCIENCE			English	Editorial Material									Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Brenner, S (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.	brenner@molsci.org						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204	3	34	34	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2173	2174		10.1126/science.287.5461.2173	http://dx.doi.org/10.1126/science.287.5461.2173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744539				2022-12-01	WOS:000086049100028
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Using the Framingham model to predict heart disease in the United Kingdom: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; CHAMBLESS LE, 1990, STAT MED, V9, P385, DOI 10.1002/sim.4780090410; KANNEL WB, 1993, CARDIOLOGY, V82, P137, DOI 10.1159/000175864; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Vanderpump MPJ, 1996, THYROID, V6, P155	5	73	78	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					676	677		10.1136/bmj.320.7236.676	http://dx.doi.org/10.1136/bmj.320.7236.676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710574	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000085895300018
J	Thomas, SL; Ellertson, C				Thomas, SL; Ellertson, C			Nuisance or natural and healthy: should monthly menstruation be optional for women?	LANCET			English	Article									Populat Council, Latin Amer & Caribbean Reg Off, Mexico City 04000, DF, Mexico		Ellertson, C (corresponding author), Populat Council, Latin Amer & Caribbean Reg Off, Escondrida 110,Col Villa Coyoacan, Mexico City 04000, DF, Mexico.							Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; COUTINHO EM, 1999, REPROD MED MILLENNIU; COUTINHO EM, 1996, IS MENSTRUATION OBSO; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; Kjerulff KH, 1996, AM J PUBLIC HEALTH, V86, P195, DOI 10.2105/AJPH.86.2.195; LOUDON NB, 1977, BRIT MED J, V2, P487, DOI 10.1136/bmj.2.6085.487; Sulak PJ, 1997, OBSTET GYNECOL, V89, P179, DOI 10.1016/S0029-7844(96)00488-7; World Health Organization, 1996, IMPR ACC QUAL CAR FA	8	114	125	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					922	924		10.1016/S0140-6736(99)11159-0	http://dx.doi.org/10.1016/S0140-6736(99)11159-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752720				2022-12-01	WOS:000085896000043
J	Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT				Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT			Hematopoietic stem cell quiescence maintained by p21(cip1/waf1)	SCIENCE			English	Article							IN-VITRO; CDK INHIBITORS; MICE; TRANSPLANTATION; CYCLE; MOUSE; DIFFERENTIATION; CAPACITY; 5-FLUOROURACIL; CHEMOTHERAPY	Relative quiescence is a defining characteristic of hematopoietic stem cells, while their progeny have dramatic proliferative ability and inexorably move toward terminal differentiation. The quiescence of stem cells has been conjectured to be of critical biologic importance in protecting the stem cell compartment, which we directly assessed using mice engineered to be deficient in the G(1) checkpoint regulator, cyclin-dependent kinase inhibitor, p21(cip1/waf1) (p21). In the absence of p21, hematopoietic stem cell proliferation and absolute number were increased under normal homeostatic conditions. Exposing the animals to cell cycle-specific myelotoxic injury resulted in premature death due to hematopoietic cell depletion. Further, self-renewal of primitive cells was impaired in serially transplanted bone marrow from p21(-/-) mice, leading to hematopoietic failure. Therefore, p21 is the molecular switch governing the entry of stem cells into the cell cycle, and in its absence, increased cell cycling leads to stem cell exhaustion. Under conditions of stress, restricted cell cycling is crucial to prevent premature stem cell depletion and hematopoietic death.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, AIDS Res Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, 149 13th St,Room 5212, Boston, MA 02129 USA.	scadden.david@mgh.harvard.edu		Cheng, Tao/0000-0002-5925-2769; Yang, Yong-Guang/0000-0003-4985-1247; Rodrigues, Neil/0000-0002-1925-7733	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL44851] Funding Source: Medline; NIAID NIH HHS [AI07387] Funding Source: Medline; NIDDK NIH HHS [DK50234] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Dao MA, 1998, EXP HEMATOL, V26, P687; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Gardner RV, 1997, EXP HEMATOL, V25, P495; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, EXP HEMATOL, V26, P562; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LERNER C, 1990, EXP HEMATOL, V18, P114; Mantel C, 1996, BLOOD, V88, P3710, DOI 10.1182/blood.V88.10.3710.bloodjournal88103710; MAUCH P, 1989, BONE MARROW TRANSPL, V4, P601; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; MULLER AM, 1993, DEVELOPMENT, V118, P1343; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; OGAWA M, 1993, BLOOD, V81, P2844; PLOEMACHER RE, 1989, BLOOD, V74, P2755; PLOEMACHER RE, 1991, BLOOD, V78, P2527; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Taniguchi T, 1999, BLOOD, V93, P4167, DOI 10.1182/blood.V93.12.4167.412k05_4167_4178; UCHIDA N, 1994, BLOOD, V83, P3758; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WOLF NS, 1993, EXP HEMATOL, V21, P614; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	35	979	1039	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1804	1808		10.1126/science.287.5459.1804	http://dx.doi.org/10.1126/science.287.5459.1804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710306				2022-12-01	WOS:000085775300038
J	Winkler, KE; Swenson, KI; Kornbluth, S; Means, AR				Winkler, KE; Swenson, KI; Kornbluth, S; Means, AR			Requirement of the prolyl isomerase Pin1 for the replication checkpoint	SCIENCE			English	Article							CELL-CYCLE; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; EGG EXTRACTS; MITOSIS; XENOPUS; COMPLETION; MATURATION; SEQUENCE; PROTEIN	The peptidyl-prolyl isomerase Pin1 has been implicated in regulating cell cycle progression. Pin1 was found to be required for the DNA replication checkpoint in Xenopus laevis, Egg extracts depleted of Pin1 inappropriately transited from the G(2) to the M phase of the cell cycle in the presence of the DNA replication inhibitor aphidicolin. This defect in replication checkpoint function was reversed after the addition of recombinant wild-type Pin1, but not an isomerase-inactive mutant, to the depleted extract. Premature mitotic entry in the absence of Pin1 was accompanied by hyperphosphorylation of Cdc25, activation of Cdc2/cyclin B, and generation of epitopes recognized by the mitotic phosphoprotein antibody, MPM-2. Therefore, Pin1 appears to be required for the checkpoint delaying the onset of mitosis in response to incomplete replication.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Means, AR (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.				NCI NIH HHS [CA 82845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albert A, 1999, J CELL SCI, V112, P2493; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Hani J, 1999, J BIOL CHEM, V274, P108, DOI 10.1074/jbc.274.1.108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; KUANG J, 1989, P NATL ACAD SCI USA, V86, P4982, DOI 10.1073/pnas.86.13.4982; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; Morris DP, 1999, J BIOL CHEM, V274, P31583, DOI 10.1074/jbc.274.44.31583; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SCHLEGEL R, 1987, P NATL ACAD SCI USA, V84, P9025, DOI 10.1073/pnas.84.24.9025; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; WILCOX C, UNPUB; WINKLER K, UNPUB; WU XT, COMMUNICATION; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957	33	148	153	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1644	1647		10.1126/science.287.5458.1644	http://dx.doi.org/10.1126/science.287.5458.1644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698738				2022-12-01	WOS:000085628200036
J	Yang, A; Walker, N; Bronson, R; Kaghad, M; Oosterwegel, M; Bonnin, J; Vagner, C; Bonnet, H; Dikkes, P; Sharpe, A; McKeon, F; Caput, D				Yang, A; Walker, N; Bronson, R; Kaghad, M; Oosterwegel, M; Bonnin, J; Vagner, C; Bonnet, H; Dikkes, P; Sharpe, A; McKeon, F; Caput, D			p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours	NATURE			English	Article							DENTATE GYRUS; P53; REELER; RECEPTORS; MAMMALS; MOUSE; ORGANIZATION; FAMILY; CELLS; DEATH	p73 (ref. 1) has high homology with the tumour suppressor p53 (refs 2-4), as well as with p63, a gene implicated in the maintenance of epithelial stem cells(5-7). Despite the localization of the p73 gene to chromosome 1p36.3, a region of frequent aberration in a wide range of human cancers(1), and the ability of p73 to transactivate p53 target genes(1), it is unclear whether p73 functions as a tumour suppressor. Here we show that mice functionally deficient for all p73 isoforms exhibit profound defects, including hippocampal dysgenesis, hydrocephalus, chronic infections and inflammation, as well as abnormalities in pheromone sensory pathways. In contrast to p53-deficient mice, however, those lacking p73 show no increased susceptibility to spontaneous tumorigenesis. We report the mechanistic basis of the hippocampal dysgenesis and the loss of pheromone responses, and show that new,potentially dominant-negative, p73 variants are the predominant expression products of this gene hi developing and adult tissues. Our data suggest that there is a marked divergence in the physiological functions of the p53 family members, and reveal unique roles for p73 in neurogenesis, sensory pathways and homeostatic control.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Sanofi Rech, F-31676 Labege, France; Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Sanofi-Aventis; Sanofi France; Tufts University; United States Department of Agriculture (USDA); Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu; daniel.caput@wanadoo.fr						Alcantara S, 1998, J NEUROSCI, V18, P7779; Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	30	831	862	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					99	103		10.1038/35003607	http://dx.doi.org/10.1038/35003607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716451				2022-12-01	WOS:000085775100054
J	Kobayashi, N; Fujiwara, T; Westerman, KA; Inoue, Y; Sakaguchi, M; Noguchi, H; Miyazaki, M; Cai, J; Tanaka, N; Fox, IJ; Leboulch, P				Kobayashi, N; Fujiwara, T; Westerman, KA; Inoue, Y; Sakaguchi, M; Noguchi, H; Miyazaki, M; Cai, J; Tanaka, N; Fox, IJ; Leboulch, P			Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes	SCIENCE			English	Article							MAMMALIAN-CELLS; TRANSPLANTATION; ACTIVATION	Because of a critical shortage in suitable organs, many patients with terminal liver disease die each year before liver transplantation can be performed. Transplantation of isolated hepatocytes has been proposed for the temporary metabolic support of patients awaiting liver transplantation or spontaneous reversion of their liver disease. A major limitation of this form of therapy is the present inability to isolate an adequate number of transplantable hepatocytes. A highly differentiated cell line, NKNT-3, was generated by retroviral transfer in normal primary adult human hepatocytes of an immortalizing gene that can be subsequently and completely excised by Cre/Lox site-specific recombination. When transplanted into the spleen of rats under transient immunosuppression, reversibly immortalized NKNT-3 cells provided life-saving metabolic support during acute liver failure induced by 90% hepatectomy.	Okayama Univ, Dept Surg 1, Okayama 7008558, Japan; Okayama Univ, Dept Cell Biol, Okayama 7008558, Japan; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Genetix Pharmaceut, Cambridge, MA 02139 USA; Univ Nebraska, Dept Surg, Omaha, NE 68198 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA	Okayama University; Okayama University; Massachusetts Institute of Technology (MIT); University of Nebraska System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kobayashi, N (corresponding author), Okayama Univ, Dept Surg 1, 2-5-1 Shikata Cho, Okayama 7008558, Japan.		Sakaguchi, Masakiyo/B-2280-2011; Inoue, Yusuke/O-6207-2018	Inoue, Yusuke/0000-0002-9710-7482; Noguchi, Hirofumi/0000-0002-0880-6805	NHLBI NIH HHS [HL55435] Funding Source: Medline; NIDDK NIH HHS [DK48794] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkadopoulos N, 1998, HEPATOLOGY, V28, P1365, DOI 10.1002/hep.510280527; Chowdhury JR, 1998, PEDIATRICS, V102, P647, DOI 10.1542/peds.102.3.647; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; GEBHARDT R, 1989, HISTOCHEMISTRY, V92, P337, DOI 10.1007/BF00500550; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Nakamura J, 1997, TRANSPLANTATION, V63, P1541, DOI 10.1097/00007890-199706150-00001; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Pawliuk R, 1999, NAT MED, V5, P768, DOI 10.1038/10488; Schumacher IK, 1996, HEPATOLOGY, V24, P337; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971	15	244	301	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1258	1262		10.1126/science.287.5456.1258	http://dx.doi.org/10.1126/science.287.5456.1258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678831				2022-12-01	WOS:000085444700048
J	Benton, MJ; Wills, MA; Hitchin, R				Benton, MJ; Wills, MA; Hitchin, R			Quality of the fossil record through time	NATURE			English	Article							TAXONOMIC DIVERSITY; MOLECULAR EVIDENCE; MASS EXTINCTIONS; METAZOAN PHYLA	Does the fossil record present a true picture of the history of life(1-3), or should it be viewed with caution(4-6)? Raup(5) argued that plots of the diversification of life(2) were an illustration of bias: the older the rocks, the less we know. The debate was partially resolved by the observation(7) that different data sets gave similar patterns of rising diversity through time. Here we show that new assessment methods, in which the order of fossils in the rocks (stratigraphy) is compared with the order inherent in evolutionary trees (phylogeny), provide a more convincing analytical tool: stratigraphy and phylogeny offer independent data on history. Assessments of congruence between stratigraphy and phylogeny for a sample of 1,000 published phylogenies show no evidence of diminution of quality backwards in time. Ancient rocks clearly preserve less information, on average, than more recent rocks. However, if scaled to the stratigraphic level of the stage and the taxonomic level of the family, the past 540 million years of the fossil record provide uniformly good documentation of the life of the past.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ Oxford, Museum Hist Nat, Oxford OX1 3PW, England	University of Bristol; University of Oxford	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Wills Mem Bldg, Bristol BS8 1RJ, Avon, England.		Benton, Michael J/A-5639-2008; Wills, Matthew Albion/AAE-1790-2019	Benton, Michael J/0000-0002-4323-1824; Wills, Matthew/0000-0002-7344-7749				Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Benton Michael J., 1996, Historical Biology, V12, P111; BENTON MJ, 1994, GEOLOGY, V22, P111, DOI 10.1130/0091-7613(1994)022<0111:TTQOTF>2.3.CO;2; Benton MJ, 1999, SYST BIOL, V48, P581, DOI 10.1080/106351599260157; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BENTON MJ, 1993, FOSSIL RECORD, V2; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; Forey P. L, 1992, CLADISTICS PRACTICAL; HARLAND WB, 1993, GEOLOGIC TIME SCALE; Hennig W., 1999, PHYLOGENETIC SYSTEMA; Hillis DM, 1996, MOL SYSTEMATICS; HUELSENBECK JP, 1994, PALEOBIOLOGY, V20, P470, DOI 10.1017/S009483730001294X; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Norell Mark A., 1992, P89; PATTERSON C, 1981, ANNU REV ECOL SYST, V12, P195, DOI 10.1146/annurev.es.12.110181.001211; Paul CRC, 1998, ADEQUACY OF THE FOSSIL RECORD, P1; RAUP DM, 1972, SCIENCE, V177, P1065, DOI 10.1126/science.177.4054.1065; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; SEPKOSKI JJ, 1981, NATURE, V293, P435, DOI 10.1038/293435a0; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Siddall ME, 1996, SYST BIOL, V45, P111, DOI 10.2307/2413516; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Smith A.B., 1994, SYSTEMATICS FOSSIL R; Valentine J. W., 1969, Palaeontology, V12, P684; Wagner PJ, 1998, ADEQUACY OF THE FOSSIL RECORD, P165; Wills MA, 1999, SYST BIOL, V48, P559, DOI 10.1080/106351599260148; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	30	153	162	0	70	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					534	537		10.1038/35000558	http://dx.doi.org/10.1038/35000558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676959				2022-12-01	WOS:000085227300047
J	Omer, AD; Lowe, TM; Russell, AG; Ebhardt, H; Eddy, SR; Dennis, PP				Omer, AD; Lowe, TM; Russell, AG; Ebhardt, H; Eddy, SR; Dennis, PP			Homologs of small nucleolar RNAs in archaea	SCIENCE			English	Article							ARCHAEBACTERIUM SULFOLOBUS-ACIDOCALDARIUS; EUKARYOTIC RIBOSOMAL-RNA; PRERIBOSOMAL RNA; GUIDE SNORNAS; METHYLATION; SOLFATARICUS; SEQUENCES; PROTEIN; 16S; IDENTIFICATION	In eukaryotes, dozens of posttranscriptional modifications are directed to specific nucleotides in ribosomal RNAs (rRNAs) by small nucleolar RNAs (snoRNAs). We identified homologs of snoRNA genes in both branches of the Archaea. Eighteen small sno-like RNAs (sRNAs) were cloned from the archaeon Sulfolobus acidocaldarius by coimmunoprecipitation with archaeal fibrillarin and NOP56, the homologs of eukaryotic snoRNA-associated proteins. We trained a probabilistic model on these sRNAs to search for more sRNAs in archaeal genomic sequences. Over 200 additional sRNAs were identified in seven archaeal genomes representing both the Crenarchaeota and the Euryarchaeota, snoRNA-based rRNA processing was therefore probably present in, the Last common ancestor of Archaea and Eukarya, predating the evolution of a morphologically distinct nucleolus.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of British Columbia; Washington University (WUSTL)	Dennis, PP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Lowe, Todd Michael/ABJ-5261-2022; Omer, Arina/AAS-7960-2021	Eddy, Sean/0000-0001-6676-4706	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001363] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01363] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIRI KA, 1994, J BACTERIOL, V176, P2124, DOI 10.1128/jb.176.7.2124-2127.1994; Armbruster DW, 1997, J BIOL CHEM, V272, P19758, DOI 10.1074/jbc.272.32.19758; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; DAMS E, 1983, NUCLEIC ACIDS RES, V11, P4667, DOI 10.1093/nar/11.14.4667; DANIELS CJ, COMMUNICATION; DUROVIC P, 1994, MOL MICROBIOL, V13, P229, DOI 10.1111/j.1365-2958.1994.tb00418.x; DUROVIC P, 1994, J BACTERIOL, V176, P514, DOI 10.1128/JB.176.2.514-517.1994; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; OLSEN GJ, 1985, J MOL EVOL, V22, P301, DOI 10.1007/BF02115685; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; STAHL DA, 1981, NUCLEIC ACIDS RES, V9, P6129, DOI 10.1093/nar/9.22.6129; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu P, 1998, J BIOL CHEM, V273, P16453, DOI 10.1074/jbc.273.26.16453	34	263	276	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					517	522		10.1126/science.288.5465.517	http://dx.doi.org/10.1126/science.288.5465.517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775111				2022-12-01	WOS:000086626000046
J	Young, RK				Young, RK			The old man's friend	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2000	283	14					1793	1794		10.1001/jama.283.14.1793	http://dx.doi.org/10.1001/jama.283.14.1793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300HY	10770128				2022-12-01	WOS:000086248600001
J	Agalarov, SC; Prasad, GS; Funke, PM; Stout, CD; Williamson, JR				Agalarov, SC; Prasad, GS; Funke, PM; Stout, CD; Williamson, JR			Structure of the S15,S18-rRNA complex: Assembly of the 30S ribosome central domain	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN S15; THERMUS-THERMOPHILUS; RIBONUCLEOPROTEIN PARTICLE; BINDING-SITE; RNA; 16S; SUBUNIT; S6	The crystal structure of a 70-kilodalton ribonucleoprotein complex from the central domain of the Thermus thermophilus 30S ribosomal subunit was solved at 2.6 angstrom resolution. The complex consists of a 104-nucleotide RNA fragment composed of two three-helix junctions that Lie at the end of a central helix, and the ribosomal proteins S15, S6, and S18. S15 binds the ribosomal RNA early in the assembly of the 30S ribosomal subunit, stabilizing a conformational reorganization of the two three-helix junctions that creates the RNA fold necessary for subsequent binding of S6 and S18. The structure of the complex demonstrates the central role of S15-induced reorganization of central domain RNA for the subsequent steps of ribosome assembly.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia; MIT, Dept Chem, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Russian Academy of Sciences; Massachusetts Institute of Technology (MIT)	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009; Agalarov, Sultan/L-1969-2015	Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Agalarov, Sultan/0000-0002-2567-447X	NIGMS NIH HHS [GM53757] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053757, R01GM053757] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGALAROV AS, UNPUB; Agalarov SC, 2000, RNA, V6, P402, DOI 10.1017/S1355838200991945; Agalarov SC, 1998, P NATL ACAD SCI USA, V95, P999, DOI 10.1073/pnas.95.3.999; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Batey RT, 1996, J MOL BIOL, V261, P550, DOI 10.1006/jmbi.1996.0482; Batey RT, 1998, RNA, V4, P984, DOI 10.1017/S1355838298980426; Batey RT, 1996, J MOL BIOL, V261, P536, DOI 10.1006/jmbi.1996.0481; Berglund H, 1997, NAT STRUCT BIOL, V4, P20, DOI 10.1038/nsb0197-20; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; GREGORY RJ, 1984, J MOL BIOL, V178, P287, DOI 10.1016/0022-2836(84)90145-1; GUTELL RR, 1994, NUCLEIC ACIDS RES, V22, P3502, DOI 10.1093/nar/22.17.3502; HELD WA, 1974, J BIOL CHEM, V249, P3103; LESLIE AGW, 1994, ACTA CRYSTALLOGR D, V50, P760; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Orr JW, 1998, J MOL BIOL, V275, P453, DOI 10.1006/jmbi.1997.1489; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; POWERS T, 1995, RNA, V1, P194; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Serganov AA, 1996, RNA, V2, P1124; SVENSSON P, 1988, J MOL BIOL, V200, P301, DOI 10.1016/0022-2836(88)90242-2; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; ZWIEB C, 1992, NUCLEIC ACIDS RES, V20, P4397, DOI 10.1093/nar/20.17.4397	33	176	197	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					107	112		10.1126/science.288.5463.107	http://dx.doi.org/10.1126/science.288.5463.107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753109				2022-12-01	WOS:000086387700043
J	Friedman, JM				Friedman, JM			Obesity in the new millennium	NATURE			English	Editorial Material							EARLY-ONSET OBESITY; BODY-WEIGHT; FRAMESHIFT MUTATION; LEPTIN LEVELS; OB/OB MICE; HUMANS; GENE; OVERWEIGHT; MC4R	Obesity has increased at ale alarming rate in recent years and is now a worldwide public health problem. In addition to suffering poor health and an increased risk of illnesses such as hypertension and heart disease, obese people are often stigmatized socially. But major advances have now been made in identifying the components of the homeostatic system that regulates body weight, including several of the genes responsible for animal and human obesity. A key element of the physiological system is the hormone leptin, which acts on nerve cells in the brain (and elsewhere) to regulate food intake and body weight. The identification of additional molecules that comprise this homeostatic system will provide further insights into the molecular basis of obesity end possibilities for new treatments.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Box 305,1230 York Ave, New York, NY 10021 USA.		Friedman, Jeffrey M/E-5784-2011					Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; James WPT, 1996, CIBA F SYMP, V201, P1; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RAVUSSIN E, 1995, METABOLISM S3, V9, P12; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Troiano RP, 1998, PEDIATRICS, V101, P497; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WADDEN TA, 1993, ANN INTERN MED, V119, P688, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00012; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	25	536	583	0	32	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					632	634		10.1038/35007504	http://dx.doi.org/10.1038/35007504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766249	Bronze			2022-12-01	WOS:000086400100062
J	Richards, MA; Stockton, D; Babb, P; Coleman, MP				Richards, MA; Stockton, D; Babb, P; Coleman, MP			How many deaths have been avoided through improvements in cancer survival?	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER	Objective To estimate holy many deaths from cancer have been avoided in England and Wales because of recent improvements in survival. Design Analysis of national statistics. Setting England and Wales. Subjects 1.5 million adults with diagnosis of one of 47 different cancers during 1981-5 or 1986-90. Main outcome measures Reduction in number of cancer deaths within five years of diagnosis among patients with cancer diagnosed during 1986-90 compared with patients with cancer diagnosed during 1981-5, Results 17 041 deaths were avoided within five years of diagnosis among patients with cancer diagnosed during 1986-90. This represents 3.3% of the cancer deaths that would have been expected if survival had been the same as for patients with cancer diagnosed during 1981-5, Two thirds of the avoided deaths arose from improvements in survival for just five cancers: female br east cancer (4822), cancers of the colon (2560), rectum (1090), and bladder (1157), and melanoma of the skin (1098). The largest proportionate reductions in excess deaths were for melanoma of the skin (23%) and cancers of the testis (17%) and bone (17%). About 12 000 (70%) of the avoided deaths arose among adults aged under 75 at death. Improvements in survival from cancers of lung, prostate, stomach, ovary, and brain were small: the) accounted for 33% of all cancers but only 11% of avoided deaths. Conclusions Small gains in survival from common cancers save more lives than larger gains for uncommon cancers. If recent rates of improvement in cancer survival continue, about 24 000 deaths within five years of diagnosis would be avoided in patents aged under 75 by the year 2010, representing about a quarter of the government's overall target of 100 000 fewer cancer deaths.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; St Thomas Hosp, Dept Palliat Med, London SE17 7EH, England; Informat & Stat Div, Scottish Canc Intelligence Unit, Canc Surveillance Grp, Edinburgh EH5 3SQ, Midlothian, Scotland; Off Natl Stat, Demog & Hlth Div, London SW1V 2QQ, England	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust	Coleman, MP (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807				Abe O, 1998, LANCET, V352, P930; BERAL V, 1995, LANCET, V345, P1642, DOI 10.1016/S0140-6736(95)90151-5; Carstairs V., 1991, DEPRIVATION HLTH SCO; COLEMAN MP, 1999, SERIES SMPS, V61; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Expert Advisory Group on Cancer, 1995, POL FRAM COMM CANC S; *OFF NAT STAT, 1999, CANC 1971 1997 CD RO; Stockton D, 1997, BRIT MED J, V314, P472, DOI 10.1136/bmj.314.7079.472	9	63	63	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 1	2000	320	7239					895	898		10.1136/bmj.320.7239.895	http://dx.doi.org/10.1136/bmj.320.7239.895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10741993	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000086337100020
J	Schoonjans, K; Auwerx, J				Schoonjans, K; Auwerx, J			Thiazolidinediones: an update	LANCET			English	Article							ACTIVATED RECEPTOR-GAMMA; II DIABETES-MELLITUS; PPAR-GAMMA; INSULIN SENSITIZER; TROGLITAZONE; MICE; ADIPOGENESIS; BINDING; OBESITY; TISSUE	Thiazolidinediones, which are being developed for the treatment of insulin resistance and type 2 diabetes mellitus bind and activate peroxisome proliferator-activated receptor gamma, a nuclear receptor that regulates the expression of several genes involved in metabolism. This receptor controls adipocyte differentation, lipid storage, and insulin sensitisation. Besides metabolic activities, thiazolidinediones have effects as diverse as the control of host defence :ell proliferation, and tumorigenesis.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Auwerx, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,Parc Innovat, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021	Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393				Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Balfour JAB, 1999, DRUGS, V57, P921; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Freid J, 2000, ANN INTERN MED, V132, P164, DOI 10.7326/0003-4819-132-2-200001180-00015; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oakes ND, 1997, METABOLISM, V46, P935, DOI 10.1016/S0026-0495(97)90083-4; Pill J, 1999, METABOLISM, V48, P34, DOI 10.1016/S0026-0495(99)90007-0; Plosker GL, 1999, DRUGS, V57, P409, DOI 10.2165/00003495-199957030-00014; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302; Shibata T, 1999, EUR J PHARMACOL, V364, P211, DOI 10.1016/S0014-2999(98)00832-2; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SUTER SL, 1992, DIABETES CARE, V15, P193, DOI 10.2337/diacare.15.2.193; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a	34	166	173	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					1008	1010		10.1016/S0140-6736(00)90002-3	http://dx.doi.org/10.1016/S0140-6736(00)90002-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768450				2022-12-01	WOS:000086054000041
J	Waller, AE; Daniels, JL; Weaver, NL; Robinson, P				Waller, AE; Daniels, JL; Weaver, NL; Robinson, P			Jockey injuries in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context: In the sport of horse racing, the position of the jockey and speed of the horse predispose the jockey to risk of injury. Objective To estimate rates of medically treated injuries among professional jockeys and identify patterns of injury events. Design Cross-sectional survey from data compiled by an insurance broker. Information on the cause of injury, location on the track, and body part injured was evaluated. Setting Official races at US professional racing facilities (n = 114) from January 1, 1993, through December 31, 1996. Participants A licensed jockey population of approximately 2700 persons. Main Outcome Measures Annual injury incidence rates per 1000 jockey-years, as well as injury type, cause, and location on the track. Results A total of 6545 injury events occurred during official races between 1993 and 1996 (606 per 1000 jockey-years). Nearly 1 in 5 injuries (18.8%) was to the jockey's head or neck. Other frequent sites included the leg (15.5%), foot/ankle (10.7%), back (10.7%), arm/hand (11.0%), and shoulder (9.6%). The most frequent location where injuries occurred was entering, within, or leaving the starting gate (35.1%), including 29.5% of head injuries, 39.8% of arm/hand injuries, and 52.0% of injuries to the leg/foot. Most head injuries resulted from being thrown from the horse (41.8%) or struck by the horse's head (23.2%), Being thrown from the horse was the cause of 55.1% of back and 49.6% of chest injuries. Conclusions Our data suggest that jockeys have a high injury rate. Efforts are needed to reduce the number of potential injury events on the track and to improve protective equipment so events do not lead to injury.	Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Waller, AE (corresponding author), Univ N Carolina, Sch Med, Dept Emergency Med, CB 7594, Chapel Hill, NC 27599 USA.				PHS HHS [R49/CCR402444] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARONE GW, 1989, J TRAUMA, V29, P245, DOI 10.1097/00005373-198902000-00019; BILES DB, 1996, BLOOD HORSE     0210, P730; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P206; Firth J., 1985, SPORTS INJURIES MECH, P431; INGEMARSON H, 1989, J TRAUMA, V29, P25, DOI 10.1097/00005373-198901000-00005; POUNDER DJ, 1984, MED J AUSTRALIA, V141, P632, DOI 10.5694/j.1326-5377.1984.tb113173.x; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Whitlock M R, 1987, Br J Sports Med, V21, P25	8	57	60	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1326	1328		10.1001/jama.283.10.1326	http://dx.doi.org/10.1001/jama.283.10.1326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289ND	10714733	Bronze			2022-12-01	WOS:000085628100030
J	Chen, FL; Hersh, BM; Conradt, B; Zhou, Z; Riemer, D; Gruenbaum, Y; Horvitz, HR				Chen, FL; Hersh, BM; Conradt, B; Zhou, Z; Riemer, D; Gruenbaum, Y; Horvitz, HR			Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BCL-X-L; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL-MEMBRANES; ENDOPLASMIC-RETICULUM; REGULATORS CED-9; OUTER-MEMBRANE; PROTEIN; APOPTOSIS; ENCODES	The Caenorhabditis elegans Bcl-2-like protein CED-9 prevents programmed cell death by antagonizing the Apaf-1-like cell-death activator CED-4. Endogenous CED-9 and CED-4 proteins localized to mitochondria in wild-type embryos, in which most cells survive. By contrast, in embryos in which cells had been induced to die, CED-4 assumed a perinuclear localization. CED-4 translocation induced by the cell-death activator EGL-1 was blocked by a gain-of-function mutation in ced-9 but was not dependent on ced-3 function, suggesting that CED-4 translocation precedes caspase activation and the execution phase of programmed cell death. Thus, a change in the subcellular Localization of CED-4 may drive programmed cell death.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Max Planck Inst Biophys Chem, Dept Biochem, D-37016 Gottingen, Germany; Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Max Planck Society; Hebrew University of Jerusalem	Chen, FL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, WI-525, Cambridge, MA 02139 USA.		Conradt, Barbara/K-2665-2014	Hersh, Bradley/0000-0003-2098-4417; Conradt, Barbara/0000-0002-3731-4308				AKAO Y, 1994, CANCER RES, V54, P2468; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; Guenther C, 1996, DEVELOPMENT, V122, P3509; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Irmler M, 1997, FEBS LETT, V406, P189, DOI 10.1016/S0014-5793(97)00271-8; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Mello C, 1995, METHOD CELL BIOL, V48, P451; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Ottilie S, 1997, CELL DEATH DIFFER, V4, P526, DOI 10.1038/sj.cdd.4400288; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; RIEMER D, 1993, EUR J CELL BIOL, V62, P214; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Xue D, 1997, NATURE, V390, P305, DOI 10.1038/36889; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	35	188	200	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1485	1489		10.1126/science.287.5457.1485	http://dx.doi.org/10.1126/science.287.5457.1485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688797	Green Submitted			2022-12-01	WOS:000085531600051
J	Priola, SA; Raines, A; Caughey, WS				Priola, SA; Raines, A; Caughey, WS			Porphyrin and phthalocyanine antiscrapie compounds	SCIENCE			English	Article							RESISTANT PRION PROTEIN; HAMSTER SCRAPIE; AMPHOTERICIN-B; VARIANT CJD; CONGO RED; PRP; INHIBITION; AGENT; PATHOGENESIS; EXPRESSION	The transmissible spongiform encephalopathies (TSEs) are fatal, neurodegenerative diseases for which no effective treatments are available. The Likelihood that a bovine form of TSE has crossed species barriers and infected humans underscores the urgent need to identify anti-TSE drugs. Certain cyclic tetrapyrroles (porphyrins and phthalocyanines) have recently been shown to inhibit the in vitro formation of PrP-res, a protease-resistant protein critical for TSE pathogenesis. We now report that treatment of TSE-infected animals with three such compounds increased survival time from 50 to 300%. The significant inhibition of TSE disease by structurally dissimilar tetrapyrroles identifies these compounds as anti-TSE drugs.	NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Priola, SA (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.				NIA NIH HHS [AG04342] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000752, ZIAAI000752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BONNETT R, 1995, CHEM SOC REV, V24, P19, DOI 10.1039/cs9952400019; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DEMAIMAY R, 1994, J GEN VIROL, V75, P2499, DOI 10.1099/0022-1317-75-9-2499; Dolphin D, 1978, PORPHYRINS; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; FRASER H, 1978, J COMP PATHOL, V88, P563, DOI 10.1016/0021-9975(78)90010-5; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paquette, 1992, PHOTODYNAMIC THERAPY, P145; POCCHIARI M, 1987, J GEN VIROL, V68, P219, DOI 10.1099/0022-1317-68-1-219; PRIOLA SA, UNPUB; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Sassa S, 1996, CURR MED CHEM, V3, P273; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1999, LANCET, V353, P979, DOI 10.1016/S0140-6736(99)01160-5	26	264	281	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1503	1506		10.1126/science.287.5457.1503	http://dx.doi.org/10.1126/science.287.5457.1503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688802				2022-12-01	WOS:000085531600056
J	Martinez, JS; Zhang, GP; Holt, PD; Jung, HT; Carrano, CJ; Haygood, MG; Butler, A				Martinez, JS; Zhang, GP; Holt, PD; Jung, HT; Carrano, CJ; Haygood, MG; Butler, A			Self-assembling amphiphilic siderophores from marine bacteria	SCIENCE			English	Article							EQUATORIAL PACIFIC-OCEAN; MYCOBACTERIUM-TUBERCULOSIS; AMINO-ACIDS; IRON; ORGANIZATION; ACQUISITION; EXOCHELINS; ECOSYSTEMS; WATERS	Most aerobic bacteria secrete siderophores to facilitate iron acquisition. Two families of siderophores were isolated from strains belonging to two different genera of marine bacteria. The aquachelins, from Halomonas aquamarina strain DS40M3, and the marinobactins, from Marinobacter sp. strains DS40M6 and DS40M8, each contain a unique peptidic head group that coordinates iron(III) and an appendage of one of a series of fatty acid moieties. These siderophores have low critical micelle concentrations (CMCs). In the absence of iron, the marinobactins are present as micelles at concentrations exceeding their CMC; upon addition of iron(III), the micelles undergo a spontaneous phase change to form vesicles. These observations suggest that unique iron acquisition mechanisms may have evolved in marine bacteria.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; SW Texas State Univ, Dept Chem, San Marcos, TX 78666 USA; Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas State University System; Texas State University San Marcos; University of California System; University of California San Diego; Scripps Institution of Oceanography	Butler, A (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.		Butler, Alison/D-5094-2015; Jung, Hee-Tae/C-1574-2011	Butler, Alison/0000-0002-3525-7864; 	NIGMS NIH HHS [GM38130] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038130, R55GM038130, R29GM038130] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DEMANGE P, 1988, J CHROMATOGR, V438, P291, DOI 10.1016/S0021-9673(00)90260-7; Evans D. F., 1994, COLLOIDAL DOMAIN; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; GOYNE ER, 1974, LIMNOL OCEANOGR, V19, P840; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HAYGOOD MG, 1993, LIMNOL OCEANOGR, V38, P1091, DOI 10.4319/lo.1993.38.5.1091; Hutchins DA, 1999, NATURE, V400, P858, DOI 10.1038/23680; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; JALAL MAF, 1989, J AM CHEM SOC, V111, P292, DOI 10.1021/ja00183a044; Lee KC, 1999, LANGMUIR, V15, P5500, DOI 10.1021/la9900775; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; OKUJO N, 1994, BIOMETALS, V7, P109; Pakulski JD, 1996, NATURE, V383, P133, DOI 10.1038/383133b0; REID RT, 1993, NATURE, V366, P455, DOI 10.1038/366455a0; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SAAGER PM, 1989, GEOCHIM COSMOCHIM AC, V53, P2259, DOI 10.1016/0016-7037(89)90348-7; Stackebrandt E, 1990, NUCL ACID TECHNIQUES, P115; SWOFFORD DL, 1999, PAUP PHYLOGENETIC AN; Tortell PD, 1999, FEMS MICROBIOL ECOL, V29, P1; Tortell PD, 1996, NATURE, V383, P330, DOI 10.1038/383330a0; TRICK CG, 1989, CURR MICROBIOL, V18, P375, DOI 10.1007/BF01571131; Wilhelm SW, 1996, LIMNOL OCEANOGR, V41, P89, DOI 10.4319/lo.1996.41.1.0089; WILHELM SW, 1994, LIMNOL OCEANOGR, V39, P1974; Wu JF, 1996, GEOCHIM COSMOCHIM AC, V60, P2729, DOI 10.1016/0016-7037(96)00135-4	34	248	259	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1245	1247		10.1126/science.287.5456.1245	http://dx.doi.org/10.1126/science.287.5456.1245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678827				2022-12-01	WOS:000085444700044
J	Vijan, S; Hofer, TP; Hayward, RA				Vijan, S; Hofer, TP; Hayward, RA			Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-HISPANIC WHITES; MEXICAN-AMERICANS; COMPLICATIONS; NIDDM; MORTALITY; CARE; OPHTHALMOSCOPY; PHOTOGRAPHY; POPULATION; MODEL	Context Annual eye screening for patients with diabetes mellitus is frequently proposed as a measure of quality of care. However, the benefit of annual vs less frequent screening intervals has not been well evaluated, especially for low-risk patients. Objective To examine the marginal cost-effectiveness of various screening intervals for eye disease in patients with type 2 diabetes, stratified by age and level of glycemic control. Design Markov cost-effectiveness model. Setting and Participants Hypothetical patients based on the US population of diabetic patients older than 40 years from the Third National Health and Nutrition Examination Survey. Main Outcome Measures Patient time spent blind, quality-adjusted life-years (QALYs), and costs of annual vs less frequent screening compared by age and level of hemoglobin A(1c). Results Retinal screening in patients with type 2 diabetes is an effective intervention; however, the risk reduction varies dramatically by age and level of glycemic control. On average, a high-risk patient who is aged 45 years and has a hemoglobin A(1c) level of 11% gains 21 days of sight when screened annually as opposed to every third year, while a low-risk patient who is aged 65 years and has a hemoglobin A(1c) level of 7% gains an average of 3 days of sight. The marginal cost-effectiveness of screening annually vs every other year also varies; patients in the high-risk group cost an additional $40 530 per QALY gained, while those in the low-risk group cost an additional $211 570 per QALY gained. In the US population, retinal screening annually vs every other year for patients with type 2 diabetes costs $107 510 per QALY gained, while screening every other year vs every third year costs $49 760 per QALY gained. Conclusions Annual retinal screening for all patients with type 2 diabetes without previously detected retinopathy may not be warranted on the basis of cost-effectiveness, and tailoring recommendations to individual circumstances may be preferable. Organizations evaluating quality of care should consider costs and benefits carefully before setting universal standards.	Vet Affairs Hlth Serv Res & Dev, Qual Enhancement Res Initiat, Ann Arbor, MI 48113 USA; Univ Michigan, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Vijan, S (corresponding author), Vet Affairs Hlth Serv Res & Dev, Qual Enhancement Res Initiat, POB 130170, Ann Arbor, MI 48113 USA.	svijan@umich.edu	Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NIDDK NIH HHS [P60 DK20572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; [Anonymous], 1991, Ophthalmology, V98, P786; [Anonymous], 1995, DIAB AM; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; CHIANG YP, 1992, MILBANK Q, V70, P319, DOI 10.2307/3350062; DASBACH EJ, 1991, MED CARE, V29, P20, DOI 10.1097/00005650-199101000-00003; DASBACH EJ, 1992, MED DECIS MAKING, V12, P4; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; FERRIS FL, 1987, OPHTHALMOLOGY, V94, P761; FREDERICK FL, 1993, JAMA-J AM MED ASSOC, V269, P1290; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; HAFFNER SM, 1988, DIABETES, V37, P878, DOI 10.2337/diabetes.37.7.878; HAMMAN RF, 1989, DIABETES, V38, P1231, DOI 10.2337/diabetes.38.10.1231; Harris EL, 1999, DIABETES CARE, V22, P779, DOI 10.2337/diacare.22.5.779; HARRIS EL, 1993, DIABETES CARE, V16, P748, DOI 10.2337/diacare.16.5.748; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; JONES D, 1988, BRIT MED J, V296, P1029, DOI 10.1136/bmj.296.6628.1029; KINYOUN J, 1989, OPHTHALMOLOGY, V96, P746; KLEIN R, 1986, AM J EPIDEMIOL, V124, P104, DOI 10.1093/oxfordjournals.aje.a114353; KLEIN R, 1987, DIABETES CARE, V10, P633, DOI 10.2337/diacare.10.5.633; KLEIN R, 1989, ARCH INTERN MED, V149, P266, DOI 10.1001/archinte.149.2.266; KLEIN R, 1985, OPHTHALMOLOGY, V92, P485; KROLEWSKI AS, 1977, DIABETOLOGIA, V13, P345, DOI 10.1007/BF01223277; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; MAYFIELD JA, 1994, DIABETES CARE, V17, P918, DOI 10.2337/diacare.17.8.918; Medhi, 1994, STOCHASTIC PROCESSES; MORRISH NJ, 1990, DIABETOLOGIA, V33, P538, DOI 10.1007/BF00404141; MOSS SE, 1985, OPHTHALMOLOGY, V92, P62; MUGGEO M, 1995, DIABETOLOGIA, V38, P318, DOI 10.1007/s001250050288; MULLAHY J, 1995, STAT ISSUES COST EFF, P149; *NAT COMM QUAL ASS, 1997, HLTH EMPL DAT INF SE, P2; NATHAN DM, 1991, DIABETES CARE, V14, P26, DOI 10.2337/diacare.14.1.26; Nathan DM, 1996, ANN INTERN MED, V124, P86, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00002; PANZRAM G, 1981, DIABETOLOGIA, V20, P587; PANZRAM G, 1987, DIABETOLOGIA, V30, P123, DOI 10.1007/BF00274216; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SINGER DE, 1992, ANN INTERN MED, V116, P660, DOI 10.7326/0003-4819-116-8-660; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; SUSSMAN EJ, 1982, JAMA-J AM MED ASSOC, V247, P3231, DOI 10.1001/jama.247.23.3231; Tudor SM, 1998, DIABETES CARE, V21, P53, DOI 10.2337/diacare.21.1.53; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; WYLIEROSETT J, 1995, J DIABETES COMPLICAT, V9, P49, DOI 10.1016/1056-8727(94)00005-9; [No title captured]; 1996, FED REG, V61; 1994, VITAL HLTH STAT 1, V32, P1	57	180	185	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					889	896		10.1001/jama.283.7.889	http://dx.doi.org/10.1001/jama.283.7.889			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	281WT	10685713				2022-12-01	WOS:000085185000027
J	Bachiller, D; Klingensmith, J; Kemp, C; Belo, JA; Anderson, RM; May, SR; McMahon, JA; McMahon, AP; Harland, RM; Rossant, J; De Robertis, EM				Bachiller, D; Klingensmith, J; Kemp, C; Belo, JA; Anderson, RM; May, SR; McMahon, JA; McMahon, AP; Harland, RM; Rossant, J; De Robertis, EM			The organizer factors Chordin and Noggin are required for mouse forebrain development	NATURE			English	Article							ANTERIOR PRIMITIVE ENDODERM; SPEMANN ORGANIZER; VISCERAL ENDODERM; SECRETED FACTOR; SONIC HEDGEHOG; NEURAL PLATE; GENE; ZEBRAFISH; CERBERUS; SUGGESTS	In mice, there is evidence suggesting that the development of head and trunk structures is organized by distinctly separated cell populations(1,2). The head organizer is located in the anterior visceral endoderm (AVE) and the trunk organizer in the node and anterior primitive streak. In amphibians, Spemann's organizer, which is homologous to the node, partially overlaps with anterior endoderm cells expressing homologues of the AVE markers cerberus, Hex and Hesx1 (refs 3-6). For mice, this raises the question of whether the AVE and node are independent of each other, as suggested by their anatomical separation, or functionally interdependent as is the case in amphibians(3-5). Chordin and Noggin are secreted bone morphogenetic protein (BMP) antagonists(7,8) expressed in the mouse node, but not in the AVE. Here we show that mice double-homozygous mutants that are for chordin and noggin display severe defects in the development of the prosencephalon, The results show that BMP antagonists in the node and its derivatives are required for head development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Duke University; Harvard University; University of California System; University of California Berkeley; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		Belo, José A. A/F-4444-2012; McMahon, Andrew P/ABE-7520-2020	Belo, José A. A/0000-0001-7384-0949; Bachiller, Daniel/0000-0002-5016-317X				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Arkell R, 1997, DEVELOPMENT, V124, P1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Dufort D, 1998, DEVELOPMENT, V125, P3015; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GOLDEN JA, 1999, P NATL ACAD SCI USA, V54, P623; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oliver G, 1995, DEVELOPMENT, V121, P4045; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rhinn M, 1998, DEVELOPMENT, V125, P845; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	30	397	423	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					658	661		10.1038/35001072	http://dx.doi.org/10.1038/35001072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688202				2022-12-01	WOS:000085288200054
J	Song, WQ; Raden, D; Mandon, EC; Gilmore, R				Song, WQ; Raden, D; Mandon, EC; Gilmore, R			Role of Sec61 alpha in the regulated transfer of the ribosome-nascent chain complex from the signal recognition particle to the translocation channel	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; GTP HYDROLYSIS; BETA-SUBUNIT; ER MEMBRANE; SEQUENCE RECOGNITION; SECRETORY PROTEIN; ALPHA-SUBUNIT; RECEPTOR; BINDING	Targeting of ribosome-nascent chain complexes to the translocon in the endoplasmic reticulum is mediated by the concerted action of the signal recognition particle (SRP) and the SRP receptor (SR). Ribosome-stripped microsomes were digested with proteases to sever cytoplasmic domains of SR alpha, SR beta, TRAM, and the Sec61 complex. We characterized protein translocation intermediates that accumulate when Sec61 alpha or SRP is inactivated by proteolysis. In the absence of a functional Sec61 complex, dissociation of SRP54 from the signal sequence is blocked. Experiments using SR proteoliposomes confirmed the assembly of a membrane-bound posttargeting intermediate. These results strongly suggest that the Sec61 complex regulates the GTP hydrolysis cycle of the SRP-SR complex at the stage of signal sequence dissociation from SRP54.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Gilmore, R (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA.	reid.gilmore@umassmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35687] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher G, 1999, J CELL BIOL, V146, P723, DOI 10.1083/jcb.146.4.723; Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; KELLARIS KV, 1991, J CELL BIOL, V114, P21, DOI 10.1083/jcb.114.1.21; Knight BC, 1998, BIOCHEM J, V331, P161, DOI 10.1042/bj3310161; LAUFFER L, 1985, NATURE, V318, P334, DOI 10.1038/318334a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Murphy EC, 1997, J CELL BIOL, V136, P1213, DOI 10.1083/jcb.136.6.1213; Neuhof A, 1998, MOL BIOL CELL, V9, P103, DOI 10.1091/mbc.9.1.103; NICCHITTA CV, 1989, J CELL BIOL, V108, P789, DOI 10.1083/jcb.108.3.789; Ogg SC, 1998, J CELL BIOL, V142, P341, DOI 10.1083/jcb.142.2.341; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; RAPIEJKO PJ, 1992, J CELL BIOL, V117, P493, DOI 10.1083/jcb.117.3.493; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cellbio.10.1.87; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilkinson BM, 1997, EMBO J, V16, P4549, DOI 10.1093/emboj/16.15.4549; YOUNG JC, 1995, J BIOL CHEM, V270, P15650, DOI 10.1074/jbc.270.26.15650	38	113	115	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2000	100	3					333	343		10.1016/S0092-8674(00)80669-8	http://dx.doi.org/10.1016/S0092-8674(00)80669-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	282ET	10676815	Bronze			2022-12-01	WOS:000085204400007
J	Jenni, OG				Jenni, OG			On the other of the tracks	LANCET			English	Editorial Material									Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich	Jenni, OG (corresponding author), Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland.		Jenni, Oskar/AAG-4391-2019	Jenni, Oskar/0000-0002-4561-6277					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 8	2000	355	9198					139	140		10.1016/S0140-6736(99)11156-5	http://dx.doi.org/10.1016/S0140-6736(99)11156-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288HT	10675183				2022-12-01	WOS:000085557200040
J	Dyck, PJ; Dyck, PJB				Dyck, PJ; Dyck, PJB			Atypical varieties of chronic inflammatory demyelinating neuropathies	LANCET			English	Editorial Material							MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; POLYRADICULONEUROPATHY		Mayo Clin & Mayo Fdn, Peripheral Neuropathy Res Ctr, Rochester, MN 55905 USA	Mayo Clinic	Dyck, PJ (corresponding author), Mayo Clin & Mayo Fdn, Peripheral Neuropathy Res Ctr, 200 1st St SW, Rochester, MN 55905 USA.							Dyck P.J., 1990, CHARCOT MARIE TOOTH, P1; DYCK PJ, 1975, MAYO CLIN PROC, V50, P621; DYCK PJ, 1991, NEW ENGL J MED, V325, P1482, DOI 10.1056/NEJM199111213252105; Dyck PJB, 1999, NEUROLOGY, V53, P2113, DOI 10.1212/WNL.53.9.2113; GOSSELIN S, 1991, ANN NEUROL, V30, P54, DOI 10.1002/ana.410300111; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; KYLE RA, 1993, MAYO CLIN PROC, V68, P26, DOI 10.1016/S0025-6196(12)60015-9; KYLE RA, 1993, PERIPHERAL NEUROPATH, P1275; Midroni G, 1996, NEUROLOGY, V46, P1206, DOI 10.1212/WNL.46.5.1206; PARRY GJ, 1988, MUSCLE NERVE, V11, P103, DOI 10.1002/mus.880110203; SIMMONS Z, 1995, BRAIN, V118, P359, DOI 10.1093/brain/118.2.359; Van den Berg-Vos RM, 2000, NEUROLOGY, V54, P26, DOI 10.1212/WNL.54.1.26	12	31	32	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1293	1294		10.1016/S0140-6736(00)02109-7	http://dx.doi.org/10.1016/S0140-6736(00)02109-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LJ	10776740				2022-12-01	WOS:000086829400007
J	Mackie, E; Hill, J; Kondryn, H; McNally, R				Mackie, E; Hill, J; Kondryn, H; McNally, R			Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms' tumour: a controlled study	LANCET			English	Article							CHILDHOOD-CANCER SURVIVORS; PSYCHOLOGICAL ADJUSTMENT; LEUKEMIA; LIFE; PSYCHOPATHOLOGY; CONSEQUENCES; ADAPTATION; ADOLESCENT; CHILDREN; DISEASE	Background Variability in methods and deficits in design have contributed to conflicting findings about adult psychosocial functioning after childhood cancer. We did a controlled study of psychosocial outcomes in adult survivors of childhood acute lymphoblastic leukaemia (ALL) and Wilms' tumour to address previous methods limitations. Methods We assessed 102 survivors of childhood ALL and Wilms' tumour, who had been free from relapse for 5 years and were aged 19-30 years, and 102 unrelated healthy controls. We used standard measures of adult psychiatric disorder, interpersonal and social-role performance, and intellectual ability to assess past and current functioning. Findings Cancer survivors had no increased rates of psychiatric disorder. Mean scores of cancer survivors were significantly higher (indicating poorer functioning) than those of controls for love/sex relationships (mean difference 0.87 [95% CI 0.53-1.22]), friendships (0.37 [0.07-0.67]), non-specific social contacts (0.40 [0.20-0.60]), and day-to-day coping (0.35 [0.14-0.57]). Cancer survivors were more likely than controls to have a combination of deficits in love/sex relationships and friendships (ALL survivors odds ratio 10.83 [95% CI 3.87-30.82], Wilms' tumour survivors 4.85 [1.43-16.47]), which was associated with more recent treatment (p=0.005). Poor coping was associated with lower intellectual ability scores (p=0.018). Interpretation Childhood ALL and Wilms' tumour have longterm effects on interpersonal functioning and coping, probably mediated by different mechanisms. Prospective studies with each of these tumour groups are needed with similar adolescent and adult outcome measures.	Royal Manchester Childrens Hosp, Paediat Oncol Unit, Manchester M27 1HA, Lancs, England; Alder Hey Childrens Hosp, Dept Psychiat, Liverpool L12 2AP, Merseyside, England; Univ Manchester, Dept Child Hlth, CRC Paediat & Familial Canc Res Grp, Manchester, Lancs, England	Royal Manchester Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Manchester	Mackie, E (corresponding author), Southampton Gen Hosp, Dept Child Hlth, Southampton SO16 6YD, Hants, England.			McNally, Richard/0000-0001-6685-6467				BIRCH JM, 1988, IARC SCI PUBL, V87, P299; BROWN RT, 1993, J AM ACAD CHILD PSY, V32, P554, DOI 10.1097/00004583-199305000-00010; BYRNE J, 1989, JAMA-J AM MED ASSOC, V262, P2683; CELLA DF, 1986, J CONSULT CLIN PSYCH, V54, P616, DOI 10.1037/0022-006X.54.5.616; CHANG P-N, 1991, Pediatrician, V18, P20; CLARE AW, 1978, PSYCHOL MED, V8, P589, DOI 10.1017/S0033291700018808; EISER C, 1991, ARCH DIS CHILD, V66, P164, DOI 10.1136/adc.66.1.164; Everitt BS., 1992, ANAL CONTINGENCY TAB; *GOV STAT SER, 1990, STAND OCC CLASS, V1; GRAY RE, 1992, CANCER-AM CANCER SOC, V70, P2713, DOI 10.1002/1097-0142(19921201)70:11<2713::AID-CNCR2820701124>3.0.CO;2-T; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; GUDJONSSON GH, 1995, PERSON INDIVIDUAL DI, V3, P441; HARRINGTON R, 1988, PSYCHOL MED, V18, P487, DOI 10.1017/S0033291700008023; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; HAWKINS MM, 1987, BRIT J CANCER, V56, P339, DOI 10.1038/bjc.1987.200; HAYS DM, 1992, J CLIN ONCOL, V10, P1397, DOI 10.1200/JCO.1992.10.9.1397; HILL J, 1989, BRIT J PSYCHIAT, P15524; Hill JM, 1998, CANCER-AM CANCER SOC, V82, P208; JANKOVIC M, 1994, LANCET, V344, P224, DOI 10.1016/S0140-6736(94)92997-1; KELAGHAN J, 1988, MED PEDIATR ONCOL, V16, P320, DOI 10.1002/mpo.2950160506; KOOCHER GP, 1980, J CHILD PSYCHOL PSYC, V21, P163, DOI 10.1111/j.1469-7610.1980.tb00028.x; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Naughton M, 1996, BRIT J PSYCHIAT, V168, P33, DOI 10.1192/bjp.168.1.33; QUINTON D, 1995, BRIT J PSYCHIAT, V167, P315, DOI 10.1192/bjp.167.3.315; Rauck AM, 1999, MED PEDIATR ONCOL, V33, P60, DOI 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H; Raven J.C., 1992, STANDARD PROGR MATRI; SAHLER OJZ, 1994, J DEV BEHAV PEDIATR, V15, P353; SHALET SM, 1989, ARCH DIS CHILD, V64, P1635, DOI 10.1136/adc.64.11.1635; STILLER CA, 1990, BRIT J CANCER, V62, P806, DOI 10.1038/bjc.1990.383; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547	31	104	105	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1310	1314		10.1016/S0140-6736(00)02112-7	http://dx.doi.org/10.1016/S0140-6736(00)02112-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	310LJ	10776743				2022-12-01	WOS:000086829400010
J	Rembacken, BJ; Fujii, T; Cairns, A; Dixon, MF; Yoshida, S; Chalmers, DM; Axon, ATR				Rembacken, BJ; Fujii, T; Cairns, A; Dixon, MF; Yoshida, S; Chalmers, DM; Axon, ATR			Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK	LANCET			English	Article							EARLY COLORECTAL-CARCINOMA; LARGE-BOWEL; LARGE-INTESTINE; ADENOMA; CANCER; POLYPECTOMY; PREVENTION; SEQUENCE; REMOVAL	Background Flat and depressed colorectal tumours were originally thought to be unique to the Japanese population. Recently there have been reports of flat and depressed lesions in western countries but they have been thought to be uncommon. Methods In this prospective study, 1000 consecutive patients attending for routine colonoscopy were examined for flat or depressed lesions. The examinations were done by one European colonoscopist using methods developed in Japan. Finding 321 adenomas were found: 202 (63%) were polypoid, 36% (117) were flat and 2 (0.6%) appeared depressed. Most adenomas contained areas of mild or moderate dysplasia but 10% (31) were severely dysplastic. Six Dukes' A adenocarcinomas were identified together with 25 more advanced adenocarcinomas. The likelihood of Dukes' A cancer or severe dysplasia increased from 4% (3/70) in small flat lesions, to 6% (9/154) in small polyps, 16% (8/50) in larger polyps, 29% (14/49) in large flat lesions, and 75% (3/4) in depressed lesions. 54% (20/37) lesions containing severe dysplasia or Dukes' A carcinoma were flat or depressed. Interpretation The polyp-carcinoma hypothesis prompts colonoscopists to search only for polypoid lesions when screening for cancer, and many early colorectal neoplasms may therefore be missed. Colonoscopists require training in the recognition of flat and depressed lesions to detect colorectal tumours in the early stages.	Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England; Natl Canc Ctr, Tokyo 104, Japan	Leeds General Infirmary; University of Leeds; National Cancer Center - Japan	Rembacken, BJ (corresponding author), Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England.	BJR@firstnet.co.uk						ADACHI M, 1988, DIS COLON RECTUM, V31, P236, DOI 10.1007/BF02552553; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Cairns A, 1999, GUT, V44, pA142; CRAWFORD BE, 1983, CANCER, V51, P1760, DOI 10.1002/1097-0142(19830501)51:9<1760::AID-CNCR2820510933>3.0.CO;2-N; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; HACHISU T, 1991, SURG ENDOSC-ULTRAS, V5, P70, DOI 10.1007/BF00316840; Hachisu T, 1988, Surg Endosc, V2, P13, DOI 10.1007/BF00591392; *JAP RES SOC CANC, 1983, GEN RUL CLIN PATH ST; JARAMILLO E, 1994, GASTROINTEST ENDOSC, V40, P369, DOI 10.1016/S0016-5107(94)70077-X; Jass JR, 1989, HISTOLOGICAL TYPING; KASUMI A, 1995, SURG ENDOSC-ULTRAS, V9, P690; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; KUDO S, 1995, EUR J CANCER, V31A, P1118, DOI 10.1016/0959-8049(95)00251-D; KUDO S, 1986, GASTROINTEST ENDOSC, V28, P2811; KUDO S, 1989, GASTROENTEROL ENDOSC, V31, P2845; KURAMOTO S, 1989, CANCER, V64, P950, DOI 10.1002/1097-0142(19890815)64:4<950::AID-CNCR2820640430>3.0.CO;2-O; LANSPA SJ, 1992, DIS COLON RECTUM, V35, P543, DOI 10.1007/BF02050533; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1968, BRIT J SURG, V55, P725, DOI 10.1002/bjs.1800551003; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; MUTO T, 1991, DIS COLON RECTUM, V34, P696, DOI 10.1007/BF02050353; MUTO T, 1985, DIS COLON RECTUM, V28, P847, DOI 10.1007/BF02555490; SAWADA T, 1989, BAILLIERE CLIN GASTR, V3, P627, DOI 10.1016/0950-3528(89)90021-3; SHIMODA T, 1989, CANCER, V64, P1138, DOI 10.1002/1097-0142(19890901)64:5<1138::AID-CNCR2820640529>3.0.CO;2-A; SPRATT JS, 1962, JAMA-J AM MED ASSOC, V179, P337, DOI 10.1001/jama.1962.03050050027005; STOLTE M, 1995, ENDOSCOPY, V27, P286, DOI 10.1055/s-2007-1005694; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; WOLBER RA, 1991, HUM PATHOL, V34, P981	30	521	537	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1211	1214		10.1016/S0140-6736(00)02086-9	http://dx.doi.org/10.1016/S0140-6736(00)02086-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770302				2022-12-01	WOS:000086448000009
J	Morita, YS; Paul, KS; Englund, PT				Morita, YS; Paul, KS; Englund, PT			Specialized fatty acid synthesis in African trypanosomes: Myristate for GPI anchors	SCIENCE			English	Article							VARIANT SURFACE GLYCOPROTEIN; BIOLOGICAL PROPERTIES; CULTURE FORMS; BRUCEI; BIOSYNTHESIS; BLOOD; THIOLACTOMYCIN; RHODESIENSE; METABOLISM; LEWISI	African trypanosomes, the cause of sleeping sickness, need massive amounts of myristate to remodel glycosyl phosphatidylinositol (GPI) anchors on their surface glycoproteins. However, it has been believed that the parasite is unable to synthesize any fatty acids, and myristate is not abundant in the hosts' bloodstreams. Thus, it has been unclear how trypanosomes meet their myristate requirement. Here we found that they could indeed synthesize fatty acids. The synthetic pathway was unique in that the major product, myristate, was preferentially incorporated into GPIs and not into other lipids. The antibiotic thiolactomycin inhibited myristate synthesis and killed the parasite, making this pathway a potential chemotherapeutic target.	Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Englund, PT (corresponding author), Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA.	penglund@jhmi.edu	Paul, Kimberly/AAO-4275-2020	Morita, Yasu/0000-0002-4514-9242	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; DIXON H, 1971, COMP BIOCHEM PHYSIOL, V39, P247, DOI 10.1016/0305-0491(71)90168-4; DOERING TL, 1994, BIOCHEM J, V299, P741, DOI 10.1042/bj2990741; DOERING TL, 1993, J BIOL CHEM, V268, P9215; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; Edelstein C., 1986, BIOCH BIOL PLASMA LI, P495; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FOSBROOKE AS, 1968, CLIN CHIM ACTA, V20, P517, DOI 10.1016/0009-8981(68)90311-2; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KLEIN RA, 1976, BIOCHEM SOC T, V4, P48, DOI 10.1042/bst0040048; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; OISHI H, 1982, J ANTIBIOT, V35, P391, DOI 10.7164/antibiotics.35.391; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Werbovetz KA, 1997, MOL BIOCHEM PARASIT, V85, P1, DOI 10.1016/S0166-6851(96)02820-4	21	99	103	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2000	288	5463					140	143		10.1126/science.288.5463.140	http://dx.doi.org/10.1126/science.288.5463.140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753118				2022-12-01	WOS:000086387700052
J	Vukusic, P; Sambles, JR; Lawrence, CR				Vukusic, P; Sambles, JR; Lawrence, CR			Structural colour - Colour mixing in wing scales of a butterfly	NATURE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; DERA, Mech Sci Sector, Farnborough GU14 0LX, Hants, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	P.Vukusic@ex.ac.uk	Sambles, John Roy/X-8675-2019	SAMBLES, John/0000-0003-2721-0692				BURNHAM RW, 1963, COLOR; Fox DL, 1976, ANIMAL BIOCHROMES ST; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; HUXLEY J, 1975, J ENTOMOL SER A, V50, P9; Kelber A, 1999, NATURE, V402, P251, DOI 10.1038/46204; SCHULTZ TD, 1989, NATURE, V337, P72, DOI 10.1038/337072a0; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	7	320	342	13	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					457	457		10.1038/35006561	http://dx.doi.org/10.1038/35006561			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761905				2022-12-01	WOS:000086257700036
J	Gould, DC; Petty, R; Jacobs, HS				Gould, DC; Petty, R; Jacobs, HS			For and against - The male menopause - does it exist?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOGONADAL MEN; BIOAVAILABLE TESTOSTERONE; ANDROGEN LEVELS; AGING MALE; LONG-TERM; OLDER MEN; ADULT MEN; PLASMA; REPLACEMENT; AGE		WellMan Clin, London W1N 3FA, England		Gould, DC (corresponding author), Goldcross Med Serv, 20 Harley St, London W1N 1AL, England.							Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; BROWN WA, 1978, ARCH SEX BEHAV, V7, P97, DOI 10.1007/BF01542059; BURRIS AS, 1992, J ANDROL, V13, P297; DAVIDSON JM, 1983, J CLIN ENDOCR METAB, V57, P71, DOI 10.1210/jcem-57-1-71; DESLYPERE JP, 1984, J CLIN ENDOCR METAB, V59, P955, DOI 10.1210/jcem-59-5-955; FELDMAN JM, 1976, ARCH INTERN MED, V136, P606, DOI 10.1001/archinte.136.5.606; FINKELSTEIN JS, 1998, TESTOSTERONE ACTION, P187; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Heller CG, 1944, J AMER MED ASSOC, V126, P472, DOI 10.1001/jama.1944.02850430006003; IDA Y, 1992, DRUG ALCOHOL DEPEN, V31, P57, DOI 10.1016/0376-8716(92)90009-2; JACKSON JA, 1992, AM J MED SCI, V304, P4, DOI 10.1097/00000441-199207000-00003; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; KAUFMAN JM, 1998, TESTOSTERONE ACTION, P437; KLEY HK, 1974, HORM METAB RES, V6, P213, DOI 10.1055/s-0028-1093855; KORENMAN SG, 1990, J CLIN ENDOCR METAB, V71, P963, DOI 10.1210/jcem-71-4-963; MANTZOROS CS, 1995, BRIT MED J, V310, P1289, DOI 10.1136/bmj.310.6990.1289; MEIKLE AW, 1988, J CLIN ENDOCR METAB, V67, P104, DOI 10.1210/jcem-67-1-104; MORLEY JE, 1986, AM J MED, V80, P897, DOI 10.1016/0002-9343(86)90635-2; NAHOUL K, 1990, J STEROID BIOCHEM, V35, P293, DOI 10.1016/0022-4731(90)90287-3; NANKIN HR, 1986, J CLIN ENDOCR METAB, V63, P1418, DOI 10.1210/jcem-63-6-1418; NIESCHLAG E, 1978, CIBA F SYMP, V62, P182; NILSSON PM, 1995, J INTERN MED, V237, P479, DOI 10.1111/j.1365-2796.1995.tb00873.x; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; SIMON D, 1992, AM J EPIDEMIOL, V135, P783, DOI 10.1093/oxfordjournals.aje.a116365; STEPAN JJ, 1989, J CLIN ENDOCR METAB, V69, P523; Tenover JL, 1997, J ANDROL, V18, P103; THEORELL T, 1990, J INTERN MED, V227, P31, DOI 10.1111/j.1365-2796.1990.tb00115.x; VERMEULEN A, 1985, MATURITAS, V7, P273, DOI 10.1016/0378-5122(85)90050-7; Vermeulen A, 1996, J CLIN ENDOCR METAB, V81, P1821, DOI 10.1210/jc.81.5.1821; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; Werner AA, 1939, J AMER MED ASSOC, V112, P1441, DOI 10.1001/jama.1939.02800150013004; *WORLD HLTH ORG, 1992, GUID US ANDR MEN	38	31	32	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					858	860		10.1136/bmj.320.7238.858	http://dx.doi.org/10.1136/bmj.320.7238.858			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731186	Green Published			2022-12-01	WOS:000086180300031
J	Feany, MB; Bender, WW				Feany, MB; Bender, WW			A Drosophila model of Parkinson's disease	NATURE			English	Article							CATECHOLAMINE-CONTAINING NEURONS; ALPHA-SYNUCLEIN; LEWY BODIES; CELL-DEATH; MELANOGASTER; MUTANT; DEGENERATION; EXPRESSION; INCLUSIONS; PATHOLOGY	Parkinson's disease is a common neurodegenerative syndrome characterized by loss of dopaminergic neurons in the substantia nigra, formation of filamentous intraneuronal inclusions (Lewy bodies) and an extrapyramidal movement disorder. Mutations in the alpha-synuclein gene are linked to familial Parkinson's disease(1,2) and alpha-synuclein accumulates in Lewy bodies and Lewy neurites(3-5). Here we express normal and mutant forms of alpha-synuclein in Drosophila and produce adult-onset loss of dopaminergic neurons, filamentous intraneuronal inclusions containing alpha-synuclein and locomotor dysfunction. Our Drosophila model thus recapitulates the essential features of the human disorder, and makes possible a powerful genetic approach to Parkinson's disease.	Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, 75 Francis St, Boston, MA 02115 USA.			Feany, Mel/0000-0003-0315-7970				Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1986, J NEUROSCI, V6, P3682; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Franceschini N., 1972, INFORMATION PROCESSI, P75; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; GIBB WRG, 1991, J NEUROL NEUROSUR PS, V54, P388, DOI 10.1136/jnnp.54.5.388; Hong L, 1998, NEUROREPORT, V9, P1239, DOI 10.1097/00001756-199804200-00051; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LEBOURG E, 1992, GERONTOLOGY, V38, P59; LI H, IN PRESS CURR BIOL; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3	30	1570	1657	6	170	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					394	398		10.1038/35006074	http://dx.doi.org/10.1038/35006074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746727				2022-12-01	WOS:000086119000052
J	Castner, SA; Williams, GV; Goldman-Rakic, PS				Castner, SA; Williams, GV; Goldman-Rakic, PS			Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; POSITRON EMISSION TOMOGRAPHY; PRIMATE CEREBRAL-CORTEX; AGE-RELATED-CHANGES; DOPAMINE-RECEPTORS; PREFRONTAL CORTEX; BEHAVIORAL SUPERSENSITIVITY; HALOPERIDOL TREATMENT; AMPHETAMINE; SENSITIZATION	Chronic blockade of dopamine D2 receptors, a common mechanism of action for antipsychotic drugs, down-regulates D1 receptors in the prefrontal cortex and, as shown here, produces severe impairments in working memory. These deficits were reversed in monkeys by short-term coadministration of a D1 agonist, ABT 431, and this improvement was sustained for more than a year after cessation of D1 treatment. These findings indicate that pharmacological modulation of the D1 signaling pathway can produce long-lasting changes in functional circuits underlying working memory. Resetting this pathway by brief exposure to the agonist may provide a valuable strategy for therapeutic intervention in schizophrenia and other dopamine dysfunctional states.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH044866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010160] Funding Source: NIH RePORTER; NIDA NIH HHS [P01DA10160] Funding Source: Medline; NIMH NIH HHS [P50MH44866] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; BACHEVALIER J, 1984, BEHAV NEUROSCI, V98, P770, DOI 10.1037/0735-7044.98.5.770; Bjijou Y, 1996, J PHARMACOL EXP THER, V277, P1177; BUCKLAND PR, 1993, NEUROSCI LETT, V150, P25, DOI 10.1016/0304-3940(93)90099-7; CAI JX, 1997, J PHARMACOL EXP THER, V282, P1; CASTNER SA, UNPUB; CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281; Crawford CA, 1997, NEUROREPORT, V8, P2523, DOI 10.1097/00001756-199707280-00021; CRISWELL H, 1989, J NEUROSCI, V9, P125; DAVIDSON M, 1990, ARCH GEN PSYCHIAT, V47, P190; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; Florijn WJ, 1997, J PHARMACOL EXP THER, V280, P561; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; GOSS JR, 1991, LIFE SCI, V48, P1015, DOI 10.1016/0024-3205(91)90367-K; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kelley JJ, 1997, EXP NEUROL, V146, P471, DOI 10.1006/exnr.1997.6552; LEZCANO, 2000, SCIENCE, V287, P1660; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lidow MS, 1997, J PHARMACOL EXP THER, V281, P597; LIDOW MS, 1994, P NATL ACAD SCI USA, V91, P4353, DOI 10.1073/pnas.91.10.4353; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; MARIN C, 1993, EUR J PHARMACOL, V231, P191, DOI 10.1016/0014-2999(93)90448-Q; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Okubo Y, 1997, MOL PSYCHIATR, V2, P291, DOI 10.1038/sj.mp.4000281; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; RINNE JO, 1990, BRAIN RES, V508, P349, DOI 10.1016/0006-8993(90)90423-9; Robinson TE, 1997, J NEUROSCI, V17, P8491; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHNEIDER JS, 1994, BRAIN RES, V663, P140, DOI 10.1016/0006-8993(94)90471-5; SEDVALL G, 1995, LANCET, V346, P743, DOI 10.1016/S0140-6736(95)91508-7; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; STEWART J, 1989, BRAIN RES, V495, P401, DOI 10.1016/0006-8993(89)90236-9; SUHARA T, 1992, PSYCHOPHARMACOLOGY, V106, P14, DOI 10.1007/BF02253582; SUHARA T, 1991, PSYCHOPHARMACOLOGY, V103, P41, DOI 10.1007/BF02244071; Vezina P, 1996, J NEUROSCI, V16, P2411; VINCENT SL, 1991, NEUROPSYCHOPHARMACOL, V5, P147; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	40	295	310	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2020	2022		10.1126/science.287.5460.2020	http://dx.doi.org/10.1126/science.287.5460.2020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720329				2022-12-01	WOS:000085902800063
J	Fliss, MS; Usadel, H; Cabellero, OL; Wu, L; Buta, MR; Eleff, SM; Jen, J; Sidransky, D				Fliss, MS; Usadel, H; Cabellero, OL; Wu, L; Buta, MR; Eleff, SM; Jen, J; Sidransky, D			Facile detection of mitochondrial DNA mutations in tumors and bodily fluids	SCIENCE			English	Article							OXIDATIVE DAMAGE; NUCLEAR	Examination of human bladder, head and neck, and lung primary tumors revealed a high frequency of mitochondrial DNA (mtDNA) mutations. The majority of these somatic mutations were homoplasmic in nature, indicating that the mutant mtDNA became dominant in tumor cells. The mutated mtDNA was readily detectable in paired bodily fluids from each type of cancer and was 19 to 220 times as abundant as mutated nuclear p53 DNA. By virtue of their clonal nature and high copy number, mitochondrial mutations may provide a powerful molecular marker for noninvasive detection of cancer.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res Div, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Sidransky, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res Div, Baltimore, MD 21205 USA.				NATIONAL CANCER INSTITUTE [P50CA058184, P01CA077664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 58184, R01 CA77664] Funding Source: Medline; NIDCR NIH HHS [R01 DE 012488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahrendt SA, 1999, JNCI-J NATL CANCER I, V91, P332, DOI 10.1093/jnci/91.4.332; Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JEN J, 1994, CANCER RES, V54, P5523; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8746; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	17	648	709	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2017	2019		10.1126/science.287.5460.2017	http://dx.doi.org/10.1126/science.287.5460.2017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720328				2022-12-01	WOS:000085902800062
J	Aldhous, P				Aldhous, P			Protests force primate farm to close	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					215	215		10.1038/35005241	http://dx.doi.org/10.1038/35005241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10766598	Bronze			2022-12-01	WOS:000086022200007
J	Boudaiffa, B; Cloutier, P; Hunting, D; Huels, MA; Sanche, L				Boudaiffa, B; Cloutier, P; Hunting, D; Huels, MA; Sanche, L			Resonant formation of DNA strand breaks by low-energy (3 to 20 eV) electrons	SCIENCE			English	Article							ATTACHMENT; DAMAGE; BASES; RADIATION; YIELDS; FILMS; WATER; O-2	Most of the energy deposited in cells by ionizing radiation is channeled into the production of abundant free secondary electrons with ballistic energies between 1 and 20 electron volts. Here it is shown that reactions of such electrons, even at energies well below ionization thresholds, induce substantial yields of single- and double-strand breaks in DNA, which are caused by rapid decays of transient molecular resonances Localized on the DNA's basic components. This finding presents a fundamental challenge to the traditional notion that genotoxic damage by secondary electrons can only occur at energies above the onset of ionization, or upon solvation when they become a slowly reacting chemical species.	Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Canadian Med Res Council,Grp Radiat Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Huels, MA (corresponding author), Univ Sherbrooke, Fac Med, Dept Med Nucl & Radiobiol, Canadian Med Res Council,Grp Radiat Sci, Sherbrooke, PQ J1H 5N4, Canada.							Aflatooni K, 1998, J PHYS CHEM A, V102, P6205, DOI 10.1021/jp980865n; Antic D, 1999, J PHYS CHEM B, V103, P6611, DOI 10.1021/jp990686l; Bass AD, 1998, J CHEM PHYS, V109, P8635, DOI 10.1063/1.477530; Bass AD, 1998, RADIAT ENVIRON BIOPH, V37, P243, DOI 10.1007/s004110050125; Christophorou L. G., 1994, LINKING GASEOUS COND; Cobut V, 1998, RADIAT PHYS CHEM, V51, P229, DOI 10.1016/S0969-806X(97)00096-0; COLSON AO, 1992, J PHYS CHEM-US, V96, P9787, DOI 10.1021/j100203a039; FOLKARD M, 1993, INT J RADIAT BIOL, V64, P651, DOI 10.1080/09553009314551891; FUCIARELLI AF, 1995, RAD DAMAGE DNA STRUC; Hendricks JH, 1998, J CHEM PHYS, V108, P8, DOI 10.1063/1.475360; HIEDA K, 1994, INT J RADIAT BIOL, V66, P561, DOI 10.1080/09553009414551631; HUELS MA, 1994, J CHEM PHYS, V100, P3940, DOI 10.1063/1.466329; Huels MA, 1998, J CHEM PHYS, V108, P1309, DOI 10.1063/1.475503; Huels MA, 1997, CHEM PHYS LETT, V279, P223, DOI 10.1016/S0009-2614(97)01026-9; International Commission on Radiation Units and Measurements, 1979, 31 ICRU; MICHAEL BD, 1995, RADIATION DAMAGE IN DNA: STRUCTURE/FUNCTION RELATIONSHIPS AT EARLY TIMES, P251; PIMBLOTT SM, 1976, AGING CARCINOGENESIS, P3; ROWNTREE P, 1991, J PHYS CHEM-US, V95, P4902, DOI 10.1021/j100165a054; ROWNTREE P, 1991, J CHEM PHYS, V94, P8570, DOI 10.1063/1.460090; SANCHE L, 1995, SCANNING MICROSCOPY, V9, P619; SANCHE L, UNPUB; Sieger MT, 1998, NATURE, V394, P554, DOI 10.1038/29015; SRDOC D, 1995, IAEA CRP ATOMIC MOL, pCH8; Stepanovic M, 1999, J CHEM PHYS, V110, P11376, DOI 10.1063/1.479078; SWARTS SG, 1992, RADIAT RES, V129, P333, DOI 10.2307/3578034; von Sonntag C., 1987, CHEM BASIS RAD BIOL; Ward J.F., 1975, ADV RAD BIOL, P181; Yamamoto O., 1976, AGING CARCINOGENESIS, P165	28	1814	1831	5	239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1658	1660		10.1126/science.287.5458.1658	http://dx.doi.org/10.1126/science.287.5458.1658			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698742				2022-12-01	WOS:000085628200040
J	Rollenhagen, JE; Olson, CR				Rollenhagen, JE; Olson, CR			Mirror-image confusion in single neurons of the macaque inferotemporal cortex	SCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; ORIENTATION DISCRIMINATION	Humans and animals confuse Lateral mirror images, such as the Letters "b" and "d," more often than vertical mirror images, such as the Letters "b" and "p," Experiments were performed to find a neural correlate of this phenomenon. Visually responsive pattern-selective neurons in the inferotemporal cortex of macaque monkeys responded more similarly to members of a Lateral mirror-image pair than to members of a vertical mirror-image pair. The phenomenon developed within 20 milliseconds of the onset of the visual response and persisted to its end. It occurred during presentation of stimuli both at the fovea and in the periphery.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Olson, CR (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003631] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008098, R01EY011831] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR03631] Funding Source: Medline; NEI NIH HHS [EY08098, R01-EY11831] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BORNSTEIN MH, 1978, COGNITION, V6, P89, DOI 10.1016/0010-0277(78)90017-3; CORBALLIS MC, 1970, PSYCHOL REV, V77, P451, DOI 10.1037/h0029805; CORBALLIS MC, 1976, PSYCHOL RIGHT LEFT; DESIMONE R, 1984, J NEUROSCI, V4, P2051; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; GROSS CG, 1977, BRAIN RES, V131, P227, DOI 10.1016/0006-8993(77)90517-0; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; GROSS CG, 1978, LEONARDO, V11, P29, DOI DOI 10.2307/1573500; HAMILTON CR, 1973, BRAIN RES, V64, P241, DOI 10.1016/0006-8993(73)90181-9; HUTTENLOCHER J, 1967, CHILD DEV, V38, P1169, DOI 10.1111/j.1467-8624.1967.tb04392.x; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Olson CR, 1999, J NEUROPHYSIOL, V81, P2340, DOI 10.1152/jn.1999.81.5.2340; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; RIOPELLE AJ, 1964, PERCEPT MOTOR SKILL, V19, P383, DOI 10.2466/pms.1964.19.2.383; RUDEL RG, 1963, J COMP PHYSIOL PSYCH, V56, P892, DOI 10.1037/h0046592; SEKULER RW, 1968, Q J EXP PSYCHOL, V20, P204, DOI 10.1080/14640746808400151; SERPELL R, 1971, J COMP PHYSIOL PSYCH, V75, P312, DOI 10.1037/h0030832; SUTHERLAND NS, 1960, BRIT J PSYCHOL, V51, P9, DOI 10.1111/j.2044-8295.1960.tb00719.x; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TODRIN DC, 1983, PERCEPT PSYCHOPHYS, V34, P397, DOI 10.3758/BF03203053; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x	25	105	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1506	1508		10.1126/science.287.5457.1506	http://dx.doi.org/10.1126/science.287.5457.1506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	287WZ	10688803				2022-12-01	WOS:000085531600057
J	Braine, J; Lisenfeld, U; Due, PA; Leon, S				Braine, J; Lisenfeld, U; Due, PA; Leon, S			Formation of molecular gas in the tidal debris of violent galaxy-galaxy interactions	NATURE			English	Article							COLD DUST; DWARF GALAXIES; SYSTEM ARP-105; LINE EMISSION; H-I; SEQUENCE	In many gravitational interactions between galaxies, gas and stars that have been torn from the precursor galaxies can collect in tidal 'tails'. Star formation begins anew in some of these regions, producing tidal dwarf galaxies(1-4). Observations of these new galaxies provides insight into processes relevant to galaxy formation more generally, because the timescale of the interaction is well defined. But tracking the star formation process has hitherto been difficult because the tidal dwarf galaxies with young stars showed no evidence of the molecular gas out of which those young stars formed(5-8). Here we report the discovery of molecular hydrogen (traced by carbon monoxide emission) in two tidal dwarf galaxies. In both cases, the concentration of molecular gas peaks at the same location as the maximum in atomic-hydrogen density, unlike the situation in most gas-rich galaxies. We infer from this that the molecular gas formed from the atomic hydrogen, rather than being torn in molecular form from the interacting galaxies. Star formation in the tidal dwarf galaxies therefore appears to mimic the process in normal spiral galaxies like our own.	Observ Bordeaux, UMR 5804, CNRS, INSU, F-33270 Floirac, France; Inst Radioastron Millimetr, Granada 18012, Spain; Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; CNRS, F-91191 Gif Sur Yvette, France; CEA, DSM, DAPNIA, Serv Astrophys, F-91191 Gif Sur Yvette, France; Acad Sinica, ASIAA, Taipei 115, Taiwan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Academia Sinica - Taiwan	Braine, J (corresponding author), Observ Bordeaux, UMR 5804, CNRS, INSU, BP89, F-33270 Floirac, France.	Jonathan.Braine@observ.u-bordeaux.fr	Lisenfeld, Ute/AAF-4987-2019; Lisenfeld, Ute/A-1637-2015	Lisenfeld, Ute/0000-0002-9471-5423				ARP H, 1966, ASTROPHYS J, VS 14, P1, DOI 10.1086/190147; BARNES JE, 1992, NATURE, V360, P715, DOI 10.1038/360715a0; BRAINE J, 1993, ASTRON ASTROPHYS, V280, P451; Braine J, 1997, ASTRON ASTROPHYS, V326, P963; BROUILLET N, 1992, ASTRON ASTROPHYS, V262, pL5; Duc PA, 1998, ASTRON ASTROPHYS, V333, P813; Duc PA, 1997, ASTRON ASTROPHYS, V326, P537; DUC PA, 1994, ASTRON ASTROPHYS, V289, P83; DUC PA, UNPUB ASTRON J; DUC PA, 1997, GALAXY INTERACTIONS, P61; Dumke M, 1997, ASTRON ASTROPHYS, V325, P124; FRITZEVALVENSLE.U, 1998, MAGELLANIC CLOUDS OT, P141; GUELIN M, 1993, ASTRON ASTROPHYS, V279, pL37; Hibbard JE, 1996, ASTRON J, V111, P655, DOI 10.1086/117815; HOLLENBACH D, 1989, ASTROPHYS J, V342, P306, DOI 10.1086/167595; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; MIRABEL IF, 1992, ASTRON ASTROPHYS, V256, pL19; Neininger N, 1996, ASTRON ASTROPHYS, V310, P725; SAGE LJ, 1990, ASTRON ASTROPHYS, V239, P125; SCHWEIZER F, 1978, STRUCTURE PROPERTIES, P279; SMITH BJ, 1994, ASTRON J, V108, P837, DOI 10.1086/117115; Smith BJ, 1999, ASTRON J, V117, P1237, DOI 10.1086/300785; Taylor CL, 1998, ASTRON J, V116, P2746, DOI 10.1086/300655; Walter F, 1999, ASTROPHYS J, V519, pL69, DOI 10.1086/312097; ZWICKY F, 1956, ERG EXAKT NATURWISS, V29, P344, DOI 10.1007/BFb0118841	25	56	56	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					867	869		10.1038/35002521	http://dx.doi.org/10.1038/35002521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706277				2022-12-01	WOS:000085559200048
J	Yu, FW; Morin, X; Cai, Y; Yang, XH; Chia, W				Yu, FW; Morin, X; Cai, Y; Yang, XH; Chia, W			Analysis of partner of inscuteable, a novel player of Drosophila asymmetric divisions, reveals two distinct steps in inscuteable apical localization	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; CAENORHABDITIS-ELEGANS; ADAPTER PROTEIN; MAMMALIAN NUMB; PROSPERO GENE; DAUGHTER CELL; FATES; NOTCH; MITOSIS	Asymmetric localization is a prerequisite for inscuteable (insc) to function in coordinating and mediating asymmetric cell divisions in Drosophila. We show here that Partner of Inscuteable (Pins), a new component of asymmetric divisions, is required for Inscuteable to asymmetrically localize. In the absence of pins, Inscuteable becomes cytoplasmic and asymmetric divisions of neuroblasts and mitotic domain 9 cells show defects reminiscent of insc mutants. Pins colocalizes with Insc and interacts with the region necessary and sufficient for directing its asymmetric localization. Analyses of pins function in neuroblasts reveal two distinct steps for Insc apical cortical localization: A pins-independent, bazooka-dependent initiation step during delamination (interphase) and a later maintenance step during which Baz, Pins, and Insc localization are interdependent.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chia, W (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbwchia@imcb.nus.edu.sg	Cai, Yu/R-7737-2019; morin, xavier/AAI-3306-2020	Cai, Yu/0000-0003-2044-3290; Yu, Fengwei/0000-0003-0268-199X; Morin, Xavier/0000-0001-9999-0355				Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; CamposOrtega JA, 1996, NEURON, V17, P1, DOI 10.1016/S0896-6273(00)80274-3; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Doe CQ, 1996, CURR OPIN GENET DEV, V6, P562, DOI 10.1016/S0959-437X(96)80084-0; Dye CA, 1998, DEVELOPMENT, V125, P1845; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Hung TJ, 1999, DEVELOPMENT, V126, P127; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tio M, 1999, J CELL SCI, V112, P1541; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	55	296	304	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					399	409		10.1016/S0092-8674(00)80676-5	http://dx.doi.org/10.1016/S0092-8674(00)80676-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693757	Bronze			2022-12-01	WOS:000085446900003
J	Wadman, M				Wadman, M			Republican candidates clash on fetal tissue in research	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					694	694		10.1038/35001743	http://dx.doi.org/10.1038/35001743			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10733383	Bronze			2022-12-01	WOS:000085423100013
J	Corey, L; Handsfield, HH				Corey, L; Handsfield, HH			Genital herpes and public health - Addressing a global problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLEX VIRUS; RISK FACTOR; TYPE-2 INFECTION; CONTROLLED TRIAL; ULCER DISEASE; ACYCLOVIR; TRANSMISSION; ASSOCIATION; SUPPRESSION	Genital herpes can be caused by herpes simplex virus 2 (HSV-2) or, less commonly, by herpes simplex virus 1 (HSV-1). With a seroprevalence of antibodies to HSV-2 of 22% in the general population, genital herpes is 1 of the 3 most prevalent sexually transmitted diseases (STDs) in the United States, A central issue in the public health problem of genital herpes is the high proportion of genital HSV infections that are unrecognized by both patients and clinicians. Persons who are HSV-2 seropositive may be symptomatic but nevertheless fail to recognize genital herpes; they serve as reservoirs for transmission. Physicians and patients must be aware of the subclinical presentation of genital herpes and the potential these patients have for transmitting HSV, Serious consequences of HSV infection include neonatal herpes and increased risk of human immunodeficiency virus transmission. Recommendations to physicians for prevention include using type-specific tests for HSV when screening for other STDs and testing for HSV when evaluating patients with genital ulcers. Researchers must evaluate the performance of type-specific tests and strategies to prevent transmission.	Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Publ Hlth Seattle & King Cty, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Corey, L (corresponding author), Fred Hutchinson Canc Res Ctr, Program Infect Dis, 1100 Fairview Ave N D3-100, Seattle, WA 98109 USA.		Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NIAID NIH HHS [AI-30731] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashley RL, 1999, J CLIN MICROBIOL, V37, P1632, DOI 10.1128/JCM.37.5.1632-1633.1999; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; CASTRO KG, 1988, SCIENCE, V239, P193, DOI 10.1126/science.3336781; CATOTTI DN, 1993, SEX TRANSM DIS, V20, P77, DOI 10.1097/00007435-199303000-00004; Corey L, 1998, SEX TRANSM DIS, V25, P58, DOI 10.1097/00007435-199802000-00002; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; COREY L, 1999, SEXUALLY TRANSMITTED, P285; Diamond C, 1999, SEX TRANSM DIS, V26, P221, DOI 10.1097/00007435-199904000-00007; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; FORSGREN M, 1990, SCAND J INFECT DIS, P37; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Gwanzura L, 1998, J INFECT DIS, V177, P481, DOI 10.1086/517381; Handsfield HH, 1999, SEX TRANSM DIS, V26, P228, DOI 10.1097/00007435-199904000-00009; HOLMBERG SD, 1988, JAMA-J AM MED ASSOC, V259, P1048, DOI 10.1001/jama.259.7.1048; HOOK EW, 1992, J INFECT DIS, V165, P251, DOI 10.1093/infdis/165.2.251; *INT HERP MAN FOR, 1999, HERPES, V6, P1; JOHNSON RE, 1990, NEW ENGL J MED, V321, P8; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; LANGENBERG A, 1989, ANN INTERN MED, V110, P882, DOI 10.7326/0003-4819-110-11-882; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; MARAZZO JM, 1997, INFECT DIS OBSTET GY, V5, P29; MERTZ GJ, 1988, J INFECT DIS, V157, P1169, DOI 10.1093/infdis/157.6.1169; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morse SA, 1997, J INFECT DIS, V175, P583, DOI 10.1093/infdis/175.3.583; NAHMIAS AJ, 1990, SCAND J INFECT DIS, P19; PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503; ROSS JDC, 1993, GENITOURIN MED, V69, P381; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Wald A, 1996, ANN INTERN MED, V124, P8, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00002; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; WHITLEY RJ, 1995, INFECT DIS FETUS NEW, P354	42	174	183	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2000	283	6					791	794		10.1001/jama.283.6.791	http://dx.doi.org/10.1001/jama.283.6.791			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280XL	10683059				2022-12-01	WOS:000085129000032
J	Tessier-Lavigne, M; Goodman, CS				Tessier-Lavigne, M; Goodman, CS			Neurobiology - Regeneration in the Nogo Zone	SCIENCE			English	Editorial Material							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH; AXONAL REGENERATION; INHIBITOR; IDENTIFICATION		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.0.CO;2-K; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403	18	19	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2000	287	5454					813	814		10.1126/science.287.5454.813	http://dx.doi.org/10.1126/science.287.5454.813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691556				2022-12-01	WOS:000085136400031
J	Soto, C; Kascsak, RJ; Saborio, GP; Aucouturier, P; Wisniewski, T; Prelli, F; Kascsak, R; Mendez, E; Harris, DA; Ironside, J; Tagliavini, F; Carp, RI; Frangione, B				Soto, C; Kascsak, RJ; Saborio, GP; Aucouturier, P; Wisniewski, T; Prelli, F; Kascsak, R; Mendez, E; Harris, DA; Ironside, J; Tagliavini, F; Carp, RI; Frangione, B			Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides	LANCET			English	Article							SCRAPIE AGENT; AMYLOIDOSIS; INHIBITION; MICE; CJD	Background Transmissible spongiform encephalopathies are associated with a structural transition in the prion protein that results in the conversion of the physiological PrPc to pathological PrPSc. We investigated whether this conformational transition can be inhibited and reversed by peptides homologous to the PrP fragments implicated in the abnormal folding. which contain specific residues acting as beta-sheet blockers (beta-sheet breaker peptides). Methods We studied the effect of a 13-residue beta-sheet breaker peptide (iPrP13) on the reversion of the abnormal structure and properties of PrPSc; purified from the brains of mice with experimental scrapie and from human beings affected by sporadic and variant Creutzfeldt-Jakob disease. In a cellular model of familial prion disease, we studied the effect of the peptide in the production of the abnormal form of PrP in intact cells. The influence of the peptide on prion infectivity was studied in vivo by incubation time assays in mice with experimental scrapie. Findings The beta-sheet breaker peptide partly reversed in-vitro PrPSc to a biochemical and structural state similar to that of PrPc. The effect of the peptide was also detected in intact cells. Treatment of prion infectious material with iPrP13 delayed the appearance of clinical symptoms and decreased infectivity by 90-95% in mice with experimental scrapie. Interpretation beta-sheet breaker peptides reverse PrP conformational changes implicated in the pathogenesis of spongiform encephalopathies, These peptides or their derivatives provide a useful tool to study the role of PrP conformation and might represent a novel therapeutic approach for prion-related disorders.	Serono Pharmaceut Res Inst, Dept Cellular Biochem, Geneva, Switzerland; NYU, Med Ctr, New York, NY 10016 USA; New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; CSIC, Ctr Nacl Biotecnol, Madrid, Spain; Washington Univ, Sch Med, St Louis, MO USA; Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Ist Nazl Neurol Carlo Besta, Milan, Italy	New York University; Institute for Basic Research in Developmental Disabilities; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Washington University (WUSTL); University of Edinburgh; IRCCS Istituto Neurologico Besta	Soto, C (corresponding author), Serono Pharmaceut Res Inst, Dept Cellular Biochem, Geneva, Switzerland.		Wisniewski, Thomas/Q-6525-2019; Tagliavini, Fabrizio/AAO-7891-2021	Wisniewski, Thomas/0000-0002-3379-8966; Tagliavini, Fabrizio/0000-0003-1039-7315; Ironside, James/0000-0001-5869-2108; Harris, David/0000-0002-6985-5790	NIAMS NIH HHS [ARD2594] Funding Source: Medline; NINDS NIH HHS [NS35496] Funding Source: Medline; PHS HHS [M56472] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR002594, R37AR002594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035496] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 1998, CNS DRUGS, V10, P83, DOI 10.2165/00023210-199810020-00001; Aucouturier P, 1999, NEUROSCI LETT, V274, P33, DOI 10.1016/S0304-3940(99)00659-X; Brown P, 1990, ANTIVIR CHEM CHEMOTH, V1, P75, DOI 10.1177/095632029000100201; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CARP RI, 1994, ANN NY ACAD SCI, V724, P221, DOI 10.1111/j.1749-6632.1994.tb38912.x; CARP RI, 1984, INTERVIROLOGY, V21, P61, DOI 10.1159/000149503; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; FAUCHERE JL, 1992, ADV DRUG RES, V23, P127; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Haywood AM, 1997, NEW ENGL J MED, V337, P1821, DOI 10.1056/NEJM199712183372508; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kascsak RJ, 1997, IMMUNOL INVEST, V26, P259, DOI 10.3109/08820139709048931; KIMBERLIN RH, 1976, SCI PROGRESS-UK, V63, P461; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; MOORE GJ, 1994, TRENDS PHARMACOL SCI, V15, P124, DOI 10.1016/0165-6147(94)90049-3; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Soto C, 1999, CNS DRUGS, V12, P347, DOI 10.2165/00023210-199912050-00002; WILL RG, 1996, LANCET, V347, P925; ZHANG H, 1995, J MOL BIOL, V250, P514, DOI 10.1006/jmbi.1995.0395	30	242	267	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 15	2000	355	9199					192	197		10.1016/S0140-6736(99)11419-3	http://dx.doi.org/10.1016/S0140-6736(99)11419-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276LR	10675119				2022-12-01	WOS:000084879700013
J	Firstenberg, MS; Thomas, JD				Firstenberg, MS; Thomas, JD			Stroke-distance measurement after acute myocardial infarction	LANCET			English	Editorial Material									Cleveland Clin Fdn, Cardiovasc Imaging Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Thomas, JD (corresponding author), Cleveland Clin Fdn, Cardiovasc Imaging Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Trent RJ, 1999, HEART, V82, P187, DOI 10.1136/hrt.82.2.187	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1204	1204		10.1016/S0140-6736(00)02084-5	http://dx.doi.org/10.1016/S0140-6736(00)02084-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770300				2022-12-01	WOS:000086448000007
J	Cavicchi, M; Beau, P; Crenn, P; Degott, C; Messing, B				Cavicchi, M; Beau, P; Crenn, P; Degott, C; Messing, B			Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure	ANNALS OF INTERNAL MEDICINE			English	Article							P-GLYCOPROTEIN GENE; URSODEOXYCHOLIC ACID; CHRONIC CHOLESTASIS; LIPID EMULSIONS; BOWEL RESECTION; FUNCTION TESTS; CHILDREN; RATS; TRANSPLANTATION; METRONIDAZOLE	Background: Liver cholestasis can be a life-threatening complication during home parenteral nutrition and may lead to combined liver-intestinal transplantation. Objective: To assess the prevalence of home parenteral nutrition-related liver disease and its contributing factors in patients with permanent intestinal failure. Design: Prospective cohort study. Setting: Two approved home parenteral nutrition centers, Patients: 90 patients with permanent intestinal failure who were receiving home parenteral nutrition were enrolled from 1985 to 1996. Intervention: Clinical, biological, endoscopic, and ultrasonographic follow-up. Histologic examination of the liver was done in 57 patients (112 liver biopsies). Measurements: The Kaplan-Meier method was used to determine the actuarial occurrence of chronic cholestasis and complicated home parenteral nutrition-related liver disease (bilirubin level greater than or equal to 60 mu mol/L [3.5 mg/dL], factor V level less than or equal to 50%, portal hypertension, encephalopathy, ascites, gastrointestinal bleeding, or histologically proven extensive fibrosis or cirrhosis). Contributing factors were assessed by using univariate and multivariate (Cox model) analysis. Results: 58 patients (65%) developed chronic cholestasis after a median of 6 months (range, 3 to 132 months), and 37 (41.5%)developed complicated home parenteral nutrition-related liver disease after a median of 17 months (range, 2 to 155 months). Of these patients, 17 showed extensive fibrosis after 26 months (range, 2 to 148 months) and 5 had cirrhosis after 37 months (range, 26 to 77 months). The prevalence of complicated home parenteral nutrition-related liver disease was 26% +/- 9% at 2 years and 50% +/- 13% at 6 years. Six patients died of liver disease (22% of all deaths). In multivariate analysis, chronic cholestasis was significantly associated with a parenteral nutrition-independent risk for liver disease, a bowel remnant shorter than 50 cm in length, and a parenteral lipid intake of 1 g/kg of body weight per day or more (omega-6-rich long-chain triglycerides), whereas complicated home parenteral nutrition-related liver disease was significantly associated with chronic cholestasis and lipid parenteral intake of 1 g/kg per day or more. Conclusion: The prevalence of complicated home parenteral nutrition-related liver disease increased with longer duration of parenteral nutrition. This condition was one of the main causes of death in patients with permanent intestinal failure. Parenteral intake of w-6-rich long-chain triglycerides lipid emulsion consisting of less than 1 g/kg per day is recommended in these patients.	Hop Lariboisiere, Serv Gastroenterol & Assistance Nutr, F-75475 Paris 10, France; Ctr Hosp La Miletrie, Poitiers, France; Hop Beaujon, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Messing, B (corresponding author), Hop Lariboisiere, Serv Gastroenterol & Assistance Nutr, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	bernard.messing@lrb.ap-hop-paris.fr	CRENN, Pascal/B-5850-2008	CRENN, Pascal/0000-0002-8213-2319				ALLARDYCE DB, 1982, SURG GYNECOL OBSTET, V154, P641; BEAU P, 1994, J HEPATOL, V20, P240, DOI 10.1016/S0168-8278(05)80064-9; BEAU P, 1994, GASTROEN CLIN BIOL, V18, P63; BELLI DC, 1987, JPEN-PARENTER ENTER, V11, P67, DOI 10.1177/014860718701100167; BENJAMIN DR, 1981, AM J CLIN PATHOL, V76, P276; BOWYER BA, 1985, JPEN-PARENTER ENTER, V9, P11, DOI 10.1177/014860718500900111; Brousse N, 1996, BRIT MED J, V312, P261; BURNES JU, 1992, JPEN-PARENTER ENTER, V16, P327, DOI 10.1177/0148607192016004327; CANO N, 1994, NUTR CLIN METAB, V8, P149; CAPRON JP, 1983, LANCET, V1, P446; CLARKE PJ, 1991, JPEN-PARENTER ENTER, V15, P54, DOI 10.1177/014860719101500154; CLAYTON PT, 1993, GASTROENTEROLOGY, V105, P1806, DOI 10.1016/0016-5085(93)91079-W; Cox D.R., 1989, MONOGRAPHS STAT APPL, V2nd ed.; CRAIG RM, 1980, GASTROENTEROLOGY, V79, P131; Crenn P, 1997, CLIN NUTR, V16, P133, DOI 10.1016/S0261-5614(97)80240-3; DAHMS BB, 1981, GASTROENTEROLOGY, V81, P136; DEGOTT C, 1988, GASTROENTEROLOGY, V95, P183, DOI 10.1016/0016-5085(88)90309-5; DRONGOWSKI RA, 1989, JPEN-PARENTER ENTER, V13, P586, DOI 10.1177/0148607189013006586; FISCHER GW, 1980, LANCET, V2, P819; Forbush B, 1998, GASTROENTEROLOGY, V114, pA1241, DOI 10.1016/S0016-5085(98)85034-8; FOUINFORTUNET H, 1982, GASTROENTEROLOGY, V82, P932; GERARDBONCOMPAIN M, 1992, JPEN-PARENTER ENTER, V16, P78, DOI 10.1177/014860719201600178; GOGOS CA, 1992, NUTRITION, V8, P26; Grant D, 1999, TRANSPLANTATION, V67, P1061, DOI 10.1097/00007890-199904150-00021; GUERTIN F, 1991, JPEN-PARENTER ENTER, V15, P247, DOI 10.1177/0148607191015003247; Harris JA., 1919, BIOMETRIC STUDY BASA; INNES GK, 1988, TRANSPLANTATION, V45, P749, DOI 10.1097/00007890-198804000-00017; ITO Y, 1991, JPEN-PARENTER ENTER, V15, P271, DOI 10.1177/0148607191015003271; KAMINSKI DL, 1980, SURGERY, V88, P93; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KONO K, 1988, GASTROENTEROLOGY, V94, P787, DOI 10.1016/0016-5085(88)90255-7; LAMBERT JR, 1985, JPEN-PARENTER ENTER, V9, P501, DOI 10.1177/0148607185009004501; LEVECQ H, 1988, GASTROEN CLIN BIOL, V12, P691; MARTINEZ M, 1987, LIPIDS, V22, P133, DOI 10.1007/BF02537290; MESSING B, 1992, NUTRITION, V8, P30; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MESSING B, 1995, GASTROENTEROLOGY, V108, P1005, DOI 10.1016/0016-5085(95)90196-5; MESSING B, 1990, AM J CLIN NUTR, V52, P1094, DOI 10.1093/ajcn/52.6.1094; MESSING B, 1994, TRANSPL P, V26, P1438; MESSING B, 1982, GASTROEN CLIN BIOL, V6, P740; MUGHAL M, 1986, LANCET, V2, P383; NANJI AA, 1985, JPEN-PARENTER ENTER, V9, P307, DOI 10.1177/0148607185009003307; PEDEN VH, 1971, J PEDIATR-US, V78, P180, DOI 10.1016/S0022-3476(71)80289-5; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; QUIGLEY EMM, 1993, GASTROENTEROLOGY, V104, P286, DOI 10.1016/0016-5085(93)90864-9; Quigley EMM, 1996, GASTROENTEROLOGY, V110, P2009, DOI 10.1053/gast.1996.v110.agast962009; Roth B, 1996, INTENS CARE MED, V22, P1224, DOI 10.1007/s001340050242; SCOTTCONNER CEH, 1994, J SURG RES, V57, P316, DOI 10.1006/jsre.1994.1151; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Spagnuolo MI, 1996, GASTROENTEROLOGY, V111, P716, DOI 10.1053/gast.1996.v111.pm8780577; Stanko RT, 1987, GASTROENTEROLOGY, V92, P197, DOI 10.1016/0016-5085(87)90859-6; Tabachnik B.G., 1983, USING MULTIVARIATE S; TKOUB M, 1997, CLIN NUTR S1, V16, P32; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDEVENTER SJH, 1988, GASTROENTEROLOGY, V94, P825, DOI 10.1016/0016-5085(88)90261-2; vanNieuwkerk CMJ, 1996, GASTROENTEROLOGY, V111, P165, DOI 10.1053/gast.1996.v111.pm8698195; WOLFE BM, 1988, ARCH SURG-CHICAGO, V123, P1084	59	432	448	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2000	132	7					525	532		10.7326/0003-4819-132-7-200004040-00003	http://dx.doi.org/10.7326/0003-4819-132-7-200004040-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298FU	10744588				2022-12-01	WOS:000086129300002
J	Schoof, H; Lenhard, M; Haecker, A; Mayer, KFX; Jurgens, G; Laux, T				Schoof, H; Lenhard, M; Haecker, A; Mayer, KFX; Jurgens, G; Laux, T			The stem cell population of Arabidopsis shoot meristems is maintained by a regulatory loop between the CLAVATA and WUSCHEL genes	CELL			English	Article							FLORAL MERISTEMS; EXPRESSION; PROTEIN; ZWILLE; FATE	The higher-plant shoot meristem is a dynamic structure whose maintenance depends on the coordination of two antagonistic processes, organ initiation and self-renewal of the stem cell population. In Arabidopsis shoot and floral meristems, the WUSCHEL (WUS) gene is required for stem cell identity, whereas the CLAVATA1, 2, and 3 (CLV) genes promote organ initiation. Our analysis of the interactions between these key regulators indicates that (1) the CLV genes repress WUS at the transcript level and that (2) WUS expression is sufficient to induce meristem cell identity and the expression of the stem cell marker CLV3. Our data suggest that the shoot meristem has properties of a self-regulatory system in which WUS/CLV interactions establish a feedback loop between the stem cells and the underlying organizing center.	Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Laux, T (corresponding author), Zentrum Mol Biol Pflanzen, Morgenstelle 1, D-72076 Tubingen, Germany.	thomas.laux@uni-tuebingen.de	Mayer, Klaus FX/M-7941-2015; Lenhard, Michael/J-1554-2015; Schoof, Heiko/Y-7073-2018	Mayer, Klaus FX/0000-0001-6484-1077; Schoof, Heiko/0000-0002-1527-3752				BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bowman J., 1994, ARABIDOPSIS ATLAS MO; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1996, DEVELOPMENT, V122, P1567; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laufs P, 1998, DEVELOPMENT, V125, P1253; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 1999, CURR OPIN PLANT BIOL, V2, P44, DOI 10.1016/S1369-5266(99)80009-0; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lynn K, 1999, DEVELOPMENT, V126, P469; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; STEWART RN, 1970, AM J BOT, V57, P816, DOI 10.2307/2441339; VANDERKROL AR, 1991, PLANT CELL, V3, P667, DOI 10.1105/tpc.3.7.667; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	25	1168	1266	16	238	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					635	644		10.1016/S0092-8674(00)80700-X	http://dx.doi.org/10.1016/S0092-8674(00)80700-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761929	Bronze			2022-12-01	WOS:000085983800006
J	Hsueh, YP; Wang, TF; Yang, FC; Sheng, M				Hsueh, YP; Wang, TF; Yang, FC; Sheng, M			Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2	NATURE			English	Article							EPITHELIAL-CELLS; BASOLATERAL MEMBRANE; PROTEIN COMPLEX; BETA-CATENIN; IDENTIFICATION; LOCALIZATION; BRACHYURY; HOMOLOG; DOMAIN	Membrane-associated guanylate kinases (MAGUKs) contain multiple protein-binding domains that allow them to assemble specific multiprotein complexes in particular regions of the cell(1,2). CASK/LIN-2, a MAGUK required for EGF receptor localization and signalling in Caenorhabditis elegans, contains a calmodulin-dependent protein kinase-like domain followed by PDZ, SH3 and guanylate kinase-like domains(3-5). In adult rat brain, CASK is concentrated at neuronal synapses and binds to the cell-surface proteins neurexin and syndecan(6-8) and the cytoplasmic proteins Mint/LIN-10 and Veli/LIN-7 (refs 4, 9, 10). Here we report that, through its guanylate kinase domain, CASK interacts with Tbr-1, a T-box transcription factor that is involved in forebrain development(11,12). CASK enters the nucleus and binds to a specific DNA sequence (the T-element) in a complex with Tbr-1. CASK acts as a coactivator of Tbr-1 to induce transcription of T-element containing genes, including reelin, a gene that is essential for cerebrocortical development. Our findings show that a MAGUK which is usually associated with cell junctions has a transcription regulation function.	Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.	sheng@helix.mgh.harvard.edu	Wang, Ting-Fang/ABI-3818-2020; Hsueh, Yi-Ping/ABH-5052-2020	Wang, Ting-Fang/0000-0001-6306-9505; Hsueh, Yi-Ping/0000-0002-0866-6275; Sheng, Morgan/0000-0002-8703-5366				Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Hata Y, 1996, J NEUROSCI, V16, P2488; Hevner R. F., 1999, Society for Neuroscience Abstracts, V25, P502; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752	22	278	288	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					298	302		10.1038/35005118	http://dx.doi.org/10.1038/35005118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749215				2022-12-01	WOS:000086022200053
J	Rein, M				Rein, M			Stress and genital herpes recurrences in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Background: Results of several studies suggest that psychological stress and negative mood can trigger genital herpes recurrences, but results are inconsistent. Objective: To determine whether short-term or persistent psychological stress or specific negative moods are predictive of genital herpes recurrences in women. Methods: A prospective cohort study followed up participants for 6 months using weekly assessments of stress and mood, monthly assessment of life chang events, and diary reports of genital herpes recurrences confirmed medical examination when feasible. The. community sample consisted of 58 women, aged 20 to 44 years; with a 1- to 10-year history of visible genital herpes recurrence and at least 1 recurrence in the previous 6 months. Results: Persistent stress predicted recurrence in the subsequent week (odds ratio, 1.08 per unit increase in stress; 95%, confidence interval, 1.01-1.15; P = .03). After adjusting for recurrence in the previous week, the more weekly persistent stress reported, the greater the likelihood of recurrence the following week. Also, an increased recurrence rate occurred after the month during which participants experienced their highest levels of anxiety (P = .03). There were no significant associations between recurrence and short-term stress, life events, depressive mood, anger, or phase of menstrual cycle. Conclusions: Persistent stressors and highest level of anxiety predicted genital herpes recurrence, whereas transient mood states, short-term stressors, and life change events did not. Women with herpes can be reassured that short-term stressful life experiences and dysphoric mood states do not put them at risk for increased outbreaks of recurrent genital herpes.	Univ Virginia, Hlth Sci Ctr, Div Infect Dis, Charlottesville, VA 22908 USA	University of Virginia	Rein, M (corresponding author), Univ Virginia, Hlth Sci Ctr, Div Infect Dis, Charlottesville, VA 22908 USA.	mfr6t@virginia.edu							0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1394	1394		10.1001/jama.283.11.1394	http://dx.doi.org/10.1001/jama.283.11.1394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732915				2022-12-01	WOS:000085696700001
J	Baker, S; Priest, P; Jackson, R				Baker, S; Priest, P; Jackson, R			Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DRUG-TREATMENT; NEW-ZEALAND; GUIDELINES; MANAGEMENT; TRIALS; METAANALYSIS; DYSLIPIDEMIA; FRAMINGHAM	Objective To estimate the impact of using thresholds based on absolute risk of cardiovascular disease to target drug treatment to lower blood pressure in the community. Design Modelling of three thresholds of treatment for hypertension based on the absolute risk of cardiovascular disease. 5 year risk of disease was estimated for each participant using an equation to predict risk. Net predicted impact of the thresholds on the number of people treated and the number of disease events averted over 5 years was calculated Setting Auckland, New Zealand. Participants 2158 men and women aged 35-79 veers randomly sampled from the general electoral rolls. Main outcome measures Predicted 5 year risk of cardiovascular disease event estimated number of people for whom treatment would be recommended and disease events averted over 5 years at different treatment thresholds. Results 46 374 (12%) Auckland residents aged 35-79 receive drug treatment to lower their blood pressure, averting an estimated 1689 disease events: over 5 years. Restricting treatment to individuals with blood pressure greater than or equal to 170/100 mm Hg and those with blood pressure between 150/90-169/99 mm Hg who have a predicted 5 year risk of disease greater than or equal to 10% would increase the net number for whom treatment would be recommended by 19 401. This 42% relative increase is predicted to avert 1139/1689 (68%) additional disease events overall over 5 years compared with current treatment. If the threshold for 5 year risk of disease is set at 15% the number recommended for treatment increases by < 10% but about 620/1689 (37%) additional events can be averted. A 20% threshold decreases the net number of patients recommended fur treatment by about 10% but averts 204/1689 (12%) more disease events than current treatment. Conclusions Implementing treatment guidelines that use treatment thresholds based on absolute risk could significantly improve the efficiency of drug treatment to lower blood pressure in primary care.	Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; Univ Oxford Wolfson Coll, Oxford OX2 6UD, England; Hlth Funding Author, Auckland, New Zealand	University of Auckland; University of Oxford	Jackson, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Private Bag 92019, Auckland 1, New Zealand.	rt.jackson@auckland.co.nz		Jackson, Rod/0000-0001-5914-6934				ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; *COR SERV COMM, 1995, GUID MAN RAIS BLOOD; Fahey TP, 1996, BMJ-BRIT MED J, V313, P93, DOI 10.1136/bmj.313.7049.93; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P236, DOI 10.1177/0272989X9401400305; LEAVERTON PE, 1987, J CHRON DIS, V40, P775, DOI 10.1016/0021-9681(87)90129-9; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MANN JI, 1993, NEW ZEAL MED J, V106, P133; MCGEE D, 1976, FRAMINGHAM STUDY EPI; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; North D, 1996, NEW ZEAL MED J, V109, P134; *NZ GUID GROUP, 2000, MAN RAIS BLOOD PRESS; PEDERSEN TR, 1994, LANCET, V344, P1383; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	28	40	40	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					680	685		10.1136/bmj.320.7236.680	http://dx.doi.org/10.1136/bmj.320.7236.680			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710577	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000085895300021
J	Musters, CJM; de Graaf, HJ; ter Keurs, WJ				Musters, CJM; de Graaf, HJ; ter Keurs, WJ			Ecology - Can protected areas be expanded in Africa?	SCIENCE			English	Article									Leiden Univ, Dept Environm Biol, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Musters, CJM (corresponding author), Leiden Univ, Dept Environm Biol, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.	musters@rulsfb.leidenuniv.nl	Musters, Cornelis/K-7828-2013	Musters, C.J.M./0000-0003-1321-6786				Daily G, 1998, SCIENCE, V281, P1291, DOI 10.1126/science.281.5381.1291; *FAO UN, 1997, STAT FOOD AGR 1997; FORD WR, 1999, 2 INT CULT C AFR AFR; Goklany IM, 1998, BIOSCIENCE, V48, P941, DOI 10.2307/1313298; Helmuth L, 1999, SCIENCE, V286, P1283, DOI 10.1126/science.286.5443.1283; Inamdar A, 1999, SCIENCE, V283, P1856, DOI 10.1126/science.283.5409.1856; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kramer R, 1997, LAST STAND PROTECTED; Kramer Randall A., 1997, P3; LUYTEN JC, 1995, 37 RES I AGR SOIL FE; *POP DIV DEP EC SO, 1999, WOLF; *S AFR RES DOC CTR, 1994, STAT ENV SO AFR; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; *UN ENV PROGR, 1991, STAT DES IMPL US NAT; *UN ENV PROGR, 1991, WORLD RESOURCES 1994; van Schaik Carel P., 1997, P212; Western D., 1994, NATURAL CONNECTIONS; WOLF EC, 1987, BRINK EXTEINCTION CO; *WORLD RES I, 1994, WORLD RESOURCES 1994; [No title captured]	20	33	34	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1759	1760		10.1126/science.287.5459.1759	http://dx.doi.org/10.1126/science.287.5459.1759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10755927				2022-12-01	WOS:000085775300023
J	Tromans, A				Tromans, A			Entomology - Love is not puffed up	NATURE			English	Editorial Material																		Funk DH, 2000, ANIM BEHAV, V59, P411, DOI 10.1006/anbe.1999.1310	1	0	0	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					138	138		10.1038/35004700	http://dx.doi.org/10.1038/35004700			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10755907	Bronze			2022-12-01	WOS:000085870900032
J	Bosch, X				Bosch, X			Newspaper apportions blame in Spanish hepatitis C scandal	LANCET			English	News Item																		MAESO, 1998, LANCET, V351, P1415	1	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					818	818		10.1016/S0140-6736(05)72446-6	http://dx.doi.org/10.1016/S0140-6736(05)72446-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711938				2022-12-01	WOS:000085766900034
J	Geijtenbeek, TBH; Kwon, DS; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Middel, J; Cornelissen, ILMHA; Nottet, HSLM; KewalRamani, VN; Littman, DR; Figdor, CG; van Kooyk, Y				Geijtenbeek, TBH; Kwon, DS; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Middel, J; Cornelissen, ILMHA; Nottet, HSLM; KewalRamani, VN; Littman, DR; Figdor, CG; van Kooyk, Y			DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TYPE LECTIN; CHEMOKINE-CORECEPTORS; HIV ENTRY; IN-VITRO; PATHOGENESIS; RECEPTORS; INHIBITION; BLOOD; USAGE	Dendritic cells (DC) capture microorganisms that enter peripheral mucosal tissues and then migrate to secondary lymphoid organs, where they present these in antigenic form to resting T cells and thus initiate adaptive immune responses. Here, we describe the properties of a DC-specific C-type lectin, DC-SIGN, that is highly expressed on DC present in mucosal tissues and binds to the HIV-1 envelope glycoprotein gp120. DC-SIGN does not function as a receptor for viral entry into DC but instead promotes efficient infection in trans of cells that express CD4 and chemokine receptors. We propose that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.	Univ Med Ctr St Radboud, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands; Univ Med Ctr St Radboud, Dept Pathol, NL-6525 EX Nijmegen, Netherlands; Univ Utrecht Hosp, Eykman Winkler Inst Microbiol, NL-3584 CX Utrecht, Netherlands; NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; New York University; New York University	van Kooyk, Y (corresponding author), Univ Med Ctr St Radboud, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.		Torensma, Ruurd/C-2853-2009; Figdor, Carl G/A-4232-2010; KewalRamani, Vineet/V-5084-2019; Geijtenbeek, Teunis/C-2229-2009	Torensma, Ruurd/0000-0002-0555-7903; Figdor, Carl G/0000-0002-2366-9212; van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665	DIVISION OF BASIC SCIENCES - NCI [Z01BC010322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33856] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Ayehunie S, 1997, BLOOD, V90, P1379, DOI 10.1182/blood.V90.4.1379.1379_1379_1386; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BarrattBoyes SM, 1997, J IMMUNOL, V158, P4543; Bjorndal A, 1997, J VIROL, V71, P7478; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; CAMERON PU, 1994, J LEUKOCYTE BIOL, V56, P257, DOI 10.1002/jlb.56.3.257; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Grouard G, 1997, CURR OPIN IMMUNOL, V9, P563, DOI 10.1016/S0952-7915(97)80111-2; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Rowland-Jones SL, 1999, CURR BIOL, V9, pR248, DOI 10.1016/S0960-9822(99)80155-9; Rubbert A, 1998, J IMMUNOL, V160, P3933; Speck RF, 1999, CURR BIOL, V9, P547, DOI 10.1016/S0960-9822(99)80241-3; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826	37	1876	1978	2	125	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					587	597		10.1016/S0092-8674(00)80694-7	http://dx.doi.org/10.1016/S0092-8674(00)80694-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721995	Bronze			2022-12-01	WOS:000085700000011
J	Farquhar, J; Savarino, J; Jackson, TL; Thiemens, MH				Farquhar, J; Savarino, J; Jackson, TL; Thiemens, MH			Evidence of atmospheric sulphur in the martian regolith from sulphur isotopes in meteorites	NATURE			English	Article							CHEMICAL-COMPOSITION; EARLY EARTH; MARS; SULFUR; CARBONATES; ALH84001; TEMPERATURE; CHONDRITES; SULFATES; SOIL	Sulphur is abundant at the martian surface, yet its origin and evolution over time remain poorly constrained(1,2). This sulphur is likely to have originated in atmospheric chemical reactions, and so should provide records of the evolution of the martian atmosphere, the cycling of sulphur between the atmosphere and crust, and the mobility of sulphur in the martian regolith(3-6). Moreover, the atmospheric deposition of oxidized sulphur species could establish chemical potential gradients in the martian near-surface environment, and so provide a potential energy source for chemolithoautotrophic organisms', Here we present measurements of sulphur isotopes in oxidized and reduced phases from the SNC meteorites-the group of related achondrite meteorites believed to have originated on Mars-together with the results of laboratory photolysis studies of two important martian atmospheric sulphur species (SO2 and H2S). The photolysis experiments can account for the observed sulphur-isotope compositions in the SNC meteorites, and so identify a mechanism for producing large abiogenic S-34 fractionations in the surface sulphur reservoirs. We conclude that the sulphur data from the SNC meteorites reflects deposition of oxidized sulphur species produced by atmospheric chemical reactions, followed by incorporation, reaction and mobilization of the sulphur within the regolith.	Univ Calif San Diego, Dept Chem 0356, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Farquhar, J (corresponding author), Univ Calif San Diego, Dept Chem 0356, La Jolla, CA 92093 USA.	jfarquha@ucsd.edu	Savarino, Joel/H-9730-2012	Savarino, Joel/0000-0002-6708-9623				Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Colman JJ, 1996, SCIENCE, V273, P774, DOI 10.1126/science.273.5276.774; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; FARQUHAR J, 1999, 30 LUN PLAN SCI C, V30, P1675; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; Greenwood JP, 1997, GEOCHIM COSMOCHIM AC, V61, P4449, DOI 10.1016/S0016-7037(97)00246-9; GREENWOOD JP, IN PRESS GEOCHIM COS; HARVEY RP, 1992, GEOCHIM COSMOCHIM AC, V56, P1655, DOI 10.1016/0016-7037(92)90232-8; Jakosky BM, 1998, J GEOPHYS RES-PLANET, V103, P19359, DOI 10.1029/98JE01892; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; KASTING JF, 1984, J ATMOS CHEM, V1, P403, DOI 10.1007/BF00053803; McSween HY, 1998, INT GEOL REV, V40, P774, DOI 10.1080/00206819809465238; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Newsom HE, 1999, J GEOPHYS RES-PLANET, V104, P8717, DOI 10.1029/1998JE900043; OKABE H., 1978, PHOTOCHEMISTRY SMALL; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Shearer CK, 1996, GEOCHIM COSMOCHIM AC, V60, P2921, DOI 10.1016/0016-7037(96)00165-2; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; Warren PH, 1998, J GEOPHYS RES-PLANET, V103, P16759, DOI 10.1029/98JE01544; Yung YL, 1997, ICARUS, V130, P222, DOI 10.1006/icar.1997.5808	29	220	228	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					50	52		10.1038/35003517	http://dx.doi.org/10.1038/35003517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716436				2022-12-01	WOS:000085775100039
J	Jadad, AR; Moher, M; Browman, GP; Booker, L; Sigouin, C; Fuentes, M; Stevens, R				Jadad, AR; Moher, M; Browman, GP; Booker, L; Sigouin, C; Fuentes, M; Stevens, R			Systematic reviews and meta-analyses on treatment of asthma: critical evaluation	BRITISH MEDICAL JOURNAL			English	Article							ACUTE CHILDHOOD ASTHMA; INHALED CORTICOSTEROIDS; CONTROLLED TRIALS; CLINICAL-TRIALS; METAANALYSIS; EFFICACY; QUALITY; SALMETEROL; ARTICLES; THERAPY	Objective To evaluate the clinical, methodological, and reporting aspects of systematic reviews and meta-analyses on the treatment of asthma and to compare those published by the Cochrane Collaboration with those published in paper based journals. Design. Analysis of studies identified from Medline, CINAHL. HealthSTAR, EMBASE, Cochrane Library, personal collections, and reference lists. Studies Articles describing a systematic review or a meta-analysis of the treatment of asthma that were published as a full report, in any language or format, in a peer reviewed journal or the Cochrane Library. Main outcome measures General characteristics of studies reviewed and methodological characteristics (sources of articles; language restrictions; format, design and publication status of studies included; type of data synthesis; and methodological quality). Results 50 systematic reviews and meta-analyses were included. More than half were published in the past two years. Twelve reviews were published in the Cochrane Library and 38 were published in 2 peer reviewed journals. Forced expiratory volume in one second was the most frequently used outcome, but few reviews evaluated the effect of treatment on costs or patient preferences. Forty reviews were judged to have serious or extensive nd rvs. All six reviews associated with industry were in this group. Seven of the 10 most rigorous reviews were published in the Cochrane Library. Conclusions Most reviews published in peer reviewed journals or funded by industry have serious methodological flaws that limit their value to guide decisions. Cochrane reviews are more rigorous and better reported than those published in peer reviewed journals.	McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Oxford, Inst Hlth Sci, Oxford OX3 7LF, England; Foresight Consultants, Dundas, ON L9H 2R5, Canada	McMaster University; University of Oxford	Jadad, AR (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.							ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; ABRAMSON MJ, ALLERGEN SPECIFIC IM; ABRAMSON MJ, 1998, COCHRANE LIB; ALLEN DB, 1994, J ALLERGY CLIN IMMUN, V93, P967, DOI 10.1016/S0091-6749(94)70043-5; Amirav I, 1997, ARCH PEDIAT ADOL MED, V151, P876, DOI 10.1001/archpedi.1997.02170460014003; ASSENDELFT WJJ, 1995, JAMA-J AM MED ASSOC, V274, P1942, DOI 10.1001/jama.274.24.1942; BARNES CL, 1993, ANN PHARMACOTHER, V27, P464; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Barnes N, 1998, J ALLERGY CLIN IMMUN, V101, pS460, DOI 10.1016/S0091-6749(98)70160-5; Barnes NC, 1998, RESP MED, V92, P95, DOI 10.1016/S0954-6111(98)90039-7; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; BERNARDBONNIN AC, 1995, J ALLERGY CLIN IMMUN, V95, P34, DOI 10.1016/S0091-6749(95)70150-8; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; BIELORY L, 1994, ANN ALLERGY, V73, P89; Calpin C, 1997, J ALLERGY CLIN IMMUN, V100, P452, DOI 10.1016/S0091-6749(97)70134-9; CATES CJ, COMP HOLDING CHAMBER; Davies B, 1998, RESP MED, V92, P256, DOI 10.1016/S0954-6111(98)90105-6; DAVIES H, 1998, COCHRANE LIB; DAVIES H, METHOTREXATE STEROID; Devine EC, 1996, RES NURS HEALTH, V19, P367, DOI 10.1002/(SICI)1098-240X(199610)19:5<367::AID-NUR1>3.0.CO;2-O; Droogan J, 1997, Nurs Times, V93, P45; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GIBSON PG, 1998, COCHRANE LIB; GIBSON PG, EFFECTS SELF MANAGEM; GIBSON PG, EFFECTS LTD INFORMAT; Goodman DC, 1996, PEDIATR PULM, V21, P211, DOI 10.1002/(SICI)1099-0496(199604)21:4<211::AID-PPUL2>3.0.CO;2-R; Gosselink HA, 1993, J REHABILITATION SCI, V6, P66; Grunfeld A.F, 1996, CAN RESPIR J, V3, P322, DOI [10.1155/1996/254627, DOI 10.1155/1996/254627]; HAMMARQUIST C, HOUSE DUST MITE CONT; HAMMERQUIST C, 1998, COCHRANE LIB; HATOUM HT, 1994, ANN PHARMACOTHER, V28, P1285; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jadad AR, 1998, MED DECIS MAKING, V18, P2, DOI 10.1177/0272989X9801800102; Kelloway JS, 1997, ANN PHARMACOTHER, V31, P1012, DOI 10.1177/106002809703100912; Kelly HW, 1998, ANN PHARMACOTHER, V32, P220, DOI 10.1345/aph.17014; LARSEN JS, 1993, ANN PHARMACOTHER, V27, P898, DOI 10.1177/106002809302700718; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LINDE K, ACUPUNCTURE TREATMEN; LINDE K, HOMEOPATHY CHRONIC A; LITTENBERG B, 1988, JAMA-J AM MED ASSOC, V259, P1678, DOI 10.1001/jama.259.11.1678; Marin MG, 1997, CHEST, V112, P29, DOI 10.1378/chest.112.1.29; MEYER JM, 1993, ANN PHARMACOTHER, V27, P1478, DOI 10.1177/106002809302701214; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MOHER D, 1999, QUOROM GROUP IMPROVI; Moore RH, 1998, CHEST, V113, P1095, DOI 10.1378/chest.113.4.1095; MULLEN M, 1993, JAMA-J AM MED ASSOC, V270, P1842, DOI 10.1001/jama.270.15.1842; MULROW CD, 1995, SYSTEMATIC REV, P1; Negro J M, 1997, Allergol Immunopathol (Madr), V25, P209; OByrne PM, 1997, ANN INTERN MED, V127, P472, DOI 10.7326/0003-4819-127-6-199709150-00009; OBYRNE PM, 1995, J AEROSOL MED, V8, pS39; OSMOND MH, 1995, ACAD EMERG MED, V2, P651, DOI 10.1111/j.1553-2712.1995.tb03607.x; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; OXMAN AD, 1988, CAN MED ASSOC J, V138, P687; PANTON J, FAMILY THERAPY TREAT; PARISH RC, 1993, ANN PHARMACOTHER, V27, P599, DOI 10.1177/106002809302700515; Petticrew M, 1997, Nurs Times, V93, P53; PLOTNICK LH, 1998, COCHRANE LIB; PLOTNICK LH, EFFICACY SAFETY COMB; ROWE BH, 1992, AM J EMERG MED, V10, P301, DOI 10.1016/0735-6757(92)90007-K; ROWE BH, 1998, COCHRANE LIB; ROWE BH, EFFECTIVENESS CORTIC; Sacks HS, 1996, MT SINAI J MED, V63, P216; SACKS HS, 1992, MED USES STATISTICS, P427; Self T H, 1992, J Am Board Fam Pract, V5, P281; SHEA B, 1999, 7 COCHR C; Smith LJ, 1996, ARCH INTERN MED, V156, P2181, DOI 10.1001/archinte.156.19.2181; SPOONER CH, 1998, COCHRANE LIB; SPOONER CH, NEDOCROMIL SODIUM SI; Turner MO, 1997, ARCH INTERN MED, V157, P1736, DOI 10.1001/archinte.157.15.1736; Van der Palen J, 1998, RESP MED, V92, P668, DOI 10.1016/S0954-6111(98)90516-9; VANDERKUY PHM, 1993, PHARM WEEKBLAD, V128, P1293; VanGanse E, 1997, EUR RESPIR J, V10, P2216, DOI 10.1183/09031936.97.10102216; Verberne AAPH, 1998, RESP MED, V92, P777, DOI 10.1016/S0954-6111(98)90012-9; Vickers A. J., 1997, COMPLEMENTARY THERAP, V5, P202	75	160	170	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					537	540D		10.1136/bmj.320.7234.537	http://dx.doi.org/10.1136/bmj.320.7234.537			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688558	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000085624000020
J	Chu, K; Vojtchovsky, J; McMahon, BH; Sweet, RM; Berendzen, J; Schlichting, I				Chu, K; Vojtchovsky, J; McMahon, BH; Sweet, RM; Berendzen, J; Schlichting, I			Structure of a ligand-binding intermediate in wild-type carbonmonoxy myoglobin	NATURE			English	Article							MOLECULAR-DYNAMICS; PROTEINS; RELAXATION; MUTANTS; STATES; XENON; SITE	Small molecules such as NO, O-2, CO or H-2 are important biological ligands that bind to metalloproteins to function crucially in processes such as signal transduction, respiration and catalysis. A key issue for understanding the regulation of reaction mechanisms in these systems is whether ligands gain access to the binding sites through specific channels and docking sites, or by random diffusion through the protein matrix. A model system for studying this issue is myoglobin, a simple haem protein. Myoglobin has been studied extensively by spectroscopy, crystallography, computation and theory(1-11). It serves as an aid to oxygen diffusion but also binds carbon mono nide, a byproduct of endogenous haem catabolism. Molecular dynamics simulations(3-5), random mutagenesis(6) and flash photolysis studies(7-10) indicate that ligand migration occurs through a limited number of pathways involving docking sites. Here we report the 1.4 Angstrom resolution crystal structure of a ligand-binding intermediate in carbonmonoxy myoglobin that may have far-reaching implications for understanding the dynamics of ligand binding and catalysis.	Univ Calif Los Alamos Natl Lab, Biophys Grp P21, Los Alamos, NM 87545 USA; Univ Vermont, Dept Phys, Burlington, VT 05405 USA; Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; Univ Calif Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Vermont; Max Planck Society; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Chu, K (corresponding author), Univ Calif Los Alamos Natl Lab, Biophys Grp P21, MS-D454, Los Alamos, NM 87545 USA.		Schlichting, Ilme/I-1339-2013	Berendzen, Joel/0000-0002-9454-9074				ABADAN Y, 1995, BIOPHYS J, V68, P2497, DOI 10.1016/S0006-3495(95)80432-7; AHMED AM, 1991, CHEM PHYS, V158, P329, DOI 10.1016/0301-0104(91)87076-8; ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; Anfinrud P, 1999, P NATL ACAD SCI USA, V96, P8328, DOI 10.1073/pnas.96.15.8328; Antonini E., 1971, FRONT BIOL, DOI DOI 10.1126/SCIENCE.178.4058.296; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BRUNGER AT, 1992, X PLOR SYSTEM CRYSTA; Brunori M, 1999, TRENDS BIOCHEM SCI, V24, P253, DOI 10.1016/S0968-0004(99)01421-8; Carlson ML, 1996, BIOCHEMISTRY-US, V35, P1125, DOI 10.1021/bi951767k; CHU K, 1995, PHYS REV LETT, V74, P2607, DOI 10.1103/PhysRevLett.74.2607; ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; Hartmann H, 1996, P NATL ACAD SCI USA, V93, P7013, DOI 10.1073/pnas.93.14.7013; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; MCMAHON BH, 1997, THESIS U ILLINOIS UR; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; POWERS L, 1987, BIOCHEMISTRY-US, V26, P4785, DOI 10.1021/bi00389a028; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; TILTON RF, 1986, J MOL BIOL, V192, P443, DOI 10.1016/0022-2836(86)90374-8; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6	30	228	232	0	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					921	923		10.1038/35002641	http://dx.doi.org/10.1038/35002641			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706294				2022-12-01	WOS:000085559200065
J	Willoughby, DA; Moore, AR; Colville-Nash, PR				Willoughby, DA; Moore, AR; Colville-Nash, PR			COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; RECEPTOR-GAMMA; CYCLOOXYGENASE; DRUGS	A new generation of non-steroidal anti-inflammatory drugs has been described that selectively targets the inducible isoform of cyclo-oxygenase, cyclo-oxygenase 2 (COX-5). This isoform is expressed at sites of inflammation, which has fed to the speculation that its inhibition could provide all the benefits of current nonsteroidal anti-inflammatory drugs, but without their major side-effects on the gastrointestinal system (which are due to inhibition of COX-1). We have shown that COX-2 (identified by use of specific antibodies) is induced during the resolution of an inflammatory response, inhibition of COX-2 resulting in persistence of the inflammation due to the prevention of the synthesis of a range of anti-inflammatory prostanoids. We propose that there is a third isoform of this enzyme family, COX-3, a proposal that will have implication for the prescription of both existing and new generation anti-inflammatory drugs, and might represent a new therapeutic target.	St Bartholomews & Royal London Hosp Sch Med, William Harvey Res Inst, Dept Expt Pathol, London EC1M 6BQ, England; St Bartholomews & Royal London Hosp Sch Dent, William Harvey Res Inst, Dept Expt Pathol, London EC1M 6BQ, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Willoughby, DA (corresponding author), St Bartholomews & Royal London Hosp Sch Med, William Harvey Res Inst, Dept Expt Pathol, Charterhouse Sq, London EC1M 6BQ, England.							Colville-Nash PR, 1998, J IMMUNOL, V161, P978; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; Gilroy DW, 1998, EUR J PHARMACOL, V355, P211, DOI 10.1016/S0014-2999(98)00508-1; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; MASFERRER JL, 1990, J CLIN INVEST, V86, P1375, DOI 10.1172/JCI114850; RASHAD S, 1989, LANCET, V2, P519; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Simmons DL, 1999, P NATL ACAD SCI USA, V96, P3275, DOI 10.1073/pnas.96.6.3275; VANE J, 1994, NATURE, V367, P215, DOI 10.1038/367215a0; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P547; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	18	215	242	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					646	648		10.1016/S0140-6736(99)12031-2	http://dx.doi.org/10.1016/S0140-6736(99)12031-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696997				2022-12-01	WOS:000085615400042
J	Masliah, E; Rockenstein, E; Veinbergs, I; Mallory, M; Hashimoto, M; Takeda, A; Sagara, Y; Sisk, A; Mucke, L				Masliah, E; Rockenstein, E; Veinbergs, I; Mallory, M; Hashimoto, M; Takeda, A; Sagara, Y; Sisk, A; Mucke, L			Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; LEWY BODIES; NACP/ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BETA; AGGREGATION; MUTATION; GENE	To elucidate the role of the synaptic protein alpha-synuclein in neurodegenerative disorders, transgenic mice expressing wild-type human alpha-synuclein were generated. Neuronal expression of human alpha-synuclein resulted in progressive accumulation of alpha-synuclein-and ubiquitin-immunoreactive inclusions in neurons in the neocortex, hippocampus, and substantia nigra. Ultrastructural analysis revealed both electron-dense intranuclear deposits and cytoplasmic inclusions. These alterations were associated with Loss of dopaminergic terminals in the basal ganglia and with motor impairments. These results suggest that accumulation of wild-type alpha-synuclein may play a causal role in Parkinson's disease and related conditions.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa 236, Japan; Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Yokohama City University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385, R01AG010689] Funding Source: NIH RePORTER; NIA NIH HHS [AG10689, AG5131, AG11385] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHEN XH, 1995, GENOMICS, V26, P425, DOI 10.1016/0888-7543(95)80237-G; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284; Forster MJ, 1999, NEUROBIOL AGING, V20, P167, DOI 10.1016/S0197-4580(99)00041-X; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GAUTHIER S, 1982, PROG NEURO-PSYCHOPH, V6, P595, DOI 10.1016/S0278-5846(82)80154-1; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOSAKA K, 1978, ACTA NEUROPATHOL, V42, P127, DOI 10.1007/BF00690978; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Masliah E, 1996, J NEUROSCI, V16, P5795; MASLIAH E, 1998, NEUROSCI NEWS, V1, P14; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141	24	1453	1560	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1265	1269		10.1126/science.287.5456.1265	http://dx.doi.org/10.1126/science.287.5456.1265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678833				2022-12-01	WOS:000085444700050
J	Lee, KJ; Dietrich, P; Jessell, TM				Lee, KJ; Dietrich, P; Jessell, TM			Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; AVIAN NEURAL CREST; SPINAL-CORD; TRANSGENIC MICE; FLOOR PLATE; COMMISSURAL INTERNEURONS; MOUSE DEVELOPMENT; TOXIN GENE; EXPRESSION; CELL	During neural development in vertebrates, a spatially ordered array of neurons is generated in response to inductive signals derived from localized organizing centres, One organizing centre that has been proposed to have a role in the control of neural patterning is the roof plate, To define the contribution of signals derived from the roof plate to the specification of neuronal cell types in the dorsal neural tube, we devised a genetic strategy to ablate the roof plate selectively in mouse embryos, Embryos without a roof plate lack all the interneuron subtypes that are normally generated in the dorsal third of the neural tube. Using a genetically based lineage analysis and in vitro assays, we show that the loss of these neurons results from the elimination of nonautonomous signals provided by the roof plate, These results reveal that the roof plate is essential for specifying multiple classes of neurons in the mammalian central nervous system.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.	tmj1@columbia.edu		Lee, Kevin/0000-0001-9823-0952				AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Arkell R, 1997, DEVELOPMENT, V124, P1; Beattie CE, 1997, DEV BIOL, V187, P171, DOI 10.1006/dbio.1997.8604; Bei M, 1998, DEVELOPMENT, V125, P4325; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; DIETRICH P, IN PRESS MAMM GENOME; Ding Q, 1998, DEVELOPMENT, V125, P2533; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Dudley AT, 1997, DEV DYNAM, V208, P349; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Helms AW, 1998, DEVELOPMENT, V125, P919; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; JONES CM, 1991, DEVELOPMENT, V111, P531; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Matise MP, 1998, DEVELOPMENT, V125, P2759; MAXWELL IH, 1986, CANCER RES, V46, P4660; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PARR BA, 1993, DEVELOPMENT, V119, P247; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Shamim H, 1999, DEVELOPMENT, V126, P945; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	50	218	221	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					734	740		10.1038/35001507	http://dx.doi.org/10.1038/35001507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693795				2022-12-01	WOS:000085423100042
J	Lemieux, C; Otis, C; Turmel, M				Lemieux, C; Otis, C; Turmel, M			Ancestral chloroplast genome in Mesostigma viride reveals an early branch of green plant evolution	NATURE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPHYLL; PHYLOGENY; ALGA	Sequence comparisons suggest that all living green plants belong to one of two major phyla(1-3): Streptophyta(4) (land plants and their closest green algal relatives, the charophytes); and Chlorophyta(5) (the rest of green algae). Because no green algae are known that pre-date the Streptophyta/Chlorophyta split, and also because the earliest diverging green algae show considerable morphological variation, the nature of the unicellular flagellate ancestor of the two green plant phyla is unknown(1,6,7). Here we report that the flagellate Mesostigma viride belongs to the earliest diverging green plant lineage discovered to date. We have sequenced the entire chloroplast DNA (118,360 base pairs) of this green alga and have conducted phylogenetic analyses of sequences derived from this genome. Mesostigma represents a lineage that emerged before the divergence of the Streptophyta and Chlorophyta, a position that is supported by several features of its chloroplast DNA. The structure and gene organization of this genome indicate that chloroplast DNA architecture has been extremely well conserved in the line leading to land plants.	Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada	Laval University	Lemieux, C (corresponding author), Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada.	clemieux@bcm.ulaval.ca	Lemieux, Claude/L-8831-2015; Turmel, Monique/AAC-9752-2020	Lemieux, Claude/0000-0001-9580-8042; Turmel, Monique/0000-0001-7060-035X				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; Bhattacharya D, 1998, J MOL EVOL, V47, P544, DOI 10.1007/PL00006410; BREMER K, 1985, Cladistics, V1, P369, DOI 10.1111/j.1096-0031.1985.tb00434.x; Chapman R.L., 1998, MOL SYSTEMATICS PLAN, VII, P508; Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; FELSENSTEIN J, 1995, PHYLIP VERSION 3 5; Friedl T, 1997, PLANT SYST EVOL, P87; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lockhart PJ, 1999, MOL BIOL EVOL, V16, P573, DOI 10.1093/oxfordjournals.molbev.a026139; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MELKONIAN M, 1989, PLANT SYST EVOL, V164, P93, DOI 10.1007/BF00940432; MELKONIAN M, 1995, B SOC ZOOL FR, V120, P191; Melkonian M., 1990, P600; Melkonian M., 1995, BIODIVERSITY EVOLUTI, P153; Nakayama T, 1998, PROTIST, V149, P367, DOI 10.1016/S1434-4610(98)70043-4; O'Kelly C.J., 1992, P315; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Palmer J.D., 1998, MOL SYSTEMATICS PLAN, P375, DOI [10.1007/978-1-4615-5419-6_13, DOI 10.1007/978-1-4615-5419-6_13]; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; SLUIMAN HJ, 1985, PLANT SYST EVOL, V149, P217, DOI 10.1007/BF00983308; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967	30	198	320	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					649	652		10.1038/35001059	http://dx.doi.org/10.1038/35001059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688199	hybrid			2022-12-01	WOS:000085288200051
J	Uetz, P; Giot, L; Cagney, G; Mansfield, TA; Judson, RS; Knight, JR; Lockshon, D; Narayan, V; Srinivasan, M; Pochart, P; Qureshi-Emili, A; Li, Y; Godwin, B; Conover, D; Kalbfleisch, T; Vijayadamodar, G; Yang, MJ; Johnston, M; Fields, S; Rothberg, JM				Uetz, P; Giot, L; Cagney, G; Mansfield, TA; Judson, RS; Knight, JR; Lockshon, D; Narayan, V; Srinivasan, M; Pochart, P; Qureshi-Emili, A; Li, Y; Godwin, B; Conover, D; Kalbfleisch, T; Vijayadamodar, G; Yang, MJ; Johnston, M; Fields, S; Rothberg, JM			A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae	NATURE			English	Article							SPINDLE CHECKPOINT; COMPLEX-FORMATION; 3-HYBRID SYSTEM; BUDDING YEAST; RECOMBINATION; GENES; CYTOPLASM; VACUOLE; ASSOCIATION; AUTOPHAGY	Two large-scale yeast two-hybrid screens were undertaken to identify protein-protein interactions between full-length open reading frames predicted from the Saccharomyces cerevisiae genome sequence. In one approach, we constructed a protein array of about 6,000 yeast transformants, with each transformant expressing one of the open reading frames as a fusion to an activation domain. This array was screened by a simple and automated procedure for 192 yeast proteins, with positive responses identified by their positions in the array, In a second approach, we pooled cells expressing one of about 6,000 activation domain fusions to generate a library. We used a high-throughput screening procedure to screen nearly all of the 6,000 predicted yeast proteins, expressed as Gal4 DNA-binding domain fusion proteins, against the library, and characterized positives by sequence analysis. These approaches resulted in the detection of 957 putative interactions involving 1,004 S. cerevisiae proteins, These data reveal interactions that place functionally unclassified proteins in a biological context, interactions between proteins involved in the same biological function, and interactions that link biological functions together into larger cellular processes. The results of these screens are shown here.	CuraGen Corp, New Haven, CT 06511 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Rothberg, JM (corresponding author), CuraGen Corp, 555 Long Wharf Dr,11th Floor, New Haven, CT 06511 USA.		Johnston, Mark/R-6156-2019; Kalbfleisch, Theodore/AAN-5407-2021; Johnston, Mark/K-3543-2019; Uetz, Peter/A-7119-2012; Cagney, Gerard/A-4648-2009	Johnston, Mark/0000-0002-4932-7229; Uetz, Peter/0000-0001-6194-4927; Kalbfleisch, Theodore/0000-0002-2370-8189; Judson, Richard/0000-0002-2348-9633; Cagney, Gerard/0000-0001-7189-9496				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GUENETTE S, 1995, J CELL SCI, V108, P1195; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; KADOWAKI T, 1994, J CELL BIOL, V126, P649, DOI 10.1083/jcb.126.3.649; KADOWAKI T, 1994, J CELL BIOL, V126, P1627; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; LEGRAIN P, 1994, NUCLEIC ACIDS RES, V22, P3241, DOI 10.1093/nar/22.15.3241; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; RAMESH V, 1991, MOL BIOL MED, V8, P81; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sherman F., 1986, METHODS YEAST GENETI; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0	42	3618	3817	8	521	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					623	627		10.1038/35001009	http://dx.doi.org/10.1038/35001009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688190				2022-12-01	WOS:000085288200042
J	Baxter, S				Baxter, S			From Caribbean to Clementine - The road to the stars begins in the ocean depths.	NATURE			English	Article																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					485	485		10.1038/35000671	http://dx.doi.org/10.1038/35000671			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676939	Bronze			2022-12-01	WOS:000085227300024
J	Fritz, J; Baller, MK; Lang, HP; Rothuizen, H; Vettiger, P; Meyer, E; Guntherodt, HJ; Gerber, C; Gimzewski, JK				Fritz, J; Baller, MK; Lang, HP; Rothuizen, H; Vettiger, P; Meyer, E; Guntherodt, HJ; Gerber, C; Gimzewski, JK			Translating biomolecular recognition into nanomechanics	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; INDUCED SURFACE STRESS; DNA; OLIGONUCLEOTIDES; MOLECULES; GOLD	We report the specific transduction, via surface stress changes, of DNA hybridization and receptor-ligand binding into a direct nanomechanical response of microfabricated cantilevers. Cantilevers in an array were functionalized with a selection of biomolecules. The differential deflection of the cantilevers was found to provide a true molecular recognition signal despite Large nonspecific responses of individual cantilevers. Hybridization of complementary oligonucleotides shows that a single base mismatch between two 12-mer oligonucleotides is clearly detectable. Similar experiments on protein A-immunoglobulin interactions demonstrate the wide-ranging applicability of nanomechanical transduction to detect biomolecular recognition.	IBM Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; Univ Basel, Inst Phys, CH-4056 Basel, Switzerland	International Business Machines (IBM); University of Basel	Gerber, C (corresponding author), IBM Res, Zurich Res Lab, Saumerstr 4, CH-8803 Ruschlikon, Switzerland.		Lang, Hans Peter/G-3884-2011; Gerber, Christoph E/G-4851-2011; Meyer, Ernst/L-3873-2016	Lang, Hans Peter/0000-0002-0012-2564; Meyer, Ernst/0000-0001-6385-3412; gimzewski, james/0000-0003-4333-6957				Abel AP, 1996, ANAL CHEM, V68, P2905, DOI 10.1021/ac960071+; Baller MK, 2000, ULTRAMICROSCOPY, V82, P1, DOI 10.1016/S0304-3991(99)00123-0; Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Butt HJ, 1996, J COLLOID INTERF SCI, V180, P251, DOI 10.1006/jcis.1996.0297; CHEN GY, 1995, J APPL PHYS, V77, P3618, DOI 10.1063/1.359562; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; IBACH H, 1994, J VAC SCI TECHNOL A, V12, P2240, DOI 10.1116/1.579122; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Lundbaek JA, 1997, BIOCHEMISTRY-US, V36, P5695, DOI 10.1021/bi9619841; Miyatani T, 1997, J APPL PHYS, V81, P7099, DOI 10.1063/1.365306; Moulin AM, 1999, LANGMUIR, V15, P8776, DOI 10.1021/la990416u; Okahata Y, 1998, ANAL CHEM, V70, P1288, DOI 10.1021/ac970584w; Rekesh D, 1996, BIOPHYS J, V71, P1079, DOI 10.1016/S0006-3495(96)79308-6; RICHMAN DD, 1982, J IMMUNOL, V128, P2300; Safran SA, 1999, ADV PHYS, V48, P395, DOI 10.1080/000187399243428; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Vettiger P, 1999, MICROELECTRON ENG, V46, P11, DOI 10.1016/S0167-9317(99)00006-4; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039	20	1394	1502	5	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					316	318		10.1126/science.288.5464.316	http://dx.doi.org/10.1126/science.288.5464.316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764640				2022-12-01	WOS:000086454300031
J	Lebestky, T; Chang, T; Hartenstein, V; Banerjee, U				Lebestky, T; Chang, T; Hartenstein, V; Banerjee, U			Specification of Drosophila hematopoietic lineage by conserved transcription factors	SCIENCE			English	Article							CHROMOSOMAL TRANSLOCATIONS; CELL LINEAGE; DIFFERENTIATION; LEUKEMIA; LOZENGE; SWITCH; BLOOD; AML1; EYE	Two major classes of cells observed within the Drosophila hematopoietic repertoire are plasmatocytes/macrophages and crystal cells. The transcription factor Lz (Lozenge), which resembles human AML1 (acute myeloid leukemia-1) protein, is necessary for the development of crystal cells during embryonic and larval hematopoiesis. Another transcription factor, Gcm (glial cells missing), has previously been shown to be required for plasmatocyte development. Misexpression of Gcm causes crystal cells to be transformed into plasmatocytes. The Drosophila GATA protein Srp (Serpent) is required for both Lz and Gcm expression and is necessary for the development of both classes of hemocytes, whereas Lz and Gcm are required in a lineage-specific manner. Given the similarities of Srp and Lz to; mammalian GATA and AML1 proteins, observations in Drosophila are Likely to have broad implications for understanding mammalian hematopoiesis and leukemias.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lebestky, T (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029367, R56NS029367] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY08152] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline; NINDS NIH HHS [NS29367] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; Bernardoni R, 1997, DEV BIOL, V191, P118; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; Flores GV, 1998, DEVELOPMENT, V125, P3681; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kanemura Y, 1999, FEBS LETT, V442, P151, DOI 10.1016/S0014-5793(98)01650-0; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Mathey-Prevot B, 1998, CELL, V92, P697, DOI 10.1016/S0092-8674(00)81396-3; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 1998, INT J DEV BIOL, V42, P927; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Riechmann V, 1998, DEVELOPMENT, V125, P713; RIZKI T M, 1981, Genetics, V97, pS90; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; RIZKI TM, 1978, GENETICS BIOL DROS B, V2, P398; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; SHRESTHA R, 1982, DEV GROWTH DIFFER, V24, P65; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Speck NA, 1999, CANCER RES, V59, p1789S; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444	29	361	376	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2000	288	5463					146	149		10.1126/science.288.5463.146	http://dx.doi.org/10.1126/science.288.5463.146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753120				2022-12-01	WOS:000086387700054
J	Murtagh, GJ; Dyer, PS; Crittenden, PD				Murtagh, GJ; Dyer, PS; Crittenden, PD			Reproductive systems - Sex and the single lichen	NATURE			English	Article							EVOLUTION; ISLAND; PLANTS		Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England	University of Nottingham	Murtagh, GJ (corresponding author), Univ Nottingham, Sch Biol Sci, Univ Pk, Nottingham NG7 2RD, England.			Dyer, Paul/0000-0003-0237-026X				BURNETT JH, 1975, MYCOGENETICS INTRO G; FAHSELT D, 1989, LICHENOLOGIST, V21, P343, DOI 10.1017/S0024282989000587; HESTMARK G, 1992, OECOLOGIA, V92, P305, DOI 10.1007/BF00317455; JAHNS H. M., 1997, BIBLIOTHECA LICHENOL, V67, P49; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; Kershaw K.A., 1985, PHYSL ECOLOGY LICHEN, DOI 10.2307/3243300; Maynard-Smith J., 1978, MODELS ECOLOGY; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Purvis O.W., 1992, LICHEN FLORA GREAT B; Richards A.J, 1997, PLANT BREEDING SYSTE; SANCHO LG, 1993, POLAR BIOL, V13, P227; WEISING K, 1995, FINGERPRINTING PLANT	13	83	86	1	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					564	564		10.1038/35007142	http://dx.doi.org/10.1038/35007142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766229				2022-12-01	WOS:000086400100040
J	Davenport, RJ; Wuite, GJL; Landick, R; Bustamante, C				Davenport, RJ; Wuite, GJL; Landick, R; Bustamante, C			Single-molecule study of transcriptional pausing and arrest by E-coli RNA polymerase	SCIENCE			English	Article							DNA; FORCE; BACTERIOPHAGE-T7; TERMINATION; MICROSCOPY; REGION	Using an optical-trap/flow-control video microscopy technique, we followed transcription by single molecules of Escherichia coli RNA polymerase in real time over long template distances. These studies reveal that RNA polymerase molecules possess different intrinsic transcription rates and different propensities to pause and stop. The data also show that reversible pausing is a kinetic intermediate between normal elongation and the arrested state. The conformational metastability of RNA polymerase revealed by this single-molecule study of transcription has direct implications for the mechanisms of gene regulation in both bacteria and eukaryotes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; wuite, gijs/0000-0002-5706-043X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038660, R37GM038660, R01GM038660, R37GM032543, R01GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-32543, GM-38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kasas S, 1997, BIOCHEMISTRY-US, V36, P461, DOI 10.1021/bi9624402; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KORNISSAROVA N, 1997, J BIOL CHEM, V272, P15329; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landick R, 1999, SCIENCE, V284, P598, DOI 10.1126/science.284.5414.598; LEE DN, 1992, J MOL BIOL, V228, P759, DOI 10.1016/0022-2836(92)90862-E; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; YAGER TD, 1987, CELLULAR MOL BIOL, P1241; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	22	266	279	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2000	287	5462					2497	2500		10.1126/science.287.5462.2497	http://dx.doi.org/10.1126/science.287.5462.2497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741971				2022-12-01	WOS:000086202200048
J	Goldman, JM				Goldman, JM			Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia	LANCET			English	Editorial Material							ABL-POSITIVE CELLS; LEUKEMIA; GROWTH		Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London W12 0NN, England	Imperial College London	Goldman, JM (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London W12 0NN, England.							Buchdunger E, 1996, CANCER RES, V56, P100; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Melo JV, 1996, LEUKEMIA, V10, P751; NOWELL PC, 1960, SCIENCE, V132, P1497; ROWLEY D, 1973, NATURE, V43, P290	8	42	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1031	1032		10.1016/S0140-6736(00)02029-8	http://dx.doi.org/10.1016/S0140-6736(00)02029-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744084				2022-12-01	WOS:000086380800005
J	Myers, EW; Sutton, GG; Delcher, AL; Dew, IM; Fasulo, DP; Flanigan, MJ; Kravitz, SA; Mobarry, CM; Reinert, KHJ; Remington, KA; Anson, EL; Bolanos, RA; Chou, HH; Jordan, CM; Halpern, AL; Lonardi, S; Beasley, EM; Brandon, RC; Chen, L; Dunn, PJ; Lai, ZW; Liang, Y; Nusskern, DR; Zhan, M; Zhang, Q; Zheng, XQ; Rubin, GM; Adams, MD; Venter, JC				Myers, EW; Sutton, GG; Delcher, AL; Dew, IM; Fasulo, DP; Flanigan, MJ; Kravitz, SA; Mobarry, CM; Reinert, KHJ; Remington, KA; Anson, EL; Bolanos, RA; Chou, HH; Jordan, CM; Halpern, AL; Lonardi, S; Beasley, EM; Brandon, RC; Chen, L; Dunn, PJ; Lai, ZW; Liang, Y; Nusskern, DR; Zhan, M; Zhang, Q; Zheng, XQ; Rubin, GM; Adams, MD; Venter, JC			A whole-genome assembly of Drosophila	SCIENCE			English	Review							SHOTGUN	We report on the quality of a whole-genome assembly of Drosophila melanogaster and the nature of the computer algorithms that accomplished it. Three independent external data sources essentially agree with and support the assembly's sequence and ordering of contigs across the euchromatic portion of the genome. In addition, there are isolated contigs that we believe represent nonrepetitive pockets within the heterochromatin of the centromeres. Comparison with a previously sequenced 2.9-megabase region indicates that sequencing accuracy within nonrepetitive segments is greater than 99.99% without manual curation. As such, this initial reconstruction of the Drosophila sequence should be of substantial value to the scientific community.	Celera Genom Inc, Rockville, MD 20850 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Myers, EW (corresponding author), Celera Genom Inc, 45 W Gude Dr, Rockville, MD 20850 USA.	Myers@celera.com	Lonardi, Stefano/AAO-8070-2020; Reinert, Knut/V-3327-2019	Lonardi, Stefano/0000-0002-2696-7274; Reinert, Knut/0000-0003-3078-8129; Rubin, Gerald/0000-0001-8762-8703				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 1999, GENETICS, V153, P179; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHURCHILL G, 1982, GENOMICS, V14, P89; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MYERS EW, 1995, J COMP BIOL, V2, P2; MYERS EW, 1999, P 7 INT C INT SYST M; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SANGER F, 1982, J MOL BIOL, V162, P4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P12; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401	20	1081	1144	9	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2196	2204		10.1126/science.287.5461.2196	http://dx.doi.org/10.1126/science.287.5461.2196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731133				2022-12-01	WOS:000086049100034
J	Adams, MM; Elam-Evans, LD; Wilson, HG; Gilbertz, DA				Adams, MM; Elam-Evans, LD; Wilson, HG; Gilbertz, DA			Rates of and factors associated with recurrence of preterm delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LINKING VITAL RECORDS; GESTATIONAL-AGE; REPRODUCTIVE HISTORIES; BIRTH; OUTCOMES; RISK; PREGNANCIES; PREDICTION; COHORT	Context Information about risk of recurrent preterm delivery is useful to clinicians, researchers, and policy makers for counseling, generating etiologic leads, and measuring the related public health burden. Objectives To identify the rate of recurrence of preterm delivery in second pregnancies, factors associated with recurrence, and the percentage of preterm deliveries in women with a history of preterm delivery. Design and Setting Population-based cohort study of data from birth and fetal death certificates from the state of Georgia between 1980 and 1995. Subjects A total of 122 722 white and 56 174 black women with first and second singleton deliveries at 20 to 44 weeks' gestation. Main Outcome Measure Length of gestation (categorized as 20-31, 32-36, or greater than or equal to 37 weeks) at second delivery compared with length of gestation at first delivery, by age and race. Results Most women whose first delivery was preterm subsequently had term deliveries. Of 1023 white women whose first delivery occurred at 20 to 31 weeks, 8.2% (95% confidence interval [CI], 6.6%-10.1%) delivered their second birth at 20 to 31 weeks and 20.1% (95 % CI, 17.7%-22.8%) at 32 to 36 weeks. Of 1084 comparable black women, 13.4% (95% CI, 11.4%-15.6%) delivered at 20 to 31 weeks and 23.4% (95% CI, 20.9%-26.1%) delivered at 32 to 36 weeks. Among women whose first delivery occurred at 32 to 36 weeks, all corresponding rates were lower than those whose first birth was at 20 to 31 weeks; the rates of second birth at 20 to 31 weeks were substantially lower (for white women, 1.9% [95% CI, 1.7%-2.2%]; for black women, 3.8% [95% CI, 3.4%-4.2%]). Compared with women aged 20 to 49 years at their second delivery, women younger than 18 years had twice the risk of recurrence of delivery at 20 to 31 weeks. Of all second deliveries at 20 to 31 weeks, 29.4% for white women and 37.8% for black women were preceded by a preterm delivery. Conclusions Our data suggest that recurrence of preterm delivery contributes a notable portion of all preterm deliveries, especially at the shortest gestations.	Ctr Dis Control & Prevent, Div Reprod Hlth, WHO, Collaborating Ctr Perinatal Care & Hlth Serv Res, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; World Health Organization	Adams, MM (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, WHO, Collaborating Ctr Perinatal Care & Hlth Serv Res, MS E 52,1600 Clifton Rd, Atlanta, GA 30333 USA.	mma1@cdc.gov		Elam-Evans, Laurie/0000-0003-1313-5484				Adams MM, 1997, AM J EPIDEMIOL, V145, P339; ADAMS MM, 1991, INT J EPIDEMIOL, V20, P950, DOI 10.1093/ije/20.4.950; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P78, DOI 10.1111/j.1365-3016.1997.tb00799.x; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P1; ALEXANDER GR, 1995, PUBLIC HEALTH REP, V110, P395; Baker RK, 1997, MEDIA STUD J, V11, P1; BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; BLANKSON ML, 1993, JAMA-J AM MED ASSOC, V269, P1401, DOI 10.1001/jama.269.11.1401; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P185; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; Emery ES, 1997, PAEDIATR PERINAT EP, V11, P313; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; KRISTENSEN J, 1995, OBSTET GYNECOL, V86, P800, DOI 10.1016/0029-7844(95)00275-V; Mercer B., 1995, American Journal of Obstetrics and Gynecology, V172, P404; Schieve LA, 1996, OBSTET GYNECOL, V88, P356, DOI 10.1016/0029-7844(96)00203-7; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	22	210	212	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1591	1596		10.1001/jama.283.12.1591	http://dx.doi.org/10.1001/jama.283.12.1591			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735396	Bronze			2022-12-01	WOS:000085857300036
J	Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF				Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF			An archaeal iron-oxidizing extreme acidophile important in acid mine drainage	SCIENCE			English	Article							AQUEOUS PYRITE OXIDATION; FAM-NOV; GEN-NOV; ENVIRONMENT; DIVERSITY	A new species of Archaea grows at pH similar to 0.5 and similar to 40 degrees C in slime streamers and attached to pyrite surfaces at a sulfide ore body, Iron Mountain, California. This iron-oxidizing Archaeon is capable of growth at pH 0. This species represents a dominant prokaryote in the environment studied (slimes and sediments) and constituted up to 85% of the microbial community when solution concentrations were high (conductivity of 100 to 160 millisiemens per centimeter). The presence of this and other closely related Thermoplasmales suggests that these acidophiles are important contributors to acid mine drainage and may substantially impact iron and sulfur cycles.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	Woods Hole Oceanographic Institution; University of Wisconsin System; University of Wisconsin Madison	Edwards, KJ (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.		Bond, Philip/C-6046-2009; Bond, Philip/N-6649-2017	Banfield, Jill/0000-0001-8203-8771; Bond, Philip/0000-0002-9025-4797				Barker WW, 1998, AM MINERAL, V83, P1551, DOI 10.2138/am-1998-11-1243; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; BOND P, UNPUB; Brimblecombe P, 1989, EVOLUTION GLOBAL BIO, P77; Edwards KJ, 1998, AM MINERAL, V83, P1444, DOI 10.2138/am-1998-11-1233; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; EDWARDS KJ, 1999, THESIS WISCONSIN MAD; GOLYSHINA OV, IN PRESS INT J SYST; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom DK, 2000, ENVIRON SCI TECHNOL, V34, P254, DOI 10.1021/es990646v; Nordstrom DK, 1999, P NATL ACAD SCI USA, V96, P3455, DOI 10.1073/pnas.96.7.3455; Nordstrom DK, 1997, REV MINERAL, V35, P361; Schleper C, 1996, INT J SYST BACTERIOL, V46, P814, DOI 10.1099/00207713-46-3-814; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schrenk MO, 1998, SCIENCE, V279, P1519, DOI 10.1126/science.279.5356.1519; SILVERMAN M. P., 1964, Advances in Applied Microbiology, V6, P153, DOI 10.1016/S0065-2164(08)70626-9; Staley JT, 1999, ASM NEWS, V65, P681; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; Vasquez M, 1999, FEMS MICROBIOL LETT, V173, P183, DOI 10.1111/j.1574-6968.1999.tb13500.x; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	26	389	422	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1796	1799		10.1126/science.287.5459.1796	http://dx.doi.org/10.1126/science.287.5459.1796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710303				2022-12-01	WOS:000085775300035
J	Thomas, PC; Malin, MC; Edgett, KS; Carr, MH; Hartmann, WK; Ingersoll, AP; James, PB; Soderblom, LA; Veverka, J; Sullivan, R				Thomas, PC; Malin, MC; Edgett, KS; Carr, MH; Hartmann, WK; Ingersoll, AP; James, PB; Soderblom, LA; Veverka, J; Sullivan, R			North-south geological differences between the residual polar caps on Mars	NATURE			English	Article							VIKING; REGION; DEPOSITS	Polar processes can be sensitive indicators of global climate, and the geological features associated with polar ice caps can therefore indicate evolution of climate with time. The polar regions on Mars have distinctive morphologic and climatologic features: thick layered deposits, seasonal CO2 frost caps extending to mid latitudes, and near-polar residual frost deposits that survive the summer(1,2). The relationship of the seasonal and residual frost caps to the layered deposits has been poorly constrained(3,4), mainly by the limited spatial resolution of the available data. In particular, it has not been known if the residual caps represent simple thin frost cover or substantial geologic features. Here we show that the residual cap on the south pole is a distinct geologic unit with striking collapse and erosional topography; this is very different from the residual cap on the north pole, which grades into the underlying layered materials. These findings indicate that the differences between the caps are substantial (rather than reflecting short-lived differences in frost cover), and so support the idea of long-term asymmetry in the polar climates of Mars.	Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; US Geol Survey, Menlo Park, CA 94025 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; US Geol Survey, Flagstaff, AZ 86001 USA	Cornell University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; University System of Ohio; University of Toledo; United States Department of the Interior; United States Geological Survey	Thomas, PC (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.			Edgett, Kenneth/0000-0001-7197-5751				CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; HERKENHOFF KE, IN PRESS ICARUS; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; Jakosky B. M., 1992, MARS, P969; James P.B., 1992, MARS, P934; JAMES PB, 1979, J GEOPHYS RES, V84, P2889, DOI 10.1029/JB084iB06p02889; Kieffer H. H., 1992, MARS, P1180; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, UNPUB J GEOPHYS RES; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MALIN MC, 2000, LUNAR PLANET SCI, V34; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P25617, DOI 10.1029/97JE02582; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; MUHLEMAN DO, 1995, ANNU REV EARTH PL SC, V23, P337, DOI 10.1146/annurev.earth.23.1.337; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PLAUT JJ, 1988, ICARUS, V76, P357, DOI 10.1016/0019-1035(88)90076-0; POLLACK JB, 1979, J GEOPHYS RES, V84, P2929, DOI 10.1029/JB084iB06p02929; SCHENK PM, INPRESS J GEOPHYS RE; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; Ward W. R., 1992, MARS, P298; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	24	88	88	1	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					161	164		10.1038/35004528	http://dx.doi.org/10.1038/35004528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724162				2022-12-01	WOS:000085870900043
J	Winker, K				Winker, K			Evolution - Migration and speciation	NATURE			English	Article									Univ Alaska Museum, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Winker, K (corresponding author), Univ Alaska Museum, 907 Yukon Dr, Fairbanks, AK 99775 USA.		Winker, Kevin/M-2042-2014	Winker, Kevin/0000-0002-8985-8104				Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; DILGER W. C., 1956, AUK, V73, P313; Grinnell J., 1922, Auk Lancaster Pa, V39, P373; Groth JG, 1993, U CALIFORNIA PUBLICA, V127, P1; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Mayr E, 1963, ANIMAL SPECIES EVOLU; Mengel R. M., 1964, LIVING BIRD, V3, P9; Montgomery Jr T. H, 1896, AM NAT, P458; RICHMAN AD, 1996, EVOLUTION, V50, P767	13	51	52	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					36	36		10.1038/35003651	http://dx.doi.org/10.1038/35003651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716433	Bronze			2022-12-01	WOS:000085775100035
J	Perry, D				Perry, D			Patients' voices: The powerful sound in the stem cell debate	SCIENCE			English	Editorial Material								Millions of patients may benefit from the applications of stem cell research, although there is disagreement about whether public funds should be used to develop the science. Patients have been key to winning political support. Acting as advocates, they have contended that public investment will speed the research and bring accountability to biomedical technology. A political dispute about the new research, which holds the potential for cures to devastating diseases and to foster healthy aging, shows the need to respect public sensibilities and to court public approval, as well as the importance of involving patients in debates where the methods of biomedical discoveries and ethical beliefs collide.	Alliance Aging Res, Washington, DC 20006 USA		Perry, D (corresponding author), Alliance Aging Res, 2021 K St NW,Suite 305, Washington, DC 20006 USA.							*ALL AG RES, 1999, 106 C CAN ACH HLTH I; Alliance for Aging Research, 1999, IND OLD AM INV OUR N; *AM ASS ADV SCI I, 1999, STEM CELL RES APPL M; DICKEY J, 1999, ROLL CALL       0603, P4; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; 1999, THEOLOGIANS 4 MAJOR	6	40	42	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1423	1423		10.1126/science.287.5457.1423	http://dx.doi.org/10.1126/science.287.5457.1423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688778				2022-12-01	WOS:000085531600032
J	McNally, JG; Muller, WG; Walker, D; Wolford, R; Hager, GL				McNally, JG; Muller, WG; Walker, D; Wolford, R; Hager, GL			The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells	SCIENCE			English	Article							TRANSCRIPTION FACTORS; MMTV PROMOTER; IN-VIVO; GENES; ACTIVATION; CHROMATIN; INTERPLAY; INVIVO	Steroid receptors bind to site-specific response elements in chromatin and modulate gene expression in a hormone-dependent fashion. With the use of a tandem array of mouse mammary tumor virus reporter elements and a form of glucocorticoid receptor labeled with green fluorescent protein, targeting of the receptor to response elements in live mouse cells was observed. Photobleaching experiments provide direct evidence that the hormone-occupied receptor undergoes rapid exchange between chromatin and the nucleoplasmic compartment. Thus, the interaction of regulatory proteins with target sites in chromatin is a more dynamic process than previously believed.	NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, Bldg 41,Room B602, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010027, ZIABC010027] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BELMONT A, 1996, J CELL BIOL, V135, P1685; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; De Angelis DA, 1998, P NATL ACAD SCI USA, V95, P12312, DOI 10.1073/pnas.95.21.12312; ELLENBERG J, UNPUB; FLETCHER TM, UNPUBHER TM; Fragoso G, 1997, METHODS, V11, P246, DOI 10.1006/meth.1996.0411; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GRONEMEYER H, 1993, STEROID HORMONE ACTI, P94; Hager GL, 1999, METHOD ENZYMOL, V302, P73, DOI 10.1016/S0076-6879(99)02011-X; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; OSTROWSKI MC, 1983, MOL CELL BIOL, V3, P2045, DOI 10.1128/MCB.3.11.2045; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	34	628	641	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2000	287	5456					1262	1265		10.1126/science.287.5456.1262	http://dx.doi.org/10.1126/science.287.5456.1262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678832				2022-12-01	WOS:000085444700049
J	Mi, S; Lee, X; Li, XP; Veldman, GM; Finnerty, H; Racie, L; LaVallie, E; Tang, XY; Edouard, P; Howes, S; Keith, JC; McCoy, JM				Mi, S; Lee, X; Li, XP; Veldman, GM; Finnerty, H; Racie, L; LaVallie, E; Tang, XY; Edouard, P; Howes, S; Keith, JC; McCoy, JM			Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis	NATURE			English	Article							EXPRESSION; CELLS; VIRUS; GENE; SEQUENCE; GROWTH; ERV3	Many mammalian viruses have acquired genes from their hosts during their evolution(1). The rationale for these acquisitions is usually quite clear: the captured genes are subverted to provide a selective advantage to the virus. Here we describe the opposite situation, where a viral gene has been sequestered to serve an important function in the physiology of a mammalian host. This gene, encoding a protein that we have called syncytin, is the envelope gene of a recently identified human endogenous defective retrovirus, HERV-W-2. We find that the major sites of syncytin expression are placental syncytiotrophoblasts, multinucleated cells that originate from fetal trophoblasts. We show that expression of recombinant syncytin in a wide variety of cell types induces the formation of giant syncytia, and that fusion of a human trophoblastic cell line expressing endogenous syncytin can be inhibited by an anti-syncytin antiserum. Our data indicate that syncytin may mediate placental cytotrophoblast fusion in vivo, and thus may be important in human placental morphogenesis.	Genet Inst, Cambridge, MA 02140 USA		McCoy, JM (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.							Baergen Rebecca N., 1997, General and Diagnostic Pathology, V143, P127; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BOYD MT, 1993, VIROLOGY, V196, P905, DOI 10.1006/viro.1993.1556; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; COHEN M, 1985, VIROLOGY, V147, P449, DOI 10.1016/0042-6822(85)90147-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; FISCHER D, 1991, CHROMOSOMA, V101, P133, DOI 10.1007/BF00355363; Fox PT, 1997, HUM BRAIN MAPP, V5, P1, DOI 10.1002/(SICI)1097-0193(1997)5:1<1::AID-HBM1>3.0.CO;2-7; GATELY MK, 1996, CURRENT PROTOCOLS IM, V6, P16; HARRIS JR, 1991, FEBS LETT, V295, P3, DOI 10.1016/0014-5793(91)81370-N; HUNT JS, 1992, CURR OPIN IMMUNOL, V4, P591, DOI 10.1016/0952-7915(92)90032-A; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Kalter S S, 1975, Bibl Haematol, P391; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KOVATS S, 1990, SCIENCE, V248, P20; Lala PK, 1996, PLACENTA, V17, P545, DOI 10.1016/S0143-4004(96)80071-3; LARSSON E, 1993, J CANC RES CLIN O S1, V119, P6; Larsson Erik, 1994, Upsala Journal of Medical Sciences, V99, P113; LIMJOCO TI, 1993, J VIROL, V67, P4163, DOI 10.1128/JVI.67.7.4163-4168.1993; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; PIJNENBORG R, 1981, PLACENTA, V2, P71, DOI 10.1016/S0143-4004(81)80042-2; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; YAMADA S, 1986, BIOCHEMISTRY-US, V25, P3703, DOI 10.1021/bi00360a034	30	1093	1147	3	103	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					785	789		10.1038/35001608	http://dx.doi.org/10.1038/35001608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693809				2022-12-01	WOS:000085423100056
J	Song, HW; Mugnier, P; Das, AK; Webb, HM; Evans, DR; Tuite, MF; Hemmings, BA; Barford, D				Song, HW; Mugnier, P; Das, AK; Webb, HM; Evans, DR; Tuite, MF; Hemmings, BA; Barford, D			The crystal structure of human eukaryotic release factor eRF1 - Mechanism of stop codon recognition and peptidyl-tRNA hydrolysis	CELL			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; TRANSFER-RNA; CHAIN TERMINATION; BINDING-SITE; FACTORS RF1; IN-VITRO; YEAST	The release factor eRF1 terminates protein biosynthesis by recognizing stop codons at the A site of the ribosome and stimulating peptidyl-tRNA bond hydrolysis at the peptidyl transferase center. The crystal structure of human eRF1 to 2.8 Angstrom resolution, combined with mutagenesis analyses of the universal GGQ motif, reveals the molecular mechanism of release factor activity. The overall shape and dimensions of eRF1 resemble a tRNA molecule with domains 1, 2, and 3 of eRF1 corresponding to the anticodon loop, aminoacyl acceptor stem, and T stem of a tRNA molecule, respectively. The position of the essential GGQ motif at an exposed tip of domain 2 suggests that the Gin residue coordinates a water molecule to mediate the hydrolytic activity at the peptidyl transferase center. A conserved groove on domain 1, 80 Angstrom from the GGQ motif, is proposed to form the codon recognition site.	Inst Canc Res, Sect Struct Biol, London SW3 6JB, England; Univ Oxford, Mol Biophys Lab, Oxford OX1 3QU, England; Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; University of Kent; Friedrich Miescher Institute for Biomedical Research	Barford, D (corresponding author), Inst Canc Res, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	dbarford@icr.ac.uk	song, haiwei/H-6082-2011; Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Andjelkovic N, 1996, EMBO J, V15, P7156, DOI 10.1002/j.1460-2075.1996.tb01107.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BARTON GJ, 1990, METHOD ENZYMOL, V183, P403; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; BROWN CM, 1994, J BIOL CHEM, V269, P33164; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P2079, DOI 10.1093/nar/18.8.2079; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckingham RH, 1997, MOL MICROBIOL, V24, P449, DOI 10.1046/j.1365-2958.1997.3711734.x; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Eurwilaichitr L, 1999, MOL MICROBIOL, V32, P485, DOI 10.1046/j.1365-2958.1999.01346.x; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; GOLDSTEIN JL, 1970, P NATL ACAD SCI USA, V67, P99, DOI 10.1073/pnas.67.1.99; Grentzmann G, 1997, J BIOL CHEM, V272, P12300, DOI 10.1074/jbc.272.19.12300; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KONECKI DS, 1977, J BIOL CHEM, V252, P4514; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; McCaughan KK, 1998, BIOL CHEM, V379, P857, DOI 10.1515/bchm.1998.379.7.857; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; MIRONOVA LN, 1986, GENETIKA+, V22, P200; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; Mottagui-Tabar S, 1998, EUR J BIOCHEM, V257, P249, DOI 10.1046/j.1432-1327.1998.2570249.x; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; Nakamura Y, 1998, GENES CELLS, V3, P265, DOI 10.1046/j.1365-2443.1998.00191.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Poole ES, 1997, RNA, V3, P974; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SIKORSKI RS, 1989, GENETICS, V122, P19; STANSFIELD I, 1995, CURR GENET, V27, P417, DOI 10.1007/BF00311210; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stansfield I, 1997, EUR J BIOCHEM, V245, P557, DOI 10.1111/j.1432-1033.1997.00557.x; Stansfield I, 1996, MOL MICROBIOL, V20, P1135, DOI 10.1111/j.1365-2958.1996.tb02634.x; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	58	367	394	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2000	100	3					311	321		10.1016/S0092-8674(00)80667-4	http://dx.doi.org/10.1016/S0092-8674(00)80667-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	282ET	10676813	Bronze			2022-12-01	WOS:000085204400005
J	Caterina, MJ; Leffler, A; Malmberg, AB; Martin, WJ; Trafton, J; Petersen-Zeitz, KR; Koltzenburg, M; Basbaum, AI; Julius, D				Caterina, MJ; Leffler, A; Malmberg, AB; Martin, WJ; Trafton, J; Petersen-Zeitz, KR; Koltzenburg, M; Basbaum, AI; Julius, D			Impaired nociception and pain sensation in mice lacking the capsaicin receptor	SCIENCE			English	Article							RAT SENSORY NEURONS; CATION CHANNEL; ION-CHANNEL; RESPONSES; PROTONS; SENSITIZATION; SENSITIVITY; INVITRO; SKIN	The capsaicin (vanilloid) receptor VR1 is a cation channel expressed by primary sensory neurons of the "pain" pathway. Heterologously expressed VR1 can be activated by vanilloid compounds, protons, or heat (>43 degrees C), but whether this channel contributes to chemical or thermal sensitivity in vivo is not known. Here, we demonstrate that sensory neurons from mice lacking VR1 are severely deficient in their responses to each of these noxious stimuli. VR1(-/-) mice showed normal responses to noxious mechanical stimuli but exhibited no vanilloid-evoked pain behavior, were impaired in the detection of painful heat, and showed little thermal hypersensitivity in the setting of inflammation. Thus, VR1 is essential for selective modalities of pain sensation and for tissue injury-induced thermal hyperalgesia.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Neurosci, San Francisco, CA 94143 USA; Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wurzburg	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@socrates.ucsf.edu	Martin, William J/L-9033-2017; Leffler, Andreas/K-1191-2012; Leffler, Andreas/C-6552-2009; Koltzenburg, Martin/C-1349-2008	Martin, William J/0000-0002-2749-3365; Leffler, Andreas/0000-0003-1121-6387; Koltzenburg, Martin/0000-0001-9181-5966	NINDS NIH HHS [NS07265] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; de Castro F, 1998, EUR J NEUROSCI, V10, P146, DOI 10.1046/j.1460-9568.1998.00037.x; DOUCETTE R, 1987, J COMP NEUROL, V261, P583, DOI 10.1002/cne.902610409; DUBNER R, 1977, PAIN TRIGEMINAL REGI, P57; FEIGIN AM, 1995, NEUROREPORT, V6, P2134, DOI 10.1097/00001756-199511000-00009; Fields H. L., 1987, PAIN; GARCIAHIRSCHFELD J, 1995, NEUROSCIENCE, V67, P235, DOI 10.1016/0306-4522(95)00055-N; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HANDWERKER HO, 1991, PAIN RES CL, V4, P59; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Helliwell RJA, 1998, NEUROSCI LETT, V250, P177, DOI 10.1016/S0304-3940(98)00475-3; HOLZER P, 1991, PHARMACOL REV, V43, P143; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; JANIG W, 1986, PROG BRAIN RES, V67, P87; Kirschstein T, 1999, J NEUROPHYSIOL, V82, P2853, DOI 10.1152/jn.1999.82.6.2853; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Kress M, 1999, TRENDS PHARMACOL SCI, V20, P112, DOI 10.1016/S0165-6147(99)01294-8; Levine J.D., 1994, TXB PAIN, P45; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MARTENSON ME, 1994, BRAIN RES, V651, P143, DOI 10.1016/0006-8993(94)90690-4; MARTIN WJ, UNPUB; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Petersen M, 1996, NEUROSCIENCE, V75, P495, DOI 10.1016/0306-4522(96)00259-X; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; RAJA SN, 1999, TXB PAIN, P00011; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; STEEN KH, 1992, J NEUROSCI, V12, P86; SZALLASI A, 1990, BRAIN RES, V524, P106, DOI 10.1016/0006-8993(90)90498-Z; Szallasi A, 1999, PHARMACOL REV, V51, P159; SZOLCSANYI J, 1975, ARZNEIMITTEL-FORSCH, V25, P1877; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	44	2639	2794	15	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					306	313		10.1126/science.288.5464.306	http://dx.doi.org/10.1126/science.288.5464.306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764638				2022-12-01	WOS:000086454300029
J	Kivimaki, M; Vahtera, J; Pentti, J; Ferrie, JE				Kivimaki, M; Vahtera, J; Pentti, J; Ferrie, JE			Factors underlying the effect of organisational downsizing on health of employees: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; SICKNESS ABSENCE; WHITEHALL-II; MORTALITY; DISEASE; ALCOHOL; MEN	Objective To explore the underlying mechanisms between organisational downsizing and deterioration of health of employees. Design Longitudinal cohort study. Data were assembled from before downsizing (time 1); during major downsizing affecting some job categories (time 2); and after downsizing (time 3), Contributions of changes in work, support, and health related behaviours between time 1 and rime 2 to the relation between downsizing and sickness absence at time 3 were assessed by multilevel modelling. Mean length of follow up was 4.9 years. Setting Raisio, a town in Finland. Subjects 764 municipal employees who remained in employment after downsizing. Main outcome measures Records of absences from work from all causes with medical certificate. Results Downsizing was associated with negative changes in work, impaired support from spouse, and increased prevalence of smoking. Sickness absence rate from all causes was 2.17 (95% confidence inter-val 1.54 to 3.07) times higher after major downsizing than after minor downsizing. Adjustment for changes in work (for instance, physical demands,job control, and job insecurity) diminished the relation between downsizing and sickness absence by 49%. Adjustments for impaired social support or increased smoking did not alter. the relation between downsizing and sickness absence. The findings were unaffected by sex and income. Conclusions The exploration of potential mediating factors provides new information about the possible of Applied causal pathways linking organisational do downsizing Psychology, and health. Downsizing results in changes in work, social relationships, and health related behaviours. The observed increase in certificated sickness absence was partially explained by concomitant increases in physical demands and job insecurity and a reduction in job control, A considerable proportion of the increase, however, remained unexplained by the factors measured.	Univ Helsinki, Dept Psychol, Div Appl Psychol, FIN-00014 Helsinki, Finland; Finnish Inst Occupat Hlth, FIN-20500 Turku, Finland; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Helsinki; Finnish Institute of Occupational Health; University of London; University College London; UCL Medical School	Kivimaki, M (corresponding author), Univ Helsinki, Dept Psychol, Div Appl Psychol, POB 13, FIN-00014 Helsinki, Finland.	mika.kivimaki@occuphealth.fi	Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020; Vahtera, Jussi/J-3271-2013	Kivimaki, Mika/0000-0002-4699-5627; 				BEALE N, 1988, BRIT MED J, V296, P1508, DOI 10.1136/bmj.296.6635.1508; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Cobb S, 1977, TERMINATION CONSEQUE; Cohen J., 2013, APPL MULTIPLE REGRES; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Ferrie JE, 1998, AM J PUBLIC HEALTH, V88, P1030, DOI 10.2105/AJPH.88.7.1030; Hurrell JJ, 1998, AM J PUBLIC HEALTH, V88, P1012, DOI 10.2105/AJPH.88.7.1012; Johnson JV, 1996, AM J PUBLIC HEALTH, V86, P324, DOI 10.2105/AJPH.86.3.324; KAPRIO J, 1987, ALCOHOL CLIN EXP RES, V11, P349, DOI 10.1111/j.1530-0277.1987.tb01324.x; Kivimaki M, 1997, J APPL PSYCHOL, V82, P858, DOI 10.1037/0021-9010.82.6.858; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; LITTELL RC, 1998, SAS SYSTEM MIXED MOD; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; MARMOT MG, 1993, ADDICTION, V88, P369, DOI 10.1111/j.1360-0443.1993.tb00824.x; McCullagh P, 2019, GEN LINEAR MODELS; North FM, 1996, AM J PUBLIC HEALTH, V86, P332, DOI 10.2105/AJPH.86.3.332; Parker S K, 1997, J Occup Health Psychol, V2, P289, DOI 10.1037/1076-8998.2.4.289; RAEL EGS, 1995, J EPIDEMIOL COMMUN H, V49, P474, DOI 10.1136/jech.49.5.474; *SAS I, 1993, P243 SAS I; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; *STAT FINL, 1998, STAT YB FINL; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Vahtera J, 1996, WORK STRESS, V10, P286, DOI 10.1080/02678379608256809; VAHTERA J, 1999, EMPLOYEES STORM EC D	24	275	279	0	28	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					971	975		10.1136/bmj.320.7240.971	http://dx.doi.org/10.1136/bmj.320.7240.971			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753148	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000086453100021
J	Nishitani, H; Lygerou, Z; Nishimoto, T; Nurse, P				Nishitani, H; Lygerou, Z; Nishimoto, T; Nurse, P			The Cdt1 protein is required to license DNA for replication in fission yeast	NATURE			English	Article							ORIGIN RECOGNITION COMPLEX; S-PHASE; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MCM PROTEINS; SACCHAROMYCES-CEREVISIAE; INITIATION; COMPONENT; XENOPUS; MITOSIS	To maintain genome stability in eukaryotic cells, DNA is licensed for replication only after the cell has completed mitosis, ensuring that DNA synthesis (S phase) occurs once every cell cycle(1). This licensing control is thought to require the protein Cdc6 (Cdc18 in fission yeast) as a mediator for association of minichromosome maintenance (MCM) proteins with chromatin(2-10). The control is overridden in fission yeast by overexpressing Cdc18 (ref. 11) which leads to continued DNA synthesis in the absence of mitosis(12). Other factors acting in this control have been postulated(13) and we have used a re-replication assay to identify Cdt1 (ref. 14) as one such factor. Cdt1 cooperates with Cdc18 to promote DNA replication, interacts with Cdc18, is located in the nucleus, and its concentration peaks as cells finish mitosis and proceed to S phase. Both Cdc18 and Cdt1 are required to load the MCM protein Cdc21 onto chromatin at the end of mitosis and this is necessary to initiate DNA replication. Genes related to Cdt1 have been found in Metazoa and plants (A. Whitaker, I. Roysman and T. Orr-Weaver, personal communication), suggesting that the cooperation of Cdc6/Cdc18 with Cdt1 to load MCM proteins onto chromatin may be a generally conserved feature of DNA licensing in eukaryotes.	Imperial Canc Res Fund, London WC2A 3PX, England; Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan	Cancer Research UK; Kyushu University	Lygerou, Z (corresponding author), Imperial Canc Res Fund, 44 Lincolns Inn Fields, London WC2A 3PX, England.	z_lygerou@yahoo.com		Nishitani, Hideo/0000-0001-5907-9380				Alfa C, 1993, EXPT FISSION YEAST L; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Greenwood E, 1998, J CELL SCI, V111, P3101; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lygerou Z, 1999, J CELL SCI, V112, P3703; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Maiorano D, 1996, EMBO J, V15, P861, DOI 10.1002/j.1460-2075.1996.tb00421.x; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; MuziFalconi M, 1996, P NATL ACAD SCI USA, V93, P1566, DOI 10.1073/pnas.93.4.1566; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Tada S, 1999, CURR BIOL, V9, P211, DOI 10.1016/S0960-9822(99)80092-X; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7	25	364	368	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					625	+		10.1038/35007110	http://dx.doi.org/10.1038/35007110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766248				2022-12-01	WOS:000086400100059
J	Phair, RD; Misteli, T				Phair, RD; Misteli, T			High mobility of proteins in the mammalian cell nucleus	NATURE			English	Article							RNA SPLICING FACTORS; LIVING CELLS; LOCALIZATION; DIFFUSION	The mammalian cell nucleus contains numerous sub-compartments, which have been implicated in essential processes such as transcription and splicing(1,2). The mechanisms by which nuclear compartments are formed and maintained are unclear. More fundamentally, it is not known how proteins move within the cell nucleus. We have measured the kinetic properties of proteins in the nucleus of living cells using photobleaching techniques. Here we show that proteins involved in diverse nuclear processes move rapidly throughout the entire nucleus. Protein movement is independent of energy, which indicates that proteins may use a passive mechanism of movement. Proteins rapidly associate and dissociate with nuclear compartments. Using kinetic modelling, we determined residence times and steady-state fluxes of molecules in two main nuclear compartments. These data show that many nuclear proteins roam the cell nucleus in vivo and that nuclear compartments are the reflection of the steady-state association/dissociation of its 'residents' with the nucleoplasmic space. Our observations have conceptual implications for understanding nuclear architecture and how nuclear processes are organized in vivo.	NCI, NIH, Bethesda, MD 20892 USA; BioInformat Serv, Rockville, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010309] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bell BM, 1996, COMPUT STAT DATA AN, V22, P119, DOI 10.1016/0167-9473(95)00043-7; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Daneholt B, 1999, CURR BIOL, V9, pR412, DOI 10.1016/S0960-9822(99)80256-5; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; FOSTER DM, 1994, P SIM HLTH SCI C SOC, P87; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Hanamura A, 1998, RNA, V4, P430; Hock R, 1998, EMBO J, V17, P6992, DOI 10.1093/emboj/17.23.6992; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1998, CURR OPIN CELL BIOL, V10, P323, DOI 10.1016/S0955-0674(98)80007-0; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; OLSON MOJ, IN PRESS TRENDS CELL; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; Sleeman J, 1998, EXP CELL RES, V243, P290, DOI 10.1006/excr.1998.4135; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	30	932	956	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					604	+		10.1038/35007077	http://dx.doi.org/10.1038/35007077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766243				2022-12-01	WOS:000086400100054
J	Dennis, MS; Eigenbrot, C; Skelton, NJ; Ultsch, MH; Santell, L; Dwyer, MA; O'Connell, MP; Lazarus, RA				Dennis, MS; Eigenbrot, C; Skelton, NJ; Ultsch, MH; Santell, L; Dwyer, MA; O'Connell, MP; Lazarus, RA			Peptide exosite inhibitors of factor VIIa as anticoagulants	NATURE			English	Article							TISSUE FACTOR PATHWAY; COAGULATION-FACTOR VIIA; SERINE PROTEASES; ALPHA-THROMBIN; PROTEINASES; LIBRARIES; DISCOVERY; COMPLEX; DISPLAY; DOMAIN	Potent anticoagulants have been derived by targeting the tissue factor-factor VIIa complex with naive peptide libraries displayed on M13 phage, The peptides specifically block the activation of factor X with a median inhibitory concentration of 1 nM and selectively inhibit tissue-factor-dependent clotting, The peptides do not bind to the active site of factor VIIa; rather, they work by binding to an exosite on the factor VIIa protease domain, and non-competitively inhibit activation of factor X and amidolytic activity. One such peptide (E-76) has a well defined structure in solution determined by NMR spectroscopy that is similar to the X-ray crystal structure when complexed with factor VIIa, These structural and functional studies indicate an allosteric 'switch' mechanism of inhibition involving an activation loop of factor VIIa and represent a new framework for developing inhibitors of serine proteases.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, S San Francisco, CA 94080 USA.							Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BODE W, 1986, MOL CELLULAR BASIS D, P213; BROZE GJ, 1993, BLOOD, V82, P1679; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DENNIS MS, 1994, J BIOL CHEM, V269, P22129; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001; Higashi S, 1998, INT J HEMATOL, V67, P229; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; Hirsh J, 1999, LANCET, V353, P1431, DOI 10.1016/S0140-6736(98)09233-2; HIRSH J, 1994, HEMOSTASIS THROMBOSI, P1567; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Johnson K, 1998, CORONARY ARTERY DIS, V9, P83, DOI 10.1097/00019501-199809020-00004; Kelley RF, 1997, BLOOD, V89, P3219, DOI 10.1182/blood.V89.9.3219; Kemball-Cook G, 1999, J STRUCT BIOL, V127, P213, DOI 10.1006/jsbi.1999.4158; Kirchhofer D, 1997, TRENDS CARDIOVAS MED, V7, P316, DOI 10.1016/S1050-1738(97)00094-7; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; MANN KG, 1993, BLOOD, V82, P1680; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; NASKI MC, 1990, J BIOL CHEM, V265, P13484; NEMERSON Y, 1988, BLOOD, V71, P1; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; POLGAR L, 1989, MECHANISMS PROTEASE, P87; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; Sanderson PEJ, 1999, MED RES REV, V19, P179, DOI 10.1002/(SICI)1098-1128(199903)19:2<179::AID-MED4>3.0.CO;2-5; Segel I. H., 1975, ENZYME KINETICS BEHA, P100; Shobe J, 1999, BIOCHEMISTRY-US, V38, P2745, DOI 10.1021/bi981951g; SKELTON NJ, 1994, BIOCHEMISTRY-US, V33, P13581, DOI 10.1021/bi00250a010; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; STUBBS MT, 1994, CURR OPIN STRUC BIOL, V4, P823, DOI 10.1016/0959-440X(94)90263-1; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; Vlasuk GP, 1998, ARCH PATHOL LAB MED, V122, P812; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	45	192	217	1	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					465	470		10.1038/35006574	http://dx.doi.org/10.1038/35006574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761907				2022-12-01	WOS:000086257700038
J	Lee, L; Tirnauer, JS; Li, JJ; Schuyler, SC; Liu, JY; Pellman, D				Lee, L; Tirnauer, JS; Li, JJ; Schuyler, SC; Liu, JY; Pellman, D			Positioning of the mitotic spindle by a cortical-microtubule capture mechanism	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; NUCLEAR MIGRATION; BINDING PROTEIN; YEAST; ORIENTATION; DYNEIN; SITES; BNI1P; EB1	Correct positioning of the mitotic spindle is critical for cell division and development. Spindle positioning involves a search-and-capture mechanism whereby dynamic microtubules find and then interact with specific sites on the submembrane cortex. Genetic, biochemical, and imaging experiments suggest a mechanism for cortical-microtubule capture. Bim1p, Located at microtubule distal ends, bound Kar9p, a protein associated with the daughter cell cortex. Bim1p is the yeast ortholog of human EB1, a binding partner for the adenomatous polyposis coli tumor suppressor. EB1 family proteins may have a general role in linking the microtubule cytoskeleton to cortical polarity determinants.	Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Princeton University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Pellman, D (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	daivd_pellman@dfci.harvard.edu			NIDDK NIH HHS [KO8 DK02578] Funding Source: Medline; NIGMS NIH HHS [GM55772] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002578] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Chant J, 1991, CURR OPIN GENET DEV, V1, P342, DOI 10.1016/S0959-437X(05)80298-9; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Gavin RH, 1997, INT REV CYTOL, V173, P207; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Heil-Chapdelaine RA, 1999, J CELL BIOL, V144, P809, DOI 10.1083/jcb.144.5.809; Hunt AJ, 1998, MOL BIOL CELL, V9, P2857, DOI 10.1091/mbc.9.10.2857; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; LEE L, UNPUB; Miller R, UNPUB; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; RHYU MS, 1995, CELL, V82, P523, DOI 10.1016/0092-8674(95)90022-5; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shaw SL, 1998, MOL BIOL CELL, V9, P1627, DOI 10.1091/mbc.9.7.1627; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890	34	237	239	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2260	2262		10.1126/science.287.5461.2260	http://dx.doi.org/10.1126/science.287.5461.2260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731147				2022-12-01	WOS:000086049100050
J	Hill, EW; Jobling, MA; Bradley, DG				Hill, EW; Jobling, MA; Bradley, DG			Y-chromosome variation and Irish origins	NATURE			English	Article									Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Trinity College Dublin; University of Leicester	Hill, EW (corresponding author), Trinity Coll, Dept Genet, Dublin 2, Ireland.		Bradley, Daniel G/A-3240-2012	Jobling, Mark/0000-0002-8061-1308; Hill, Emmeline/0000-0002-1805-2250; Bradley, Daniel G/0000-0001-7335-7092	Wellcome Trust [057559] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; MacLYSAGHT EDWARD, 1997, SURNAMES IRELAND; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	6	96	97	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					351	352		10.1038/35006158	http://dx.doi.org/10.1038/35006158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746711				2022-12-01	WOS:000086119000036
J	Nielsen, LK; Bjornholm, T; Mouritsen, OG				Nielsen, LK; Bjornholm, T; Mouritsen, OG			Critical phenomena - Fluctuations caught in the act	NATURE			English	Article							MEMBRANES		Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Nielsen, LK (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	ogm@kemi.dtu.dk		Bjornholm, Thomas/0000-0002-2981-8290; Mouritsen, Ole G./0000-0002-4258-8960				ALBRECHT O, 1978, J PHYS-PARIS, V39, P301, DOI 10.1051/jphys:01978003903030100; Andrews T, 1869, PHILOS T R SOC LOND, V159, P575, DOI [10.1098/rstl.1869.0021, DOI 10.1098/RSTL.1869.0021]; Edidin M, 1997, CURR OPIN STRUC BIOL, V7, P528, DOI 10.1016/S0959-440X(97)80117-0; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Knobler CM, 1999, CURR OPIN COLLOID IN, V4, P46, DOI 10.1016/S1359-0294(99)00002-3; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; MONRITSEN OG, 1997, CURR OPIN STRUC BIOL, V7, P518; Mouritsen O. G., 1998, BIOL SKR DAN VID SEL, V49, P1; MUSTONEN P, 1987, BIOCHEMISTRY-US, V26, P2991, DOI 10.1021/bi00385a006; Nielsen LK, 2000, J PHYS-CONDENS MAT, V12, pA309, DOI 10.1088/0953-8984/12/8A/340; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358	12	79	80	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					352	352		10.1038/35006162	http://dx.doi.org/10.1038/35006162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746712				2022-12-01	WOS:000086119000037
J	Caplan, AL; Snyder, L; Faber-Langendoen, K				Caplan, AL; Snyder, L; Faber-Langendoen, K		Univ Pennsylvania	The role of guidelines in the practice of physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							DEATH; NETHERLANDS; EUTHANASIA; MODEL; CARE	Oregon has legalized and implemented physician-assisted suicide, while observers argue about the moral import of attempting to formulate guidelines; the utility any set of guidelines can have for physician practice, health care providers, patients, or families; and whether guidelines can really protect against harm or abuse. What were once theoretical questions have taken on new urgency. The debate over the value and power of guidelines includes the following questions: What has been the experience of efforts to implement physician-assisted suicide using consensus guidelines? What goals are guidelines intended to serve? Who should formulate guidelines? What features should be reflected in any proposed guidelines to make them practical and to permit achievement of their goals? Are there any fundamental obstacles to the creation or implementation of guidelines', Is dying a process that is amenable to direction under guidelines, be they issued by physicians, departments of health, blue ribbon panels, or other regulatory bodies? This paper explores these questions as physician-assisted suicide becomes legal.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.	lsnyder@mail.acponline.org						Albom M., 1997, TUESDAYS MORRIE OLD; Anderson P, 1996, ALL US AM TALK MEANI; Baron CH, 1996, HARVARD J LEGIS, V33, P1; Battin Margaret, 1994, LEAST WORST DEATH ES; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Byock I., 1997, DYING WELL; Callahan Daniel, 1996, Univ Richmond Law Rev, V30, P1; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Coleman CH, 1996, J LAW MED ETHICS, V24, P217, DOI 10.1111/j.1748-720X.1996.tb01855.x; *COMM STUD MED PRA, 1991, MED DEC END LIF; Drickamer MA, 1997, ANN INTERN MED, V126, P146, DOI 10.7326/0003-4819-126-2-199701150-00009; *DUTCH SOC ADV PHA, 1994, ADM PREP EUTH; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Faber-Langendoen K, 2000, ANN INTERN MED, V132, P482, DOI 10.7326/0003-4819-132-6-200003210-00010; Field MJ, 1997, APPROACHING DEATH IM; Fins, 1996, Cancer Control, V3, P272; Gomez Carlos F., 1991, REGULATING DEATH EUT; Heilig S, 1997, WESTERN J MED, V166, P370; Hendin H., 1998, SEDUCED DEATH DOCTOR; Humphrey D., 1991, FINAL EXIT PRACTICAL; HUMPHREY D, 1993, LAWFUL EXIT LIMITS F; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kubler-Ross Elisabeth, 1997, WHEEL LIFE MEMOIR LI; LARUE GA, 1996, PLAYING GOD 50 RELIG; MCNEES P, 1998, DYING BOOK COMFORT; MILLER FG, 1994, NEW ENGL J MED, V331, P119, DOI 10.1056/NEJM199407143310211; Miller FG, 1997, CAMB Q HEALTHC ETHIC, V6, P78, DOI 10.1017/S0963180100007635; *NEW YORK STAT TAS, 1994, DEATH IS SOUGHT ASS; Nuland S.B., 1994, WE DIE REFLECTIONS L; PECK MS, 1997, DENIAL SOUL; PIJNENBORG P, 1995, END LIFE DECISIONS D; Quill T, 1996, MIDWIFE DYING PROCES; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; Rabe David, 1998, QUESTION MERCY; ROLLIN B, 1985, LAST WISH; SHAVELSON L, 1995, CHOSEN DEATH DYING C; SIMONS M, 1995, NY TIMES        0909; Smith W.J., 1997, FORCED EXIT SLIPPERY; SNEIDERMAN B, 1992, HUM MED, V8, P104; Snyder L, 1996, Pa Med, V99, P10; TILDEN VP, 1997, J FAMILY NURSING, V3, P120; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; VITEZ M, 1998, FINAL CHOICES SEEKIN; Webb M, 1997, GOOD DEATH NEW AM SE; Young EWD, 1997, WESTERN J MED, V166, P381	47	24	24	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					476	481		10.7326/0003-4819-132-6-200003210-00009	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733448				2022-12-01	WOS:000085834700008
J	Russell, CT; Kivelson, MG				Russell, CT; Kivelson, MG			Detection of SO in lo's exosphere	SCIENCE			English	Article							ION-CYCLOTRON WAVES; PLASMA TORUS; GALILEO; ENCOUNTER	The Galileo orbiter's close pass by Io in 1995 produced evidence for extensive mass Loading of the plasma torus through the ionization of SO2. On 11 October 1999, Galileo passed even closer to Io, this time across the upstream side relative to the flow of magnetospheric plasma that corotates with Jupiter. On the first flyby, ion cyclotron waves gave direct evidence for the production of SO2+ ions. On the second flyby, ion cyclotron waves associated with SO+ were stronger and more persistent. Moreover, SO+ emissions were seen closer to lo than SO2+ emissions, suggesting that the exosphere was spatially inhomogeneous. The location of the waves suggests a fan-shaped region of ion pickup extending in the anti-Jupiter direction. Because the wave spectra were different even where the 1995 and 1999 trajectories crossed, we infer that lo's exosphere is temporally variable.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Russell, CT (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, 3845 Slichter Hall, Los Angeles, CA 90095 USA.		Russell, Christopher T/E-7745-2012; Kivelson, Margaret G/I-9019-2012	Russell, Christopher T/0000-0003-1639-8298; Kivelson, Margaret G/0000-0003-3859-8581				BALCHER JW, 1983, PHYSICS JOVIAN MAGNE, P68; Frank LA, 1996, SCIENCE, V274, P394, DOI 10.1126/science.274.5286.394; Gurnett DA, 1996, SCIENCE, V274, P391, DOI 10.1126/science.274.5286.391; Huddleston DE, 1997, GEOPHYS RES LETT, V24, P2143, DOI 10.1029/97GL01203; Kivelson MG, 1996, SCIENCE, V274, P396, DOI 10.1126/science.274.5286.396; Lellouch E, 1996, ICARUS, V124, P1, DOI 10.1006/icar.1996.0186; Lopes-Gautier R, 1999, ICARUS, V140, P243, DOI 10.1006/icar.1999.6129; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; Russell CT, 1999, J GEOPHYS RES-SPACE, V104, P17471, DOI 10.1029/1999JA900202; Warnecke J, 1997, GEOPHYS RES LETT, V24, P2139, DOI 10.1029/97GL01129; Williams DJ, 1996, SCIENCE, V274, P401, DOI 10.1126/science.274.5286.401; Zolotov MY, 1998, ICARUS, V132, P431, DOI 10.1006/icar.1998.5906	12	45	45	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1998	1999		10.1126/science.287.5460.1998	http://dx.doi.org/10.1126/science.287.5460.1998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720321				2022-12-01	WOS:000085902800055
J	Meijers, JCM; Tekelenburg, WLH; Bouma, BN; Bertina, RM; Rosendaal, FR				Meijers, JCM; Tekelenburg, WLH; Bouma, BN; Bertina, RM; Rosendaal, FR			High levels of coagulation factor XI as a risk factor for venous thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVATED PROTEIN-C; MOLECULAR-WEIGHT KININOGEN; DEEP-VEIN THROMBOSIS; LEIDEN THROMBOPHILIA; BLOOD-COAGULATION; FIBRINOLYSIS INHIBITOR; ASHKENAZI JEWS; HUMAN PLASMA; DEFICIENCY; CARBOXYPEPTIDASE	Background: Factor XI, a component of the intrinsic pathway of coagulation, contributes to the generation of thrombin, which is involved in both the formation of fibrin and protection against fibrinolysis. A deficiency of factor XI is associated with bleeding, but a role of high factor XI levels in thrombosis has not been investigated. Methods: We determined factor XI antigen levels in the patients enrolled in the Leiden Thrombophilia Study, a large population-based, case-control study (with a total of 474 patients and 474 controls) designed to estimate the contributions of genetic and acquired factors to the risk of deep venous thrombosis. Odds ratios were calculated as a measure of relative risk. Results: The age- and sex-adjusted odds ratio for deep venous thrombosis in subjects who had factor XI levels above the 90th percentile, as compared with those who had factor XI levels at or below that value, was 2.2 (95 percent confidence interval, 1.5 to 3.2). There was a dose-response relation between the factor XI level and the risk of venous thrombosis. Adjustment of the odds ratios for other risk factors such as oral-contraceptive use, homocysteine, fibrinogen, factor VIII, female sex, and older age did not alter the result. Also, when we excluded subjects who had known genetic risk factors for thrombosis (e.g., protein C or S deficiency, antithrombin deficiency, the factor V Leiden mutation, or the prothrombin G20210A mutation), the odds ratio remained the same, indicating that the risk of venous thrombosis associated with elevated levels of factor XI was not the result of one of the known risk factors for thrombosis. Conclusions: High levels of factor XI are a risk factor for deep venous thrombosis, with a doubling of the risk at levels that are present in 10 percent of the population. (N Engl J Med 2000;342:696-701.) (C)2000, Massachusetts Medical Society.	Univ Med Ctr, Dept Hematol, Thrombosis & Hemostasis Lab, Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, Utrecht, Netherlands; Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Meijers, JCM (corresponding author), Acad Med Ctr, Dept Vasc Med, G1-143,POB 22660, NL-1100 DD Amsterdam, Netherlands.		Rosendaal, Frits/Q-3842-2017; Bertina, Rogier/AGQ-5246-2022; Meijers, J.C.M./S-5981-2019	Rosendaal, Frits/0000-0003-2558-7496; Meijers, J.C.M./0000-0002-4198-6780				ASAKAI R, 1991, NEW ENGL J MED, V325, P153, DOI 10.1056/NEJM199107183250303; BERLINER S, 1992, BLOOD COAGUL FIBRIN, V3, P465, DOI 10.1097/00001721-199203040-00014; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BOUMA BN, 1983, BLOOD, V62, P1123; Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; EATON DL, 1991, J BIOL CHEM, V266, P21833; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Minnema MC, 1998, J CLIN INVEST, V101, P10, DOI 10.1172/JCI781; Minnema MC, 1998, J CLIN INVEST, V101, P917; NAITO K, 1991, J BIOL CHEM, V266, P7353; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; Oliver JA, 1999, ARTERIOSCL THROM VAS, V19, P170, DOI 10.1161/01.ATV.19.1.170; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; RAPAPORT SI, 1961, BLOOD, V18, P149, DOI 10.1182/blood.V18.2.149.149; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P35; SELIGSOHN U, 1993, THROMB HAEMOSTASIS, V70, P68; SELIGSOHN U, 1978, BLOOD, V51, P1223; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; VONDEMBORNE PAK, 1994, THROMB HAEMOSTASIS, V72, P397; VONDEMBORNE PAK, 1995, BLOOD, V86, P3035; VondemBorne PAK, 1997, J CLIN INVEST, V99, P2323, DOI 10.1172/JCI119412; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; WANG W, 1994, J BIOL CHEM, V269, P15937; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; WUILLEMIN WA, 1995, BLOOD, V85, P1517, DOI 10.1182/blood.V85.6.1517.bloodjournal8561517	33	488	539	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					696	701		10.1056/NEJM200003093421004	http://dx.doi.org/10.1056/NEJM200003093421004			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706899				2022-12-01	WOS:000085708800004
J	Williams, RJ; Martinez, ND				Williams, RJ; Martinez, ND			Simple rules yield complex food webs	NATURE			English	Article							TROPHIC INTERACTIONS; PATTERNS; SCALE; ECOSYSTEM; PREY	Several of the most ambitious theories in ecology(1-14) describe food webs that document the structure of strong and weak trophic links(9) that is responsible for ecological dynamics among diverse assemblages of species(4,11-13). Early mechanism-based theory asserted that food webs have little omnivory and several properties that are independent of species richness(1-4,6). This theory was overturned by empirical studies that found food webs to be much more complex(5,7-9,14-18), but these studies did not provide mechanistic explanations for the complexity(9). Here we show that a remarkably simple model. fills this scientific void by successfully predicting key structural properties of the most complex and comprehensive food webs in the primary literature. These properties include the fractions of species at top, intermediate and basal trophic levels, the means and variabilities of generality, vulnerability and food-chain length, and the degrees of cannibalism, omnivory, looping and trophic similarity. Using only two empirical parameters, species number and connectance, our 'niche model' extends the existing 'cascade model'(3,19) and improves its fit ten-fold by constraining species to consume a contiguous sequence of prey in a one-dimensional trophic niche(20).	San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	California State University System; San Francisco State University	Martinez, ND (corresponding author), San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr, POB 855, Tiburon, CA 94920 USA.		Williams, Richard J/B-8344-2011; Martinez, Neo/A-5312-2008	Williams, Richard J/0000-0001-8847-3213; Martinez, Neo/0000-0002-1130-5550				BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Begon M., 1996, ECOLOGY INDIVIDUALS; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Cohen J., 1978, FOOD WEBS NICHE SPAC; Cohen J. E., 1990, BIOMATHEMATICS, V20; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUXMAN M, 1995, J ANIM ECOL, V64, P168; Lawton J.H., 1989, P43; LAWTON JH, 1995, OIKOS, V72, P305, DOI 10.2307/3546114; Marcogliese DJ, 1997, TRENDS ECOL EVOL, V12, P320, DOI 10.1016/S0169-5347(97)01080-X; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1994, AM NAT, V144, P935, DOI 10.1086/285719; MARTINEZ ND, 1993, SCIENCE, V260, P242, DOI 10.1126/science.260.5105.242; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Murtaugh PA, 1997, ECOLOGY, V78, P1382; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Polis G.A., 1996, FOOD WEBS INTEGRATIO; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Solow AR, 1998, ECOLOGY, V79, P2013, DOI 10.1890/0012-9658(1998)079[2013:OLSIFW]2.0.CO;2; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; WARREN PH, 1987, OECOLOGIA, V74, P231, DOI 10.1007/BF00379364; Warren Philip H., 1996, P142	30	945	984	13	333	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					180	183		10.1038/35004572	http://dx.doi.org/10.1038/35004572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724169				2022-12-01	WOS:000085870900050
J	Spechler, SJ; Fischbach, L; Feldman, M				Spechler, SJ; Fischbach, L; Feldman, M			Clinical aspects of genetic variability in Helicobacter pylori	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUODENAL-ULCER DISEASE; GASTRIC-CANCER; REFLUX ESOPHAGITIS; INCREASED RISK; CAGA GENE; CYTOTOXIN ACTIVITY; INFECTION; STRAINS; ANTIGENS; STOMACH		Dept Vet Affairs Med Ctr, Dallas, TX USA; Univ Texas, SW Med Ctr, Houston, TX USA; Univ Texas, Sch Publ Hlth, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Spechler, SJ (corresponding author), Dallas VA Med Ctr, Div Gastroenterol 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.							Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Atherton JC, 1998, BRIT MED BULL, V54, P105; Atherton JC, 1999, GUT, V44, P307, DOI 10.1136/gut.44.3.307; Blaser MJ, 1998, GUT, V43, P721, DOI 10.1136/gut.43.5.721; Blaser MJ, 1997, LANCET, V349, P1020, DOI 10.1016/S0140-6736(96)09133-7; Blaser MJ, 1996, ALIMENT PHARM THER, V10, P73, DOI 10.1046/j.1365-2036.1996.22164008.x; BLASER MJ, 1995, CANCER RES, V55, P2111; Ching CK, 1996, AM J GASTROENTEROL, V91, P949; Cover TL, 1999, GASTROENTEROLOGY, V117, P257, DOI 10.1016/S0016-5085(99)70575-5; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1990, INFECT IMMUN, V58, P603, DOI 10.1128/IAI.58.3.603-610.1990; FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672; Go M F, 1996, Helicobacter, V1, P107, DOI 10.1111/j.1523-5378.1996.tb00019.x; Graham DY, 1998, HELICOBACTER, V3, P145, DOI 10.1046/j.1523-5378.1998.08031.x; Hamlet A, 1999, GASTROENTEROLOGY, V116, P259, DOI 10.1016/S0016-5085(99)70121-6; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Holtmann G, 1998, AM J GASTROENTEROL, V93, P1222, DOI 10.1111/j.1572-0241.1998.00399.x; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; Kikuchi S, 1999, AM J GASTROENTEROL, V94, P3455, DOI 10.1111/j.1572-0241.1999.01607.x; Klaamas K, 1996, INT J CANCER, V67, P1, DOI 10.1002/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0; Labenz J, 1997, GASTROENTEROLOGY, V112, P1442, DOI 10.1016/S0016-5085(97)70024-6; Miehlke S, 1996, AM J GASTROENTEROL, V91, P1322; Mitchell HM, 1996, AM J GASTROENTEROL, V91, P1785; Park SM, 1998, SCAND J GASTROENTERO, V33, P923, DOI 10.1080/003655298750026921; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; PEEK RM, 1995, LAB INVEST, V71, P760; Rudi J, 1997, DIGEST DIS SCI, V42, P1652, DOI 10.1023/A:1018849112533; Scheiman JM, 1999, AM J MED, V106, P222, DOI 10.1016/S0002-9343(98)00393-3; Shyu RY, 1998, J CLIN GASTROENTEROL, V27, P54, DOI 10.1097/00004836-199807000-00011; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Vicari JJ, 1998, GASTROENTEROLOGY, V115, P50, DOI 10.1016/S0016-5085(98)70364-6; Vorobjova T, 1998, EUR J GASTROEN HEPAT, V10, P41, DOI 10.1097/00042737-199801000-00008; Werdmuller BFM, 1997, DIGEST DIS SCI, V42, P103, DOI 10.1023/A:1018841222856; Wong BCY, 1999, ALIMENT PHARM THER, V13, P1295; Yamaoka Y, 1999, J CLIN PATHOL, V52, P215, DOI 10.1136/jcp.52.3.215	36	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1264	1266		10.1001/jama.283.10.1264	http://dx.doi.org/10.1001/jama.283.10.1264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289ND	10714712				2022-12-01	WOS:000085628100001
J	Willis, KJ; Whittaker, RJ				Willis, KJ; Whittaker, RJ			Paleoecology - The refugial debate	SCIENCE			English	Editorial Material							PHYLOGEOGRAPHY; SPECIATION; FOREST; EUROPE		Univ Oxford, Sch Geog, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog, Mansfield Rd, Oxford OX1 3TB, England.		Whittaker, Robert J/H-1548-2015	Whittaker, Robert J/0000-0001-7775-3383; Willis, Katherine/0000-0002-6763-2489				Aide TM, 1998, J BIOGEOGR, V25, P695, DOI 10.1046/j.1365-2699.1998.2540695.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028	12	180	187	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1406	1407		10.1126/science.287.5457.1406	http://dx.doi.org/10.1126/science.287.5457.1406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10722388				2022-12-01	WOS:000085531600024
J	Gajiwala, KS; Chen, H; Cornille, F; Roques, BP; Reith, W; Mach, B; Burley, SK				Gajiwala, KS; Chen, H; Cornille, F; Roques, BP; Reith, W; Mach, B; Burley, SK			Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding	NATURE			English	Article							LINKER HISTONE H5; GLOBULAR DOMAIN; NUCLEOSOME BINDING; CRYSTAL-STRUCTURE; SITE; IDENTIFICATION; RECOGNITION; FAMILY; MOTIF; HEAD	Regulatory factor X (RFX) proteins are transcriptional activators that recognize X-boxes (DNA of the sequence 5'-GTNRCC(0-3N) RGYAAC-3', where N is any nucleotide, R is a purine and Y is a pyrimidine) using a highly conserved 76-residue DNA-binding domain (DBD). DNA-binding defects in the protein RFX5 cause bare lymphocyte syndrome or major histocompatibility antigen class II defciency(1), RFXI, -2 and -3 regulate expression of other medically important gene products (for example, interleukin-5 receptor alpha chain, IL-5R alpha)(2). Fusions of the ligand-binding domain of the oestrogen receptor with the DBD of RFX4 occur in some human breast tumours'. Here we present a 1.5 Angstrom-resolution structure of two copies of the DBD of human RFXI (hRFX1) binding cooperatively to a symmetrical X-box(4,5), hRFX1 is an unusual member of the winged-helix subfamily of helix-turn-helix proteins(6) because it uses a beta-hairpin (or wing) to recognize DNA instead of the recognition helix typical of helix-turn-helix proteins. A new model for interactions between linker histones and DNA is proposed.	Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; UFR Sci Pharmaceut & Biol, Dept Pharmacol Mol & Struct, CNRS,URA D1500, INSERM,U266, F-75720 Paris, France; Ctr Med Univ Geneva, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Burley, SK (corresponding author), Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.			Burley, Stephen/0000-0002-2487-9713				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE RS, 1992, J MOL BIOL, V223, P651, DOI 10.1016/0022-2836(92)90981-O; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Cornille F, 1998, NUCLEIC ACIDS RES, V26, P2143, DOI 10.1093/nar/26.9.2143; DOTZLAW H, 1992, MOL ENDOCRINOL, V6, P773, DOI 10.1210/me.6.5.773; Emery P, 1996, MOL CELL BIOL, V16, P4486; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Iwama A, 1999, MOL CELL BIOL, V19, P3940; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; THOMAS JO, 1986, EMBO J, V5, P3531, DOI 10.1002/j.1460-2075.1986.tb04679.x; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	25	261	272	1	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					916	921		10.1038/35002634	http://dx.doi.org/10.1038/35002634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706293				2022-12-01	WOS:000085559200064
J	Bochtler, M; Hartmann, C; Song, HK; Bourenkov, GP; Bartunik, HD; Huber, R				Bochtler, M; Hartmann, C; Song, HK; Bourenkov, GP; Bartunik, HD; Huber, R			The structures of HsIU and ATP-dependent protease HsIU-HsIV	NATURE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; UBIQUITIN SYSTEM; 20S PROTEASOME; P-LOOP; DEGRADATION; PROTEINS; BINDING; CHAPERONES; RESOLUTION	The degradation of cytoplasmic proteins is an ATP-dependent process'. Substrates are targeted to a single soluble protease, the 26S proteasome(2,3), in eukaryotes and to a number of unrelated proteases in prokaryotes(4,5). A surprising Link emerged with the discovery of the ATP-dependent protease HslVU (heat shock locus VU)(6-8) in Escherichia coli. Its protease component HsIV shares similar to 20% sequence similarity(6) and a conserved fold(9) with 20S proteasome beta-subunits. HslU is a member of the Hsp100 (Clp) family of ATPases. Here we report the crystal structures of free HslU and an 820,000 relative molecular mass complex of HslU and HslV-the first structure of a complete set of components of an ATP-dependent protease. HslV and HslU display sixfold symmetry, ruling out mechanisms of protease activation that require a symmetry mismatch between the two components. Instead, there is conformational flexibility and domain motion in HslU and a localized order-disorder transition in HslV. Individual subunits of HslU contain two globular domains in relative orientations that correlate with nucleotide bound and unbound states. They are surprisingly similar to their counterparts in N-ethylmaleimide-sensitive fusion protein(10,11), the prototype of an AAA-ATPase. A third, mostly a-helical domain in HslU mediates the contact with HslV and may be the structural equivalent of the amino-terminal domains in proteasomal AAA-ATPases.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Max Planck Gesell, Arbeitsgrp Strukturelle Mol Biol, D-22603 Hamburg, Germany	Max Planck Society; Max Planck Society	Bochtler, M (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	bochtler@bio-chem.mpg.de	Bochtler, Matthias/A-4514-2010; Song, Hyun Kyu/D-6763-2016; Bourenkov, Gleb P/C-7794-2017	Song, Hyun Kyu/0000-0001-5684-4059; Bourenkov, Gleb P/0000-0002-2617-5920; Bochtler, Matthias/0000-0001-7884-4463				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Feng HP, 1998, CURR BIOL, V8, pR464, DOI 10.1016/S0960-9822(98)70294-5; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Levchenko I, 1997, CELL, V91, P939, DOI 10.1016/S0092-8674(00)80485-7; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; Neuwald AF, 1999, GENOME RES, V9, P27; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	30	362	370	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					800	805		10.1038/35001629	http://dx.doi.org/10.1038/35001629			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693812				2022-12-01	WOS:000085423100059
J	Gylfe, A; Bergstrom, S; Lunstrom, J; Olsen, B				Gylfe, A; Bergstrom, S; Lunstrom, J; Olsen, B			Epidemiology - Reactivation of Borrelia infection in birds	NATURE			English	Article							BURGDORFERI SENSU-LATO		Umea Univ, Dept Microbiol, SE-90187 Umea, Sweden; Uppsala Univ, Dept Populat Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Umea Univ, Dept Infect Dis, SE-90187 Umea, Sweden; Kalmar Cty Hosp, Dept Infect Dis, SE-39185 Kalmar, Sweden	Umea University; Uppsala University; Umea University	Gylfe, A (corresponding author), Umea Univ, Dept Microbiol, SE-90187 Umea, Sweden.	bjornol@ltkalmar.se		Olsen, Bjorn/0000-0002-4646-691X				Alerstam T., 1990, BIRD MIGRATION, DOI 10.1046/j.1420-9101.1992.5030529.x; Apanius V, 1998, ADV STUD BEHAV, V27, P133; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/edrv-17-1-64; Holberton RL, 1996, AUK, V113, P558, DOI 10.2307/4088976; Hubalek Z, 1998, J MED MICROBIOL, V47, P929, DOI 10.1099/00222615-47-10-929; Humair PF, 1998, ZBL BAKT-INT J MED M, V287, P521, DOI 10.1016/S0934-8840(98)80194-1; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; WELTY JC, 1988, LIFE BIRDS, P119	11	134	138	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					724	725		10.1038/35001663	http://dx.doi.org/10.1038/35001663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693792				2022-12-01	WOS:000085423100039
J	Chen, CK; Burns, ME; He, W; Wensel, TG; Baylor, DA; Simon, MI				Chen, CK; Burns, ME; He, W; Wensel, TG; Baylor, DA; Simon, MI			Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1	NATURE			English	Article							PHOTORECEPTOR G-PROTEIN; CGMP PHOSPHODIESTERASE; TARGET ENZYME; GAMMA-SUBUNIT; RETINAL RODS; TRANSDUCIN; PHOTOTRANSDUCTION; DEACTIVATION; ACTIVATION; EXPRESSION	Timely deactivation of the alpha-subunit of the rod G-protein transducin (G alpha t) is essential for the temporal resolution of rod vision(1). Regulators of G-protein signalling (RGS) proteins accelerate hydrolysis of GTP by the alpha-subunits of heterotrimeric G proteins(2-4) in vitro. Several retinal RGS proteins can act in vitro as GTPase accelerating proteins (GAP) for G alpha t(5-8). Recent reconstitution experiments indicate that one of these, RGS9-1, may account for much of the G alpha t GAP activity in rod outer segments (ROS)(8,9). Here we report that ROS membranes from mice lacking RGS9-1 hydrolyse GTP more slowly than ROS membranes from control mice. The G beta 5-L protein that forms a complex with RGS9-1 (ref. 10) was absent from RGS9(-/-) retinas, although G beta 5-L messenger RNA was still present. The flash responses of RGS9(-/-) rods rose normally, but recovered much more slowly than normal. We conclude that RGS9-1, probably in a complex with G beta 5-L, is essential for acceleration of hydrolysis of GTP by G alpha t and for normal recovery of the photoresponse.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem, Houston, TX 77030 USA	California Institute of Technology; Stanford University; Baylor College of Medicine	Simon, MI (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Wensel, Theodore/0000-0003-3518-9352				ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Cowan CW, 2000, METHOD ENZYMOL, V315, P524; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P129; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; PAGES F, 1992, J BIOL CHEM, V267, P22018; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wieland T, 1999, N-S ARCH PHARMACOL, V360, P14, DOI 10.1007/s002109900031; Wieland T, 1997, J BIOL CHEM, V272, P8853; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	30	315	320	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					557	560		10.1038/35000601	http://dx.doi.org/10.1038/35000601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676965				2022-12-01	WOS:000085227300053
J	Schiller, LR				Schiller, LR			Pathophysiology and treatment ed microscopic-colitis syndrome	LANCET			English	Editorial Material							COLLAGENOUS-COLITIS; CHRONIC DIARRHEA		Baylor Univ, Med Ctr, Dept Gastroenterol, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center	Schiller, LR (corresponding author), Baylor Univ, Med Ctr, Dept Gastroenterol, Dallas, TX 75246 USA.							Bohr J, 1996, GUT, V39, P846, DOI 10.1136/gut.39.6.846; Fine K, 1999, GASTROENTEROLOGY, V116, pA880; Fine KD, 1999, GASTROENTEROLOGY, V116, pA879; Fine KD, 1998, GASTROENTEROLOGY, V114, P29, DOI 10.1016/S0016-5085(98)70629-8; Fine KD, 2000, GASTROINTEST ENDOSC, V51, P318, DOI 10.1016/S0016-5107(00)70362-2; LAZENBY AJ, 1989, HUM PATHOL, V20, P18, DOI 10.1016/0046-8177(89)90198-6; LEE E, 1988, GASTROENTEROLOGY, V94, P409, DOI 10.1016/0016-5085(88)90430-1; LEE E, 1992, GASTROENTEROLOGY, V103, P1790, DOI 10.1016/0016-5085(92)91436-8; LINDSTROM CG, 1976, PATHOL EUR, V11, P87; NELSON RW, 1988, J VET INTERN MED, V2, P133, DOI 10.1111/j.1939-1676.1988.tb02809.x; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; READ NW, 1980, GASTROENTEROLOGY, V78, P264; Schiller L R, 1999, Semin Gastrointest Dis, V10, P145; SCHILLER LR, 1990, GASTROENTEROLOGY, V98, P1036, DOI 10.1016/0016-5085(90)90031-U; Ung KA, 2000, GUT, V46, P170, DOI 10.1136/gut.46.2.170	15	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1198	1199		10.1016/S0140-6736(00)02079-1	http://dx.doi.org/10.1016/S0140-6736(00)02079-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770295				2022-12-01	WOS:000086448000002
J	Sims, DW; Andrews, PLR; Young, JZ				Sims, DW; Andrews, PLR; Young, JZ			Fish behaviour - Stomach rinsing in rays	NATURE			English	Article									Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; St George Hosp, Sch Med, Dept Physiol, London SW17 0RE, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Aberdeen; St Georges University London; University of Oxford	Sims, DW (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.			Sims, David/0000-0002-0916-7363				Andrews PLR, 1998, J MAR BIOL ASSOC UK, V78, P1269, DOI 10.1017/S0025315400044489; ANDREWS PLR, IN PRESS J EXP BIOL; BEINTEMA AJ, 1991, NATURE, V352, P480, DOI 10.1038/352480b0; BORISON HL, 1952, J PHARMACOL EXP THER, V105, P317; Budker P., 1971, LIFE SHARKS; CROW G L, 1990, Copeia, P226; NAITOH T, 1991, COMP BIOCHEM PHYS C, V100, P353; Naitoh T, 1996, NATURE, V380, P30, DOI 10.1038/380030b0; NAITOH T, 1989, PHYSIOL ZOOL, V62, P819, DOI 10.1086/physzool.62.3.30157929; Wake M. H, 1979, HYMANS COMP VERTEBRA, VThird	10	25	27	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					566	566		10.1038/35007149	http://dx.doi.org/10.1038/35007149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766231	Bronze			2022-12-01	WOS:000086400100042
J	Hayashi, Y; Shi, SH; Esteban, JA; Piccini, A; Poncer, JC; Malinow, R				Hayashi, Y; Shi, SH; Esteban, JA; Piccini, A; Poncer, JC; Malinow, R			Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction	SCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; IN-VIVO; CALMODULIN; NEURONS; PHOSPHORYLATION; MECHANISMS; COMPONENT	To elucidate mechanisms that control and execute activity-dependent synaptic plasticity, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPA-Rs) with an electrophysiological tag were expressed in rat hippocampal neurons. Long-term potentiation (LTP) or increased activity of the calcium/calmodulin-dependent protein kinase II (CaMKII) induced delivery of tagged AMPA-Rs into synapses. This effect was not diminished by mutating the CaMKII phosphorylation site on the GLuR1 AMPA-R subunit, but was blocked by mutating a predicted PDZ domain interaction site. These results show that LTP and CaMKII activity drive AMPA-Rs to synapses by a mechanism that requires the association between GluR1 and a PDZ domain protein.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Esteban, Jose/L-4944-2014; Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019; Poncer, Jean Christophe/R-6362-2016	Esteban, Jose/0000-0002-3759-3300; Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Poncer, Jean Christophe/0000-0001-5729-3009				Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BARRIA A, 1998, THESIS VOLLUM I PORT; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; HAYASHI Y, UNPUB; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MALINOW R, 1999, IMAGING LIVING CELLS; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Saras J, 1997, J BIOL CHEM, V272, P20979, DOI 10.1074/jbc.272.34.20979; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wyszynski M, 1999, Methods Enzymol, V294, P371	40	1164	1202	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2262	2267		10.1126/science.287.5461.2262	http://dx.doi.org/10.1126/science.287.5461.2262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731148				2022-12-01	WOS:000086049100051
J	Filatov, DA; Moneger, F; Negrutiu, I; Charlesworth, D				Filatov, DA; Moneger, F; Negrutiu, I; Charlesworth, D			Low variability in a Y-linked plant gene and its implications for Y-chromosome evolution	NATURE			English	Article							SEX-DETERMINING LOCUS; DIOECIOUS PLANT; MELANDRIUM-ALBUM; DNA-SEQUENCES; POLYMORPHISM; HITCHHIKING; HYPOTHESIS; MICE; SRY	Sex chromosomes have evolved independently in several different groups of organisms, but they share common features, including genetic degeneration of the Y chromosome(1,2). Suppression of recombination between ancestral proto-X and proto-Y chromosomes is thought to have led to their gradual divergence, and to degeneration of the Y chromosome(2), but the evolutionary forces responsible are unknown. In non-recombining Y chromosomes, deleterious mutations may be carried to fixation by linked advantageous mutations ("selective sweeps")(3). Occurrence of deleterious mutations may drive "Muller's ratchet" (stochastic loss of chromosomes with the fewest mutations)(2,4). Selective elimination of deleterious mutations, causing "background selection"(5,6) may accelerate stochastic fixation of mildly detrimental mutations(2). All these processes lower effective population sizes, and therefore reduce variability of genes in evolving Y chromosomes. We have studied DNA diversity and divergence in a recently described X- and Y-linked gene pair(7) (SLX-1 and SLY-1) of the plant Silene latifolia to obtain evidence about the early stages of Y degeneration. Here we show that DNA polymorphism in SLY-1 is 20-fold lower than in SLX-1, but the pattern of polymorphism does not suggest a selective sweep.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Ecole Normale Super Lyon, ENS Lyon 1, INRA, CNRS,UMR 5667, F-69364 Lyon, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Charlesworth, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Deborah.Charlesworth@ed.ac.uk	Charlesworth, Deborah/F-3071-2011	Filatov, Dmitry/0000-0001-8077-5452; Moneger, Francoise/0000-0003-2107-5696				Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; BULL JJ, 1993, EVOLUTION SEX DETERM; Burrows W, 1997, NATURE, V385, P125, DOI 10.1038/385125a0; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Delichere C, 1999, EMBO J, V18, P4169, DOI 10.1093/emboj/18.15.4169; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Filatov DA, 1999, GENETICS, V153, P1423; FU YX, 1993, GENETICS, V133, P693; Gaut BS, 1998, EVOL BIOL, V30, P93; GRANT S, 1994, DEV GENET, V15, P214, DOI 10.1002/dvg.1020150304; Guttman DS, 1998, NATURE, V393, P263, DOI 10.1038/30492; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; KUMAR S, 1993, MEGA MOL EVOLUTION G; LUNDRIGAN BL, 1994, MOL BIOL EVOL, V11, P483; MANNING JT, 1984, ACTA BIOTHEOR, V33, P219, DOI 10.1007/BF00048429; McAllister BF, 1999, GENETICS, V153, P221; NACHMAN MW, 1994, MOL BIOL EVOL, V11, P539; Nei M., 1987, MOL EVOLUTIONARY GEN; Orr HA, 1998, GENETICS, V150, P1693; RICE WR, 1987, GENETICS, V116, P161; TAJIMA F, 1989, GENETICS, V123, P585; VAGERA J, 1994, ANN BOT-LONDON, V73, P455, DOI 10.1006/anbo.1994.1056; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; YE D, 1990, SEX PLANT REPROD, V3, P179, DOI 10.1007/BF00205227; Zurovcova M, 1999, GENETICS, V153, P1709	30	147	151	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					388	390		10.1038/35006057	http://dx.doi.org/10.1038/35006057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746725				2022-12-01	WOS:000086119000050
J	Lewis, KA; Gray, PC; Blount, AL; MacConnell, LA; Wiater, E; Bilezikjian, LM; Vale, W				Lewis, KA; Gray, PC; Blount, AL; MacConnell, LA; Wiater, E; Bilezikjian, LM; Vale, W			Betaglycan binds inhibin and can mediate functional antagonism of activin signalling	NATURE			English	Article							RECEPTOR COMPLEX; CLONING; KINASE; GROWTH	Activins and inhibins(1), structurally related members of the TGF-beta superfamily of growth and differentiation factors(2), are mutually antagonistic regulators of reproductive and other functions(1,3). Activins bind specific type II receptor serine kinases (ActRII or IIB)(4-6) to promote the recruitment and phosphorylation of the type I receptor serine kinase, ALK4 (refs 7-9), which then regulates gene expression by activating Smad proteins(2). Inhibins also bind type II activin receptors but do not recruit ALK4, providing a competitive model for the antagonism of activin by inhibing(9-11). Inhibins fail to antagonize activin in some tissues and cells, however, suggesting that additional components are required for inhibin action(9,12,13). Here we show that the type III TGF-beta receptor, betaglycan(14,15), can function as an inhibin coreceptor with ActRII. Betaglycan binds inhibin with high affinity and enhances binding in cells co-expressing ActRII and betaglycan. Inhibin also forms crosslinked complexes with both recombinant and endogenously expressed betaglycan and ActRII. Finally, betaglycan confers inhibin sensitivity to cell lines that otherwise respond poorly to this hormone. The ability of betaglycan to facilitate inhibin antagonism of activin provides a variation on the emerging roles of proteoglycans as co-receptors modulating ligand-receptor sensitivity, selectivity and function(16-19).	Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Vale, W (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vale@salk.edu			PHS HHS [13527] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Draper LB, 1998, J BIOL CHEM, V273, P398, DOI 10.1074/jbc.273.1.398; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; Martens JWM, 1997, ENDOCRINOLOGY, V138, P2928, DOI 10.1210/en.138.7.2928; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; MATZUK MM, 1996, RECENT PROG HORM RES, V51, P155; VALE W, 1988, RECENT PROG HORM RES, V44, P1; XU JM, 1995, J BIOL CHEM, V270, P6308, DOI 10.1074/jbc.270.11.6308	13	464	486	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					411	414		10.1038/35006129	http://dx.doi.org/10.1038/35006129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746731				2022-12-01	WOS:000086119000056
J	Rademann, J; Jung, G				Rademann, J; Jung, G			Drug discovery - Integrating combinatorial synthesis and bioassays	SCIENCE			English	Article							LIBRARY; SPECIFICITY; CRUZIPAIN; ASSAY		Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Rademann, J (corresponding author), Univ Tubingen, Inst Organ Chem, Morgenstelle 18, D-72076 Tubingen, Germany.		Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165				Bianco A, 1998, J PEPT SCI, V4, P471, DOI 10.1002/(SICI)1099-1387(199812)4:8<471::AID-PSC166>3.0.CO;2-8; BUCHARDT J, 1999, 16 AM PEPT S MINN MN; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; Fleckenstein B, 1999, SEMIN IMMUNOL, V11, P405, DOI 10.1006/smim.1999.0198; FLECKENSTEIN B, 1999, COMBINATORIAL CHEM S, P355; FRANK R, 1996, PEPTIDE NONPEPTIDE L; Hemmer B, 1999, NAT MED, V5, P1375; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Jung G., 1999, COMBINATORIAL CHEM S; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lebl M, 1999, J COMB CHEM, V1, P3, DOI 10.1021/cc9800327; Leipert D, 1999, ANAL CHIM ACTA, V392, P213, DOI 10.1016/S0003-2670(99)00178-6; Leipert D, 1998, ANGEW CHEM INT EDIT, V37, P3308, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3308::AID-ANIE3308>3.0.CO;2-#; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Meldal M, 1998, J PEPT SCI, V4, P83, DOI 10.1002/(SICI)1099-1387(199804)4:2<83::AID-PSC124>3.0.CO;2-Z; MELDAL M, 1994, P NATL ACAD SCI USA, V91, P3314, DOI 10.1073/pnas.91.8.3314; MELDAL M, 1992, TETRAHEDRON LETT, V33, P3077, DOI 10.1016/S0040-4039(00)79604-3; Piehler J, 1996, ANAL CHEM, V68, P139, DOI 10.1021/ac9504878; Rademann J, 1999, J AM CHEM SOC, V121, P5459, DOI 10.1021/ja984355i; Rothmund M, 1997, FRESEN J ANAL CHEM, V359, P15, DOI 10.1007/s002160050529; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Walk TB, 1999, ANGEW CHEM INT EDIT, V38, P1763, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1763::AID-ANIE1763>3.0.CO;2-#	22	37	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1947	1948		10.1126/science.287.5460.1947	http://dx.doi.org/10.1126/science.287.5460.1947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755947				2022-12-01	WOS:000085902800036
J	Poulin, EC; Schlachta, CM; Mamazza, J				Poulin, EC; Schlachta, CM; Mamazza, J			Early laparoscopy to help diagnose acute non-specific abdominal pain	LANCET			English	Editorial Material							ACUTE ABDOMEN		Univ Toronto, St Michaels Hosp, Ctr Minimally Invas Surg, Toronto, ON M46 1J3, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Poulin, EC (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Minimally Invas Surg, Toronto, ON M46 1J3, Canada.							ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; Allemann F, 1999, EUR J SURG, V165, P966; Decadt B, 1999, BRIT J SURG, V86, P1383, DOI 10.1046/j.1365-2168.1999.01239.x; Gupta H, 1997, SURG CLIN N AM, V77, P1245, DOI 10.1016/S0039-6109(05)70616-2; Hawthorn I E, 1992, J R Coll Surg Edinb, V37, P389; IRVIN TT, 1989, BRIT J SURG, V76, P1121, DOI 10.1002/bjs.1800761105; RAHEJA SK, 1990, J ROY SOC MED, V88, P10; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Salky BA, 1998, SURG ENDOSC-ULTRAS, V12, P911, DOI 10.1007/s004649900744; VIPOND MN, 1990, BRIT J SURG, V77, P86, DOI 10.1002/bjs.1800770130	10	22	24	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					861	863		10.1016/S0140-6736(99)00432-8	http://dx.doi.org/10.1016/S0140-6736(99)00432-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752698				2022-12-01	WOS:000085896000004
J	Nuorti, JP; Butler, JC; Farley, MM; Harrison, LH; McGeer, A; Kolczak, MS; Breiman, RF				Nuorti, JP; Butler, JC; Farley, MM; Harrison, LH; McGeer, A; Kolczak, MS; Breiman, RF		Active Bacterial Core Surveillance	Cigarette smoking and invasive pneumococcal disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIBIOTIC-RESISTANT PNEUMOCOCCI; LOS-ANGELES-COUNTY; RISK-FACTORS; STREPTOCOCCUS-PNEUMONIAE; MENINGOCOCCAL DISEASE; NASOPHARYNGEAL COLONIZATION; POLYSACCHARIDE VACCINE; RESPIRATORY-TRACT; EPITHELIAL-CELLS	Background: Approximately half of otherwise healthy adults with invasive pneumococcal disease are cigarette smokers. We conducted a population-based case-control study to assess the importance of cigarette smoking and other factors as risk factors for pneumococcal infections. Methods: We identified immunocompetent patients who were 18 to 64 years old and who had invasive pneumococcal disease (as defined by the isolation of Streptococcus pneumoniae from a normally sterile site) by active surveillance of laboratories in metropolitan Atlanta, Baltimore, and Toronto. Telephone interviews were conducted with 228 patients and 301 control subjects who were reached by random-digit dialing. Results: Fifty-eight percent of the patients and 24 percent of the control subjects were current smokers. Invasive pneumococcal disease was associated with cigarette smoking (odds ratio, 4.1; 95 percent confidence interval, 2.4 to 7.3) and with passive smoking among nonsmokers (odds ratio, 2.5; 95 percent confidence interval, 1.2 to 5.1) after adjustment by logistic-regression analysis for age, study site, and independent risk factors such as male sex, black race, chronic illness, low level of education, and living with young children who were in day care. There were dose-response relations for the current number of cigarettes smoked per day, pack-years of smoking, and time since quitting. The adjusted population attributable risk was 51 percent for cigarette smoking, 17 percent for passive smoking, and 14 percent for chronic illness. Conclusions: Cigarette smoking is the strongest independent risk factor for invasive pneumococcal disease among immunocompetent, nonelderly adults. Because of the high prevalence of smoking and the large population attributable risk, programs to reduce both smoking and exposure to environmental tobacco smoke have the potential to reduce the incidence of pneumococcal disease. (N Engl J Med 2000;342:681-9.) (C)2000, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Butler, JC (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	jcb3@cdc.gov	McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137				*ACP TASK FORC AD, 1994, INF DIS SOC AM GUID, P107; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; *BEH RISK FACT SUR, 1997, MMWR SURVEILL SUMM, V46, P1; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BURMAN LA, 1985, REV INFECT DIS, V7, P133; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; Dagan R, 1996, J INFECT DIS, V174, P1352, DOI 10.1093/infdis/174.6.1352; DYE JA, 1994, THORAX, V49, P825, DOI 10.1136/thx.49.8.825; ESCOBEDO LG, 1995, J NATL CANCER I, V87, P1552, DOI 10.1093/jnci/87.20.1552; FAINSTEIN V, 1979, INFECT IMMUN, V26, P178, DOI 10.1128/IAI.26.1.178-182.1979; FINKLEA JF, 1969, AM J EPIDEMIOL, V90, P390, DOI 10.1093/oxfordjournals.aje.a121084; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; GREEN GM, 1967, NEW ENGL J MED, V276, P421, DOI 10.1056/NEJM196702232760801; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; HENDERSON FW, 1988, J INFECT DIS, V157, P256, DOI 10.1093/infdis/157.2.256; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; JANOFF EN, 1993, J INFECT DIS, V167, P49, DOI 10.1093/infdis/167.1.49; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kim PE, 1996, CLIN INFECT DIS, V22, P100, DOI 10.1093/clinids/22.1.100; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P320; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; LIPSKY BA, 1986, ARCH INTERN MED, V146, P2179, DOI 10.1001/archinte.146.11.2179; Margolis PA, 1997, PEDIATR PULM, V23, P417, DOI 10.1002/(SICI)1099-0496(199706)23:6<417::AID-PPUL4>3.0.CO;2-F; MILI F, 1991, CLIN IMMUNOL IMMUNOP, V59, P187, DOI 10.1016/0090-1229(91)90017-5; Musher DM, 1997, CLIN INFECT DIS, V24, P441, DOI 10.1093/clinids/24.3.441; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; ODempsey TJD, 1996, INT J EPIDEMIOL, V25, P885, DOI 10.1093/ije/25.4.885; OLSON SH, 1992, AM J EPIDEMIOL, V135, P210, DOI 10.1093/oxfordjournals.aje.a116273; Pastor P, 1998, CLIN INFECT DIS, V26, P590, DOI 10.1086/514589; *PHS, 1991, DHHS PUBL; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Plouffe JF, 1996, JAMA-J AM MED ASSOC, V275, P194, DOI 10.1001/jama.275.3.194; RAMAN AS, 1983, CHEST, V83, P23, DOI 10.1378/chest.83.1.23; RodriguezBarradas MC, 1997, J INFECT DIS, V175, P590, DOI 10.1093/infdis/175.3.590; Sankilampi U, 1997, INT J EPIDEMIOL, V26, P420, DOI 10.1093/ije/26.2.420; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P181; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; Straus WL, 1996, ARCH INTERN MED, V156, P1685, DOI 10.1001/archinte.156.15.1685; STUART JM, 1988, COMMUNITY MED, V10, P139; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; TAKALA AK, 1995, JAMA-J AM MED ASSOC, V273, P859, DOI 10.1001/jama.273.11.859; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; THOMAS JC, 1991, AM J EPIDEMIOL, V133, P286, DOI 10.1093/oxfordjournals.aje.a115873; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Zhu BP, 1997, AM J PUBLIC HEALTH, V87, P168; Zhu BP, 1996, AM J PUBLIC HEALTH, V86, P1582, DOI 10.2105/AJPH.86.11.1582; 1993, MMWR MORB MORTAL WKL, V42, P645; 1997, MMWR MORB MORTAL WKL, V46, P1217	58	557	577	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					681	689		10.1056/NEJM200003093421002	http://dx.doi.org/10.1056/NEJM200003093421002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706897				2022-12-01	WOS:000085708800002
J	Coulehan, J				Coulehan, J			Attention must be paid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					976	976		10.1001/jama.283.8.976	http://dx.doi.org/10.1001/jama.283.8.976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697044				2022-12-01	WOS:000085308600001
J	Sanders, J; Milne, S; Brown, P; Bell, AJ				Sanders, J; Milne, S; Brown, P; Bell, AJ			Assessment of aggression in psychiatric admissions: semistructured interview and case note survey	BRITISH MEDICAL JOURNAL			English	Article							RISK		St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England		Milne, S (corresponding author), St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England.							APPLEBY L, 1988, MED SCI LAW, V28, P291, DOI 10.1177/002580248802800405; Ferris LE, 1997, CAN J PSYCHIAT, V42, P1051, DOI 10.1177/070674379704201006; Reed J, 1997, BRIT J PSYCHIAT, V170, P4, DOI 10.1192/S0007125000298644; YRNE P, 1998, PSYCHIAT B, V22, P174	4	25	25	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 22	2000	320	7242					1112	1112		10.1136/bmj.320.7242.1112	http://dx.doi.org/10.1136/bmj.320.7242.1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	309RJ	10775220	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000086782800017
J	Naslund, J; Haroutunian, V; Mohs, R; Davis, KL; Davies, P; Greengard, P; Buxbaum, JD				Naslund, J; Haroutunian, V; Mohs, R; Davis, KL; Davies, P; Greengard, P; Buxbaum, JD			Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; SENILE PLAQUES; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; REGIONAL DISTRIBUTION; DEMENTIA SEVERITY; A-BETA-42(43); MECHANISMS; DEPOSITION; DURATION	Context Alzheimer disease (AD) is characterized neuropathologically by the presence of amyloid beta-peptide (A beta)-containing plaques and neurofibrillary tangles composed of abnormal tau protein. Considerable controversy exists as to whether the extent of accumulation of A beta correlates with dementia and whether A beta alterations precede or follow changes in tau. Objectives To determine whether accumulation of A beta correlates with the earliest signs of cognitive deterioration and to define the relationship between A beta accumulation and early tau changes, Design, Setting, and Patients Postmortem cross-sectional study of 79 nursing home residents with Clinical Dementia Rating (CDR) scale scores of 0.0 to 5.0 who died between 1986 and 1997, comparing the levels of A beta variants in the cortices of the subjects with no (CDR score, 0.0 [n = 16]), questionable (CDR score, 0.5 [n = 11]), mild (CDR score, 1.0 [n = 22]), moderate (CDR score, 2.0 [n = 15]), or severe (CDR score, 4.0 or 5.0 [n = 15]) dementia. Main Outcome Measures Levels of total A beta peptides with intact or truncated amino termini and ending in either amino acid 40 (A beta x-40) or 42 (A beta x-42) in 5 neocortical brain regions as well as levels of tau protein undergoing early conformational changes in frontal cortex, as a function of CDR score. Results The levels of both A beta x-40 and A beta x-42 were elevated even in cases classified as having questionable dementia (CDR score = 0.5), and increases of both peptides correlated with progression of dementia, Levels of the more fibril-prone A beta x-42 peptide were higher than those of A beta x-40 in nondemented cases and remained higher throughout progression of disease in all regions examined. Finally, increases in A beta x-40 and A beta x-42 precede significant tau pathology at least in the frontal cortex, an area chosen for examination because of the absence of neuritic changes in the absence of disease. Conclusions In this study, levels of total A beta x-40 and A beta x-42 were elevated early in dementia and levels of both peptides were strongly correlated with cognitive decline. Of particular interest, in the frontal cortex, A beta was elevated before the occurrence of significant tau pathology, These results support an important role for A beta in mediating initial pathogenic events in AD dementia and suggest that treatment strategies targeting the formation, accumulation, or cytotoxic effects of A beta should be pursued.	CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Buxbaum, JD (corresponding author), CUNY Mt Sinai Sch Med, Dept Psychiat, Box 1230,1 Gustave L Levy Pl, New York, NY 10029 USA.		Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	NATIONAL INSTITUTE ON AGING [R55AG014996, R01AG014996, P01AG002219] Funding Source: NIH RePORTER; NIA NIH HHS [AG02219, AG05138, AG14996] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AISEN PS, 1994, AM J PSYCHIAT, V151, P1105; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BIERER LM, 1995, J NEUROCHEM, V64, P749; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Davis JN, 1997, TRENDS NEUROSCI, V20, P558; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Desdouits F, 1996, J BIOL CHEM, V271, P24670, DOI 10.1074/jbc.271.40.24670; GIANNAKOPOULOS P, 1995, ARCH NEUROL-CHICAGO, V52, P1150, DOI 10.1001/archneur.1995.00540360028012; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; HEYMAN A, 1987, NEUROLOGY, V37, P980, DOI 10.1212/WNL.37.6.980; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kanne SM, 1998, NEUROLOGY, V50, P979, DOI 10.1212/WNL.50.4.979; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MYERS JL, 1973, FUNDAMENTS EXPT DESI; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Tamaoka A, 1998, MOL BRAIN RES, V56, P178, DOI 10.1016/S0169-328X(98)00044-8; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	29	1024	1082	1	86	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1571	1577		10.1001/jama.283.12.1571	http://dx.doi.org/10.1001/jama.283.12.1571			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735393				2022-12-01	WOS:000085857300033
J	Post, JC; Ehrlich, GD				Post, JC; Ehrlich, GD			The impact of the polymerase chain reaction in clinical medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENZYMATIC AMPLIFICATION; OTITIS-MEDIA; DNA; PATHOGENS; SEQUENCES; DIAGNOSIS; EFFUSION; DISEASE; BLOOD; CELLS		Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; Allegheny Gen Hosp, Dept Surg, Pittsburgh, PA 15212 USA; MCP Hahnemann Univ, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; MCP Hahnemann Univ, Sch Med, Dept Human Genet, Pittsburgh, PA USA	Allegheny General Hospital; Allegheny General Hospital; Drexel University; Drexel University	Ehrlich, GD (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Room 1030,320 E North Ave, Pittsburgh, PA 15212 USA.	gehrlich@pgh.auhs.edu		Ehrlich, Garth/0000-0003-1140-6594	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002398, R01DC002398] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02398, DC01248] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABBOTT MA, 1988, J INFECT DIS, V158, P1158, DOI 10.1093/infdis/158.6.1158; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Ehrlich GD, 1994, PCR BASED DIAGNOSTIC; FOO I, 1992, BIOTECHNIQUES, V12, P811; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; HOEFFEL DP, 1999, CLIN ORTHOP RELAT R, V360, P37; KWOK S, 1988, BLOOD, V72, P1117; KWOK S, 1988, J INFECT DIS, V158, P1193, DOI 10.1093/infdis/158.6.1193; KWOK S, 1988, HIV DETECTION GENETI, P243; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P1363, DOI 10.1001/jama.270.11.1363; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Post JC, 1996, AM J OTOLARYNG, V17, P106, DOI 10.1016/S0196-0709(96)90005-8; Rayner MG, 1998, JAMA-J AM MED ASSOC, V279, P296, DOI 10.1001/jama.279.4.296; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; ROMERO JR, 1994, PCR BASED DIAGNOSTIC, P341; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sidransky D, 1997, SCIENCE, V278, P1054, DOI 10.1126/science.278.5340.1054; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; WEGEL JG, 1994, J FORENSIC SCI, V39, P844; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	25	19	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1544	1546		10.1001/jama.283.12.1544	http://dx.doi.org/10.1001/jama.283.12.1544			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735373				2022-12-01	WOS:000085857300001
J	Bates, DW				Bates, DW			Using information technology to reduce rates of medication errors in hospitals	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; SYSTEM; PREVENTION		Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.		Bates, David/AAE-7283-2019					Allan E L, 1995, Am Pharm, VNS35, P25; BARKER KN, 1984, AM J HOSP PHARM, V41, P1352, DOI 10.1093/ajhp/41.7.1352; BARKER KN, 1995, AM J HEALTH-SYST PH, V52, P2445, DOI 10.1093/ajhp/52.21.2445; BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BOREL JM, 1995, AM J HEALTH-SYST PH, V52, P1875, DOI 10.1093/ajhp/52.17.1875; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CHESTER MIS, 1989, AM J HOSP PHARM, V46, P1380, DOI 10.1093/ajhp/46.7.1380; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; CULLEN DJ, 1995, JOINT COMM J QUAL IM, V21, P541, DOI 10.1016/S1070-3241(16)30180-8; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; *MA HOSP ASS B, 1999, MASS HOSP ASS B 0303; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Sheridan T.B., 2018, HUMAN ERROR MED, P141	21	243	255	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					788	791		10.1136/bmj.320.7237.788	http://dx.doi.org/10.1136/bmj.320.7237.788			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720369	Green Published			2022-12-01	WOS:000086054700034
J	Ketting, RF; Plasterk, RHA				Ketting, RF; Plasterk, RHA			A genetic link between co-suppression and RNA interference in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; TRANSGENIC PLANTS; EXPRESSION; PETUNIA; METHYLATION; GLD-1; VIRUS; DNA	Originally discovered in plants(1,2), the phenomenon of co-suppression by transgenic DNA has since been observed in many organisms from fungi(3) to animals(4-7): introduction of transgenic copies of a gene results in reduced expression of the transgene as well as the endogenous gene. The effect depends on sequence identity between transgene and endogenous gene. Some cases of cosuppression resemble RNA interference (the experimental silencing of genes by the introduction of double-stranded RNA)(8), as RNA seems to be both an important initiator and a target in these processes(9-13). Here we show that co-suppression in Caenorhabditis elegans is also probably mediated by RNA molecules. Both RNA interference(14,15) and co-suppression(16) have been implicated in the silencing of transposons. We now report that mutants of C. elegans that are defective in transposon silencing and RNA interference (mut-2, mut-7, mut-8 and mut-9) are in addition resistant to co-suppression. This indicates that RNA interference and co-suppression in C. elegans may be mediated at least in part by the same molecular machinery, possibly through RNA-guided degradation of messenger RNA molecules.	Netherlands Canc Inst, Div Mol Biol, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Plasterk, RHA (corresponding author), Ctr Biomed Genet, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.know.nl		Ketting, Rene/0000-0001-6161-5621				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Baulcombe DC, 1996, CURR OPIN BIOTECH, V7, P173, DOI 10.1016/S0958-1669(96)80009-7; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRANCIS R, 1995, GENETICS, V139, P579; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; INGELBRECHT I, 1994, P NATL ACAD SCI USA, V91, P10502, DOI 10.1073/pnas.91.22.10502; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; Jorgensen RA, 1999, TRENDS GENET, V15, P11, DOI 10.1016/S0168-9525(98)01651-5; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mette MF, 1999, EMBO J, V18, P241, DOI 10.1093/emboj/18.1.241; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; MORI I, 1988, GENETICS, V120, P397; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	30	163	199	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					296	298		10.1038/35005113	http://dx.doi.org/10.1038/35005113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749214				2022-12-01	WOS:000086022200052
J	Frank, C; Mohamed, MK; Strickland, GT; Lavanchy, D; Arthur, RR; Magder, LS; El Khoby, T; Abdel-Wahab, Y; Ohn, EA; Anwar, W; Sallam, I				Frank, C; Mohamed, MK; Strickland, GT; Lavanchy, D; Arthur, RR; Magder, LS; El Khoby, T; Abdel-Wahab, Y; Ohn, EA; Anwar, W; Sallam, I			The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt	LANCET			English	Article							HIGH SEROPREVALENCE; BLOOD-DONORS; B INFECTION; SCHISTOSOMIASIS; PREVALENCE; GENOTYPES; REGIONS	Background The population of Egypt has a heavy burden of liver disease, mostly due to chronic infection with hepatitis C virus (HCV). Overall prevalence of antibody to HCV in the general population is around 15-20%. The risk factor for HCV transmission that specifically sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy (PAT). A review of the Egyptian PAT mass-treatment campaigns, discontinued only in the 1980s, show a very high potential for transmission of blood-borne pathogens. We examine the relative importance of PAT in the spread of HCV in Egypt. Methods The degree of exposure to PAT by cohort was estimated from 1961-86 Ministry of Health data. A cohort-specific exposure index for PAT was calculated and compared with cohort-specific HCV prevalence rates in four regions. Findings HCV prevalence was calculated for 8499 Egyptians aged 10-50 years. A significant association between seroprevalence of antibodies to HCV and the exposure index (1.31 [95% CI 1.08-1.59]; p=0.007) was identified across four different regions. In all regions cohort-specific HCV prevalence was lowest in children and young adults than in older cohorts. These lower prevalence rates coincided with the gradual and final replacement of PAT with oral antischistosomal drugs at different points in time in the four regions. Interpretation The data suggest that PAT had a major role in the spread of HCV throughout Egypt. This intensive transmission established a large reservoir of chronic HCV infection, responsible for the high prevalence of HCV infection and current high rates of transmission. Egypt's mass campaigns of PAT may represent the world's largest iatrogenic transmission of blood-borne pathogens.	Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Ain Shams Univ, Fac Med, Dept Community Environm & Occupat Med, Cairo, Egypt; WHO, Div Communicable Dis Surveillance & Response, CH-1211 Geneva, Switzerland; Egyptian Minist Hlth & Populat, Cairo, Egypt	University System of Maryland; University of Maryland Baltimore; Egyptian Knowledge Bank (EKB); Ain Shams University; World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt	Strickland, GT (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA.		mohamed, mostafa/AFE-7371-2022	mohamed, mostafa/0000-0002-1421-2667; Frank, Christina/0000-0001-6776-8450				ABDALLAH A, 1972, SCHISTOWP7241 WHO; ABDELWAHAB MF, 1994, AM J TROP MED HYG, V51, P563, DOI 10.4269/ajtmh.1994.51.563; Arthur R. R., 1997, T R SOC TROP MED HYG, V91, P121; *CENTR AG PUBL MOB, 1993, AR REP EG STAT YB 19; DARWISH MA, 1993, AM J TROP MED HYG, V49, P440, DOI 10.4269/ajtmh.1993.49.440; Darwish MA, 1996, AM J TROP MED HYG, V54, P554, DOI 10.4269/ajtmh.1996.54.554; Davis A., 1993, Human schistosomiasis., P367; DEELDER AM, 1990, LANCET, V335, P724, DOI 10.1016/0140-6736(90)90838-V; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; ELGOHARY A, 1995, ACTA TROP, V59, P155, DOI 10.1016/0001-706X(95)00075-P; ELKHOBY T, IN PRESS AM J TROP M; ElSayed HF, 1997, ACTA TROP, V68, P229, DOI 10.1016/S0001-706X(97)00097-1; ElSayed NM, 1996, AM J TROP MED HYG, V55, P179, DOI 10.4269/ajtmh.1996.55.179; FARGHALY AG, 1993, EGYPT PUBL HLTH ASS, V68, P63; GHAFFAR YA, 1991, AM J TROP MED HYG, V45, P743, DOI 10.4269/ajtmh.1991.45.743; HYAMS KC, 1987, J MED VIROL, V23, P109, DOI 10.1002/jmv.1890230203; MADWAR MA, 1989, T ROY SOC TROP MED H, V83, P233, DOI 10.1016/0035-9203(89)90657-3; MAEGRAITH BG, 1964, TREATMENT BILHARZIAS; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; MOHAMED MK, 1996, EGYPT PUBL HLTH ASS, V71, P79; MOHAMED MK, 1996, EGYPT PUBL HLTH ASS, V71, P113; Quinti I, 1995, ZBL BAKT-INT J MED M, V283, P239; Quinti I, 1997, DIGEST DIS SCI, V42, P2017, DOI 10.1023/A:1018897813268; SHERIF MM, 1985, J MED VIROL, V15, P129, DOI 10.1002/jmv.1890150205; World Health Organization, 1993, WHO TECHN REP SER	26	745	768	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					887	891		10.1016/S0140-6736(99)06527-7	http://dx.doi.org/10.1016/S0140-6736(99)06527-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752705				2022-12-01	WOS:000085896000011
J	Hicks, D				Hicks, D			Is there a case for school-based screening for sexually transmitted diseases?	LANCET			English	Editorial Material									Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Hicks, D (corresponding author), Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England.							Cohen DA, 1999, PEDIATRICS, V104, P1281, DOI 10.1542/peds.104.6.1281; GARLICK R, 1993, PUBLIC HEALTH, V107, P135, DOI 10.1016/S0033-3506(05)80411-1; Lacey CJN, 1997, BRIT MED J, V314, P1715, DOI 10.1136/bmj.314.7096.1715; *OFF NAT STAT, 1999, AB STAT 1998; *SOC EXCL UN, 1999, CN4342 SOC EXCL UN	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					864	864		10.1016/S0140-6736(00)90030-8	http://dx.doi.org/10.1016/S0140-6736(00)90030-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294DM	10752700				2022-12-01	WOS:000085896000006
J	Raoult, D; Birg, ML; La Scola, B; Fournier, PE; Enea, M; Lepidi, H; Roux, V; Piette, JC; Vandenesch, F; Vital-Durand, D; Marrie, TJ				Raoult, D; Birg, ML; La Scola, B; Fournier, PE; Enea, M; Lepidi, H; Roux, V; Piette, JC; Vandenesch, F; Vital-Durand, D; Marrie, TJ			Cultivation of the bacillus of Whipple's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSIS; PATIENT; FEVER; BLOOD	Background: Whipple's disease is a systemic bacterial infection, but to date no isolate of the bacterium has been established in subculture, and no strain of this bacterium has been available for study. Methods: Using specimens from the mitral valve of a patient with endocarditis due to Whipple's disease, we isolated and propagated a bacterium by inoculation in a human fibroblast cell line (HEL) with the use of a shell-vial assay. We tested serum samples from our patient, other patients with Whipple's disease, and control subjects for the presence of antibodies to this bacterium. Results: The bacterium of Whipple's disease was grown successfully in HEL cells, and we established subcultures of the isolate. Indirect immunofluorescence assays showed that the patient's serum reacted specifically against the bacterium. Seven of 9 serum samples from patients with Whipple's disease had IgM antibody titers of 1:50 or more, as compared with 3 of 40 samples from the control subjects (P<0.001). Polyclonal antibodies against the bacterium were generated by inoculation of the microorganism into mice and were used to detect bacteria in the excised cardiac tissue from our patient on immunohistochemical analysis. The 16S ribosomal RNA gene of the cultured bacterium was identical to the sequence for Tropheryma whippelii identified previously in tissue samples from patients with Whipple's disease. The strain we have grown is available in the French National Collection. Conclusions: We cultivated the bacterium of Whipple's disease, detected specific antibodies in tissue from the source patient, and generated specific antibodies in mice to be used in the immunodetection of the microorganism in tissues. The development of a serologic test for Whipple's disease may now be possible. (N Engl J Med 2000;342:620-5.) (C)2000, Massachusetts Medical Society.	Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRESA 6020, F-13385 Marseille, France; Univ Alberta, Dept Med, Edmonton, AB, Canada; Ctr Hosp Lyon Sud, Serv Med Interne, Lyon, France; Hop Louis Pradel, Bacteriol Lab, Lyon, France; Grp Hosp Pitie Salpetriere, Serv Med Interne, F-75634 Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; University of Alberta; CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS UPRESA 6020, 27 Blvd Jean Moulin, F-13385 Marseille, France.		LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; Fournier, Pierre-Edouard/AAC-6155-2021; Vandenesch, Francois/C-7209-2014	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885; Vandenesch, Francois/0000-0001-9412-7106				BLACKSCHAFFER B, 1949, P SOC EXP BIOL MED, V72, P225; BOSTWICK DG, 1981, NEW ENGL J MED, V305, P995, DOI 10.1056/NEJM198110223051708; Celard M, 1999, CLIN INFECT DIS, V29, P1348, DOI 10.1086/313477; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Hinrikson HP, 1999, INT J SYST BACTERIOL, V49, P1701, DOI 10.1099/00207713-49-4-1701; La Scola B, 1998, J CLIN MICROBIOL, V36, P2847, DOI 10.1128/JCM.36.10.2847-2852.1998; La Scola B, 1999, J CLIN MICROBIOL, V37, P1899, DOI 10.1128/JCM.37.6.1899-1905.1999; La Scola B, 1999, J CLIN MICROBIOL, V37, P785, DOI 10.1128/JCM.37.3.785-787.1999; LaScola B, 1997, CLIN INFECT DIS, V24, P1161, DOI 10.1086/513631; LaScola B, 1996, J CLIN MICROBIOL, V34, P2722, DOI 10.1128/JCM.34.11.2722-2727.1996; MAIZEL H, 1970, MEDICINE, V49, P175, DOI 10.1097/00005792-197005000-00001; MARSHALL B, 1983, LANCET, V1, P1273; MURRAY RGE, 1994, INT J SYST BACTERIOL, V44, P174, DOI 10.1099/00207713-44-1-174; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; RATLIFF NB, 1984, NEW ENGL J MED, V311, P902, DOI 10.1056/NEJM198410043111407; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Relman DA, 1997, J INFECT DIS, V176, P752, DOI 10.1086/514100; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; ROSE AG, 1978, THORAX, V33, P500, DOI 10.1136/thx.33.4.500; Schoedon G, 1997, J INFECT DIS, V176, P672, DOI 10.1086/514089; SHEPARD CC, 1960, J EXP MED, V112, P445, DOI 10.1084/jem.112.3.445; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; VITALDURAND D, 1997, MEDICINE, V76, P170; WEISS E, 1960, P SOC EXP BIOL MED, V103, P691, DOI 10.3181/00379727-103-25637; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z; Woods GL, 1996, CLIN MICROBIOL REV, V9, P382, DOI 10.1128/CMR.9.3.382; YARDLEY JH, 1961, B JOHNS HOPKINS HOSP, V109, P80	29	300	316	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					620	625		10.1056/NEJM200003023420903	http://dx.doi.org/10.1056/NEJM200003023420903			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699161	Bronze			2022-12-01	WOS:000085575500003
J	Gavrilets, S				Gavrilets, S			Rapid evolution of reproductive barriers driven by sexual conflict	NATURE			English	Article							INTERSPECIFIC POLLEN COMPETITION; SELECTION; SPECIATION; REARRANGEMENTS; POLYMORPHISM; CHASE	A growing amount of experimental data indicates extremely rapid evolution of traits and proteins related to fertilization in many diverging taxa(1-3). These data come from studies of sperm or pollen competition between closely related species(3-6), and from molecular studies of fertilization proteins(2,7-10). The positive selection for evolutionary novelty that appears to be acting on fertilization systems seems paradoxical because successful reproduction requires the close matching of female and male traits. It has been suggested(11-13) that perpetual coevolution between the sexes can result from sexual conflict in mating. Sexual conflict occurs when characteristics that enhance the reproductive success of one sex reduce the fitness of the other sex(14). Numerous examples of sexual conflict resulting from sensory exploitation, polyspermy and the cost of mating have been discussed in detail(1-3,14,15). The potential for coevolution due to such conflict has been evaluated experimentally(15,16). Here I develop a simple mathematical model describing coevolutionary dynamics of male and female traits involved in reproduction. The model shows that continual change in such traits at a constant speed is expected whenever females (or eggs) experience fitness loss from having too many compatible males (or sperms). The plausibility of runaway coevolution increases with increasing population size. Rapid evolution of reproductive barriers driven by sexual conflict may explain increased speciation rates after colonization of new habitats ('adaptive radiation') and high species richness in resource-rich environments.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Tennessee, Dept Math, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Gavrilets, S (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	sergey@tiem.utk.edu	Langerhans, R. Brian/A-7205-2009					AGUADE M, 1992, GENETICS, V132, P755; ARNOLD ML, 1993, J HERED, V84, P13, DOI 10.1093/oxfordjournals.jhered.a111269; ARNQVIST G, UNPUB P R SOC LOND B; ARNQVIST G, UNPUB ANIM BEHAV; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; BARTON NH, 1991, GENETICS, V127, P229; BURGER R, 1995, EVOLUTION, V49, P151, DOI [10.2307/2410301, 10.1111/j.1558-5646.1995.tb05967.x]; Gavrilets S, 1997, J THEOR BIOL, V186, P527, DOI 10.1006/jtbi.1997.0426; Gavrilets S, 1999, AM NAT, V154, P1, DOI 10.1086/303217; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; GAVRILETS S, 1995, GENET RES, V65, P63, DOI 10.1017/S0016672300033012; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Howard DJ, 1998, ENDLESS FORMS, P279; IWASA Y, 1995, NATURE, V377, P420, DOI 10.1038/377420a0; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi SR, 1998, ENDLESS FORMS, P271; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; RIESEBERG LH, 1995, AM J BOT, V82, P515, DOI 10.2307/2445699; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schluter D, 1998, ENDLESS FORMS, P114; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Vacquier VD, 1993, ZYGOTE, V1, P181, DOI 10.1017/S0967199400001465; WADE MJ, 1994, HEREDITY, V72, P163, DOI 10.1038/hdy.1994.23; WALSH JB, 1982, AM NAT, V120, P510, DOI 10.1086/284008	30	414	429	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					886	889		10.1038/35002564	http://dx.doi.org/10.1038/35002564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706284				2022-12-01	WOS:000085559200055
J	Holmgren, M; Wagg, J; Bezanilla, F; Rakowski, RF; De Weer, P; Gadsby, DC				Holmgren, M; Wagg, J; Bezanilla, F; Rakowski, RF; De Weer, P; Gadsby, DC			Three distinct and sequential steps in the release of sodium ions by the Na+/K+-ATPase	NATURE			English	Article							VOLTAGE DEPENDENCE; NA,K PUMP; TRANSLOCATION; CHANNEL; NA,K-ATPASE; PATHWAY	The Na+/K+ pump, a P-type ion-motive ATPase, exports three sodium ions and then imports two potassium ions in each transport cycle. Ions on one side of the membrane bind to sites within the protein and become temporarily occluded (trapped within the protein) before being released to the other side(1,2), but details of these occlusion and de-occlusion transitions remain obscure for all P-type ATPases, If it is deprived of potassium ions, the Na+/K+ pump is restricted to sodium translocation steps(3), at least one involving charge movement through the membrane's electric field(4,5). Changes in membrane potential alter the rate of such electrogenic reactions and so shift the distribution of enzyme conformations. Here we use high-speed voltage jumps to initiate this redistribution and show that the resulting pre-steady-state charge movements relax in three identifiable phases, apparently reflecting de-occlusion and release of the three sodium ions. Reciprocal relationships among the sizes of these three charge components show that the three sodium ions are de-occluded and released to the extracellular solution one at a time, in a strict order.	Marine Biol Lab, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.							BEAUGE LA, 1979, NATURE, V280, P510, DOI 10.1038/280510a0; BEZANILLA F, 1982, NATURE, V296, P657, DOI 10.1038/296657a0; FENDLER K, 1985, EMBO J, V4, P3079, DOI 10.1002/j.1460-2075.1985.tb04048.x; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; Friedrich T, 1997, BIOPHYS J, V73, P186, DOI 10.1016/S0006-3495(97)78059-7; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; GARRAHAM PJ, 1967, J PHYSL, V192, P161; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; HILGEMANN DW, 1994, SCIENCE, V263, P1429, DOI 10.1126/science.8128223; INESI G, 1987, J BIOL CHEM, V262, P16338; LAIGER P, 1991, ELECTROGENIC ION PUM; LAUGER P, 1988, BIOCHIM BIOPHYS ACTA, V944, P451, DOI 10.1016/0005-2736(88)90516-0; LU CC, 1995, P NATL ACAD SCI USA, V92, P11220, DOI 10.1073/pnas.92.24.11220; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; POST RL, 1972, J BIOL CHEM, V247, P6350; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; WUDDEL I, 1995, BIOPHYS J, V69, P909, DOI 10.1016/S0006-3495(95)79965-9	17	136	138	5	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					898	901		10.1038/35002599	http://dx.doi.org/10.1038/35002599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706288				2022-12-01	WOS:000085559200059
J	Mullen, PE; Burgess, P; Wallace, C; Palmer, S; Ruschena, D				Mullen, PE; Burgess, P; Wallace, C; Palmer, S; Ruschena, D			Community care and criminal offending in schizophrenia	LANCET			English	Article							MENTAL DISORDER; VIOLENCE	Background The introduction of community care in psychiatry is widely thought to have resulted in more offending among the seriously mentally ill. This view affects public policy towards and public perceptions of such people. We investigated the association between the introduction of community care and the pattern of offending in patients with schizophrenia in Victoria, Australia. Methods We established patterns of offending from criminal records in two groups of patients with schizophrenia over their lifetime to date and in the 10 years after their first hospital admission. One group was first admitted in 1975 before major deinstitutionalisation in Victoria, the second group in 1985 when community care was becoming the norm. Each patient was matched to a control, by age, sex, and place of residence to allow for changing patterns of offending over time in the wider community. Findings Compared with controls, significantly more of those with schizophrenia were convicted at least once for ail categories of criminal offending except sexual offences (relative risk of offending in 1975=3.5 [95% CI 2.0-5.5), p=0.001, in 1985=3.0 [1.9-4.9], p=0.001). Among men, more offences were committed in the 1985 group than the 1975 group, but this was matched by a similar increase in convictions among the community controls. Those with schizophrenia who had also received treatment for substance abuse accounted for a disproportionate amount of offending. Analysis of admission data for the patients and the total population of admissions with schizophrenia showed that although there had been an increase of 74 days per annum spent in the community for each of the study population as a whole, first admissions spent only 1 more day in the community in 1985 compared with 1975. Interpretation Increased rates in criminal conviction for those with schizophrenia over the last 20 years are consistent with change in the pattern of offending in the general community. Deinstitutionalisation does not adequately explain such change. Mental-health services should aim to reduce the raised rates of criminal offending associated with schizophrenia, but turning the clock back on community care is unlikely to contribute towards any positive outcome.	Victorian Inst Forens Mental Hlth, Fairfield, Vic 3084, Australia; Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; Monash Univ, Dept Psychol Med, Clayton, Vic 3168, Australia	Monash University	Mullen, PE (corresponding author), Victorian Inst Forens Mental Hlth, Locked Bag 10, Fairfield, Vic 3084, Australia.	pmullen@vicnet.net.au	Burgess, Philip/ABD-3040-2020	Burgess, Philip/0000-0001-7184-0363				BURGESS PM, 1992, SOC PSYCH PSYCH EPID, V27, P83, DOI 10.1007/BF00788511; EATON WW, 1992, SCHIZOPHRENIA BULL, V18, P217, DOI 10.1093/schbul/18.2.217; HALL C, 1998, DAILY TELEGRAPH  FEB; *HLTH COMM SERV, 1993, VICT HLTH REF PSYCH; *HLTH COMM SERV, 1996, VICT MENT HLTH SERV; Krupinski J, 1982, SPECIAL PUBLICATION, V12; LINDQVIST P, 1990, BRIT J PSYCHIAT, V157, P345, DOI 10.1192/bjp.157.3.345; Modestin J, 1996, SCHIZOPHRENIA BULL, V22, P69, DOI 10.1093/schbul/22.1.69; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; TAYLOR PJ, 1984, BRIT MED J, V288, P1945, DOI 10.1136/bmj.288.6435.1945; Taylor PJ, 1999, BRIT J PSYCHIAT, V174, P9, DOI 10.1192/bjp.174.1.9; TAYLOR PJ, 1993, CRIME MENTAL DISORDE, P63; Torrey EF, 1995, AM J PUBLIC HEALTH, V85, P1611, DOI 10.2105/AJPH.85.12.1611; Wallace C, 1998, BRIT J PSYCHIAT, V172, P477, DOI 10.1192/bjp.172.6.477; WESSELY S, 1994, PSYCHOL MED, V24, P483, DOI 10.1017/S0033291700027458	16	139	142	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					614	617		10.1016/S0140-6736(99)05082-5	http://dx.doi.org/10.1016/S0140-6736(99)05082-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289HX	10696982				2022-12-01	WOS:000085615400013
J	DeLano, WL; Ultsch, MH; de Vos, AM; Wells, JA				DeLano, WL; Ultsch, MH; de Vos, AM; Wells, JA			Convergent solutions to binding at a protein-protein interface	SCIENCE			English	Article							CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; DOMAIN; FC; RECEPTOR; COMPLEX; IGG; VARIANTS; FRAGMENT; HORMONE	The hinge region on the Fe fragment of human immunoglobulin G interacts with at least four different natural protein scaffolds that bind at a common site between the C-H2 and C-H3 domains. This "consensus" site was also dominant for binding of random peptides selected in vitro for high affinity (dissociation constant, about 25 nanomolar) by bacteriophage display, Thus, this site appears to be preferred owing to its intrinsic physiochemical properties, and not for biological function alone. A 2.7 angstrom crystal structure of a selected 13-amino acid peptide in complex with Fc demonstrated that the peptide adopts a compact structure radically different from that of the other Fc binding proteins. Nevertheless, the specific Fc binding interactions of the peptide strongly mimic those of the other proteins. Juxtaposition of the available Fc-complex crystal structures showed that the convergent binding surface is highly accessible, adaptive, and hydrophobic and contains relatively few sites for polar interactions. These are all properties that may promote cross-reactive binding, which is common to protein-protein interactions and especially hormone-receptor complexes.	Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Sunesis Pharmaceut, Redwood City, CA 94063 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; Roche Holding; Genentech	Wells, JA (corresponding author), Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA.	jaw@sunesis-pharma.com	Wells, Jim A/O-9854-2016					BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELANO WL, UNPUB; FAHNESTOCK SR, 1990, BACTERIAL IMMUNOGLOB, V1, pCH11; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; JENDEBERG L, 1995, J MOL RECOGNIT, V8, P270, DOI 10.1002/jmr.300080405; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KARLSSON R, 1995, J IMMUNOL METHODS, V183, P43, DOI 10.1016/0022-1759(95)00030-E; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Medesan C, 1997, J IMMUNOL, V158, P2211; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; YOUNG L, 1994, PROTEIN SCI, V3, P717	26	565	647	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2000	287	5456					1279	1283		10.1126/science.287.5456.1279	http://dx.doi.org/10.1126/science.287.5456.1279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678837				2022-12-01	WOS:000085444700054
J	Rudolph, KL; Chang, S; Millard, M; Schreiber-Agus, N; DePinho, RA				Rudolph, KL; Chang, S; Millard, M; Schreiber-Agus, N; DePinho, RA			Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery	SCIENCE			English	Article							MOUSE CELLS LACKING; LIFE-SPAN; HEPATOCELLULAR-CARCINOMA; PLASMINOGEN-ACTIVATOR; HUMAN FIBROBLASTS; DEATH RATES; LENGTH; DISEASES; PATHOGENESIS; REGENERATION	Accelerated telomere loss has been proposed to be a factor Leading to end-stage organ failure in chronic diseases of high cellular turnover such as liver cirrhosis. To test this hypothesis directly, telomerase-deficient mice, null for the essential telomerase RNA (mTR) gene, were subjected to genetic, surgical, and chemical ablation of the liver. Telomere dysfunction was associated with defects in liver regeneration and accelerated the development of liver cirrhosis in response to chronic liver injury. Adenoviral delivery of mTR into the livers of mTR(-/-) mice with short dysfunctional telomeres restored telomerase activity and telomere function, alleviated cirrhotic pathology, and improved liver function. These studies indicate that telomere dysfunction contributes to chronic diseases of continual cellular loss-replacement and encourage the evaluation of "telomerase therapy" for such diseases.	Dana Farber Canc Inst, Dept Adult Oncol Med & Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yeshiva University; Albert Einstein College of Medicine	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol Med & Genet, 44 Binney St,M413, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X; Rudolph, Karl Lenhard/0000-0002-4839-2862	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034880, R01HD028317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG001019] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG001019] Funding Source: Medline; NICHD NIH HHS [R01HD28317, R01HD34880] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; ANTHONY PP, 1977, B WORLD HEALTH ORGAN, V55, P521; Ball SE, 1998, BLOOD, V91, P3582; BEDOSSA P, 1972, HEPATOLOGY, V21, P76095; Blackburn E, 1997, Ciba Found Symp, V211, P2; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Delhaye M, 1996, HEPATOLOGY, V23, P1003, DOI 10.1002/hep.510230510; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; FAUSTO N, 1991, CIBA F SYMP, V157, P165; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Huang GT, 1998, EUR J CANCER, V34, P1946, DOI 10.1016/S0959-8049(98)00237-8; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; KOJLMA H, 1997, GASTROENTEROLOGY, V112, P493; KORULA J, 1992, LIVER BILIARY DIS, P529; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; McClintock B, 1941, GENETICS, V26, P234; MILANI S, 1991, AM J PATHOL, V139, P1221; Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9; Mondello C, 1997, EXP CELL RES, V236, P385, DOI 10.1006/excr.1997.3756; NAKISHIO R, 1998, NIPPON RINSHO, V56, P1239; Nichols WS, 1999, SCAND J IMMUNOL, V49, P302, DOI 10.1046/j.1365-3083.1999.00505.x; Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580; Ohyashiki JH, 1999, CLIN CANCER RES, V5, P1155; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Pan CG, 1997, EXP CELL RES, V231, P346, DOI 10.1006/excr.1997.3475; Park YM, 1998, EXP MOL MED, V30, P35, DOI 10.1038/emm.1998.5; PODOLSKY DK, 1998, HARRISONS PRINCIPLES, P17084; Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Roulot D, 1999, HEPATOLOGY, V29, P1730, DOI 10.1002/hep.510290622; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 1999, HEPATOLOGY, V30, P1159, DOI 10.1002/hep.510300502; RUDOLPH KL, UNPUB; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Shay JW, 1997, J CELL PHYSIOL, V173, P266, DOI 10.1002/(SICI)1097-4652(199711)173:2<266::AID-JCP33>3.0.CO;2-B; Smart RG, 1998, J STUD ALCOHOL, V59, P245, DOI 10.15288/jsa.1998.59.245; Smart RG, 1996, ALCOHOL ALCOHOLISM, V31, P487; SMART RG, 1991, J STUD ALCOHOL, V52, P232, DOI 10.15288/jsa.1991.52.232; SMART RG, 1993, MMWR-MORBID MORTAL W, V41, P969; Suda T, 1998, HEPATOLOGY, V27, P402, DOI 10.1002/hep.510270213; TAHARA H, 1995, CANCER RES, V55, P2734; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; Urabe Y, 1996, LIVER, V16, P293; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Williams EJ, 1998, POSTGRAD MED J, V74, P193, DOI 10.1136/pgmj.74.870.193	59	305	324	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2000	287	5456					1253	1258		10.1126/science.287.5456.1253	http://dx.doi.org/10.1126/science.287.5456.1253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678830				2022-12-01	WOS:000085444700047
J	Capaldi, EA; Smith, AD; Osborne, JL; Fahrbach, SE; Farris, SM; Reynolds, DR; Edwards, AS; Martin, A; Robinson, GE; Poppy, GM; Riley, JR				Capaldi, EA; Smith, AD; Osborne, JL; Fahrbach, SE; Farris, SM; Reynolds, DR; Edwards, AS; Martin, A; Robinson, GE; Poppy, GM; Riley, JR			Ontogeny of orientation flight in the honeybee revealed by harmonic radar	NATURE			English	Article							BEES	Cognitive ethology focuses on the study of animals under natural conditions to reveal ecologically adapted modes of learning. But biologists can more easily study what an animal learns than how it learns. For example, honeybees take repeated 'orientation' flights before becoming foragers at about three weeks of age(1). These flights are a prerequisite for successful homing.(2) Little is known(2,3) about these flights because orienting bees rapidly fly out of the range of human observation. Using harmonic radar, we show for the first time a striking ontogeny to honeybee orientation flights. With increased experience, bees hold trip duration constant but fly faster, so later trips cover a larger area than earlier trips. In addition, each flight is typically restricted to a narrow sector around the hive. Orientation flights provide honeybees with repeated opportunities to view the hive and landscape features from different viewpoints, suggesting that bees learn the local landscape in a progressive fashion. We also show that these changes in orientation flight are related to the number of previous flights taken instead of chronological age, suggesting a learning process adapted to changes in weather conditions, flower availability and the needs of bee colonies.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Greenwich, Nat Resources Inst, Radar Entomol Unit, Malvern WR14 1LL, Worcs, England; IACR Rothamsted, Dept Entomol & Nematol, Harpenden AL5 2JQ, Herts, England	University of Illinois System; University of Illinois Urbana-Champaign; University of Greenwich; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Capaldi, EA (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.	ecapaldi@life.uiuc.edu	Osborne, Juliet L/I-6776-2012; Reynolds, Donald R/C-7361-2013; Poppy, Guy m/D-7513-2012	Reynolds, Donald/0000-0001-8749-7491; Farris, Sarah/0000-0003-3307-0550	Biotechnology and Biological Sciences Research Council [BBS/E/C/00004179] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Capaldi EA, 1999, J EXP BIOL, V202, P1655; COLLETT TS, 1992, PHILOS T R SOC B, V337, P295, DOI 10.1098/rstb.1992.0107; DYER FC, 1994, P NATL ACAD SCI USA, V91, P4471, DOI 10.1073/pnas.91.10.4471; LINDAUER M, 1959, Z VERGL PHYSIOL, V42, P43, DOI 10.1007/BF00297689; OBSORNE JL, 1999, J APPL ECOL, V36, P519; Ribbands C.R., 1953, BEHAV SOCIAL LIFE HO; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; *SAS I, 1988, SAS STAT US GUID; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Vollbehr J., 1975, Zoologische Jb (Allg Zool), V79, P33; Wehner R, 1981, HDB SENSORY PHYSL, V6B, P287, DOI DOI 10.1007/978-3642-67868-4; White G.C., 1990, ANAL WILDLIFE RADIO; Winston M., 1987, The biology of the honey bee.; Zar J., 1996, BIOSTAT ANAL	15	230	234	5	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2000	403	6769					537	540		10.1038/35000564	http://dx.doi.org/10.1038/35000564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676960				2022-12-01	WOS:000085227300048
J	Turley, SJ; Inaba, K; Garrett, WS; Ebersold, M; Unternaehrer, J; Steinman, RM; Mellman, I				Turley, SJ; Inaba, K; Garrett, WS; Ebersold, M; Unternaehrer, J; Steinman, RM; Mellman, I			Transport of peptide-MHC class II complexes in developing dendritic cells	SCIENCE			English	Article							BONE-MARROW CULTURES; DEVELOPMENTAL REGULATION; B-LYMPHOCYTES; LARGE NUMBERS; T-CELLS; MOLECULES; ACCUMULATION; COMPARTMENT; GENERATION; LYSOSOMES	Major histocompatibility complex class II (MHC II) molecules capture peptides within the endocytic pathway to generate T cell receptor (TCR) ligands. Immature dendritic cells (DCs) sequester intact antigens in Lysosomes, processing and converting antigens into peptide-MHC II complexes upon induction of DC maturation. The complexes then accumulate in distinctive, nonlysosomal MHC II+ vesicles that appear to migrate to the cell surface. Although the vesicles exclude soluble lysosomal contents and antigen-processing machinery, many contain MHC I and B7 costimulatory molecules. After arrival at the cell surface, the MHC and costimulatory molecules remain clustered. Thus, transport of peptide-MHC II complexes by DCs not only accomplishes transfer from late endocytic compartments to the plasma membrane, but does so in a manner that selectively concentrates TCR ligands and costimulatory molecules for T cell contact.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Immunobiol Sect, New Haven, CT 06520 USA; Kyoto Univ, Grad Sch Biostudies, Immunobiol Lab, Kyoto 6068502, Japan; Rockefeller Univ, Cellular Physiol & Immunol Lab, Lab Cellular Immunol & Physiol, New York, NY 10021 USA	Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University; Kyoto University; Rockefeller University	Mellman, I (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020; Steinman, Ralph/F-7729-2012	Garrett, Wendy/0000-0002-5092-0150; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034098, P01AI039672, R37AI034098, R01AI013013, R37AI013013] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34098, AI-39672, AI-13013] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; GARRETT WR, UNPUB; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; KLEIJMEER MJ, 1994, J INVEST DERMATOL, V103, P516, DOI 10.1111/1523-1747.ep12395666; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; UNTERMAEHRER J, UNPUB; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	28	384	395	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					522	527		10.1126/science.288.5465.522	http://dx.doi.org/10.1126/science.288.5465.522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775112				2022-12-01	WOS:000086626000047
J	Scott, JAG; Hall, AJ; Muyodi, C; Lowe, B; Ross, M; Chohan, B; Mandaliya, K; Getambu, E; Gleeson, F; Drobniewski, F; Marsh, K				Scott, JAG; Hall, AJ; Muyodi, C; Lowe, B; Ross, M; Chohan, B; Mandaliya, K; Getambu, E; Gleeson, F; Drobniewski, F; Marsh, K			Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY COMPLICATIONS; BACTERIAL PNEUMONIA; ETIOLOGY; ADMISSIONS; INFECTION; GUINEA	Background Despite a substantial disease burden, there is little descriptive epidemiology of acute pneumonia in sub-Saharan Africa. We did this study to define the aetiology of acute pneumonia, to estimate mortality at convalescence, and to analyse mortality risk-factors. Methods We studied 281 Kenyan adults who presented to two public hospitals (one urban and one rural) with acute radiologically confirmed pneumonia during 1994-96. We did blood and lung-aspirate cultures, mycobacterial cultures, serotype-specific pneumococcal antigen detection, and serology for viral and atypical agents. Findings Aetiology was defined in 182 (65%) patients. Streptococcus pneumoniae was the most common causative agent, being found in 129 (46%) cases; Mycobacterium tuberculosis was found in 26 (9%). Of 255 patients followed up for at least 3 weeks, 25 (10%) died at a median age of 33 years. In multivariate analyses, risk or protective factors for mortality were age (odds ratio 1.51 per decade [95% CI 1.04-2.19]), unemployment (4.42 [1.21-16.1]), visiting a traditional healer (5.26 [1.67-16.5]), visiting a pharmacy (0.30 [0.10-0.91]), heart rate (1.64 per 10 beats [1.24-2.16]), and herpes labialis (1.54 [2.22-107]). HIV-1 seropositivity, found in 52%, was not associated with mortality. Death or failure to recover after 3 weeks was more common in patients with pneumococci of intermediate resistance to benzylpenicillin, which comprised 28% of pneumococcal isolates, than in those infected with susceptible pneumococci (5.60 [1.33-23.6]). Interpretation We suggest that tuberculosis is a sufficiently common cause of acute pneumonia in Kenyan adults to justify routine sputum culture, and that treatment with benzylpenicillin remains appropriate for clinical failure due to M tuberculosis, intermediate-resistant pneumococci, and other bacterial pathogens. However, interventions restricted to hospital management will fail to decrease mortality associated with socioeconomic, educational, and behavioural factors.	London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; Coast Prov Gen Hosp, Mombasa, Kenya; Royal Berkshire Hosp, Publ Hlth Lab, Reading RG1 5AN, Berks, England; Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England; Publ Hlth Lab Serv, Mycobacterium Reference Unit, London, England; Publ Hlth Lab Serv, Reg Ctr Mycobacteriol, London, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of London; London School of Hygiene & Tropical Medicine; Royal Berkshire Hospital; University of Oxford; Public Health England; Public Health England; University of Oxford	Scott, JAG (corresponding author), Wellcome Trust Res Labs, Kenya Med Res Inst, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	ascott@kilifi.mimcom.net			Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; ADERAYE G, 1994, ETHIOPIAN MED J, V32, P115; ALLEN SC, 1984, THORAX, V39, P612, DOI 10.1136/thx.39.8.612; ANDREWS BE, 1987, Q J MED, V62, P195; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; BATUNGWANAYO J, 1994, AM J RESP CRIT CARE, V149, P1591, DOI 10.1164/ajrccm.149.6.8004318; Daley CL, 1996, AM J RESP CRIT CARE, V154, P105, DOI 10.1164/ajrccm.154.1.8680664; DAVIDSON M, 1976, JAMA-J AM MED ASSOC, V235, P158, DOI 10.1001/jama.235.2.158; Drobniewski FA, 1998, METH MOL B, V101, P323, DOI 10.1385/0-89603-471-2:323; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; FINE MJ, 1990, AM J MED, V88, pN1; HARRIES AD, 1990, TROP GEOGR MED, V42, P274; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; KAMANFU G, 1993, AM REV RESPIR DIS, V147, P658, DOI 10.1164/ajrccm/147.3.658; Klugman KP, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.suppl_A.133; KoullaShiro S, 1996, TUBERCLE LUNG DIS, V77, P47, DOI 10.1016/S0962-8479(96)90075-1; LIND K, 1988, EPIDEMIOL INFECT, V101, P377, DOI 10.1017/S0950268800054327; MACFARLANE JT, 1979, THORAX, V34, P713, DOI 10.1136/thx.34.6.713; MACFARLANE JT, 1982, LANCET, V2, P255; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MUNDY LM, 1995, AM J RESP CRIT CARE, V152, P1309, DOI 10.1164/ajrccm.152.4.7551387; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; Scott JAG, 1998, CLIN INFECT DIS, V27, P1442, DOI 10.1086/515013; Scott JAG, 1999, CLIN INFECT DIS, V28, P764, DOI 10.1086/515198; SHANN F, 1984, LANCET, V2, P537; Sofowora E O, 1973, Niger Med J, V3, P144; Sow O, 1996, THORAX, V51, P385, DOI 10.1136/thx.51.4.385; WALLACE RJ, 1978, AM J MED, V64, P87, DOI 10.1016/0002-9343(78)90182-1; WILLIAMS EH, 1986, J TROP MED HYG, V89, P193	30	138	140	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1225	1230		10.1016/S0140-6736(00)02089-4	http://dx.doi.org/10.1016/S0140-6736(00)02089-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770305				2022-12-01	WOS:000086448000012
J	LeVier, K; Phillips, RW; Grippe, VK; Roop, RM; Walker, GC				LeVier, K; Phillips, RW; Grippe, VK; Roop, RM; Walker, GC			Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival	SCIENCE			English	Article							BRUCELLA-ABORTUS; SYSTEM; MUTAGENESIS; VIRULENCE; SBMA; GENE	Brucella abortus, a mammalian pathogen, and Rhizobium meliloti, a phylogenetically related plant symbiont, establish chronic infections in their respective hosts. Here a highly conserved B, abortus homolog of the R, meliloti bacA gene, which encodes a putative cytoplasmic membrane transport protein required for symbiosis, was identified. An isogenic B, abortus bacA mutant exhibited decreased survival in macrophages and greatly accelerated clearance from experimentally infected mice compared to the virulent parental strain. Thus, the bacA gene product is critical for the maintenance of two very diverse host-bacterial relationships.	MIT, Dept Biol, Cambridge, MA 02139 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA	Massachusetts Institute of Technology (MIT); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031030] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31030] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin C.L., 2002, INFEC AGENT, P255; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; DELEY J, 1987, INT J SYST BACTERIOL, V37, P35, DOI 10.1099/00207713-37-1-35; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Elzer PH, 1996, INFECT IMMUN, V64, P4838, DOI 10.1128/IAI.64.11.4838-4841.1996; *GENB, X73522 GENB; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; GRIPPE VK, UNPUB; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ichige A, 1997, J BACTERIOL, V179, P209, DOI 10.1128/jb.179.1.209-216.1997; LONG S, 1988, J BACTERIOL, V170, P4257, DOI 10.1128/jb.170.9.4257-4265.1988; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; MELLOR RB, 1989, J EXP BOT, V40, P831, DOI 10.1093/jxb/40.8.831; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Niner BM, 1998, SYMBIOSIS, V24, P51; PHILLIPS RA, UNPUB; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x	20	139	147	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2000	287	5462					2492	2493		10.1126/science.287.5462.2492	http://dx.doi.org/10.1126/science.287.5462.2492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741969				2022-12-01	WOS:000086202200046
J	Chen, P; Luo, C; Deng, YL; Ryan, K; Register, J; Margosiak, S; Tempczyk-Russell, A; Nguyen, B; Myers, P; Lundgren, K; Kan, CC; O'Connor, PM				Chen, P; Luo, C; Deng, YL; Ryan, K; Register, J; Margosiak, S; Tempczyk-Russell, A; Nguyen, B; Myers, P; Lundgren, K; Kan, CC; O'Connor, PM			The 1.7 angstrom crystal structure of human cell cycle checkpoint kinase Chk1: Implications for Chk1 regulation	CELL			English	Article							DNA-DAMAGE CHECKPOINT; DEPENDENT PROTEIN-KINASE; REPLICATION CHECKPOINT; TYROSINE KINASE; FISSION YEAST; PEPTIDE SUBSTRATE; CATALYTIC SUBUNIT; PHOSPHORYLATION; ACTIVATION; CDC2	The checkpoint kinase Chk1 is an important mediator of cell cycle arrest following DNA damage. The 1.7 Angstrom resolution crystal structures of the human Chk1 kinase domain and its binary complex with an ATP analog has revealed an identical open kinase conformation. The secondary structure and side chain interactions stabilize the activation loop of Chk1 and enable kinase activity without phosphorylation of the catalytic domain. Molecular modeling of the interaction of a Cdc25C peptide with Chk1 has uncovered several conserved residues that are important for substrate selectivity. In addition, we found that the less conserved C-terminal region negatively impacts Chk1 kinase activity.	Agouron Pharmaceut Inc, San Diego, CA 92121 USA	Pfizer	Chen, P (corresponding author), Agouron Pharmaceut Inc, 3565 Gen Atom Court, San Diego, CA 92121 USA.							Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR V3 1 SYSTEM XR; Chen P, 1999, ONCOGENE, V18, P249, DOI 10.1038/sj.onc.1202257; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; FAN SJ, 1995, CANCER RES, V55, P1649; Francesconi S, 1997, EMBO J, V16, P1332, DOI 10.1093/emboj/16.6.1332; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GRAVES PR, 2000, IN PRESS J BIOL CHEM; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; LEE YY, 1992, APPL BIOCHEM BIOTECH, V34-5, P3, DOI 10.1007/BF02920529; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Martinho RG, 1998, EMBO J, V17, P7239, DOI 10.1093/emboj/17.24.7239; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; O'Connor P M, 1996, Prog Cell Cycle Res, V2, P165; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; OConnor PM, 1997, CANCER SURV, V29, P151; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sarkaria JN, 1999, CANCER RES, V59, P4375; Suganuma M, 1999, CANCER RES, V59, P5887; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	59	176	186	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					681	692		10.1016/S0092-8674(00)80704-7	http://dx.doi.org/10.1016/S0092-8674(00)80704-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761933	Bronze			2022-12-01	WOS:000085983800010
J	Weinrich, M; Stuart, M				Weinrich, M; Stuart, M			Provision of methadone treatment in primary care medical practices - Review of the Scottish experience and implications for US policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GENERAL-PRACTITIONERS; MAINTENANCE TREATMENT; OUTCOMES	Context Under new proposed regulations, US physicians outside of traditional methadone clinics could prescribe methadone to patients with opioid dependence. No large-scale evaluations of US programs in which methadone maintenance is provided by primary care physicians are available, but primary care physicians in Scotland have participated in such programs on a large scale. Objective To review the history, operation, and outcome data on the efficacy and safety of 2 Scottish primary care-based opioid agonist treatment programs to derive lessons for the US context. Design and Setting Naturalistic study of programs in Edinburgh and Glasgow, Scotland, with data obtained through site visits and interviews conducted in 1996 and 1998, as well as from published reports and retrospective analysis of electronic databases. Main Outcome Measures Proportions of injection drug users who were enrolled in the methadone maintenance programs, average methadone doses in the pro grams, and methadone-related deaths. Results A total of 60% to 80% of injection drug users in Edinburgh and 41% to 73% of those in Glasgow were enrolled in methadone maintenance in 1998-1999, Dose levels are consistent with US recommendations (for Edinburgh in 1998, 61 mg; for Glasgow in 1994-1996, 54 mg). The Glasgow program required supervised consumption of methadone in community pharmacies for the first year and experienced significantly fewer methadone-related deaths than Edinburgh in 1997 (17 vs 30 deaths; P<.0001). Programs in both Edinburgh and Glasgow provided support to primary care physicians and achieved levels of general practitioner participation of 59% (1998) and 30% (1999), respectively. Conclusions The Scottish experience indicates that prescription of methadone in office-based settings can expand access to an important treatment modality. Primary care physicians safely prescribed methadone for maintenance treatment when provided with adequate support. Diversion of methadone was minimized by requiring supervised consumption in community pharmacies.	Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Sociol & Anthropol, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Weinrich, M (corresponding author), NICHHD, Natl Ctr Med Rehabil Res, NIH, 6100 Execut Blvd,Room 2A03,MSC 7510, Bethesda, MD 20892 USA.	mw287k@nih.gov						[Anonymous], 1995, FEDERAL REGULATION M; Bach PB, 1999, AM J PUBLIC HEALTH, V89, P662, DOI 10.2105/AJPH.89.5.662; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V279, P827, DOI 10.1001/jama.279.11.827; BURY J, 1998, SUPPORTING PRACTICES; BURY J, 1995, INT J DRUG POLICY, V6, P267; Christian J, 1999, DRUG ALCOHOL DEPEN, V55, P265, DOI 10.1016/S0376-8716(99)00021-6; COLE SK, 1998, DRUG RELATED DEATHS; *COMM DRUG PROBL S, 1998, AUD DAT APR 1997 MAR; Conrad DA, 1998, JAMA-J AM MED ASSOC, V279, P853, DOI 10.1001/jama.279.11.853; Cooper GAA, 1999, MED SCI LAW, V39, P233, DOI 10.1177/002580249903900308; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; Deehan A, 1997, BRIT J GEN PRACT, V47, P705; DEMARIA PA, 1995, POSTGRAD MED, V97, P83, DOI 10.1080/00325481.1995.11945971; *DEP HLTH, 1995, TACKL DRUGS STRAT EN; *DEP HLTH, 1998, TACKL DRUGS BUILD BR; *DEP HLTH SCOTT OF, 1999, DRUG MIS DEP GUID CL; DESMOND DP, 1997, EFFECTIVE MED TREATM; DuPont RL, 1996, SUBST USE MISUSE, V31, P1929, DOI 10.3109/10826089609066439; EGERTSON JA, 1997, TREATING DRUG USERS; ETHERIDGE RM, 1997, EFFECTIVE MED TREATM; Gerada C, 1999, BRIT J GEN PRACT, V49, P125; GLANZ A, 1986, BRIT MED J, V293, P486, DOI 10.1136/bmj.293.6545.486; *GREAT GLASG DRUG, 1998, GETT GRIPS DRUGS GRE; *GREAT GLASG HLTH, 1999, GUID GREAT GLASG GP; GREENWOOD J, 1992, BRIT J ADDICT, V87, P567; GREENWOOD J, 1990, BRIT MED J, V300, P587, DOI 10.1136/bmj.300.6724.587; GREENWOOD J, 1996, PSYCHIAT B, V20, P8; GREENWOOD J, 1994, LOTHIAN COMMUNITY DR; Gruer L, 1997, BMJ-BRIT MED J, V314, P1730, DOI 10.1136/bmj.314.7096.1730; JAFFE JH, 1997, EFFECTIVE MED TREATM; Lewis DC, 1996, J ADDICT DIS, V15, P1, DOI 10.1300/J069v15n01_01; LEWIS DC, 1997, EFFECTIVE MED TREATM; MacGowan RJ, 1996, J PSYCHOACTIVE DRUGS, V28, P259, DOI 10.1080/02791072.1996.10472487; Martin E, 1998, BRIT J GEN PRACT, V48, P1679; Massing M., 1998, THE FIX; McCarty D, 1999, MILBANK Q, V77, P341, DOI 10.1111/1468-0009.00139; MCCLELLAN AT, 1997, TREATING DRUG USERS, P7; McLellan AT, 1996, MILBANK Q, V74, P51, DOI 10.2307/3350433; NELSON H, 1996, TREATING DRUG USERS; NOVICK DM, 1994, J GEN INTERN MED, V9, P127, DOI 10.1007/BF02600025; OCONNOR PG, 1995, J GEN INTERN MED, V10, P255, DOI 10.1007/BF02599882; *OFF NAT DRUG AB P, 1999, ROAD AHEA CONS DOC O; PAYTE JY, 1997, EFFECTIVE MED TREATM; PETERS A, 1994, AUDIT EVALUATION COM; *PRIM CAR FACT TEA, 1996, MAN DRUG US GEN PRAC; Reinhardt UE, 1999, JAMA-J AM MED ASSOC, V281, P462, DOI 10.1001/jama.281.5.462; ROSENBAUM M, 1995, J PSYCHOACTIVE DRUGS, V27, P145, DOI 10.1080/02791072.1995.10471683; SIMON D, 1997, CORNER; Stuart ME, 1998, MILBANK Q, V76, P251, DOI 10.1111/1468-0009.00088; UMBRICHTSCHNEITER A, 1994, AM J PUBLIC HEALTH, V84, P207, DOI 10.2105/AJPH.84.2.207; *US DHHS, 1999, DRUG ABU WARN NETW; *US DHHS, 1999, FED REG         0722, V64, P39810; WILSON P, 1994, BRIT MED J, V309, P641, DOI 10.1136/bmj.309.6955.641; 1998, JAMA, V280, P1936, DOI DOI 10.1001/JAMA.280.22.1936	54	52	53	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1343	1348		10.1001/jama.283.10.1343	http://dx.doi.org/10.1001/jama.283.10.1343			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289ND	10714738				2022-12-01	WOS:000085628100035
J	Cluzel, P; Surette, M; Leibler, S				Cluzel, P; Surette, M; Leibler, S			An ultrasensitive bacterial motor revealed by monitoring signaling proteins in single cells	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; FLAGELLAR ROTATION; ESCHERICHIA-COLI; CHEMOTAXIS; SWITCH; PHOSPHORYLATION; DIAGNOSTICS; ADAPTATION; MOLECULES; DIRECTION	Understanding biology at the single-cell Level requires simultaneous measurements of biochemical parameters and behavioral characteristics in individual cells. Here, the output of individual flagellar motors in Escherichia coli was measured as a function of the intracellular concentration of the chemotactic signaling protein. The concentration of this molecule, fused to green fluorescent protein, was monitored with fluorescence correlation spectroscopy. Motors from different bacteria exhibited an identical steep input-output relation, suggesting that they actively contribute to signal amplification in chemotaxis. This experimental approach can be extended to quantitative in vivo studies of other biochemical networks.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	Princeton University; Princeton University; University of Calgary	Cluzel, P (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	phcluzel@phoenix.princeton.edu						Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blat Y, 1998, J MOL BIOL, V284, P1191, DOI 10.1006/jmbi.1998.2224; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Brock R, 1999, P NATL ACAD SCI USA, V96, P10123, DOI 10.1073/pnas.96.18.10123; CLUZEL P, UNPUB; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; ISHIHARA A, 1983, J BACTERIOL, V155, P228, DOI 10.1128/JB.155.1.228-237.1983; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; MACNAB RM, 1995, 2 COMPONENT SIGNAL T, P181; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; RIGLER R, 1992, FLUORESCENCE SPECTRO, P13; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WELCH M, 1994, BIOCHEMISTRY-US, V33, P10470, DOI 10.1021/bi00200a031; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Zhao RB, 1996, J BACTERIOL, V178, P258, DOI 10.1128/jb.178.1.258-265.1996	31	459	464	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1652	1655		10.1126/science.287.5458.1652	http://dx.doi.org/10.1126/science.287.5458.1652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698740				2022-12-01	WOS:000085628200038
J	Farr, GW; Furtak, K; Rowland, MB; Ranson, NA; Saibil, HR; Kirchhausen, T; Horwich, AL				Farr, GW; Furtak, K; Rowland, MB; Ranson, NA; Saibil, HR; Kirchhausen, T; Horwich, AL			Multivalent binding of nonnative substrate proteins by the chaperonin GroEL	CELL			English	Article							CRYSTAL-STRUCTURE; FOLDING REACTION; MECHANISM; POLYPEPTIDE; RELEASE; ATP	The chaperonin GroEL binds nonnative substrate protein in the central cavity of an open ring through exposed hydrophobic residues at the inside aspect of the apical domains and then mediates productive folding upon binding ATP and the cochaperonin GroES. Whether nonnative proteins bind to more than one of the seven apical domains of a GroEL ring is unknown. We have addressed this using rings with various combinations of wild-type and binding-defective mutant apical domains, enabled by their production as single polypeptides. A wild-type extent of binary complex formation with two stringent substrate proteins, malate dehydrogenase or Rubisco, required a minimum of three consecutive binding-proficient apical domains. Rhodanese, a less-stringent substrate, required only two wild-type domains and was insensitive to their arrangement. As a physical correlate, multivalent binding of Rubisco was directly observed in an oxidative cross-linking experiment.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of London; Birkbeck University London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Horwich, AL (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.			Ranson, Neil/0000-0002-3640-5275				BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 1997, PROTEIN SCI, V6, P743; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HLODAN R, 1995, NAT STRUCT BIOL, V2, P587, DOI 10.1038/nsb0795-587; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642	28	152	157	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					561	573		10.1016/S0092-8674(00)80692-3	http://dx.doi.org/10.1016/S0092-8674(00)80692-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721993	Bronze			2022-12-01	WOS:000085700000009
J	Christensen, SK; Dagenais, N; Chory, J; Weigel, D				Christensen, SK; Dagenais, N; Chory, J; Weigel, D			Regulation of auxin response by the protein kinase PINOID	CELL			English	Article							ARABIDOPSIS GENE MONOPTEROS; TRANSCRIPTION FACTOR; VASCULAR DEVELOPMENT; AUX/IAA PROTEINS; POLAR TRANSPORT; THALIANA; MUTANTS; EXPRESSION; ENCODES; EMBRYO	Arabidopsis plants carrying mutations in the PINOID (PID) gene have a pleiotropic shoot phenotype that mimics that of plants grown on auxin transport inhibitors or of plants mutant for the auxin efflux carrier PINFORMED (PIN), with defects in the formation of cotyledons, flowers, and floral organs. We have cloned PID and find that it is transiently expressed in the embryo and in initiating floral anlagen, demonstrating a specific role for PID in promoting primordium development. Constitutive expression of PID causes a phenotype in both shoots and roots that is similar to that of auxin-insensitive plants, implying that PID, which encodes a serine-threonine protein kinase, negatively regulates auxin signaling.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; 				Aloni Roni, 1995, P531; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; BERLETH T, 1993, DEVELOPMENT, V118, P575; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Davies Peter J., 1995, P1; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Fischer C, 1996, PLANT J, V9, P659, DOI 10.1046/j.1365-313X.1996.9050659.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hadfi K, 1998, DEVELOPMENT, V125, P879; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JURGENS G, 1993, COLOUR ATLAS DEV EMB, P7; Kaufman Peter B., 1995, P547; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; LIU CM, 1993, PLANT CELL, V5, P621, DOI 10.1105/tpc.5.6.621; Long JA, 1998, DEVELOPMENT, V125, P3027; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MAHER EP, 1980, BIOCHEM GENET, V18, P1041, DOI 10.1007/BF00484337; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mattsson J, 1999, DEVELOPMENT, V126, P2979; MIZOGUCHI T, 1994, PLANT J, V5, P111, DOI 10.1046/j.1365-313X.1994.5010111.x; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nilsson O, 1998, PLANT J, V15, P799, DOI 10.1046/j.1365-313X.1998.00260.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; SCIAVONE FM, 1987, CELL DIFFER, V21, P53; SESSIONS RA, 1995, DEVELOPMENT, V121, P1519; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Tian Q, 1999, DEVELOPMENT, V126, P711; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 2000, IN PRESS PLANT PHYSL	63	352	381	2	52	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					469	478		10.1016/S0092-8674(00)80682-0	http://dx.doi.org/10.1016/S0092-8674(00)80682-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693763	Bronze			2022-12-01	WOS:000085446900009
J	Mao, YX; Nickitenko, A; Duan, XQ; Lloyd, TE; Wu, MN; Bellen, H; Quiocho, FA				Mao, YX; Nickitenko, A; Duan, XQ; Lloyd, TE; Wu, MN; Bellen, H; Quiocho, FA			Crystal structure of the VHS and FYVE tandem domains of Hrs, a protein involved in membrane trafficking and signal transduction	CELL			English	Article							ZINC-FINGER DOMAIN; ADAPTER MOLECULE; CELL-GROWTH; MOLSCRIPT; BINDING; PROGRAM; MOTIF; STAM; EEA1	We have determined the 2 Angstrom X-ray structure of the 219-residue N-terminal VHS and MIE tandem domain unit of Drosophila Hrs. The unit assumes a pyramidal structure in which the much larger YHS domain (residues 1-153) forms a rectangular base and the FYVE domain occupies the apical end. The VHS domain is comprised of an unusual "superhelix" of eight alpha helices, and the MIE domain is mainly built of loops, two double-stranded antiparallel sheets, and a helix stabilized by two tetrahedrally coordinated zinc atoms. The two-domain structure forms an exact 2-fold-related homodimer through antiparallel association of mainly FYVE domains. Dimerization creates two identical pockets designed for binding ligands with multiple negative charges such as citrate or phosphatidylinositol 3-phosphate.	Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Quiocho, FA (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA.			Lloyd, Thomas/0000-0003-4756-3700; Bellen, Hugo/0000-0001-5992-5989; Mao, Yuxin/0000-0002-5064-1397				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Carbone R, 1997, CANCER RES, V57, P5498; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Lohi O, 1998, J BIOL CHEM, V273, P21408, DOI 10.1074/jbc.273.33.21408; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Sack JS, 1997, METHOD ENZYMOL, V277, P158, DOI 10.1016/S0076-6879(97)77011-3; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; [No title captured]	39	137	138	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					447	456		10.1016/S0092-8674(00)80680-7	http://dx.doi.org/10.1016/S0092-8674(00)80680-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693761	Bronze			2022-12-01	WOS:000085446900007
J	Donovan, A; Brownlie, A; Zhou, Y; Shepard, J; Pratt, SJ; Moynihan, J; Paw, BH; Drejer, A; Barut, B; Zapata, A; Law, TC; Brugnara, C; Kingsley, PD; Palis, J; Fleming, MD; Andrews, NC; Zon, LI				Donovan, A; Brownlie, A; Zhou, Y; Shepard, J; Pratt, SJ; Moynihan, J; Paw, BH; Drejer, A; Barut, B; Zapata, A; Law, TC; Brugnara, C; Kingsley, PD; Palis, J; Fleming, MD; Andrews, NC; Zon, LI			Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter	NATURE			English	Article							DANIO-RERIO; GENE; HEMATOPOIESIS; TRANSPORTER; MUTATION; DEFECTS; ANEMIA; MAP	Defects in iron absorption and utilization lead to iron deficiency and overload disorders. Adult mammals absorb iron through the duodenum, whereas embryos obtain iron through placental transport. Iron uptake from the intestinal lumen through the apical surface of polarized duodenal enterocytes is mediated by the divalent metal transporter, DMT1 (refs 1-3). A second transporter has been postulated to export iron across the basolateral surface to the circulation. Here we have used positional cloning to identify the gene responsible for the hypochromic anaemia of the zebrafish mutant weissherbst. The gene, ferroportin1, encodes a multiple-transmembrane domain protein, expressed in the yolk sac, that is a candidate for the elusive iron exporter. Zebrafish ferroportin1 is required for the transport of iron from maternally derived yolk stores to the circulation and functions as an iron exporter when expressed in Xenopus oocytes. Human Ferroportin1 is found at the basal surface of placental syncytiotrophoblasts, suggesting that it also transports iron from mother to embryo. Mammalian Ferroportin1 is expressed at the basolateral surface of duodenal enterocytes and could export cellular iron into the circulation. We propose that Ferroportin1 function may be perturbed in mammalian disorders of iron deficiency or overload.	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Washington University (WUSTL); Complutense University of Madrid; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; University of Rochester; University of Rochester	Zon, LI (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	zon@rascal.med.harvard.edu	Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713; Palis, James/0000-0001-7324-1049; Paw, Barry/0000-0002-0492-1419; Fleming, Mark/0000-0003-0948-4024; Cutts, Alison/0000-0002-4986-573X; Andrews, Nancy/0000-0003-0243-4462; Zapata, Agustin G/0000-0003-0576-2672				ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BANNERMAN RM, 1976, FED PROC, V35, P2281; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; CRAIK JCA, 1986, COMP BIOCHEM PHYS A, V83, P515, DOI 10.1016/0300-9629(86)90138-6; DUMONT JN, 1978, J EXP ZOOL, V204, P193, DOI 10.1002/jez.1402040208; Einstein RS, 1998, J NUTR, V128, P2295, DOI 10.1093/jn/128.12.2295; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haffter P, 1996, DEVELOPMENT, V123, P1; JOHNSON SL, 1995, GENETICS, V139, P1727; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KINGSTON PJ, 1978, BRIT J HAEMATOL, V40, P265, DOI 10.1111/j.1365-2141.1978.tb03663.x; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; PALIS J, 1995, MOL REPROD DEV, V42, P19, DOI 10.1002/mrd.1080420104; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ransom DG, 1999, METHOD CELL BIOL, V60, P195; Ransom DG, 1996, DEVELOPMENT, V123, P311; Richards MP, 1997, POULTRY SCI, V76, P152, DOI 10.1093/ps/76.1.152; RIEB J-P, 1973, Annales d'Embryologie et de Morphogenese, V6, P43; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Westerfield M., 1993, ZEBRAFISH BOOK; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	29	1241	1320	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					776	781		10.1038/35001596	http://dx.doi.org/10.1038/35001596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693807				2022-12-01	WOS:000085423100054
J	Drummond, SPA; Brown, GG; Gillin, JC; Stricker, JL; Wong, EC; Buxton, RB				Drummond, SPA; Brown, GG; Gillin, JC; Stricker, JL; Wong, EC; Buxton, RB			Altered brain response to verbal learning following sleep deprivation	NATURE			English	Article							PERFORMANCE; MEMORY; TOMOGRAPHY; LANGUAGE; HUMANS; FMRI	The effects of sleep deprivation on the neural substrates of cognition are poorly understood. Here we used functional magnetic resonance imaging to measure the effects of 35 hours of sleep deprivation on cerebral activation during verbal learning in normal young volunteers. On the basis of a previous hypothesis', we predicted that the prefrontal cortex (PFC) would be less responsive to cognitive demands following sleep deprivation. Contrary to our expectations, however, the PFC was more responsive after one night of sleep deprivation than after normal sleep. Increased subjective sleepiness in sleep-deprived subjects correlated significantly with activation of the PFC. The temporal lobe was activated after normal sleep but not after sleep deprivation; in contrast, the parietal lobes were not activated after normal sleep but were activated after sleep deprivation. Although sleep deprivation significantly impaired free recall compared with the rested state, better free recall in sleep-deprived subjects was associated with greater parietal lobe activation, These findings show that there are dynamic, compensatory changes in cerebral activation during verbal learning after sleep deprivation and implicate the PFC and parietal lobes in this compensation.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92120 USA; Vet Adm San Diego Healthcare Syst, Psychiat Serv 116A, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Gillin, JC (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jgillin@ucsd.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Drummond, Sean/0000-0002-9815-626X				BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dinges D. F., 1991, SLEEP SLEEPINESS PER, P97; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRACKOWIAK RSJ, 1994, TRENDS NEUROSCI, V17, P109, DOI 10.1016/0166-2236(94)90119-8; Harrison Y, 1997, SLEEP, V20, P871, DOI 10.1093/sleep/20.10.871; Harrison Y, 1998, J SLEEP RES, V7, P95, DOI 10.1046/j.1365-2869.1998.00104.x; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE JA, 1988, SLEEP, V11, P528, DOI 10.1093/sleep/11.6.528; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; LUBIN A, 1976, PSYCHOPHYSIOLOGY, V13, P334, DOI 10.1111/j.1469-8986.1976.tb03086.x; PIETAU C, 1998, J SLEEP RES, V7, P208; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; POLZELLA DJ, 1975, J EXP PSYCHOL-HUM L, V104, P194; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Portas CM, 1998, J NEUROSCI, V18, P8979; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; THOMAS ML, 1993, J CEREBR BLOOD FLOW, V13, pS531; Werth E, 1996, NEUROREPORT, V8, P123, DOI 10.1097/00001756-199612200-00025; WILLIAMS HL, 1966, PERCEPT MOTOR SKILL, V23, P1287, DOI 10.2466/pms.1966.23.3f.1287; WOLFE N, 1995, ARCH NEUROL-CHICAGO, V52, P257, DOI 10.1001/archneur.1995.00540270049018; WONG EC, 1992, P SOC MAGN RESON MED, V1, P105; WU JC, 1991, SLEEP, V14, P155	30	378	390	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					655	657		10.1038/35001068	http://dx.doi.org/10.1038/35001068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	283RD	10688201				2022-12-01	WOS:000085288200053
J	Williams, AG; Rayson, MP; Jubb, M; World, M; Woods, DR; Hayward, M; Martin, J; Humphries, SE; Montgomery, HE				Williams, AG; Rayson, MP; Jubb, M; World, M; Woods, DR; Hayward, M; Martin, J; Humphries, SE; Montgomery, HE			Physiology - The ACE gene and muscle performance	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MUSCULAR EFFICIENCY; HUMAN HEART; POLYMORPHISM		Optimal Preformance, Farnham GU9 7EB, Surrey, England; Rayne Inst, RFUCLMS, Ctr Cardiovasc Genet, British Heart Fdn, London WC1E 6JJ, England	University of London; King's College London; University College London	Williams, AG (corresponding author), Optimal Preformance, 93-94 West St, Farnham GU9 7EB, Surrey, England.		Williams, Alun G/B-6817-2008; Montgomery, Hugh/L-1229-2019; Humphries, Stephen E/C-5075-2008; Montgomery, Hugh/C-2592-2008	Williams, Alun G/0000-0002-8052-8184; Montgomery, Hugh/0000-0001-8797-5019; Jubb, Michael/0000-0001-5639-473X				BALL SG, 1993, LANCET, V342, P821; Boss O, 1998, FASEB J, V12, P335, DOI 10.1096/fasebj.12.3.335; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; DRAGOVIC T, 1996, DIABETES S1, V45, P34; GAESSER GA, 1975, J APPL PHYSIOL, V38, P1132, DOI 10.1152/jappl.1975.38.6.1132; Kemp GJ, 1996, HEART, V76, P35, DOI 10.1136/hrt.76.1.35; KULKARNI RN, 1992, ANN HUM BIOL, V19, P421, DOI 10.1080/03014469200002272; McArdle W., 2014, EXERCISE PHYSL ENERG, P253; Montgomery H, 1999, LANCET, V353, P541, DOI 10.1016/S0140-6736(98)07131-1; Montgomery HE, 1997, CIRCULATION, V96, P741; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Morris SD, 1997, J AM COLL CARDIOL, V29, P1599, DOI 10.1016/S0735-1097(97)00087-9; Spurr GB, 1998, EUR J CLIN NUTR, V52, P17, DOI 10.1038/sj.ejcn.1600504; Zhao G, 1999, CORONARY ARTERY DIS, V10, P315, DOI 10.1097/00019501-199907000-00007	16	209	226	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					614	614		10.1038/35001141	http://dx.doi.org/10.1038/35001141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688186	Green Accepted			2022-12-01	WOS:000085288200038
J	Cane, DE				Cane, DE			Biosynthetic pathways - Biosynthesis meets bioinformatics	SCIENCE			English	Editorial Material							CLAVULANIC ACID; 1-DEOXY-D-XYLULOSE 5-PHOSPHATE; PRECURSOR; PYRIDOXOL; THIAMIN; ENZYME		Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Cane, DE (corresponding author), Brown Univ, Dept Chem, Box H, Providence, RI 02912 USA.	David_Cane@brown.edu						Baggaley KH, 1997, NAT PROD REP, V14, P309, DOI 10.1039/np9971400309; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; ELSON SW, 1978, J ANTIBIOT, V31, P586, DOI 10.7164/antibiotics.31.586; Jensen SE, 1999, ANTON LEEUW INT J G, V75, P125, DOI 10.1023/A:1001755724055; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Khaleeli N, 1999, J AM CHEM SOC, V121, P9223, DOI 10.1021/ja9923134; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; Lloyd MD, 1999, TETRAHEDRON, V55, P10201, DOI 10.1016/S0040-4020(99)00547-5; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Perez-Redondo R, 1999, J BACTERIOL, V181, P6922; Pitlik J, 1997, CHEM COMMUN, P225, DOI 10.1039/a607078g; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857	14	15	17	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2000	287	5454					818	819		10.1126/science.287.5454.818	http://dx.doi.org/10.1126/science.287.5454.818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281AR	10691559				2022-12-01	WOS:000085136400035
J	Bergquist, DC; Williams, FM; Fisher, CR				Bergquist, DC; Williams, FM; Fisher, CR			Longevity record for deep-sea invertebrate - The growth rate of a marine tubeworm is tailored to different environments.	NATURE			English	Article							COMMUNITIES; ECOLOGY; VENTS		Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bergquist, DC (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.		Fisher, Charles/H-7912-2012					ANDERSON RK, 1983, SCIENCE, V222, P619, DOI 10.1126/science.222.4624.619; FISHER CR, 1997, PSZNI MAR ECOL, V18, P83; GRASSLE JF, 1986, ADV MAR BIOL, V23, P301; HECKER B, 1985, BIOL SOC WASH B, V6, P465; KENNICUTT MC, 1988, DEEP-SEA RES, V35, P1639, DOI 10.1016/0198-0149(88)90107-0; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Sarrazin J, 1997, MAR ECOL PROG SER, V153, P5, DOI 10.3354/meps153005; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Urcuyo IA, 1998, CAH BIOL MAR, V39, P267	10	80	85	2	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					499	500		10.1038/35000647	http://dx.doi.org/10.1038/35000647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676948				2022-12-01	WOS:000085227300034
J	Port, S; Demer, L; Jennrich, R; Walter, D; Garfinkel, A				Port, S; Demer, L; Jennrich, R; Walter, D; Garfinkel, A			Systolic blood pressure and mortality	LANCET			English	Article								Background The current systolic blood-pressure threshold for hypertension treatment is 140 mm Hg for all adults. WHO and the International Society of Hypertension have proposed that normal pressure be lower than 130 mm Hg, with an optimum pressure of less than 120 mm Hg. These recommendations are based largely on the assumption that cardiovascular and overall mortality depend in a strictly increasing manner on systolic blood pressure. The Framingham study was instrumental in establishing this viewpoint. We reassessed data from that study to find out whether the relation is strictly increasing or whether there is a threshold in this relation. Methods We used logistic splines to model the relation of risk of cardiovascular and all-cause death with systolic blood pressure, using age-specific and sex-specific rates. We tested for the independence of the slope parameters from age and sex, and the reduced model with common slopes was used to produce a model different from the conventional linear logistic model. Findings Against the predictions of the linear logistic model, neither all-cause nor cardiovascular deaths depended on systolic blood pressure in a strictly increasing manner. The linear logistic model was rejected by the Framingham data. Instead, risk was independent of systolic blood pressure for all pressures lower than a threshold at the 70th percentile for a person of a given age and sex. Risk sharply increased with pressure higher than the 80th percentile. Since systolic blood pressure steadily increases with age, the threshold increases with age, but more rapidly in women than in men. Interpretation The Framingham data contradict the concept that lower pressures imply lower risk and the idea that 140 mm Hg is a useful cut-off value for hypertension for all adults. There is an age-dependent and sex-dependent threshold for hypertension. A substantial proportion of the population who would currently be thought to be at increased risk are, therefore, at no increased risk.	Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Dept Med Cardiol, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90025 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Port, S (corresponding author), Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90025 USA.		Demer, Linda L/I-5770-2013	Demer, Linda L/0000-0002-9618-6895	NHLBI NIH HHS [P50 HL52319] Funding Source: Medline; PHS HHS [P01 30568] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052319] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1997, ARCH INTERN MED, V157, P2413; Borghi C, 1998, J CARDIOVASC PHARM, V32, pS24, DOI 10.1097/00005344-199800004-00005; Chalmers J, 1999, J HYPERTENS, V17, P151; *COOP RES, 1991, JAMA-J AM MED ASSOC, V275, P1557; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; Keys A.B., 1980, 7 COUNTRIES MULTIVAR, P381; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; *NAT CTR HLTH STAT, 1964, BLOOD PRESS AD AG SE; O'Brien E, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00157-9; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; *USHEW, 1968, 74599 USHEW NIH	11	159	161	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 15	2000	355	9199					175	180		10.1016/S0140-6736(99)07051-8	http://dx.doi.org/10.1016/S0140-6736(99)07051-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276LR	10675116				2022-12-01	WOS:000084879700010
J	MacNeilage, PF; Davis, BL				MacNeilage, PF; Davis, BL			On the origin of internal structure of word forms	SCIENCE			English	Article							SPEECH	This study shows that a corpus of proto-word forms shares four sequential sound patterns with words of modern languages and the first words of infants. Three of the patterns involve intrasyllabic consonant-vowel (CV) co-occurrence: labial (Lip) consonants with central vowels, coronal (tongue front) consonants with front vowels, and dorsal (tongue back) consonants with back vowels. The fourth pattern is an intersyllabic preference for initiating words with a labial consonant-vowel-coronal consonant sequence (LC). The CV effects may be primarily biomechanically motivated. The LC effect may be self-organizational, with multivariate causality. The findings support the hypothesis that these four patterns were basic to the origin of words.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	MacNeilage, PF (corresponding author), Univ Texas, Dept Psychol, Austin, TX 78712 USA.	macneilage@psy.utexas.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027733] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 27733-07] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bengtson J. D., 1994, ORIGIN LANGUAGES STU, P277; Boe L.-J., 1999, P 14 INT C PHON SCI, P2501; Boysson-Bardies B., 1992, PHONOLOGICAL DEV MOD, P369; CHOMSKY N, 1968, LANGUAGE PROBLEMS KN; Clark A., 1997, BEING THERE PUTTING, DOI DOI 10.7551/MITPRESS/1552.001.0001; DAVIS BD, UNPUB; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; DAVIS BL, 1999, 20 ANN CHILD PHON C; DEBOYSSONBARDIES B, 1993, NATO ADV SCI INST SE, V69, P353; Dixon R.M.W., 1980, LANGUAGES AUSTR; GILDERSLEEVE C, THESIS U TEXAS; GODDARD I, 1987, CURR ANTHROPOL, V28, P657; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1963, LANGUAGES AFRICA; Hockett CF., 1960, ANIMAL SOUNDS COMMUN, P392; Ingram D., 1974, J CHILD LANG, V1, P49; Janson T., 1986, PHONOLOGY YB, V3, P179, DOI DOI 10.1017/S0952675700000634; KORNHUBER HH, 1987, ENCY NEUROSCIENCE, P1302; Langsdale, 1996, FIRST LANG, V16, P159, DOI 10.1177/014272379601604702; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; LOCKE JL, 1990, J CHILD LANG, V17, P1, DOI 10.1017/S0305000900013076; LOCKE JL, 1993, PHONOLOGICAL ACQUISI; LOEB GE, 1987, ENCY NEUROSCIENCE, P690; MACKEN M, 1987, LINGUA, V44, P219; MacNeilage PF, 1997, SPEECH COMMUN, V22, P269, DOI 10.1016/S0167-6393(97)00022-8; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; MacNeilage PF, 1999, PSYCHOL SCI, V10, P459, DOI 10.1111/1467-9280.00187; MacNeilage PF, 2000, CHILD DEV, V71, P153, DOI 10.1111/1467-8624.00129; MACNEILAGE PF, 1993, DEV NEUROCOGNITION S, P123; MACNEILAGE PF, IN PRESS EVOLUTIONAR; Maddieson Ian, 1992, PHONOLOGY, V9.1, P45; MENSTOWICZ M, 1994, PHONOLOGY GEN GRAMMA; Oller DK, 1993, 1 2 LANGUAGE PHONOLO, P45; Ruhlen Merritt, 1994, ORIGIN LANGUAGES STU; TEIXERA E, UNPUB; Vihman M. M, 1992, PHONOLOGICAL DEV MOD, P393	36	195	197	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					527	531		10.1126/science.288.5465.527	http://dx.doi.org/10.1126/science.288.5465.527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	306YJ	10775113				2022-12-01	WOS:000086626000048
J	McKeganey, N; Norrie, J				McKeganey, N; Norrie, J			Association between illegal drugs and weapon carrying in young people in Scotland: schools' survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCOTTISH SCHOOLCHILDREN; VIOLENT BEHAVIOR; SAMPLE; ADOLESCENTS; STUDENTS	Objectives To identify the type and extent of weapons being carried among young people in Scotland, and to determine the relation between use of illegal drugs and weapon carrying. Design Questionnaire school survey. Setting Independent schools in central Scotland and schools in Lanarkshire and Perth and Kinross. Participants 3121 students aged 11 to 16 in 20 schools. Main outcome measures Self completion questionnaire reporting history of drug use and weapon carrying. Results Overall, 34.1% of males and 8.6% of females reported having carried a weapon (P < 0.0001), ranging From 29.2% of boys aged 11-13 (classes S1 to S2) to 39.3% of boys aged 13-15 (S3 to S4). These values are higher than those in a recent survey of young people in England. Weapon carrying in Lanarkshire was 70% higher for males than in the rural area of Perth and Kinross. Both males and females who had taken drugs were more likely to carry weapons (63.5% of male drug users versus 20.5%, of non-users and 22.8% of female drug users versus 3.7% of non-users; both P < 0.0001). The proportions of males carrying weapons who used none, one, two, three or four, or five or more illegal drugs were 21%, 52%, 68% 74%, and 92% respectively. A similar trend was found among females. Conclusions Better information is needed on the nature and extent of weapon carrying by young people in the United Kingdom, and better educational campaigns are needed warning of the dangers of carrying weapons.	Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	McKeganey, N (corresponding author), Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland.	gkua27@udcf.gla.ac.uk						BALDING J, 1996, CASH CARRY YOUNG PEO; Barnard M, 1996, DRUG-EDUC PREV POLIC, V3, P81, DOI 10.3109/09687639609019313; Barnard M, 1998, ADDICT RES, V6, P421, DOI 10.3109/16066359809026060; DuRant RH, 1997, ARCH PEDIAT ADOL MED, V151, P360, DOI 10.1001/archpedi.1997.02170410034004; Forsyth A, 1998, DRUG-EDUC PREV POLIC, V5, P157, DOI 10.3109/09687639809006681; Friedman AS, 1998, AGGRESS VIOLENT BEH, V3, P339, DOI 10.1016/S1359-1789(97)00012-8; Komro KA, 1998, J CHILD ADOLES SUBST, V8, P77; Lowry R, 1998, AM J PREV MED, V14, P122, DOI 10.1016/S0749-3797(97)00020-2; McKeganey N, 1996, BRIT MED J, V313, P401; McKeganey N, 1999, ADDICT RES, V7, P493, DOI 10.3109/16066359909004402; Presley CA, 1997, J AM COLL HEALTH, V46, P3, DOI 10.1080/07448489709595580; VALOIS RF, 1995, J ADOLESCENT HEALTH, V16, P26, DOI 10.1016/1054-139X(95)94070-O; Wagner EF, 1996, AGGRESS VIOLENT BEH, V1, P375, DOI 10.1016/S1359-1789(96)00008-0	13	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2000	320	7240					982	984		10.1136/bmj.320.7240.982	http://dx.doi.org/10.1136/bmj.320.7240.982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753152	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-01	WOS:000086453100024
J	Matsunami, H; Montmayeur, JP; Buck, LB				Matsunami, H; Montmayeur, JP; Buck, LB			A family of candidate taste receptors in human and mouse	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; MAMMALS; TRANSDUCTION; GENETICS; MICE	The gustatory system of mammals can sense four basic taste qualities, bitter, sweet, salty and sour, as well as umami, the taste of glutamate(1-6). Previous studies suggested that the detection of bitter and sweet tastants by taste receptor cells in the mouth is likely to involve G-protein-coupled receptors(2,7,8). Although two putative G-protein-coupled bitter/sweet taste receptors have been identified(9), the chemical diversity of bitter and sweet compounds leads one to expect that there is a larger number of different receptors(8,10,11). Here we report the identification of a family of candidate taste receptors (the TRBs) that are members of the G-protein-coupled receptor superfamily and that are specifically expressed by taste receptor cells. A cluster of genes encoding human TRBs is located adjacent to a Prp gene locus(12), which in mouse is tightly linked to the SOA genetic locus that is involved in detecting the bitter compound sucrose octaacetate(13-15). Another TRB gene is found on a human contig assigned to chromosome 5p15, the location of a genetic locus (PROP) that controls the detection of the bitter compound 6-n-propyl-2-thiouracil in humans(16,17).	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buck, LB (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02215 USA.	lbuck@hms.harvard.edu	Montmayeur, Jean-Pierre R/A-5723-2009	Montmayeur, Jean-Pierre/0000-0002-0942-1114				AZEN E, 1984, P NATL ACAD SCI-BIOL, V81, P5561, DOI 10.1073/pnas.81.17.5561; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; BARTOSHUK LM, 1994, ANNU REV PSYCHOL, V45, P419, DOI 10.1146/annurev.ps.45.020194.002223; Berghard A, 1996, J NEUROSCI, V16, P909; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Lindemann B, 1999, NAT MED, V5, P381, DOI 10.1038/7377; Lindemann B, 2000, NAT NEUROSCI, V3, P99, DOI 10.1038/72153; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; ROUX KH, 1995, PCR PRIMER LAB MANUA; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Smith DV, 1999, CURR BIOL, V9, pR453, DOI 10.1016/S0960-9822(99)80280-2; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	29	537	580	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					601	+		10.1038/35007072	http://dx.doi.org/10.1038/35007072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766242				2022-12-01	WOS:000086400100053
J	Mitchell, SJ; Silver, RA				Mitchell, SJ; Silver, RA			Glutamate spillover suppresses inhibition by activating presynaptic mGluRs	NATURE			English	Article							PURKINJE-CELL SYNAPSES; RAT CEREBELLUM; SYNAPTIC INHIBITION; GABA(A) RECEPTORS; GRANULE CELLS; MODULATION; TRANSMISSION; PROBABILITY; DEPRESSION; CURRENTS	Metabotropic glutamate receptors (mGluRs) found on synaptic terminals throughout the brain are thought to be important in modulating neurotransmission(1,2). Activation of mGluRs by synaptically released glutamate depresses glutamate release from excitatory terminals(3-5) but the physiological role of mGluRs on inhibitory terminals is unclear. We have investigated activation of mGluRs on inhibitory terminals within the cerebellar glomerulus, a structure in which GABA (gamma-aminobutyric acid)-releasing inhibitory terminals and glutamatergic excitatory terminals are in close apposition and make axo-dendritic synapses onto granule cells(6). Here we show that 'spillover' of glutamate, which is released from excitatory mossy fibres, inhibits GABA release from Golgi cell terminals by activating presynaptic mGluRs under physiological conditions. The magnitude of the depression of the inhibitory postsynaptic current is dependent on the frequency of mossy fibre stimulation, reaching 50% at 100 Hz. Furthermore, the duration of inhibitory postsynaptic current depression mirrors the time course of mossy fibre activity. Our results establish that mGluRs on inhibitory interneuron axons(7) sense the activity of neighbouring excitatory synapses. This heterosynaptic mechanism is likely to boost the efficacy of active excitatory fibres by locally reducing the level of inhibition.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638				Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Eccles J. C. M., 1967, CEREBELLUM NEURONAL; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Ito M., 1984, CEREBELLUM NEURAL CO; Jaarsma D, 1998, J NEUROCYTOL, V27, P303, DOI 10.1023/A:1006982023657; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Knoflach F, 1998, J PHYSIOL-LONDON, V509, P347, DOI 10.1111/j.1469-7793.1998.347bn.x; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Morishita W, 1998, J NEUROSCI, V18, P4870; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neki A, 1996, NEUROSCIENCE, V75, P815, DOI 10.1016/0306-4522(96)00316-8; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tia S, 1996, J NEUROSCI, V16, P3630; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vetter P, 1999, NEUROPHARMACOLOGY, V38, P805, DOI 10.1016/S0028-3908(99)00003-9; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x	30	195	198	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					498	502		10.1038/35006649	http://dx.doi.org/10.1038/35006649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761918				2022-12-01	WOS:000086257700049
J	Reilly, JG; Ayis, SA; Ferrier, IN; Jones, SJ; Thomas, SHL				Reilly, JG; Ayis, SA; Ferrier, IN; Jones, SJ; Thomas, SHL			QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients	LANCET			English	Article							TORSADE-DE-POINTES; SUDDEN-DEATH; DISPERSION; THIORIDAZINE; NEUROLEPTICS; GUIDELINES; MEDICATION; DOSAGE; RISK	Background Sudden unexplained death in psychiatric patients may be due to drug-induced arrhythmia, of which lengthening of the rate-corrected QT interval (QTc) on the electrocardiogram is a predictive marker. We estimated the point prevalence of QTc lengthening in psychiatric patients and the effects of various psychotropic drugs. Methods Electrocardiograms were obtained from 101 healthy reference individuals and 495 psychiatric patients in various inpatient and community settings and were analysed with a previously validated digitiser technique. Patients with and without QTc lengthening, QTc dispersion, and T-wave abnormality were compared by logistic regression to calculate odds ratios for predictive variables. Findings Abnormal QTc was defined from the healthy reference group as more than 456 ms and was present in 8% (40 of 495) of patients. Age over 65 years (odds ratio 3.0 [95% CI 1.1-8.3]), use of tricyclic antidepressants (4.4 [1.6-12.1]), thioridazine (5.4 [2.0-13.7]), and droperidol (6.7 [1.8-24.8]) were robust predictors of QTc lengthening, as was antipsychotic dose (high dose 5.3 [1.2-24.4]; very high dose 8.2 [1.5-43.6]). Abnormal QT dispersion or T-wave abnormalities were not significantly associated with antipsychotic treatment, but were associated with lithium therapy. Interpretation Antipsychotic drugs cause QTc lengthening in a dose-related manner. Risks are substantially higher for thioridazine and droperidol. These drugs may therefore confer an increased risk of drug-induced arrhythmia.	Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Acad Dept Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Parkside Community Mental Hlth Ctr, Tees & NE Yorkshire NHS Trust, Middlesbrough, Cleveland, England	Newcastle University - UK; Newcastle University - UK	Thomas, SHL (corresponding author), Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Ayis, Salma/AAD-5336-2019	Ayis, Salma/0000-0002-0449-869X				ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Atkins M, 1997, PSYCHIAT B, V21, P224, DOI [10.1192/pb.21.4.224, DOI 10.1192/PB.21.4.224]; Barnett AA, 1996, LANCET, V348, P256, DOI 10.1016/S0140-6736(05)65549-3; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; DAY CP, 1990, BRIT HEART J, V63, P342; DONATINI B, 1992, CARDIOLOGY, V81, P340, DOI 10.1159/000175827; Drolet B, 1999, J PHARMACOL EXP THER, V288, P1261; FABER TS, 1994, DRUG SAFETY, V11, P463, DOI 10.2165/00002018-199411060-00007; GIARDINA EGV, 1979, CIRCULATION, V60, P1045, DOI 10.1161/01.CIR.60.5.1045; Hartigan-Go K., 1995, British Journal of Clinical Pharmacology, V39, p104P; HartiganGo K, 1996, CLIN PHARMACOL THER, V60, P543, DOI 10.1016/S0009-9236(96)90150-2; HENDERSON RA, 1991, HUM EXP TOXICOL, V10, P59, DOI 10.1177/096032719101000110; HII JTY, 1992, CIRCULATION, V86, P1376, DOI 10.1161/01.CIR.86.5.1376; Huston J R, 1966, JAMA, V198, P134, DOI 10.1001/jama.198.1.134; KAUTZNER J, 1994, PACE, V17, P928, DOI 10.1111/j.1540-8159.1994.tb01435.x; KIRCHNER V, 1998, COCHRANE LIB; Lawrence KR, 1997, PHARMACOTHERAPY, V17, P531; LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143; MITCHELL JE, 1982, J CLIN PSYCHIAT, V43, P47; NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401; REY MJ, 1989, INT CLIN PSYCHOPHARM, V4, P95, DOI 10.1097/00004850-198904000-00001; Royal College of psychiatrists, 1997, CR57 ROYAL COLL PSYC; SCHULZ P, 1989, INT CLIN PSYCHOPHARM, V4, P105, DOI 10.1097/00004850-198904000-00002; THOMAS SHL, 1994, ADVERSE DRUG REACT T, V13, P77; THOMPSON C, 1994, BRIT J PSYCHIAT, V164, P448, DOI 10.1192/bjp.164.4.448; Warner JP, 1996, ACTA PSYCHIAT SCAND, V93, P311, DOI 10.1111/j.1600-0447.1996.tb10653.x	26	444	463	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1048	1052		10.1016/S0140-6736(00)02035-3	http://dx.doi.org/10.1016/S0140-6736(00)02035-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	302TB	10744090				2022-12-01	WOS:000086380800011
J	Kornberg, TB; Krasnow, MA				Kornberg, TB; Krasnow, MA			The Drosophila genome sequence: Implications for biology and medicine	SCIENCE			English	Editorial Material								The 120-megabase euchromatic portion of the Drosophila melanogaster genome has been sequenced. Because the genome is compact and many genetic tools are available, and because fly cell biology and development have much in common with mammals, this sequence may be the Rosetta stone for deciphering the human genome.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; Stanford University	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BODMER R, 1999, HEART DEV, P65; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; KERKUT GA, 1985, COMP INSECT PHYSIOL; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Riddle RD, 1999, SCI AM, V280, P74, DOI 10.1038/scientificamerican0299-74; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Spradling AC, 1999, GENETICS, V153, P135; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wigglesworth, 1939, PRINCIPLES INSECT PH; XU T, 1993, DEVELOPMENT, V117, P1223	25	55	63	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2218	2220		10.1126/science.287.5461.2218	http://dx.doi.org/10.1126/science.287.5461.2218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731136				2022-12-01	WOS:000086049100037
J	Matsuoka, T; Hirata, M; Tanaka, H; Takahashi, Y; Murata, T; Kabashima, K; Sugimoto, Y; Kobayashi, T; Ushikubi, F; Aze, Y; Eguchi, N; Urade, Y; Yoshida, N; Kimura, K; Mizoguchi, A; Honda, Y; Nagai, H; Narumiya, S				Matsuoka, T; Hirata, M; Tanaka, H; Takahashi, Y; Murata, T; Kabashima, K; Sugimoto, Y; Kobayashi, T; Ushikubi, F; Aze, Y; Eguchi, N; Urade, Y; Yoshida, N; Kimura, K; Mizoguchi, A; Honda, Y; Nagai, H; Narumiya, S			Prostaglandin D-2 as a mediator of allergic asthma	SCIENCE			English	Article							CELL-DEFICIENT; D RECEPTOR; AIRWAYS; HYPERREACTIVITY; ACCUMULATION; INFLAMMATION; EXPRESSION; CHALLENGE; RELEASE; POTENT	Allergic asthma is caused by the aberrant expansion in the lung of T helper cells that produce type 2 (T(H)2) cytokines and is characterized by infiltration of eosinophils and bronchial hyperreactivity. This disease is often triggered by mast cells activated by immunoglobulin E (IgE)-mediated allergic challenge. Activated mast cells release Various chemical mediators, including prostaglandin D-2 (PCD2), whose role in allergic asthma has now been investigated by the generation of mice deficient in the PCD receptor (DP). Sensitization and aerosol challenge of the homozygous mutant (DP-/-) mice with ovalbumin (OVA) induced increases in the serum concentration of IgE similar to those in wild-type mice subjected to this model of asthma. However, the concentrations of T(H)2 cytokines and the extent of lymphocyte accumulation in the lung of OVA-challenged DP-/- mice were greatly reduced compared with those in wild-type animals. Moreover, DP-/- mice showed only marginal infiltration of eosinophils and failed to develop airway hyperreactivity. Thus, PGD(2) functions as a mast cell-derived mediator to trigger asthmatic responses.	Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Ophthalmol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Anat, Sakyo Ku, Kyoto 6068501, Japan; Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5020003, Japan; Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan; Ono Pharmaceut Co, Fukui Safety Res Labs, Fukui 9138538, Japan; Osaka Biosci Inst, Osaka 5650874, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan	Kyoto University; Kyoto University; Kyoto University; Gifu Pharmaceutical University; Kyoto University; Ono Pharmaceutical Co Ltd; University of Tokyo	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Kimura, Kazushi/ABB-4007-2020; Sugimoto, Yukihiko/AAV-6470-2021; Kabashima, Kenji/G-2521-2014	Sugimoto, Yukihiko/0000-0001-6973-932X; Kabashima, Kenji/0000-0002-0773-0554; Murata, Takahiko/0000-0003-0132-5424				AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; BARR RM, 1988, BRIT J PHARMACOL, V94, P773, DOI 10.1111/j.1476-5381.1988.tb11588.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; EMERY DL, 1989, J APPL PHYSIOL, V67, P959, DOI 10.1152/jappl.1989.67.3.959; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; FUJITANI Y, UNPUB; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; Howarth PH, 1997, ALLERGY, V52, P12, DOI 10.1111/j.1398-9995.1997.tb04878.x; IKAI K, 1985, J INVEST DERMATOL, V85, P82, DOI 10.1111/1523-1747.ep12275365; Konzett H, 1940, N-S ARCH EX PATH PH, V195, P71, DOI 10.1007/BF01861842; LEWIS RA, 1981, NATURE, V293, P103, DOI 10.1038/293103a0; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; MATSUOKA T, UNPUB; MIZOGUCHI A, IN PRESS P NATL ACAD; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; O'Sullivan S, 1999, ACTA PHYSIOL SCAND, V166, P1; Oida H, 1997, FEBS LETT, V417, P53, DOI 10.1016/S0014-5793(97)01253-2; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; Tanaka H, 1998, LIFE SCI, V62, pPL169, DOI 10.1016/S0024-3205(98)00047-2; Tsuri T, 1997, J MED CHEM, V40, P3504, DOI 10.1021/jm970343g; URADE Y, 1989, J IMMUNOL, V143, P2982; WALLS AF, 1991, LUNG, V169, P227, DOI 10.1007/BF02714157; WENZEL SE, 1991, J ALLERGY CLIN IMMUN, V87, P540, DOI 10.1016/0091-6749(91)90013-E; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	28	602	641	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2000	287	5460					2013	2017		10.1126/science.287.5460.2013	http://dx.doi.org/10.1126/science.287.5460.2013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720327	Green Submitted			2022-12-01	WOS:000085902800061
J	Reich, MR				Reich, MR			The global drug cap	SCIENCE			English	Article							COMMUNITY; HEALTH	Global inequities in access to pharmaceutical products exist between rich and poor countries because of market and government failures as well as huge income differences. Multiple policies are required to address this global drug gap for three categories of pharmaceutical products: essential drugs, new drugs, and yet-to-be-developed drugs. Policies should combine "push" approaches of financial subsidies to support targeted drug development, "pull" approaches of financial incentives such as market guarantees, and "process" approaches aimed at improved institutional-capacity. Constructive solutions are needed that can both protect the incentives for research and development and reduce the inequities of access.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Reich, MR (corresponding author), Harvard Univ, Sch Publ Hlth, 667 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 1993, WORLD DEV REP 1993 I; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; FUJISAKI T, 1997, ASSESSMENT TDRS CONT; *IMS, 1999, IMS HLTH; Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865; KREMER M, 1999, PURCHASE PRECOMMITME; Lanjouw J.O., 1999, 6366 NAT BUR EC RES; Management Sciences for Health, 1997, MAN DRUG SUPPL; MCPAKE B, 1993, SOC SCI MED, V36, P1383, DOI 10.1016/0277-9536(93)90381-D; Milstien JB, 1998, DRUG INF J, V32, P175, DOI 10.1177/009286159803200125; Olliaro P, 1996, JAMA-J AM MED ASSOC, V275, P230, DOI 10.1001/jama.275.3.230; Parry E, 1997, THORAX, V52, P589, DOI 10.1136/thx.52.7.589; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Reich M.R., 1998, DAP RES SERIES; REICH MR, 1987, HEALTH POLICY, V8, P39, DOI 10.1016/0168-8510(87)90129-1; Reich MR, 1999, B WORLD HEALTH ORGAN, V77, P675; Trouiller P, 1999, TROP MED INT HEALTH, V4, P412, DOI 10.1046/j.1365-3156.1999.00420.x; *UNDP WORLD BANK W, 1995, TROP DIS RES PROGR 1; Wehrwein P, 1999, HARV PUBLIC HLTH SUM, P32; *WHO EXP COMM, 1998, WHO TECHN REP SER, V882; 1999, GUIDELINES DRUG DONA; 1999, SUPPLY DIVISION ANN; 1998, AIDS EPIDEMIC UPDATE	24	50	51	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1979	1981		10.1126/science.287.5460.1979	http://dx.doi.org/10.1126/science.287.5460.1979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755953				2022-12-01	WOS:000085902800051
J	Hulka, BS; Kerkvliet, NL; Tugwell, P				Hulka, BS; Kerkvliet, NL; Tugwell, P			Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA; Oregon State Univ, Corvallis, OR 97331 USA; Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada	University of North Carolina; University of North Carolina Chapel Hill; Oregon State University; University of Ottawa; Ottawa Hospital Research Institute	Hulka, BS (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.		Tugwell, Peter/AFD-8076-2022	Tugwell, Peter/0000-0001-5062-0556				Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; Bondurant S., 1999, SAFETY SILICONE BREA; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Kaiser J, 1999, SCIENCE, V284, P1600; 1975, FED REG, P706	5	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					812	815		10.1056/NEJM200003163421111	http://dx.doi.org/10.1056/NEJM200003163421111			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717019				2022-12-01	WOS:000085846900011
J	Savaglio, S; Carbone, V				Savaglio, S; Carbone, V			Human performance - Scaling in athletic world records	NATURE			English	Article									Space Telescope Sci Inst, Baltimore, MD 21218 USA; Univ Calabria, Dipartimento Fis, I-87036 Arcavacata Di Rende, CS, Italy; Univ Calabria, Ist Nazl Fis Mat, Unita Cosenza, I-87036 Arcavacata Di Rende, CS, Italy	Space Telescope Science Institute; University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Calabria	Savaglio, S (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	savaglio@stsci.edu	Carbone, Vincenzo/AAD-8557-2020	Carbone, Vincenzo/0000-0002-3182-6679; Savaglio, Sandra/0000-0003-2354-3238				di Prampero P E, 1981, Rev Physiol Biochem Pharmacol, V89, P143; Henry FM, 1955, RES QUART, V26, P147, DOI 10.1080/10671188.1955.10612815; Katz JS, 1999, J SPORT SCI, V17, P467; Kennelly AE, 1906, P AM ACAD ARTS SCI, V42, P273; MOGNONI P, 1982, EUR J APPL PHYSIOL O, V49, P287, DOI 10.1007/BF00441290	5	26	26	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					244	244		10.1038/35005165	http://dx.doi.org/10.1038/35005165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749198	Bronze, Green Submitted			2022-12-01	WOS:000086022200036
J	Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ				Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ			Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity	SCIENCE			English	Article							HEMISPHERIC DICHOTOMY; GIANT IMPACT; FLOW; CONSTRAINTS; THICKNESS; DYNAMICS; MISSION; CHANNEL; BASINS; MANTLE	Topography and gravity measured by the Mars Global Surveyor have enabled determination of the global crust and upper mantle structure of Mars. The planet displays two distinct crustal zones that do not correlate globally with the geologic dichotomy: a region of crust that thins progressively from south to north and encompasses much of the southern highlands and Tharsis province and a region of approximately uniform crustal thickness that includes the northern lowlands and Arabia Terra. The strength of the lithosphere beneath the ancient southern highlands suggests that the northern hemisphere was a locus of high heat flow early in martian history. The thickness of the elastic lithosphere increases with time of loading in the northern plains and Tharsis. The northern lowlands contain structures interpreted as large buried channels that are consistent with northward transport of water and sediment to the lowlands before the end of northern hemisphere resurfacing.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; NASA, Goddard Space Flight Ctr, Earth Sci Directorate, Greenbelt, MD 20771 USA; Stanford Univ, Ctr Radio Astron, Moffett Field, CA 94035 USA; Grp Rech Geodesie Spatiale, Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Neumann, Gregory A/I-5591-2013; Lemoine, Frank/D-1215-2013; Banerdt, William/Q-7324-2019; Rowlands, David/D-2751-2012; Zhong, Shijie/A-5290-2010	Neumann, Gregory A/0000-0003-0644-9944; Banerdt, William/0000-0003-3125-1542; Aharonson, Oded/0000-0001-9930-2495				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; BANERDT WB, 1992, MARS, P249; BILLS BG, 1978, J GEOPHYS RES, V83, P3497, DOI 10.1029/JB083iB07p03497; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; Carr M., 1981, SURFACE MARS; CHOBLET G, 1998, LUNAR PLANET SCI, V30, P1556; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Dunlop D, 1997, ROCK MAGNETISM; FORSYTH DW, 1985, J GEOPHYS RES-SOLID, V90, P2623, DOI 10.1029/JB090iB14p12623; FORSYTH DW, 1993, J GEOPHYS RES-SOL EA, V98, P16073, DOI 10.1029/93JB01722; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey H, 1998, GEOPHYS RES LETT, V25, P4409, DOI 10.1029/1998GL900095; Frey HV, 1996, GEOPHYS RES LETT, V23, P721, DOI 10.1029/96GL00744; GOETZE C, 1978, PHILOS T R SOC A, V288, P99, DOI 10.1098/rsta.1978.0008; Grasset O, 1998, J GEOPHYS RES-SOL EA, V103, P18171, DOI 10.1029/98JB01492; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Kaula W. M., 1966, THEORY SATELLITE GEO; Kiefer WS, 1996, J GEOPHYS RES-PLANET, V101, P9239, DOI 10.1029/95JE03699; Klaucke I, 1997, SEDIMENTOLOGY, V44, P1093, DOI 10.1111/j.1365-3091.1997.tb02180.x; Klaucke I, 1998, GEOL SOC AM BULL, V110, P22, DOI 10.1130/0016-7606(1998)110<0022:MASOAD>2.3.CO;2; LEMOINE FG, 1999, EOS S, V80, pF618; LEMOINE FG, UNPUB; MCGILL GE, 1989, J GEOPHYS RES-SOLID, V94, P2753, DOI 10.1029/JB094iB03p02753; MCNUTT MK, 1984, J GEOPHYS RES, V89, P1180, DOI 10.1029/JB089iB13p11180; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Morgan J, 1999, GEOLOGY, V27, P407, DOI 10.1130/0091-7613(1999)027<0407:CTTDOA>2.3.CO;2; NIMMO F, IN PRESS J GEOPHYS R; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PHILLIPS RJ, 1973, J GEOPHYS RES, V78, P4815, DOI 10.1029/JB078i023p04815; PHILLIPS RJ, 2000, LUNEAR PLANET SCI, V31; SCHUBERT G, 1990, J GEOPHYS RES-SOLID, V95, P14095, DOI 10.1029/JB095iB09p14095; SIMONS FJ, IN PRESS J GEOPHYS R; Simons M, 1997, GEOPHYS J INT, V131, P24, DOI 10.1111/j.1365-246X.1997.tb00593.x; SJOGREN WL, 1999, EOS S, V80, pF618; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1998, SCIENCE, V279, P1686, DOI 10.1126/science.279.5357.1686; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; SOLOMON SC, 1990, J GEOPHYS RES-SOLID, V95, P11073, DOI 10.1029/JB095iB07p11073; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; SPOHN T, 1999, EOS S, V80, pF619; Tanaka K. L., 1992, MARS, P345; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; TYLER GL, 1992, J GEOPHYS RES-PLANET, V97, P7759, DOI 10.1029/92JE00513; WATTS AB, 1980, J GEOPHYS RES, V85, P5369; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; ZHONG S, IN PRESS J GEOPHYS R; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	55	433	441	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1788	1793		10.1126/science.287.5459.1788	http://dx.doi.org/10.1126/science.287.5459.1788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710301				2022-12-01	WOS:000085775300033
J	Brown, BE; Dunne, RP; Goodson, MS; Douglas, AE				Brown, BE; Dunne, RP; Goodson, MS; Douglas, AE			Marine ecology - Bleaching patterns in reef corals	NATURE			English	Article							EVENT		Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	Newcastle University - UK; University of York - UK	Brown, BE (corresponding author), Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Brown, Barbara E/N-2104-2015; Brown, Barbara/AAT-7991-2021	Goodson, Michael/0000-0002-5004-551X				ADACHI M, 1994, J PHYCOL, V30, P857, DOI 10.1111/j.0022-3646.1994.00857.x; Brown BE, 1996, CORAL REEFS, V15, P151, DOI 10.1007/BF01145885; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; BROWN BE, IN PRESS MAR ECOL PR; Brown BE, 1997, CORAL REEFS, V16, P129; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Jones RJ, 1997, MAR ECOL PROG SER, V158, P51, DOI 10.3354/meps158051; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843	11	141	147	5	61	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					142	143		10.1038/35004657	http://dx.doi.org/10.1038/35004657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724156				2022-12-01	WOS:000085870900036
J	Schlossmann, J; Ammendola, A; Ashman, K; Zong, XG; Huber, A; Neubauer, G; Wang, GX; Allescher, HD; Korth, M; Wilm, M; Hofmann, F; Ruth, P				Schlossmann, J; Ammendola, A; Ashman, K; Zong, XG; Huber, A; Neubauer, G; Wang, GX; Allescher, HD; Korth, M; Wilm, M; Hofmann, F; Ruth, P			Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase I beta	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; VASCULAR SMOOTH-MUSCLE; MEMBRANE-PROTEIN; CA2+ RELEASE; ION; PHOSPHORYLATION; PURIFICATION; SUBSTRATE	Calcium release from the endoplasmic reticulum controls a number of cellular processes, including proliferation and contraction of smooth muscle and other cells(1,2). Calcium release from inositol 1,4,5-trisphosphate (IP3)-sensitive stores is negatively regulated by binding of calmodulin to the IP3 receptor (IP3R)(3,4) and the NO/cGMP/cGMP kinase I (cGKI) signalling pathways(5,6). Activation of cGKI decreases IP3-stimulated elevations in intracellular calcium(7), induces smooth muscle relaxation(8) and contributes to the antiproliferative(9) and pro-apoptotic effects of NO/cGMP(10). Here we show that, in microsomal smooth muscle membranes, cGKI beta phosphorylated the IP3R and cGKI beta, and a protein of relative molecular mass 125,000 which we now identify as the IP3R-associated cGMP kinase substrate (IRAG). These proteins were co-immunoprecipitated by antibodies directed against cGKI, IP3R or IRAG. IRAG was found in many tissues including aorta, trachea and uterus, and was localized perinuclearly after heterologous expression in COS-7 cells. Bradykinin-stimulated calcium release was not affected by the expression of either IRAG or cGKI beta, which we tested in the absence and presence of cGMP. However, calcium release was inhibited after co-expression of IRAG and cGKI beta in the presence of cGMP. These results identify IRAG as an essential NO/cGKI-dependent regulator of IP3-induced calcium release.	Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; European Mol Biol Lab, Prot & Peptide Grp, D-69117 Heidelberg, Germany; Univ Hamburg, Hosp Eppendorf, Abt Pharmakol Pharmazeuten, D-20246 Hamburg, Germany	Technical University of Munich; European Molecular Biology Laboratory (EMBL); University of Hamburg	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Biedersteiner Str 29, D-80802 Munich, Germany.		Schlossmann, Jens/I-7743-2016; Ashman, Keith/G-2328-2011	Schlossmann, Jens/0000-0002-2550-6839; Wilm, Matthias/0000-0002-5461-6834				BALTENSPERGER K, 1988, EUR J BIOCHEM, V172, P7, DOI 10.1111/j.1432-1033.1988.tb13848.x; BEHRENS TW, 1994, J IMMUNOL, V153, P682; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Brenman JE, 1997, DEV NEUROSCI-BASEL, V19, P224, DOI 10.1159/000111211; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; CASNELLI.JE, 1974, P NATL ACAD SCI USA, V71, P1891, DOI 10.1073/pnas.71.5.1891; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Eigenthaler M, 1999, Rev Physiol Biochem Pharmacol, V135, P173, DOI 10.1007/BFb0033673; Fujita S, 1999, J VASC RES, V36, P299, DOI 10.1159/000025658; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; KOGA T, 1994, J BIOL CHEM, V269, P11640; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rooney TA, 1996, J BIOL CHEM, V271, P19817, DOI 10.1074/jbc.271.33.19817; RUTH P, 1993, P NATL ACAD SCI USA, V90, P2623, DOI 10.1073/pnas.90.7.2623; Shaughnessy JD, 1999, ONCOGENE, V18, P2069; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; VONDERLEYEN H, 1994, P NATL ACAD SCI USA, V92, P1137; Wilm M, 1996, ANAL CHEM, V68, P527, DOI 10.1021/ac950875+	29	350	370	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					197	201		10.1038/35004606	http://dx.doi.org/10.1038/35004606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724174				2022-12-01	WOS:000085870900055
J	Voss, LD; Mulligan, J				Voss, LD; Mulligan, J			Bullying in school: are short pupils at risk? Questionnaire study in a cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp, Univ Child Hlth, Southampton SO21 16YD, Hants, England		Voss, LD (corresponding author), Southampton Gen Hosp, Univ Child Hlth, Southampton SO21 16YD, Hants, England.	linda.voss@phnt.swest.nhs.uk						Leff S, 1999, BRIT MED J, V318, P1076, DOI 10.1136/bmj.318.7190.1076; Olweus D., 1994, AGGRESSIVE BEHAV CUR, P97; Salmon G, 1998, BRIT MED J, V317, P924; VOSS L, 1989, ACTA PAEDIATR SCAND, P65; WHITNEY I, 1993, EDUC RES, V35, P3, DOI 10.1080/0013188930350101	5	82	82	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2000	320	7235					612	613		10.1136/bmj.320.7235.612	http://dx.doi.org/10.1136/bmj.320.7235.612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291NH	10698879	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000085742600025
J	Distel, DL; Baco, AR; Chuang, E; Morrill, W; Cavanaugh, C; Smith, CR				Distel, DL; Baco, AR; Chuang, E; Morrill, W; Cavanaugh, C; Smith, CR			Marine ecology - Do mussels take wooden steps to deep-sea vents?	NATURE			English	Article							WHALE FALL; ENVIRONMENTS; BIVALVIA; COMMUNITY; MYTILIDAE; OCEAN		Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Harvard Univ, Biol Labs, Cambridge, MA 02138 USA	University of Maine System; University of Maine Orono; University of Hawaii System; Harvard University	Distel, DL (corresponding author), Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA.		Distel, Daniel/A-8047-2017	Distel, Daniel/0000-0002-3860-194X				BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; CAMPBELL KA, 1995, GEOLOGY, V23, P321, DOI 10.1130/0091-7613(1995)023<0321:BACBIP>2.3.CO;2; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; DEAN HK, 1993, MALACOLOGIA, V35, P21; DELL R K, 1987, National Museum of New Zealand Records, V3, P17; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; DISTEL DL, IN PRESS MOL PHYLOGE; Feldman RA, 1998, BIOL BULL, V194, P116, DOI 10.2307/1543041; GRASSLE JF, 1987, DEEP-SEA RES, V34, P1911, DOI 10.1016/0198-0149(87)90091-4; Gustafson RG, 1998, MALACOLOGIA, V40, P63; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; KENK VC, 1985, MALACOLOGIA, V26, P253; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; REID RGB, 1980, CAN J ZOOL, V58, P386, DOI 10.1139/z80-050; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SWOFFORD DL, 1997, PAUP 4 0; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373	17	231	244	2	67	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					725	726		10.1038/35001667	http://dx.doi.org/10.1038/35001667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693793				2022-12-01	WOS:000085423100040
J	Imai, S; Armstrong, CM; Kaeberlein, M; Guarente, L				Imai, S; Armstrong, CM; Kaeberlein, M; Guarente, L			Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ADP-RIBOSYLATION; RIBOSOMAL DNA; YEAST; INVIVO; HETEROCHROMATIN; RECOMBINATION; ACETYLATION; RESTRICTION; REPRESSION	Yeast Sir2 is a heterochromatin component that silences transcription at silent mating loci(1), telomeres(2) and the ribosomal DNA(3,4), and that also suppresses recombination in the rDNA(5) and extends replicative life span(6). Mutational studies indicate that lysine 16 in the amino-terminal tail of histone H4 and lysines 9, 14 and 18 in H3 are critically important in silencing, whereas lysines 5, 8 and 12 of H4 have more redundant functions(7-9). Lysines 9 and 14 of histone H3 and lysines 5, 8 and 16 of H4 are acetylated in active chromatin and hypoacetylated in silenced chromatin, and overexpression of Sir2 promotes global deacetylation of histones(9,10), indicating that Sir2. may be a histone deacetylase. Deacetylation of lysine 16 of H4 is necessary for binding the silencing protein, Sir3 (ref. 8). Here we show that yeast and mouse Sir2 proteins are nicotinamide adenine dinucleotide (NAD)dependent histone deacetylases, which deacetylate lysines 9 and 14 of H3 and specifically lysine 16 of H4. Our analysis of two SIR2 mutations supports the idea that this deacetylase activity accounts for silencing, recombination suppression and extension of life span in vivo. These findings provide a molecular framework of NAD-dependent histone deacetylation that connects metabolism, genomic silencing and ageing in yeast and, perhaps, in higher eukaryotes.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841; BANASIK M, 1994, MOL CELL BIOCHEM, V138, P185, DOI 10.1007/BF00928461; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KREIMEYER A, 1984, J BIOL CHEM, V259, P890; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MEYER T, 1986, EUR J BIOCHEM, V155, P157, DOI 10.1111/j.1432-1033.1986.tb09471.x; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; PERO RW, 1985, MUTAT RES, V142, P69, DOI 10.1016/S0165-7992(85)80016-6; RINE J, 1987, GENETICS, V116, P9; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; SINCLAIR DA, 1997, CELL, V91, P1; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	30	2637	2772	13	252	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					795	800		10.1038/35001622	http://dx.doi.org/10.1038/35001622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693811				2022-12-01	WOS:000085423100058
J	Mesecar, AD; Koshland, DE				Mesecar, AD; Koshland, DE			Structural biology - A new model for protein stereospecificity	NATURE			English	Article									Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Adv Mat, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mesecar, AD (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, 900 S Ashland Ave MC 870, Chicago, IL 60607 USA.			Mesecar, Andrew/0000-0002-1241-2577				Dixon M., 1979, ENZYMES, Vthird; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; Lehninger A.L., 1982, PRINCIPLES BIOCH; Lewis DL, 1999, NATURE, V401, P898, DOI 10.1038/44801; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; OGSTON AG, 1948, NATURE, V162, P963, DOI 10.1038/162963b0; SEGEL IH, 1972, ENZYME KINETICS; STRYER L, 1988, BIOCHEMISTRY; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409	9	106	107	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					614	615		10.1038/35001144	http://dx.doi.org/10.1038/35001144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688187				2022-12-01	WOS:000085288200039
J	Cates, W; Dallabetta, G				Cates, W; Dallabetta, G			The staying power of sexually transmitted diseases	LANCET			English	Article									Family Hlth Int, HIV AIDS Prevent & Care Dept, Tech Support, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), Family Hlth Int, HIV AIDS Prevent & Care Dept, Tech Support, POB 13950, Res Triangle Pk, NC 27709 USA.								0	9	10	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON WC1B 3SL, ENGLAND	0140-6736			LANCET	Lancet	DEC	1999	354			S			62	62						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267DT	10691477				2022-12-01	WOS:000084342100063
J	Ong, EK; Glantz, SA				Ong, EK; Glantz, SA			Tobacco industry efforts subverting international Agency for Research on Cancer's second-hand smoke study	LANCET			English	Article							RESPIRABLE SUSPENDED PARTICLES; PASSIVE SMOKING; LUNG-CANCER; NONSMOKING WOMEN; AIR-QUALITY; EXPOSURE; MISCLASSIFICATION; MULTICENTER; HEALTH; RISK	Scientific reports on second-hand smoke have stimulated legislation on clean indoor air in the USA, but less so in Europe. Recently, the largest European study, by the International Agency for Research on Cancer (IARC), demonstrated a 16% increase in the point estimate of risk in lung cancer for nonsmokers, a result consistent with earlier studies. However, the study was described by newspapers and the tobacco industry as demonstrating no increase in risk. To understand the tobacco industry's strategy on the IARC study we analysed industry documents released in US litigation and interviewed IARC investigators, The Philip Morris tobacco company feared that the study (and a possible IARC monograph on second-hand smoke) would lead to increased restrictions in Europe so they spearheaded an inter-industry, three-prong strategy to subvert IARC's work. The scientific strategy attempted to undercut IARC's research and to develop industry-directed research to counter the anticipated findings. The communications strategy planned to shape opinion by manipulating the media and the public. The government strategy sought to prevent increased smoking restrictions. The IARC study cost $2 million over ten years; Philip Morris planned to spend $2 million in one year alone and up to $4 million on research. The documents and Interviews suggest that the tobacco industry continues to conduct a sophisticated campaign against conclusions that secondhand smoke causes lung cancer and other diseases, subverting normal scientific processes.	Univ Calif San Francisco, Inst Hlth Policy Studies, Cardiovasc Res Inst, Dept Med,Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Cardiovasc Res Inst, Dept Med,Div Cardiol, Box 0130, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NCI NIH HHS [CA-61021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNES D, 1995, JAMA-J AM MED ASSOC, P248; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; BERO LA, 1993, TOB CONTROL, V2, P103; Blot WJ, 1998, J NATL CANCER I, V90, P1416, DOI 10.1093/jnci/90.19.1416; Boffetta P, 1998, J NATL CANCER I, V90, P1440, DOI 10.1093/jnci/90.19.1440; California Environmental Protection Agency, 1997, HLTH EFF EXP ENV TOB; Chapman S, 1998, BRIT MED J, V316, P727; DYER C, 1998, GUARDIAN        0707; FONTHAM ETH, 1994, JAMA-J AM MED ASSOC, V271, P1752, DOI 10.1001/jama.271.22.1752; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; GARFINKEL L, 1984, NY TIMES        0605; Gelbspan R., 1997, HEAT IS HIGH STAKES; GLANTZ S, 1983, P 12 WORLD C TOB HLT, P287; Glantz S A, 1997, Tob Control, V6, P164; Glantz SA., 1996, CIGARETTE PAPERS; *IMP TOB, 1999, IMP TOB POS SMOK REL; *INT AG RES CANC, 1998, PASS SMOK LUNG CANC; Jenkins RA, 1996, LUNG CANCER-J IASLC, V14, pS195; Jenkins RA, 1996, J EXPO ANAL ENV EPID, V6, P473; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; LEGRAND C, 1998, AUSTRALIAN      0310; MACDONALD V, 1998, SUNDAY TELEGRAP 0308; Manley M W, 1997, Tob Control, V6 Suppl 2, pS12, DOI 10.1136/tc.6.suppl_2.S12; MATANOSKI G, 1995, AM J EPIDEMIOL, V142, P149, DOI 10.1093/oxfordjournals.aje.a117613; MATTHEWS R, 1998, SUNDAY TELEGRAP 0816; MOONEY L, 1998, WALL STREET J   0319, pA18; *NAT HLTH MRC, 1986, EFF PASS SMOK HLTH; *NAT HLTH MRC, 1997, HLTH EFF PASS SMOK; National Research Council, 1986, ENV TOB SMOK MEAS EX; *NZ DEP HLTH, 1998, CREAT SMOK ENV; Phillips K, 1997, ENVIRON INT, V23, P173, DOI 10.1016/S0160-4120(97)00004-4; PHILLIPS K, 1994, ENVIRON INT, V20, P693, DOI 10.1016/0160-4120(94)90303-4; Phillips K, 1997, ENVIRON INT, V23, P851, DOI 10.1016/S0160-4120(97)00097-4; Phillips K, 1999, ATMOS ENVIRON, V33, P1889, DOI 10.1016/S1352-2310(98)00205-2; Phillips K, 1996, SCAND J WORK ENV HEA, V22, P1; Phillips K, 1998, ENVIRON INT, V24, P405, DOI 10.1016/S0160-4120(98)00020-8; Phillips K, 1998, INT ARCH OCC ENV HEA, V71, P379, DOI 10.1007/s004200050296; Phillips K, 1998, ENVIRON INT, V24, P301, DOI 10.1016/S0160-4120(98)00009-9; Phillips K, 1998, INT ARCH OCC ENV HEA, V71, P201, DOI 10.1007/s004200050271; Proctor CJ, 1998, BRIT MED J, V317, P349; REPACE J, 1998, NAT TOX PROGR BOARD; REPACE JL, 1985, ENVIRON INT, V11, P3, DOI 10.1016/0160-4120(85)90098-4; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; RIBOLI E, 1995, EUR RESPIR J, V8, P285, DOI 10.1183/09031936.95.08020285; *ROP ORG, 1978, STUD PUBL ATT CIG SM, V1; SCHLESINGER J, 1998, WALL STREET J   0720; Simpson D, 1998, TOB CONTROL, V7, P117; SIMPSON D, 1998, TOB CONTROL, V7, P228; Smith GD, 1996, BRIT MED J, V313, P929; Stead LF, 2006, REP SCI COMM TOB HLT, DOI 10.1002/14651858.CD002850.pub2; SWEET M, 1998, SYDNEY MORNING  0203; TEINKEN J, 1990, SMOKESCREEN CRITIQUE; THOMAS H, 1999, S CHINA MORNING 0118; *TOB I SO AFR, 1998, TISA SUBM IND PORTF; *TRONDH EUR WORK P, 1996, ENV TOB SMOK LUNG CA; *US DEP HHS, 1986, DHHS PUB; *US EPA, 1992, RESP HLTH EFF PASS S; Wells AJ, 1998, AM J PUBLIC HEALTH, V88, P1503, DOI 10.2105/AJPH.88.10.1503; *WHO, 1998, PASS SMOK DOES CAUS; *WHO, 1998, ZIMBABWE INDEPE 1023; 1997, PR NEWSWIRE     1203; 1999, EUR SCI ENV FOR APR	66	144	144	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1253	1259		10.1016/S0140-6736(00)02098-5	http://dx.doi.org/10.1016/S0140-6736(00)02098-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770318				2022-12-01	WOS:000086448000039
J	Goldberg, J				Goldberg, J			Decoding of sorting signals by coatomer through a GTPase switch in the COPI coat complex	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ADP-RIBOSYLATION FACTOR; EARLY SECRETORY PATHWAY; HUMAN KDEL RECEPTOR; ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; GOLGI TRANSPORT; BINDING-PROTEIN; ACTIVATING PROTEIN; ARF GTPASE	Sorting signals on cargo proteins are recognized by coatomer for selective uptake into COPI (coatomer)-coated vesicles. This study shows that coatomer couples sorting signal recognition to the GTP hydrolysis reaction on ARF1. Coatomer responds differently to different signals. The cytoplasmic signal sequence of hp24a inhibits coatomer-dependent GTP hydrolysis. By contrast, the dilysine retrieval signal, which competes for the same binding site on coatomer, has no effect on GTPase activity. It is inferred that, in vivo, sorting signal selection is under kinetic control, with coatomer governing a GTPase discard pathway that excludes dilysine-tagged proteins from one class of COPI-coated vesicles. The concept of competing sets of sorting signals that act positively and negatively during vesicle budding through a GTPase switch in the COPI coat complex suggests mechanisms for cargo segregation in which specificity is conferred by GTP hydrolysis.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; BURGESS SM, 1993, TRENDS BIOCHEM SCI, V18, P381, DOI 10.1016/0968-0004(93)90094-4; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DUDEN R, 1994, J BIOL CHEM, V269, P24486; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; YARUS M, 1992, TRENDS BIOCHEM SCI, V17, P171, DOI 10.1016/0968-0004(92)90257-A; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	58	106	110	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					671	679		10.1016/S0092-8674(00)80703-5	http://dx.doi.org/10.1016/S0092-8674(00)80703-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761932	Bronze			2022-12-01	WOS:000085983800009
J	Robson, J; Boomla, K; Hart, B; Feder, G				Robson, J; Boomla, K; Hart, B; Feder, G			Estimating cardiovascular risk for primary prevention: outstanding questions for primary care	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; GUIDELINES; FRAMINGHAM; PROFILE; TRIAL		Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Chrisp St Hlth Ctr, London E14 6PG, England	University of London; Queen Mary University London	Robson, J (corresponding author), Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, Mile End Rd, London E1 4NS, England.		Robson, John/H-3904-2014	Robson, John/0000-0001-6889-0415; Feder, Gene/0000-0002-7890-3926				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; FIELD K, 1995, BRIT MED J, V310, P1109, DOI 10.1136/bmj.310.6987.1109; Gotto AM, 1997, JAMA-J AM MED ASSOC, V277, P595, DOI 10.1001/jama.277.7.595; Gregory J., 1990, DIETARY NUTR SURVEY; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; GUEFFIYER F, 1997, ANN INTERN MED, V126, P761; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; HAQ IU, 1997, HEART, V77, P36; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; JACKSON R, 1998, 5 YEAR CARDIOVASCULA; Messerli FH, 1998, LANCET, V352, P1006, DOI 10.1016/S0140-6736(05)60073-6; *MRS GEN PRACT RES, 1998, LANCET, V315, P233; ODELL PM, 1994, J CLIN EPIDEMIOL, V47, P583, DOI 10.1016/0895-4356(94)90206-2; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; ROBSON J, 1997, FRAMINGHAM RISK SCOR; Unwin N, 1998, BMJ-BRIT MED J, V317, P1125; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Wood D, 1998, HEART, V80, pS1	24	25	28	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					702	704		10.1136/bmj.320.7236.702	http://dx.doi.org/10.1136/bmj.320.7236.702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710585	Green Published			2022-12-01	WOS:000085895300027
J	Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC				Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC			Complete genome sequence of Neisseria meningitidis serogroup B strain MC58	SCIENCE			English	Article							ESCHERICHIA-COLI; HELICOBACTER-PYLORI; PATHOGENIC BACTERIA; INSERTION-SEQUENCE; ENDOTHELIAL-CELLS; DNA-SEQUENCE; GENE; EXPRESSION; IDENTIFICATION; GONORRHOEAE	The 2,272,351-base pair genome of Neisseria meningitidis strain MC58 (serogroup B), a causative agent of meningitis and septicemia, contains 2158 predicted coding regions, 1158 (53.7%) of which were assigned a biological role. Three major islands of horizontal DNA transfer were identified; two of these contain genes encoding proteins involved in pathogenicity, and the third island contains coding sequences only for hypothetical proteins. Insights into the commensal and virulence behavior of N, meningitidis can be gleaned from the genome, in which sequences for structural proteins of the pilus are clustered and several coding regions unique to serogroup B capsular polysaccharide synthesis can be identified. Finally, N. meningitidis contains more genes that undergo phase variation than any pathogen studied to date, a mechanism that controls their expression and contributes to the evasion of the host immune system.	Inst Genom Res, Rockville, MD 20850 USA; Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England; Chiron SpA, Immunol Res Inst Siena, I-53100 Siena, Italy	J. Craig Venter Institute; University of Oxford; Novartis	Tettelin, H (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Scarlato, Vincenzo/B-8558-2019; Nelson, William C/E-9263-2016; Saunders, Nigel J/W-6745-2019; Salzberg, Steven/Q-6514-2019; Eisen, Jonathan A./H-2706-2019; Salzberg, Steven L/F-6162-2011	Scarlato, Vincenzo/0000-0003-4227-677X; Nelson, William C/0000-0002-1873-3929; Salzberg, Steven/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven L/0000-0002-8859-7432; Grandi, Guido/0000-0001-9724-2185; Vamathevan, Jessica/0000-0003-2016-9754; Heidelberg, John/0000-0003-0673-3224				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON RP, 1978, COLD SPRING HARB SYM, V43, P1083; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Carrick CS, 1998, GENE, V220, P21, DOI 10.1016/S0378-1119(98)00424-7; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; DIAZ JL, 1984, FEMS MICROBIOL LETT, V21, P181; DOBSON SRM, 1992, INFECT IMMUN, V60, P618, DOI 10.1128/IAI.60.2.618-622.1992; DURBIN R, 1991, C ELEGANS DATABASE; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669; FROSCH M, 1991, MOL MICROBIOL, V5, P1251, DOI 10.1111/j.1365-2958.1991.tb01899.x; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; *GENB, D90911; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GOTSCHLICH EC, 1969, J EXP MED, V129, P349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1369; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HILL CW, 1988, GENETICS, V119, P771; HOLTEN E, 1976, ACTA PATH MICRO IM B, V84, P9; JENNINGS HJ, 1987, J EXP MED, V165, P1207, DOI 10.1084/jem.165.4.1207; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; JONES D, 1995, MENINGOCOCCAL DIS, P147; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; KNIGHT AI, 1992, MOL MICROBIOL, V6, P1565, DOI 10.1111/j.1365-2958.1992.tb00878.x; KROLL JS, 1991, MOL MICROBIOL, V5, P1549, DOI 10.1111/j.1365-2958.1991.tb00802.x; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARRS CF, 1990, J BACTERIOL, V172, P4370, DOI 10.1128/jb.172.8.4370-4377.1990; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MORSE SA, 1978, INFECT IMMUN, V21, P87, DOI 10.1128/IAI.21.1.87-95.1978; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NEUBAUER H, 1994, J BACTERIOL, V176, P3007, DOI 10.1128/JB.176.10.3007-3012.1994; PINNER RW, 1991, INFECT IMMUN, V59, P3169, DOI 10.1128/IAI.59.9.3169-3175.1991; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; RASMUSSEN JL, 1987, J BACTERIOL, V169, P3573, DOI 10.1128/jb.169.8.3573-3580.1987; RAYNER CFJ, 1995, J INFECT DIS, V171, P113, DOI 10.1093/infdis/171.1.113; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; SAUNDERS N, UNPUB; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SCHWARTZ B, 1989, CLIN MICROBIOL REV, V2, pS118, DOI 10.1128/CMR.2.Suppl.S118-S124.1989; SHIMIZU R, AB015669 GENB; Sutton G.G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Wainwright LA, 1997, NUCLEIC ACIDS RES, V25, P1362, DOI 10.1093/nar/25.7.1362; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W; YOON H, 1989, J GEN MICROBIOL, V135, P245; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	68	902	1600	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1809	1815		10.1126/science.287.5459.1809	http://dx.doi.org/10.1126/science.287.5459.1809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710307				2022-12-01	WOS:000085775300039
J	Kirchner, JW; Weil, A				Kirchner, JW; Weil, A			Delayed biological recovery from extinctions throughout the fossil record	NATURE			English	Article							TIME-SERIES ANALYSIS; UNEVENLY SPACED DATA; SPECTRAL-ANALYSIS; END	How quickly does biodiversity rebound after extinctions? Palaeobiologists have examined the temporal, taxonomic and geographic patterns of recovery following individual mass extinctions in detail(1-5), but have not analysed recoveries from extinctions throughout the fossil record as a whole. Here, we measure how fast biodiversity rebounds after extinctions in general, rather than after individual mass extinctions, by calculating the cross-correlation between extinction and origination rates across the entire Phanerozoic marine fossil record. Our results show that extinction rates are not significantly correlated with contemporaneous origination rates, but instead are correlated with origination rates roughly 10 million years later. This lagged correlation persists when we remove the 'Big Five' major mass extinctions, indicating that recovery times following mass extinctions and background extinctions are similar. Our results suggest that there are intrinsic limits to how quickly global biodiversity can recover after extinction events, regardless of their magnitude. They also imply that today's anthropogenic extinctions will diminish biodiversity for millions of years to come.	Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA	University of California System; University of California Berkeley; Duke University	Kirchner, JW (corresponding author), Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA.		Kirchner, James/AAC-4707-2019; Kirchner, James W/B-6126-2009	Kirchner, James/0000-0001-6577-3619; Kirchner, James W/0000-0001-6577-3619				Agterberg F P, 1970, GEOSTATISTICS, P113; Bracewell R., 2000, FOURIER TRANSFORM IT; CLEVELAND WS, 1984, J AM STAT ASSOC, V79, P807, DOI 10.2307/2288711; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; GILINSKY NL, 1991, ANAL PALEOBIOLOGY, P157; Hallam A., 1991, Historical Biology, V5, P257; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski David, 1995, P25; Kirchner JW, 1998, NATURE, V395, P337, DOI 10.1038/26384; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Press W. H., 1988, Computers in Physics, V2, p77, 80; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SCARGLE JD, 1989, ASTROPHYS J, V343, P874, DOI 10.1086/167757; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Sepkoski J. J., 1996, GLOBAL EVENTS EVENT, DOI DOI 10.1007/978-3-642-79634-0_4; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Signor P.W., 1982, GEOLOGICAL SOC AM SP, V190, P291, DOI DOI 10.1130/SPE190-P291; Walliser O.H., 1996, GLOBAL EVENTS EVENT, P7, DOI DOI 10.1007/978-3-642-79634-0_2	19	119	124	0	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					177	180		10.1038/35004564	http://dx.doi.org/10.1038/35004564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724168				2022-12-01	WOS:000085870900049
J	Geijtenbeek, TBH; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Adema, GJ; van Kooyk, Y; Figdor, CG				Geijtenbeek, TBH; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Adema, GJ; van Kooyk, Y; Figdor, CG			Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses	CELL			English	Article							INTERCELLULAR-ADHESION MOLECULE-3; PERIPHERAL LYMPHOID ORGANS; CLASS-II COMPARTMENT; C-TYPE LECTIN; MANNOSE RECEPTOR; LYMPHOCYTES-T; HUMAN BLOOD; ANTIGEN; ACTIVATION; LFA-1	Contact between dendritic cells (DC) and resting T cells is essential to initiate a primary immune response. Here, we demonstrate that ICAM-3 expressed by resting T cells is important in this first contact with DC. We discovered that instead of the common ICAM-3 receptors LFA-1 and alpha D beta 2, a novel DC-specific C-type lectin, DC-SIGN, binds ICAM-3 with high affinity. DC-SIGN, which is abundantly expressed by DC both in vitro and in vivo, mediates transient adhesion with T cells. Since antibodies against DC-SIGN inhibit DC-induced proliferation of resting T cells, our findings predict that DC-SIGN enables T cell receptor engagement by stabilization of the DC-T cell contact zone.	Radboud Univ Nijmegen Med Ctr, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands	Radboud University Nijmegen	van Kooyk, Y (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.	y.vankooyk@dent.kun.nl	Geijtenbeek, Teunis/C-2229-2009; Figdor, Carl G/A-4232-2010; Adema, G.J./H-8007-2014; Torensma, Ruurd/C-2853-2009	Figdor, Carl G/0000-0002-2366-9212; Torensma, Ruurd/0000-0002-0555-7903; van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; ALBEROLAILA J, 1991, J IMMUNOL, V146, P1085; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Binnerts ME, 1999, IMMUNOL TODAY, V20, P240, DOI 10.1016/S0167-5699(99)01467-X; BINNERTS ME, 1994, EUR J IMMUNOL, V24, P2155, DOI 10.1002/eji.1830240933; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; David LR, 1996, J CRANIOFAC SURG, V7, P177, DOI 10.1097/00001665-199605000-00003; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DELPOZO MA, 1994, CELL ADHES COMMUN, V2, P211, DOI 10.3109/15419069409004439; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; HERNANDEZCASELLES T, 1993, EUR J IMMUNOL, V23, P2799, DOI 10.1002/eji.1830231112; HOCK BD, 1994, IMMUNOLOGY, V83, P573; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; PARRA E, 1993, SCAND J IMMUNOL, V38, P508, DOI 10.1111/j.1365-3083.1993.tb03233.x; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STARLING GC, 1995, EUR J IMMUNOL, V25, P2528, DOI 10.1002/eji.1830250918; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VILELLA R, 1990, TISSUE ANTIGENS, V36, P203, DOI 10.1111/j.1399-0039.1990.tb01830.x; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	47	1360	1496	4	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					575	585		10.1016/S0092-8674(00)80693-5	http://dx.doi.org/10.1016/S0092-8674(00)80693-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721994	Bronze			2022-12-01	WOS:000085700000010
J	Baker, D; Pryce, G; Croxford, JL; Brown, P; Pertwee, RG; Huffman, JW; Layward, L				Baker, D; Pryce, G; Croxford, JL; Brown, P; Pertwee, RG; Huffman, JW; Layward, L			Cannabinoids control spasticity and tremor in a multiple sclerosis model	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CB1	Chronic relapsing experimental allergic encephalomyelitis (CREAE) is an autoimmune model of multiple sclerosis(1). Although both these diseases are typified by relapsing-remitting paralytic episodes, after CREAE induction by sensitization to myelin antigens(1) Biozzi ABH mice also develop spasticity and tremor. These symptoms also occur during multiple sclerosis and are difficult to control. This has prompted some patients to find alternative medicines, and to perceive benefit from cannabis use(2), Although this benefit has been backed up by small clinical studies, mainly With non-quantifiable outcomes(3-7) the value of cannabis use in multiple sclerosis remains anecdotal. Here we show that cannabinoid (CB) receptor agonism using R(+)-WIN 55,212, Delta(9)-tetrahydrocannabinol, methanandamide and JWH-133 (ref. 8) quantitatively ameliorated both tremor and spasticity in diseased mice. The exacerbation Of these signs after antagonism of the CB(1) and CB(2) receptors, notably the CB(1) receptor, using SR141716A and SR144528 (ref. 8) indicative that the endogenous cannabinoid system may be tonically active in the control of tremor and spasticity. This provides a rationale for patients' indications of the therapeutic potential of cannabis in the control of the symptoms of multiple sclerosis(2), and provides a means of evaluating more selective cannabinoids in the future.	UCL, Inst Neurol, Dept Neurochem, Neuroinflammat Grp, London WC1N 1PJ, England; UCL, Inst Ophthalmol, London EC1V 9EL, England; Natl Hosp Neurol & Neurosurg, MRC, Human Movement & Balance Unit, London WC1N 3BG, England; Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland; Clemson Univ, Dept Chem, Clemson, SC 29634 USA; Multiple Sclerosis Soc Great Britain & No Ireland, London SW6 1EE, England	University of London; King's College London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Aberdeen; Clemson University	Baker, D (corresponding author), UCL, Inst Neurol, Dept Neurochem, Neuroinflammat Grp, 1 Wakefield St, London WC1N 1PJ, England.	D.Baker@ion.ucl.ac.uk	Brown, Peter/J-4307-2016; Pertwee, Roger Guy/E-1312-2011	Brown, Peter/0000-0002-5201-3044; Pertwee, Roger/0000-0003-3227-2783	Multiple Sclerosis Society [541] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Breivogel CS, 1998, NEUROBIOL DIS, V5, P417, DOI 10.1006/nbdi.1998.0229; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHAI CK, 1961, J HERED, V52, P241, DOI 10.1093/oxfordjournals.jhered.a107083; CLIFFORD DB, 1983, ANN NEUROL, V13, P669, DOI 10.1002/ana.410130616; Consroe P, 1998, NEUROBIOL DIS, V5, P534, DOI 10.1006/nbdi.1998.0220; Consroe P, 1997, EUR NEUROL, V38, P44, DOI 10.1159/000112901; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Landsman RS, 1997, EUR J PHARMACOL, V334, pR1, DOI 10.1016/S0014-2999(97)01160-6; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; MARTYN CN, 1995, LANCET, V345, P579, DOI 10.1016/S0140-6736(95)90485-9; NOTH J, 1991, J NEUROL, V238, P131, DOI 10.1007/BF00319679; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Petro D. J., 1981, J CLIN PHARMACOL, P413; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; UNDERLEIDER JT, 1987, ADV ALCOHOL SUBSTANC, V7, P39; WIRGUIN I, 1994, IMMUNOPHARMACOLOGY, V28, P209, DOI 10.1016/0162-3109(94)90056-6	20	410	477	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					84	87		10.1038/35003583	http://dx.doi.org/10.1038/35003583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716447				2022-12-01	WOS:000085775100050
J	Fernandes, PG; Brierley, AS; Simmonds, EJ; Millard, NW; McPhail, SD; Armstrong, F; Stevenson, P; Squiress, M				Fernandes, PG; Brierley, AS; Simmonds, EJ; Millard, NW; McPhail, SD; Armstrong, F; Stevenson, P; Squiress, M			Oceanography - Fish do not avoid survey vessels	NATURE			English	Article									FRS Marine Lab Aberdeen, Aberdeen AB11 9DB, Scotland; British Antarctic Survey, Cambridge CB3 0ET, England; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; NERC National Oceanography Centre; University of Southampton	Fernandes, PG (corresponding author), FRS Marine Lab Aberdeen, POB 101,Victoria Rd, Aberdeen AB11 9DB, Scotland.		Brierley, Andrew S/G-8019-2011; Fernandes, Paul/H-2972-2013	Brierley, Andrew S/0000-0002-6438-6892; Fernandes, Paul/0000-0003-4135-115X				Brierley AS, 1998, DEEP-SEA RES PT II, V45, P1155, DOI 10.1016/S0967-0645(98)00025-3; Ferng W. R., 1991, Numerical Algorithms, V1, P1, DOI 10.1007/BF02145580; FOOTE KG, 1983, J ACOUST SOC AM, V73, P1932, DOI 10.1121/1.389583; FREON P, 1992, FISH RES, V15, P45, DOI 10.1016/0165-7836(92)90004-D; HOLLIDAY DV, 1995, ICES J MAR SCI, V52, P279, DOI 10.1016/1054-3139(95)80044-1; MacLennan D.N., 1992, SPRINGER SCI BUS MED, V5, P54; MAGURRAN AE, 1999, DYNAMICS PELAGIC FIS, pR9; Millard NW, 1998, UNDERWATER TECHNOL, V23, P7, DOI 10.3723/175605498783259894; MILLARD NW, 1999, P INT C REM TECHN HA, P19; Mitson R.B., 1995, ICES Cooperative Research Report, V209, P1; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Simmonds EJ, 1996, ICES J MAR SCI, V53, P189; WALTERS CJ, 1996, W FISHERIES      JAN, P41	13	90	92	1	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					35	36		10.1038/35003648	http://dx.doi.org/10.1038/35003648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716432				2022-12-01	WOS:000085775100034
J	Lenoir, N				Lenoir, N			Europe confronts the embryonic stem cell research challenge	SCIENCE			English	Editorial Material								Europe's historic plurality and the Lack of a commonly accepted definition of the moral status of the embryo have led to varying regulation in European countries. Council of Europe and European Union Legislation, based on fundamental ethical principles, does exist for specific issues, such as prohibition against producing embryos solely for research. Such principles have recently been elucidated by the European Group on Ethics in Science and New Technologies. Newly emerging research techniques are beginning to cause reconsideration of the regulation of embryo research in Europe.	Conseil Constitut, F-75001 Paris, France		Lenoir, N (corresponding author), Conseil Constitut, 2 Rue Montpensier, F-75001 Paris, France.							Deutsch E, 1993, Med Law, V12, P535; KNOPPERS M, HUMAN DIGNITY GENETI; Marshall E, 1998, SCIENCE, V282, P1014, DOI 10.1126/science.282.5391.1014; McLaren Angus, 1990, HIST CONTRACEPTION; Noonan John T., 1965, CONTRACEPTION HIST I; RABELAIS F, 1991, GARGANTUA PANTAGRUEL	6	56	63	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1425	1427		10.1126/science.287.5457.1425	http://dx.doi.org/10.1126/science.287.5457.1425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688780				2022-12-01	WOS:000085531600034
J	Braun, S; Pantel, K; Muller, P; Janni, W; Hepp, F; Kentenich, CRM; Gastroph, S; Wischnik, A; Dimpfl, T; Kindermann, G; Riethmuller, G; Schlimok, G				Braun, S; Pantel, K; Muller, P; Janni, W; Hepp, F; Kentenich, CRM; Gastroph, S; Wischnik, A; Dimpfl, T; Kindermann, G; Riethmuller, G; Schlimok, G			Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDIAN FOLLOW-UP; MONOCLONAL-ANTIBODIES; PROGNOSTIC-SIGNIFICANCE; PREMENOPAUSAL WOMEN; ANTI-CYTOKERATIN; PRIMARY SURGERY; NODAL STATUS; TUMOR-CELLS; MICROMETASTASES; CARCINOMA	Background: Cytokeratins are specific markers of epithelial cancer cells in bone marrow. We assessed the influence of cytokeratin-positive micrometastases in the bone marrow on the prognosis of women with breast cancer. Methods: We obtained bone marrow aspirates from both upper iliac crests of 552 patients with stage I, II, or III breast cancer who underwent complete resection of the tumor and 191 patients with nonmalignant disease. The specimens were stained with the monoclonal antibody A45-B/B3, which binds to an antigen on cytokeratins. The median follow-up was 38 months (range, 10 to 70). The primary end point was survival. Results: Cytokeratin-positive cells were detected in the bone marrow specimens of 2 of the 191 control patients with nonmalignant conditions (1 percent) and 199 of the 552 patients with breast cancer (36 percent). The presence of occult metastatic cells in bone marrow was unrelated to the presence or absence of lymph-node metastasis (P = 0.13). After four years of follow-up, the presence of micrometastases in bone marrow was associated with the occurrence of clinically overt distant metastasis and death from cancer-related causes (P<0.001), but not with locoregional relapse (P = 0.77). Of 199 patients with occult metastatic cells, 49 died of cancer, whereas of 353 patients without such cells, 22 died of cancer-related causes (P<0.001). Among the 301 women without lymph-node metastases, 14 of the 100 with bone marrow micrometastases died of cancer-related causes, as did 2 of the 201 without bone marrow micrometastases (P<0.001). The presence of occult metastatic cells in bone marrow, as compared with their absence, was an independent prognostic indicator of the risk of death from cancer (relative risk, 4.17; 95 percent confidence interval, 2.51 to 6.94; P<0.001), after adjustment for the use of systemic adjuvant chemotherapy. Conclusions: The presence of occult cytokeratin-positive metastatic cells in bone marrow increases the risk of relapse in patients with stage I, II, or III breast cancer. (N Engl J Med 2000;342:525-33.) (C)2000, Massachusetts Medical Society.	Univ Munich, Klinikum Innenstadt, Frauenklin 1, D-80337 Munich, Germany; Univ Munich, Klinikum Innenstadt, Inst Immunol, D-80337 Munich, Germany; Univ Hamburg, Krankenhaus Eppendorf, Frauenklin, D-2000 Hamburg, Germany; Zent Klinikum, Med Klin 2, Augsburg, Germany; Zent Klinikum, Frauenklin, Augsburg, Germany	University of Munich; University of Munich; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Braun, S (corresponding author), Univ Munich, Klinikum Innenstadt, Frauenklin 1, Maistr 11, D-80337 Munich, Germany.	sbraun@fk-i.med.uni-muenchen.de						Black, 1997, EUR J CANCER, V33, P2440; Black RJ, 1997, EUR J CANCER, V33, P1075, DOI 10.1016/S0959-8049(96)00492-3; Braun S, 1998, J NATL CANCER I, V90, P1099, DOI 10.1093/jnci/90.14.1099; Braun S, 2000, J CLIN ONCOL, V18, P80, DOI 10.1200/JCO.2000.18.1.80; Brugger W, 1999, J CLIN ONCOL, V17, P1535, DOI 10.1200/JCO.1999.17.5.1535; Cevatli BS, 1999, EUR J CANCER, V35, pS86, DOI 10.1016/S0959-8049(99)80716-3; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; COTE RJ, 1991, J CLIN ONCOL, V9, P1749, DOI 10.1200/JCO.1991.9.10.1749; COURTEMANCHE DJ, 1991, CAN J SURG, V34, P21; COX DR, 1972, J R STAT SOC B, V34, P187; DEARNALEY DP, 1981, BRIT J CANCER, V44, P85, DOI 10.1038/bjc.1981.152; DELSOL G, 1984, LANCET, V2, P1124; DEVITA VT, 1989, NEW ENGL J MED, V320, P527, DOI 10.1056/NEJM198902233200812; Diel IJ, 1996, JNCI-J NATL CANCER I, V88, P1652, DOI 10.1093/jnci/88.22.1652; DOGLIONI C, 1990, VIRCHOWS ARCH A, V416, P479, DOI 10.1007/BF01600298; FISHER B, 1981, CANCER-AM CANCER SOC, V48, P1863, DOI 10.1002/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; HARBECK N, 1994, BRIT J CANCER, V69, P566, DOI 10.1038/bjc.1994.103; Hellman S, 1997, NEW ENGL J MED, V337, P996, DOI 10.1056/NEJM199710023371408; International Union Against Cancer (UICC), 1997, J CLIN PATHOL; Jauch KW, 1996, J CLIN ONCOL, V14, P1810, DOI 10.1200/JCO.1996.14.6.1810; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASPER M, 1987, EUR J CANCER CLIN ON, V23, P137, DOI 10.1016/0277-5379(87)90007-1; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Landys K, 1998, BREAST CANCER RES TR, V49, P27, DOI 10.1023/A:1005980919916; LINDEMANN F, 1992, LANCET, V340, P685, DOI 10.1016/0140-6736(92)92230-D; Liu D., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P268; Mansi JL, 1999, LANCET, V354, P197, DOI 10.1016/S0140-6736(98)10175-7; MENARD S, 1994, BRIT J CANCER, V70, P709, DOI 10.1038/bjc.1994.379; Molino A, 1997, BREAST CANCER RES TR, V42, P23, DOI 10.1023/A:1005747711084; Mueller P, 1998, CANCER-AM CANCER SOC, V83, P538, DOI 10.1002/(SICI)1097-0142(19980801)83:3<538::AID-CNCR23>3.0.CO;2-W; Muller P, 1996, CANCER GENET CYTOGEN, V88, P8, DOI 10.1016/0165-4608(95)00189-1; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Pantel K, 1999, JNCI-J NATL CANCER I, V91, P1113, DOI 10.1093/jnci/91.13.1113; Pantel K, 1994, J Hematother, V3, P165, DOI 10.1089/scd.1.1994.3.165; PANTEL K, 1993, JNCI-J NATL CANCER I, V85, P1419, DOI 10.1093/jnci/85.17.1419; Pantel K, 1996, LANCET, V347, P649, DOI 10.1016/S0140-6736(96)91203-9; Ragaz J, 1997, NEW ENGL J MED, V337, P956, DOI 10.1056/NEJM199710023371402; RIETHMULLER G, 1992, CURR OPIN IMMUNOL, V4, P647, DOI 10.1016/0952-7915(92)90041-C; SALVADORI B, 1990, EUR J CANCER, V26, P865, DOI 10.1016/0277-5379(90)90185-V; Schaller G, 1996, CLIN CANCER RES, V2, P1879; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Stigbrand T, 1998, TUMOR BIOL, V19, P132, DOI 10.1159/000029984; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; THOR A, 1988, BREAST CANCER RES TR, V11, P133, DOI 10.1007/BF01805837	45	766	805	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2000	342	8					525	533		10.1056/NEJM200002243420801	http://dx.doi.org/10.1056/NEJM200002243420801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286AX	10684910				2022-12-01	WOS:000085422400001
J	Eeva, T; Lehikoinen, E				Eeva, T; Lehikoinen, E			Pollution - Recovery of breeding success in wild birds	NATURE			English	Article							FICEDULA-HYPOLEUCA; PIED FLYCATCHERS; METAL POLLUTION; PARUS-MAJOR; PASSERINES; GRADIENT; FINLAND		Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland	University of Turku	Eeva, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland.		Eeva, Tapio/V-8922-2018; Lehikoinen, Esa/I-6128-2013	Eeva, Tapio/0000-0002-0395-1536; Lehikoinen, Esa/0000-0002-6932-3604				Eeva T, 1997, ECOLOGY, V78, P1120, DOI 10.1890/0012-9658(1997)078[1120:PRVIFS]2.0.CO;2; Eeva T, 1996, OECOLOGIA, V108, P631, DOI 10.1007/BF00329036; EEVA T, 1995, OECOLOGIA, V102, P312, DOI 10.1007/BF00329798; FRITZE H, 1989, BIOL FERT SOILS, V8, P87, DOI 10.1007/BF00260522; GRAVELAND J, 1994, NATURE, V368, P446, DOI 10.1038/368446a0; Heliovaara K, 1990, ACIDIFICATION FINLAN, P447; HYNNINEN V, 1986, ANN BOT FENN, V23, P83; Jussila I, 1997, SYKESARJA B, V12, P1; Nyholm NEI, 1998, ARCH ENVIRON CON TOX, V35, P632, DOI 10.1007/s002449900425	9	59	59	0	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					851	852		10.1038/35002672	http://dx.doi.org/10.1038/35002672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706274				2022-12-01	WOS:000085559200045
J	Groenewoud, JH; van der Heide, A; Onwuteaka-Philipsen, BD; Willems, DL; van der Maas, PJ; van der Wal, G				Groenewoud, JH; van der Heide, A; Onwuteaka-Philipsen, BD; Willems, DL; van der Maas, PJ; van der Wal, G			Clinical problems with the performance of euthanasia and physician-assisted suicide in the netherlands.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ATTITUDES; LIFE; END; ONCOLOGISTS; DECISIONS; OREGON; DEATH	Background and Methods: The characteristics and frequency of clinical problems with the performance of euthanasia and physician-assisted suicide are uncertain. We analyzed data from two studies of euthanasia and physician-assisted suicide in the Netherlands (one conducted in 1990 and 1991 and the other in 1995 and 1996), with a total of 649 cases. We categorized clinical problems as technical problems, such as difficulty inserting an intravenous line; complications, such as myoclonus or vomiting; or problems with completion, such as a longer-than-expected interval between the administration of medications and death. Results: In 114 cases, the physician's intention was to provide assistance with suicide, and in 535, the intention was to perform euthanasia. Problems of any type were more frequent in cases of assisted suicide than in cases of euthanasia. Complications occurred in 7 percent of cases of assisted suicide, and problems with completion (a longer-than-expected time to death, failure to induce coma, or induction of coma followed by awakening of the patient) occurred in 16 percent of the cases; complications and problems with completion occurred in 3 percent and 6 percent of cases of euthanasia, respectively. The physician decided to administer a lethal medication in 21 of the cases of assisted suicide (18 percent), which thus became cases of euthanasia. The reasons for this decision included problems with completion (in 12 cases) and the inability of the patient to take all the medications (in 5). Conclusions: There may be clinical problems with the performance of euthanasia and physician-assisted suicide. In the Netherlands, physicians who intend to provide assistance with suicide sometimes end up administering a lethal medication themselves because of the patient's inability to take the medication or because of problems with the completion of physician-assisted suicide. (N Engl J Med 2000;342:551-6.) (C)2000, Massachusetts Medical Society.	Erasmus Univ, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Vrije Univ Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Social Med, Amsterdam, Netherlands	Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Groenewoud, JH (corresponding author), Erasmus Univ, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.							Asch DA, 1996, NEW ENGL J MED, V334, P1374, DOI 10.1056/NEJM199605233342106; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BAUME P, 1994, MED J AUSTRALIA, V161, P137, DOI 10.5694/j.1326-5377.1994.tb127345.x; BAUME P, 1994, MED J AUSTRALIA, V161, P142; BAUME P, 1994, MED J AUSTRALIA, V161, P140; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; DOUKAS DJ, 1995, J CLIN ONCOL, V13, P1055, DOI 10.1200/JCO.1995.13.5.1055; Drickamer MA, 1997, ANN INTERN MED, V126, P146, DOI 10.7326/0003-4819-126-2-199701150-00009; Emanuel EJ, 1998, JAMA-J AM MED ASSOC, V280, P507, DOI 10.1001/jama.280.6.507; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; *GEN BOARD RDMA, 1996, EUTH NETH; Gevers S, 1996, BRIT MED BULL, V52, P326; *KON NED MAATSCH B, 1994, TOEP BER EUTH SGRAV; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; LEGEMAATE J, 1995, CAMB Q HEALTHC ETHIC, V4, P112; Matzo M L, 1997, Oncol Nurs Forum, V24, P1725; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MULLER MT, 1992, VOX HOSP, V16, P3; Onwuteaka-Philipsen B D, 1995, Arch Fam Med, V4, P951, DOI 10.1001/archfami.4.11.951; OnwuteakaPhilipsen BD, 1997, J AM GERIATR SOC, V45, P1208, DOI 10.1111/j.1532-5415.1997.tb03771.x; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; van der Wal G, 1992, Ned Tijdschr Geneeskd, V136, P1299; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; *WET I NED AP, 1998, MED CONTACT, V53, P1366; Woolfrey J, 1998, HASTINGS CENT REP, V28, P9, DOI 10.2307/3528645	28	123	123	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2000	342	8					551	556		10.1056/NEJM200002243420805	http://dx.doi.org/10.1056/NEJM200002243420805			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286AX	10684914	Green Published, Bronze			2022-12-01	WOS:000085422400005
J	Dawkins, MS; Woodington, A				Dawkins, MS; Woodington, A			Pattern recognition and active vision in chickens	NATURE			English	Article							ORIENTATION FLIGHTS; WASPS	Recognition of objects or environmental landmarks is problematic because appearance can vary widely depending on illumination, viewing distance, angle of view and so on(1). Storing a separate image or 'template' for every possible view requires vast numbers to be stored and scanned, has a high probability of recognition error and appears not to be the solution adopted by primates(2-3). However, some invertebrate template matching systems can achieve recognition by 'active vision' in which the animal's own behaviour is used to achieve a fit between template and object(4), for example by repeatedly following a set path(5-7). Recognition is thus limited to views from the set path but achieved with a minimal number of templates. Here we report the first evidence of similar active vision in a bird, in the form of locomotion and individually distinct head movements that give the eyes a similar series of views on different occasions. The hens' ability to recognize objects is also found to decrease when their normal paths are altered.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Dawkins, MS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	marian.dawkins@zoo.ox.ac.uk						Andrew R.J., 1993, VISION BRAIN BEHAV B, P319; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; COLLETT TS, 1992, PHILOS T R SOC B, V337, P295, DOI 10.1098/rstb.1992.0107; COLLETT TS, 1995, J COMP PHYSIOL A, V177, P737, DOI 10.1007/BF00187632; Dawkins MS, 1996, BEHAVIOUR, V133, P663, DOI 10.1163/156853996X00413; Edelman S, 1997, TRENDS COGN SCI, V1, P296, DOI 10.1016/S1364-6613(97)01090-5; Land MF, 1997, FROM LIVING EYES TO SEEING MACHINES, P16; PRATT DW, 1982, J EXP BIOL, V97, P217; ROLLS ET, 1994, BEHAV PROCESS, V33, P113, DOI 10.1016/0376-6357(94)90062-0; TURKEL J, 1977, NEUR ABSTR, V3, P158; Ullman S., 1996, HIGH LEVEL VISION OB; Wallman Josh, 1993, P245; ZEIL J, 1993, J COMP PHYSIOL A, V172, P189, DOI 10.1007/BF00189396	13	46	46	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					652	655		10.1038/35001064	http://dx.doi.org/10.1038/35001064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688200				2022-12-01	WOS:000085288200052
J	Bello, YM; Phillips, TJ				Bello, YM; Phillips, TJ			Recent advances in wound healing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GROWTH FACTOR-BB; PRESSURE ULCERS; SKIN		Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Phillips, TJ (corresponding author), 609 Albany St, Boston, MA 02118 USA.	skin@bu.edu		Phillips, Tania/0000-0003-2744-4931				Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Association A.D., 1999, DIABETES CARE, V22, P1354, DOI DOI 10.2337/DIACARE.22.8.1354; Bello YM, 1999, WOUNDS, V11, P2; BERGSTROM N, 1994, AHCPR PUBLICATION; CAPUTO GM, 1994, NEW ENGL J MED, V331, P854, DOI 10.1056/NEJM199409293311307; CULLUM N, 1999, COMPRESSION BANDAGES; DARKE SG, 1992, EUR J VASCULAR SURG, V6, P4, DOI 10.1016/S0950-821X(05)80086-6; Eaglstein WH, 1997, SURG CLIN N AM, V77, P689, DOI 10.1016/S0039-6109(05)70575-2; Falanga V, 1999, WOUND REPAIR REGEN, V7, P208, DOI 10.1046/j.1524-475X.1999.00208.x; Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293; Kanj LF, 1998, J AM ACAD DERMATOL, V38, P517, DOI 10.1016/S0190-9622(98)70113-6; LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489; MASUDA EM, 1994, J VASC SURG, V19, P391, DOI 10.1016/S0741-5214(94)70066-4; MUSTOE TA, 1994, ARCH SURG-CHICAGO, V129, P213; OUAHES N, 1995, CURR PROBL DERMATOL, V7, P109; OVINGTON LG, 1999, OSTOMY WOUND MAN S1A, V45, P94; Pham HT, 1999, WOUNDS, V11, P79; Phillips TJ, 1998, ARCH DERMATOL, V134, P344, DOI 10.1001/archderm.134.3.344; Rees RS, 1999, WOUND REPAIR REGEN, V7, P141, DOI 10.1046/j.1524-475X.1999.00141.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Whiteley MS, 1998, ANN ROY COLL SURG, V80, P104; Wieman TJ, 1998, DIABETES CARE, V21, P822, DOI 10.2337/diacare.21.5.822	23	84	90	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2000	283	6					716	718		10.1001/jama.283.6.716	http://dx.doi.org/10.1001/jama.283.6.716			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280XL	10683040	Green Submitted			2022-12-01	WOS:000085129000001
J	Fransz, PF; Armstrong, S; de Jong, JH; Parnell, LD; van Drunen, C; Dean, C; Zabel, P; Bisseling, T; Jones, GH				Fransz, PF; Armstrong, S; de Jong, JH; Parnell, LD; van Drunen, C; Dean, C; Zabel, P; Bisseling, T; Jones, GH			Integrated cytogenetic map of chromosome arm 4S of A-thaliana: Structural organization of heterochromatic knob and centromere region	CELL			English	Article							RECOMBINANT INBRED LINES; ARABIDOPSIS-THALIANA; REPETITIVE DNA; SEQUENCES; GENOME; RETROELEMENT; LIBRARY; MEIOSIS; MARKERS; ATHILA	We have constructed an integrated cytogenetic map of chromosome arm 4S of Arabidopsis thaliana. The map shows the detailed positions of various multicopy and unique sequences relative to euchromatin and heterochromatin segments. A quantitative analysis of the map positions at subsequent meiotic stages revealed a striking pattern of spatial and temporal variation in chromatin condensation for euchromatin and heterochromatin. For example, the centromere region consists of three domains with distinguishable structural, molecular, and functional properties. We also characterized a conspicuous heterochromatic knob of approximately 700 kb that accommodates a tandem repeat and several dispersed pericentromere-specific repeats. Moreover, our data provide evidence for an inversion event that relocated pericentromeric sequences to an interstitial position, resulting in the heterochromatic knob.	Univ Birmingham, Sch Biol Sci, Birmingham B15 2TT, W Midlands, England; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Amsterdam, EC Slater Inst Biochem Res, NL-1018 TV Amsterdam, Netherlands; John Innes Ctr Plant Sci Res, Dept Mol Genet, Norwich NR4 7UH, Norfolk, England	University of Birmingham; Cold Spring Harbor Laboratory; University of Amsterdam; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Fransz, PF (corresponding author), Inst Plant Genet & Crop Plant Res IPK, Corrensstr 3, D-06466 Gatersleben, Germany.	fransz@ipk-gatersleben.de	Bisseling, Ton/A-2421-2013	van Drunen, Cornelis M/0000-0001-5503-066X				Ananiev EV, 1998, GENETICS, V149, P2025; Brandes A, 1997, CHROMOSOME RES, V5, P238, DOI 10.1023/A:1018415502795; CAMPELL BR, 1992, GENE, V112, P225, DOI 10.1016/0378-1119(92)90380-8; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Copenhaver GP, 1998, P NATL ACAD SCI USA, V95, P247, DOI 10.1073/pnas.95.1.247; Copenhaver GP, 1996, PLANT J, V9, P259, DOI 10.1046/j.1365-313X.1996.09020259.x; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; CREUSOT F, 1995, PLANT J, V8, P763, DOI 10.1046/j.1365-313X.1995.08050763.x; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Fuchs J, 1996, CHROMOSOMA, V104, P315, DOI 10.1007/BF00337219; Gasser SM, 1998, CELL MOL LIFE SCI, V54, P1, DOI 10.1007/s000180050120; GOLDSTEIN P, 1986, J CELL SCI, V82, P119; Hardtke CS, 1996, PLANT MOL BIOL, V32, P915, DOI 10.1007/BF00020488; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Heslop-Harrison JS, 1999, PLANT CELL, V11, P31, DOI 10.1105/tpc.11.1.31; HESLOPHARRISON JS, 1990, HEREDITY, V65, P385, DOI 10.1038/hdy.1990.108; Jackson SA, 1998, GENOME, V41, P566, DOI 10.1139/gen-41-4-566; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; LIMADEFARIA A, 1983, MOL EVOLUTION ORG CH; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Liu YG, 1996, PLANT J, V10, P733, DOI 10.1046/j.1365-313X.1996.10040733.x; LOIDL J, 1991, CHROMOSOMA, V100, P221, DOI 10.1007/BF00344155; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; MARTINEZZAPATER JM, 1986, MOL GEN GENET, V204, P417, DOI 10.1007/BF00331018; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McClintock B, 1929, SCIENCE, V69, P629, DOI 10.1126/science.69.1798.629; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mozo T, 1998, PLANT J, V16, P377, DOI 10.1046/j.1365-313x.1998.00299.x; NEUFFER MG, 1997, MUTANTS MAIZE, P32; Pelissier T, 1995, PLANT MOL BIOL, V29, P441, DOI 10.1007/BF00020976; Pelissier T, 1996, GENETICA, V97, P141, DOI 10.1007/BF00054621; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; SCHERTHAN H, 1992, CHROMOSOMA, V101, P590, DOI 10.1007/BF00360535; Schmidt R, 1996, PLANT J, V9, P755, DOI 10.1046/j.1365-313X.1996.9050755.x; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Thompson HL, 1996, NUCLEIC ACIDS RES, V24, P3017, DOI 10.1093/nar/24.15.3017; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4	46	249	275	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2000	100	3					367	376		10.1016/S0092-8674(00)80672-8	http://dx.doi.org/10.1016/S0092-8674(00)80672-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	282ET	10676818	Bronze			2022-12-01	WOS:000085204400010
J	Smith, MA; Brandt, J; Shadmehr, R				Smith, MA; Brandt, J; Shadmehr, R			Motor disorder in Huntington's disease begins as a dysfunction in error feedback control	NATURE			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; STRIATAL GLUCOSE CONSUMPTION; BASAL GANGLIA VOLUME; GENE; CARRIERS; MEMORY; DYNAMICS; MODEL; RISK	A steady progression of motor dysfunction takes place in Huntington's disease(1) (HD), The origin of this disturbance with relation to the motor control process is not understood. Here we studied reaching movements in asymptomatic HD gene-carriers (AGCs) and subjects with manifest HD. We found that movement jerkiness, which characterizes the smoothness and efficiency of motion, was a sensitive indicator of presymptomatic HD progression. A large fraction of AGCs displayed elevated jerk even when more than seven years remained until predicted disease onset. Movement termination was disturbed much more than initiation and was highly variable from trial to trial. Analysis of this variability revealed that the sensitivity of end-movement jerk to subtle, self-generated early-movement errors was greater in HD subjects than in controls. Additionally, we found that HD corrective responses to externally-generated force pulses were greatly disturbed, indicating that HD subjects display aberrant responses to both external and self-generated errors. Because feedback corrections are driven by error and are delayed such that they predominantly affect movement termination, these findings suggest that a dysfunction in error correction characterizes the motor control deficit in early HD. This dysfunction may be observed years before clinical disease onset and grows worse as the disease progresses.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Smith, MA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.			Brandt, Jason/0000-0001-7381-6244; smith, maurice/0000-0003-4214-1277	NIGMS NIH HHS [T32 GM007057] Funding Source: Medline; NINDS NIH HHS [R01 NS037422-02, R01 NS037422] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATKESON CG, 1985, J NEUROSCI, V5, P2318; Aylward EH, 1997, NEUROLOGY, V48, P394, DOI 10.1212/WNL.48.2.394; Aylward EH, 1996, ARCH NEUROL-CHICAGO, V53, P1293, DOI 10.1001/archneur.1996.00550120105023; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; BLACKMORE L, 1995, J MED GENET, V32, P358, DOI 10.1136/jmg.32.5.358; BRANDT J, 1984, J CLIN NEUROPSYCHOL, V6, P401, DOI 10.1080/01688638408401231; CORDO PJ, 1990, J NEUROPHYSIOL, V63, P161, DOI 10.1152/jn.1990.63.1.161; deBoo GM, 1997, ARCH NEUROL-CHICAGO, V54, P1353, DOI 10.1001/archneur.1997.00550230030012; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FOLSTEIN SE, 1989, HUNTIGNTONS DIS DISO; FOROUD T, 1995, ANN NEUROL, V37, P657, DOI 10.1002/ana.410370516; Gabrieli JDE, 1997, NEUROPSYCHOLOGY, V11, P272, DOI 10.1037/0894-4105.11.2.272; Hogan N., 1990, MULTIPLE MUSCLE SYST, P149, DOI [10.1007/978-1-4613-9030-5_9, DOI 10.1007/978-1-4613-9030-5_9]; KUWERT T, 1993, MOVEMENT DISORD, V8, P98, DOI 10.1002/mds.870080118; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAZZIOTTA JC, 1987, NEW ENGL J MED, V316, P357, DOI 10.1056/NEJM198702123160701; MEYER BU, 1992, ELECTROEN CLIN NEURO, V85, P197, DOI 10.1016/0168-5597(92)90133-V; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; NOTH J, 1985, BRAIN, V108, P65, DOI 10.1093/brain/108.1.65; ROTHLIND JC, 1993, ARCH NEUROL-CHICAGO, V50, P799, DOI 10.1001/archneur.1993.00540080010005; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Siemers E, 1996, ARCH NEUROL-CHICAGO, V53, P487, DOI 10.1001/archneur.1996.00550060029011; TOPPER R, 1993, BRAIN, V116, P87, DOI 10.1093/brain/116.1.87; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	29	262	262	0	15	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					544	549		10.1038/35000576	http://dx.doi.org/10.1038/35000576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676962	Green Published, Green Accepted			2022-12-01	WOS:000085227300050
J	Lowrey, PL; Shimomura, K; Antoch, MP; Yamazaki, S; Zemenides, PD; Ralph, MR; Menaker, M; Takahashi, JS				Lowrey, PL; Shimomura, K; Antoch, MP; Yamazaki, S; Zemenides, PD; Ralph, MR; Menaker, M; Takahashi, JS			Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau	SCIENCE			English	Article							CASEIN KINASE-I; REPRESENTATIONAL DIFFERENCE ANALYSIS; DROSOPHILA PERIOD GENE; DIRECTED PROTEIN-KINASE; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; SUBSTRATE DETERMINANTS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; DOUBLE-TIME	The tau mutation is a semidominant autosomal allele that dramatically shortens period Length of circadian rhythms in Syrian hamsters. We report the molecular identification of the tau Locus using genetically directed representational difference analysis to define a region of conserved synteny in hamsters with both the mouse and human genomes. The tau Locus is encoded by casein kinase I epsilon (CKl epsilon), a homolog of the Drosophila circadian gene double-time. in vitro expression and functional studies of wild-type and tau mutant CKl epsilon enzyme reveal that the mutant enzyme has a markedly reduced maximal velocity and autophosphorylation state. In addition, in vitro CKl epsilon can interact with mammalian PERIOD proteins, and the mutant enzyme is deficient in its ability to phosphorylate PERIOD. We conclude that tau is an allele of hamster CKl epsilon and propose a mechanism by which the mutation Leads to the observed aberrant circadian phenotype in mutant animals.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Univ Virginia, Dept Biol, Natl Sci Fdn, Ctr Biol Timing, Charlottesville, VA 22903 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	Northwestern University; Howard Hughes Medical Institute; Northwestern University; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; University of Toronto	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Antoch, mantoch/0000-0003-3001-8511; Yamazaki, Shin/0000-0002-6691-1531	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056647, R37MH039592] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R37MH39592, R01MH56647] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADLER S, 1948, NATURE, V162, P256, DOI 10.1038/162256b0; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Anderson SL, 1997, ADV GENET, V35, P1, DOI 10.1016/S0065-2660(08)60446-0; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Aschoff J., 1981, HDB BEHAV NEUROBIOLO, V4; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bae K, 2000, J NEUROSCI, V20, P1746; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DIETRICH W, 1992, GENETICS, V131, P423; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings M H, 1999, J Neurosci, V19, pRC11; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LANDER ES, 1993, NAT GENET, V4, P5, DOI 10.1038/ng0593-5; Lee C, 1999, MOL CELL BIOL, V19, P5316; LISITSYN N, 1995, METHOD ENZYMOL, V254, P291; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57; LISITSYN NA, 1995, TRENDS GENET, V11, P303, DOI 10.1016/S0168-9525(00)89087-3; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; Murphy M.R., 1985, P3; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Okuizumi H, 1997, MAMM GENOME, V8, P121, DOI 10.1007/s003359900370; Ott J., 1991, ANAL HUMAN GENETIC L; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tischkau S A, 1999, J Neurosci, V19, pRC15; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wilsbacher LD, 1998, CURR OPIN GENET DEV, V8, P595, DOI 10.1016/S0959-437X(98)80017-8; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	80	645	667	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					483	491		10.1126/science.288.5465.483	http://dx.doi.org/10.1126/science.288.5465.483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775102	Green Accepted			2022-12-01	WOS:000086626000037
J	Gress, TW; Nieto, FJ; Shahar, E; Wofford, MR; Brancati, FL				Gress, TW; Nieto, FJ; Shahar, E; Wofford, MR; Brancati, FL		Atherosclerosis Risk Communities S	Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; HIGH-BLOOD-PRESSURE; FOLLOW-UP; MILD HYPERTENSION; PREVENTION TRIAL; LONG-TERM; MEN; DIURETICS; HEALTH; AGENTS	Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (N Engl J Med 2000;342:905-12.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, Div Hypertens, Jackson, MS USA	Johns Hopkins University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center	Brancati, FL (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA.	fbrancat@welch.jhu.edu			NHLBI NIH HHS [N01-HC-55018, N01-HC-55016, N01-HC-55015] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055018, N01HC055016] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; *ATH RISK COMM STU, 1987, OP MAN; AUBERT RE, 1995, NIH PUBLICATION, P553; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BENGTSSON C, 1984, BMJ-BRIT MED J, V289, P1495, DOI 10.1136/bmj.289.6457.1495; BERGLUND G, 1986, ACTA MED SCAND, V220, P419; Black HR, 1998, ARCH INTERN MED, V158, P573; Bray GA, 1999, DIABETES CARE, V22, P623; BRECKENR.A, 1967, LANCET, V1, P61; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CHIANG CL, 1961, VITAL STAT SPECIAL R, V47; FLETCHER AE, 1991, AM J MED, V90, pS42, DOI 10.1016/0002-9343(91)90435-Z; GEISS LS, 1995, DIABETES AM, P233; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P1235, DOI 10.1111/j.1532-5415.1994.tb06503.x; Hammersley MS, 1997, METABOLISM, V46, P44, DOI 10.1016/S0026-0495(97)90317-6; HARDMAN JG, 1996, GOODMAN GILMANS PHAR, P1465; HELGELAND A, 1984, AM J MED, V76, P802, DOI 10.1016/0002-9343(84)90990-2; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; Jacob S, 1998, AM J HYPERTENS, V11, P1258, DOI 10.1016/S0895-7061(98)00141-1; JAVITT JC, 1995, DIABETES AM, P601; Kenny S.J., 1995, NIH PUBLICATION, P47; KOHNER EM, 1971, LANCET, V1, P986; LUSTGARTEN JA, 1972, CLIN CHEM, V18, P1419; MORALES PA, 1993, DIABETES, V42, P154, DOI 10.2337/diabetes.42.1.154; MURPHY MB, 1982, LANCET, V2, P1293; MYKKANEN L, 1994, J HYPERTENS, V12, P1425; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; NEESE JW, 1976, DEHW PUBLICATION; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; RAMIREZ EA, 1985, HYPERTENSION, V7, P1008; ROSE GA, 1968, WHO MONOGRAPH SERIES, V56; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHAPIRO AP, 1961, NEW ENGL J MED, V265, P1028, DOI 10.1056/NEJM196111232652102; SIEDEL J, 1983, CLIN CHEM, V29, P1075; SKARFORS ET, 1989, BRIT MED J, V298, P1147, DOI 10.1136/bmj.298.6681.1147; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; *STAT, 1997, STAT STAT SOFTW; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; STRUTHERS AD, 1985, HYPERTENSION, V7, P95; Teuscher AU, 1997, J HYPERTENS, V15, pS67, DOI 10.1097/00004872-199715022-00006; TURNER R, 1999, EARLY DIABETES INTER; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WOLFF FW, 1963, JAMA-J AM MED ASSOC, V185, P568, DOI 10.1001/jama.1963.03060070036019; [No title captured]	50	795	852	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2000	342	13					905	912		10.1056/NEJM200003303421301	http://dx.doi.org/10.1056/NEJM200003303421301			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DC	10738048				2022-12-01	WOS:000086179700001
J	Nowak, MA; Plotkin, JB; Jansen, VAA				Nowak, MA; Plotkin, JB; Jansen, VAA			The evolution of syntactic communication	NATURE			English	Article							LANGUAGE	Animal communication is typically non-syntactic, which means that signals refer to whole situations(1-7). Human language is syntactic, and signals consist of discrete components that have their own meaning(8). Syntax is a prerequisite for taking advantage of combinatorics, that is, "making infinite use of finite means"(9-11) The vast expressive power of human language would be impossible without syntax, and the transition from non-syntactic to syntactic communication was an essential step in the evolution of human language(12-16). We aim to understand the evolutionary dynamics of this transition and to analyse how natural selection can guide it. Here we present a model for the population dynamics of language evolution, define the basic reproductive ratio of words and calculate the maximum size of a lexicon. Syntax allows larger repertoires and the possibility to formulate messages that have not been learned beforehand. Nevertheless, according to our model natural selection can only favour the emergence of syntax if the number of required signals exceeds a threshold value. This result might explain why only humans evolved syntactic communication and hence complex language.	Inst Adv Study, Princeton, NJ 08540 USA; Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Institute for Advanced Study - USA; University of London; Royal Holloway University London	Nowak, MA (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.		Nowak, Martin A/A-6977-2008; Plotkin, Joshua B/E-6947-2013; Galantucci, Bruno/E-5770-2010; Jansen, Vincent A A/C-8353-2009	Jansen, Vincent A.A./0000-0002-6518-2090				Batali J., 1998, APPROACHES EVOLUTION; BATES E, 1991, BIOL BEHAV DETERMINA; BICKERTON D, 1990, SPECIES LANGUAGE; BURLING R, 1993, CURR ANTHROPOL, V34, P25, DOI 10.1086/204132; Cheney D.L., 1990, MONKEYS SEE WORLD IN; Chomsky N., 1965, ASPECTS THEORY SYNTA; CHOMSKY N., 1972, LANGUAGE MIND; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; Dunbar, 1998, GROOMING GOSSIP EVOL; GOULD JL, 1987, SCI AM, V256, P74, DOI 10.1038/scientificamerican0187-74; Hauser MD., 1996, EVOLUTION COMMUNICAT; Jackendoff R., 1997, ARCHITECTURE LANGUAG; Lieberman P., 1984, BIOL EVOLUTION LANGU; MARLER P, 1970, AM SCI, V58, P669; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Miller G.A., 1963, HDB MATH PSYCHOL, VII, P419; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Pinker S, 2007, LANGUAGE INSTINCT MI; PREMACK D, 1985, COGNITION, V19, P207, DOI 10.1016/0010-0277(85)90036-8; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONHUMBOLDT W, 1972, LINGUISTIC VARIABILI; WILSON EO, 1972, SCI AM, V227, P52, DOI 10.1038/scientificamerican0972-52; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA	24	196	202	0	41	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					495	498		10.1038/35006635	http://dx.doi.org/10.1038/35006635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761917				2022-12-01	WOS:000086257700048
J	Schiller, J; Major, G; Koester, HJ; Schiller, Y				Schiller, J; Major, G; Koester, HJ; Schiller, Y			NMDA spikes in basal dendrites of cortical pyramidal neurons	NATURE			English	Article							RAT HIPPOCAMPAL SLICES; ACTION-POTENTIALS; CELLS; ACTIVATION; COMPONENTS; SPINES; MODEL	Basal dendrites are a major target for synaptic inputs innervating cortical pyramidal neurons(1). At present little is known about signal processing in these fine dendrites. Here we show that coactivation of clustered neighbouring basal inputs initiated local dendritic spikes, which resulted in a 5.9 +/- 1.5 mV (peak) and 64.4 +/- 19.8 ms (half-width) cable-filtered voltage change at the soma that amplified the somatic voltage response by 226 +/- 46%. These spikes were accompanied by large calcium transients restricted to the activated dendritic segment. In contrast to conventional sodium or calcium spikes, these spikes were mediated mostly by NMDA (N-methyl-D-aspartate) receptor channels, which contributed at least 80% of the total charge. The ionic mechanism of these NMDA spikes may allow 'dynamic spike-initiation zones', set by the spatial distribution of glutamate pre-bound to NMDA receptors, which in turn would depend on recent and ongoing activity in the cortical network. In addition, NMDA spikes may serve as a powerful mechanism for modification of the cortical network by inducing long-term strengthening of co-activated neighbouring inputs.	Technion Med Sch, Dept Physiol, IL-31096 Haifa, Israel; Technion Med Sch, Dept Biophys, IL-31096 Haifa, Israel; Lucent Technol, Biol Computat Res Bell Labs, Murray Hill, NJ USA; Univ Lab Physiol, Oxford, England; Max Planck Inst Med Res, Dept Cell Physiol, Heidelberg, Germany; Rambam Med Ctr, Dept Neurol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Alcatel-Lucent; Lucent Technologies; University of Oxford; Max Planck Society; Rambam Health Care Campus; Technion Israel Institute of Technology	Schiller, J (corresponding author), Technion Med Sch, Dept Physiol, Bat Galim, IL-31096 Haifa, Israel.	Jackie@tx.technion.ac.il	Major, Guy/A-4335-2010					ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; BROWN AM, 1993, J NEUROPHYSIOL, V70, P1530, DOI 10.1152/jn.1993.70.4.1530; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; MAJOR G, 1994, J NEUROSCI, V14, P4613; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949	17	457	464	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					285	289		10.1038/35005094	http://dx.doi.org/10.1038/35005094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749211				2022-12-01	WOS:000086022200049
J	O'Brien, CM; Fox, CJ; Planque, B; Casey, J				O'Brien, CM; Fox, CJ; Planque, B; Casey, J			Fisheries - Climate variability and North Sea cod	NATURE			English	Article									Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	O'Brien, CM (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England.		Planque, Benjamin/D-2729-2013; Fox, Clive/C-5935-2012	Planque, Benjamin/0000-0002-0557-7410; 				Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; COUTANT CC, 1987, ENVIRON BIOL FISH, V18, P161, DOI 10.1007/BF00000356; CUSHING DH, 1996, EXCELLENCE ECOLOGY, V7; *ICES COOP RES REP, 1999, REP ICES ADV COMM FI; Longhurst A, 1998, FISH RES, V38, P101, DOI 10.1016/S0165-7836(98)00152-0; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069	6	221	228	0	43	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					142	142		10.1038/35004654	http://dx.doi.org/10.1038/35004654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724155	Bronze			2022-12-01	WOS:000085870900035
J	Cunningham, EJA; Russell, AF				Cunningham, EJA; Russell, AF			Egg investment is influenced by male attractiveness in the mallard	NATURE			English	Article							DIFFERENTIAL-ALLOCATION HYPOTHESIS; EXTRA-PAIR PATERNITY; REPRODUCTIVE EFFORT; BLUE TIT; SURVIVAL; SIZE; QUALITY; VIABILITY; PEACOCKS; TRAINS	Why females prefer to copulate with particular males is a contentious issue. Attention is currently focused on whether females choose males on the basis of their genetic quality, in order to produce more viable offspring(1). Support for this hypothesis in birds has come from studies showing that preferred males tend to father offspring of better condition or with increased survivorship(2-8). Before attributing greater offspring viability to a male's heritable genetic quality, however, it is important: to discount effects arising from confounding sources, including maternal effects. This has generally been addressed by comparing offspring viability from two different breeding attempts by the same female: one when offspring; are sired by a preferred male, and one when offspring are sired by a less preferred male, However, here we show that individual female mallard (Anas platyrhynchos) lay larger eggs after copulating: with preferred males and smaller eggs after copulating with less preferred males. As a result, females produced offspring of better body condition when paired with preferred males. After controlling: for these differences in maternal investment, we found no effect: of paternity on offspring condition. This shows that differences between half-sibs cannot always be attributed to paternal or maternal genetic effects.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Cunningham, EJA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	ejac3@hermes.cam.ac.uk	Cunningham, Emma/I-9190-2012	Russell, Andy/0000-0002-1299-8555				Andersson Malte, 1994; Balzer AL, 1998, BEHAVIOUR, V135, P297, DOI 10.1163/156853998793066230; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; BOLTON M, 1991, J ANIM ECOL, V60, P949, DOI 10.2307/5424; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CluttonBrock T, 1997, BEHAV ECOL, V8, P392, DOI 10.1093/beheco/8.4.392; CUNNINGHAM EJA, 1997, FORCED COPULATION SP; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.1111/j.1558-5646.1993.tb02142.x; ELDER WH, 1954, J WILDLIFE MANAGE, V18, P495, DOI 10.2307/3797084; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; HOYT DF, 1979, AUK, V96, P73; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Lorenz K., 1951, Avicultural Magazine, V57, P157; Mjelstad Hermund, 1990, Wildfowl, V41, P150; MOLLER AP, 1994, P NATL ACAD SCI USA, V91, P6929, DOI 10.1073/pnas.91.15.6929; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P353, DOI 10.1007/s002650050300; PETRIE M, 1993, P ROY SOC B-BIOL SCI, V251, P127, DOI 10.1098/rspb.1993.0018; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; SORENSON LG, 1994, BEHAV ECOL SOCIOBIOL, V35, P389, DOI 10.1007/s002650050111; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Witte K, 1995, EVOLUTION, V49, P1289, DOI 10.1111/j.1558-5646.1995.tb04458.x	29	287	291	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					74	77		10.1038/35003565	http://dx.doi.org/10.1038/35003565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716444				2022-12-01	WOS:000085775100047
J	da Silva, JMC; Tabarelli, M				da Silva, JMC; Tabarelli, M			Tree species impoverishment and the future flora of the Atlantic forest of northeast Brazil	NATURE			English	Article								Estimates of species extinction due to human impact on tropical forests have previously been based on the relationship between species number and area(1). Here we use a different approach to estimate loss of tree species in the Atlantic forest of northeast Brazil. We evaluate the characteristics of plant species, their avian dispersers and the distribution of the forest remnants on the landscape to estimate that about 33.9% of tree species in this region will become extinct on a regional scale. Because northeast Brazil is the most threatened sector of South American Atlantic forest(2), our results highlight the need. to change the current conservation paradigm for this region. Rather than focus on the creation of isolated reserves in any medium-to-large forest remnant, a bioregional planning approach is urgently required to rescue this unique biota from extinction.	Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Zool, BR-50670020 Recife, PE, Brazil; Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Bot, BR-50670020 Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	da Silva, JMC (corresponding author), Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Zool, Av Prof Moraes Rego 1235, BR-50670020 Recife, PE, Brazil.		Tabarelli, Marcelo/F-1088-2010; da Silva, José Maria Cardoso/K-3479-2016	Tabarelli, Marcelo/0000-0001-7573-7216; da Silva, José Maria Cardoso/0000-0002-7229-6694				Almeida Roberval T., 1995, Neotropical Primates, V3, P174; Bierregaard Richard O. Jr., 1996, P187; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Corlett Richard T., 1997, P333; DIAS IS, 1990, WORKSH MAT ATL PROBL; Galetti M, 1997, BIOL CONSERV, V82, P31, DOI 10.1016/S0006-3207(97)00004-9; GUIDON FC, 1996, FOREST PATCHES TROPI, P163; Laurance WF, 1997, TROPICAL FOREST REMN, P275; LIMA D, 1997, RAIN REV, V4, P1; Moermond T.C., 1985, ORNITHOL MONOGR, V865, P897, DOI [10.2307/40168322, DOI 10.2307/40168322]; MORAES P. L. R., 1992, REV I FLORESTAL, V4, P1206; Muller P, 1973, DISPERSAL CTR TERRES; Murcia Carolina, 1996, P19; Offerman Holly L., 1995, Environmental Reviews, V3, P191, DOI 10.1139/a95-009; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pijl L., 1982, PRINCIPLES DISPERSAL; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; Ranta P, 1998, BIODIVERS CONSERV, V7, P385, DOI 10.1023/A:1008885813543; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson John G., 1996, P111; Sick H., 1985, ORNITOLOGIA BRASILEI; Silva Jose Maria Cardoso Da, 1996, Conservation Biology, V10, P491; Soule Michael E., 1999, P1; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Viana Virgilio M., 1997, P351; WILLIS E O, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V33, P1; WUNDERLEE JM, 1997, FOREST ECOL MANAGMT, V9, P223	28	283	308	1	51	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					72	74		10.1038/35003563	http://dx.doi.org/10.1038/35003563			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716443				2022-12-01	WOS:000085775100046
J	Annane, D; Sebille, V; Troche, G; Raphael, JC; Gajdos, P; Bellissant, E				Annane, D; Sebille, V; Troche, G; Raphael, JC; Gajdos, P; Bellissant, E			A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEPSIS SYNDROME; ADRENOCORTICAL RESPONSIVENESS; HEMODYNAMIC IMPROVEMENT; ADRENAL INSUFFICIENCY; REPLACEMENT; SURVIVAL; ILLNESS; SERUM; MULTICENTER; MORTALITY	Context The hypothalamic-pituitary-adrenal axis is a major determinant of the host response to stress. The relationship between its activation and patient outcome is not known. Objective To evaluate the prognostic Value of cortisol levels and a short corticotropin stimulation test in patients with septic shock. Design and Setting Prospective inception cohort study conducted between October 1991 and September 1995 in 2 teaching hospital adult intensive care units in France. Participants A total of 189 consecutive patients who met clinical criteria for septic shock. Intervention A short corticotropin stimulation test was performed in all patients by intravenously injecting 0.25 mg of tetracosactrin; blood samples were taken immediately before the test (T0) and 30 (T30) and 60 (T60) minutes afterward, Main Outcome Measures Twenty-eight-day mortality as a function of variables collected at the onset of septic shock, including cortisol levels before the corticotropin test and the cortisol response to corticotropin (Delta max, defined as the difference between T0 and the highest value between T30 and T60). Results The 28-day mortality was 58% (95% confidence interval [CI], 51%-65%)and median time to death was 17 days (95% CI, 14-27 days). In multivariate analysis, independent predictors of death (P less than or equal to.001 for all) were McCabe score greater than 0, organ system failure score greater than 2, arterial lactate level greater than 2.8 mmol/L, ratio of PaO2 to fraction of inspired oxygen no more than 160 mm Hg, cortisol level at T0 greater than 34 mu g/dL and Delta max no more than 9 mu g/dL. Three groups of patient prognoses were identified: good (cortisol level at T0 less than or equal to 34 mu g/dL and Delta max >9 mu g/dL; 28-day mortality rate, 26%), intermediate (cortisol level at T0 34 mu g/dL and Delta max less than or equal to 9 mu g/dL or cortisol level at T0 >34 mu g/dL and Delta max >9 Delta g/dL; 28-day mortality rate, 67%), and poor (cortisol level at T0 >34 mu g/dL and Delta max less than or equal to 9 mu g/dL; 28-day mortality rate, 82%). Conclusion Our data suggest that a short corticotropin test has a good prognostic value and could be helpful in identifying patients with septic shock at high risk for death.	Hop Raymond Poincare, Serv Reanimat Med, Dept Intens Care Unit, Sch Med Paris Ouest, F-92380 Garches, France; Hosp Antoine Beclerc, Dept Intens Care Unit, Clamart, France; Univ Rennes 1, Hosp Pontchaillou, Dept Pharmacol, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Rennes; Universite de Rennes 1	Annane, D (corresponding author), Hop Raymond Poincare, Serv Reanimat Med, Dept Intens Care Unit, Sch Med Paris Ouest, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Annane, Djillali/R-7947-2019; Sebille, Veronique/I-3309-2015	Troche, Gilles/0000-0002-8150-6630; Sebille, Veronique/0000-0002-0780-7742				Annane D, 1998, BRIT J CLIN PHARMACO, V46, P589; Annane D, 1996, CRIT CARE MED, V24, P899, DOI 10.1097/00003246-199605000-00035; Aygen B, 1997, EXP CLIN ENDOCR DIAB, V105, P182, DOI 10.1055/s-0029-1211749; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1991, JAMA-J AM MED ASSOC, V266, P1686, DOI 10.1001/jama.266.12.1686; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; BOUACHOUR G, 1995, INTENS CARE MED, V21, P57, DOI 10.1007/BF02425155; BRIEGEL J, 1992, INTENS CARE MED, V18, P318, DOI 10.1007/BF01706486; BRIEGEL J, 1991, LANCET, V338, P507, DOI 10.1016/0140-6736(91)90575-A; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; CLEMMER TP, 1992, CRIT CARE MED, V20, P1395, DOI 10.1097/00003246-199210000-00006; DRUCKER D, 1985, CRIT CARE MED, V13, P477, DOI 10.1097/00003246-198506000-00007; FINLAY WEI, 1982, LANCET, V1, P1414; FIRSCHEIN HE, 1957, ENDOCRINOLOGY, V60, P347, DOI 10.1210/endo-60-3-347; FRIDERICHSEN C, 1918, JB KINDERHEILKUNDE, P87; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; JURNEY TH, 1987, CHEST, V92, P292, DOI 10.1378/chest.92.2.292; KNAUS WA, 1993, JAMA-J AM MED ASSOC, V270, P1233, DOI 10.1001/jama.270.10.1233; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Matot I, 1998, CRIT CARE MED, V26, P627, DOI 10.1097/00003246-199804000-00002; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MCKEE JI, 1983, LANCET, V1, P484; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; MORAN JL, 1994, INTENS CARE MED, V20, P489, DOI 10.1007/BF01711901; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PUGEAT M, 1989, CLIN CHEM, V35, P1675; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; SCHEIN RMH, 1990, CRIT CARE MED, V18, P259, DOI 10.1097/00003246-199003000-00002; SCHNEIDER AJ, 1991, INTENS CARE MED, V17, P436, DOI 10.1007/BF01720688; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIBBALD WJ, 1977, ANN SURG, V186, P29, DOI 10.1097/00000658-197707000-00005; SONI A, 1995, AM J MED, V98, P266, DOI 10.1016/S0002-9343(99)80373-8; SPAN LFR, 1992, INTENS CARE MED, V18, P93, DOI 10.1007/BF01705039; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Waterhouse R, 1911, LANCET, V1, P577; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; [No title captured]	46	680	743	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1038	1045		10.1001/jama.283.8.1038	http://dx.doi.org/10.1001/jama.283.8.1038			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284AM	10697064	Bronze			2022-12-01	WOS:000085308600033
J	Zeng, WL; Wharton, KA; Mack, JA; Wang, K; Gadbaw, M; Suyama, K; Klein, PS; Scott, MP				Zeng, WL; Wharton, KA; Mack, JA; Wang, K; Gadbaw, M; Suyama, K; Klein, PS; Scott, MP			Naked cuticle encodes an inducible antagonist of Wnt signalling	NATURE			English	Article							DROSOPHILA EMBRYOS; IMAGINAL DISKS; CELL FATES; WINGLESS; POLARITY; GENE; EXPRESSION; XENOPUS; EPIDERMIS; INDUCTION	During animal development, cells have to respond appropriately to localized secreted signals. Proper responses to Hedgehog, transforming growth factor-beta, epidermal growth factor and fibroblast growth factor/Ras signals require cognate inducible antagonists such as Patched, Dad, Argos and Sprouty(1). Wnt signals are crucial in development and neoplasia(2). Here we show that naked cuticle (nkd), a Drosophila segment-polarity gene, encodes an inducible antagonist for the Wnt signal Wingless (Wg). In fly embryos and imaginal discs nkd transcription is induced by Wg. In embryos, decreased nkd function has an effect similar to excess Wg; at later stages such a decrease appears to have no effect. Conversely, overproduction of Nkd in Drosophila and misexpression of Nkd in the vertebrate Xenopus laevis result in phenotypes resembling those of loss of Wg/Wnt function. nkd encodes a protein with a single EF hand (a calcium-binding motif) that is most similar to the recoverin family of myristoyl switch proteins. Nkd may therefore Link ion fluxes to the regulation of the potency, duration or distribution of Wnt signals. Signal-inducible feedback antagonists such as nkd may limit the effects of Wnt proteins in development and disease.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Pathol, Stanford, CA 94305 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Internal Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; University of Pennsylvania	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Beckman Ctr B300,Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Wang, Kevin/0000-0002-5305-6791	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BAKER NE, 1988, DEVELOPMENT, V102, P489; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; BEJSOVEC A, 1993, DEVELOPMENT, V119, P501; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170; COUSO JP, 1994, DEVELOPMENT, V120, P621; Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Itoh K, 1999, GENE DEV, V13, P2328, DOI 10.1101/gad.13.17.2328; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; MA CY, 1995, DEVELOPMENT, V121, P2279; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Moline MM, 1999, DEVELOPMENT, V126, P4375; Moon RT, 1997, CELL, V88, P725, DOI 10.1016/S0092-8674(00)81915-7; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Shirras AD, 1996, DEV BIOL, V175, P24, DOI 10.1006/dbio.1996.0092; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Steitz MC, 1998, DEV BIOL, V197, P218, DOI 10.1006/dbio.1998.8884	30	176	186	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					789	795		10.1038/35001615	http://dx.doi.org/10.1038/35001615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693810				2022-12-01	WOS:000085423100057
J	Porath, D; Bezryadin, A; de Vries, S; Dekker, C				Porath, D; Bezryadin, A; de Vries, S; Dekker, C			Direct measurement of electrical transport through DNA molecules	NATURE			English	Article							DISTANCE	Attempts to infer DNA electron transfer from fluorescence quenching measurements(1-9) on DNA strands doped with donor and acceptor molecules have spurred intense debate(10,11) over the question of whether or not this important biomolecule is able to conduct electrical charges. More recently, first electrical transport measurements on micrometre-long DNA 'ropes'(12), and also on large numbers of DNA molecules in films(13), have indicated that DNA behaves as a good linear conductor. Here we present measurements of electrical transport through individual 10.4-nm-long, double-stranded poly(G)-poly(C) DNA molecules connected to two metal nanoelectrodes, that indicate, by contrast, large-bandgap semiconducting behaviour. We obtain nonlinear current-voltage curves that exhibit a voltage gap at low applied bias. This is observed in air as well as in vacuum down to cryogenic temperatures. The voltage dependence of the differential conductance exhibits a peak structure, which is suggestive of the charge carrier transport being mediated by the molecular energy bands of DNA.	Delft Univ Technol, Dept Appl Sci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Appl Sci, POB 5046, NL-2628 CJ Delft, Netherlands.	dekker@qt.tn.tudelft.nl	Bezryadin, Alexey/H-1815-2016	Bezryadin, Alexey/0000-0002-4822-6960; Dekker, Cees/0000-0001-6273-071X				Arkin MR, 1996, SCIENCE, V273, P475, DOI 10.1126/science.273.5274.475; BAKHSHI AK, 1994, PROG BIOPHYS MOL BIO, V61, P187, DOI 10.1016/0079-6107(94)90001-9; BARBARA PF, 1999, ADV CHEM PHYS, V107, pCH13; Beratan DN, 1997, CHEM BIOL, V4, P3, DOI 10.1016/S1074-5521(97)90230-1; Bezryadin A, 1997, J VAC SCI TECHNOL B, V15, P793, DOI 10.1116/1.589411; Bezryadin A, 1997, APPL PHYS LETT, V71, P1273, DOI 10.1063/1.119871; Datta S, 1997, PHYS REV LETT, V79, P2530, DOI 10.1103/PhysRevLett.79.2530; ELEY DD, 1962, T FARADAY SOC, V58, P411, DOI 10.1039/tf9625800411; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Grabert H., 1992, SINGLE CHARGE TUNNEL; Grozema FC, 1999, INT J QUANTUM CHEM, V75, P1009, DOI 10.1002/(SICI)1097-461X(1999)75:6<1009::AID-QUA5>3.0.CO;2-A; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hutter M, 1996, J AM CHEM SOC, V118, P7574, DOI 10.1021/ja953370+; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; LADIK J, 1971, INT J QUANTUM CHEM, V4, P307; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w; Taubes G, 1997, SCIENCE, V275, P1420, DOI 10.1126/science.275.5305.1420; VANLITH D, 1986, J CHEM SOC FARAD T 1, V82, P2933, DOI 10.1039/f19868202933; Wan CZ, 1999, P NATL ACAD SCI USA, V96, P6014, DOI 10.1073/pnas.96.11.6014; WILSON EK, 1998, CHEM ENG NEWS, P2751	22	1531	1595	6	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					635	638		10.1038/35001029	http://dx.doi.org/10.1038/35001029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688194				2022-12-01	WOS:000085288200046
J	Burns, A				Burns, A			Might olfactory dysfunction be a marker of early Alzheimer's disease?	LANCET			English	Editorial Material							DEFICITS		Univ Manchester, Withington Hosp, Sch Psychiat & Behav Sci, Manchester M20 8LR, Lancs, England	University of Manchester	Burns, A (corresponding author), Univ Manchester, Withington Hosp, Sch Psychiat & Behav Sci, Manchester M20 8LR, Lancs, England.			Burns, Alistair/0000-0002-9837-0645				BERRIOS GE, 1984, BRIT J PSYCHIAT, V144, P662, DOI 10.1192/bjp.144.6.662; COOPER AF, 1976, BRIT J PSYCHIAT, V129, P216, DOI 10.1192/bjp.129.3.216; EICHENBAUM H, 1983, BRAIN RES B, V18, P597; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Graves AB, 1999, NEUROLOGY, V53, P1480, DOI 10.1212/WNL.53.7.1480; KOSS E, 1988, NEUROLOGY, V38, P1228, DOI 10.1212/WNL.38.8.1228; Pearson RCA, 1996, NEURODEGENERATION, V5, P429, DOI 10.1006/neur.1996.0058; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Serby M, 1996, BIOL PSYCHIAT, V39, P375, DOI 10.1016/0006-3223(95)00472-6; SERBY M, 1991, AM J PSYCHIAT, V148, P357	10	18	19	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 8	2000	355	9198					84	85		10.1016/S0140-6736(99)90402-6	http://dx.doi.org/10.1016/S0140-6736(99)90402-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288HT	10675162				2022-12-01	WOS:000085557200006
J	Rudolph, RE; Vaughan, TL; Storer, BE; Haggitt, RC; Rabinovitch, PS; Levine, DS; Reid, BJ				Rudolph, RE; Vaughan, TL; Storer, BE; Haggitt, RC; Rabinovitch, PS; Levine, DS; Reid, BJ			Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus	ANNALS OF INTERNAL MEDICINE			English	Article						aneuploidy; Barrett esophagus; adenocarcinoma; esophageal neoplasms; endoscopy	COLUMNAR-LINED ESOPHAGUS; HIGH-GRADE DYSPLASIA; INTESTINAL METAPLASIA; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL JUNCTION; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; ADENOCARCINOMA; PREVALENCE; MANAGEMENT	Background: The increased risk for esophageal adenocarcinoma associated with long-segment (greater than or equal to 3 cm) Barrett esophagus is well recognized. Recent studies suggest that short-segment (<3 cm) Barrett esophagus is substantially more common; however, the risk for neoplastic progression in patients with this disorder is largely unknown. Objective: To examine the relation between segment length and risk for aneuploidy and esophageal adenocarcinoma in patients with Barrett esophagus. Design: Prospective cohort study. Setting: University medical center in Seattle, Washington. Patients: 309 patients with Barrett esophagus. Measurements: Patients were monitored for progression to aneuploidy and adenocarcinoma by repeated endoscopy with biopsy for an average of 3.8 years. Cox proportional hazards analysis was used to calculate adjusted relative risks and 95% Cls. Results: After adjustment for histologic diagnosis at study entry, segment length was not related to risk for cancer in the full cohort (P > 0.2 for trend). When patients with high-grade dysplasia at baseline were excluded, however, a nonsignificant trend was observed; based on a linear model, a 5-cm difference in segment length was associated with a 1.7-fold (95% CI, 0.8-fold to 3.8-fold) increase in cancer risk. Among all eligible patients, a 5-cm difference in segment length was associated with a small increase in the risk for aneuploidy (relative risk, 1.4 [CI, 1.0 to 2.1]; P = 0.06 far trend). A similar trend was observed among patients without high-grade dysplasia at baseline. Conclusions: The risk for esophageal adenocarcinoma in patients with short-segment Barrett esophagus was not substantially lower than that in patients with longer segments. Although our results suggest a small increase in risk for neoplastic progression with increasing segment length, additional follow-up is needed to determine whether the patterns of risk occurred by chance or represent true differences. Until more data are available, the frequency of endoscopic surveillance should be selected without regard to segment length.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Rudolph, RE (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,MP-474,Box 19024, Seattle, WA 98109 USA.		Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	NCI NIH HHS [R25 CA57734, R01 CA61202] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA057734, R01CA061202] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; BANERJEE B, 1994, GASTROENTEROLOGY, V106, pA45; Beck I T, 1997, Can J Gastroenterol, V11 Suppl B, p7B; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Cameron AJ, 1998, MAYO CLIN PROC, V73, P457; Chalasani N, 1997, DIGEST DIS SCI, V42, P603, DOI 10.1023/A:1018863529777; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Farrow DC, 1996, CANCER CAUSE CONTROL, V7, P322, DOI 10.1007/BF00052937; Fitzgerald RC, 1998, DIGEST DIS, V16, P63, DOI 10.1159/000016850; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; HAMILTON SR, 1988, HUM PATHOL, V19, P942, DOI 10.1016/S0046-8177(88)80010-8; HARLE IA, 1985, ANN THORAC SURG, V40, P330, DOI 10.1016/S0003-4975(10)60062-8; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; HONG MK, 1995, CANCER, V75, P423, DOI 10.1002/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5; IFTIKHAR SY, 1992, GUT, V33, P1155, DOI 10.1136/gut.33.9.1155; Johnston MH, 1996, AM J GASTROENTEROL, V91, P1507; KIM SL, 1994, GASTROENTEROLOGY, V107, P945, DOI 10.1016/0016-5085(94)90217-8; KINGSNORTH AN, 1983, CANCER RES, V43, P2545; LERUT T, 1994, J THORAC CARDIOV SUR, V107, P1059, DOI 10.1016/S0022-5223(94)70381-7; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; LEVINE DS, 1991, GASTROINTEST ENDOSC, V37, P332, DOI 10.1016/S0016-5107(91)70726-8; MENKEPLUYMERS MBE, 1994, GUT, V35, P1348, DOI 10.1136/gut.35.10.1348; MENKEPLUYMERS MBE, 1993, CANCER, V72, P1155, DOI 10.1002/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C; MIROS M, 1991, GUT, V32, P1441, DOI 10.1136/gut.32.12.1441; Morales TG, 1997, AM J GASTROENTEROL, V92, P414; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; RANSOM JM, 1982, ANN THORAC SURG, V33, P19, DOI 10.1016/S0003-4975(10)63192-X; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; REID BJ, 1987, GASTROENTEROLOGY, V93, P1; Riddell RH, 1996, AM J GASTROENTEROL, V91, P853; RUSCH VW, 1994, CANCER, V74, P1225, DOI 10.1002/1097-0142(19940815)74:4<1225::AID-CNCR2820740408>3.0.CO;2-Q; Sampliner RE, 1998, AM J GASTROENTEROL, V93, P1028; SCHNELL TG, 1992, DIGEST DIS SCI, V37, P137, DOI 10.1007/BF01308357; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; *STAT CORP, 1997, STAT STAT SOFTW REL; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; STREITZ JM, 1991, ANN SURG, V213, P122, DOI 10.1097/00000658-199102000-00005; TERPSTRA OT, 1981, GASTROENTEROLOGY, V81, P475; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Weston AP, 1996, AM J GASTROENTEROL, V91, P981; Weston AP, 1997, AM J GASTROENTEROL, V92, P407; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212	48	201	204	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					612	+		10.7326/0003-4819-132-8-200004180-00003	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766679				2022-12-01	WOS:000086497500002
J	Velicer, GJ; Kroos, L; Lenski, RE				Velicer, GJ; Kroos, L; Lenski, RE			Developmental cheating in the social bacterium Myxococcus xanthus	NATURE			English	Article							CELL; EVOLUTION; DICTYOSTELIUM; MUTANTS; LOCUS; GENES	Cheating is a potential problem in any social system that depends on cooperation and in which actions that benefit a group are costly to individuals that perform them(1-5). Genetic mutants that fail to perform a group-beneficial function but that reap the benefits of belonging to the group should have a within-group selective advantage, provided that the mutants are not too common. Here we show that social cheating exists even among prokaryotes. The bacterium Myxococcus xanthus exhibits several social behaviours, including aggregation of cells into spore-producing fruiting bodies during starvation. We examined a number of M. xanthus genotypes that were defective for fruiting-body development, including several lines that evolved for 1,000 generations under asocial conditions(6) and others carrying defined mutations in developmental pathways(7-10), to determine whether they behaved as cheaters when mixed with their developmentally proficient progenitor. Clones from several evolved lines and two defined mutants exhibited cheating during development, being overrepresented among resulting spores relative to their initial frequency in the mixture. The ease of finding anti-social behaviours suggests that cheaters may be common in natural populations of M. xanthus.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Velicer, GJ (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.	velicerg@pilot.msu.edu		Lenski, Richard/0000-0002-1064-8375				Axelrod Robert K., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BONNER JT, 1967, CELLULAR SLIME MOLDS; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Buss LW, 1999, P NATL ACAD SCI USA, V96, P8801, DOI 10.1073/pnas.96.16.8801; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; DWORKIN M, 1993, MYCOBACTERIA, V2; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Garza AG, 2000, MOL MICROBIOL, V35, P812, DOI 10.1046/j.1365-2958.2000.01753.x; Grosberg RK, 1998, TRENDS ECOL EVOL, V13, P112, DOI 10.1016/S0169-5347(97)01313-X; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; KAISER D, 1986, ANNU REV GENET, V20, P539; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; KUSPA A, 1989, J BACTERIOL, V171, P2762, DOI 10.1128/jb.171.5.2762-2772.1989; KUSPA A, 1986, DEV BIOL, V117, P267, DOI 10.1016/0012-1606(86)90369-6; LAUE BE, 1995, J BACTERIOL, V177, P4089, DOI 10.1128/jb.177.14.4089-4096.1995; Matapurkar AK, 1997, AM NAT, V150, P790, DOI 10.1086/286094; Maynard Smith J., 1982, pi; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Reichenbach H, 1993, MYXOBACTERIA, P13; Rosenberg E, 1984, MYXOBACTERIA DEV CEL, P109; SHIMKETS LJ, 1988, MOL GEN GENET, V211, P63, DOI 10.1007/BF00338394; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999	30	234	238	1	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					598	+		10.1038/35007066	http://dx.doi.org/10.1038/35007066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766241				2022-12-01	WOS:000086400100052
J	Keck, JL; Roche, DD; Lynch, AS; Berger, JM				Keck, JL; Roche, DD; Lynch, AS; Berger, JM			Structure of the RNA polymerase domain of E-coli primase	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; REPLICATION FORK; PROTEIN MODELS; HELICASE; BACTERIOPHAGE-T7; TOPOISOMERASES; RECOGNITION; REFINEMENT; EVOLUTION	All cellular organisms use specialized RNA polymerases called "primases" to synthesize RNA primers for the initiation of DNA replication. The high-resolution crystal structure of a primase, comprising the catalytic core of the Escherichia coli DnaG protein, was determined. The core structure contains an active-site architecture that is unrelated to other DNA or RNA polymerase palm folds, but is instead related to the "toprim" fold. On the basis of the structure, it is Likely that DnaG binds nucleic acid in a groove clustered with invariant residues and that DnaG is positioned within the replisome to accept single-stranded DNA directly from the replicative helicase.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Tularik, S San Francisco, CA 94080 USA	University of California System; University of California Berkeley	Lynch, AS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall,No 3206, Berkeley, CA 94720 USA.			Keck, James/0000-0002-5961-0220				Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BRUTLAG D, 1971, P NATL ACAD SCI USA, V68, P2826, DOI 10.1073/pnas.68.11.2826; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLTON J, UNPUB; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABASCH W, 1988, J APPL CRYSTALLOGR, V21, P916; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KECK J, UNPUB; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; Kornberg A., 1992, DNA REPLICATION; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie A, 1992, NEWSLETTER PROTEIN C; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR D, V50, P1507; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Sun WL, 1999, J BACTERIOL, V181, P3761, DOI 10.1128/JB.181.12.3761-3767.1999; SUN WL, 1994, P NATL ACAD SCI USA, V91, P11462, DOI 10.1073/pnas.91.24.11462; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; TOUGU K, 1994, J BIOL CHEM, V269, P4675; VERSALOVIC J, 1993, GENE, V136, P281, DOI 10.1016/0378-1119(93)90480-Q; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; ZECHNER EL, 1992, J BIOL CHEM, V267, P4054; ZIEGELIN G, 1995, J BACTERIOL, V177, P4333, DOI 10.1128/jb.177.15.4333-4341.1995	40	124	126	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2482	2486		10.1126/science.287.5462.2482	http://dx.doi.org/10.1126/science.287.5462.2482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741967				2022-12-01	WOS:000086202200044
J	Difilippantonio, MJ; Zhu, J; Chen, HT; Meffre, E; Nussenzweig, MC; Max, EE; Ried, T; Nussenzweig, A				Difilippantonio, MJ; Zhu, J; Chen, HT; Meffre, E; Nussenzweig, MC; Max, EE; Ried, T; Nussenzweig, A			DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation	NATURE			English	Article							V(D)J RECOMBINATION; MICE; P53; TRANSPOSITION; GROWTH; RAG1; GENE	Cancer susceptibility genes have been classified into two groups: gatekeepers and caretakers(1). Gatekeepers are genes that control cell proliferation and death, whereas caretakers are DNA repair genes whose inactivation leads to genetic instability. Abrogation of both caretaker and gatekeeper function markedly increases cancer susceptibility. Although the importance of Ku80 in DNA double-strand break repair is well established, neither Ku80 nor other components of the non-homologous end-joining pathway are known to have a caretaker role in maintaining genomic stability. Here we show that mouse cells deficient for Ku80 display a marked increase in chromosomal aberrations, including breakage, translocations and aneuploidy. Despite the observed chromosome instabilities, Ku80(-/-) mice have only a slightly earlier onset of cancer(2,3). Loss of p53 synergizes with Ku80 to promote tumorigenesis such that all Ku80(-/-) p53(-/-) mice succumb to disseminated pro-B-cell lymphoma before three months of age. Tumours result from a specific set of chromosomal translocations and gene amplications involving IgH and c-Myc, reminiscent of Burkitt's lymphoma. We conclude that Ku80 is a caretaker gene that maintains the integrity of the genome by a mechanism involving the suppression of chromosomal rearrangements.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Dept Genet, NIH, Bethesda, MD 20892 USA; Rockefeller Inst, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Inst, Howard Hughes Med Inst, New York, NY 10021 USA; US FDA, Lab Cell Regulat, Ctr Biol Evaluat & Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Difilippantonio, Michael/AAF-2839-2021; Nussenzweig, Michel/AAE-7292-2019	Difilippantonio, Michael/0000-0002-4676-7034; 	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010298, Z01SC010299] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; GU Y, 1997, IMMUNITY, V7, P367; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TIMME TL, 1994, BIOTECHNIQUES, V17, P462; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	30	440	451	0	15	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					510	514		10.1038/35006670	http://dx.doi.org/10.1038/35006670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761921	Green Accepted			2022-12-01	WOS:000086257700052
J	Emanuel, EJ; Fairclough, DL; Slutsman, J; Emanuel, LL				Emanuel, EJ; Fairclough, DL; Slutsman, J; Emanuel, LL			Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers	ANNALS OF INTERNAL MEDICINE			English	Article						terminally ill; terminal care; cost of illness; caregivers; physician role	PHYSICIAN-ASSISTED SUICIDE; MENTAL-HEALTH; UNITED-STATES; CARE; EUTHANASIA; CANCER; ATTITUDES; FAMILIES; ADULTS; NEEDS	Background: Terminal illness imposes substantial burdens-economic and otherwise-on patients and caregivers. The cause of these burdens is not understood. Objective: To determine the mechanism for economic and noneconomic burdens of terminal illness and to identify potential ameliorating interventions. Design: In-person interviews of terminally ill patients and their caregivers. Setting: Six randomly selected U.S. sites: Worcester, Massachusetts; St. Louis, Missouri; Tucson, Arizona; Birmingham, Alabama; Brooklyn, New York; and Mesa County, Colorado. Participants: 988 terminally ill patients and 893 caregivers. Measurements: Needs for transportation, nursing care, homemaking, and personal care; subjective perception of economic burden; expenditure of more than 10% of household income on health care costs; caregiver depression and sense of interference with his or her life; and patient consideration of euthanasia or physician-assisted suicide. Results: Of all patients, 34.7% had substantial care needs. Patients who had substantial care needs were more likely to report that they had a subjective sense of economic burden (44.9% compared with 35.3%; difference, 9.6 percentage points [95% CI, 3.1 to 16.1]; P = 0.005); that 10% of their household income was spent on health care (28.0% compared with 17.0%; difference, 11.0 percentage points [CI, 4.8 to 17.1]; P less than or equal to 0.001); and that they or their families had to take out a loan or mortgage, spend their savings, or obtain an additional job (16.3% compared with 10.2%; difference, 6.1 percentage points [CI, 1.4 to 10.6]; P = 0.004). Patients with substantial care needs were more likely to consider euthanasia or physician-assisted suicide (P = 0.001). Caregivers of these patients were more likely to have depressive symptoms (31.4% compared with 24.8%; difference, 6.6 percentage points [CI, 0.4 to 12.8]; P = 0.01) and to report that caring for the patients interfered with their lives (35.6% compared with 24.3%; difference, 11.3 percentage points [CI, 5.0 to 17.7]; P = 0.001). Caregivers of patients whose physicians listened to patients' and caregivers' needs had fewer burdens. Conclusions: Substantial care needs are an important cause of the economic and other burdens imposed by terminal illness. Through empathy, physicians may be able to ameliorate some of these burdens.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; AMC Canc Res Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA	National Institutes of Health (NIH) - USA; AMC Cancer Research Center; Johns Hopkins University; American Medical Association	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.							BERKMAN BJ, 1993, CANCER-AM CANCER SOC, V72, P2846, DOI 10.1002/1097-0142(19931101)72:9+<2846::AID-CNCR2820721515>3.0.CO;2-3; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; *BUR CENS, 1998, STAT ABSTR US 1998; CANTOR MH, 1983, GERONTOLOGIST, V23, P597, DOI 10.1093/geront/23.6.597; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EPSTEIN AM, 1995, INQUIRY-J HEALTH CAR, V32, P211; Field MJ, 1997, APPROACHING DEATH IM; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; *GROUP HLTH ASS AM, 1992, NAT DIR HMOS; HOUTS PS, 1988, CANCER, V62, P627, DOI 10.1002/1097-0142(19880801)62:3<627::AID-CNCR2820620331>3.0.CO;2-1; KISSANE DW, 1994, PSYCHO-ONCOLOGY, V3, P47, DOI DOI 10.1002/P0N.2960030109; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MOR V, 1987, Journal of Psychosocial Oncology, V5, P1, DOI 10.1300/J077v05n01_01; *OFF PROT RES RISK, 1993, PROT HUM RES SUBJ I; PATRICK C, 1992, GEN HOSP PSYCHIAT, V14, P219, DOI 10.1016/0163-8343(92)90091-N; PRUCHNO RA, 1989, J AM GERIATR SOC, V37, P697, DOI 10.1111/j.1532-5415.1989.tb02230.x; RICE DP, 1993, HEALTH AFFAIR, V12, P164, DOI 10.1377/hlthaff.12.2.164; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; Ware J.E., 1993, SCORING SF 36 SF 36, DOI DOI 10.6-10.7; Zubrod CG, 1960, J CHRON DIS, V11, P7	30	293	298	0	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					451	+		10.7326/0003-4819-132-6-200003210-00005	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733444				2022-12-01	WOS:000085834700004
J	Ling, LH; Oh, JK; Breen, JF; Schaff, HV; Danielson, GK; Mahoney, DW; Seward, JB; Tajik, AJ				Ling, LH; Oh, JK; Breen, JF; Schaff, HV; Danielson, GK; Mahoney, DW; Seward, JB; Tajik, AJ			Calcific constrictive pericarditis: Is it still with us?	ANNALS OF INTERNAL MEDICINE			English	Article						pericarditis, constrictive; calcinosis; heart failure, congestive; dyspnea	TUBERCULOUS PERICARDITIS; ETIOLOGY	Background: The presence of pericardial calcification on a plain radiograph strongly suggests constrictive pericarditis in patients with heart failure. However, calcific constrictive pericarditis is considered rare in the United States since tuberculosis incidence has decreased, and doubt has therefore been raised about the importance of this radiologic finding in modern cardiovascular practice. Objective: To determine the clinical and prognostic significance of pericardial calcification on radiography in patients with constrictive pericarditis. Design: Retrospective cohort study. Setting: Tertiary referral center. Patients: A consecutive series of 135 patients (mean age +/- SD, 56 +/- 16 years) who from 1985 through 1995 had constrictive pericarditis confirmed surgically (n = 133) or by autopsy (n = 2). Patients were divided into two groups: those with pericardial calcification on chest radiography (group I) and those without (group II). Measurements: Clinical and diagnostic findings were compared in both groups, and outcome was compared in 132 patients who had pericardiectomy. Results: Pericardial calcification was seen in 36 patients (27%). The cause of constrictive pericardial disease was indeterminate in 67% of patients in group I and in 21% of patients in group II(P < 0.001). Patients in group I had had symptoms for a longer period and were more likely to have pericardial knock, larger atrial size, and atrial arrhythmia. Significantly more perioperative deaths were seen in group I, but incidence of late survival and incidence of noncalcific disease were similar in both groups. Conclusions: Pericardial calcification is a common finding in patients with constrictive pericarditis. It is often associated with idiopathic disease and other markers of disease chronicity and is an independent predictor of increased perioperative mortality rates.	Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Oh, JK (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.			Ling, Lieng H./0000-0001-6063-8530; Schaff, Hartzell/0000-0003-0994-027X				AAGAARD MT, 1984, THORAC CARDIOV SURG, V32, P311, DOI 10.1055/s-2007-1023411; BASHI VV, 1988, THORAX, V43, P637, DOI 10.1136/thx.43.8.637; BLAKE S, 1983, BRIT HEART J, V50, P273; CAMERON J, 1987, AM HEART J, V113, P354, DOI 10.1016/0002-8703(87)90278-X; CHAMBLISS JR, 1951, CIRCULATION, V4, P816, DOI 10.1161/01.CIR.4.6.816; CIMINO JJ, 1989, AM HEART J, V118, P1292, DOI 10.1016/0002-8703(89)90021-5; DALTON JC, 1956, ANN INTERN MED, V45, P445, DOI 10.7326/0003-4819-45-3-445; DCRUZ IA, 1978, RADIOLOGY, V127, P755, DOI 10.1148/127.3.755; DINES DE, 1958, P STAFF M MAYO CLIN, V33, P93; FEIRING AJ, 1985, CIRCULATION, V72, P1355, DOI 10.1161/01.CIR.72.6.1355; FOWLER NO, 1991, JAMA-J AM MED ASSOC, V266, P99, DOI 10.1001/jama.266.1.99; GIMLETTE TMD, 1959, BRIT HEART J, V21, P9; HAGEMAN JH, 1964, NEW ENGL J MED, V270, P327, DOI 10.1056/NEJM196402132700702; HARVEY RM, 1953, CIRCULATION, V8, P695, DOI 10.1161/01.CIR.8.5.695; HEINZ R, 1957, RADIOLOGY, V69, P54, DOI 10.1148/69.1.54; HOLMAN E, 1955, JAMA-J AM MED ASSOC, V157, P789, DOI 10.1001/jama.1955.02950270007003; LEVINE HD, 1973, CIRCULATION, V48, P1268, DOI 10.1161/01.CIR.48.6.1268; Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380; MACGREGOR JH, 1987, AM J ROENTGENOL, V148, P675, DOI 10.2214/ajr.148.4.675; Matsubara H, 1995, J Cardiol, V25, P89; MCCAUGHAN BC, 1985, J THORAC CARDIOV SUR, V89, P340; NI Y, 1990, ANN THORAC SURG, V49, P445, DOI 10.1016/0003-4975(90)90252-2; PAUL O, 1948, AM J MED SCI, V216, P361, DOI 10.1097/00000441-194810000-00001; Potwar S A, 1989, Indian Heart J, V41, P30; RIENMULLER R, 1993, J THORAC IMAG, V8, P108; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; SCHIAVONE WA, 1989, AM J CARDIOL, V63, P145, DOI 10.1016/0002-9149(89)91106-5; SCHIAVONE WA, 1986, AM J CARDIOL, V58, P373, DOI 10.1016/0002-9149(86)90087-1; SCHOENFELD MH, 1987, CIRCULATION, V75, P1012, DOI 10.1161/01.CIR.75.5.1012; STEINBERG I, 1961, AM J CARDIOL, V7, P33, DOI 10.1016/0002-9149(61)90421-0; SUWAN PK, 1995, BRIT HEART J, V73, P187; TIRILOMIS T, 1994, EUR J CARDIO-THORAC, V8, P487, DOI 10.1016/1010-7940(94)90020-5; Wise D E, 1976, Cardiovasc Clin, V7, P197; WOOD P, 1961, AM J CARDIOL, V7, P48, DOI 10.1016/0002-9149(61)90422-2; WYCHULIS AR, 1971, J THORAC CARDIOV SUR, V62, P608, DOI 10.1016/S0022-5223(19)42030-8	35	102	112	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					444	+		10.7326/0003-4819-132-6-200003210-00004	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733443				2022-12-01	WOS:000085834700003
J	Bell, S; Kamm, MA				Bell, S; Kamm, MA			Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease	LANCET			English	Editorial Material							INFLAMMATORY BOWEL-DISEASE; AZATHIOPRINE; TERM; CA2		St Marks Hosp, Dept Gastroenterol, Harrow HA1 3UJ, Middx, England	Imperial College London	Bell, S (corresponding author), St Marks Hosp, Dept Gastroenterol, Harrow HA1 3UJ, Middx, England.							Baert FJ, 1999, INT J COLORECTAL DIS, V14, P47, DOI 10.1007/s003840050182; Bickston SJ, 1999, GASTROENTEROLOGY, V117, P1433, DOI 10.1016/S0016-5085(99)70294-5; CONNELL WR, 1994, GUT, V35, P347, DOI 10.1136/gut.35.3.347; CONNELL WR, 1994, LANCET, V343, P1249, DOI 10.1016/S0140-6736(94)92150-4; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Dalum I, 1999, NAT BIOTECHNOL, V17, P666, DOI 10.1038/10878; GREENSTEIN AJ, 1992, CANCER-AM CANCER SOC, V69, P1119; Hanauer SB, 1999, GASTROENTEROLOGY, V116, pA731; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; SANDBORN WJ, 1999, GUT, V45, pA133; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Stack WA, 1997, LANCET, V349, P521, DOI 10.1016/S0140-6736(97)80083-9; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502	15	79	81	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					858	860		10.1016/S0140-6736(99)00442-0	http://dx.doi.org/10.1016/S0140-6736(99)00442-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752696				2022-12-01	WOS:000085896000002
J	Russ, AP; Wattler, S; Colledge, WH; Aparicio, SAJR; Carlton, MBL; Pearce, JJ; Barton, SC; Surani, MA; Ryan, K; Nehls, MC; Wilson, V; Evans, MJ				Russ, AP; Wattler, S; Colledge, WH; Aparicio, SAJR; Carlton, MBL; Pearce, JJ; Barton, SC; Surani, MA; Ryan, K; Nehls, MC; Wilson, V; Evans, MJ			Eomesodermin is required for mouse trophoblast development and mesoderm formation	NATURE			English	Article							CHIMERIC ANALYSIS; T-GENE; EMBRYO; GASTRULATION; EXPRESSION; FAMILY	The earliest cell fate decision in the mammalian embryo separates the extra-embryonic trophoblast lineage, which forms the fetal portion of the placenta, from the embryonic cell lineages. The body plan of the embryo proper is established only later at gastrulation, when the pluripotent epiblast gives rise to the germ layers ectoderm, mesoderm and endoderm. Here we show that the T-box gene Eomesodermin(1) performs essential functions in both trophoblast development and gastrulation, Mouse embryos lacking Eomesodermin arrest at the blastocyst stage. Mutant trophoectoderm does not differentiate into trophoblast, indicating that Eomesodermin may be required for the development of trophoblast stem cells(2), In the embryo proper, Eomesodermin is essential for mesoderm formation. Although the specification of the anterior-posterior axis and the initial response to mesoderm-inducing signals is intact in mutant epiblasts, the prospective mesodermal cells are not recruited into the primitive streak. Our results indicate that Eomesodermin defines a conserved molecular pathway controlling the morphogenetic movements of germ layer formation and has acquired a new function in mammals in the differentiation of trophoblast.	Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England; Paradigm Therapeut Ltd, Cambridge CB2 3EG, England; Niedersachs Inst Peptidforsch, D-30625 Hannover, Germany; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Oncol, Cambridge CB2 2XY, England; Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh	Russ, AP (corresponding author), Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.		Colledge, William/X-4976-2019; Wilson, Valerie A/H-5427-2011	Colledge, William/0000-0002-9603-4429; Aparicio, Samuel/0000-0002-0487-9599				Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Casey ES, 1999, DEVELOPMENT, V126, P4193; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hogan B., 2014, MANIPULATING MOUSE E; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; ROSSANT J, 1981, J EMBRYOL EXP MORPH, V62, P217; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; Tada M, 1998, DEVELOPMENT, V125, P3997; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Wattler S, 1998, GENOMICS, V48, P24, DOI 10.1006/geno.1997.5150; WILSON V, 1993, DEVELOPMENT, V117, P1321; WILSON V, 1995, DEVELOPMENT, V121, P877	29	465	473	0	40	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					95	99		10.1038/35003601	http://dx.doi.org/10.1038/35003601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716450				2022-12-01	WOS:000085775100053
J	Henney, JE				Henney, JE			Revised labeling for cisapride	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-01	WOS:000085424100006
J	Cruz, A; Green, BG				Cruz, A; Green, BG			Thermal stimulation of taste	NATURE			English	Article							TEMPERATURE-DEPENDENCE; RESPONSES; HAMSTER; NERVE	The first electrophysiological recordings from animal(1) and human(2) taste nerves gave clear evidence of thermal sensitivity, and studies have shown that as many as half of the neurons in mammalian taste pathways respond to temperature(3-6). Because temperature has never been shown to induce sensations of taste, it has been assumed that thermal stimulation in the gustatory system is somehow nulled(6). Here we show that heating or cooling small areas of the tongue can in fact cause sensations of taste: warming the anterior edge of the tongue (chorda tympani nerve) from a cold temperature can evoke sweetness, whereas cooling can evoke sourness and/or saltiness. Thermal taste also occurs on the rear of the tongue (glossopharyngeal nerve), but the relationship between temperature and taste is different there than on the front of the tongue. These observations indicate the human gustatory system contains several different types of thermally sensitive neurons that normally contribute to the sensory code for taste.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06519 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University	Green, BG (corresponding author), John B Pierce Fdn Lab, 290 Congress Ave, New Haven, CT 06519 USA.	green@jbpierce.org						BARTOSHUK LM, 1982, PHYSIOL BEHAV, V28, P905, DOI 10.1016/0031-9384(82)90212-8; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GREEN BG, 1987, CHEM SENSES, V12, P609, DOI 10.1093/chemse/12.4.609; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MCBURNEY DH, 1973, PHYSIOL BEHAV, V11, P89, DOI 10.1016/0031-9384(73)90127-3; NAKAMURA M, 1988, BRAIN RES, V444, P159, DOI 10.1016/0006-8993(88)90923-7; OAKLEY B, 1985, CHEM SENSES, V10, P469, DOI 10.1093/chemse/10.4.469; OGAWA H, 1968, J PHYSIOL-LONDON, V199, P223, DOI 10.1113/jphysiol.1968.sp008650; SATO M, 1975, J GEN PHYSIOL, V66, P781, DOI 10.1085/jgp.66.6.781; TRAVERS SP, 1984, J GEN PHYSIOL, V84, P221, DOI 10.1085/jgp.84.2.221; VONBEKESY G, 1964, SCIENCE, V145, P834, DOI 10.1126/science.145.3634.834; WHITEHEAD MC, 1994, J COMP NEUROL, V340, P515, DOI 10.1002/cne.903400405; Whitehead MC, 1999, NEUROSCIENCE, V93, P931, DOI 10.1016/S0306-4522(99)00115-3; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zotterman Y, 1935, SKAND ARCH PHYSIOL, V72, P73, DOI 10.1111/j.1748-1716.1935.tb00412.x	16	169	173	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					889	892		10.1038/35002581	http://dx.doi.org/10.1038/35002581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706285				2022-12-01	WOS:000085559200056
J	Guo, HF; Tong, JY; Hannan, F; Luo, L; Zhong, Y				Guo, HF; Tong, JY; Hannan, F; Luo, L; Zhong, Y			A neurofibromatosis-1-regulated pathway is required for learning in Drosophila	NATURE			English	Article							PROTEIN-KINASE-A; ADENYLATE-CYCLASE; MUSHROOM BODIES; TERM-MEMORY; GENE; NF1; TYPE-1; RAS; MELANOGASTER; RUTABAGA	The tumour-suppressor gene Neurofibromatosis 1 (Nf1) encodes a Ras-specific GTPase activating protein (Ras-GAP)(1-5). In addition to being involved in tumour formation(6,7), NF1 has been reported to cause learning defects in humans(8-10) and Nf1 knockout mice(11) However, it remains to be determined whether the observed learning defect is secondary to abnormal development. The Drosophila NF1 protein is highly conserved, showing 60% identity of its 2,803 amino acids with human NF1 (ref. 12), Previous studies have suggested that Drosophila NF1 acts not only as a Ras-GAP but also as a possible regulator of the cAMP pathway that involves the rutabaga (rut)-encoded adenylyl cyclase(13). Because rut was isolated as a learning and short-term memory mutant(14,15), we have pursued the hypothesis that NF1 may affect learning through its control of the Rut-adenylyl cyclase/cAMP pathway. Here we show that NF1 affects learning and short-term memory independently of its developmental effects. We show that G-protein-activated adenylyl cyclase activity consists of NF1-independent and NF1-dependent components, and that the mechanism of the NF1-dependent activation of the Rut-adenylyl cyclase pathway is essential for mediating Drosophila learning and memory.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Guo, HF (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899				BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BERNARDS A, 1995, BBA-REV CANCER, V1242, P43, DOI 10.1016/0304-419X(95)00003-X; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CHEN CN, 1986, P NATL ACAD SCI USA, V86, P3599; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Ferner RE, 1996, J NEUROL SCI, V138, P125, DOI 10.1016/0022-510X(96)00022-6; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; MITTS MR, 1991, MOL CELL BIOL, V11, P4591, DOI 10.1128/MCB.11.9.4591; NORTH K, 1995, DEV MED CHILD NEUROL, V37, P427, DOI 10.1111/j.1469-8749.1995.tb12026.x; NORTH K, 1994, NEUROLOGY, V44, P878, DOI 10.1212/WNL.44.5.878; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	29	186	191	3	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					895	898		10.1038/35002593	http://dx.doi.org/10.1038/35002593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706287				2022-12-01	WOS:000085559200058
J	Xue, YQ; Sherman, DH				Xue, YQ; Sherman, DH			Alternative modular polyketide synthase expression controls macrolactone structure	NATURE			English	Article							STREPTOMYCES-VENEZUELAE; BIOSYNTHESIS; ACID	Modular polyketide synthases are giant multifunctional enzymes that catalyse the condensation of small carboxylic acids such as acetate and propionate into structurally diverse polyketides that possess a spectrum of biological activities(1,2). In a modular polyketide synthase, an enzymatic domain catalyses a specific reaction, and three to six enzymatic domains involved in a condensation-processing cycle are organized into a module(3). A fundamental aspect of a modular polyketide synthase is that its module arrangement linearly specifies the structure of its polyketide product(3). Here we report a natural example in which alternative expression of the pikromycin polyketide synthase results in the generation of two macrolactone structures. Expression of the full-length modular polyketide synthase PikAIV in Streptomyces venezuelae generates the 11-membered ring macrolactone narbonolide, whereas expression of the amino-terminal truncated form of PikAIV leads to 'skipping' of the final condensation cycle in polyketide biosynthesis to generate the 12-membered ring macrolactone 10-deoxymethynolide. Our findings provide insight into the structure and function of modular polyketide synthases, as well as a new set of tools to generate structural diversity in polyketide natural products.	Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Biol Proc Technol Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sherman, DH (corresponding author), Univ Minnesota, Dept Microbiol, Box 196,1460 Mayo Mem Bldg, Minneapolis, MN 55455 USA.			Xue, Alex/0000-0002-7388-6899				Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; CORTES J, 1995, SCIENCE, V268, P1487, DOI 10.1126/science.7770773; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gokhale RS, 1999, CHEM BIOL, V6, P117, DOI 10.1016/S1074-5521(99)80008-8; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; HORI T, 1971, J CHEM SOC CHEM COMM, P304, DOI 10.1039/c29710000304; KAO CM, 1995, J AM CHEM SOC, V117, P9105, DOI 10.1021/ja00140a043; LAMBALOT RH, 1992, J ANTIBIOT, V45, P1981, DOI 10.7164/antibiotics.45.1981; LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0; Rangaswamy V, 1998, J BACTERIOL, V180, P3330, DOI 10.1128/JB.180.13.3330-3338.1998; Sambrook J., 1989, MOL CLONING LAB MANU; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; SHERMAN DH, 1988, P 8 INT BIOT S SOC F, V1, P123; Staunton J, 1996, NAT STRUCT BIOL, V3, P188, DOI 10.1038/nsb0296-188; Tang L, 1999, CHEM BIOL, V6, P553, DOI 10.1016/S1074-5521(99)80087-8; Xue YQ, 1998, CHEM BIOL, V5, P661, DOI 10.1016/S1074-5521(98)90293-9; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111	21	90	95	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					571	575		10.1038/35000624	http://dx.doi.org/10.1038/35000624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676969				2022-12-01	WOS:000085227300057
J	Ginsburg, J; Prelevic, GM				Ginsburg, J; Prelevic, GM			Lack of significant hormonal effects and controlled trials of phyto-oestrogens	LANCET			English	Editorial Material							SOY; MENOPAUSE; ESTROGEN; WOMEN		UCL Royal Free & Univ Coll, Sch Med, Dept Med, London NW3 2QG, England	University of London; University College London; UCL Medical School	Ginsburg, J (corresponding author), UCL Royal Free & Univ Coll, Sch Med, Dept Med, London NW3 2QG, England.							ALDERCREUTZ H, 1987, J STEROID BIOCHEM, V27, P1135; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; BAIRD DD, 1995, J CLIN ENDOCR METAB, V80, P1685, DOI 10.1210/jc.80.5.1685; BOULET MJ, 1994, MATURITAS, V19, P157, DOI 10.1016/0378-5122(94)90068-X; Duncan AM, 1999, J CLIN ENDOCR METAB, V84, P3479, DOI 10.1210/jc.84.10.3479; HUNTER MS, 1990, PSYCHOSOM MED, V52, P357, DOI 10.1097/00006842-199005000-00009; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Martini MC, 1999, NUTR CANCER, V34, P133, DOI 10.1207/S15327914NC3402_2; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Nestel PJ, 1999, J CLIN ENDOCR METAB, V84, P895, DOI 10.1210/jc.84.3.895; TANG DG, 1993, PROSTAG OTH LIPID M, V45, P249, DOI 10.1016/0090-6980(93)90051-8; Xu X, 1998, CANCER EPIDEM BIOMAR, V7, P1101	12	28	29	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 15	2000	355	9199					163	164		10.1016/S0140-6736(99)00428-6	http://dx.doi.org/10.1016/S0140-6736(99)00428-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276LR	10675113				2022-12-01	WOS:000084879700007
J	Beach, R				Beach, R			Minimally invasive approach to management of irritable hip in children	LANCET			English	Editorial Material							HOSPITAL ADMISSION; ULTRASOUND		Norfolk & Norwich Hlth Care NHS Trust, Dept Paediat, Norwich NR1 3SR, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust	Beach, R (corresponding author), Norfolk & Norwich Hlth Care NHS Trust, Dept Paediat, Norwich NR1 3SR, Norfolk, England.							BENNETT OM, 1992, CLIN ORTHOP RELAT R, P123; Eich GF, 1999, EUR J PEDIATR, V158, P923, DOI 10.1007/s004310051243; FINK AM, 1995, ARCH DIS CHILD, V72, P110, DOI 10.1136/adc.72.2.110; Fischer SU, 1999, J BONE JOINT SURG BR, V81B, P1029, DOI 10.1302/0301-620X.81B6.9607; GOPAKUMAR TS, 1992, EUR J RADIOL, V15, P113, DOI 10.1016/0720-048X(92)90134-U; Loder RT, 1996, CLIN ORTHOP RELAT R, P8; MAH ET, 1994, PEDIATR RADIOL, V24, P484, DOI 10.1007/BF02015005; Mattick A, 1999, J ACCID EMERG MED, V16, P345; TAYLOR GR, 1994, ARCH DIS CHILD, V71, P59, DOI 10.1136/adc.71.1.59	9	10	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1202	1203		10.1016/S0140-6736(00)02082-1	http://dx.doi.org/10.1016/S0140-6736(00)02082-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770298				2022-12-01	WOS:000086448000005
J	Arico, M; Valsecchi, MG; Camitta, B; Schrappe, M; Chessells, J; Baruchel, A; Gaynon, P; Silverman, L; Janka-Schaub, G; Kamps, W; Pui, CH; Masera, G				Arico, M; Valsecchi, MG; Camitta, B; Schrappe, M; Chessells, J; Baruchel, A; Gaynon, P; Silverman, L; Janka-Schaub, G; Kamps, W; Pui, CH; Masera, G			Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; PEDIATRIC-ONCOLOGY-GROUP; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; PROSPECTIVE METAANALYSIS; INTENSIVE CHEMOTHERAPY; INTERIM ANALYSIS; CANCER GROUP; CHILDHOOD; THERAPY	Background: Children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL) have a poor prognosis, and there is no consensus on the optimal treatment for this variant of ALL. Methods: We reviewed the medical records of patients with Ph-positive ALL who were treated with intensive chemotherapy, with or without bone marrow transplantation, by 10 study groups or large single institutions from 1986 to 1996. Data on 326 children and young adults, who ranged in age from 0.4 to 19.9 years (median, 8.1), were analyzed to determine the rate of complete remission and the probability of event-free, disease-free, and overall survival according to standard prognostic factors and type of treatment. Results: The 267 patients who had a complete remission after induction chemotherapy (82 percent) were stratified into three subgroups according to the age and leukocyte count at the time of diagnosis: those with the best prognosis (a leukocyte count of less than 50,000 per cubic millimeter and an age of less than 10 years; 95 patients); those with an intermediate prognosis (intermediate-risk features; 92 patients); and those with the worst prognosis (a leukocyte count of more than 100,000 per cubic millimeter; 80 patients). The estimates of disease-free survival at five years (+/-SE) were 49+/-5 percent (for patients with the best prognosis), 30+/-5 percent (for those with an intermediate prognosis), and 20+/-5 percent (for those with the worst prognosis) (P<0.001 for the overall comparison). We also found that transplantation of bone marrow from an HLA-matched related donor offered significantly greater benefit than intensive chemotherapy alone in terms of protecting patients from relapse or other adverse events (relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.5; P<0.001). This finding was consistent in all three subgroups. Conclusions: Unlike the usual type of ALL, Ph-positive ALL is associated with a poor prognosis. Nevertheless, in some patients with favorable prognostic features, the disease can be controlled by intensive chemotherapy. Transplantation of bone marrow from an HLA-matched related donor is superior to other types of transplantation and to intensive chemotherapy alone in prolonging initial complete remissions. (N Engl J Med 2000;342:998-1006.) (C) 2000, Massachusetts Medical Society.	Policlin San Matteo, IRCCS, Pediat Clin, Dept Pediat, I-27100 Pavia, Italy; Univ Verona, Dept Publ Hlth, I-37100 Verona, Italy; Med Coll Wisconsin, Midw Childrens Canc Ctr, Dept Pediat, Milwaukee, WI 53226 USA; Med Hsch Hannover, Dept Pediat Hematol Oncol, Hannover, Germany; Inst Child Hlth, Leukemia Res Fund, London, England; Hop St Louis, Serv Pediat Hematol, Paris, France; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Univ So Calif, Los Angeles, CA USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Hamburg, Dept Pediat Hematol & Oncol, Hamburg, Germany; Beatrix Children Hosp, Dept Pediat Oncol, Groningen, Netherlands; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN USA; Univ Milan, Dept Pediat, Monza, Italy; Osped San Gerardo, Monza, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Verona; Medical College of Wisconsin; Hannover Medical School; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Los Angeles; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Hamburg; University of Groningen; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Milan; San Gerardo Hospital	Arico, M (corresponding author), Policlin San Matteo, IRCCS, Pediat Clin, Dept Pediat, I-27100 Pavia, Italy.		Schrappe, Martin/A-8109-2010; SESM, SESM/C-1440-2008; Schrappe, Martin/ABA-6144-2020; Valsecchi, Maria Grazia/K-8891-2016; Pui, Ching-Hon/N-8076-2018; Arico, Maurizio/S-3039-2019	Valsecchi, Maria Grazia/0000-0001-5574-3504; Pui, Ching-Hon/0000-0003-0303-5658; Arico, Maurizio/0000-0002-1908-6671	NCI NIH HHS [CA 51001, CA 36401, CA21765] Funding Source: Medline; Telethon [E.0755] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA036401, R29CA051001, P30CA021765, R01CA051001, R01CA036401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRETT AJ, 1992, BLOOD, V79, P3067; Bassan R, 1999, ADV EXP MED BIOL, V457, P489; CASPER J, 1992, BLOOD S, V80, pA65; CHESSELLS JM, 1995, LANCET, V345, P143, DOI 10.1016/S0140-6736(95)90164-7; Conter V, 1998, HAEMATOLOGICA, V83, P791; CONTER V, 1995, J CLIN ONCOL, V13, P2497, DOI 10.1200/JCO.1995.13.10.2497; CRIST W, 1990, BLOOD, V76, P489; FLETCHER JA, 1991, BLOOD, V77, P435; GAJJAR A, 1995, BLOOD, V86, P1292, DOI 10.1182/blood.V86.4.1292.bloodjournal8641292; GAYNON PS, 1990, MED PEDIATR ONCOL, V18, P273, DOI 10.1002/mpo.2950180403; Harbott J, 1993, Recent Results Cancer Res, V131, P123; JankaSchaub GE, 1996, EUR J PEDIATR, V155, P640; KANTARJIAN HM, 1991, BLOOD, V78, P2411, DOI 10.1182/blood.V78.9.2411.bloodjournal7892411; Marks DI, 1998, J CLIN ONCOL, V16, P931, DOI 10.1200/JCO.1998.16.3.931; MARUBINI E, 1995, ANAL SURVIVAL DATA C, P171; MASTRANGELO R, 1986, MED PEDIATR ONCOL, V14, P191, DOI 10.1002/mpo.2950140317; MAURER J, 1991, LANCET, V337, P1055, DOI 10.1016/0140-6736(91)91706-Z; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; PUI CH, 1990, BLOOD, V76, P1449; PUI CH, 1994, J PEDIATR-US, V124, P491, DOI 10.1016/S0022-3476(05)83125-7; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; RAIMONDI SC, 1999, CHILDHOOD LEUKEMIAS, P168; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIBEIRO RC, 1987, BLOOD, V70, P948; Ribeiro RC, 1997, LEUKEMIA, V11, P1493, DOI 10.1038/sj.leu.2400749; RIEHM H, 1987, KLIN PADIATR, V199, P151, DOI 10.1055/s-2008-1026781; ROBERTS WM, 1994, LANCET, V343, P331, DOI 10.1016/S0140-6736(94)91166-5; RUSSO C, 1991, BLOOD, V77, P1050; Schlieben S, 1996, LEUKEMIA, V10, P957; Schrappe M, 1998, BLOOD, V92, P2730; SCHRAPPE M, 1994, KLIN PADIATR, V206, P208, DOI 10.1055/s-2008-1046607; Shuster JJ, 1996, ANN ONCOL, V7, P1009; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; Steinherz PG, 1996, J CLIN ONCOL, V14, P389, DOI 10.1200/JCO.1996.14.2.389; Stram DO, 1996, BIOMETRICS, V52, P1079, DOI 10.2307/2533069; SURYANARAYAN K, 1991, BLOOD, V77, P324; Thomas X, 1998, HEMATOL CELL THER, V40, P119; Uckun FM, 1998, CANCER-AM CANCER SOC, V83, P2030, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2030::AID-CNCR21>3.3.CO;2-H; Uderzo C, 1997, BRIT J HAEMATOL, V96, P387, DOI 10.1046/j.1365-2141.1997.d01-2033.x; Valsecchi MG, 1996, ANN ONCOL, V7, P1005	42	415	442	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2000	342	14					998	1006		10.1056/NEJM200004063421402	http://dx.doi.org/10.1056/NEJM200004063421402			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300JB	10749961	Bronze			2022-12-01	WOS:000086248900002
J	DiTullio, GR; Grebmeier, JM; Arrigo, KR; Lizotte, MP; Robinson, DH; Leventer, A; Barry, JB; VanWoert, ML; Dunbar, RB				DiTullio, GR; Grebmeier, JM; Arrigo, KR; Lizotte, MP; Robinson, DH; Leventer, A; Barry, JB; VanWoert, ML; Dunbar, RB			Rapid and early export of Phaeocystis antarctica blooms in the Ross Sea, Antarctica	NATURE			English	Article							PHYTOPLANKTON; CARBON; DIMETHYLSULFIDE; POUCHETII; PRYMNESIOPHYCEAE; POLYNYA; OCEAN; CYCLE	The Southern Ocean is very important for the potential sequestration of carbon dioxide in the oceans(1) and is expected to be vulnerable to changes in carbon export forced by anthropogenic climate warming(2). Annual phytoplankton blooms in seasonal ice zones are highly productive and are thought to contribute significantly to pCO(2) drawdown in the Southern Ocean. Diatoms are assumed to be the most important phytoplankton class with respect to export production in the Southern Ocean; however, the colonial prymnesiophyte Phaeocystis antarctica regularly forms huge blooms in seasonal ice zones and coastal Antarctic waters(3). There is little evidence regarding the fate of carbon produced by P. antarctica in the Southern Ocean, although remineralization in the upper water column has been proposed to be the main pathway in polar waters(4,5). Here we present evidence for early and rapid carbon export from P. antarctica blooms to deep water and sediments in the Ross Sea. Carbon sequestration from P. antarctica blooms may influence the carbon cycle in the Southern Ocean, especially if projected climatic changes lead to an alteration in the structure of the phytoplankton community(6,7).	Univ Charleston, Grice Marine Lab, Charleston, SC 29412 USA; Univ Tennessee, Knoxville, TN 37996 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA; Colgate Univ, Dept Geol, Hamilton, NY 13346 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; NOAA, NESDIS, Off Res & Applicat, Camp Springs, MD 20746 USA; Natl Ice Ctr, Washington, DC 20395 USA; Stanford Univ, Stanford, CA 94305 USA	College of Charleston; University of Tennessee System; University of Tennessee Knoxville; Stanford University; University of Wisconsin System; California State University System; San Francisco State University; Colgate University; Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Stanford University	DiTullio, GR (corresponding author), Univ Charleston, Grice Marine Lab, 205 Ft Johnson, Charleston, SC 29412 USA.	ditullioj@cofc.edu	Grebmeier, Jacqueline/L-9805-2013	Grebmeier, Jacqueline/0000-0001-7624-3568; Dunbar, Robert/0000-0002-9728-5609; Arrigo, Kevin/0000-0002-7364-876X; Leventer, Amy/0000-0001-9401-0987				Accornero A, 1999, OCEANOGRAPHY OF THE ROSS SEA, P177; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; ARRIGO KR, IN PRESS J GEOPHYS R; Asper VL, 1999, J GEOPHYS RES-OCEANS, V104, P5345, DOI 10.1029/1998JC900067; CANTONI GL, 1956, J BIOL CHEM, V222, P171; Carlson CA, 1998, LIMNOL OCEANOGR, V43, P375, DOI 10.4319/lo.1998.43.3.0375; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; DITULLIO GR, 1995, DEEP-SEA RES PT I, V42, P873, DOI 10.1016/0967-0637(95)00051-7; Dunbar R., 1985, ANTARCT RES SER, P291, DOI [DOI 10.1029/AR043P0291), 10.1029/AR043p0291, DOI 10.1029/AR043P0291]; ELSAYED SZ, 1983, DEEP-SEA RES, V30, P871, DOI 10.1016/0198-0149(83)90005-5; HANSEN FC, 1991, MAR ECOL PROG SER, V78, P123, DOI 10.3354/meps078123; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LEGRAND M, 1991, NATURE, V350, P144, DOI 10.1038/350144a0; MARTIN JH, 1992, ENVIR SCI R, V43, P123; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MATRAI PA, 1995, MAR BIOL, V124, P157, DOI 10.1007/BF00349157; MOORE JK, IN PRESS GLOB BIOGEO; PASSOW U, 1994, MAR ECOL PROG SER, V104, P153, DOI 10.3354/meps104153; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SEDWICK PN, IN PRESS J GEOPHYS R; Smith WO, 1997, GEOPHYS RES LETT, V24, P233, DOI 10.1029/96GL03926; Stefels J, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P305; Stefels J, 1998, J PHYCOL, V34, P486, DOI 10.1046/j.1529-8817.1998.340486.x; SWEENEY C, IN PRESS DEEP SEA RE; VERITY PG, 1989, MAR BIOL, V100, P161, DOI 10.1007/BF00391955; WASSMANN P, 1990, MAR ECOL PROG SER, V66, P183, DOI 10.3354/meps066183	28	236	244	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					595	598		10.1038/35007061	http://dx.doi.org/10.1038/35007061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766240				2022-12-01	WOS:000086400100051
J	Smith, GD; Harding, S; Rosato, M				Smith, GD; Harding, S; Rosato, M			Relation between infants' birth weight and mothers' mortality: prospective observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Off Natl Stat, London SW1V 2QQ, England	University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Barker D. J. P., 1994, MOTHERS BABIES DIS L; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Goldblatt P, 1990, LONGITUDINAL STUDY M; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Smith GD, 1997, BRIT MED J, V315, P1189, DOI 10.1136/bmj.315.7117.1189	5	108	108	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					839	840		10.1136/bmj.320.7238.839	http://dx.doi.org/10.1136/bmj.320.7238.839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731177	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000086180300025
J	Stevens, B; Fields, RD				Stevens, B; Fields, RD			Response of Schwann cells to action potentials in development	SCIENCE			English	Article							INCREASES INTRACELLULAR CALCIUM; PERIPHERAL NERVOUS-SYSTEM; DIFFERENTIAL REGULATION; NEUROMUSCULAR-JUNCTION; DEPENDENT REGULATION; MYELINATION; PATTERNS; L1; MECHANISMS; ACTIVATION	Sensory axons become functional late in development when Schwann cells (SC) stop proliferating and differentiate into distinct phenotypes, We report that impulse activity in premyelinated axons can inhibit proliferation and differentiation of SCs. This neuron-glial signaling is mediated by adenosine triphosphate acting through PZ receptors on SCs and intracellular signaling pathways involving Ca(2+), Ca(2+)/calmodulin kinase, mitogen-activated protein kinase, cyclic adenosine 3',5'-monophosphate response element binding protein, and expression of c-fos and Krox-24. Adenosine triphosphate arrests maturation of SCs in an immature morphological stage and prevents expression of O4, myelin basic protein, and the formation of myelin. Through;this mechanism, functional activity in the developing nervous system could delay terminal differentiation of SCs until exposure to appropriate axon-derived signals.	NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHHD, Dev Neurobiol Lab, NIH, Bldg 49,Room 5A38,49 Convent Dr, Bethesda, MD 20892 USA.	fields@helix.nih.gov	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Ansselin AD, 1997, NEUROSCIENCE, V76, P947, DOI 10.1016/S0306-4522(96)00370-3; COLELLO RJ, 1995, J NEUROSCI, V15, P7665; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields RD, 1997, J NEUROSCI, V17, P7252; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Green AC, 1997, NEUROSCIENCE, V80, P635, DOI 10.1016/S0306-4522(97)00117-6; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; LEVRAM V, 1995, J NEUROSCI, V15, P2628; LYONS SA, 1995, GLIA, V13, P27, DOI 10.1002/glia.440130104; Mayer C, 1998, GLIA, V23, P374, DOI 10.1002/(SICI)1098-1136(199808)23:4<374::AID-GLIA9>3.0.CO;2-2; MINXU I, 1996, J NEUROPHYSIOL, V76, P2595; Mirsky R, 1999, BRAIN PATHOL, V9, P293; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; ROBITAILLE R, 1995, J NEUROSCI, V15, P7121; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHENG HZ, 1993, J NEUROSCI RES, V35, P459, DOI 10.1002/jnr.490350502; SHENG HZ, 1994, ANAL BIOCHEM, V222, P123, DOI 10.1006/abio.1994.1463; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Stevens B, 1998, J NEUROSCI, V18, P9303; STEVENS B, UNPUB; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; WOOD PM, 1990, J NEUROSCI, V10, P3635; Zorick TS, 1999, DEVELOPMENT, V126, P1397	32	202	206	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2267	2271		10.1126/science.287.5461.2267	http://dx.doi.org/10.1126/science.287.5461.2267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731149				2022-12-01	WOS:000086049100052
J	Gaba, DM				Gaba, DM			Anaesthesiology as a model for patient safety in health care	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA; ERRORS; ENVIRONMENT; INCIDENTS; MORTALITY; MISHAPS; SYSTEM		VA Palo Alto Hlth Care Syst, Patient Safety Ctr Inquiry, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Gaba, DM (corresponding author), VA Palo Alto Hlth Care Syst, Patient Safety Ctr Inquiry, 112PSCI,3801 Miranda Ave, Palo Alto, CA 94304 USA.		Gaba, David M/D-5229-2009	Gaba, David M/0000-0002-0657-5396				ARENS J, 1999, ASA NEWSLETTER, V63, P26; Beckmann U, 1996, ANAESTH INTENS CARE, V24, P314, DOI 10.1177/0310057X9602400303; Bhasale AL, 1998, MED J AUSTRALIA, V169, P73, DOI 10.5694/j.1326-5377.1998.tb140186.x; Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; COOPER JB, 1984, ANESTHESIOLOGY, V60, P34, DOI 10.1097/00000542-198401000-00008; COOPER JB, 1978, ANESTHESIOLOGY, V49, P399, DOI 10.1097/00000542-197812000-00004; DEANDA A, 1991, ANESTH ANALG, V72, P308; DERRINGTON MC, 1987, BRIT J ANAESTH, V59, P815, DOI 10.1093/bja/59.7.815; DRUI AB, 1973, ANESTH ANALG, V52, P584; EAGLE CJ, 1992, CAN J ANAESTH, V39, P118, DOI 10.1007/BF03008640; EICHHORN JH, 1986, JAMA-J AM MED ASSOC, V256, P1017; GABA D, 1999, ANESTHESIA; GABA DM, 1987, ANESTHESIOLOGY, V66, P670, DOI 10.1097/00000542-198705000-00013; GABA DM, 1988, ANESTHESIOLOGY, V69, P387, DOI 10.1097/00000542-198809000-00017; GABA DM, 1991, PROBLEMS ANESTHESIA, V5, P329; GALLETLY DC, 1991, ANAESTH INTENS CARE, V19, P66, DOI 10.1177/0310057X9101900112; GOOD ML, 1989, INT ANESTHESIOL CLIN, V27, P161, DOI 10.1097/00004311-198902730-00005; KURREK M, 1998 M SOC TECHN AN; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LUNN JN, 1986, EPIDEMIOLOGY ANAESTH; MACKENZIE CF, 1994, ANESTHESIOLOGY, V81, P763, DOI 10.1097/00000542-199409000-00030; MARSCH S, 1998, SIMULATORS ANESTHESI; *NAT PAT SAF FDN, 1997, PROSP NPSF IMP LEAD; ORKIN FK, 1993, ANESTHESIOLOGY, V78, P417; PETTY C, 1987, ANESTHESIA MACH; RAEMER D, 1998 M SOC TECHN AN; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; SCHWID HA, 1987, COMPUT BIOMED RES, V20, P64, DOI 10.1016/0010-4809(87)90019-X; Small SD, 1999, ACAD EMERG MED, V6, P312, DOI 10.1111/j.1553-2712.1999.tb00395.x; WARDEN JC, 1994, MED J AUSTRALIA, V161, P585, DOI 10.5694/j.1326-5377.1994.tb127636.x; WEBB RK, 1993, ANAESTH INTENS CARE, V21, P520, DOI 10.1177/0310057X9302100507; Weinger MB, 1997, ANESTHESIOLOGY, V87, P144, DOI 10.1097/00000542-199707000-00019; XIAO Y, 1992, PROCEEDINGS OF THE HUMAN FACTORS SOCIETY, 36TH ANNUAL MEETING, VOLS 1 AND 2, P1279	33	305	315	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					785	788		10.1136/bmj.320.7237.785	http://dx.doi.org/10.1136/bmj.320.7237.785			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720368	Green Published			2022-12-01	WOS:000086054700033
J	Schimel, D; Melillo, J; Tian, HQ; McGuire, AD; Kicklighter, D; Kittel, T; Rosenbloom, N; Running, S; Thornton, P; Ojima, D; Parton, W; Kelly, R; Sykes, M; Neilson, R; Rizzo, B				Schimel, D; Melillo, J; Tian, HQ; McGuire, AD; Kicklighter, D; Kittel, T; Rosenbloom, N; Running, S; Thornton, P; Ojima, D; Parton, W; Kelly, R; Sykes, M; Neilson, R; Rizzo, B			Contribution of increasing CO2 and climate to carbon storage by ecosystems in the United States	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; VARIABILITY; DATABASE; PRECIPITATION; DIOXIDE; CYCLE; SINK	The effects of increasing carbon dioxide (CO2) and climate on net carbon storage in terrestrial ecosystems of the conterminous United States for the period 1895-1993 were modeled with new, detailed historical climate information. For the period 1980-1993, results from an ensemble of three models agree within 25%, simulating a land carbon sink from CO2 and climate effects of 0.08 gigaton of carbon per year. The best estimates of the total sink from inventory data are about three times larger, suggesting that processes such as regrowth on abandoned agricultural land or in forests harvested before 1980 have effects as large as or larger than the direct effects of CO2 and climate. The modeled sink varies by about 100% from year to year as a result of climate variability.	Max Planck Inst Biogeochem, D-07701 Jena, Germany; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alaska, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Montana, Missoula, MT 59812 USA; Colorado State Univ, NREL, Ft Collins, CO 80523 USA; Univ Lund, Ekol Huset, S-22362 Lund, Sweden; Oregon State Univ, Forest Sci Lab, USDA, US Forest Serv, Corvallis, OR 97333 USA; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Max Planck Society; Marine Biological Laboratory - Woods Hole; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; National Center Atmospheric Research (NCAR) - USA; University of Montana System; University of Montana; Colorado State University; Lund University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; University of Virginia	Schimel, D (corresponding author), Max Planck Inst Biogeochem, Postfach 10 01 64, D-07701 Jena, Germany.		Kittel, Timothy G. F./F-2792-2011; Ojima, Dennis/C-5272-2016; Tian, Hanqin/A-6484-2012; Noojipady, Praveen/B-2511-2010; Gutierrez, Emilia/O-7568-2014; Thornton, Peter E/B-9145-2012	Kittel, Timothy G. F./0000-0002-4153-1006; Tian, Hanqin/0000-0002-1806-4091; Gutierrez, Emilia/0000-0002-6085-5700; Thornton, Peter E/0000-0002-4759-5158				BIRDSEY RA, 1995, PRODUCTIVITY AM FORE, P56; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; CIAS P, 1995, SCIENCE, V269, P1098; DAI A, 1993, GLOBAL BIOGEOCHEM CY, V7, P599, DOI 10.1029/93GB01165; DALY C, 1994, J APPL METEOROL, V33, P140, DOI [10.1175/1520-0450(1994)033<0140:ASTMFM>2.0.CO;2, 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2]; ENTING IG, 1994, CSIRO DIV ATMOS RES, V31, P1; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Holland EA, 1997, J GEOPHYS RES-ATMOS, V102, P15849, DOI 10.1029/96JD03164; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; Kittel TGF, 1995, J BIOGEOGR, V22, P857, DOI 10.2307/2845986; KITTEL TGF, 1997, P 10 C APPL CLIM BOS, P222; LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Parton W.J., 1994, SSSA SPECIAL PUBLICA, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; SAMIENTO JL, 1999, US CARBON CYCLE SCI; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Steffen W, 1998, SCIENCE, V280, P1393; Tian H, 1999, TELLUS B, V51, P414, DOI 10.1034/j.1600-0889.1999.00021.x	26	434	534	9	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2004	2006		10.1126/science.287.5460.2004	http://dx.doi.org/10.1126/science.287.5460.2004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720324				2022-12-01	WOS:000085902800058
J	Mendez, R; Hake, LE; Andresson, T; Littlepage, LE; Ruderman, JV; Richter, JD				Mendez, R; Hake, LE; Andresson, T; Littlepage, LE; Ruderman, JV; Richter, JD			Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA	NATURE			English	Article							XENOPUS OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION; RNA-BINDING; KINASE; PATHWAY; PROTEIN; SPECIFICITY; ACTIVATION; SEPARATION; ELEMENTS	Full-grown Xenopus oocytes arrest at the G2/M border of meiosis. I. Progesterone breaks this arrest, leading to the resumption of the meiotic cell cycles and maturation of the oocyte into a fertilizable egg. In these oocytes, progesterone interacts with an unidentified surface-associated receptor, which induces a non-transcriptional signalling pathway that stimulates the translation of dormant c-mos messenger RNA. Mos, a mitogen-activated protein (MAP) kinase kinase kinase, indirectly activates MAP kinase, which in turn leads to oocyte maturation. The translational recruitment of c-mos and several other mRNAs is regulated by cytoplasmic polyadenylation, a process that requires two 3' untranslated regions, the cytoplasmic polyadenylation element (CPE) and the polyadenylation hexanucleotide AAUAAA(1-4). Although the signalling events that trigger c-mos mRNA polyadenylation and translation are unclear, they probably involve the activation of CPEB, the CPE binding factor(5,6), Here we show that an early site-specific phosphorylation of CPEB is essential for the polyadenylation of c-mos mRNA and its subsequent translation, and for oocyte maturation. In addition, we show that this selective, early phosphorylation of CPEB is catalysed by Eg2, a member of the Aurora family of serine/threonine protein kinases.	Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Richter, JD (corresponding author), Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	joel.richter@umassmed.edu		Mendez, Raul/0000-0002-1952-6905				Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1992, EMBO J, V11, P5021, DOI 10.1002/j.1460-2075.1992.tb05609.x; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1997, BBA-REV CANCER, V1332, pM31, DOI 10.1016/S0304-419X(96)00039-X; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Katsu Y, 1999, DEV BIOL, V209, P186, DOI 10.1006/dbio.1999.9247; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tatsuka M, 1998, CANCER RES, V58, P4811; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	24	284	290	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					302	307		10.1038/35005126	http://dx.doi.org/10.1038/35005126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749216				2022-12-01	WOS:000086022200054
J	Hall, AC; Lucas, FR; Salinas, PC				Hall, AC; Lucas, FR; Salinas, PC			Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling	CELL			English	Article							SYNAPSIN-I; GRANULE CELLS; NEURONS; LOCALIZATION; EXPRESSION; TARGET; MOUSE; CLONING; MOSSY; MECHANISMS	Synapse formation requires changes in cell morphology and the upregulation and localization of synaptic proteins. In the cerebellum, mossy fibers undergo extensive remodeling as they contact several granule cells and form complex, multisynaptic glomerular rosettes. Here we show that granule cells secrete factors that induce axon and growth cone remodeling in mossy fibers. This effect is blocked by the WNT antagonist, sFRP-1, and mimicked by WNT-7a, which is expressed by granule cells. WNT-7a also induces synapsin I clustering at remodeled areas of mossy fibers, a: preliminary step in synaptogenesis. Wnt-7a mutant mice show a delay in the morphological maturation of glomerular rosettes and in the accumulation of synapsin I. We propose that WNT-7a can function as a synaptogenic factor.	Kings Coll London, Randall Inst, Dev Biol Res Ctr, London WC2B 5RL, England	University of London; King's College London	Salinas, PC (corresponding author), Kings Coll London, Randall Inst, Dev Biol Res Ctr, 26-29 Drury Lane, London WC2B 5RL, England.	patricia.salinas@kcl.ac.uk						ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P470; ATACK JR, 1995, TRENDS NEUROSCI, V18, P343, DOI 10.1016/0166-2236(95)93926-O; BAIRD DH, 1992, J NEUROSCI, V12, P619; BOWIE JE, 1977, ACTA CYTOL, V21, P455; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; EISENMAN LM, 1991, BRAIN RES, V558, P149, DOI 10.1016/0006-8993(91)90733-C; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Katoh M, 1996, ONCOGENE, V13, P873; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas FR, 1998, J CELL SCI, V111, P1351; Martin CS, 1998, NEUROSCIENCE, V87, P861, DOI 10.1016/S0306-4522(98)00195-X; MASON CA, 1984, J NEUROSCI, V4, P1715; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wang JW, 1996, ONCOGENE, V13, P1537; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Zhang Q, 1998, DEV BIOL, V195, P75, DOI 10.1006/dbio.1997.8837	41	559	578	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					525	535		10.1016/S0092-8674(00)80689-3	http://dx.doi.org/10.1016/S0092-8674(00)80689-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721990	Bronze			2022-12-01	WOS:000085700000006
J	Ma, HT; Patterson, RL; van Rossum, DB; Birnbaumer, L; Mikoshiba, K; Gill, DL				Ma, HT; Patterson, RL; van Rossum, DB; Birnbaumer, L; Mikoshiba, K; Gill, DL			Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2+ channels	SCIENCE			English	Article							CAPACITATIVE CALCIUM-ENTRY; DEPLETION; CELLS; RELEASE; SIGNAL; INFLUX	The coupling mechanism between endoplasmic reticulum (ER) calcium ion (Ca2+) stores and plasma membrane (PM) store-operated channels (SOCs) is crucial to Ca2+ signaling but has eluded detection. SOCs may be functionally related to the TRP family of receptor-operated channels. Direct comparison of endogenous SOCs with stably expressed TRP3 channels in human embryonic kidney (HEK293) cells revealed that TRP3 channels differ in being store independent. However, condensed cortical F-actin prevented activation of both SOC and TRP3 channels, which suggests that ER-PM interactions underlie coupling of both channels. A cell-permeant inhibitor of inositol trisphosphate receptor (InsP(2)R) function, 2-aminoethoxydiphenyl berate, prevented both receptor-induced TRP3 activation and receptor-induced SOC activation. It is concluded that InsP(3)Rs mediate both SOC and TRP channel opening and that the InsP(3)R is essential for maintaining coupling between store emptying and physiological activation of SOCs.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo, Japan	University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of Tokyo	Gill, DL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dgill@umaryland.edu	Mikoshiba, Katsuhiko/N-7943-2015	van Rossum, Damian/0000-0003-1011-2586	NHLBI NIH HHS [HL55426] Funding Source: Medline; NIAMS NIH HHS [AR07592] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Favre CJ, 1998, J BIOL CHEM, V273, P30855, DOI 10.1074/jbc.273.47.30855; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MA HT, UNPUB; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	23	508	523	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 3	2000	287	5458					1647	1651		10.1126/science.287.5458.1647	http://dx.doi.org/10.1126/science.287.5458.1647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698739				2022-12-01	WOS:000085628200037
J	Pearson, GD; Veille, JC; Rahimtoola, S; Hsia, J; Oakley, CM; Hosenpud, JD; Ansari, A; Baughman, KL				Pearson, GD; Veille, JC; Rahimtoola, S; Hsia, J; Oakley, CM; Hosenpud, JD; Ansari, A; Baughman, KL			Peripartum cardiomyopathy - National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR FUNCTION; ENDOMYOCARDIAL BIOPSY; MYOCARDITIS; PREGNANCY; FAILURE; CELLS; CARVEDILOL; AMLODIPINE; DIAGNOSIS; MORBIDITY	Objective Peripartum cardiomyopathy (PPCM) is a rare life-threatening cardiomyopathy of unknown cause that occurs in the peripartum period in previously healthy women. In April 1997, the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Rare Diseases of the National Institutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review of information and to develop recommendations for research and education. Participants Fourteen workshop participants were selected by NHLBI staff and represented cardiovascular medicine, obstetrics, immunology, and pathology. A representative subgroup of 8 participants and NHLBI staff formed the writing group for this article and updated the literature on which the conclusions were based. The workshop was an open meeting, consistent with NIH policy. Evidence Data presented at the workshop were augmented by a MEDLINE search for English-language articles published from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy. Articles on the epidemiology, pathogenesis, pathophysiology, diagnosis, treatment, and prognosis of PPCM were included. Recommendation Process After discussion of data presented, workshop participants agreed on a standardized definition of PPCM, a general clinical approach, and the need for a registry to provide an infrastructure for future research. Conclusions Peripartum cardiomyopathy is a rare lethal disease about which little is known. Diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Symptomatic patients should receive standard therapy for heart failure, managed by a multidisciplinary team. If subsequent pregnancies occur, they should be managed in collaboration with a high-risk perinatal center. Systematic data collection is required to answer important questions about incidence, treatment, and prognosis.	NHLBI, Div Heart & Vasc Dis, NIH, Bethesda, MD 20892 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27103 USA; Univ So Calif, Div Cardiol, Los Angeles, CA USA; George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC 20052 USA; Imperial Coll Med Sch, London, England; Med Coll Wisconsin, Div Cardiovasc Med, Milwaukee, WI 53226 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University; Wake Forest Baptist Medical Center; University of Southern California; George Washington University; Imperial College London; Medical College of Wisconsin; Emory University; Johns Hopkins University	Pearson, GD (corresponding author), NHLBI, Div Heart & Vasc Dis, NIH, 6701 Rockledge Dr,Room 9146,MSC 7940, Bethesda, MD 20892 USA.							ANSARI AA, 1993, CLIN IMMUNOL IMMUNOP, V68, P208, DOI 10.1006/clin.1993.1120; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Bozkurt B, 1999, J AM COLL CARDIOL, V34, P177, DOI 10.1016/S0735-1097(99)00161-8; Ceci O, 1998, EUR J OBSTET GYN R B, V76, P29, DOI 10.1016/S0301-2115(97)00148-6; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; COSTANZONORDIN MR, 1989, PROG CARDIOL, V2, P225; Coulson CC, 1996, OBSTET GYNECOL, V87, P610, DOI 10.1016/0029-7844(95)00493-9; CUNNINGHAM FG, 1986, OBSTET GYNECOL, V67, P157; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; FARBER PA, 1970, AM HEART J, V80, P96, DOI 10.1016/0002-8703(70)90042-6; Frishman WH, 1998, NEW ENGL J MED, V339, P1759, DOI 10.1056/NEJM199812103392407; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Goulet B, 1937, AM J MED SCI, V194, P185; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; JULIAN DG, 1985, PROG CARDIOVASC DIS, V27, P223, DOI 10.1016/0033-0620(85)90007-6; KEOGH A, 1994, J HEART LUNG TRANSPL, V13, P202; KOTHARI SS, 1977, INT J CARDIOL, V60, P111; LAMPERT MB, 1995, AM HEART J, V130, P860, DOI 10.1016/0002-8703(95)90089-6; Lampert MB, 1997, AM J OBSTET GYNECOL, V176, P189, DOI 10.1016/S0002-9378(97)80034-8; LUDWIG P, 1997, AUST N Z J OBSTET GY, V37, P156; LYDEN DC, 1984, CELL IMMUNOL, V87, P462, DOI 10.1016/0008-8749(84)90015-7; Mann Douglas L., 1996, Cytokine and Growth Factor Reviews, V7, P341, DOI 10.1016/S1359-6101(96)00043-3; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MASSAD LS, 1993, OBSTET GYNECOL, V81, P886; MELVIN KR, 1982, NEW ENGL J MED, V307, P731, DOI 10.1056/NEJM198209163071207; MIDEI MG, 1990, CIRCULATION, V81, P922, DOI 10.1161/01.CIR.81.3.922; Mohler ER, 1997, J AM COLL CARDIOL, V30, P35, DOI 10.1016/S0735-1097(97)00145-9; Mone SM, 1996, CIRCULATION, V94, P667, DOI 10.1161/01.CIR.94.4.667; Nelson J L, 1998, J Am Med Womens Assoc (1972), V53, P31; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; OCONNELL JB, 1986, J AM COLL CARDIOL, V8, P52, DOI 10.1016/S0735-1097(86)80091-2; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEARL W, 1995, AM HEART J, V129, P421, DOI 10.1016/0002-8703(95)90032-2; Pierce JA, 1962, ARCH INTERN MED, V111, P163; Rahimtoola S H, 1996, Curr Probl Cardiol, V21, P781, DOI 10.1016/S0146-2806(96)80001-6; SUTTON MS, 1991, AM HEART J, V121, P1776; VEILLE JC, 1984, AM J OBSTET GYNECOL, V148, P805, DOI 10.1016/0002-9378(84)90572-6; Ventura S J, 1997, Mon Vital Stat Rep, V46, P1; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6	43	532	571	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1183	1188		10.1001/jama.283.9.1183	http://dx.doi.org/10.1001/jama.283.9.1183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703781	Bronze			2022-12-01	WOS:000085424100028
J	Donovan, JL; Blake, DR				Donovan, JL; Blake, DR			Qualitative study of interpretation of reassurance among patients attending rheumatology clinics: "just a touch of arthritis, doctor?"	BRITISH MEDICAL JOURNAL			English	Article							DECISION-MAKING; LAY BELIEFS; CONSULTATION; EDUCATION; DISEASE	Objectives To examine commonly used methods of reassurance by clinicians and explore their effect on patients. Design Qualitative study of tape recordings of in-depth, semistructured interviews with patients before and after consultation and of their consultations with doctors. Setting NHS specialist rheumatology clinics in two large British cities. Participants 35 patients selected by consultant rheumatologists from general practitioner referral letters (28 women, 7 men; 24 with inflammatory arthropathies, ii other rheumatological complaints). Main outcome measures Patients' perceptions of reassurance. Results Reassurance was an important part of consultations, whether the diagnosis was clear or uncertain. Clinicians tried to reduce anxiety by emphasising the mildness, early stage, or non-seriousness of the disorder and the likelihood that patients would recover. Patients interpreted reassurance in the context of their own views and perceptions. Doctors' emphasis on the mildness or earliness of the condition raised the spectre of future pain and disability rather than providing reassurance. Patients who felt;hat their problems were properly acknowledged felt more reassured. Conclusions Typical patterns of reassurance were not successful because of the differences in perspective of patients and doctors. A key to successful reassurance seemed to be the doctor's ability to acknowledge patients' perspectives of their difficulties.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England	University of Bristol; Royal National Hospital for Rheumatic Diseases (RNHRD)	Donovan, JL (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.							BARTLETT EE, 1984, J CHRON DIS, V37, P755, DOI 10.1016/0021-9681(84)90044-4; BLAXTER M, 1983, SOC SCI MED, V17, P59, DOI 10.1016/0277-9536(83)90356-8; DONOVAN J, 1991, ANN RHEUM DIS, V50, P418, DOI 10.1136/ard.50.Suppl_3.418; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; DONOVAN JL, 1989, BRIT J RHEUMATOL, V28, P58; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; EYLES J, 1990, SOCIAL EFFECTS HLTH; Fitzpatrick R, 1996, BRIT MED J, V313, P311, DOI 10.1136/bmj.313.7053.311; FITZPATRICK R, 1981, J NEUROL NEUROSUR PS, V44, P1061, DOI 10.1136/jnnp.44.12.1061; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Freidson E., 1970, PROFESSION MED STUDY; Glaser B. G., 1978, THEORETICAL SENSITIV; Hammersley M., 1983, ETHNOGRAPHY; HENBEST RJ, 1990, FAM PRACT, V7, P28, DOI 10.1093/fampra/7.1.28; KESSEL N, 1979, LANCET, V1, P1128; MAYOU R, 1976, BRIT J PSYCHIAT, V129, P55, DOI 10.1192/bjp.129.1.55; Mays N, 1996, QUALITATIVE RES HLTH; McDonald IG, 1996, BRIT MED J, V313, P329, DOI 10.1136/bmj.313.7053.329; Miles M., 2019, QUALITATIVE DATA ANA, V4th; Mishler EG, 1984, DISCOURSE MED DIALEC; PILOWSKY I, 1969, BRIT J MED PSYCHOL, V42, P347, DOI 10.1111/j.2044-8341.1969.tb02089.x; Silverman D., 1987, COMMUNICATION MED PR; Williams S, 1996, MODER MED LAY PERSPE; 1993, ANN PHARMACOTHERAPY, V27, pS5	24	97	98	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 26	2000	320	7234					541	544		10.1136/bmj.320.7234.541	http://dx.doi.org/10.1136/bmj.320.7234.541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289LV	10688559	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000085624000021
J	Greenbaum, L				Greenbaum, L			That's what it is	LANCET			English	Article									Indiana Internal Med, Beech Grove Off, Beech Grove, IN 46107 USA		Greenbaum, L (corresponding author), Indiana Internal Med, Beech Grove Off, Beech Grove, IN 46107 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 26	2000	355	9205					745	+		10.1016/S0140-6736(99)11157-7	http://dx.doi.org/10.1016/S0140-6736(99)11157-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HZ	10703817				2022-12-01	WOS:000085615600044
J	Alizadeh, AA; Eisen, MB; Davis, RE; Ma, C; Lossos, IS; Rosenwald, A; Boldrick, JG; Sabet, H; Tran, T; Yu, X; Powell, JI; Yang, LM; Marti, GE; Moore, T; Hudson, J; Lu, LS; Lewis, DB; Tibshirani, R; Sherlock, G; Chan, WC; Greiner, TC; Weisenburger, DD; Armitage, JO; Warnke, R; Levy, R; Wilson, W; Grever, MR; Byrd, JC; Botstein, D; Brown, PO; Staudt, LM				Alizadeh, AA; Eisen, MB; Davis, RE; Ma, C; Lossos, IS; Rosenwald, A; Boldrick, JG; Sabet, H; Tran, T; Yu, X; Powell, JI; Yang, LM; Marti, GE; Moore, T; Hudson, J; Lu, LS; Lewis, DB; Tibshirani, R; Sherlock, G; Chan, WC; Greiner, TC; Weisenburger, DD; Armitage, JO; Warnke, R; Levy, R; Wilson, W; Grever, MR; Byrd, JC; Botstein, D; Brown, PO; Staudt, LM			Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling	NATURE			English	Article							NON-HODGKINS-LYMPHOMA; GERMINAL-CENTER FORMATION; CHROMOSOMAL TRANSLOCATION; PROGNOSTIC-SIGNIFICANCE; PROTEIN EXPRESSION; MOLECULAR-CLONING; BCL-6 EXPRESSION; ANTIGEN; CLASSIFICATION; TRANSCRIPTION	Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease. We proposed that this variability in natural history reflects unrecognized molecular heterogeneity in the tumours, Using DNA microarrays, we have conducted a systematic characterization of gene expression in B-cell malignancies. Here we show that there is diversity in gene expression among the tumours of DLBCL patients, apparently reflecting the variation in tumour proliferation rate, host response and differentiation state of the tumour. We identified two molecularly distinct forms of DLBCL which had gene expression patterns indicative of different stages of B-cell differentiation. One type expressed genes characteristic of germinal centre B cells ('germinal centre B-like DLBCL'); the second type expressed genes normally induced during in vitro activation of peripheral blood B cells ('activated B-like DLBCL'), Patients with germinal centre B-like DLBCL had a significantly better overall survival than those with activated B-like DLBCL, The molecular classification of tumours on the basis of gene expression can thus identify previously undetected and clinically significant subtypes of cancer.	NCI, Metab Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy Stat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; NIH, Bioinformat & Mol Anal Sect, CBEL, CIT, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Res Genet Inc, Huntsville, AL 35801 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; NCI, Med Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); US Food & Drug Administration (FDA); University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA.		Sherlock, Gavin J/E-9110-2012; Sherlock, Gavin J/B-1831-2009; B, shaizimah/AAS-2555-2020; Staudt, Louis/AAC-5324-2019; Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Sherlock, Gavin/0000-0002-1692-4983; Levy, Ronald/0000-0003-2061-0650	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260, ZIACT000260] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))		Alizadeh A, 1998, J CLIN IMMUNOL, V18, P373, DOI 10.1023/A:1023293621057; ALIZADEH AA, IN PRESS COLD SPRING; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Chan WC, 1997, BLOOD, V89, P3909; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DeRisi J, 1996, NAT GENET, V14, P457; Djerbi M, 1999, J EXP MED, V190, P1025, DOI 10.1084/jem.190.7.1025; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; FLENGHI L, 1995, AM J PATHOL, V147, P405; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; GOLAY J, 1994, J IMMUNOL, V153, P543; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GROGAN TM, 1988, BLOOD, V71, P1157; Harada S, 1999, LEUKEMIA, V13, P1441, DOI 10.1038/sj.leu.2401487; HARRIS NL, 1994, BLOOD, V84, P1361; Hodgkin, 1832, Med Chir Trans, V17, P68; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; JALKANEN S, 1991, J CLIN INVEST, V87, P1835, DOI 10.1172/JCI115205; Khan J, 1998, CANCER RES, V58, P5009; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klein U, 1998, IMMUNOL REV, V162, P261; Kramer MHH, 1996, J CLIN ONCOL, V14, P2131, DOI 10.1200/JCO.1996.14.7.2131; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Kuo FC, 1997, J EXP MED, V186, P1547, DOI 10.1084/jem.186.9.1547; Liu J, 1996, Biomed Environ Sci, V9, P1; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pittaluga S, 1996, J PATHOL, V179, P145; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Reed D., 1902, JOHNS HOPKINS HOS RE, V10, P133; ROSENBERG SA, 1994, BLOOD, V84, P1359; SCHEINER SM, 1995, ACADEME, V81, P4; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Sternberg C. U., 1898, Z HEILK, V19, P21; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Vose UM, 1998, SEMIN ONCOL, V25, P483; Wang K, 1999, GENE, V229, P101, DOI 10.1016/S0378-1119(99)00035-9; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124	50	7071	7521	11	556	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					503	511		10.1038/35000501	http://dx.doi.org/10.1038/35000501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676951				2022-12-01	WOS:000085227300039
J	Ludwig, MZ; Bergman, C; Patel, NH; Kreitman, M				Ludwig, MZ; Bergman, C; Patel, NH; Kreitman, M			Evidence for stabilizing selection in a eukaryotic enhancer element	NATURE			English	Article							EVEN-SKIPPED PROMOTER; DROSOPHILA EMBRYO; EXPRESSION; EVOLUTION; STRIPE; PATTERNS; REGION; SITES	Eukaryotic gene expression is mediated by compact cis-regulatory modules, or enhancers, which are bound by specific sets of transcription factors(1). The combinatorial interaction of these bound transcription factors determines time- and tissue-specific gene activation or repression. The even-skipped stripe 2 element controls the expression of the second transverse stripe of a even-skipped messenger RNA in Drosophila melanogaster embryos, and is one of the best characterized eukaryotic enhancers(2-4). Although even-skipped stripe 2 expression is strongly conserved in Drosophila, the stripe 2 element itself has undergone considerable evolutionary change in its binding-site sequences and the spacing between them. We have investigated this apparent contradiction, and here we show that two chimaeric enhancers, constructed by swapping the 5' and 3' halves of the native stripe 2 elements of two species, no longer drive expression of a reporter gene in the wildtype pattern. Sequence differences between species have functional consequences, therefore, but they are masked by other coevolved differences. On the basis of these results, we present a model for the evolution of eukaryotic regulatory sequences.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Ludwig, MZ (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Bergman, Casey/F-7854-2010	Bergman, Casey/0000-0002-5462-9854; Patel, Nipam/0000-0003-4328-654X				Arnone MI, 1997, DEVELOPMENT, V124, P1851; Arnosti DN, 1996, DEVELOPMENT, V122, P205; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hewitt GF, 1999, DEVELOPMENT, V126, P1201; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P5773, DOI 10.1073/pnas.78.9.5773; Kimura M., 1983, NEUTRAL THEORY MOL E; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Long AD, 1998, GENETICS, V149, P999; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; OHTA T, 1990, GENETICS, V126, P219; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715	19	435	448	1	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					564	567		10.1038/35000615	http://dx.doi.org/10.1038/35000615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676967				2022-12-01	WOS:000085227300055
J	Unger, MA; Chou, HP; Thorsen, T; Scherer, A; Quake, SR				Unger, MA; Chou, HP; Thorsen, T; Scherer, A; Quake, SR			Monolithic microfabricated valves and pumps by multilayer soft lithography	SCIENCE			English	Article							CAPILLARY ELECTROPHORESIS; ELECTROOSMOTIC FLOW; SYSTEMS; CHIP; DIELECTROPHORESIS	Soft Lithography is an alternative to silicon-based micromachining that uses replica molding of nontraditional elastomeric materials to fabricate stamps and microfluidic channels. We describe here an extension to the soft Lithography. paradigm. multilayer soft lithography, with which devices consisting of multiple Layers may be fabricated from soft materials. We used this technique to build active microfluidic systems containing on-off valves, switching valves, and pumps entirely out of elastomer. The softness of these materials allows the device areas to be reduced by more than two orders of magnitude compared with silicon-based devices. The other advantages of soft Lithography, such as rapid prototyping, ease of fabrication, and biocompatibility, are retained.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Quake, SR (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009121] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-9121] Funding Source: Medline; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRECHTEL R, 1995, J CHROMATOGR A, V716, P97, DOI 10.1016/0021-9673(95)00717-2; Buchaillot L, 1997, JPN J APPL PHYS 2, V36, pL794, DOI 10.1143/JJAP.36.L794; Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779; Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211; Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919; FAHRENBERG J, 1995, J MICROMECH MICROENG, V5, P77; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Goll C, 1996, J MICROMECH MICROENG, V6, P77, DOI 10.1088/0960-1317/6/1/017; Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Hosokawa K, 1999, ANAL CHEM, V71, P4781, DOI 10.1021/ac990571d; Ikuta K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P1, DOI 10.1109/MEMSYS.1994.555588; Jacobson SC, 1999, ANAL CHEM, V71, P4455, DOI 10.1021/ac990576a; JACOBSON SC, 1994, ANAL CHEM, V66, P1114, DOI 10.1021/ac00079a029; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; KUHN L, 1978, IEEE T ELECTRON DEV, V25, P1257, DOI 10.1109/T-ED.1978.19261; Lin LY, 1999, IEEE J SEL TOP QUANT, V5, P4, DOI 10.1109/2944.748098; Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017; Lucy CA, 1996, ANAL CHEM, V68, P300, DOI 10.1021/ac950632h; Muller RS, 1998, P IEEE, V86, P1705, DOI 10.1109/5.704276; Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2; PJA, 1999, SCIENCE, V285, P83; ROYLANCE LM, 1979, IEEE T ELECTRON DEV, V26, P1911, DOI 10.1109/T-ED.1979.19795; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; Shoji S, 1998, TOP CURR CHEM, V194, P163; TUFTE ON, 1962, J APPL PHYS, V33, P3322, DOI 10.1063/1.1931164; WASHIZU M, 1994, IEEE T IND APPL, V30, P835, DOI 10.1109/28.297897; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yang X, 1998, SENSOR ACTUAT A-PHYS, V64, P101, DOI 10.1016/S0924-4247(97)01660-9; Yazdi N, 1998, P IEEE, V86, P1640, DOI 10.1109/5.704269; Young A. M., 1999, Transactions of the ASME. Journal of Biomechanical Engineering, V121, P2, DOI 10.1115/1.2798039; [No title captured]	35	3082	3533	43	1267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					113	116		10.1126/science.288.5463.113	http://dx.doi.org/10.1126/science.288.5463.113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753110				2022-12-01	WOS:000086387700044
J	Nakanishi-Matsui, M; Zheng, YW; Sulciner, DJ; Weiss, EJ; Ludeman, MJ; Coughlin, SR				Nakanishi-Matsui, M; Zheng, YW; Sulciner, DJ; Weiss, EJ; Ludeman, MJ; Coughlin, SR			PAR3 is a cofactor for PAR4 activation by thrombin	NATURE			English	Article							RECEPTOR ACTIVATION; SPECIFICITY; CLEAVAGE; CLONING	Identification of the mechanisms by which the coagulation protease thrombin activates platelets is critical for understanding haemostasis and thrombosis. Thrombin activates cells at least in part by cleaving protease-activated G-protein-coupled receptors (PARs)(1). PAR3 and PAR4 are thrombin receptors expressed in mouse platelets(2,3). Inhibition of thrombin binding to mPAR3 (ref. 4) and knockout of the mPAR3 gene 3 inhibited mouse platelet activation at low but not high concentrations of thrombin. Thus PAR3 is important for thrombin signalling in mouse platelets. Expression of human PAR3 in heterologous expression systems reliably resulted in responsiveness to thrombin(2). Curiously, despite its importance for the activation of mouse platelets by thrombin 3,4, mouse PAR3 (mPAR3) did not lead to thrombin signalling even when overexpressed. We now report that mPAR3 and mPAR4 interact in a novel way: mPAR3 does not itself mediate transmembrane signalling but instead functions as a cofactor for the cleavage and activation of mPAR4 by thrombin. This establishes a paradigm for cofactor-assisted PAR activation and for a G-protein-coupled receptor's acting as an accessory molecule to present ligand to another receptor.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Daiichi Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 505 Parnassus Ave, San Francisco, CA 94143 USA.			Nakanishi-Matsui, Mayumi/0000-0001-9219-7442				CHEN J, 1994, J BIOL CHEM, V269, P16041; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; ISHII K, 1993, J BIOL CHEM, V268, P9780; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LIU LW, 1991, J BIOL CHEM, V266, P16977; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; OKAMURA T, 1978, J BIOL CHEM, V253, P3435; Sage S.O., 1996, PRACT APPROACH SER, P67; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	25	437	453	0	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					609	+		10.1038/35007085	http://dx.doi.org/10.1038/35007085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766244				2022-12-01	WOS:000086400100055
J	Diamond, J				Diamond, J			Archaeology - Blitzkrieg against the moas	SCIENCE			English	Editorial Material									Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Diamond, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	jdiamond@mednet.ucla.edu						ANDERSON A, 1991, ANTIQUITY, V65, P767, DOI 10.1017/S0003598X00080510; ANDERSON A, 1996, SHAG RIVER MOUTH; Anderson A., 1989, PRODIGIOUS BIRDS; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Martin P. S., 1984, QUATERNARY EXTINCTIO; MOSIMANN JE, 1975, AM SCI, V63, P304	6	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2170	2171		10.1126/science.287.5461.2170	http://dx.doi.org/10.1126/science.287.5461.2170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744538				2022-12-01	WOS:000086049100025
J	Hoskins, RA; Nelson, CR; Berman, BP; Laverty, TR; George, RA; Ciesiolka, L; Naeemuddin, M; Arenson, AD; Durbin, J; David, RG; Tabor, PE; Bailey, MR; DeShazo, DR; Catanese, J; Mammoser, A; Osoegawa, K; de Jong, PJ; Celniker, SE; Gibbs, RA; Rubin, GM; Scherer, SE				Hoskins, RA; Nelson, CR; Berman, BP; Laverty, TR; George, RA; Ciesiolka, L; Naeemuddin, M; Arenson, AD; Durbin, J; David, RG; Tabor, PE; Bailey, MR; DeShazo, DR; Catanese, J; Mammoser, A; Osoegawa, K; de Jong, PJ; Celniker, SE; Gibbs, RA; Rubin, GM; Scherer, SE			A BAC-based physical map of the major autosomes of Drosophila melanogaster	SCIENCE			English	Article							YEAST ARTIFICIAL CHROMOSOMES; GENOME; CLONES; CONTIGS	We constructed a bacterial artificial chromosome (BAC)-based physical map of chromosomes 2 and 3 of Drosophila melanogaster, which constitute 81% of the genome. Sequence tagged site (STS) content, restriction fingerprinting, and polytene chromosome in situ hybridization approaches were integrated to produce a map spanning the euchromatin. Three of five remaining gaps are in repeat-rich regions near the centromeres. A tiling path of clones spanning this map and STS maps of chromosomes X and 4 was sequenced to low coverage; the maps and tiling path sequence were used to support and verify the whole-genome sequence assembly, and tiling path BACs were used as templates in sequence finishing.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Baylor College of Medicine; Roswell Park Cancer Institute	Hoskins, RA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA.	hoskins@bdgp.lbl.gov	BERMAN, BENJAMIN/AAT-3720-2021; Berman, Benjamin P/D-5942-2014	BERMAN, BENJAMIN/0000-0002-2099-9005; Berman, Benjamin P/0000-0002-2099-9005; Rubin, Gerald/0000-0001-8762-8703	NHGRI NIH HHS [HG00750] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000750] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AJIOKA JW, 1991, CHROMOSOMA, V100, P495, DOI 10.1007/BF00352200; Ashburner M, 1999, GENETICS, V153, P179; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; BRIZUELA BJ, 1994, GENETICS, V137, P803; CAI HN, 1994, GENETICS, V136, P1385; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; GARZA D, 1989, SCIENCE, V246, P641, DOI 10.1126/science.2510296; Green E D, 1991, PCR Methods Appl, V1, P77; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; LOCKE J, IN PRESS GENETICS; MADUENO E, 1995, GENETICS, V139, P1631; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; PETERS AHF, UNPUB; RIETHMAN H, 1997, GENOME ANAL LAB MANU, V1, P106; Ross M.T., 1999, CURRENT PROTOCOLS HU; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; [No title captured]	24	106	112	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2271	2274		10.1126/science.287.5461.2271	http://dx.doi.org/10.1126/science.287.5461.2271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731150				2022-12-01	WOS:000086049100053
J	Pertea, M; Salzberg, SL; Gardner, MJ				Pertea, M; Salzberg, SL; Gardner, MJ			Bioinformatics - Finding genes in Plasmodium falciparum	NATURE			English	Article									Inst Genom Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Pertea, M (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637				Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854	3	18	18	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					34	34		10.1038/35003643	http://dx.doi.org/10.1038/35003643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716431	Bronze			2022-12-01	WOS:000085775100032
J	During, MJ; Symes, CW; Lawlor, PA; Lin, J; Dunning, J; Fitzsimons, HL; Poulsen, D; Leone, P; Xu, RA; Dicker, BL; Lipski, J; Young, D				During, MJ; Symes, CW; Lawlor, PA; Lin, J; Dunning, J; Fitzsimons, HL; Poulsen, D; Leone, P; Xu, RA; Dicker, BL; Lipski, J; Young, D			An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy	SCIENCE			English	Article							BLOOD-BRAIN-BARRIER; GLUTAMIC-ACID DECARBOXYLASE; GLYCINE-BINDING-SITE; D-ASPARTATE RECEPTOR; STIFF-MAN SYNDROME; STATUS EPILEPTICUS; RAT; AUTOANTIBODIES; SUBUNIT; MK-801	The brain is generally considered immunoprivileged, although increasing examples of immunological responses to brain antigens, neuronal expression of major histocompatibility class I genes, and neurological autoimmunity have been recognized. An adeno-associated virus (AAV) vaccine generated autoantibodies that targeted a specific brain protein, the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor. After peroral administration of the AAV vaccine, transgene expression persisted for at least 5 months and was associated with a robust humoral response in the absence of a significant cell-mediated response. This single-dose vaccine was associated with strong anti-epileptic and neuroprotective activity in rats for both a kainate-induced seizure model and also a middle cerebral artery occlusion stroke model at 1 to 5 months following vaccination. Thus, a vaccination strategy targeting brain proteins is feasible and may have therapeutic potential for neurological disorders.	Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand; Univ Auckland, Sch Med, Dept Physiol, Auckland, New Zealand; Thomas Jefferson Univ, Philadelphia, PA 19107 USA; Jefferson Med Coll, Dept Neurosurg, Philadelphia, PA 19107 USA	University of Auckland; University of Auckland; Jefferson University; Jefferson University	During, MJ (corresponding author), Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand.	matthew.during@mail.tju.edu	During, Matthew/AAC-1388-2020; Dicker, Bridget/F-8770-2019	Dicker, Bridget/0000-0002-8151-7356; Lipski, Janusz/0000-0001-6109-8724; Fitzsimons, Helen/0000-0001-7825-3911; Young, Deborah/0000-0003-1085-2824; Lin, John/0000-0002-1723-4597				AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; BARAN H, 1994, BRAIN RES, V652, P195, DOI 10.1016/0006-8993(94)90227-5; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; BEAR MF, 1990, J NEUROSCI, V10, P909; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Butcher SP, 1997, J NEUROSCI, V17, P6939; CARLSSON M, 1990, LIFE SCI, V47, P1729, DOI 10.1016/0024-3205(90)90346-S; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; DRAGUNOW M, 1995, MOL BRAIN RES, V32, P279, DOI 10.1016/0169-328X(95)00088-A; During MJ, 1998, NAT MED, V4, P1131, DOI 10.1038/2625; DURING MJ, UNPUB; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gusev EI, 1996, ZH NEVROPATOL PSIKH, V96, P68; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; LOTHMAN EW, 1993, EPILEPSIA, V34, pS59, DOI 10.1111/j.1528-1157.1993.tb05907.x; Mayhan WG, 1996, STROKE, V27, P965, DOI 10.1161/01.STR.27.5.965; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; POSNER JB, 1990, RES P ARNMD, V68, P187; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Schehr RS, 1996, NAT BIOTECHNOL, V14, P1549, DOI 10.1038/nbt1196-1549; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHALABY WSW, 1995, CLIN IMMUNOL IMMUNOP, V74, P127, DOI 10.1006/clin.1995.1019; SHARKEY J, 1995, J NEUROSCI METH, V60, P125, DOI 10.1016/0165-0270(95)00003-D; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; STEINBERG GK, 1995, NEUROSCIENCE, V64, P99, DOI 10.1016/0306-4522(94)00374-E; TWYMAN RE, 1995, NEURON, V14, P755, DOI 10.1016/0896-6273(95)90219-8; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wood MW, 1997, J BIOL CHEM, V272, P3532, DOI 10.1074/jbc.272.6.3532; WOZNIAK DF, 1990, PSYCHOPHARMACOLOGY, V101, P47, DOI 10.1007/BF02253717; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; ZUCKER DK, 1983, EXP NEUROL, V79, P422, DOI 10.1016/0014-4886(83)90223-6	38	183	218	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2000	287	5457					1453	1460		10.1126/science.287.5457.1453	http://dx.doi.org/10.1126/science.287.5457.1453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688787				2022-12-01	WOS:000085531600041
J	Ganzini, L; Nelson, HD; Schmidt, TA; Kraemer, DF; Delorit, MA; Lee, MA				Ganzini, L; Nelson, HD; Schmidt, TA; Kraemer, DF; Delorit, MA; Lee, MA			Physicians' experiences with the Oregon Death with Dignity Act.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSISTED SUICIDE; TERMINALLY ILL; EUTHANASIA; DESIRE; CARE	Background: Physician-assisted suicide was legalized in Oregon in October 1997. There are data on patients who have received prescriptions for lethal medications and died after taking the medications. There is little information, however, on physicians' experiences with requests for assistance with suicide. Methods: Between February and August 1999, we mailed a questionnaire to physicians who were eligible to prescribe lethal medications under the Oregon Death with Dignity Act. Results: Of 4053 eligible physicians, 2649 (65 percent) returned the survey. Of the respondents, 144 (5 percent) had received a total of 221 requests for prescriptions for lethal medications since October 1997. We received information on the outcome in 165 patients (complete information for 143 patients and partial for an additional 22). The mean age of the patients was 68 years; 76 percent had an estimated life expectancy of less than six months. Thirty-five percent requested a prescription from another physician. Twenty-nine patients (18 percent) received prescriptions, and 17 (10 percent) died from taking the prescribed medication. Twenty percent of the patients had symptoms of depression; none of these patients received a prescription for a lethal medication. In the case of 68 patients, including 11 who received prescriptions and 8 who died by taking the prescribed medication, the physician implemented at least one substantive palliative intervention, such as control of pain or other symptoms, referral to a hospice program, a consultation, or a trial of antidepressant medication. Forty-six percent of the patients for whom substantive interventions were made changed their minds about assisted suicide, as compared with 15 percent of those for whom no substantive interventions were made (P<0.001). Conclusions: Our data indicate that in Oregon, physicians grant about 1 in 6 requests for a prescription for a lethal medication and that 1 in 10 requests actually results in suicide. Substantive palliative interventions lead some -- but not all -- patients to change their minds about assisted suicide. (N Engl J Med 2000;342:557-63.) (C)2000, Massachusetts Medical Society.	Dept Vet Affairs, Portland, OR USA; Oregon Hlth Sci Univ, Dept Psychiat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Ctr Eth Hlth Care, Portland, OR 97201 USA; Providence Hlth Syst, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Vet Affairs Med Ctr, Div Mental Hlth, P-7-1DMH,POB 1034, Portland, OR 97207 USA.							Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BATTIN MP, 1995, ACAD MED, V70, P583; Breitbart W., 1998, OXFORD TXB PALLIATIV, P933; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; EMANUEL EJ, 1998, 1997 98 ASCO SURVEY; Faber-Langendoen K, 1998, CANCER-AM CANCER SOC, V82, P35, DOI 10.1002/(SICI)1097-0142(19980101)82:1<35::AID-CNCR4>3.3.CO;2-#; Fisher LD, 1993, BIOSTATISTICS METHOD; Foley KM, 1997, NEW ENGL J MED, V336, P54, DOI 10.1056/NEJM199701023360109; Henriksson MM, 1995, J AFFECT DISORDERS, V36, P11, DOI 10.1016/0165-0327(95)00047-X; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *OR HLTH DIV, 1997, OR VIT STAT ANN REP, V12; Reagan P, 1999, LANCET, V353, P1265, DOI 10.1016/S0140-6736(98)12219-5; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L	19	275	275	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2000	342	8					557	563		10.1056/NEJM200002243420806	http://dx.doi.org/10.1056/NEJM200002243420806			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286AX	10684915				2022-12-01	WOS:000085422400006
J	Christakis, NA; Lamont, EB				Christakis, NA; Lamont, EB			Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							INDEX HELP; PREFERENCES; SURVIVAL; CANCER; UNCERTAINTY; PREDICTIONS; ACCURACY; CARE	Objective To describe doctors' prognostic accuracy in terminally ill patients and to evaluate the determinants of that accuracy. Design Prospective cohort study. Setting Five outpatient hospice programmes in Chicago. Participants 343 doctors provided survival estimates for 468 terminally ill patients at the time of hospice referral. Main outcome measures Patients' estimated and actual survival. Results Median survival was 24 days. Only 20% (92/468) of predictions were accurate (within 33% of actual survival); 63% (295/468) were overoptimistic and 17% (81/468) were over-pessimistic. Overall, doctors overestimated survival by a factor of 5.3. Few patient or doctor characteristics were associated with prognostic accuracy. Male patients were 58% less likely to have over-pessimistic predictions. Non-oncology medical specialists were 326% more likely than general internists to make overpessimistic predictions. Doctors in the upper quartile of practice experience were the most accurate. As duration of doctor-patient relationship increased and time since last contact decreased, prognostic accuracy decreased. Conclusion Doctors are inaccurate in their prognoses for terminally ill patients and the error is systematically optimistic The inaccuracy is, in general, not restricted to certain kinds of doctors or patients. These phenomena may be adversely affecting the quality of care given to patients near the end of life.	Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Med Ctr, Robert Wood Johnson Clin Scholars Program, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center	Christakis, NA (corresponding author), Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA.		Ram, Prem/K-4511-2012; Christakis, Nicholas A/B-6690-2008; Christakis, Nicholas A/C-3205-2009	Lamont, Elizabeth/0000-0001-6604-678X				ADDINGTONHALL JM, 1990, BRIT J CANCER, V62, P695, DOI 10.1038/bjc.1990.360; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 1997, SOC SCI MED, V44, P301, DOI 10.1016/S0277-9536(96)00100-1; Christakis Nicholas A., 1999, DEATH FORETOLD PROPH; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; EVANS C, 1985, LANCET, V1, P1204; FLETCHER SW, 1981, BIOMEDICAL INNOVATIO; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; HEVSEMOORE LH, 1987, PALLIATIVE MED, V1, P165; IWASHYNA TJ, 1998, PALLIATIVE MED, V1, P241; LYNN J, 1995, WESTERN J MED, V163, P250; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; PEARLMAN RA, 1988, ARCH INTERN MED, V148, P2537, DOI 10.1001/archinte.148.12.2537; POSES RM, 1991, CRIT CARE MED, V19, P1533, DOI 10.1097/00003246-199112000-00016; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Zubrod CG, 1960, J CHRON DIS, V11, P7	21	904	911	0	33	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 19	2000	320	7233					469	472		10.1136/bmj.320.7233.469	http://dx.doi.org/10.1136/bmj.320.7233.469			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KP	10678857	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000085562200018
J	Wang, BL; Fallon, JF; Beachy, PA				Wang, BL; Fallon, JF; Beachy, PA			Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb	CELL			English	Article							PROTEIN-KINASE-A; GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; TERMINAL CLEAVAGE PRODUCT; VENTRAL NEURAL-TUBE; SONIC-HEDGEHOG; FLOOR PLATE; CUBITUS-INTERRUPTUS; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; PATTERNING ACTIVITY	Ci/Gli zinc finger proteins mediate the transcriptional effects of Hedgehog protein signals. In Drosophila, Ci action as transcriptional repressor or activator is contingent upon Hedgehog-regulated, PKA-dependent proteolytic processing. We demonstrate that PKA-dependent processing of vertebrate Gli3 in developing limb similarly generates a potent repressor in a manner antagonized by apparent long-range signaling from posteriorly localized Sonic hedgehog protein. The resulting anterior/posterior Gli3 repressor gradient can be perturbed by mutations of Gli3 in human genetic syndromes or by misregulation of Gli3 processing in the chicken mutant talpid(2), producing a range of limb patterning malformations. The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for negative Hedgehog pathway regulation.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Howard Hughes Medical Institute; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.				NICHD NIH HHS [HD32551] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032551] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Borycki AG, 1998, DEVELOPMENT, V125, P777; Buscher D, 1998, MAMM GENOME, V9, P676, DOI 10.1007/s003359900845; Caruccio NC, 1999, DEV BIOL, V212, P137, DOI 10.1006/dbio.1999.9321; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DANIELS K, 1998, METHOD CELL BIOL, P237; Ding Q, 1998, DEVELOPMENT, V125, P2533; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Hughes DC, 1997, GENOMICS, V39, P205, DOI 10.1006/geno.1996.4468; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Lee J, 1997, DEVELOPMENT, V124, P2537; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MARTI E, 1995, DEVELOPMENT, V121, P2537; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1111/j.1574-6968.1999.tb13575.x; Tatusova TA, 1999, FEMS MICROBIOL LETT, V177, P187, DOI 10.1111/j.1574-6968.1999.tb13730.x; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; VORTKAMP A, 1992, MAMM GENOME, V3, P461, DOI 10.1007/BF00356157; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BL, 1996, ONCOGENE, V12, P1921; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Yang Y, 1997, DEVELOPMENT, V124, P4393; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zou H, 1997, COLD SPRING HARB SYM, V62, P269	57	786	814	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					423	434		10.1016/S0092-8674(00)80678-9	http://dx.doi.org/10.1016/S0092-8674(00)80678-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693759	Bronze			2022-12-01	WOS:000085446900005
J	Lichtenstein, GR; Yang, YX; Nunes, FA; Lewis, JD; Tuchman, M; Tino, G; Kaiser, LR; Palevsky, HI; Kotloff, RM; Furth, EE; Bavaria, JE; Stecker, MM; Kaplan, P; Berry, GT				Lichtenstein, GR; Yang, YX; Nunes, FA; Lewis, JD; Tuchman, M; Tino, G; Kaiser, LR; Palevsky, HI; Kotloff, RM; Furth, EE; Bavaria, JE; Stecker, MM; Kaplan, P; Berry, GT			Fatal hyperammonemia after orthotopic lung transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC HYPERAMMONEMIA; ENCEPHALOPATHY; AMMONIA	Background: A case of fatal hyperammonemia complicating orthotopic lung transplantation was previously reported. Objective: To describe the incidence, clinical features, and treatment of hyperammonemia associated with orthotopic lung transplantation. Design: Retrospective cohort analysis. Setting: Academic medical center and lung transplantation center in Philadelphia, Pennsylvania. Patients: 145 sequential adult patients who underwent orthotopic lung transplantation. Measurements: Plasma ammonium levels. Results: Six of the 145 patients who had had orthotopic lung transplantation developed hyperammonemia, all within the first 26 days after transplantation. The 30-day post-transplantation mortality rate was 67% for patients with hyperammonemia compared with 17% for those without hyperammonemia (P = 0.01). Development of major gastrointestinal complications (P = 0.03), use of total parenteral nutrition (P < 0.001), and lung transplantation for primary pulmonary hypertension (P = 0.045) were associated with hyperammonemia. Conclusions: Hyperammonemia is a potentially fatal event occurring after orthotopic lung transplantation. It is associated with high nitrogen load, concurrent medical stressors, primary pulmonary hypertension, and hepatic glutamine synthetase deficiency.	Hosp Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Washington Childrens Hosp, Washington, DC USA	University of Pennsylvania; Pennsylvania Medicine; Children's National Health System	Lichtenstein, GR (corresponding author), Hosp Univ Penn, Sch Med, Dept Med, Div Gastroenterol, 3 Ravdin Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.		Kotloff, Robert/R-2579-2019; Kaiser, Larry/L-7940-2019	Stecker, Mark/0000-0002-9632-168X; Berry, Gerard/0000-0001-5299-3313				Armitage P., 1987, STAT METHODS MED RES; Berry GT, 1999, ARCH NEUROL-CHICAGO, V56, P481, DOI 10.1001/archneur.56.4.481; Breningstall G N, 1986, Pediatr Neurol, V2, P253, DOI 10.1016/0887-8994(86)90016-0; BRESSLER R, 1969, PHARMACOL REV, V21, P105; Brusilow SW HA., 1995, METABOLIC MOL BASES, P1187; COULTER DL, 1981, J PEDIATR-US, V99, P317, DOI 10.1016/S0022-3476(81)80489-1; Davies SM, 1996, BONE MARROW TRANSPL, V17, P1119; EGGERMONT E, 1980, ACTA PAEDIATR BELG, V33, P163; GLASGOW AM, 1972, AM J DIS CHILD, V124, P827, DOI 10.1001/archpedi.1972.02110180029003; HOYUMPA AM, 1979, GASTROENTEROLOGY, V76, P184; Lichtenstein GR, 1997, GASTROENTEROLOGY, V112, P236, DOI 10.1016/S0016-5085(97)70240-3; MOURE JMB, 1970, ARCH NEUROL-CHICAGO, V23, P365, DOI 10.1001/archneur.1970.00480280079009; Rueda JF, 1998, ANN INTERN MED, V128, P956, DOI 10.7326/0003-4819-128-11-199806010-00022; SAMTOY B, 1980, PEDIATRICS, V65, P294, DOI 10.1542/peds.65.2.294; TRULOCK EP, 1993, CHEST, V103, P1566, DOI 10.1378/chest.103.5.1566; Tuchman M, 1997, ANN INTERN MED, V127, P446, DOI 10.7326/0003-4819-127-6-199709150-00005; WATSON AJ, 1985, LANCET, V2, P1271	17	65	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2000	132	4					283	287		10.7326/0003-4819-132-4-200002150-00006	http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285CY	10681283				2022-12-01	WOS:000085372900005
J	Hemminki, E; McPherson, K				Hemminki, E; McPherson, K			Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease	LANCET			English	Article							REPLACEMENT THERAPY; CLINICAL-TRIALS; INFORMATION	Background In a previous study of pooled data from published trials, we found no evidence to support the claim that postmenopausal hormone therapy (PHT) is associated with a decrease in cardiovascular disease. The purpose of this study was to see whether reports of clinical trials attached to drug-licensing applications in Finland could be obtained for scientific purposes, whether they are useful for studying cardiovascular events resulting from PHT, and if so, whether these unpublished reports corroborate the results of published reports. Methods Since clinical trials in drug-licensing documents are confidential, we had to obtain special permission from the Ministry of Social Affairs and Health to use the data for research purposes. After permission was granted, we studied the clinical sections of licensing documents for PHT drugs sent by drug companies to the Finnish Drug Agency. We aimed to identify trials that compared PHT and a placebo (or no therapy, or vitamin-mineral drugs), and that reported on cardiovascular and thromboembolic events or superficial phlebitis. New trials were identified and their data were pooled with those of published trials. Findings 17 licensing applications for drugs used as PHT were found. The number, type, and quality of reporting of clinical trials varied widely between applications. The trials and their reporting of unanticipated adverse events were mostly inadequate. Six new trials tie, those fulfilling the inclusion criteria and not included in our earlier report) were found. The new trials added little to the conclusions of previously published studies: the calculated odds ratios of cardiovascular and thromboembolic events for women taking PHT versus those not taking it was 1.97 (95% CI 0.84-4.63), compared with 1.65 (0.65-4.21) in our previous study. Interpretation In this case, unpublished trials added only a little to the data available from published trials, mainly due to the type of clinical data used in the licensing applications. The new data did not change the previous conclusion that clinical trials do not support a beneficial effect of PHT on cardiovascular diseases.	Natl Res & Dev Ctr Welf & Hlth, Hlth Serv Res Unit, FIN-00531 Helsinki, Finland; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Hemminki, E (corresponding author), Natl Res & Dev Ctr Welf & Hlth, Hlth Serv Res Unit, POB 220, FIN-00531 Helsinki, Finland.							Bardy AH, 1998, LANCET, V352, P1229, DOI 10.1016/S0140-6736(05)60576-4; Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Barrett-Connor E, 1998, BMJ-BRIT MED J, V317, P457; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Josefson D, 1999, BRIT MED J, V318, P753, DOI 10.1136/bmj.318.7186.753; Meschia M, 1998, MENOPAUSE, V5, P157; Ollila E, 1996, Int J Risk Saf Med, V9, P161, DOI 10.3233/JRS-1996-9306; 1996, INT J RISK SAFETY ME, V9, P131	10	30	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2000	355	9203					566	569		10.1016/S0140-6736(99)03432-7	http://dx.doi.org/10.1016/S0140-6736(99)03432-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287CN	10683020				2022-12-01	WOS:000085487400039
J	Banfield, JF; Marshall, CR				Banfield, JF; Marshall, CR			Earth science and evolution - Genomics and the geosciences	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard University	Banfield, JF (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.	jill@geology.wisc.edu; marshall@eps.harvard.edu		Banfield, Jill/0000-0001-8203-8771				Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; DAVIDSON EH, 1995, SCIENCE, V270, P1319, DOI 10.1126/science.270.5240.1319; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Nealson KH, 1997, REV MINERAL, V35, P5; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Valentine JW, 1999, DEVELOPMENT, V126, P851; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	12	13	16	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					605	606		10.1126/science.287.5453.605	http://dx.doi.org/10.1126/science.287.5453.605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691543				2022-12-01	WOS:000084989400034
J	EHRHARDT, DW; ATKINSON, EM; LONG, SR				EHRHARDT, DW; ATKINSON, EM; LONG, SR			DEPOLARIZATION OF ALFALFA ROOT HAIR MEMBRANE-POTENTIAL BY RHIZOBIUM-MELILOTI NOD FACTORS	SCIENCE			English	Article							ELONGATION; SIGNAL; CELLS; AUXIN	Although much is known about the bacterial genetics of early nodulation, little is known about the plant cell response. Alfalfa root hair cells were impaled with intracellular micro-electrodes to measure a membrane potential depolarizing activity in Rhizobium meliloti cell-free filtrates, a plant response dependent on the bacterial nodulation genes. The depolarization was desensitized by repeated exposure to factors and was not observed in a representative nonlegume. A purified extracellular Nod factor, NodRm-IV(S), caused membrane potential depolarization at nanomolar concentrations. This rapid single-cell assay provides a tool for dissecting the mechanisms of host cell response in early nodulation.	STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA	Stanford University								BATES GW, 1982, J MEMBRANE BIOL, V66, P15, DOI 10.1007/BF01868478; BISSELING T, COMMUNICATION; CLARKSON DT, 1988, J CELL SCI, V91, P71; CLELAND RE, 1977, PLANT PHYSIOL, V60, P709, DOI 10.1104/pp.60.5.709; DJORDJEVIC MA, 1987, ANNU REV PHYTOPATHOL, V25, P145, DOI 10.1146/annurev.py.25.090187.001045; DUDLEY ME, 1987, PLANTA, V171, P289, DOI 10.1007/BF00398674; DUDLEY ME, 1989, PLANT CELL, V1, P65, DOI 10.1105/tpc.1.1.65; EHRHARDT DW, UNPUB; FAUCHER C, 1988, J BACTERIOL, V170, P5489, DOI 10.1128/jb.170.12.5489-5499.1988; HAGER A, 1971, PLANTA, V100, P47, DOI 10.1007/BF00386886; HOPE AB, 1978, PHYSL GIANT ALGAL CE; LEROUGE P, 1990, NITROGEN FIXATION : ACHIEVEMENTS AND OBJECTIVES, P177; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LICHTNER FT, 1981, PLANT PHYSIOL, V67, P869, DOI 10.1104/pp.67.4.869; Long S. R., 1984, Plant-microbe interactions. Molecular and genetic perspectives. Volume I., P265; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MAYER MG, 1988, PHYSIOL MOL PLANT P, V33, P397, DOI 10.1016/0885-5765(88)90006-9; PAVLOVKIN J, 1986, PHYSIOL MOL PLANT P, V28, P125, DOI 10.1016/S0048-4059(86)80014-5; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; RYAN CA, 1987, ANNU REV CELL BIOL, V3, P295, DOI 10.1146/annurev.cellbio.3.1.295; SCHROEDER JI, 1989, TRENDS BIOCH SCI, V14; SCHWEDOCK J, 1990, NATURE, V348, P644, DOI 10.1038/348644a0; SPAINK H, COMMUNICATION; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0	25	316	325	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	1992	256	5059					998	1000		10.1126/science.10744524	http://dx.doi.org/10.1126/science.10744524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU224	10744524				2022-12-01	WOS:A1992HU22400030
J	Pouyanne, P; Haramburu, F; Imbs, JL; Begaud, B				Pouyanne, P; Haramburu, F; Imbs, JL; Begaud, B		French Pharmacovigliance Centres	Admissions to hospital caused by adverse drug reactions: cross sectional incidence study	BRITISH MEDICAL JOURNAL			English	Article									Univ Victor Segalen, CHU, Ctr Pharmacovigilance, Dept Pharmacol, F-33076 Bordeaux, France; Hop Univ, Serv Pharmacol Clin, Ctr Reg Pharmacovigilance Alsace, F-67091 Strasbourg, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Strasbourg	Haramburu, F (corresponding author), Univ Victor Segalen, CHU, Ctr Pharmacovigilance, Dept Pharmacol, F-33076 Bordeaux, France.							EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Imbs JL, 1999, THERAPIE, V54, P21; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Roughead EE, 1998, MED J AUSTRALIA, V168, P405, DOI 10.5694/j.1326-5377.1998.tb138996.x; *WHO, 1996, WHO TECHN REP SER, V425	5	281	296	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 15	2000	320	7241					1036	1036		10.1136/bmj.320.7241.1036	http://dx.doi.org/10.1136/bmj.320.7241.1036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307VW	10764362	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000086675700021
J	von Helden, G; Tielens, ACGM; van Heijnsbergen, D; Duncan, MA; Hony, S; Waters, LBFM; Meijer, G				von Helden, G; Tielens, ACGM; van Heijnsbergen, D; Duncan, MA; Hony, S; Waters, LBFM; Meijer, G			Titanium carbide nanocrystals in circumstellar environments	SCIENCE			English	Article							RICH PROTOPLANETARY NEBULAE; MASS-LOSS; EMISSION; STARS; EVOLUTION; GRAPHITE; SHELLS; SIS2; DUST	Meteorites contain micrometer-sized graphite grains with embedded titanium carbide grains. Although isotopic analysis identifies asymptotic giant branch stars as the birth sites of these grains, there is no direct observational identification of these grains in astronomical sources. We report that infrared wavelength spectra of gas-phase titanium carbide nanocrystals derived in the laboratory show a prominent feature at a wavelength of 20.1 micrometers, which compares well to a similar feature in observed spectra of postasymptotic giant branch stars. It is concluded that titanium carbide forms during a short (approximately 100 years) phase of catastrophic mass Loss (>0.001 solar masses per year) in dying, Low-mass stars.	EURATOM, FOM, Inst Plasma Phys Rijnhuizen, NL-3430 BE Nieuwegein, Netherlands; Catholic Univ Nijmegen, Dept Mol & Laser Phys, NL-6525 ED Nijmegen, Netherlands; Univ Groningen, SRON Kapteyn Inst, NL-9700 AV Groningen, Netherlands; Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Amsterdam, Astron Inst, NL-1098 SJ Amsterdam, Netherlands; Katholieke Univ Leuven, Sterrekundig Inst, B-3001 Heverlee, Belgium	Euratom; Radboud University Nijmegen; University of Groningen; University System of Georgia; University of Georgia; University of Amsterdam; KU Leuven	von Helden, G (corresponding author), EURATOM, FOM, Inst Plasma Phys Rijnhuizen, Edisonbaan 14, NL-3430 BE Nieuwegein, Netherlands.	gertvh@rijnh.nl	von Helden, Gert/H-9357-2012; Meijer, Gerard/D-2141-2009	von Helden, Gert/0000-0001-7611-8740; Meijer, Gerard/0000-0001-9669-8340				ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; Begemann B, 1996, ASTROPHYS J, V464, pL195, DOI 10.1086/310110; Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; BUSS RH, 1993, ASTROPHYS J, V415, P250, DOI 10.1086/173160; Cherchneff I, 1999, IAU SYMP, P251; Crovisier J., 1999, UNIVERSE SEEN ISO ES, V427, P161; DANCE I, COMMUNICATION; Dayal A, 1998, ASTROPHYS J, V492, P603, DOI 10.1086/305051; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; DEMUIZON MJ, 1992, LES HOUCHES, P489; GOEBEL JH, 1993, ASTRON ASTROPHYS, V278, P226; GUO BC, 1992, SCIENCE, V255, P1411, DOI 10.1126/science.255.5050.1411; Hill HGM, 1998, ASTRON ASTROPHYS, V336, pL41; Hofner S, 1998, ASTRON ASTROPHYS, V340, P497; HRIVNAK BJ, 1995, ASTROPHYS J, V438, P341, DOI 10.1086/175078; JURA M, 1997, AIP C P, V402, P379; JUSTTANONT K, 1992, ASTROPHYS J, V389, P400, DOI 10.1086/171215; JUSTTANONT K, 1996, ASTROPHYS J, V476, P319; KWOK S, 1989, ASTROPHYS J, V345, pL51, DOI 10.1086/185550; Meixner M, 1997, ASTROPHYS J, V482, P897, DOI 10.1086/304174; Molster FJ, 1996, ASTRON ASTROPHYS, V315, pL373; OEPTS D, 1995, INFRARED PHYS TECHN, V36, P297, DOI 10.1016/1350-4495(94)00074-U; OSHLMA C, 1987, PHYS REV B, V36, P7510; PILGRIM JS, 1993, J AM CHEM SOC, V115, P9724, DOI 10.1021/ja00074a044; Renzini A., 1981, PHYS PROCESSES RED G, P431; SOURISSEAU C, 1992, ASTRON ASTROPHYS, V254, pL1; Tielens AGGM, 1999, NATO ADV SCI I C-MAT, V523, P331; van Heijnsbergen D, 1999, PHYS REV LETT, V83, P4983, DOI 10.1103/PhysRevLett.83.4983; Van Winckel H, 1999, IAU SYMP, P465; van Winckel H, 2000, ASTRON ASTROPHYS, V354, P135; VASSILIADIS E, 1993, ASTROPHYS J, V413, P641, DOI 10.1086/173033; Volk K, 1999, ASTROPHYS J, V516, pL99, DOI 10.1086/312007	32	132	133	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					313	316						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764639				2022-12-01	WOS:000086454300030
J	Snyder, L; Caplan, AL				Snyder, L; Caplan, AL			Assisted suicide: Finding common ground	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.	lsnyder@mail.acponline.org						Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Doerflinger RM, 1999, HASTINGS CENT REP, V29, P52	2	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					468	469		10.7326/0003-4819-132-6-200003210-00007	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733446				2022-12-01	WOS:000085834700006
J	Chandrashekar, J; Mueller, KL; Hoon, MA; Adler, E; Feng, LX; Guo, W; Zuker, CS; Ryba, NJP				Chandrashekar, J; Mueller, KL; Hoon, MA; Adler, E; Feng, LX; Guo, W; Zuker, CS; Ryba, NJP			T2Rs function as bitter taste receptors	CELL			English	Article							G-PROTEIN; SUCROSE OCTAACETATE; EXPRESSION; GUSTDUCIN; NERVE; MICE; RAT; TRANSDUCTION; COUPLE; SWEET	Bitter taste perception provides animals with critical protection against ingestion of poisonous compounds. In the accompanying paper, we report the characterization of a large family of putative mammalian taste receptors (T2Rs). Here we use a heterologous expression system to show that specific T2Rs function as bitter taste receptors. A mouse T2R (mT2R-5) responds to the bitter tastant cycloheximide, and a human and a mouse receptor (hT2R-4 and mT2R-8) responded to denatonium and 6-n-propyl-2-thiouracil. Mice strains deficient in their ability to detect cycloheximide have amino acid substitutions in the mT2R-5 gene; these changes render the receptor significantly less responsive to cycloheximide. We also expressed mT2R-5 in insect cells and demonstrate specific tastant-dependent activation of gustducin, a G protein implicated in bitter signaling. Since a single taste receptor cell expresses a large repertoire of T2Rs, these findings provide a plausible explanation for the uniform bitter taste that is evoked by many structurally unrelated toxic compounds.	NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Dept Neurosci, La Jolla, CA 92093 USA; Aurora Biosci, San Diego, CA 92121 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), NIH, Natl Inst Dent & Craniofacial Res, Bldg 10, Bethesda, MD 20892 USA.			Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABE K, 1993, J BIOL CHEM, V268, P12033; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FRANK ME, 1983, J NEUROPHYSIOL, V50, P941, DOI 10.1152/jn.1983.50.4.941; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; HARGRAVE PA, 1986, EXP EYE RES, V42, P363, DOI 10.1016/0014-4835(86)90030-8; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; KINNAMON SC, 1992, ANNU REV PHYSIOL, V54, P715, DOI 10.1146/annurev.physiol.54.1.715; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUSANO T, 1971, Applied Entomology and Zoology, V6, P40; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Lindemann B, 1996, CURR BIOL, V6, P1234, DOI 10.1016/S0960-9822(96)00704-X; LINDEMANN B, 1996, GENET RES, V44, P151; LUSH IE, 1986, GENET RES, V47, P117, DOI 10.1017/S0016672300022941; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCBURNEY DH, 1979, PSYCHOL BULL, V86, P151, DOI 10.1037/0033-2909.86.1.151; Mehta RK, 1999, BIOTECHNIQUES, V26, P1082, DOI 10.2144/99266bm17; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; NEJAD MS, 1986, CHEM SENSES, V11, P283, DOI 10.1093/chemse/11.3.283; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; REISINE T, 1995, NEUROPHARMACOLOGY, V34, P463, DOI 10.1016/0028-3908(95)00025-2; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; SAROLI A, 1984, NATURWISSENSCHAFTEN, V71, P428, DOI 10.1007/BF00365895; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Tsunoda S, 1998, CURR OPIN GENET DEV, V8, P419, DOI 10.1016/S0959-437X(98)80112-3; WARREN RP, 1970, NATURE, V227, P77, DOI 10.1038/227077a0; WHITNEY G, 1986, BEHAV GENET, V16, P559, DOI 10.1007/BF01066342; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	41	1013	1121	7	282	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					703	711		10.1016/S0092-8674(00)80706-0	http://dx.doi.org/10.1016/S0092-8674(00)80706-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761935	Bronze			2022-12-01	WOS:000085983800012
J	Hirotsu, T; Saeki, S; Yamamoto, M; Ilno, Y				Hirotsu, T; Saeki, S; Yamamoto, M; Ilno, Y			The Ras-MAPK pathway is important for olfaction in Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; KSR-1 GENE ENCODES; C-ELEGANS; SENSORY NEURONS; CHEMOTAXIS; PROTEIN; TRANSDUCTION; MAINTENANCE; ACTIVATION; MECHANISMS	The Ras-MAPK (mitogen-activated protein kinase) signal transduction pathway is well known to control cellular proliferation and differentiation in response to extracellular signals, but its other functions are less understood. In Caenorhabditis elegans this pathway regulates several developmental events, such as vulval induction and progression of meiosis(1), but its function in the nervous system is unknown. Here we report that the Ras-MAPK pathway is involved in olfaction in this organism. Mutational inactivation and hyperactivation of this pathway impairs efficiency of chemotaxis to a set of odorants. Experiments in which let-60 ras was expressed using a heat-shock promoter and a cell-specific promoter show that a normal activity of LET-60 Ras is required in mature olfactory neurons. Application of the odorant isoamylalcohol to wild-type animals leads to the activation of MAP kinase in olfactory neurons within 10 seconds. This induction is dependent on the function of the nucleotide-gated channel TAX-2/TAX-4 and the voltage-activated calcium channel subunit UNC-2. These results suggest a dynamic regulatory role for the Ras-MAPK pathway in perception and transmission of sensory signals in olfactory neurons.	Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Ilno, Y (corresponding author), Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan.	iino@ims.u-tokyo.ac.jp	Hirotsu, Takaaki/G-9358-2013; IINO, YUICHI/G-4962-2014	Hirotsu, Takaaki/0000-0003-3936-8382; 				ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; DUSENBERY DB, 1975, GENETICS, V80, P297; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nonet ML, 1997, J NEUROSCI, V17, P8061; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	29	59	76	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					289	293		10.1038/35005101	http://dx.doi.org/10.1038/35005101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749212				2022-12-01	WOS:000086022200050
J	Brown, BH; Tidy, JA; Boston, K; Blackett, AD; Smallwood, RH; Sharp, F				Brown, BH; Tidy, JA; Boston, K; Blackett, AD; Smallwood, RH; Sharp, F			Relation between tissue structure and imposed electrical current flow in cervical neoplasia	LANCET			English	Article							UTERINE CERVIX; CANCER	Background When an electrical potential is applied to human tissue, the pattern of the resulting current flow is determined by the shapes, arrangements, and internal structure of the tissue cells. By measurement of the electrical current patterns over a range of frequencies, and use of an inverse modelling procedure, electrical variables describing the tissue structure can be calculated, We used this method to develop a screening technique for the detection of cervical precancers. Methods We used a pencil probe (diameter 5 mm) to measure electrical impedance spectra from eight points on the cervix in 124 women with abnormal cervical smears. Variables that should be sensitive to the expected tissue changes were calculated. These were compared with the colposcopic results. Findings The measured electrical impedance changes were those predicted on the basis of the expected tissue structures. Measurements made on normal squamous tissues were well separated from those made on precancerous tissues. We constructed receiver-operating-characteristic curves, comparing measurements made on normal tissue and that showing cervical intraepithelial neoplasia grade 2/3; the area under the curve was 0.951. These groups of women could be separated with a sensitivity of 0.92 and a specificity of 0.92. Interpretation Characteristics of the electrical impedance spectra of tissues can be explained by changes in cell arrangements (layering) and in the size of the nuclei. This relation opens the way to deriving tissue structure from electrical impedance spectral measurements. We show that this approach can be used to give good separation of normal and precancerous cervical tissues.	Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, No Gen Hosp Trust, Ctr Clin Sci, Dept Obstet & Gynaecol, Sheffield, S Yorkshire, England	University of Sheffield; Northern General Hospital; University of Sheffield	Brown, BH (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys, Sheffield S10 2JF, S Yorkshire, England.		Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632				ANDERSON MC, 1992, TEXT ATLAS INTEGRATE; BOON ME, 1985, HISTOPATHOLOGY, V9, P751, DOI 10.1111/j.1365-2559.1985.tb02861.x; BROWN BH, 1995, PHYSIOL MEAS, V16, P57; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; COPPLESON M, 1994, INT J GYNECOL CANCER, V4, P79, DOI 10.1046/j.1525-1438.1994.04020079.x; DUCK FA, 1990, PHYSICAL PROPERTIES; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mitchell MF, 1999, OBSTET GYNECOL, V93, P462, DOI 10.1016/S0029-7844(98)00385-8; PRITCHARD DA, 1996, NHS CERVICAL SCREENI, V3; SASIENI P, 1995, LANCET, V346, P1566, DOI 10.1016/S0140-6736(95)92099-4; SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147; SORENSEN FB, 1991, VIRCHOWS ARCH A, V418, P225, DOI 10.1007/BF01606060	13	136	156	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					892	895		10.1016/S0140-6736(99)09095-9	http://dx.doi.org/10.1016/S0140-6736(99)09095-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752706				2022-12-01	WOS:000085896000012
J	Kazemi-Esfarjani, P; Benzer, S				Kazemi-Esfarjani, P; Benzer, S			Genetic suppression of polyglutamine toxicity in Drosophila	SCIENCE			English	Article							DNA-BINDING PROTEIN; CELL FATES; J-DOMAIN; LOCALIZATION; DEGENERATION; EXPRESSION; PHENOTYPES; INCLUSIONS; HSP70; EYE	A Drosophila model for Huntington's and other polyglutamine diseases was used to screen for genetic factors modifying the degeneration caused by expression of polyglutamine in the eye. Among 7000 P-element insertions, several suppressor strains were isolated, two of which Led to the discovery of the suppressor genes described here. The predicted product of one, dHDJ1, is homologous to human heat shock protein 40/HDJ1. That of the second, dTPR2, is homologous to the human tetratricopeptide repeat protein 2. Each of these molecules contains a chaperone-related J domain. Their suppression of polyglutamine toxicity was verified in transgenic flies.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kazemi-Esfarjani, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hata M, 1996, GENOMICS, V38, P446, DOI 10.1006/geno.1996.0653; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Murthy AE, 1996, DNA CELL BIOL, V15, P727, DOI 10.1089/dna.1996.15.727; PIRROTTA V, 1986, CLONING DROSOPHILA G, P83; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SEROUDE L, UNPUB; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss B, 1999, AM J MED GENET, V89, P14, DOI 10.1002/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.3.CO;2-W	30	452	477	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1837	1840		10.1126/science.287.5459.1837	http://dx.doi.org/10.1126/science.287.5459.1837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710314				2022-12-01	WOS:000085775300046
J	Yankner, BA				Yankner, BA			A century of cognitive decline	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.								0	20	22	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					125	125		10.1038/35004673	http://dx.doi.org/10.1038/35004673			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724145				2022-12-01	WOS:000085870900023
J	Holt, IJ; Lorimer, HE; Jacobs, HT				Holt, IJ; Lorimer, HE; Jacobs, HT			Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA	CELL			English	Article							REPLICATION ORIGINS; ETHIDIUM-BROMIDE; GEL-ELECTROPHORESIS; 2-DIMENSIONAL GELS; YEAST; SEQUENCE; ORGANIZATION	Analysis of mammalian mtDNA by two-dimensional agarose gel electrophoresis revealed two classes of replication intermediate. One was resistant to single-strand nuclease digestion and displayed the mobility properties of coupled leading- and lagging- strand replication products, Intermediates of coupled, unidirectional mtDNA replication were found in mouse liver and human placenta and were the predominant species in cultured cells recovering from transient mtDNA replication. Replication intermediates sensitive to single-strand nuclease were most abundant in untreated cultured cells, These are presumed to derive from the orthodox, strand-asynchronous mode of mtDNA replication. These findings indicate that two modes of mtDNA replication operate in mammalian cells and that changes in mtDNA copy number involve an alteration in the mode of mtDNA replication.	Univ Dundee, Ninewells Med Sch, Dept Mol Pathol, Dundee DD1 9SY, Scotland; Youngstown State Univ, Dept Biol Sci, Youngstown, OH 44555 USA; Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Dundee; University System of Ohio; Youngstown State University; Tampere University; Tampere University; Tampere University Hospital; University of Glasgow	Holt, IJ (corresponding author), Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		Jacobs, Howard T/G-2434-2011	holt, ian/0000-0001-5468-0193; Jacobs, Howard/0000-0003-1895-6003	MRC [MC_U105663140] Funding Source: UKRI; Medical Research Council [MC_U105663140] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BRUN C, 1995, CHROMOSOMA, V104, P92; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; GOLDRING ES, 1970, J MOL BIOL, V52, P323, DOI 10.1016/0022-2836(70)90033-1; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; IKEDA S, 1994, CELL MOL BIOL, V40, P489; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KOIKE K, 1974, J CELL BIOL, V61, P14, DOI 10.1083/jcb.61.1.14; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MAYHOOK AG, 1992, P ROY SOC B-BIOL SCI, V248, P85, DOI 10.1098/rspb.1992.0046; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAWOTKA KA, 1988, MOL CELL BIOL, V8, P1408, DOI 10.1128/MCB.8.4.1408; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Sambrook J., 1989, MOL CLONING LAB MANU; SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1; WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321; Wolstenholme D R, 1974, Cold Spring Harb Symp Quant Biol, V38, P267	28	283	290	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					515	524		10.1016/S0092-8674(00)80688-1	http://dx.doi.org/10.1016/S0092-8674(00)80688-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721989	Bronze			2022-12-01	WOS:000085700000005
J	Plugge, B; Gazzarrini, S; Nelson, M; Cerana, R; Van Etten, JL; Derst, C; DiFrancesco, D; Moroni, A; Thiel, G				Plugge, B; Gazzarrini, S; Nelson, M; Cerana, R; Van Etten, JL; Derst, C; DiFrancesco, D; Moroni, A; Thiel, G			A potassium channel protein encoded by chlorella virus PBCV-1	SCIENCE			English	Article							XENOPUS OOCYTES; K+ CHANNELS; SEQUENCE	The Large chlorella virus PBCV-1, which contains double-stranded DNA (dsDNA), encodes a 94-codon open reading frame (ORF) that contains a motif resembling the signature sequence of the pore domain of potassium channel proteins. Phylogenetic analyses of the encoded protein, Kcv, indicate a previously unidentified type of potassium channel. The messenger RNA encoded by the ORF Leads to functional expression of a potassium-selective conductance in Xenopus laevis oocytes. The channel blockers amantadine and barium, but not cesium, inhibit this conductance, in addition to virus plaque formation. Thus, PBCV-1 encodes the first known viral protein that functions as a potassium-selective channel and is essential in the virus Life cycle.	Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, D-37073 Gottingen, Germany; Univ Milan, I-20133 Milan, Italy; Megabase Res Prod, Lincoln, NE 68604 USA; Univ Milano Bicocca, DISAT, I-20126 Milan, Italy; Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; Univ Marburg, Inst Physiol, D-35033 Marburg, Germany	University of Gottingen; University of Milan; University of Milano-Bicocca; University of Nebraska System; University of Nebraska Lincoln; Philipps University Marburg	Thiel, G (corresponding author), Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, D-37073 Gottingen, Germany.		Ebert, Barbara/E-5709-2012; DiFrancesco, Dario/G-8408-2017; moroni, anna/H-2097-2014	DiFrancesco, Dario/0000-0002-7322-1790; moroni, anna/0000-0002-1860-406X; Thiel, Gerhard/0000-0002-2335-1351; Ebert, Barbara/0000-0003-3328-6693; gazzarrini, sabrina/0000-0003-3062-7536	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41333, GM32441] Funding Source: Medline; Telethon [971] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon)		Bauer CK, 1996, PFLUG ARCH EUR J PHY, V432, P812, DOI 10.1007/s004240050203; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Derst C, 1998, J EXP BIOL, V201, P2791; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hille B., 1992, IONIC CHANNELS EXCIT; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamb RA, 1997, VIROLOGY, V229, P1, DOI 10.1006/viro.1997.8451; Landstein D, 1995, VIROLOGY, V214, P413, DOI 10.1006/viro.1995.0051; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Owen JM, 1999, EXP PHYSIOL, V84, P471, DOI 10.1017/S0958067099018060; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; VANETTEN JL, UNPUB; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yellen G, 1999, CURR OPIN NEUROBIOL, V9, P267, DOI 10.1016/S0959-4388(99)80039-7	26	143	154	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1641	1644		10.1126/science.287.5458.1641	http://dx.doi.org/10.1126/science.287.5458.1641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698737	Green Published			2022-12-01	WOS:000085628200035
J	Lee, SH; Wolf, PL; Escudero, R; Deutsch, R; Jamieson, SW; Thistlethwaite, PA				Lee, SH; Wolf, PL; Escudero, R; Deutsch, R; Jamieson, SW; Thistlethwaite, PA			Early expression of angiogenesis factors in acute myocardial ischemia and infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; PHENOL-CHLOROFORM EXTRACTION; FACTOR MESSENGER-RNA; SINGLE-STEP METHOD; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; O-2 HOMEOSTASIS; FACTOR 1-ALPHA; DNA-BINDING	Background: When the myocardium is deprived of blood, a process of ischemia, infarction, and myocardial remodeling is initiated. Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of vascular endothelial growth factor (VEGF) and is critical for initiating early cellular responses to hypoxia. We investigated the temporal and spatial patterns of expression of the alpha subunit of HIF-1 (HIF-1 alpha) and VEGF in specimens of human heart tissue to elucidate the early molecular responses to myocardial hypoxia. Methods: Ventricular-biopsy specimens from 37 patients undergoing coronary bypass surgery were collected. The specimens were examined by microscopy for evidence of ischemia, evolving infarction, or a normal histologic appearance. The specimens were also analyzed with the reverse-transcriptase polymerase chain reaction for HIF-1 alpha and VEGF messenger RNA (mRNA) expression and by immunohistochemical analysis for the location of the HIF-1 alpha and VEGF proteins. Results: HIF-1 alpha mRNA was detected in myocardial specimens with pathological evidence of acute ischemia (onset, <48 hours before surgery) or early infarction (onset, <24 hours before surgery). In contrast, VEGF transcripts were seen in specimens with evidence of acute ischemia or evolving infarction (onset, 24 to 120 hours before surgery). Patients with normal ventricles or evidence of infarction in the distant past had no detectable levels of either VEGF mRNA or HIF-1 alpha mRNA. HIF-1 alpha immunoreactivity was detected in the nuclei of myocytes and endothelial cells, whereas VEGF immunoreactivity was found in the cytoplasm of endothelial cells lining capillaries and arterioles. Conclusions: An increase in the level of HIF-1 alpha is an early response to myocardial ischemia or infarction. This response defines, at a molecular level, one of the first adaptations of human myocardium to a deprivation of blood. HIF-1 alpha is a useful temporal marker of acutely jeopardized myocardium. (N Engl J Med 2000;342:626-33.) (C)2000, Massachusetts Medical Society.	Univ Calif San Diego, Div Cardiothorac Surg 8892, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; Univ Calif San Diego, Gen Clin Res Ctr, San Diego, CA 92103 USA; Vet Affairs Med Ctr, Dept Pathol, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Thistlethwaite, PA (corresponding author), Univ Calif San Diego, Div Cardiothorac Surg 8892, 200 W Arbor Dr, San Diego, CA 92103 USA.	pthistlethwaite@ucsd.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR 0827] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTRAN RS, 1999, ROBBINS PATHOLOGIC B, P554; Deindl E, 1998, MOL CELL BIOCHEM, V186, P43, DOI 10.1023/A:1006853432678; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hashimoto Etsuo, 1994, American Journal of Physiology, V267, pH1948; Hearse DJ, 1998, MOL CELL BIOCHEM, V186, P177, DOI 10.1023/A:1006808507605; Heusch G, 1998, MOL CELL BIOCHEM, V186, P185, DOI 10.1023/A:1006816725351; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LEVY AP, 1995, CIRC RES, V76, P758, DOI 10.1161/01.RES.76.5.758; Martin C, 1998, AM J OBSTET GYNECOL, V178, P527, DOI 10.1016/S0002-9378(98)70433-8; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Wenger RH, 1997, BIOL CHEM, V378, P609; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; [No title captured]	36	569	635	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 2	2000	342	9					626	633		10.1056/NEJM200003023420904	http://dx.doi.org/10.1056/NEJM200003023420904			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288QV	10699162				2022-12-01	WOS:000085575500004
J	Birk, OS; Casiano, DE; Wassif, CA; Cogliati, T; Zhao, LP; Zhao, YG; Grinberg, A; Huang, SP; Kreidberg, JA; Parker, KL; Porter, FD; Westphal, H				Birk, OS; Casiano, DE; Wassif, CA; Cogliati, T; Zhao, LP; Zhao, YG; Grinberg, A; Huang, SP; Kreidberg, JA; Parker, KL; Porter, FD; Westphal, H			The LIM homeobox gene Lhx9 is essential for mouse gonad formation	NATURE			English	Article							SEXUAL-DIFFERENTIATION; EXPRESSION	During mammalian embryonic development, the ovaries and testes develop from somatic cells of the urogenital ridges as indifferent gonads, harbouring primordial germ cells that have migrated there. After sex determination of the gonads, the testes produce testosterone and anti-Mullerian hormone which mediate male sexual differentiation, and the female developmental pathway ensues in their absence(1-3). Here we show that transcripts of the LIM homeobox gene Lhx9 are present in urogenital ridges of mice at embryonic day 9.5; later they localize to the interstitial region as morphological differentiation occurs. In mice lacking Lhx9 function, germ cells migrate normally, but somatic cells of the genital ridge fail to proliferate and a discrete gonad fails to form. In the absence of testosterone and anti-Mullerian hormone, genetically male mice are phenotypically female. The expression of steroidogenic factor 1 (Sf1), a nuclear receptor essential for gonadogenesis2, is reduced to minimal levels in the Lhx9-deficient genital ridge, indicating that Lhx9 may lie upstream of Sf1 in a developmental cascade. Unlike mice lacking other genes that mediate early stages of gonadogenesis(4-6), Lhx9 mutants do not exhibit additional major developmental defects. Thus, LHX9 mutations may underlie certain forms of isolated gonadal agenesis in humans.	NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; NCI, Dept Genet, Med Branch, NIH, Bethesda, MD 20889 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital	Westphal, H (corresponding author), NICHHD, Lab Mammalian Genes & Dev, NIH, Bethesda, MD 20892 USA.			Birk, Ohad/0000-0003-1430-1296; Wassif, Christopher/0000-0002-2524-1420	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139, ZIAHD000071] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000071, Z01HD000139] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Bertuzzi S, 1999, MECH DEVELOP, V81, P193, DOI 10.1016/S0925-4773(98)00233-0; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; FUJII T, 1994, DEV DYNAM, V199, P73, DOI 10.1002/aja.1001990108; Gilbert S., 1997, DEV BIOL; Goodfellow PN, 1999, CELL MOL LIFE SCI, V55, P857, DOI 10.1007/PL00013201; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; JOST A, 1953, RECENT PROG HORM RES, V8, P379; KAUFMAN MH, 1999, ANATOMICAL BASIS MOU, P117; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Parker KL, 1999, ANNU REV PHYSIOL, V61, P417, DOI 10.1146/annurev.physiol.61.1.417; Porter FD, 1997, DEVELOPMENT, V124, P2935; Retaux S, 1999, J NEUROSCI, V19, P783; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Warne GL, 1998, ENDOCRIN METAB CLIN, V27, P945, DOI 10.1016/S0889-8529(05)70049-9; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	23	254	263	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					909	913		10.1038/35002622	http://dx.doi.org/10.1038/35002622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706291				2022-12-01	WOS:000085559200062
J	Kew, MC				Kew, MC			Serum aminotransferase concentration as evidence of hepatocellular damage	LANCET			English	Editorial Material							ASPARTATE-AMINOTRANSFERASE; LIVER		Univ Witwatersrand, Sch Med, Dept Med, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Kew, MC (corresponding author), Univ Witwatersrand, Sch Med, Dept Med, ZA-2193 Johannesburg, South Africa.							BATZAKIS KG, 1979, INTREPRETIVE ENZYMOL; COHEN GA, 1976, ANN INTERN MED, V84, P275, DOI 10.7326/0003-4819-84-3-275; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; DAVIS GL, 1982, MAYO CLIN PROC, V57, P303; ELLIS G, 1978, AM J CLIN PATHOL, V70, P248; NALPAS B, 1984, HEPATOLOGY, V4, P893, DOI 10.1002/hep.1840040517; PATWARDHAN RV, 1987, ARCH INTERN MED, V147, P1249, DOI 10.1001/archinte.147.7.1249; REJ R, 1978, CLIN CHEM, V24, P1971; SCHMIDT E, 1979, ADV CLIN ENZYMOL, V1, P239; Whitehead MW, 1999, GUT, V45, P129, DOI 10.1136/gut.45.1.129	10	180	202	2	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					591	592		10.1016/S0140-6736(99)00219-6	http://dx.doi.org/10.1016/S0140-6736(99)00219-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696975				2022-12-01	WOS:000085615400005
J	Kroman, N; Jensen, MB; Wohlfahrt, J; Mouridsen, HT; Andersen, PK; Melbye, M				Kroman, N; Jensen, MB; Wohlfahrt, J; Mouridsen, HT; Andersen, PK; Melbye, M			Factors influencing the effect of age on prognosis in breast cancer: population based study	BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL CONSENSUS PANEL; YOUNG-WOMEN; CARCINOMA; SURVIVAL; RISK; CHEMOTHERAPY; RADIOTHERAPY; RECURRENCE; HIGHLIGHTS; CHILDBIRTH	Objective To investigate whether young age at diagnosis is a negative prognostic factor in primary breast cancer and how stage of disease at diagnosis and treatment influences such an association. Design Retrospective cohort study based on a population based database of patients with breast cancer containing detailed information on tumour characteristics, treatment regimens, and survival. Setting Denmark. Subjects 10 356 women with primary breast cancer who were less than 50 years old at diagnosis. Main outcome measures Relative risk of dying within the first 10 years after. diagnosis according to age at diagnosis after adjustment for known prognostic factors and expected mortality. Results Overall, young women with low risk disease who did not receive adjuvant treatment had a significantly increased risk of dying; risk increased with decreasing age at diagnosis (adjusted relative risk: 45-49 years (reference): 1: 40-44 years: 1.12 (95% confidence interval 0.89 to 1.40): 35-39 years: 1.40 (1.10 to 1.78); < 35 years: 2.18 (1.64 to 2.89). However, no similar trend was seen in patients who received adjuvant cytotoxic treatment. The increased risk in younger women who did not receive adjuvant treatment compared with those who did remained when women were grouped according to presence of node negative disease and by tumour size. Conclusion The negative prognostic effect of young age is almost exclusively seen in women diagnosed with low risk disease who did not receive adjuvant cytotoxic treatment. These results suggest that young women with breast cancer on the basis of age alone, should be regarded as high risk patients and be given adjuvant cytotoxic treatment.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Rigshosp, Danish Breast Canc Cooperat Grp, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Dept Biostat, DK-2200 Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Danish Breast Cancer Cooperative Group (DBCG); Rigshospitalet; University of Copenhagen; University of Copenhagen	Melbye, M (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.			melbye, mads/0000-0001-8264-6785				ABE O, 1992, LANCET, V339, P71; ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; AFZELIUS P, 1994, ACTA ONCOL, V33, P345, DOI 10.3109/02841869409098427; ALBAIN KS, 1994, MONOGR NATL CANC I, V16, P35; ANDERSEN KW, 1988, ACTA ONCOL, V27, P627, DOI 10.3109/02841868809091763; ANDERSON BO, 1995, ANN SURG ONCOL, V2, P407, DOI 10.1007/BF02306373; BONNIER P, 1995, INT J CANCER, V62, P138, DOI 10.1002/ijc.2910620205; BOYAGES J, 1990, RADIOTHER ONCOL, V19, P29, DOI 10.1016/0167-8140(90)90163-Q; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; Fisher B, 1997, JNCI-J NATL CANCER I, V89, P1673, DOI 10.1093/jnci/89.22.1673; FOURQUET A, 1989, INT J RADIAT ONCOL, V17, P719, DOI 10.1016/0360-3016(89)90057-6; FOWBLE BL, 1994, INT J RADIAT ONCOL, V30, P23, DOI 10.1016/0360-3016(94)90515-0; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; GOLDHIRSCH A, 1995, J NATL CANCER I, V87, P1441, DOI 10.1093/jnci/87.19.1441; Henderson IC, 1997, LANCET, V349, P1488, DOI 10.1016/S0140-6736(97)22021-0; HOST H, 1986, CANCER-AM CANCER SOC, V57, P2217, DOI 10.1002/1097-0142(19860601)57:11<2217::AID-CNCR2820571124>3.0.CO;2-T; Kollias J, 1997, BRIT J CANCER, V75, P1318, DOI 10.1038/bjc.1997.223; Kroman N, 1997, BRIT MED J, V315, P851, DOI 10.1136/bmj.315.7112.851; Kroman N, 1998, BRIT J CANCER, V78, P1529, DOI 10.1038/bjc.1998.718; LEES AW, 1989, BREAST CANCER RES TR, V13, P143, DOI 10.1007/BF01806526; MAX MH, 1984, AM SURGEON, V50, P23; Melbye M, 1997, NEW ENGL J MED, V336, P81, DOI 10.1056/NEJM199701093360201; *MIN INT, 1994, STAT YB 1994; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Petrek J A, 1994, J Natl Cancer Inst Monogr, P113; REMVIKOS Y, 1995, BREAST CANCER RES TR, V34, P25, DOI 10.1007/BF00666488; SCHMIDT RT, 1991, AM J SURG, V162, P197, DOI 10.1016/0002-9610(91)90068-O; Storm H H, 1991, IARC Sci Publ, P220; VERONESI U, 1990, ANN SURG, V211, P250; Walker RA, 1996, BRIT J CANCER, V74, P1796, DOI 10.1038/bjc.1996.632; Winchester DP, 1996, CANCER-AM CANCER SOC, V78, P1838, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1838::AID-CNCR27>3.0.CO;2-Y	33	258	268	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 19	2000	320	7233					474	478		10.1136/bmj.320.7233.474	http://dx.doi.org/10.1136/bmj.320.7233.474			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KP	10678859	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000085562200021
J	Lyons, RA; Wareham, K; Hutchings, HA; Major, E; Ferguson, B				Lyons, RA; Wareham, K; Hutchings, HA; Major, E; Ferguson, B			Population requirement for adult critical-care beds: a prospective quantitative and qualitative study	LANCET			English	Article								Background The provision of adult critical-care facilities is not based on a rational or scientific assessment of need. We aimed to define the numbers of adult critical-care beds required for a population of 500 000. Methods In five hospitals in Wales, UK, we classified patients who might be suitable for critical care in intensive-care or high-dependency units. On every 12th day for 1 calendar year, we counted the numbers of such patients admitted in a defined geographical population. A panel of ten intensivists made consensus decisions about whether individual patients were in the appropriate unit. The data were used to predict the numbers of beds and units required for the population. Findings 4058 patients were suitable for critical care, of whom 3028 lived in the study area. 56.4% were in general wards, 22.3% in high-dependency units, and 21.3% in intensive-care units. The mean risk of death was 22.0% and the in-hospital death rate 17.3%. According to the masked consensus, 41.3% of patients required high-dependency beds and 21.5% intensive-care beds. Mean risk of death increased from general wards (14.7%) to high-dependency units (19.2%) to intensive care (37.0%). Based on the consensus decisions, the average daily requirement of intensive-care beds was 21 and of high-dependency beds 43; to meet needs 95% of times required 30 and 55 beds, respectively, in a single critical-care unit. Interpretation We estimated, scientifically, numbers of adult critical-care beds required to meet population needs. Studies are necessary periodically to track changes in admissions requiring critical care.	Univ Wales Coll Med, Dept Epidemiol & Publ Hlth, Swansea SA1 1LT, W Glam, Wales; Morriston Hosp, Sch Postgrad Studies Med & Hlth Care, Clin Res Unit, Swansea, W Glam, Wales; Prince Wales Hosp, Bridgend, Wales	Cardiff University; Morriston Hospital; Swansea University	Lyons, RA (corresponding author), Univ Wales Coll Med, Dept Epidemiol & Publ Hlth, Swansea SA1 1LT, W Glam, Wales.		Hutchings, Hayley A/C-9944-2013; Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X; Hutchings, Hayley Anne/0000-0003-4155-1741				Audit Commission, 1999, CRIT SUCC PLAC EFF E; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; METCALF A, 1993, STUDY PROVISION INTE; *NAT HLTH SERV WAL, 1999, CLIN IND NHS 1995 19; Townsend P, 1988, HLTH DEPRIVATION INE; *WORK GROUP GUID A, 1996, DISCH INT CAR HIGH D	7	61	61	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					595	598		10.1016/S0140-6736(00)01265-4	http://dx.doi.org/10.1016/S0140-6736(00)01265-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696978				2022-12-01	WOS:000085615400009
J	Beech, PL; Nheu, T; Schultz, T; Herbert, S; Lithgow, T; Gilson, PR; McFadden, GI				Beech, PL; Nheu, T; Schultz, T; Herbert, S; Lithgow, T; Gilson, PR; McFadden, GI			Mitochondrial FtsZ in a chromophyte alga	SCIENCE			English	Article							BACTERIAL-CELL-DIVISION; ESCHERICHIA-COLI; PROTEIN FTSZ; HOMOLOG; DYNAMICS; FISSION; TUBULIN; FUSION; RING	A homolog of the bacterial cell division gene ftsZ was isolated from the alga Mallomonas splendens. The nuclear-encoded protein (MsFtsZ-mt) was closely related to FtsZs of the alpha-proteobacteria, possessed a mitochondrial targeting signal, and localized in a pattern consistent with a role in mitochondrial division. Although FtsZs are known to act in the division of chloroplasts, MsFtsZ-mt appears to be a mitochondrial FtsZ and may represent a mitochondrial division protein.	Deakin Univ, Sch Biol & Chem Sci, Ctr Cellular & Mol Biol, Melbourne, Vic 3125, Australia; Univ Melbourne, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia; Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	Deakin University; University of Melbourne; University of Melbourne; University of Melbourne	Beech, PL (corresponding author), Deakin Univ, Sch Biol & Chem Sci, Ctr Cellular & Mol Biol, 221 Burwood Highway, Melbourne, Vic 3125, Australia.		Beech, Peter/C-3709-2014; Lithgow, Trevor/H-5925-2017	Beech, Peter/0000-0003-1669-6623; Schultz, Thomas/0000-0001-9694-9920; Lithgow, Trevor/0000-0002-0102-7884				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BEECH PL, 1990, J PHYCOL, V26, P90, DOI 10.1111/j.0022-3646.1990.00090.x; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; GAFFAL KP, 1987, ENDOCYTOBIOSIS CELL, V4, P41; George R, 1998, P NATL ACAD SCI USA, V95, P2296, DOI 10.1073/pnas.95.5.2296; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Margolin W, 1998, TRENDS MICROBIOL, V6, P233, DOI 10.1016/S0966-842X(98)01280-3; MARGOLIN W, 1991, J BACTERIOL, V173, P5822, DOI 10.1128/jb.173.18.5822-5830.1991; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Palmer JD, 1997, SCIENCE, V275, P790, DOI 10.1126/science.275.5301.790; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493	26	135	146	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1276	1279		10.1126/science.287.5456.1276	http://dx.doi.org/10.1126/science.287.5456.1276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678836				2022-12-01	WOS:000085444700053
J	Truog, RD; Burns, JP; Mitchell, C; Johnson, J; Robinson, W				Truog, RD; Burns, JP; Mitchell, C; Johnson, J; Robinson, W			Pharmacologic paralysis and withdrawal of mechanical ventilation at the end of life.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPIRATORY-DISTRESS SYNDROME; CRITICALLY ILL PATIENTS; CLINICAL MANAGEMENT; DYING PATIENTS; STRATEGY; CARE		Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.		Burns, Jeffrey P/AAW-8474-2021					Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; BURNS JP, IN PRESS CRIT CARE M; deLeeuw R, 1996, J PEDIATR-US, V129, P661, DOI 10.1016/S0022-3476(96)70146-4; Domino KB, 1999, ANESTHESIOLOGY, V90, P1053, DOI 10.1097/00000542-199904000-00019; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Field MJ, 1997, APPROACHING DEATH IM; Hatherill M, 1998, BMJ-BRIT MED J, V317, P80, DOI 10.1136/bmj.317.7150.80a; Hoyt J W, 1994, New Horiz, V2, P48; HUNTER JM, 1995, NEW ENGL J MED, V332, P1691, DOI 10.1056/NEJM199506223322507; KIRKLAND L, 1994, J CLIN ETHIC, V5, P38; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LOPER KA, 1989, PAIN, V37, P315, DOI 10.1016/0304-3959(89)90196-6; MEISEL A, 1995, RIGHT DIE; RIDDICK CA, 1994, J CLIN ETHIC, V5, P41; Rushton C H, 1995, Am J Crit Care, V4, P112; SCHNEIDERMAN LJ, 1988, NEW ENGL J MED, V318, P984, DOI 10.1056/NEJM198804143181509; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; SOTTILE FD, 1995, CHEST, V108, P887, DOI 10.1378/chest.108.3.887-a; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; The SUPPORT Principal Investigators, 1995, J AMER MED ASSOC, V274, P1591; TRUOG RD, 1992, NEW ENGL J MED, V327, P1678, DOI 10.1056/NEJM199212033272311; TRUOG RD, 1994, J CLIN ETHIC, V5, P39; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	24	55	56	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2000	342	7					508	511		10.1056/NEJM200002173420712	http://dx.doi.org/10.1056/NEJM200002173420712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284FA	10675435				2022-12-01	WOS:000085319100012
J	Greer, JM; Puetz, J; Thomas, KR; Capecchi, MR				Greer, JM; Puetz, J; Thomas, KR; Capecchi, MR			Maintenance of functional equivalence during paralogous Hox gene evolution	NATURE			English	Article							STEM-CELLS; TARGETED DISRUPTION; MICE; TRANSFORMATIONS; VERTEBRAE; HINDBRAIN; REVEAL; RESCUE; THYMUS	Biological diversity is driven mainly by gene duplication followed by mutation and selection. This divergence in either regulatory or protein-coding sequences can result in quite different biological functions for even closely related genes. This concept is exemplified by the mammalian Hox gene complex, a group of 39 genes which are located on 4 linkage groups, dispersed on 4 chromosomes(1-4). The evolution of this complex bee;an with amplification in cis of a primordial Hox gene to produce 13 members, followed by duplications in tuans of much of the entire unit. As a consequence, Hox genes that occupy the same relative position along the 5' to 3' chromosomal coordinate (trans-paralogous genes) share more similarity in sequence and expression pattern than do adjacent Hox genes on the same chromosome. Studies in mice indicate that although individual family members may have unique biological roles, they also share overlapping functions with their paralogues(5-12). Here we show that the proteins encoded by the paralogous genes, Hoxa3 and Hoxd3, can carry out identical biological functions, and that the different roles attributed to these genes are the result of quantitative modulations in gene expression.	Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu						Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gavalas A, 1998, DEVELOPMENT, V125, P1123; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; HUNT P, 1991, DEVELOPMENT, P63; KAPPEN C, 1989, P NATL ACAD SCI USA, V86, P5459, DOI 10.1073/pnas.86.14.5459; LONAI P, 1987, DNA-J MOLEC CELL BIO, V6, P409, DOI 10.1089/dna.1987.6.409; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ROSSEL M, IN PRESS DEVELOPMENT, V126; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; Studer M, 1998, DEVELOPMENT, V125, P1025; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137	30	208	211	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					661	665		10.1038/35001077	http://dx.doi.org/10.1038/35001077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688203				2022-12-01	WOS:000085288200055
J	Corper, AL; Stratmann, T; Apostolopoulos, V; Scott, CA; Garcia, KC; Kang, AS; Wilson, IA; Teyton, L				Corper, AL; Stratmann, T; Apostolopoulos, V; Scott, CA; Garcia, KC; Kang, AS; Wilson, IA; Teyton, L			A structural framework for deciphering the link between I-A(g7) and autoimmune diabetes	SCIENCE			English	Article							BIOZZI AB/H MICE; A BETA-CHAIN; CRYSTAL-STRUCTURE; PEPTIDE; PROTEIN; COMPLEX; MELLITUS; MOLECULES; EPITOPE; DRA-ASTERISK-0101	Susceptibility to murine and human insulin-dependent diabetes mellitus correlates strongly with major histocompatibility complex (MHC) class II I-A or HLA-DQ alleles that lack an aspartic acid at position beta 57. I-A(g7) lacks this aspartate and is the only class II allele expressed by the nonobese diabetic mouse. The crystal structure of I-A(g7) was determined at 2.6 angstrom resolution as a complex with a high-affinity peptide from the autoantigen glutamic acid decarboxylase (CAD) 65. I-A(g7) has a substantially wider peptide-binding groove around beta 57, which accounts for distinct peptide preferences compared with other MHC class II alleles. Loss of Asp(beta 57) Leads to an oxyanion hole in I-A(g7) that can be filled by peptide carboxyl residues or, perhaps, through interaction with the T cell receptor.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; lteyton@scripps.edu	Apostolopoulos, Vasso/Q-4525-2019	Kang, Angray/0000-0002-4672-4114; Apostolopoulos, Vasso/0000-0001-6788-2771; Stratmann, Thomas/0000-0001-6196-1487	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055037] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIDDK NIH HHS [DK55037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; AMOR S, 1993, J IMMUNOL, V150, P5666; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartnes K, 1997, INT IMMUNOL, V9, P1185, DOI 10.1093/intimm/9.8.1185; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrasco-Marin E, 1999, P NATL ACAD SCI USA, V96, P8621, DOI 10.1073/pnas.96.15.8621; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; CORPER A, UNPUB; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Harrison LC, 1997, J EXP MED, V185, P1013, DOI 10.1084/jem.185.6.1013; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HURTENBACH U, 1993, J EXP MED, V177, P1499, DOI 10.1084/jem.177.5.1499; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU GY, 1993, IMMUNOGENETICS, V37, P296, DOI 10.1007/BF00187458; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; NALEFSKI EA, 1995, J BIOL CHEM, V270, P22351, DOI 10.1074/jbc.270.38.22351; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUARTEYPAPAFIO R, 1995, J IMMUNOL, V154, P5567; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Read RJ, 1997, METHOD ENZYMOL, V277, P110, DOI 10.1016/S0076-6879(97)77009-5; REICH EP, 1994, J IMMUNOL, V152, P2279; Reizis B, 1997, INT IMMUNOL, V9, P43, DOI 10.1093/intimm/9.1.43; Ridgway WM, 1999, CURR OPIN IMMUNOL, V11, P638, DOI 10.1016/S0952-7915(99)00030-8; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SINGER SM, 1993, P NATL ACAD SCI USA, V90, P9566, DOI 10.1073/pnas.90.20.9566; SMILEK DE, 1990, IMMUNOL REV, V118, P37, DOI 10.1111/j.1600-065X.1990.tb00813.x; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; STIFFEL C, 1987, IMMUNOL LETT, V16, P205, DOI 10.1016/0165-2478(87)90149-0; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	47	221	233	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					505	511		10.1126/science.288.5465.505	http://dx.doi.org/10.1126/science.288.5465.505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775108				2022-12-01	WOS:000086626000043
J	Morrison, RS; Wallenstein, S; Natale, DK; Senzel, RS; Huang, LL				Morrison, RS; Wallenstein, S; Natale, DK; Senzel, RS; Huang, LL			"We don't carry that" - Failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; CANCER PAIN; SURGERY; MANAGEMENT; MEDICATION; ATTITUDES; RELIEF	Background: We have observed that many black and Hispanic patients receiving palliative care at a major urban teaching hospital are unable to obtain prescribed opioids from their neighborhood pharmacies. In this study, we investigated the availability of commonly prescribed opioids in New York City pharmacies. Methods: We surveyed a randomly selected sample of 30 percent of New York City pharmacies to obtain information about their stock of opioids. For each pharmacy, U.S. Census estimates for 1997 were used to determine the racial and ethnic composition of the neighborhood (defined as the area within a 0.4-km [0.25-mile] radius of the pharmacy) and the proportion of residents who were more than 65 years old. Data on robberies, burglaries, and arrests involving illicit drugs in 1997 were obtained for the precinct in which each pharmacy was located. We used a generalized linear model to examine the relation between the racial or ethnic composition of neighborhoods and the opioid supplies of pharmacies, while controlling for the proportion of elderly persons at the census-block level and for crime rates at the precinct level. Results: Pharmacists representing 347 of 431 eligible pharmacies (81 percent) responded to the survey. A total of 176 pharmacies (51 percent) did not have sufficient supplies of opioids to treat patients with severe pain. Only 25 percent of pharmacies in predominantly nonwhite neighborhoods (those in which less than 40 percent of residents were white) had opioid supplies that were sufficient to treat patients in severe pain, as compared with 72 percent of pharmacies in predominantly white neighborhoods (those in which at least 80 percent of residents were white) (P<0.001). Conclusions: Pharmacies in predominantly nonwhite neighborhoods of New York City do not stock sufficient medications to treat patients with severe pain adequately. (N Engl J Med 2000;342:1023-6.) (C) 2000, Massachusetts Medical Society.	Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, New York, NY USA; Mt Sinai Sch Med, Dept Biomath Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Morrison, RS (corresponding author), CUNY Mt Sinai Sch Med, Dept Geriatr, Box 1070,1 Gustave L Levy Pl, New York, NY 10029 USA.			Natale, Dana/0000-0003-4976-0310	NIA NIH HHS [K08AG00833-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG000833] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Breitbart W, 1996, PAIN, V68, P315, DOI 10.1016/S0304-3959(96)03215-0; Cleeland CS, 1997, ANN INTERN MED, V127, P813, DOI 10.7326/0003-4819-127-9-199711010-00006; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; CLOSS SJ, 1990, J ADV NURS, V15, P42, DOI 10.1111/j.1365-2648.1990.tb01671.x; COHEN FL, 1980, PAIN, V9, P265, DOI 10.1016/0304-3959(80)90013-5; FAHERTY BS, 1984, NURS RES, V33, P369, DOI 10.1097/00006199-198411000-00013; JACOX A, 1994, CLIN PRACTICE GUIDEL, V9, P257; KANNER RM, 1986, J PAIN SYMPTOM MANAG, V1, P187; KELSEN DP, 1995, J CLIN ONCOL, V13, P748, DOI 10.1200/JCO.1995.13.3.748; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; Lynch EP, 1997, ANESTH ANALG, V85, P117, DOI 10.1097/00000539-199707000-00021; MCDONALD DD, 1994, RES NURS HEALTH, V17, P45, DOI 10.1002/nur.4770170107; *MED EC, 1998, PHYS DESK REF; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; MORRISON RS, IN PRESS J PAIN SYMP; *NYNEX INF RES, 1998, NYNEX YELL PAG; OATES JDL, 1994, ANAESTHESIA, V49, P755; Tay W. K. J., 1994, Annals Academy of Medicine Singapore, V23, P191; The SUPPORT Principal Investigators, 1995, J AMER MED ASSOC, V274, P1591; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; TWYCROSS RG, 1982, PAIN, V14, P303, DOI 10.1016/0304-3959(82)90137-3; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; ZENZ M, 1995, J PAIN SYMPTOM MANAG, V10, P187, DOI 10.1016/0885-3924(94)00122-2	25	281	283	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2000	342	14					1023	1026		10.1056/NEJM200004063421406	http://dx.doi.org/10.1056/NEJM200004063421406			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300JB	10749965				2022-12-01	WOS:000086248900006
J	Joranson, DE; Ryan, KM; Gilson, AM; Dahl, JL				Joranson, DE; Ryan, KM; Gilson, AM; Dahl, JL			Trends in medical use and abuse of opioid analgesics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAIN MANAGEMENT; ADDICTION; BARRIERS; SYSTEM	Context Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. Objective To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. Design and Setting Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data)and the Automation of Reports and Consolidated Orders System (source of medical use data). Patients Nationally representative sample of hospital emergency department admissions resulting from drug abuse. Main Outcome Measures Medical use in grams and grams per 100 000 population and mentions of drug abuse by number and percentage of the population. Results From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41 371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118 455 to 141 325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32 430 to 34 563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). Conclusions The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.	Univ Wisconsin, Sch Med, Pain & Policy Studies Grp, Ctr Comprehens Canc, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Joranson, DE (corresponding author), Univ Wisconsin, Sch Med, Pain & Policy Studies Grp, Ctr Comprehens Canc, 1900 Univ Ave, Madison, WI 53705 USA.							*AC PAIN MAN GUID, 1992, CLIN PRACT GUID; ADAMS EH, 1991, NEW YORK STATE J MED, V91, pS32; *ALC DRUG AB MENT, 1990, DAT DRUG AB WARN NET; *AM AC PAIN MED AM, 1997, US OP TREATM CHRON P; Doyle D, 1993, OXFORD TXB PALLIATIV; *DRUG ENF ADM, 1997, ARCOS DAT SEL OP AN; *DRUG ENF ADM, 1984, ARCOS DADS STATE LOC; Federation of State Medical Boards of the United States, 1998, MOD GUID US CONTR SU; Field MJ, 1997, APPROACHING DEATH IM; HILL CS, 1993, SEMIN ONCOL, V20, P1; Jacox A, 1994, CLIN PRACTICE GUIDEL; Joranson D E, 1998, Semin Oncol Nurs, V14, P158, DOI 10.1016/S0749-2081(98)80022-3; JORANSON DE, 1993, MONOGRAPH NATL I DRU, V131, P18; KAIKO RF, 1983, ANN NEUROL, V13, P180, DOI 10.1002/ana.410130213; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lebovits AH, 1997, CLIN J PAIN, V13, P237, DOI 10.1097/00002508-199709000-00009; Litovitz TL, 1998, AM J EMERG MED, V16, P443, DOI 10.1016/S0735-6757(98)90000-6; MCCAFFERY M, 1995, AM J NURS, V95, P61; *OFF INSP GEN US D, 1991, AUD REP DRUG ENF ADM; Paice JA, 1998, J PAIN SYMPTOM MANAG, V16, P1, DOI 10.1016/S0885-3924(98)00025-6; *SUBST AB MENT HLT, 1996, DAT DRUG AB WARN NET; *SUBST AB MENT HLT, 1997, NATL HOUSEHOLD SURVE; *UN, 1977, SINGL CONV NARC DRUG; Ward SE, 1996, RES NURS HEALTH, V19, P205, DOI 10.1002/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O; WEISSMAN DE, 1993, SEMIN ONCOL, V20, P53; World Health Organization, 1986, CANC PAIN REL; World Health Organization, 1996, CANC PAIN REL GUID O, V2nd	27	354	370	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2000	283	13					1710	1714		10.1001/jama.283.13.1710	http://dx.doi.org/10.1001/jama.283.13.1710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298BK	10755497				2022-12-01	WOS:000086119300031
J	Thomas, DD; Donnelly, CA; Wood, RJ; Alphey, LS				Thomas, DD; Donnelly, CA; Wood, RJ; Alphey, LS			Insect population control using a dominant, repressible, lethal genetic system	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; EXPRESSION	A major modification to the sterile insect technique is described, in which transgenic insects homozygous for a dominant, repressible, female-specific lethal gene system are used. We demonstrate two methods that give the required genetic characteristics in an otherwise wild-type genetic background. The first system uses a sex-specific promoter or enhancer to drive the expression of a repressible transcription factor, which in turn controls the expression of a toxic gene product. The second system uses non-sex-specific expression of the repressible transcription factor to regulate a selectively Lethal gene product. Both methods work efficiently in Drosophila melanogaster, and we expect these principles to be widely applicable to more economically important organisms.	Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3PS, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Oxford; University of Manchester	Alphey, LS (corresponding author), Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, S Parks Rd, Oxford OX1 3PS, England.			Donnelly, Christl/0000-0002-0195-2463; Alphey, Luke/0000-0002-2916-3802				Bello B, 1998, DEVELOPMENT, V125, P2193; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FOSTER GG, 1988, THEOR APPL GENET, V76, P870, DOI 10.1007/BF00273675; Gebauer F, 1998, RNA, V4, P142; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; LIDDELL S, 1991, MOL GEN GENET, V230, P219, DOI 10.1007/BF00290671; Matsuo T, 1997, DEVELOPMENT, V124, P2671; ROBINSON A, IN PRESS TRENDS ENTO; ROGERS DJ, 1984, INSECT SCI APPL, V5, P419, DOI 10.1017/S1742758400008766; RONALDSON E, 1995, GENET RES, V66, P9, DOI 10.1017/S0016672300034340; SEAWRIGHT JA, 1978, SCIENCE, V200, P1303, DOI 10.1126/science.663614; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; THOMAS D, UNPUB	18	406	448	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2474	2476		10.1126/science.287.5462.2474	http://dx.doi.org/10.1126/science.287.5462.2474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741964				2022-12-01	WOS:000086202200041
J	Spurgeon, P; Barwell, F; Kerr, D				Spurgeon, P; Barwell, F; Kerr, D			Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England; Univ Birmingham, Sch Med, CRC, Inst Canc Studies, Birmingham B15 2TJ, W Midlands, England	University of Birmingham; University of Birmingham	Spurgeon, P (corresponding author), Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Pk House, Birmingham B15 2RT, W Midlands, England.							Berrino F, 1999, IARC SCI PUBLICATION, V151; Coleman MP., 1999, CANC SURVIVAL TRENDS; National Cancer Institute, 1998, SEER STAT CANC INC P	3	53	53	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					838	839		10.1136/bmj.320.7238.838	http://dx.doi.org/10.1136/bmj.320.7238.838			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731176	Bronze			2022-12-01	WOS:000086180300024
J	Thum, T; Borlak, J				Thum, T; Borlak, J			Gene expression in distinct regions of the heart	LANCET			English	Article							CONVERTING ENZYME-INHIBITORS; CYTOCHROME-P450; ACID; LIVER	Background Cytochrome P450 mono-oxygenases bring about metabolism of marry drugs, including verapamil, but no information is available on the metabolism of such drugs in the human heart. Methods We investigated the gene expression of major human cytochrome P450 monooxygenases in the various regions of explanted hearts from six patients with dilated cardiomyopathy and one with transposition of the arterial trunk. For comparison we also studied samples of liver and lung from three patients and two samples of normal heart. The biological significance of tissue-specific cytochrome monooxygenase gene expression was further investigated by study of the microsomal metabolism of verapamil in ventricular tissue. Findings mRNA for the cytochromes 1A1, 2B6/7, 2C8-19, 2D6, and 4B1 was predominantly expressed in the right ventricle, the unilateral expression of the 2D6 gene in right-venticular tissue is important because of its key role in the metabolism of beta-blockers. A strong correlation between tissue-specific gene expression and enzyme activity was found; microsomal metabolism of verapamil was confined to the right ventricle. By contrast, cytochrome P450 3A genes (which are the major drug-metabolising enzymes in the liver and the lung) were not expressed in any of the human heart tissues, and mRNA transcripts for epoxide hydrolase, cytochrome P450 2E1, and flavin-containing monooxygenases 2 and 5 were detected in all regions of the human heart and the great vessels. Interpretation These findings show that expression of genes for cytochrome P450 monooxygenases and verapamil metabolism are found predominantly in the right side of the heart. This finding may explain lack of efficacy of certain cardioselective drugs.	Fraunhofer Inst Toxicol & Aerosol Res, Dept Mol Toxicol & Pharmacokinet, D-30659 Hannover, Germany	Fraunhofer Gesellschaft	Borlak, J (corresponding author), Fraunhofer Inst Toxicol & Aerosol Res, Dept Mol Toxicol & Pharmacokinet, Nicolal Fuchs Str 1, D-30659 Hannover, Germany.			Thum, Thomas/0000-0003-4360-1511				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARISTIZABAL D, 1994, AM J CARDIOL, V73, P483, DOI 10.1016/0002-9149(94)90679-3; BORLAK JT, 1994, BIOCHEM PHARMACOL, V48, P1717, DOI 10.1016/0006-2952(94)90456-1; Cheng YF, 1998, J CHROMATOGR A, V828, P273, DOI 10.1016/S0021-9673(98)00823-1; Clarke SE, 1998, XENOBIOTICA, V28, P1167, DOI 10.1080/004982598238877; HAKKOLA J, 1994, BIOCHEM PHARMACOL, V48, P59, DOI 10.1016/0006-2952(94)90223-2; JURIMAROMET M, 1993, BIOCHEM PHARMACOL, V46, P2163, DOI 10.1016/0006-2952(93)90605-V; Kivisto KT, 1996, N-S ARCH PHARMACOL, V353, P207; MCCALLUM GP, 1993, CAN J PHYSIOL PHARM, V71, P151, DOI 10.1139/y93-021; Oldham HG, 1997, DRUG METAB DISPOS, V25, P970; PRICE T, 1992, J CLIN ENDOCR METAB, V74, P879, DOI 10.1210/jc.74.4.879; RAUNIO H, 1995, ADV DRUG METABOLISM, P233; Smith DA, 1998, XENOBIOTICA, V28, P1095, DOI 10.1080/004982598238859; Smith G, 1998, XENOBIOTICA, V28, P1129, DOI 10.1080/004982598238868; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEARNS RA, 1995, DRUG METAB DISPOS, V23, P207; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; Wu S, 1996, J BIOL CHEM, V271, P3460; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; ZIERHUT W, 1990, J CARDIOVASC PHARM, V16, P480, DOI 10.1097/00005344-199009000-00019	20	158	166	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2000	355	9208					979	983		10.1016/S0140-6736(00)99016-0	http://dx.doi.org/10.1016/S0140-6736(00)99016-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768437				2022-12-01	WOS:000086054000013
J	Szabo, SJ; Kim, ST; Costa, GL; Zhang, XK; Fathman, CG; Glimcher, LH				Szabo, SJ; Kim, ST; Costa, GL; Zhang, XK; Fathman, CG; Glimcher, LH			A novel transcription factor, T-bet, directs Th1 lineage commitment	CELL			English	Article							INTERFERON-GAMMA PROMOTER; CYTOKINE GENE-EXPRESSION; HELPER CELL SUBSETS; NATURAL-KILLER; IFN-GAMMA; IMMUNE-RESPONSES; TRANSGENIC MICE; FACTOR GATA-3; DNA-BINDING; T-HELPER-1	Naive T helper cells differentiate into two subsets, Th1 and Th2, each with distinct functions and cytokine profiles. Here, we report the isolation of T-bet, a Th1-specific T box transcription factor that controls the expression of the hallmark Th1 cytokine, IFN gamma. T-bet expression correlates with IFN gamma expression in Th1 and NK cells. Ectopic expression of T-bet both transactivates the IFN gamma gene and induces endogenous IFN gamma production. Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFN gamma and repression of IL-4 and IL-5. Thus, T-bet initiates Th1 lineage development from naive Thp cells both by activating Th1 genetic programs and by repressing the opposing Th2 programs.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Stanford University; Medical University of South Carolina	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI036535, P01AI037833, P01AI039646] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/AG 37833, AI 39646, AI 36535] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; BROMBACHER F, 1994, INT IMMUNOL, V6, P189, DOI 10.1093/intimm/6.2.189; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Coccia EM, 1999, J BIOL CHEM, V274, P6698, DOI 10.1074/jbc.274.10.6698; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang H, 1997, J IMMUNOL, V159, P3731; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KORNBLUTH J, 1982, J IMMUNOL, V129, P2831; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEDERER JA, 1994, J IMMUNOL, V152, P77; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nakamura T, 1997, J IMMUNOL, V158, P1085; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.immunol.12.1.635; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TONY Y, 1995, CURR BIOL, V5, P1; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yasui DH, 1998, J IMMUNOL, V160, P4433; YODOI J, 1985, J IMMUNOL, V134, P1623; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	64	2598	2831	1	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					655	669		10.1016/S0092-8674(00)80702-3	http://dx.doi.org/10.1016/S0092-8674(00)80702-3			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761931	Bronze			2022-12-01	WOS:000085983800008
J	Trachtenberg, JT; Trepel, C; Stryker, MP				Trachtenberg, JT; Trepel, C; Stryker, MP			Rapid extragranular plasticity in the absence of thalamocortical plasticity in the developing primary visual cortex	SCIENCE			English	Article							MONOCULAR DEPRIVATION; HORIZONTAL CONNECTIONS; OCULAR DOMINANCE; CORTICAL PLASTICITY; BRIEF PERIODS; KITTENS; MAPS; CATS	Monocular deprivation during early postnatal development remodels the circuitry of the primary visual cortex so that most neurons respond poorly to stimuli presented to the deprived eye. This rapid physiological change is ultimately accompanied by a matching anatomical loss of input from the deprived eye. This remodeling is thought to be initiated at the thalamocortical synapse. Ocular dominance plasticity after brief (24 hours) monocular deprivation was analyzed by intrinsic signal optical imaging and by targeted extracellular unit recordings. Deprived-eye responsiveness was lost in the extragranular Layers, whereas normal binocularity in layer IV was preserved. This finding supports the hypothesis that thalamocortical organization is guided by earlier changes at higher stages.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [U10EY006824, R37EY002874] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY002874, R37 EY002874-21, F32 EY006824, R37-EY02874, EY06824] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; MALONEK D, 1990, 20 ANN M SOC NEUR ST; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MITCHELL DE, 1991, PHILOS T R SOC B, V333, P51, DOI 10.1098/rstb.1991.0060; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; REITER H, 1986, P NATL ACAD SCI USA, V85, P3623; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Stryker Michael P., 1999, Journal of Physiology (Cambridge), V515P, p25S	23	182	193	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2029	2032		10.1126/science.287.5460.2029	http://dx.doi.org/10.1126/science.287.5460.2029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720332	Green Accepted			2022-12-01	WOS:000085902800066
J	Ostermann, A; Waschipky, R; Parak, FG; Nienhaus, GU				Ostermann, A; Waschipky, R; Parak, FG; Nienhaus, GU			Ligand binding and conformational motions in myoglobin	NATURE			English	Article							SPERM WHALE MYOGLOBIN; CARBONMONOXY-MYOGLOBIN; MOLECULAR-DYNAMICS; HEME-PROTEINS; MONOXIDE; CRYSTALLOGRAPHY; SPECTROSCOPY; TRANSITION; SCATTERING; PHOTOLYSIS	Myoglobin, a small globular haem protein that binds gaseous ligands such as O-2, CO and NO reversibly at the haem iron, serves as a model for studying structural and dynamic aspects of protein reactions. Time-resolved spectroscopic measurements after photodissociation of the ligand revealed a complex ligand-binding reaction with multiple kinetic intermediates, resulting from protein relaxation and movements of the ligand within the protein(1-3). To observe the structural changes induced by ligand dissociation, we have carried out X-ray crystallographic investigations of carbon monoxy-myoglobin (MbCO mutant L29W) crystals illuminated below and above 180 K, complemented by time-resolved infrared spectroscopy of CO rebinding. Here we show that below 180 K photodissociated ligands migrate to specific sites within an internal cavity-the distal haem pocket-of an essentially immobilized, frozen protein, from where they subsequently rebind by thermally activated barrier crossing. Upon photodissociation above 180 K. Ligands escape from the distal pocket, aided by protein fluctuations that transiently open exit channels. We recover most of the ligands in a cavity on the opposite side of the haem group.	Univ Ulm, Dept Biophys, D-89069 Ulm, Germany; Tech Univ Munich, Fak Phys E17, D-85747 Garching, Germany; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ulm University; Technical University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Nienhaus, GU (corresponding author), Univ Ulm, Dept Biophys, D-89069 Ulm, Germany.		Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Ostermann, Andreas/0000-0002-1477-5590				ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, X PLOR VERSION 3 1; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Hartmann H, 1996, P NATL ACAD SCI USA, V93, P7013, DOI 10.1073/pnas.93.14.7013; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; Nienhaus G. U., 1996, ENCY APPL PHYSICS, V15, P163; NIENHAUS GU, 1989, NATURE, V338, P665, DOI 10.1038/338665a0; NIENHAUS GU, 1992, P NATL ACAD SCI USA, V89, P2902, DOI 10.1073/pnas.89.7.2902; NIENHAUS GU, 1994, BIOCHEMISTRY-US, V33, P13413, DOI 10.1021/bi00249a030; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PARAK F, 1982, J MOL BIOL, V161, P177, DOI 10.1016/0022-2836(82)90285-6; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vitkup D, 1997, NAT STRUCT BIOL, V4, P202, DOI 10.1038/nsb0397-202	31	359	361	2	54	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					205	208		10.1038/35004622	http://dx.doi.org/10.1038/35004622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724176				2022-12-01	WOS:000085870900057
J	Diaz, PT; King, MA; Pacht, ER; Wewers, MD; Gadek, JE; Nagaraja, HN; Drake, J; Clanton, TL				Diaz, PT; King, MA; Pacht, ER; Wewers, MD; Gadek, JE; Nagaraja, HN; Drake, J; Clanton, TL			Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers	ANNALS OF INTERNAL MEDICINE			English	Article							CELLS; VIRUS; LUNG; PNEUMONITIS; EXPRESSION; INFECTION; DISEASE	Background: Previous uncontrolled reports have suggested that HIV-seropositive persons develop an accelerated form of emphysema. Objective: To characterize the risk for emphysema in a stable HIV-seropositive outpatient population. Design: Controlled, cross-sectional analysis. Setting: Midwestern urban community. Participants: HIV-seropositive persons (n = 114)without AIDS-related pulmonary complications and HIV-seronegative controls (n = 44), matched for age and smoking history. Measurements: Measurement of pulmonary function, bronchoalveolar lavage, and high-resolution computed tomography of the chest. Results: The incidence of emphysema was 15 % (17 of 114) in the HIV-seropositive group compared with 2 % (1 of 44) in the HIV-seronegative group (P = 0.025). The incidence of emphysema in participants with a smoking history of 12 pack-years or greater was 37% (14 of 38 persons) in the HIV-seropositive group compared with 0% (0 of 14 persons) in the HIV-seronegative group (P = 0.011). The percentage of cytotoxic lymphocytes in lavage fluid was much higher in HIV-seropositive smokers with emphysema. Conclusions: infection with HIV accelerates the onset of smoking-induced emphysema. The results of this study support the emerging concept that cytotoxic lymphocytes may have an important role in emphysema pathogenesis.	Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Diaz, PT (corresponding author), Pulm & Crit Care Med, N 325 Means Hall,1654 Upham Dr, Columbus, OH 43210 USA.		Clanton, Thomas/AAS-9422-2020; Wewers, Mark/AAB-6202-2021	Clanton, Thomas/0000-0003-0600-7150; 	NCRR NIH HHS [2MO1-RR0034] Funding Source: Medline; NHLBI NIH HHS [R01-HL49730, R01-HL53229] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053229, R01HL049730] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agostini C, 1998, LUNG BIOL HEALTH DIS, V119, P127; BLOT F, 1991, REV MAL RESPIR, V8, P121; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; *CYT SOFTW CORP, 1995, STAT XACT 3; Dhawan S, 1997, BLOOD, V90, P1535; DIAZ PT, 1992, ANN INTERN MED, V116, P124, DOI 10.7326/0003-4819-116-2-124; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Guillemi SA, 1996, EUR RESPIR J, V9, P33, DOI 10.1183/09031936.96.09010033; Hogg J C, 1995, Semin Respir Infect, V10, P244; Keicho N, 1997, AM J RESP CELL MOL, V16, P23, DOI 10.1165/ajrcmb.16.1.8998075; Keicho N, 1997, AM J PHYSIOL-LUNG C, V272, pL1046, DOI 10.1152/ajplung.1997.272.6.L1046; KUHLMAN JE, 1989, RADIOLOGY, V173, P23, DOI 10.1148/radiology.173.1.2781013; LAMB D, 1996, SPENCERS PATHOLOGY L, P597; OGNIBENE FP, 1988, ANN INTERN MED, V109, P874, DOI 10.7326/0003-4819-109-11-874; Pacht ER, 1997, AM J RESP CRIT CARE, V155, P374, DOI 10.1164/ajrccm.155.1.9001339; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAS, 1995, JMP VERS 3; SEMENZATO G, 1991, EUR RESPIR J, V4, P94; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615	20	227	231	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2000	132	5					369	372		10.7326/0003-4819-132-5-200003070-00006	http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KY	10691587				2022-12-01	WOS:000085563000005
J	Myers, N; Mittermeier, RA; Mittermeier, CG; da Fonseca, GAB; Kent, J				Myers, N; Mittermeier, RA; Mittermeier, CG; da Fonseca, GAB; Kent, J			Biodiversity hotspots for conservation priorities	NATURE			English	Article							EXTINCTION; DIVERSITY; RICHNESS; FOREST; BIRDS; AREAS	Consenrationists are far from able to assist all species under threat, if only for lack of funding. This places a premium on priorities: how can we support the most species at the least cost? One way is to identify 'biodiversity hotspots' where exceptional concentrations of endemic species are undergoing exceptional loss of habitat. As many as 44% of all species of vascular plants and 35% of all species in four vertebrate groups are confined to 25 hotspots comprising only 1.4% of the land surface of the Earth. This opens the way for a 'silver bullet' strategy on the part of conservation planners, focusing on these hotspots in proportion to their share of the world's species at risk.	Univ Oxford Green Coll, Oxford OX3 8SZ, England; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20037 USA	University of Oxford; Conservation International	Myers, N (corresponding author), Univ Oxford Green Coll, Upper Meadow,Old Rd, Oxford OX3 8SZ, England.	myersln@aol.com	burke, daniel/D-3668-2009; campbell, Ian G/F-6006-2011					Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Cowlishaw G, 1999, CONSERV BIOL, V13, P1183, DOI 10.1046/j.1523-1739.1999.98433.x; Davis S.D., 1994, CTR PLANT DIVERSITY; DINERSTEIN E, 1996, GLOBAL 200 KEY ECORE; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; EHRLICH PR, 1994, PHILOS T R SOC B, V344, P99, DOI 10.1098/rstb.1994.0057; Eschmeyer W.N., 1998, CATALOG FISHES; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; GASTON KJ, 1995, P ROY SOC B-BIOL SCI, V259, P119, DOI 10.1098/rspb.1995.0018; Ginsberg J, 1999, CONSERV BIOL, V13, P5, DOI 10.1046/j.1523-1739.1999.013001005.x; Glaw Frank, 1998, Herpetological Review, V29, P11; Groombridge B, 1992, GLOBAL BIODIVERSITY; Heywood V. H., 1995, GLOBAL BIODIVERSITY; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Laurance WF, 1999, BIOL CONSERV, V91, P101, DOI 10.1016/S0006-3207(99)00087-7; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.2307/1796430; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 1998, NATURE, V392, P327, DOI 10.1038/32761; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Myers N, 1996, BIODIVERS CONSERV, V5, P1025, DOI 10.1007/BF00052713; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Nowak R.M., 1999, MAMMALS WORLD; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; PRANCE GT, IN PRESS TROPICAL FL; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Price P. W., 1997, INSECT ECOLOGY; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Sibley CG, 1990, DISTRIBUTION TAXONOM; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Strong D.R., 1984, INSECTS PLANTS COMMU; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Uetz P., 1996, HERPETOL REV, V27, P175; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; WILLIAMS P H, 1991, Australian Systematic Botany, V4, P665, DOI 10.1071/SB9910665; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; WILSON E O, 1992	48	17211	19053	196	563	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					853	858		10.1038/35002501	http://dx.doi.org/10.1038/35002501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706275				2022-12-01	WOS:000085559200046
J	Takasaki, T; Hatakeyama, K; Suzuki, G; Watanabe, M; Isogai, A; Hinata, K				Takasaki, T; Hatakeyama, K; Suzuki, G; Watanabe, M; Isogai, A; Hinata, K			The S receptor kinase determines self-incompatibility in Brassica stigma	NATURE			English	Article							CAMPESTRIS L; MOLECULAR-CLONING; LOCUS GENES; RAPA L; OLERACEA; TRANSFORMATION; ALLELES; GLYCOPROTEINS; EXPRESSION; SEQUENCE	The self-incompatibility possessed by Brassica is an intraspecific reproductive barrier by which the stigma rejects self-pollen but accepts non-self-pollen for fertilization. The molecular/biochemical bases of recognition and rejection have been intensively studied. Self-incompatibility in Brassica is sporophytically controlled by the polymorphic S locus(1). Two tightly linked polymorphic genes at the S locus, S receptor kinase gene (SRK) and S locus glycoprotein gene (SLG), are specifically expressed in the papillar cells of the stigma(2-4), and analyses of self-compatible lines(5-7) of Brassica have suggested that together they control stigma function in self-incompatibility interactions. Here we show, by transforming self-incompatible plants of Brassica rapa with an SRK28 and an SLG(28) transgene separately, that expression of SRK28 alone, but not SLG(28) alone, conferred the ability to reject self (S-28)-pollen on the transgenic plants. We also show that the ability of SRK28 to reject S-28 pollen was enhanced by SLG(28). We conclude that SRK alone determines S haplotype specificity of the stigma, and that SLG acts to promote a full manifestation of the self-incompatibility response.	Seed Prod Co Ltd, Res Inst, Aoba Ku, Sendai, Miyagi 9893204, Japan; Kobe Univ, Fac Agr, Nada Ku, Kobe, Hyogo 6578501, Japan; Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Kobe University; Osaka University of Education; Iwate University; Nara Institute of Science & Technology	Takasaki, T (corresponding author), Seed Prod Co Ltd, Res Inst, Aoba Ku, 6-6-3 Minamiyoshinari, Sendai, Miyagi 9893204, Japan.		Watanabe, Masao/E-6300-2011; Watanabe, Masao/N-1465-2019; Isogai, Akira/O-8897-2017	Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149; Isogai, Akira/0000-0001-8095-0441				Bateman AJ, 1955, HEREDITY, V9, P52, DOI DOI 10.1038/HDY.1955.2; BRACE J, 1993, SEX PLANT REPROD, V6, P133, DOI 10.1007/BF00227658; Conner JA, 1997, PLANT J, V11, P809, DOI 10.1046/j.1365-313X.1997.11040809.x; GORING DR, 1992, PLANT CELL, V4, P1273, DOI 10.1105/tpc.4.10.1273; GORING DR, 1993, PLANT CELL, V5, P531, DOI 10.1105/tpc.5.5.531; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Hatakeyama K, 1998, GENETICS, V149, P1587; HINATA K, 1993, INT REV CYTOL, V143, P257; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KHO YO, 1968, EUPHYTICA, V17, P298; KISHINISHIZAWA N, 1990, PLANT CELL PHYSIOL, V31, P1207; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; NASRALLAH JB, 1994, PLANT J, V5, P373, DOI 10.1111/j.1365-313X.1994.00373.x; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; NASRALLAH ME, 1992, PLANT J, V2, P497, DOI 10.1111/j.1365-313X.1992.00497.x; Nishio T, 1996, THEOR APPL GENET, V92, P388, DOI 10.1007/BF00223684; Nishio T, 1997, THEOR APPL GENET, V95, P335, DOI 10.1007/s001220050568; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; SHIBA H, 1995, P JPN ACAD B-PHYS, V71, P81, DOI 10.2183/pjab.71.81; Stahl RJ, 1998, PLANT CELL, V10, P209, DOI 10.1105/tpc.10.2.209; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Suzuki G, 1996, PLANT CELL PHYSIOL, V37, P866, DOI 10.1093/oxfordjournals.pcp.a029024; SUZUKI G, 1995, PLANT CELL PHYSIOL, V36, P1273; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 1997, BREEDING SCI, V47, P127; Takasaki T, 1999, PLANT MOL BIOL, V40, P659, DOI 10.1023/A:1006274525421; TAKAYAMA S, 1987, NATURE, V326, P102, DOI 10.1038/326102a0; WATANABE M, 1994, PLANT CELL PHYSIOL, V35, P1221, DOI 10.1093/oxfordjournals.pcp.a078716	30	372	446	6	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					913	916		10.1038/35002628	http://dx.doi.org/10.1038/35002628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706292				2022-12-01	WOS:000085559200063
J	Walter, P; Keenan, R; Schmitz, U				Walter, P; Keenan, R; Schmitz, U			Structural biology - SRP - Where the RNA and membrane worlds meet	SCIENCE			English	Editorial Material							SIGNAL RECOGNITION PARTICLE; SEQUENCE; SUBUNIT		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Maxygen, Redwood City, CA 94063 USA; Genelab Technol, Redwood City, CA 94063 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Keenan, Robert/0000-0003-1466-0889				Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BUTLER S, 1904, NOT SAD STYGIAN SHOR; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Khvorova A, 1999, P NATL ACAD SCI USA, V96, P10649, DOI 10.1073/pnas.96.19.10649; PORITZ MA, 1988, CELL, V55, P4, DOI 10.1016/0092-8674(88)90003-7; Royer WE, 1996, P NATL ACAD SCI USA, V93, P14526, DOI 10.1073/pnas.93.25.14526; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schmitz U, 1999, NAT STRUCT BIOL, V6, P634, DOI 10.1038/10683; Schmitz U, 1999, RNA, V5, P1419, DOI 10.1017/S1355838299991458	12	24	25	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1212	1213		10.1126/science.287.5456.1212	http://dx.doi.org/10.1126/science.287.5456.1212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10712156				2022-12-01	WOS:000085444700033
J	Burrows, A				Burrows, A			Supernova explosions in the Universe	NATURE			English	Review							GAMMA-RAY BURST; 28 FEBRUARY 1997; NEUTRINO BURST; ELECTRON-CAPTURE; CORE-COLLAPSE; IA SUPERNOVAE; BLACK-HOLES; ERROR BOX; LOW-MASS; STARS	During the lifetime of our Milky Way galaxy, there have been something like 100 million supernova explosions, which have enriched the Galaxy with the oxygen we breathe, the iron in our cars, the calcium in our bones and the silicon in the rocks beneath our feet. These exploding stars also influence the birth of new stars and are the source of the energetic cosmic rays that irradiate us on the Earth. The prodigious amount of energy (similar to 10(51), Or similar to 2.5 x 10(28) megatonnes of TNT equivalent) and momentum associated with each supernova may even have helped to shape galaxies as they formed in the early Universe. Supernovae are now being used to measure the geometry of the Universe, and have recently been implicated in the decades-old mystery of the origin of the gamma-ray bursts. Together with major conceptual advances in our theoretical understanding of supernovae, these developments have made supernovae the centre of attention in astrophysics.	Univ Arizona, Dept Astron, Tucson, AZ 85721 USA	University of Arizona	Burrows, A (corresponding author), Univ Arizona, Dept Astron, Tucson, AZ 85721 USA.	aburrows@as.arizona.edu						Aguirre AN, 1999, ASTROPHYS J, V512, pL19, DOI 10.1086/311862; ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Aschenbach B, 1998, NATURE, V396, P141, DOI 10.1038/24103; Ashworth W. B.  Jr., 1980, Journal for the History of Astronomy, V11, P1; BARI C, 1988, NUCL INSTRUM METH A, V264, P5, DOI 10.1016/0168-9002(88)91094-7; BELLOTTI E, 1988, NUCL INSTRUM METH A, V264, P1, DOI 10.1016/0168-9002(88)91093-5; BETHE HA, 1979, NUCL PHYS A, V324, P487, DOI 10.1016/0375-9474(79)90596-7; BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; Bloom JS, 1999, NATURE, V401, P453, DOI 10.1038/46744; BROWN GE, 1994, ASTROPHYS J, V423, P659, DOI 10.1086/173844; Brown GE, 1996, ASTROPHYS J, V463, P297, DOI 10.1086/177241; BRUENN SW, 1985, ASTROPHYS J SUPPL S, V58, P771, DOI 10.1086/191056; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; BURROWS A, 1993, ASTROPHYS J, V416, pL75, DOI 10.1086/187074; BURROWS A, 1988, ASTROPHYS J, V334, P891, DOI 10.1086/166885; BURROWS A, 1982, ASTROPHYS J, V259, P330, DOI 10.1086/160169; BURROWS A, 1995, ASTROPHYS J, V450, P830, DOI 10.1086/176188; BURROWS A, 1986, ASTROPHYS J, V307, P178, DOI 10.1086/164405; BURROWS A, 1988, PHYS REP, V163, P51, DOI 10.1016/0370-1573(88)90035-X; Chaboyer B, 1996, SCIENCE, V271, P957, DOI 10.1126/science.271.5251.957; Chaboyer B, 1998, ASTROPHYS J, V494, P96, DOI 10.1086/305201; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; COLGATE SA, 1960, PHYS REV LETT, V5, P235, DOI 10.1103/PhysRevLett.5.235; CORDES JM, 1993, NATURE, V362, P133, DOI 10.1038/362133a0; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; Cowan JJ, 1999, ASTROPHYS J, V521, P194, DOI 10.1086/307512; EWAN GT, 1987, SNO8712; Fryer C, 1998, ASTROPHYS J, V496, P333, DOI 10.1086/305348; FRYER C, 1999, CORE COLLAPSE SIMULA; FRYXELL B, 1991, ASTROPHYS J, V367, P619, DOI 10.1086/169657; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; GIBSON BK, 1999, HST KEY PROJECT EXTR; Hamuy M, 1996, ASTRON J, V112, P2408, DOI 10.1086/118192; HERANT M, 1994, ASTROPHYS J, V435, P339, DOI 10.1086/174817; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; *IC COLL, 1994, 94991 LNGS GRANS LAB; Iyudin AF, 1998, NATURE, V396, P142, DOI 10.1038/24106; Janka HT, 1996, ASTRON ASTROPHYS, V306, P167; KENNICUTT RC, 1995, ASTRON J, V110, P1476, DOI 10.1086/117621; KOSHIBA M, 1992, PHYS REP, V220, P229, DOI 10.1016/0370-1573(92)90083-C; LYNE AG, 1994, NATURE, V369, P127, DOI 10.1038/369127a0; MacFadyen AI, 1999, ASTROPHYS J, V524, P262, DOI 10.1086/307790; Madau P, 1998, MON NOT R ASTRON SOC, V297, pL17, DOI 10.1046/j.1365-8711.1998.01697.x; MAYLE R, 1988, ASTROPHYS J, V334, P909, DOI 10.1086/166886; McNamara BJ, 1998, NATURE, V396, P233, DOI 10.1038/24317; Messer OEB, 1998, ASTROPHYS J, V507, P353, DOI 10.1086/306323; METZGER MR, 1997, NATURE, V387, P879; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; NOMOTO K, 1988, PHYS REP, V163, P13, DOI 10.1016/0370-1573(88)90032-4; OSTRIKER JP, 1971, ASTROPHYS J, V164, pL95, DOI 10.1086/180699; PACZYNSKI B, 1999, GAMMARAY BURST SUPER; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; PHILLIPS MM, 1993, ASTROPHYS J, V413, pL105, DOI 10.1086/186970; PIRO L, 1997, JOINT EUR NAT ASTR M, P284; Reichart DE, 1999, ASTROPHYS J, V521, pL111, DOI 10.1086/312203; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RIESS AG, 1999, INDICATION EVOLUTION; SAKAI S, 1999, HUBBLE SPACE TELESCO; Schmidt BP, 1998, ASTROPHYS J, V507, P46, DOI 10.1086/306308; Sollerman J, 1998, ASTROPHYS J, V493, P933, DOI 10.1086/305163; Suntzeff NB, 1999, ASTRON J, V117, P1175, DOI 10.1086/300771; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Totani T, 1998, ASTROPHYS J, V496, P216, DOI 10.1086/305364; TUELLER J, 1990, ASTROPHYS J, V351, pL41, DOI 10.1086/185675; Turatto M, 1998, ASTROPHYS J, V498, pL129, DOI 10.1086/311324; Turner MS, 1999, REV MOD PHYS, V71, pS145, DOI 10.1103/RevModPhys.71.S145; Umeda H, 1999, ASTROPHYS J, V522, pL43, DOI 10.1086/312213; vanParadijs J, 1997, NATURE, V386, P686, DOI 10.1038/386686a0; Wang LF, 1997, ASTROPHYS J, V476, pL27, DOI 10.1086/310495; WHEELER JC, 1999, ASYMMETRIC SUPERNOVA; Wilson J.R., 1985, NUMERICAL ASTROPHYSI, P422; WOODEN DH, 1993, ASTROPHYS J SUPPL S, V88, P477, DOI 10.1086/191830; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1992, ASTROPHYS J, V395, P202, DOI 10.1086/171644; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Woosley SE, 1999, ASTROPHYS J, V516, P788, DOI 10.1086/307131; Zlatev I, 1999, PHYS REV LETT, V82, P896, DOI 10.1103/PhysRevLett.82.896	78	146	146	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					727	733		10.1038/35001501	http://dx.doi.org/10.1038/35001501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693794				2022-12-01	WOS:000085423100041
J	Prakash, B; Praefcke, GJK; Renault, L; Wittinghofer, A; Herrmann, C				Prakash, B; Praefcke, GJK; Renault, L; Wittinghofer, A; Herrmann, C			Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins	NATURE			English	Article							INTERFERON; GTPASES; PROGRAM; MOTIF; RAS; GMP	Interferon-gamma is an immunomodulatory substance that induces the expression of many genes to orchestrate a cellular response and establish the antiviral state of the cell. Among the most abundant antiviral proteins induced by interferon-gamma are guanylate-binding proteins such as GBP1 and GBP2 (refs 1, 2). These are large GTP-binding proteins of relative molecular mass 67,000 with a high-turnover GTPase activity(3) and an antiviral effect(4). Here we have determined the crystal structure of full-length human GBP1 to 1.8 Angstrom resolution. The amino-terminal 278 residues constitute a modified G domain with a number of insertions compared to the canonical pas structure, and the carboxy-terminal part is an extended helical domain with unique features. From the structure and biochemical experiments reported here, GBP1 appears to belong to the group of large GTP-binding proteins that includes Mx and dynamin, the common property of which is the ability to undergo oligomerization with a high concentration-dependent GTPase activity(5).	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; christian.herrmann@mpi-dortmund.mpg.de	BS, Prakash/D-2337-2010	Praefcke, Gerrit/0000-0001-8818-1499				Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehm U, 1998, J IMMUNOL, V161, P6715; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Praefcke GJK, 1999, J MOL BIOL, V292, P321, DOI 10.1006/jmbi.1999.3062; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; WEIJLAND A, 1993, SCIENCE, V259, P1311, DOI 10.1126/science.8446899	30	251	257	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2000	403	6769					567	571		10.1038/35000617	http://dx.doi.org/10.1038/35000617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676968				2022-12-01	WOS:000085227300056
J	Hasle, H; Clemmensen, IH; Mikkelsen, M				Hasle, H; Clemmensen, IH; Mikkelsen, M			Risks of leukaemia and solid tumours in individuals with Down's syndrome	LANCET			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; CANCER INCIDENCE; CHILDREN; GENE; MALFORMATIONS; DISORDER; WOMEN	Background Individuals with Down's syndrome have a greater risk for leukaemia than the general population, but reliable estimates of the age-specific risk are lacking and little is known about the risk of solid tumours. Methods We identified 2814 individuals with Down's syndrome from the Danish Cytogenetic Register, and linked the data to the Danish Cancer Registry. The number of person-years at risk was 48 453. Standardised incidence ratio (SIR) and 95% CI were calculated of the basis of cancer rates specific for age and sex in the general population. Findings 60 cases of cancer were found, with 49.8 expected (SIR 1.20 [95% CI 0.92-1.55]). Leukaemia constituted 60% of cases of malignant disease overall and 97% of cases in children. The SIR for leukaemia varied with age, being 56 (38-81) at age 0-4 years and 10 (4-20) at 5-29 years. No cases of leukaemia were seen after the age of 29 years. The SIR for acute myeloid leukaemia was 3.8 (1.7-8.4) times higher than that for acute lymphoblastic leukaemia in children aged 0-4 years. The cumulative risk for leukaemia by the age of 5 years was 2.1% and that by 30 years was 2.7%. Only 24 solid tumours were seen, with 47.8 expected (0.50 [0.32-0.75]). No cases of breast cancer were found, with 7.3 expected (p=0.0007). Higher than expected numbers of testicular cancers, ovarian cancers, and retinoblastomas were seen but were not significant. Intrepretation The occurrence of cancer in Down's syndrome is unique with a high risk of leukaemia in children and a decreased risk of solid tumours in all age-groups. The distinctive pattern of malignant diseases may provide clues in the search for leukaemogenic genes and tumour-suppressor genes on chromosome 21.	Aarhus Univ Hosp Skejby, Dept Paediat, DK-8200 Aarhus N, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; John F Kennedy Inst, DK-2600 Glostrup, Denmark	Aarhus University; Danish Cancer Society	Hasle, H (corresponding author), Aarhus Univ Hosp Skejby, Dept Paediat, DK-8200 Aarhus N, Denmark.			Hasle, Henrik/0000-0003-3976-9231				AVETLOISEAU H, 1995, J PEDIAT HEMATOL ONC, V17, P19, DOI 10.1097/00043426-199502000-00003; BAIN B, 1991, LEUKEMIA LYMPHOMA, V3, P309, DOI 10.3109/10428199109070274; BALARAJAN R, 1982, J EPIDEMIOL COMMUN H, V36, P127, DOI 10.1136/jech.36.2.127; BENTLEY D, 1975, PEDIATRICS, V56, P131; BRAVARD A, 1992, INT J CANCER, V51, P476, DOI 10.1002/ijc.2910510323; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Chik KW, 1999, J PEDIAT HEMATOL ONC, V21, P149, DOI 10.1097/00043426-199903000-00012; DelaTorre R, 1996, EXPERIENTIA, V52, P871; FABIA J, 1970, PEDIATRICS, V45, P60; FESTER A, 1986, CANCER GENET CYTOGEN, V20, P109; FONG C, 1987, CANCER GENET CYTOGEN, V28, P55, DOI 10.1016/0165-4608(87)90354-2; GERICKE GS, 1977, S AFR MED J, V51, P369; Hasle H, 1996, BRIT J CANCER, V73, P1156, DOI 10.1038/bjc.1996.222; HASLE H, 1995, BRIT J CANCER, V71, P416, DOI 10.1038/bjc.1995.85; HASLE H, 1995, LEUKEMIA, V9, P1569; HAYASHI Y, 1988, BLOOD, V72, P15; Ho CY, 1996, BLOOD, V87, P5218, DOI 10.1182/blood.V87.12.5218.bloodjournal87125218; ISELIUS L, 1990, HUM GENET, V85, P477; Ives JH, 1998, GENE CHROMOSOME CANC, V23, P61, DOI 10.1002/(SICI)1098-2264(199809)23:1<61::AID-GCC9>3.3.CO;2-F; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; KRIVIT W, 1957, AMA J DIS CHILD, V94, P289, DOI 10.1001/archpedi.1957.04030040075012; NAROD SA, 1991, BRIT J CANCER, V63, P993, DOI 10.1038/bjc.1991.216; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; OLSON JM, 1995, MED PEDIATR ONCOL, V24, P305, DOI 10.1002/mpo.2950240507; OSTER J, 1975, ACTA PAEDIATR SCAND, V64, P322, DOI 10.1111/j.1651-2227.1975.tb03842.x; ROBISON LL, 1984, J PEDIATR-US, V105, P235, DOI 10.1016/S0022-3476(84)80119-5; Sakata K, 1997, GENE CHROMOSOME CANC, V18, P318, DOI 10.1002/(SICI)1098-2264(199704)18:4<318::AID-GCC12>3.3.CO;2-#; SALO MK, 1979, SCAND J CLIN LAB INV, V39, P485, DOI 10.3109/00365517909106135; SARGE D, 1996, PATHOL RES PRACT, V192, P1266; Satge D, 1998, CANCER RES, V58, P448; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M; Satge D, 1997, CANCER, V80, P929; SCHOLL T, 1982, DEV MED CHILD NEUROL, V24, P817; Schupf N, 1997, J INTELL DISABIL RES, V41, P264, DOI 10.1111/j.1365-2788.1997.tb00706.x; SHEN JJ, 1995, AM J HUM GENET, V56, P915; SIMON JH, 1987, CANCER-AM CANCER SOC, V60, P2515, DOI 10.1002/1097-0142(19871115)60:10<2515::AID-CNCR2820601028>3.0.CO;2-F; SLORDAHL SH, 1993, MED PEDIATR ONCOL, V21, P254, DOI 10.1002/mpo.2950210404; STORM HH, 1997, DAN MED B, V44, P549; WINDHAM GC, 1985, AM J EPIDEMIOL, V121, P49, DOI 10.1093/oxfordjournals.aje.a113982; ZIPURSKY A, 1994, LEUKEMIA RES, V18, P163, DOI 10.1016/0145-2126(94)90111-2; ZIPURSKY A, 1992, PEDIATR HEMAT ONCOL, V9, P139, DOI 10.3109/08880019209018329	41	545	559	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 15	2000	355	9199					165	169		10.1016/S0140-6736(99)05264-2	http://dx.doi.org/10.1016/S0140-6736(99)05264-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276LR	10675114				2022-12-01	WOS:000084879700008
J	Peterson, S; Sanga, A; Eklof, H; Bunga, B; Taube, A; Gebre-Medhin, M; Rosling, H				Peterson, S; Sanga, A; Eklof, H; Bunga, B; Taube, A; Gebre-Medhin, M; Rosling, H			Classification of thyroid size by palpation and ultrasonography in field surveys	LANCET			English	Article							VOLUME; ULTRASOUND; IODINE	Background Goitre surveys are used to assess the degree of iodine deficiency in a population. The change of goitre classification made by WHO in 1994 implied that a smaller thyroid size should be regarded as goitre. Furthermore, the acceptable goitre prevalence was lowered from 10% to 5%, and ultrasonography was recommended as a more precise method for diagnosis of goitre. We studied the effects of the change of palpation system, and compared the precision of the old and new systems ultrasonographic examination. Methods We studied 225 schoolchildren (aged 7-14 years) in a highland village in Tanzania. The size of the thyroid was assessed in duplicate by ultrasonography and by WHO's 1960 and 1994 palpation systems. The latter were done by three examiners. Variations within and between examination methods and examiners were assessed. and measurement errors by ultrasonography were assessed from duplicate examinations. The sensitivity and specificity of the two palpation systems were calculated, with diagnosis by ultrasonography as the gold standard. Apparent palpation prevalences were calculated at a "true" 5% prevalence. Findings The lowered criterion for goitre resulted in an extra 20-33% of children being diagnosed as having goitre by palpation. The variation between repeat examinations was only slightly smaller by ultrasonography (kappa=0.63) than by experienced examiners (kappa=0.57-0.58). The variation between thyroid volume estimation by ultrasonography and the true volume was about 50% due to both measurement error and variation in the shape of thyroid lobes. The new goitre criterion decreased specificity from 76% to 29%, whereas sensitivity rose from 56% to 80%. In contrast, a suggested sharpening of the old criterion increased specificity to 90%. Interpretation A return to the old (1960) palpation criterion for goitre: "lobes larger than the terminal phalanxes of thumbs" and to an accepted palpation goitre prevalence of 10% can allow affordable monitoring of thyroid size through palpation in field surveys.	Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth, SE-17176 Stockholm, Sweden; Tanzania Food & Nutr Ctr, Dar Es Salaam, Tanzania; Univ Uppsala, Dept Womens & Childrens Hlth, S-75105 Uppsala, Sweden; Univ Uppsala, Dept Radiol, S-75105 Uppsala, Sweden; Univ Uppsala, Dept Stat, S-75105 Uppsala, Sweden	Karolinska Institutet; Uppsala University; Uppsala University; Uppsala University	Rosling, H (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth, SE-17176 Stockholm, Sweden.			Peterson, Stefan/0000-0001-7203-3096				AGHINILOMBARDI F, 1995, THYROID S1, V5, pS36; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; CHANOINE JP, 1991, EUR J PEDIATR, V150, P395, DOI 10.1007/BF02093716; Delange F, 1997, EUR J ENDOCRINOL, V136, P180, DOI 10.1530/eje.0.1360180; Delange F, 1999, EUR J ENDOCRINOL, V140, P486, DOI 10.1530/eje.0.1400486; Delange F, 1997, B WORLD HEALTH ORGAN, V75, P95; Delange F, 1986, PAHO WHO SCI PUBLICA, P373; Demaeyer EM, 1979, CONTROL ENDEMIC GOIT; Foo LC, 1999, EUR J ENDOCRINOL, V140, P491, DOI 10.1530/eje.0.1400491; GUTEKUNST R, 1986, ACTA ENDOCRINOL-COP, V112, P494, DOI 10.1530/acta.0.1120494; GUTEKUNST R, 1993, IODINE DEFICIENCY EU; HETZEL BS, 1988, ACC SCN STATE ART SE; MACLENNAN R, 1974, ENDEMIC GOITER CRETI, P195; MACLENNAN R, 1969, ENDEMIC GOITER, P67; Nordmeyer JP, 1997, EXP CLIN ENDOCR DIAB, V105, P366, DOI 10.1055/s-0029-1211781; Perez C, 1960, ENDEMIC GOITRE, P369; PETERSON S, 1999, HLTH POLICY PLANN, V14, P400; QUERIDO A, 1974, Pan American Health Organization Scientific Publication, V292, P267; Taube A., 1995, Archives d'Anatomie et de Cytologie Pathologiques, V43, P227; TAUBE A, 1990, ACTA ONCOL, V29, P1; Tonglet Rene, 1994, Food and Nutrition Bulletin, V15, P64; 1993, METHODS MEASURING IO; VITTI P, 1994, J CLIN ENDOCR METAB, V79, P600, DOI 10.1210/jc.79.2.600; WHO/UNICEF/ICCIDD, 1994, IND ASS IOD DEF DIS; World Health Organization, 1997, WHO GLOB DAT CHILD G	25	55	60	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 8	2000	355	9198					106	110		10.1016/S0140-6736(99)07221-9	http://dx.doi.org/10.1016/S0140-6736(99)07221-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288HT	10675168				2022-12-01	WOS:000085557200012
J	Bishop, KM; Goudreau, G; O'Leary, DDM				Bishop, KM; Goudreau, G; O'Leary, DDM			Regulation of area identity in the mammalian neocortex by Emx2 and Pax6	SCIENCE			English	Article							EMBRYONIC CEREBRAL-CORTEX; DROSOPHILA EMBRYO; VISUAL-CORTEX; CORTICAL-NEURONS; MOUSE; EXPRESSION; GENE; MICE; DIFFERENTIATION; PROJECTIONS	The contribution of extrinsic and genetic mechanisms in determining areas of the mammalian neocortex has been a contested issue. This study analyzes the roles of the regulatory genes Emx2 and Pax6, which are expressed in opposing gradients in the neocortical ventricular zone, in specifying areas. Changes in the patterning of molecular markers and area-specific connections between the colter and thalamus suggest that arealization of the neocortex is disproportionately altered in Emx2 and Pax6 mutant mice in opposing manners predicted from their countergradients of expression: rostral areas expand and caudal areas contract in Emx2 mutants, whereas the opposite effect is seen in Pax6 mutants. These findings suggest that Emx2 and Pax6 cooperate to regulate arealization of the neocortex and to confer area identity to cortical cells.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Salk Institute; Max Planck Society	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031558, R37NS031558] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31558] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1988, J COMP NEUROL, V275, P346, DOI 10.1002/cne.902750304; BISHOP KM, UNPUB; CHENN A, 1997, MOL CELLULAR APPROAC, P440; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Livy DJ, 1997, HIPPOCAMPUS, V7, P2, DOI 10.1002/(SICI)1098-1063(1997)7:1<2::AID-HIPO2>3.0.CO;2-R; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; SCHLAGGAR BL, 1993, DEV BRAIN RES, V75, P19, DOI 10.1016/0165-3806(93)90061-E; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Theil T, 1999, DEVELOPMENT, V126, P3561; Tuttle R, 1999, DEVELOPMENT, V126, P1903; TUTTLE R, 1999, J COMP NEUROL, V408, P147; WALTHER C, 1991, DEVELOPMENT, V113, P1435	40	440	445	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					344	349		10.1126/science.288.5464.344	http://dx.doi.org/10.1126/science.288.5464.344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764649				2022-12-01	WOS:000086454300040
J	Davis, BM; Lawson, EH; Sandkvist, M; Ali, A; Sozhamannan, S; Waldor, MK				Davis, BM; Lawson, EH; Sandkvist, M; Ali, A; Sozhamannan, S; Waldor, MK			Convergence of the secretory pathways for cholera toxin and the filamentous phage, CTX phi	SCIENCE			English	Article							PROTEIN SECRETION; VIBRIO-CHOLERAE; MEMBRANE; GENES	Virulence of Vibrio cholerae depends on secretion of cholera toxin (CT), which is encoded within the genome of a filamentous phage, CTX phi. Release of CT is mediated by the extracellular protein secretion (eps) type II secretion system. Here. the outer membrane component of this system, EpsD, was shown to be required for secretion of the phage as well. Thus, EpsD plays a role both in pathogenicity and in horizontal transfer of a key virulence gene. Genomic analysis suggests that additional filamentous phages also exploit chromosome-encoded outer membrane channels.	Tufts Univ, Sch Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA; Amer Red Cross, Holland Lab, Dept Biochem, Rockville, MD 20855 USA; Univ Maryland, Sch Med, Dept Med, Div Hosp Epidemiol, Baltimore, MD 21201 USA	Tufts University; American Red Cross; University System of Maryland; University of Maryland Baltimore	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA.		Sozhamannan, Shanmuga/AGF-2410-2022; Sozhamannan, Shanmuga/AAN-7809-2020	Sozhamannan, Shanmuga/0000-0002-6762-7874	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347, R01AI042347] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-42347] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997; DAVIS BD, UNPUB; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; HASE CC, 1991, J BACTERIOL, V173, P3311; JUDSON M, UNPUB; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KOONIN EV, 1992, FEBS LETT, V312, P3, DOI 10.1016/0014-5793(92)81398-6; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x; Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Pugsley AP, 1998, CELL MOL LIFE SCI, V54, P347, DOI 10.1007/s000180050162; RUSSEL M, 1995, TRENDS MICROBIOL, V3, P223, DOI 10.1016/S0966-842X(00)88929-5; RUSSEL M, 1993, J MOL BIOL, V231, P689, DOI 10.1006/jmbi.1993.1320; Russel M, 1998, J MOL BIOL, V279, P485, DOI 10.1006/jmbi.1998.1791; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	22	86	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					333	335		10.1126/science.288.5464.333	http://dx.doi.org/10.1126/science.288.5464.333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764646				2022-12-01	WOS:000086454300037
J	Brook, BW; O'Grady, JJ; Chapman, AP; Burgman, MA; Akcakaya, HR; Frankham, R				Brook, BW; O'Grady, JJ; Chapman, AP; Burgman, MA; Akcakaya, HR; Frankham, R			Predictive accuracy of population viability analysis in conservation biology	NATURE			English	Article							MODELS; VALIDATION; ECOLOGY; RISK	Population viability analysis (PVA) is widely applied in conservation biology to predict extinction risks for threatened species and to compare alternative options for their mangement(1-4). It can also be used as a basis for listing species as endangered under World Conservation Union criteria(5), However, there is considerable scepticism regarding the predictive accuracy of PVA, mainly because of a lack of validation in real systems(2,6-8). Here we conducted a retrospective test of PVA based on 21 long-term ecological studies-the first comprehensive and replicated evaluation of the predictive powers of PVA. Parameters were estimated from the first half of each data set and the second half was used to evaluate the performance of the model. Contrary to recent criticisms, we found that PVA predictions were surprisingly accurate. The risk of population decline closely matched observed outcomes, there was no significant bias, and population size projections did not differ significantly from reality. Furthermore, the predictions of the five PVA software packages were highly concordant. We conclude that PVA is a valid and sufficiently accurate tool for categorizing and managing endangered species.	Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; Appl Biomath, Setauket, NY 11733 USA; Macquarie Univ, Dept Biol Sci, Key Ctr Biodivers & Bioresources, N Ryde, NSW 2109, Australia	University of Melbourne; Macquarie University	Brook, BW (corresponding author), No Terr Univ, Key Ctr Trop Wildlife Management, Darwin, NT 0909, Australia.		Brook, Barry W./G-2686-2011; Akcakaya, H. Resit/A-7830-2008	Brook, Barry W./0000-0002-2491-1517; Akcakaya, H. Resit/0000-0002-8679-5929				Aku║akaya H.R., 1999, APPL POPULATION ECOL; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; BELOVSKY GE, 1994, OECOLOGIA, V100, P475, DOI 10.1007/BF00317870; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 1999, ANIM CONSERV, V2, P23, DOI 10.1111/j.1469-1795.1999.tb00045.x; Brook BW, 1997, BIOL CONSERV, V82, P119, DOI 10.1016/S0006-3207(97)00026-8; Burgman MA, 1993, RISK ASSESSMENT CONS; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Ginzburg LR, 1982, RISK ANAL, V2, P171, DOI 10.1111/j.1539-6924.1982.tb01379.x; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GROEEM MJ, 1998, CONSERV BIOL, P4; HUGGARD DJ, 1994, OECOLOGIA, V100, P470, DOI 10.1007/BF00317869; International Union for the Conservation of Nature, 1994, IUCN RED LIST CAT; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.2307/176998; Mills LS, 1996, CONSERV BIOL, V10, P863, DOI 10.1046/j.1523-1739.1996.10030863.x; NORTON TW, 1995, BIOL CONSERV, V73, P91, DOI 10.1016/0006-3207(95)90027-6; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; POSSINGHAM HP, 1993, PAC CONSEV BIOL, V1, P38; Ralls Katherine, 1997, P228; Ramanathan R., 1995, INTRO ECONOMETRICS; REYNOLDS MR, 1981, FOREST SCI, V27, P349; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Soule ME, 1989, RES PRIORITIES CONSE; TAYLOR BL, 1995, CONSERV BIOL, V9, P551, DOI 10.1046/j.1523-1739.1995.09030551.x; Wahlberg N, 1996, SCIENCE, V273, P1536, DOI 10.1126/science.273.5281.1536; WIGLEY TML, 1995, NATURE, V376, P463, DOI 10.1038/376463a0; ZECKHAUSER RJ, 1990, SCIENCE, V248, P559, DOI 10.1126/science.2333509	28	393	432	1	234	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					385	387		10.1038/35006050	http://dx.doi.org/10.1038/35006050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746724				2022-12-01	WOS:000086119000049
J	Richmond, BG; Strait, DS				Richmond, BG; Strait, DS			Evidence that humans evolved from a knuckle-walking ancestor	NATURE			English	Article							HOMINID; QUADRUPEDALISM; MORPHOLOGY; HOMINOIDS; PLIOCENE; ETHIOPIA; RADIUS; ORIGIN; KENYA; HAND	Bipedalism has traditionally been regarded as the fundamental adaptation that sets hominids apart from other primates. Fossil I evidence demonstrates that by 4.1 million years ago(1), and perhaps earlier(2), hominids exhibited adaptations to bipedal walking. At present, however, the fossil record offers little information about the origin of bipedalism, and despite nearly a century of research on existing fossils and comparative anatomy, there is still no consensus concerning the mode of locomotion that preceded bipedalism(3-10). Here we present evidence that fossils attributed to Australopithecus anamensis (KNM-ER 20419)(11) and A. afarensis (AL 288-1)(12) retain specialized wrist morphology associated with knuckle-walking. This distal radial morphology differs from that of later hominids and non-knuckle-walking anthropoid primates, suggesting that knuckle-walking is a derived feature of the African ape and human clads. This removes key morphological evidence for a Pan-Gorilla clade, and suggests that bipedal hominids evolved from a knuckle-walking ancestor that was already partly terrestrial.	George Washington Univ, Dept Anthropol, Washington, DC 20052 USA	George Washington University	Richmond, BG (corresponding author), George Washington Univ, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.	brich@gwu.edu						ANDREWS P, 1987, J HUM EVOL, V16, P101, DOI 10.1016/0047-2484(87)90062-5; BEGUN DR, 1992, SCIENCE, V257, P1929, DOI 10.1126/science.1411507; BEGUN DR, 1993, SCIENCE, V259, P294; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; FLEAGLE JG, 1981, S ZOOLOGICAL SOC LON, V48, P359; Gebo DL, 1996, AM J PHYS ANTHROPOL, V101, P55, DOI 10.1002/(SICI)1096-8644(199609)101:1<55::AID-AJPA5>3.0.CO;2-C; GRINE FE, 1991, AM J PHYS ANTHROPOL, V84, P229, DOI 10.1002/ajpa.1330840302; HEINRICH RE, 1993, AM J PHYS ANTHROPOL, V92, P139, DOI 10.1002/ajpa.1330920203; HEWES GW, 1961, AM ANTHROPOL, V63, P687, DOI 10.1525/aa.1961.63.4.02a00020; Hunt KD, 1996, S AFR J SCI, V92, P77; Jenkins F.A. Jr., 1975, P213; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; Keith A, 1923, BMJ-BRIT MED J, V1923, P669, DOI 10.1136/bmj.1.3251.669; Keith A, 1923, BRIT MED J, V1923, P624; Keith A, 1923, BRIT MED J, V1923, P587; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; MARZKE MW, 1971, AM J PHYS ANTHROPOL, V34, P61, DOI 10.1002/ajpa.1330340106; Napier J. R., 1959, Fossil Mammals of Africa, V16, P1; Richmond BG, 1998, THESIS STATE U NEW Y; Rose M.D., 1991, P37; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SCHMITT D, 1994, J HUM EVOL, V26, P441, DOI 10.1006/jhev.1994.1027; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P565, DOI 10.1002/ajpa.1330500408; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P215, DOI 10.1002/ajpa.1330500211; TUTTLE R, 1974, CURR ANTHROPOL, V15, P389, DOI 10.1086/201494; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; TUTTLE RH, 1969, J MORPHOL, V128, P309, DOI 10.1002/jmor.1051280304; Washburn SL, 1967, P ROYAL ANTHR I GREA, V3, P21; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0	35	178	181	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					382	385		10.1038/35006045	http://dx.doi.org/10.1038/35006045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298BG	10746723				2022-12-01	WOS:000086119000048
J	Faber-Langendoen, K; Karlawish, JHT				Faber-Langendoen, K; Karlawish, JHT		Univ Pennsylvania	Should assisted suicide be only physician assisted?	ANNALS OF INTERNAL MEDICINE			English	Article							ATTITUDES; EUTHANASIA; DEATH; ONCOLOGISTS; RELIGION; CANCER	Discussions in the media, courts, legislatures, and professional societies generally assume assistance with suicide to be a-physician's task; in these venues it is commonly referred to as "physician-assisted suicide." This paper defines both the necessity and the limits of the physician's role in assisted suicide by asking the question: Should assisted suicide be only physician assisted? Although physician involvement is necessary, we argue that it is not sufficient to ensure that patients requesting assisted suicide receive the best care. Assisted suicide requires physician involvement, but physicians' limited competence in performing the full range of tasks, the competencies of other professions, and the possibility that other professions could expand their authority in this area suggest that physician-assisted suicide is a far too narrow construct of the task. The willingness of other professionals-including nurses, social workers, and clergy-to participate and even take the lead in assisting suicides is critical to meet society's interest that assisted suicide should be humane, effective, and confined to appropriate cases. As long as legislation and guidelines focus exclusively on the physician's role, our laws and regulations will fall short of meeting societal expectations.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Faber-Langendoen, K (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE ON AGING [K01AG000931] Funding Source: NIH RePORTER; NIA NIH HHS [1K01-AG00931] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Admiraal P V, 1995, Ned Tijdschr Geneeskd, V139, P265; *AM MED ASS COUNC, 1932, JAMA-J AM MED ASSOC, V270, P365; *AM NURS ASS, 1994, POS STAT ASS SUIC, P1; Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; BATTIN MP, 1996, DRUG USE ASSISTED SU, P267; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BRODY H, 1997, PHYSICIAN ASSISTED S, P136; BYOCK I, 1997, PHYSICIAN ASSISTED S, P107; CALLAHAN D, 1997, PHYSICIAN ASSISTED S, P69; CAPLAN AL, 2000, ANN INTERN MED, V132, P482; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; DOUKAS DJ, 1995, J CLIN ONCOL, V13, P1055, DOI 10.1200/JCO.1995.13.5.1055; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FIELD MJ, 1997, APPROACHING DEATH IM, P363; GILLESPIE M, 1999, KEVORKIAN FACE MURDE; Goldfarb LM, 1996, AM J DRUG ALCOHOL AB, V22, P549, DOI 10.3109/00952999609001680; Humphry D, 1991, FINAL EXIT PRACTICAL; JAMISON S, 1995, FINAL ACTS LOVE FAMI; Koenig H G, 1991, J Pastoral Care, V45, P254; Loewy E H, 1992, J Clin Ethics, V3, P29; MAUGANS TA, 1991, J FAM PRACTICE, V32, P210; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; Miller FG, 1998, ANN INTERN MED, V128, P559, DOI 10.7326/0003-4819-128-7-199804010-00007; *N CUMM FDN FETZ I, 1997, SPIR BEL DYING PROC; *NAT ASS BOARDS PH, 1997, 1997 98 SURV PHARM L, P65; *NAT ASS SOC WORK, 1994, CLIENT SELF DET END, P58; NEELEMAN J, 1993, ACTA PSYCHIAT SCAND, V88, P420, DOI 10.1111/j.1600-0447.1993.tb03484.x; *ONC NURS SOC, 1995, ONC NURS SOC END AM; RUPP MT, 1994, AM J HOSP PHARM, V51, P69, DOI 10.1093/ajhp/51.1.69; SuarezAlmazor ME, 1997, J CLIN ONCOL, V15, P418, DOI 10.1200/JCO.1997.15.2.418; Tulsky JA, 2000, ANN INTERN MED, V132, P494, DOI 10.7326/0003-4819-132-6-200003210-00012; van der Wal G, 1992, Ned Tijdschr Geneeskd, V136, P1299; 1997, OREG NURSE, V62, P5	36	22	22	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					482	487		10.7326/0003-4819-132-6-200003210-00010	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733449				2022-12-01	WOS:000085834700009
J	Saxon, E; Bertozzi, CR				Saxon, E; Bertozzi, CR			Cell surface engineering by a modified Staudinger reaction	SCIENCE			English	Article								Selective chemical reactions enacted within a cellular environment can be powerful tools for elucidating biological processes or engineering novel interactions. A chemical transformation that permits the selective formation of covalent adducts among richly functionalized biopolymers within a cellular context is presented. A ligation modeled after the Staudinger reaction forms an amide bond by coupling of an azide and a specifically engineered triarylphosphine. Both reactive partners are abiotic and chemically orthogonal to native cellular components. Azides installed within cell surface glycoconjugates by metabolism of a synthetic azidosugar were reacted with a biotinylated triarylphosphine to produce stable cell-surface adducts. The tremendous selectivity of the transformation should permit its execution within a cell's interior, offering new possibilities for probing intracellular interactions.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R37GM058867] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58867-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTWRIGHT IL, 1976, NUCLEIC ACIDS RES, V3, P2331, DOI 10.1093/nar/3.9.2331; GOLOLOBOV YG, 1992, TETRAHEDRON, V48, P1353, DOI 10.1016/S0040-4020(01)92229-X; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; JACOBS AK, 1995, P NATL ACAD SCI USA, V92, P3323; Lee JH, 1999, J BIOL CHEM, V274, P21878, DOI 10.1074/jbc.274.31.21878; Lemieux GA, 1999, J AM CHEM SOC, V121, P4278, DOI 10.1021/ja984228m; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Staudinger H, 1919, HELV CHIM ACTA, V2, P635, DOI 10.1002/hlca.19190020164; van Hest JCM, 1998, FEBS LETT, V428, P68, DOI 10.1016/S0014-5793(98)00489-X; Winans KA, 1998, CHEM BIOL, V5, pR313, DOI 10.1016/S1074-5521(98)90658-5; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168	12	1750	1944	67	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2007	2010		10.1126/science.287.5460.2007	http://dx.doi.org/10.1126/science.287.5460.2007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720325				2022-12-01	WOS:000085902800059
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Med Stat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Meade TW, 1998, LANCET, V351, P233; Shepherd J, 1996, LANCET, V348, P1339; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					677	679		10.1136/bmj.320.7236.677	http://dx.doi.org/10.1136/bmj.320.7236.677			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710575	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000085895300019
J	Kim, AS; Kakalis, LT; Abdul-Manan, M; Liu, GA; Rosen, MK				Kim, AS; Kakalis, LT; Abdul-Manan, M; Liu, GA; Rosen, MK			Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein	NATURE			English	Article							X-LINKED THROMBOCYTOPENIA; TYROSINE PHOSPHORYLATION; WASP GENE; NMR; CDC42; BINDING; MUTATIONS; DOMAIN; C-13; IDENTIFICATION	The Rho-family GTPase, Cdc42, can regulate the actin cytoskeleton through activation of Wiskott-Aldrich syndrome protein (WASP) family members. Activation relieves an autoinhibitory contact between the GTPase-binding domain and the carboxyterminal region of WASP proteins. Here we report the autoinhibited structure of the GTPase-binding domain of WASP, which can be induced by the C-terminal region or by organic co-solvents, In the autoinhibited complex, intramolecular interactions with the GTPase-binding domain occlude residues of the C terminus that regulate the Arp2/3 actin-nucleating complex. Binding of Cdc42 to the GTPase-binding domain causes a dramatic conformational change, resulting in disruption of the hydrophobic core and release of the C terminus, enabling its interaction with the actin regulatory machinery. These data show that 'intrinsically unstructured' peptides such as the GTPase-binding domain of WASP can be induced into distinct structural and functional states depending on context.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rosen, MK (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	rosen@mrnmrl.ski.mskcc.org						Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Bi EF, 1999, CURR BIOL, V9, pR160, DOI 10.1016/S0960-9822(99)80102-X; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1993, XPLOR MANUAL; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KOLLURI R, 1995, HUM MOL GENET, V4, P1119, DOI 10.1093/hmg/4.7.1119; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; KWAN SP, 1995, HUM MOL GENET, V4, P1995, DOI 10.1093/hmg/4.10.1995; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Oda A, 1998, BLOOD, V92, P1852, DOI 10.1182/blood.V92.6.1852.418k36_1852_1858; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Scherbina A, 1999, J IMMUNOL, V163, P6314; Sharman GJ, 1998, J AM CHEM SOC, V120, P5291, DOI 10.1021/ja9705405; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	44	589	600	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					151	158		10.1038/35004513	http://dx.doi.org/10.1038/35004513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724160				2022-12-01	WOS:000085870900041
J	Pomeroy, VM; Tallis, RC				Pomeroy, VM; Tallis, RC			Need to focus research in stroke rehabilitation	LANCET			English	Editorial Material							CENTRALLY PARETIC HAND; MOTOR CORTEX; SUPPORT		Univ Manchester, Sch Med, Stroke Assoc Therapy Res Unit, Manchester M13 9PL, Lancs, England; Univ Manchester, Sch Med, Dept Geriatr Med, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Pomeroy, VM (corresponding author), Hope Hosp, Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	vpomeroy@fs1.ho.man.ac.uk		Pomeroy, Valerie/0000-0003-4487-823X				Ada L, 1998, J NEUROL NEUROSUR PS, V64, P628, DOI 10.1136/jnnp.64.5.628; Bonn D, 1998, LANCET, V352, P119, DOI 10.1016/S0140-6736(98)85026-5; Boult C, 1997, J AM GERIATR SOC, V45, P881, DOI 10.1111/j.1532-5415.1997.tb01519.x; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; DICKSTEIN R, 1986, PHYS THER, V66, P1233, DOI 10.1093/ptj/66.8.1233; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; Hallett M, 1998, NEUROREHABILITATION, V10, P131, DOI 10.3233/NRE-1998-10205; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HUMMELSHEIM H, 1995, ELECTROMYOGR MOTOR C, V97, P18, DOI 10.1016/0924-980X(94)00279-G; Indredavik B, 1997, STROKE, V28, P1861, DOI 10.1161/01.STR.28.10.1861; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Langhorne P, 1996, Physiother Res Int, V1, P75; Nudo RJ, 1996, J NEUROSCI, V16, P785; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; POMEROY VM, IN PRESS CLIN REHABI; Tyson SF, 1998, CLIN REHABIL, V12, P395, DOI 10.1191/026921598669871795; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; Young J, 1996, BRIT MED J, V313, P677	20	34	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2000	355	9206					836	837		10.1016/S0140-6736(99)08143-X	http://dx.doi.org/10.1016/S0140-6736(99)08143-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711941				2022-12-01	WOS:000085766900038
J	Horvath, A; Berry, EA; Maslov, DA				Horvath, A; Berry, EA; Maslov, DA			Translation of the edited mRNA for cytochrome b in trypanosome mitochondria	SCIENCE			English	Article							CRITHIDIA-FASCICULATA; C-OXIDASE; MESSENGER-RNA; KINETOPLASTID MITOCHONDRIA; SUBUNIT-II; BRUCEI; OXIDOREDUCTASE; NUCLEOTIDES; TRANSCRIPT; MECHANISM	The type of RNA editing found in the kinetoplast-mitochondria of trypanosomes and related protozoa, involving uridylate insertions and deletions, creates translatable messenger RNAs (mRNAs) out of nonsense pre-edited RNAs by correcting encoded defects that vary from simple frameshifts to Large "cryptic" regions. However, any evidence for translation of these mRNAs in the kinetoplast has been missing for decades. We identified a kinetoplast-encoded protein, apocytochrome b, whose mRNA is edited in the 5' region. The determined amino-terminal sequence of the protein coincides with the predicted sequence derived from the edited region, demonstrating that the cognate apocytochrome b mRNA is translated into a functional protein. This finding represents the first direct evidence for a functional translation system in the kinetoplasts.	Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; Univ Calif Berkeley, Div Struct Biol, Berkeley, CA 94720 USA	University of California System; University of California Riverside; University of California System; University of California Berkeley	Maslov, DA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.		Horvath, Anton/I-3626-2014; Horvath, Anton/V-1097-2018	Horvath, Anton/0000-0003-0785-4204	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044842] Funding Source: NIH RePORTER; NIAID NIH HHS [R29AI40634] Funding Source: Medline; NIDDK NIH HHS [R01DK44842] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; AVILA HA, COMMUNICATION; Beattie DS, 1996, EUR J BIOCHEM, V241, P888, DOI 10.1111/j.1432-1033.1996.00888.x; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BERRY EA, 1991, J BIOL CHEM, V266, P9064; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Breek CKD, 1997, BIOL CHEM, V378, P837, DOI 10.1515/bchm.1997.378.8.837; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; MARRES CAM, 1977, BIOCHIM BIOPHYS ACTA, V462, P531, DOI 10.1016/0005-2728(77)90099-8; PRIEST JW, 1992, J BIOL CHEM, V267, P20188; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; Simpson L, 1998, NUCLEIC ACIDS RES, V26, P170, DOI 10.1093/nar/26.1.170; Speijer D, 1997, MOL BIOCHEM PARASIT, V85, P171, DOI 10.1016/S0166-6851(96)02823-X; Speijer D, 1996, MOL BIOCHEM PARASIT, V79, P47, DOI 10.1016/0166-6851(96)02648-5; STEFFENS GJ, 1979, H-S Z PHYSIOL CHEM, V360, P613	18	58	62	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1639	1640		10.1126/science.287.5458.1639	http://dx.doi.org/10.1126/science.287.5458.1639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698736				2022-12-01	WOS:000085628200034
J	Cox, MM; Goodman, MF; Kreuzer, KN; Sherratt, DJ; Sandler, SJ; Marians, KJ				Cox, MM; Goodman, MF; Kreuzer, KN; Sherratt, DJ; Sandler, SJ; Marians, KJ			The importance of repairing stalled replication forks	NATURE			English	Article							STRAND-BREAK REPAIR; INDUCED DNA-REPLICATION; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; RECA PROTEIN; SACCHAROMYCES-CEREVISIAE; GENETIC-RECOMBINATION; SOS RESPONSE; PRIA; BACTERIOPHAGE-T4	The bacterial SOS response to unusual levels of DNA damage has been recognized and studied for several decades. Pathways for re-establishing inactivated replication forks under normal growth conditions have received far less attention. In bacteria growing aerobically in the absence of SOS-inducing conditions, many replication forks encounter DNA damage, leading to inactivation. The pathways for fork reactivation involve the homologous recombination systems, are nonmutagenic, and integrate almost every aspect of DNA metabolism. On a frequency-of-use basis, these pathways represent the main function of bacterial DNA recombination systems, as well as the main function of a number of other enzymatic systems that are associated with replication and site-specific recombination.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; Duke University; University of Oxford; University of Massachusetts System; University of Massachusetts Amherst; Memorial Sloan Kettering Cancer Center	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM034557] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Arai K, 1981, Prog Nucleic Acid Res Mol Biol, V26, P9, DOI 10.1016/S0079-6603(08)60392-X; Bidnenko V, 1999, MOL MICROBIOL, V33, P846, DOI 10.1046/j.1365-2958.1999.01532.x; Bosco G, 1998, GENETICS, V150, P1037; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; CLARK AJ, 1994, CRIT REV MICROBIOL, V20, P125, DOI 10.3109/10408419409113552; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Cox MM, 1997, P NATL ACAD SCI USA, V94, P11764, DOI 10.1073/pnas.94.22.11764; Cox MM, 1998, GENES CELLS, V3, P65, DOI 10.1046/j.1365-2443.1998.00175.x; COX MM, 1999, PROG NUCL ACID RES M, V63, P310; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Galitski T, 1997, GENETICS, V146, P751; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Le S, 1999, GENETICS, V152, P143; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LUDER A, 1982, P NATL ACAD SCI-BIOL, V79, P1101, DOI 10.1073/pnas.79.4.1101; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MARIANS KJ, 1984, CRC CR REV BIOCH MOL, V17, P153, DOI 10.3109/10409238409113604; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Morrow DM, 1997, GENETICS, V147, P371; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; Saveson CJ, 1999, GENETICS, V152, P5; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shinagawa H, 1996, EXS, V77, P221; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; SKARSTAD K, 1993, J BACTERIOL, V175, P5505, DOI 10.1128/JB.175.17.5505-5509.1993; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; WEST SC, 1981, NATURE, V294, P659, DOI 10.1038/294659a0; WOODGATE R, 1991, MOL GEN GENET, V229, P10, DOI 10.1007/BF00264207; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x	62	844	872	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					37	41		10.1038/35003501	http://dx.doi.org/10.1038/35003501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716434				2022-12-01	WOS:000085775100037
J	Dickson, D				Dickson, D			... amid calls for international biotech panel	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					821	821		10.1038/35002766	http://dx.doi.org/10.1038/35002766			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10733386	Bronze			2022-12-01	WOS:000085559200015
J	Gavrilova, O; Marcus-Samuels, B; Leon, LR; Vinson, C; Reitman, ML				Gavrilova, O; Marcus-Samuels, B; Leon, LR; Vinson, C; Reitman, ML			Hormones - Leptin and diabetes in lipoatrophic mice	NATURE			English	Article							ADIPOSE-TISSUE; OBESITY		NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gavrilova, O (corresponding author), NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA.	mlr@helix.nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK047031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FOSTER DW, 1994, HARRISONS PRINCIPLES, P2131; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213	9	63	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					850	850		10.1038/35002663	http://dx.doi.org/10.1038/35002663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706272				2022-12-01	WOS:000085559200042
J	Reinhart, BJ; Slack, FJ; Basson, M; Pasquinelli, AE; Bettinger, JC; Rougvie, AE; Horvitz, HR; Ruvkun, G				Reinhart, BJ; Slack, FJ; Basson, M; Pasquinelli, AE; Bettinger, JC; Rougvie, AE; Horvitz, HR; Ruvkun, G			The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; HETEROCHRONIC MUTANTS; GENE; NEMATODE; PROTEIN; LIN-14; ENCODES; SWITCH; REGION	The C. elegans heterochronic gene pathway consists of a cascade of regulatory genes that are temporally controlled to specify the timing of developmental events(1). Mutations in heterochronic genes cause temporal transformations in cell fates in which stage-specific events are omitted or reiterated(2). Here we show that let-7 is a heterochronic switch gene. Loss of let-7 gene activity causes reiteration of larval cell fates during the adult stage, whereas increased let-7 gene dosage causes precocious expression of adult fates during larval stages. let-7 encodes a temporally regulated 21-nucleotide RNA that is complementary to elements in the 3' untranslated regions of the heterochronic genes lin-14, lin-28, lin-41, lin-42 and daf-12, indicating that expression of these genes may be directly controlled by let-7. A reporter gene bearing the lin-41 3' untranslated region is temporally regulated in a let-7-dependent manner. A second regulatory RNA, lin-4, negatively regulates lin-14 and lin-28 through RNA-RNA interactions with their 3' untranslated regions(3,4). We propose that the sequential stage-specific expression of the lin-4 and let-7 regulatory RNAs triggers transitions in the complement of heterochronic regulatory proteins to coordinate developmental timing.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.			Slack, Frank/0000-0001-8263-0409	NIAMS NIH HHS [P30 AR046032] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrahante JE, 1998, GENETICS, V149, P1335; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ausubel F.M., 1995, CURRENT PROTOCOLS MO; Bettinger JC, 1996, DEVELOPMENT, V122, P2517; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KENNEDY BP, 1993, J MOL BIOL, V229, P890, DOI 10.1006/jmbi.1993.1094; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LIU Z, 1990, THESIS HARVARD U; MENEELY PM, 1979, GENETICS, V92, P99; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TRENT C, 1983, GENETICS, V104, P619; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WIGHTMAN B, 1991, GENE DEV, V5, P1813, DOI 10.1101/gad.5.10.1813; YEH WY, 1991, THESIS U MISSOURI CO; ZUCKERAPRISON E, 1989, J MOL EVOL, V28, P487, DOI 10.1007/BF02602929	21	3219	3760	19	445	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					901	906		10.1038/35002607	http://dx.doi.org/10.1038/35002607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706289				2022-12-01	WOS:000085559200060
J	Bui, JD; Calbo, S; Hayden-Martinez, K; Kane, LP; Gardner, P; Hedrick, SM				Bui, JD; Calbo, S; Hayden-Martinez, K; Kane, LP; Gardner, P; Hedrick, SM			A role for CaMKII in T cell memory	CELL			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; STAPHYLOCOCCAL ENTEROTOXIN-B; II MUTANT MICE; TRANSGENIC MICE; MOLECULAR MECHANISM; POSITIVE SELECTION; ANTIGEN RECEPTOR; EXPRESSION; CALCIUM	In order to study the role of calcium/calmodulin kinase II (CaMKII) in T cells, we generated transgenic mice expressing CaMKII gamma B* (T287D), a partially calcium-independent mutant of CaMKII gamma B. In these mice, the size of the thymus was increased 1.5- to 2-fold, at least in part due to an increase in the lifespan of double-positive (DP) thymocytes. More importantly, there was an increase in the number of T cells in the secondary lymphoid organs that had acquired an antigen-dependent memory phenotype. These T cells were bonafide memory cells as assessed by a variety of criteria. In addition, T cells from wild-type mice acquired calcium-independent CaMKII activity after several rounds of antigen-stimulated division. We propose that CaMKII controls a distinct process of activation-induced cellular differentiation.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Stanford Univ, Dept Mol Pharmacol & Med, Stanford, CA 94305 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Stanford University	Hedrick, SM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751; Kane, Lawrence/0000-0001-5198-516X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021372] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI21372-15] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlberolaIla J, 1997, ANNU REV IMMUNOL, V15, P125, DOI 10.1146/annurev.immunol.15.1.125; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; ERNST DN, 1993, J IMMUNOL, V151, P575; Fukunaga K, 1996, NEUROCHEM INT, V28, P343, DOI 10.1016/0197-0186(95)00097-6; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Heist EK, 1998, CELL CALCIUM, V23, P103; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; LEE WT, 1990, J IMMUNOL, V144, P3288; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; NGHIEM P, 1993, J BIOL CHEM, V268, P5471; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; NISHIMOTO I, 1991, NEURON, V6, P547, DOI 10.1016/0896-6273(91)90057-7; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Petschner F, 1998, EUR J IMMUNOL, V28, P560, DOI 10.1002/(SICI)1521-4141(199802)28:02<560::AID-IMMU560>3.0.CO;2-Q; Philpott NJ, 1996, BLOOD, V87, P2244, DOI 10.1182/blood.V87.6.2244.bloodjournal8762244; PICKER LJ, 1995, BLOOD, V86, P1408, DOI 10.1182/blood.V86.4.1408.bloodjournal8641408; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SODERLING TR, 1993, MOL CELL BIOCHEM, V128, P93, DOI 10.1007/BF01076760; Sprent J, 1997, IMMUNOL REV, V156, P79, DOI 10.1111/j.1600-065X.1997.tb00960.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TAO W, 1994, J EXP MED, V179, P145, DOI 10.1084/jem.179.1.145; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Vasseur F, 1999, J IMMUNOL, V162, P5164; WEBB SR, 1994, J IMMUNOL, V152, P586; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	69	54	54	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					457	467		10.1016/S0092-8674(00)80681-9	http://dx.doi.org/10.1016/S0092-8674(00)80681-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693762	Bronze			2022-12-01	WOS:000085446900008
J	Prober, DA; Edgar, BA				Prober, DA; Edgar, BA			Ras1 promotes cellular growth in the Drosophila wing	CELL			English	Article							EGF RECEPTOR GENE; SACCHAROMYCES-CEREVISIAE; TYROSINE KINASE; CYCLE MACHINERY; PROTO-ONCOGENE; LOCUS ENCODES; EXPRESSION; DIVISION; PATHWAY; PROLIFERATION	The Ras GTPase links extracellular mitogens to intracellular mechanisms that control cell proliferation. To understand how Ras regulates proliferation in vivo, we activated or inactivated Ras in cell clones in the developing Drosophila wing. Cells lacking Ras were smaller, had reduced growth rates, accumulated in G1, and underwent apoptosis due to cell competition. Conversely, activation of Ras increased cell size and growth rates and promoted G1/S transitions. Ras upregulated the growth driver dMyc, and both Pas and dMyc increased levels of cyclin E posttranscriptionally. We propose that Pas primarily promotes growth and that growth is coupled to G1/S progression via cyclin E. Interestingly, upregulation of growth by Pas did not deregulate G2/M progression or a developmentally regulated cell cycle exit.	Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98109 USA.				NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA15704-26] Funding Source: Medline; NIGMS NIH HHS [GM51186] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON S, 1994, GENETICS, V137, P513; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CLIFFORD RJ, 1989, GENETICS, V123, P771; Dang CV, 1999, MOL CELL BIOL, V19, P1; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Downward J, 1997, CURR BIOL, V7, P258; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Fan JG, 1997, ONCOGENE, V14, P2595, DOI 10.1038/sj.onc.1201105; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GRAVES BJ, 1982, DEV BIOL, V93, P104, DOI 10.1016/0012-1606(82)90243-3; Guichard A, 1999, DEVELOPMENT, V126, P2663; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HAY BA, 1994, DEVELOPMENT, V120, P2121; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Karim FD, 1998, DEVELOPMENT, V125, P1; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee T, 1996, DEVELOPMENT, V122, P409; Lehman DA, 1999, DEVELOPMENT, V126, P1793; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; LU XY, 1993, GENE DEV, V7, P621, DOI 10.1101/gad.7.4.621; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Mittnacht S, 1997, CURR BIOL, V7, P219, DOI 10.1016/S0960-9822(97)70094-0; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Schnorr JD, 1996, GENETICS, V144, P1545; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Simcox A, 1997, MECH DEVELOP, V62, P41, DOI 10.1016/S0925-4773(96)00643-0; Simcox AA, 1996, DEV BIOL, V177, P475, DOI 10.1006/dbio.1996.0179; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Winston JT, 1996, ONCOGENE, V12, P127; XU T, 1993, DEVELOPMENT, V117, P1223	64	233	238	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					435	446		10.1016/S0092-8674(00)80679-0	http://dx.doi.org/10.1016/S0092-8674(00)80679-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693760	Bronze, Green Accepted			2022-12-01	WOS:000085446900006
J	Parkhill, J; Wren, BW; Mungall, K; Ketley, JM; Churcher, C; Basham, D; Chillingworth, T; Davies, RM; Feltwell, T; Holroyd, S; Jagels, K; Karlyshev, AV; Moule, S; Pallen, MJ; Penn, CW; Quail, MA; Rajandream, MA; Rutherford, KM; van Vliet, AHM; Whitehead, S; Barrell, BG				Parkhill, J; Wren, BW; Mungall, K; Ketley, JM; Churcher, C; Basham, D; Chillingworth, T; Davies, RM; Feltwell, T; Holroyd, S; Jagels, K; Karlyshev, AV; Moule, S; Pallen, MJ; Penn, CW; Quail, MA; Rajandream, MA; Rutherford, KM; van Vliet, AHM; Whitehead, S; Barrell, BG			The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences	NATURE			English	Article							HELICOBACTER-PYLORI; GENES; VIRULENCE; IDENTIFICATION; BACTERIA; PROGRAM; CELLS	Campylobacter jejuni, from the delta-epsilon group of proteobacteria, is a microaerophilic, Gram-negative, flagellate, spiral bacterium-properties it shares with the related gastric pathogen Helicobacter pylori. It is the leading cause of bacterial food-borne diarrhoeal disease throughout the world(1). In addition, infection with C. jejuni is the most frequent antecedent to a form of neuromuscular paralysis known as Guillain-Barre syndrome(2). Here we report the genome sequence of C. jejuni NCTC11168. C. jejuni has a circular chromosome of 1,641,481 base pairs (30.6% G+C) which is predicted to encode 1,654 proteins and 54 stable RNA species. The genome is unusual in that there are virtually no insertion sequences or phage-associated sequences and very few repeat sequences. One of the most striking findings in the genome was the presence of hypervariable sequences. These short homopolymeric runs of nucleotides were commonly found in genes encoding the biosynthesis or modification of surface structures, or in closely linked genes of unknown function. The apparently high rate of variation of these homopolymeric tracts may be important in the survival strategy of C. jejuni.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Queens Univ Belfast, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Free Univ Amsterdam, Fac Med, Dept Med Microbiol, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Fac Med, Dept Gastroenterol, NL-1081 BT Amsterdam, Netherlands	Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of Leicester; Queens University Belfast; University of Birmingham; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		Pallen, Mark J./E-7619-2011; Karlyshev, Andrey/D-2797-2011; Parkhill, Julian/G-4703-2011; van Vliet, Arnoud HM/B-5155-2013; Quail, michael/ABE-6131-2020; Rutherford, Kim/Y-7995-2018	Karlyshev, Andrey/0000-0003-3124-019X; Parkhill, Julian/0000-0002-7069-5958; Rutherford, Kim/0000-0001-6277-726X; van Vliet, Arnoud/0000-0003-0203-1305; Davies, Robert/0000-0002-9983-1378; Pallen, Mark/0000-0003-1807-3657				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; *CPHLS, 1999, COMMUNICAB DIS REP, V9, P11; Doig P, 1996, MOL MICROBIOL, V20, P885, DOI 10.1111/j.1365-2958.1996.tb02526.x; Domingo E, 1997, REV MED VIROL, V7, P87, DOI 10.1002/(SICI)1099-1654(199707)7:2<87::AID-RMV188>3.0.CO;2-0; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; FRY B, IN PRESS CAMPYLOBACT; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Hughes NJ, 1998, J BACTERIOL, V180, P1119, DOI 10.1128/JB.180.5.1119-1128.1998; Jones AC, 1997, J BACTERIOL, V179, P5643, DOI 10.1128/jb.179.17.5643-5647.1997; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Lavitola A, 1999, MOL MICROBIOL, V33, P119, DOI 10.1046/j.1365-2958.1999.01454.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; Wood AC, 1999, MICROBIOL-UK, V145, P379, DOI 10.1099/13500872-145-2-379; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Yao RJ, 1997, MOL MICROBIOL, V23, P1021, DOI 10.1046/j.1365-2958.1997.2861650.x; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	30	1536	2086	4	146	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					665	668		10.1038/35001088	http://dx.doi.org/10.1038/35001088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688204	Bronze			2022-12-01	WOS:000085288200056
J	Wei, M; Gibbons, LW; Kampert, JB; Nichaman, MZ; Blair, SN				Wei, M; Gibbons, LW; Kampert, JB; Nichaman, MZ; Blair, SN			Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article						diabetes mellitus, non-insulin-dependent; exercise; exercise tolerance; oxygen uptake	ALL-CAUSE MORTALITY; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; EXERCISE; WOMEN; DISEASE; HEALTHY; PROGRAM; CANCER; NIDDM	Background: Although physical activity is recommended as a basic treatment for patients with diabetes, its longterm association with mortality in these patients is unknown. Objective: To evaluate the association of low cardiorespiratory fitness and physical inactivity with mortality in men with type 2 diabetes. Design: Prospective cohort study. Setting: Preventive medicine clinic. Patients: 1263 men (50 +/- 10 years of age) with type 2 diabetes who received a thorough medical examination between 1970 and 1993 and were followed for mortality up to 31 December 1994. Measurements: Cardiorespiratory fitness measured by a maximal exercise test, self-reported physical inactivity at baseline, and subsequent death determined by using the National Death Index. Results: During an average follow-up of 12 years, 180 patients died. After adjustment for age, baseline cardiovascular disease, fasting plasma glucose level, high cholesterol level, overweight, current smoking, high blood pressure, and parental history of cardiovascular disease, men in the low-fitness group had an adjusted risk for all-cause mortality of 2.1 (95% Cl, 1.5 to 2.9) compared with fit men. Men who reported being physically inactive had an adjusted risk for mortality that was 1.7-fold (Cl, 1.2-fold to 2.3-fold) higher than that in men who reported being physically active. Conclusions: Low cardiorespiratory fitness and physical inactivity are independent predictors of all-cause mortality in men with type 2 diabetes. Physicians should encourage patients with type 2 diabetes to participate in regular physical activity and improve cardiorespiratory fitness.	Cooper Inst, Dallas, TX 75230 USA; Cooper Clin, Dallas, TX USA; Westat Corp, Rockville, MD USA	Cooper Institute; Cooper Institute; Westat	Wei, M (corresponding author), Cooper Inst, 12330 Preston Rd, Dallas, TX 75230 USA.	mwei@cooperinst.org			NHLBI NIH HHS [HL62508] Funding Source: Medline; NIA NIH HHS [AG06945] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006945, R37AG006945] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS49; [Anonymous], 1996, JAMA, V276, P241; BAKTH S, 1986, J CLIN INVEST, V77, P382, DOI 10.1172/JCI112316; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, AM J EPIDEMIOL, V129, P1145, DOI 10.1093/oxfordjournals.aje.a115236; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Chalmers J, 1999, J HYPERTENS, V17, P151; Coupland CAC, 1999, INT J EPIDEMIOL, V28, P241, DOI 10.1093/ije/28.2.241; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Eriksson J, 1997, DIABETOLOGIA, V40, P125; GARBER AJ, 1998, INTERNAL MED, P1850; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Kampert JB, 1996, ANN EPIDEMIOL, V6, P452, DOI 10.1016/S1047-2797(96)00059-2; Kiningham RB, 1998, PRIMARY CARE, V25, P515, DOI 10.1016/S0095-4543(05)70080-4; KOHL HW, 1992, DIABETES CARE, V15, P184, DOI 10.2337/diacare.15.2.184; KUUSISTO J, 1994, STROKE, V25, P1157, DOI 10.1161/01.STR.25.6.1157; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martynenko OG, 1997, INT J HEAT MASS TRAN, V40, P1; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; *NIH, 1988, LIP RES CLIN POP STU; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; REWERS M, 1995, NIH PUBLICATION, P179; ROGERS MA, 1988, DIABETES CARE, V11, P613, DOI 10.2337/diacare.11.8.613; ROGERS MA, 1989, MED SCI SPORT EXER, V21, P362; *SAS I, 1989, SAS STAT US GUID VER; SCHNEIDER SH, 1992, DIABETES CARE, V15, P1800, DOI 10.2337/diacare.15.11.1800; SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wei M, 1997, J CLIN EPIDEMIOL, V50, P1137, DOI 10.1016/S0895-4356(97)00150-9; 1981, CANADA FITNESS SURVE	43	439	451	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					605	+		10.7326/0003-4819-132-8-200004180-00002	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766678				2022-12-01	WOS:000086497500001
J	Sharp, PA; Zamore, PD				Sharp, PA; Zamore, PD			Molecular biology - RNA interference	SCIENCE			English	Editorial Material									MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester	Sharp, PA (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 2000, CURR BIOL, V10, pR137, DOI 10.1016/S0960-9822(00)00325-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Schmidt A, 1999, GENETICS, V151, P749; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; ZAMORE PD, IN PRESS CELL	12	91	173	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2431	+		10.1126/science.287.5462.2431	http://dx.doi.org/10.1126/science.287.5462.2431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10766620				2022-12-01	WOS:000086202200030
J	Tulsky, JA; Ciampa, R; Rosen, EJ				Tulsky, JA; Ciampa, R; Rosen, EJ		Univ Pennsylvania	Responding to legal requests for physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							WASHINGTON-STATE; PATIENT REQUESTS; EUTHANASIA; ATTITUDES; CARE; AUTONOMY; PERSPECTIVE; CHOICE; WILL; DIE	In 1998, 15 terminally ill Oregon residents ended their lives with overdoses of medications supplied legally by their physicians. Many more people consider this possibility. This paper examines the ways in which the physician's response to requests for assisted suicide may change in an era of legalization, articulates some of the resulting conceptual challenges, and provides practical advice to physicians facing such requests. In areas where it is legal, assisted dying becomes one of the many options that can be freely considered for terminally ill patients with extreme suffering. Some patients even view assisted death as a right that can be expected on demand. We consider the ethical implications of disclosing assisted dying to patients as an option of last resort: and suggest that physicians working in environments where assisted dying is legal are obliged to do so. However, we conclude that physicians should not encourage patients to hasten death even when practicing in jurisdictions that allow assisted dying. Furthermore, without abandoning the model, we suggest that strict informed consent does not fully address patients' needs at this time. Physicians must also focus on patients' broader biopsychosocial concerns and help them identify solutions through empathic listening and emotional support. We provide a framework and vocabulary for physicians to use when responding to requests for assisted suicide. Physicians should clarify the request, explore and address the patient's concerns, achieve a shared understanding of the goals of treatment, search for less harmful alternatives, express to the patient what they are willing to do, discuss the relevant legal issues, and share their decision making with colleagues.	Vet Affairs Med Ctr, Durham, NC 27705 USA; Duke Univ, Med Ctr, Durham, NC USA; Hosp Univ Penn, Philadelphia, PA 19104 USA; Family Inst Westchester, Scarsdale, NY USA; Phelps Mem Hospice, Scarsdale, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; University of Pennsylvania; Northwell Health	Tulsky, JA (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.							APPELBAUM P, 1987, INFORMED CONSENT LEG; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; BRODY H, 1992, HEALERS POWER; Byock I., 1997, DYING WELL PEACE POS; CAPLAN AL, 1993, PRESCRIBING OUR FUTU, P149; CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; Cole Roger M., 1993, Palliative Medicine, V7, P139, DOI 10.1177/026921639300700208; Drickamer MA, 1997, ANN INTERN MED, V126, P146, DOI 10.7326/0003-4819-126-2-199701150-00009; Dunn PM, 1996, J GEN INTERN MED, V11, P689, DOI 10.1007/BF02600161; EDWARDS MJ, 1992, ANN INTERN MED, V117, P254, DOI 10.7326/0003-4819-117-3-254; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL L, 1999, ED PHYSICIANS END OF; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Lee MA, 1996, ANN INTERN MED, V124, P267, DOI 10.7326/0003-4819-124-2-199601150-00014; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Rose PG, 1998, J CLIN ONCOL, V16, P405, DOI 10.1200/JCO.1998.16.2.405; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Teno JM, 1996, J CLIN ETHIC, V7, P205; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	34	18	18	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					494	499		10.7326/0003-4819-132-6-200003210-00012	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733451				2022-12-01	WOS:000085834700011
J	Adler, E; Hoon, MA; Mueller, KL; Chandrashekar, J; Ryba, NJP; Zuker, CS				Adler, E; Hoon, MA; Mueller, KL; Chandrashekar, J; Ryba, NJP; Zuker, CS			A novel family of mammalian taste receptors	CELL			English	Article							ALPHA-GUSTDUCIN; CHORDA TYMPANI; G-PROTEIN; RAT; TRANSDUCTION; CELLS; AMILORIDE; GENES; NERVE; MICE	In mammals, taste perception is a major mode of sensory input. We have identified a novel family of 40-80 human and rodent G protein-coupled receptors expressed in subsets of taste receptor cells of the tongue and palate epithelia. These candidate taste receptors (T2Rs) are organized in the genome in clusters and are genetically linked to loci that influence bitter perception in mice and humans. Notably, a single taste receptor cell expresses a large repertoire of T2Rs, suggesting that each cell may be capable of recognizing multiple tastants. T2Rs are exclusively expressed in taste receptor cells that contain the G protein alpha subunit gustducin, implying that they function as gustducin-linked receptors. In the accompanying paper, we demonstrate that T2Rs couple to gustducin in vitro, and respond to bitter tastants in a functional expression assay.	NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Dept Neurosci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Ryba, NJP (corresponding author), NIH, Natl Inst Dent & Craniofacial Res, Bldg 10, Bethesda, MD 20892 USA.	nr13k@nih.gov; czucker@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AZEN EA, 1986, TRENDS GENET, V2, P199, DOI 10.1016/0168-9525(86)90228-3; Boughter JD, 1997, J NEUROSCI, V17, P2852; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FRANK ME, 1983, J NEUROPHYSIOL, V50, P941, DOI 10.1152/jn.1983.50.4.941; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hofer D, 1998, HISTOCHEM CELL BIOL, V110, P303, DOI 10.1007/s004180050292; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; KINNAMON SC, 1992, ANNU REV PHYSIOL, V54, P715, DOI 10.1146/annurev.physiol.54.1.715; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1986, GENET RES, V47, P117, DOI 10.1017/S0016672300022941; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MCBURNEY DH, 1972, PERCEPT PSYCHOPHYS, V11, P228, DOI 10.3758/BF03206255; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MILLER IJ, 1974, J COMP NEUROL, V158, P155, DOI 10.1002/cne.901580204; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; NEJAD MS, 1986, CHEM SENSES, V11, P283, DOI 10.1093/chemse/11.3.283; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WARREN RP, 1970, NATURE, V227, P77, DOI 10.1038/227077a0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	40	968	1078	3	224	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					693	702		10.1016/S0092-8674(00)80705-9	http://dx.doi.org/10.1016/S0092-8674(00)80705-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761934	Bronze			2022-12-01	WOS:000085983800011
J	Merz, CNB; Paul-Labrador, M; Vongvanich, P				Merz, CNB; Paul-Labrador, M; Vongvanich, P			Time to reevaluate risk stratification guidelines for medically supervised exercise training in patients with coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; MULTIFACTORIAL INTERVENTION PROGRAM; CARDIAC REHABILITATION; SUDDEN DEATHS; REDUCTION; TRIALS		Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Prevent & Rehabil Cardiac Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Merz, CNB (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Prevent & Rehabil Cardiac Ctr, 444 S San Vicente Blvd,Suite 901, Los Angeles, CA 90048 USA.	merz@cshs.org						*AG HLTH CAR POL R, 1995, CARD REH GUID; *AM ASS CARD PULM, 1995, GUID CARD REH PROGR; *ANT TRIAL COLL, 1983, BMJ-BRIT MED J, V296, P320; BONDESTAM E, 1995, AM J CARDIOL, V75, P767, DOI 10.1016/S0002-9149(99)80408-1; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dorn J, 1999, CIRCULATION, V100, P1764, DOI 10.1161/01.CIR.100.17.1764; FLETCHER GF, 1990, CIRCULATION, V82, P2286, DOI 10.1161/01.CIR.82.6.2286; Gordon NF, 1997, AM J CARDIOL, V80, pH69, DOI 10.1016/S0002-9149(97)00825-4; HAMALAINEN H, 1989, EUR HEART J, V10, P55; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; KALLIO V, 1979, LANCET, V2, P1091; LEIZOROVICZ A, 1988, EUR HEART J, V9, P8; LEVIN LA, 1991, J INTERN MED, V230, P427, DOI 10.1111/j.1365-2796.1991.tb00468.x; Merz CNB, 1996, AM HEART J, V132, P418; MILLER NH, 1984, CIRCULATION, V70, P645, DOI 10.1161/01.CIR.70.4.645; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE N, 1993, AM J CARDIOL, V72, P154, DOI 10.1016/0002-9149(93)90152-3; OLDRIDGE N, 1991, AM J CARDIOL, V67, P1084, DOI 10.1016/0002-9149(91)90870-Q; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; PASHKOW FJ, 1993, J AM COLL CARDIOL, V21, P822, DOI 10.1016/0735-1097(93)90116-I; Paul-Labrador M, 1999, J Cardiopulm Rehabil, V19, P118, DOI 10.1097/00008483-199903000-00006; PAULLABRADOR M, 1994, J CARDIOPULM REHABIL, V14, P328; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; SCHULER G, 1988, CIRCULATION, V77, P172, DOI 10.1161/01.CIR.77.1.172; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9; Vongvanich P, 1996, J Cardiopulm Rehabil, V16, P233, DOI 10.1097/00008483-199607000-00004; Wenger N K, 1992, Ann Acad Med Singap, V21, P141; WHITE LJ, 1988, ANN INTERN MED, V109, P671, DOI 10.7326/0003-4819-109-8-671; [No title captured]	31	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1476	1478						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732938				2022-12-01	WOS:000085696700033
J	Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC				Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC			gridlock, an HLH gene required for assembly of the aorta in zebrafish	SCIENCE			English	Article							REPRESSION; RECEPTOR; HOMOLOG; DOMAIN; CLOCHE; ACTS	The first artery and vein of the vertebrate embryo assemble in the trunk by migration and coalescence of angioblasts to form endothelial tubes. The gridlock (grl) mutation in zebrafish selectively perturbs assembly of the artery (the aorta). Here it is shown that grl encodes a basic helix-loop-helix (bHLH) protein belonging to the Hairy/Enhancer of the split family of bHLH proteins. The grl gene is expressed in Lateral plate mesoderm before vessel formation, and thereafter in the aorta and not in the vein. These results suggest that the arterial endothelial identity is established even before the onset of blood flow and implicate the grl gene in assignment of vessel-specific cell fate.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Fishman, MC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, 149 13th St,4th Floor, Boston, MA 02129 USA.	fishman@cvrc.mgh.harvard.edu			NCRR NIH HHS [R01RR0888] Funding Source: Medline; NHLBI NIH HHS [T32HL07208] Funding Source: Medline; NIDDK NIH HHS [R01DK55383] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055383] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMEMIYA CT, 1999, ZEBRAFISH GENETICS G, P236; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Burge CB, 1998, N COMP BIOC, V32, P129; Carmeliet P, 1999, NATURE, V401, P657, DOI 10.1038/44304; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Liao W, 1997, DEVELOPMENT, V124, P381; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; PIERPONT MEM, 1986, GENETICS CARDIOVASCU, P13; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 1998, GENOMICS, V48, P136, DOI 10.1006/geno.1997.5155	24	323	332	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1820	1824		10.1126/science.287.5459.1820	http://dx.doi.org/10.1126/science.287.5459.1820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710309				2022-12-01	WOS:000085775300041
J	Gabashvili, IS; Agrawal, RK; Spahn, CMT; Grassucci, RA; Svergun, DI; Frank, J; Penczek, P				Gabashvili, IS; Agrawal, RK; Spahn, CMT; Grassucci, RA; Svergun, DI; Frank, J; Penczek, P			Solution structure of the E. coli 70S ribosome at 11.5 angstrom resolution	CELL			English	Article							CONTRAST TRANSFER-FUNCTION; ELONGATION-FACTOR-G; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; TRANSFER-RNA; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON CRYOMICROSCOPY; THERMUS-THERMOPHILUS; PROTEIN S7	Over 73,000 projections of the E. coli ribosome bound with formyl-methionyl initiator tRNA(f)(Met) were used to obtain an 11.5 Angstrom cryo-electron microscopy map of the complex. This map allows identification of RNA helices, peripheral proteins, and intersubunit bridges. Comparison of double-stranded RNA regions and positions of proteins identified in both cryo-EM and X-ray maps indicates good overall agreement but points to rearrangements of ribosomal components required for the subunit association. Fitting of known components of the 50S stalk base region into the map defines the architecture of the GTPase-associated center and reveals a major change in the orientation of the alpha-sarcin-ricin loop. Analysis of the bridging connections between the subunits provides insight into the dynamic signaling mechanism between the ribosomal subunits.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; DESY, European Mol Biol Lab, D-22603 Hamburg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org	Gabashvili, Irene/S-8737-2019	Gabashvili, Irene/0000-0002-0097-1478; Svergun, Dmitri/0000-0003-0830-5696	NIGMS NIH HHS [R01 GM55440, R37 GM29169, R37 GM029169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; Bottcher B, 1998, J MOL BIOL, V281, P757, DOI 10.1006/jmbi.1998.1957; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Correll CC, 1999, J MOL BIOL, V292, P275, DOI 10.1006/jmbi.1999.3072; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; FANNING TG, 1978, NUCLEIC ACIDS RES, V5, P933, DOI 10.1093/nar/5.3.933; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; FRANK J, 1995, OPTIK, V98, P125; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; GLAESER RM, 1992, ULTRAMICROSCOPY, V47, P256, DOI 10.1016/0304-3991(92)90201-T; Harms J, 1999, STRUCTURE, V7, P931, DOI 10.1016/S0969-2126(99)80120-8; Hosaka H, 1997, STRUCTURE, V5, P1199, DOI 10.1016/S0969-2126(97)00270-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; LAMBERT JM, 1981, J MOL BIOL, V149, P451, DOI 10.1016/0022-2836(81)90481-2; LATA KR, 1995, ULTRAMICROSCOPY, V58, P381, DOI 10.1016/0304-3991(95)00002-I; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Li YH, 1997, J STRUCT BIOL, V120, P266, DOI 10.1006/jsbi.1997.3917; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Nikonov S, 1996, EMBO J, V15, P1350, DOI 10.1002/j.1460-2075.1996.tb00477.x; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Peltz SW, 1999, MOL CELL BIOL, V19, P384; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; Schlunzen F, 1999, J SYNCHROTRON RADIAT, V6, P928, DOI 10.1107/S0909049599006664; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Spahn CMT, 1999, STRUCT FOLD DES, V7, P1567, DOI 10.1016/S0969-2126(00)88347-1; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; Stemmer C, 1997, J MOL BIOL, V273, P52, DOI 10.1006/jmbi.1997.1270; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; VANHEEL M, 1986, OPTIK, V73, P83; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANN HG, 1982, FEBS LETT, V146, P217, DOI 10.1016/0014-5793(82)80739-4; WittmannLiebold B, 1995, BIOCHEM CELL BIOL, V73, P1187, DOI 10.1139/o95-128; Zhu J, 1997, J STRUCT BIOL, V118, P197, DOI 10.1006/jsbi.1997.3845	63	336	352	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					537	549		10.1016/S0092-8674(00)80690-X	http://dx.doi.org/10.1016/S0092-8674(00)80690-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721991	Bronze			2022-12-01	WOS:000085700000007
J	Patel, AD; Balaban, E				Patel, AD; Balaban, E			Temporal patterns of human cortical activity reflect tone sequence structure	NATURE			English	Article							STEADY-STATE RESPONSES; TONOTOPIC ORGANIZATION; MUSIC; PERCEPTION; PITCH	Despite growing interest in temporal aspects of auditory neural processing(1,2), little is known about large-scale timing patterns of brain activity during the perception of auditory sequences(3). This is partly because it has not been possible ro distinguish stimulus-related activity from other, endogenous brain signals recorded by electrical or magnetic sensors. Here we use amplitude modulation of unfamiliar, unfamiliar, similar to 1-minute-long tone sequences to label stimulus-related magnetoencephalographic neural activity in human subjects(4-9). We show that temporal patterns of activity recorded over particular brain regions track the pitch contour of tone sequences, with the accuracy of tracking increasing as tone sequences become more predictable in structure. In contrast, temporal synchronization between recording locations, particularly between sites over the left posterior hemisphere and the rest of the brain, is greatest when sequences have melody-like statistical properties(10,11) which may reflect the perceptual integration of local ant; global pitch patterns in melody-like sequences(12). This method is particularly well suited to studying temporal neural correlates of complex auditory sequences (such as speech or music) which engage multiple brain areas as perception unfolds in time.	Inst Neurosci, San Diego, CA 92121 USA		Patel, AD (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	apatel@nsi.edu; evan@nsi.edu	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433				BENDAT J, 1993, ENG APPL CORRELATION; BOON JP, 1995, CHAOS, V5, P501, DOI 10.1063/1.166145; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; GREENBERG S, **NON-TRADITIONAL**; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; NETTHEIM N, 1992, INTERFACE-J NEW MUS, V21, P135, DOI 10.1080/09298219208570604; PANTEV C, 1993, ELECTROEN CLIN NEURO, V88, P389, DOI 10.1016/0168-5597(93)90015-H; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; PETSCHE H, 1993, MUSIC PERCEPT, V11, P117; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; SCHMUCKLER MA, 1993, J EXP PSYCHOL HUMAN, V19, P641; SIEGEL S, 1988, MONPARAMETRIC STAT B; Srinivasan R, 1999, J NEUROSCI, V19, P5435; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; [No title captured]	23	82	83	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					80	84		10.1038/35003577	http://dx.doi.org/10.1038/35003577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716446				2022-12-01	WOS:000085775100049
J	Odenbreit, S; Puls, J; Sedlmaier, B; Gerland, E; Fischer, W; Haas, R				Odenbreit, S; Puls, J; Sedlmaier, B; Gerland, E; Fischer, W; Haas, R			Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion	SCIENCE			English	Article							VACUOLATING CYTOTOXIN; SHUTTLE MUTAGENESIS; VIRULENCE FACTORS; SYSTEM; PROTEIN; STRAINS; TRANSFORMATION; EXPRESSION	The Gram-negative bacterium Helicobacter pylori is a causative agent of gastritis and peptic ulcer disease in humans. Strains producing the CagA antigen (cagA(+)) induce strong gastric inflammation and are strongly associated with gastric adenocarcinoma and MALT Lymphoma. We show here that such strains translocate the bacterial protein CagA into gastric epithelial cells by a type IV secretion system, encoded by the cag pathogenicity island. CagA is tyrosine-phosphorylated and induces changes in the tyrosine phosphorylation state of distinct cellular proteins. Modulation of host cells by bacterial protein translocation adds a new dimension to the chronic Helicobacter infection with yet unknown consequences.	Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany	University of Munich	Haas, R (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Pettenkoferstr 9A, D-80336 Munich, Germany.							Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Blaser MJ, 1996, SCI AM, V274, P104, DOI 10.1038/scientificamerican0296-104; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Kahrs AF, 1995, GENE, V167, P53, DOI 10.1016/0378-1119(95)00671-0; POHLNER J, 1993, GENE, V130, P121, DOI 10.1016/0378-1119(93)90354-6; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Segal ED, 1997, P NATL ACAD SCI USA, V94, P7595, DOI 10.1073/pnas.94.14.7595; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; XIANG ZY, 1995, INFECT IMMUN, V63, P94, DOI 10.1128/IAI.63.1.94-98.1995	18	981	1038	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1497	1500		10.1126/science.287.5457.1497	http://dx.doi.org/10.1126/science.287.5457.1497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688800				2022-12-01	WOS:000085531600054
J	Neda, Z; Ravasz, E; Brechet, Y; Vicsek, T; Barabasi, AL				Neda, Z; Ravasz, E; Brechet, Y; Vicsek, T; Barabasi, AL			The sound of many hands clapping - Tumultuous applause can transform itself into waves of synchronized clapping	NATURE			English	Article									Univ Babes Bolyai, Dept Theoret Phys, RO-3400 Cluj Napoca, Romania; INP Grenoble, ENSEEG, LTPCM, St Martin Dheres, France; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Babes Bolyai University from Cluj; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Eotvos Lorand University; University of Notre Dame	Neda, Z (corresponding author), Univ Babes Bolyai, Dept Theoret Phys, Str Kogalniceanu 1, RO-3400 Cluj Napoca, Romania.		Néda, Zoltán/C-3754-2011; Barabasi, Albert-Laszlo/S-6474-2017; Vicsek, Tamas/A-3305-2009; Regan, Erzsébet Ravasz/AAG-8989-2019	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Barabasi, Albert/0000-0002-4028-3522				Bottani S, 1996, PHYS REV E, V54, P2334, DOI 10.1103/PhysRevE.54.2334; Glass L., 1988, CLOCKS CHAOS RHYTHMS; KURAMOTO Y, 1987, J STAT PHYS, V49, P569, DOI 10.1007/BF01009349; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; STROGATZ SH, 1997, SCI AM, V54, P2334; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3	6	436	455	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					849	850		10.1038/35002660	http://dx.doi.org/10.1038/35002660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706271	Green Submitted			2022-12-01	WOS:000085559200041
J	de Costa, CM				de Costa, CM			A matter of choice	LANCET			English	Article									Univ Queensland, Cairns Base Hosp, N Queensland Clin Sch, Dept Obstet & Gynaecol, Cairns, Qld 4870, Australia	University of Queensland	de Costa, CM (corresponding author), Univ Queensland, Cairns Base Hosp, N Queensland Clin Sch, Dept Obstet & Gynaecol, POB 902, Cairns, Qld 4870, Australia.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 19	2000	355	9204					649	650		10.1016/S0140-6736(99)11158-9	http://dx.doi.org/10.1016/S0140-6736(99)11158-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696998				2022-12-01	WOS:000085615400043
J	Hofmann, HA; Stevenson, PA				Hofmann, HA; Stevenson, PA			Flight restores fight in crickets	NATURE			English	Article									Univ Leipzig, Inst Zool, D-04103 Leipzig, Germany	Leipzig University	Hofmann, HA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Stevenson, Paul A/A-2048-2010; Hofmann, Hans A/A-1437-2008; Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CAREW TJ, 1998, MECH RELATIONSHIPS D; CHENG MF, 1992, ANIM BEHAV, V43, P1035, DOI 10.1016/0003-3472(92)90016-3; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Hofmann H, 1996, BIOL ZBL, V115, P206; Huber F., 1955, Zeitschrift fuer Tierpsychologie Berlin, V12, P12; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Lorenz Konrad, 1981, FDN ETHOLOGY; STEVENSON PA, 1987, J COMP PHYSIOL A, V161, P115, DOI 10.1007/BF00609460; WU JC, 1990, AM J PSYCHIAT, V147, P14; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366	11	84	88	9	117	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					613	613		10.1038/35001137	http://dx.doi.org/10.1038/35001137			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688185	Bronze			2022-12-01	WOS:000085288200037
J	Gartner, S				Gartner, S			AIDS - HIV infection and dementia	SCIENCE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; COLONY-STIMULATING FACTOR; EARLY SIV ENCEPHALOPATHY; BONE-MARROW MACROPHAGES; MYELODYSPLASTIC SYNDROMES; CEREBROSPINAL-FLUID; NONHUMAN-PRIMATES; POSITIVE PATIENTS; MONOCYTE SUBSET; BRAIN		Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Gartner, S (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, Meyer Bldg 6-181,600 N Wolfe St, Baltimore, MD 21287 USA.	sgartner@jhmi.edu						BELL JE, 1993, J INFECT DIS, V168, P818, DOI 10.1093/infdis/168.4.818; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; BUDKA H, 1987, ACTA NEUROPATHOL, V75, P185, DOI 10.1007/BF00687080; CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DONALDSON YK, 1994, LANCET, V343, P382, DOI 10.1016/S0140-6736(94)91222-X; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Dunne J, 1996, BRIT J BIOMED SCI, V53, P263; GALLO P, 1990, J NEUROIMMUNOL, V29, P105, DOI 10.1016/0165-5728(90)90152-D; GARTNER S, 1999, 6 C RETR OPP INF CHI; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; GOSZTONYI G, 1994, J NEUROPATH EXP NEUR, V53, P521, DOI 10.1097/00005072-199409000-00012; HIRSCH VM, 1991, J INFECT DIS, V163, P976, DOI 10.1093/infdis/163.5.976; HURTREL B, 1991, J MED PRIMATOL, V20, P159; HURTREL B, 1993, RES VIROLOGY, V144, P41, DOI 10.1016/S0923-2516(06)80010-5; KALOUTSI V, 1994, AM J CLIN PATHOL, V101, P123, DOI 10.1093/ajcp/101.2.123; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; KITAGAWA M, 1991, AM J PATHOL, V138, P921; Lane JH, 1996, J NEUROVIROL, V2, P423, DOI 10.3109/13550289609146909; LIU Y, IN PRESS J NEUROVIRO; MANDELL CP, 1995, LAB INVEST, V72, P323; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; Munn DH, 1996, BLOOD, V88, P1215, DOI 10.1182/blood.V88.4.1215.bloodjournal8841215; MUNN DH, 1990, BLOOD, V75, P2042; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Otani I, 1998, AIDS RES HUM RETROV, V14, P1181, DOI 10.1089/aid.1998.14.1181; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Persidsky Y, 1997, J IMMUNOL, V158, P3499; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; SALEH MN, 1995, BLOOD, V85, P2910, DOI 10.1182/blood.V85.10.2910.bloodjournal85102910; Sasseville VG, 1996, AM J PATHOL, V149, P1459; SASSEVILLE VG, 1992, AM J PATHOL, V141, P1021; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; SCHNEIDER DR, 1985, AM J CLIN PATHOL, V84, P144, DOI 10.1093/ajcp/84.2.144; SHAW GM, 1985, SCIENCE, V227, P177, DOI 10.1126/science.2981429; SINCLAIR E, 1994, J NEUROPATH EXP NEUR, V53, P43, DOI 10.1097/00005072-199401000-00006; Teo I, 1997, J VIROL, V71, P2928, DOI 10.1128/JVI.71.4.2928-2933.1997; TITIUS BR, 1994, ACTA HAEMATOL-BASEL, V91, P144; VAZEUX R, 1991, PATHOBIOLOGY, V59, P214, DOI 10.1159/000163648; Weiser B, 1996, AIDS RES HUM RETROV, V12, P1551, DOI 10.1089/aid.1996.12.1551; WILLIAMS K, 1999, 6 C RETR OPP INF CHI; Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999	43	272	284	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2000	287	5453					602	604		10.1126/science.287.5453.602	http://dx.doi.org/10.1126/science.287.5453.602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278KR	10691542				2022-12-01	WOS:000084989400032
J	Vella, K; Goldfrad, C; Rowan, K; Bion, J; Black, N				Vella, K; Goldfrad, C; Rowan, K; Bion, J; Black, N			Use of consensus development to establish national research priorities in critical care	BRITISH MEDICAL JOURNAL			English	Article							DELPHI	Objectives To test the Feasibility of using a nominal group technique to establish clinical and health services research priorities in critical care and to test the representativeness of the group's views. Design Generation of topics by means of a national survey a nominal group technique to establish the level of consensus: a survey to test the representativeness of the results. Setting United Kingdom and Republic of Ireland. Subjects Nominal group composed of 10 doctors (8 consultants, 2 trainees) and 2 nurses. Main outcome measure Level of support (median) and level of agreement (mean absolute deviation from the median) derived from a 9 point Likert scale. Results Of the 325 intensive care units approached. 187 (58%) responded, providing about 1000 suggestions for research Of the 106 most frequently suggested topics considered by the nominal group. 37 attracted strong support. 48 moderate support and 21 weak support. There was more agreement after the group had met-overall mean of the mean absolute deviations from the median fell from 1.41 to 1.26. The group's views represented the views of the wider community of critical care staff (r = 0.73, P < 0.01). There was no significant difference in the views of staff from teaching or from non-teaching hospitals. Of the 37 topics that attracted the strongest support, 24 were concerned with organisational aspects of critical care and only 13 with technology assessment or clinical research. Conclusions A nominal group technique is feasible and reliable for determining research priorities among clinicians. This approach is more democratic and transparent than the traditional methods used by research funding bodies. The results suggest that clinicians perceive research into the best ways of delivering and organising services as a high priority.	London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Intens Care & Natl Audit & Res Ctr, London WC1H 9HR, England; Univ Birmingham, Dept Anaesthesia & Intens Care, Birmingham B15 2TH, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre; University of Birmingham	Black, N (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.			Bion, Julian/0000-0003-0344-5403				Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Black N, 1999, J Health Serv Res Policy, V4, P236; BOND S, 1982, J ADV NURS, V7, P565, DOI 10.1111/j.1365-2648.1982.tb00277.x; Brittenham GM, 1998, ANN INTERN MED, V129, P993, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00011; Harrington JM, 1996, OCCUP ENVIRON MED, V53, P642, DOI 10.1136/oem.53.9.642; LINDEMAN CA, 1975, NURS RES, V24, P434, DOI 10.1097/00006199-197511000-00006; Mootz RD, 1997, J MANIP PHYSIOL THER, V20, P201; Rudy S F, 1996, ORL Head Neck Nurs, V14, P16; Schmidt K, 1997, J Pediatr Nurs, V12, P201, DOI 10.1016/S0882-5963(97)80002-4; Sedlak C, 1998, Orthop Nurs, V17, P51; THOMAS B, 1983, J NURS EDUC, V22, P335; vanderBeek AJ, 1997, OCCUP ENVIRON MED, V54, P504, DOI 10.1136/oem.54.7.504	12	122	123	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					976	980		10.1136/bmj.320.7240.976	http://dx.doi.org/10.1136/bmj.320.7240.976			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753149	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000086453100022
J	Kim, S; Wadsworth, WG				Kim, S; Wadsworth, WG			Positioning of longitudinal nerves in C-elegans by nidogen	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; GLR-1 GLUTAMATE-RECEPTOR; EPITHELIAL MORPHOGENESIS; BASEMENT-MEMBRANES; AXON GUIDANCE; IN-VITRO; LAMININ; COLLAGEN; BINDING; MIGRATIONS	Basement membranes can help determine pathways of migrating axons. Although members of the nidogen (entactin) protein family are structural components of basement membranes, we find that nidogen is not required for basement membrane assembly in the nematode Caenorhabditis elegans. Nidogen is Localized to body wall basement membranes and is required to direct longitudinal nerves dorsoventrally and to direct axons at the midlines. By examining migration of a single axon in vivo, we show that nidogen is required for the axon to switch from circumferential to Longitudinal migration. Specialized basement membranes may thus regulate nerve position.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wadsworth, WG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08854 USA.		Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948				Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Kadoya Y, 1997, DEVELOPMENT, V124, P683; Kim S, 1999, DEVELOPMENT, V126, P3881; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moerman DG, 1996, DEV BIOL, V173, P228, DOI 10.1006/dbio.1996.0019; NICOSIA RF, 1994, DEV BIOL, V164, P197, DOI 10.1006/dbio.1994.1191; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923; [No title captured]	30	84	95	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					150	154		10.1126/science.288.5463.150	http://dx.doi.org/10.1126/science.288.5463.150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753123				2022-12-01	WOS:000086387700055
J	Porter, EA; Wang, XF; Lee, HS; Weisblum, B; Gellman, SH				Porter, EA; Wang, XF; Lee, HS; Weisblum, B; Gellman, SH			Antibiotics - Non-haemolytic beta-amino-acid oligomers	NATURE			English	Article							PEPTIDES		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Porter, EA (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.		Lee, Hee-Seung/C-1627-2011					Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; DeGrado WF, 1999, J PEPT RES, V54, P206, DOI 10.1034/j.1399-3011.1999.00131.x; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hamuro Y, 1999, J AM CHEM SOC, V121, P12200, DOI 10.1021/ja992728p; Hintermann T, 1997, CHIMIA, V51, P244; Oren Z, 1998, BIOPOLYMERS, V47, P451; SABERWAL G, 1994, BBA-REV BIOMEMBRANES, V1197, P109, DOI 10.1016/0304-4157(94)90002-7; SEEBACH D, 1997, J CHEM SOC CHEM COMM, P2015, DOI DOI 10.1039/A704933A; Werder M, 1999, HELV CHIM ACTA, V82, P1774; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	14	619	640	1	90	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					565	565		10.1038/35007145	http://dx.doi.org/10.1038/35007145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766230	Bronze			2022-12-01	WOS:000086400100041
J	Hippisley-Cox, J; Allen, J; Pringle, M; Ebdon, D; McPhearson, M; Churchill, D; Bradley, S				Hippisley-Cox, J; Allen, J; Pringle, M; Ebdon, D; McPhearson, M; Churchill, D; Bradley, S			Association between teenage pregnancy rates and the age and sex of general practitioners: cross sectional survey in Trent 1994-7	BRITISH MEDICAL JOURNAL			English	Article							FAMILY-PLANNING-SERVICES; WOMENS HEALTH; PHYSICIANS; PREFERENCE; CARE; CONSULTATION; PREVENTION; PATTERNS; MEN	Objective To examine variations in teenage pregnancy rates in Trent region and to determine possible associations with local general practice characteristics such as the age and sex of the doctors. Design Cross sectional survey. Setting All 526 general practices in Trent region in existence between 1994 and 1997. Subjects All pregnancies of teenagers aged 13 to 19 between 1994 and 1997 that resulted in an admission to an NHS hospital. Main outcome measures Pregnancy rates for teenagers aged 13 to 19 and general practice characteristics: presence of a female or young doctor (under 36 years old), number of whole time equivalent practice nurses, Townsend score, vocational training status, list size per whole time equivalent doctor, fundholding status, and partnership size. Results On multivariate analysis, lower teenage pregnancy rates were associated with the presence of a female or young doctor and more nurse time. Practices in deprived areas had higher teenage pregnancy rates. Conclusion General practices with female doctors, young doctors, or more nurse time had lower teenage pregnancy rates. The findings may have implications for the mix of health professionals within primary care.	Queens Med Ctr, Sch Med, Div Gen Practice, Nottingham NG7 2UH, England; Queens Med Ctr, Dept Obstet & Gynaecol, Nottingham NG7 2UH, England; Queens Med Ctr, Sch Nursing, Nottingham NG7 2UH, England; Univ Nottingham, Dept Geog, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Queens Med Ctr, Sch Med, Div Gen Practice, Nottingham NG7 2UH, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Churchill, Richard/0000-0003-0049-8200; Bethea, Jane/0000-0003-0297-0468				Adler MW, 1997, BRIT MED J, V314, P1743, DOI 10.1136/bmj.314.7096.1743; BABB P, 1993, POPULATION TRENDS, V74, P12; BAKER D, 1991, BRIT MED J, V303, P225, DOI 10.1136/bmj.303.6796.225; Britt H, 1996, MED CARE, V34, P403, DOI 10.1097/00005650-199605000-00003; Carstairs V, 1991, DEPRIVATION HLTH; Craft N, 1997, BRIT MED J, V315, P1301, DOI 10.1136/bmj.315.7118.1301; CURTIS HA, 1988, ARCH DIS CHILD, V63, P373, DOI 10.1136/adc.63.4.373; Frank E, 1996, ARCH FAM MED, V5, P215, DOI 10.1001/archfami.5.4.215; GARLICK R, 1993, PUBLIC HEALTH, V107, P135, DOI 10.1016/S0033-3506(05)80411-1; Glatstein IZ, 1997, FERTIL STERIL, V67, P443, DOI 10.1016/S0015-0282(97)80067-2; JACOBSON LD, 1995, FAM PRACT, V12, P232, DOI 10.1093/fampra/12.2.232; JEFFREYS LA, 1995, BRIT J GEN PRACT, V45, P415; Kerssens JJ, 1997, SOC SCI MED, V44, P1531, DOI 10.1016/S0277-9536(96)00272-9; Langille DB, 1997, CAN FAM PHYSICIAN, V43, P1563; LAW SAT, 1995, BRIT J GEN PRACT, V45, P520; Maheux B, 1997, CAN FAM PHYSICIAN, V43, P1089; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; MELLANBY AR, 1995, BRIT MED J, V311, P414, DOI 10.1136/bmj.311.7002.414; MOORE AT, 1989, BRIT MED J, V298, P500, DOI 10.1136/bmj.298.6672.500; NHS Centre for Reviews and Dissemination University of York, 1997, EFFECTIVE HLTH CARE, V3, P1; *OFF NAT STAT, 1996, MONITOR POPUL HLTH, V96, P1; PEARSON VAH, 1995, BRIT J FAM PLAN, V21, P45; PHILLIPS DR, 1995, ATTITUDES FAMILY PLA, P403; Reid I, 1998, BRIT MED J, V317, P1051; ROWLANDS S, 1991, BRIT J GEN PRACT, V41, P138; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Secretary of State for Health, 1992, HLTH NAT STRAT HLTH; SMITH R, 1997, BRIT MED J, V314, P695; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; van den Brink-Muinen A, 1998, MED CARE, V36, P100, DOI 10.1097/00005650-199801000-00012; WEYRAUCH KF, 1990, J FAM PRACTICE, V30, P559; WILSON SH, 1992, J PUBLIC HEALTH MED, V14, P17	32	33	33	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					842	845		10.1136/bmj.320.7238.842	http://dx.doi.org/10.1136/bmj.320.7238.842			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	299DJ	10731180	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000086180300027
J	Jasny, BR				Jasny, BR			The universe of Drosophila genes	SCIENCE			English	Editorial Material																			0	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2181	2181		10.1126/science.287.5461.2181	http://dx.doi.org/10.1126/science.287.5461.2181			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744541				2022-12-01	WOS:000086049100030
J	Ritchie, KB; Nagelkerken, I; James, S; Smith, GW				Ritchie, KB; Nagelkerken, I; James, S; Smith, GW			Environmental microbiology - A tetrodotoxin-producing marine pathogen	NATURE			English	Article							MASS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Carmabi Fdn, Curacao, Neth Antilles; Clemson Univ, Dept Microbiol & Mol Med, Clemson, SC 29634 USA; Univ S Carolina, Dept Biol, Aiken, SC 29801 USA	University of North Carolina; University of North Carolina Chapel Hill; Clemson University; University of South Carolina	Ritchie, KB (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	Smithres@aiken.ac.edu	Nagelkerken, Ivan/E-1093-2011	Nagelkerken, Ivan/0000-0003-4499-3940				BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Brigmon RL, 1998, APPL ENVIRON MICROB, V64, P3491; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; MARTINEZMURCIA AJ, 1992, INT J SYST BACTERIOL, V42, P412, DOI 10.1099/00207713-42-3-412; Nagelkerken I, 1999, DIS AQUAT ORGAN, V38, P71, DOI 10.3354/dao038071; NOGUCHI T, 1987, MAR BIOL, V94, P625, DOI 10.1007/BF00431409; PETERS EC, 1993, ADV FISH SC, P393; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; SIMIDU U, 1987, APPL ENVIRON MICROB, V53, P1714, DOI 10.1128/AEM.53.7.1714-1715.1987; YOTSU M, 1987, TOXICON, V25, P225, DOI 10.1016/0041-0101(87)90245-5	12	40	42	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					354	354		10.1038/35006168	http://dx.doi.org/10.1038/35006168			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746714	Bronze			2022-12-01	WOS:000086119000039
J	Cook, RI; Render, M; Woods, DD				Cook, RI; Render, M; Woods, DD			Gaps in the continuity of care and progress on patient safety	BRITISH MEDICAL JOURNAL			English	Article									Univ Chicago, VA Patient Safety Ctr Inquiry GAPS, Chicago, IL 60637 USA; Cincinnati VAMC, VA Patient Safety Ctr Inquiry GAPS, Cincinnati, OH 45220 USA; Ohio State Univ, VA Patient Safety Ctr Inquiry GAPS, Columbus, OH 43210 USA	University of Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; Ohio State University	Cook, RI (corresponding author), Univ Chicago, VA Patient Safety Ctr Inquiry GAPS, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.							BARLEY SR, 1997, CRAFT SCI TECHNICAL, P16; Cook R., 1998, TALE 2 STORIES CONTR; Cook RI, 1994, HUMAN ERROR MED, P255; COOK RI, 1999, ENHANCING PATIENT SA, P61; Klein G., 2017, SOURCES POWER PEOPLE, V20th Anniversary Edition; Kohn LTCJ., BUILDING SAFER HLTH; *NAT PAT SAF FDN, 1999, AG RES DEV PAT SAF; RASMUSSEN J, 1994, COGNITIVE SYSTEMS EN, P135; SENDERS JW, 1999, ENHANCING PATIENT SA, P65; Woods D.D., 1988, TASKS ERRORS MENTAL, P128; WOODS DD, 1999, HDB APPL COGNITION, P141	11	323	327	0	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					791	794		10.1136/bmj.320.7237.791	http://dx.doi.org/10.1136/bmj.320.7237.791			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720370	Green Published			2022-12-01	WOS:000086054700035
J	Doncaster, CP; Pound, GE; Cox, SJ				Doncaster, CP; Pound, GE; Cox, SJ			The ecological cost of sex	NATURE			English	Article							COEXISTENCE; COEVOLUTION; DIVERSITY; SELECTION; CLONES; MODEL	Why sex prevails in nature remains one of the great puzzles of evolution(1,2). Sexual reproduction has an immediate cost relative to asexual reproduction, as males only express their contribution to population growth through females. With no males to sustain, an asexual mutant can double its relative representation in the population in successive generations. This is the widely accepted 'twofold cost of males'(1-3). Many studies(4-7) have attempted to explain how sex can recoup this cost from fitness benefits associated with the recombination of parental genotypes, but these require complex biological environments that cycle over evolutionary timescales. In contrast, we have considered the ecological dynamics that govern asexual invasion. Here we show the existence of a threshold growth rate for the sexual population, above which the invasion is halted by intraspecific competition. The asexual population then exerts a weaker inhibitory effect on the carrying capacity of the sexual population than on its own carrying capacity. The stable outcome of this is coexistence on a depleted resource base. Under these ecological circumstances, longer-term benefits of sex may eventually drive out the asexual competitor.	Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Southampton SO16 7PX, Hants, England; Univ Southampton, Dept Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton	Doncaster, CP (corresponding author), Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	cpd@soton.ac.uk	Doncaster, C. Patrick/AAT-7621-2020	Doncaster, C. Patrick/0000-0001-9406-0693				Begon M., 1996, ECOLOGY; Bell G., 1982, MASTERPIECE NATURE; BOLGER DT, 1994, OECOLOGIA, V100, P397, DOI 10.1007/BF00317861; BROWNE RA, 1990, EVOLUTION, V44, P1035, DOI 10.1111/j.1558-5646.1990.tb03824.x; BULEMR M, 1994, THEORETICAL EVOLUTIO; CASE TJ, 1986, EVOLUTION, V40, P366, DOI 10.1111/j.1558-5646.1986.tb00478.x; CASE TJ, 1990, OECOLOGIA, V83, P220, DOI 10.1007/BF00317756; Connolly SR, 1999, ECOL MONOGR, V69, P277, DOI 10.1890/0012-9615(1999)069[0277:TOMCCP]2.0.CO;2; Doebeli M, 1996, ECOLOGY, V77, P510, DOI 10.2307/2265626; Futuyama D.J., 1998, EVOLUTIONARY BIOL; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Jokela J, 1997, EVOLUTION, V51, P1120, DOI 10.1111/j.1558-5646.1997.tb03959.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Levins R., 1970, SOME MATH PROBLEMS B, P75; Lively CM, 1996, BIOSCIENCE, V46, P107, DOI 10.2307/1312813; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; Maynard Smith, 1998, EVOL GENET; Maynard-Smith J., 1978, MODELS ECOLOGY; Ridley M., 1996, EVOLUTION; Semlitsch RD, 1997, EVOLUTION, V51, P1249, DOI 10.1111/j.1558-5646.1997.tb03972.x; Skelton P., 1993, EVOLUTION BIOL PALAE; Stearns S.C., 2000, EVOLUTION INTRO; VJIJENHOEK RC, 1997, EVOLUTION, V51, P1593; Volterra V., 1931, ANIMAL ECOLOGY, P409; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Weeks AR, 1998, EVOLUTION, V52, P1325, DOI 10.2307/2411302; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	29	111	114	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					281	285		10.1038/35005078	http://dx.doi.org/10.1038/35005078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749210				2022-12-01	WOS:000086022200048
J	Yudkin, JS				Yudkin, JS			Insulin for the world's poorest countries	LANCET			English	Article							AFRICA	In the industrialised world, type 1 diabetes rarely results in death from ketoacidosis. The same is not true in many countries in the developing world where insulin availability is intermittent, and insulin may not even be included on national formularies of essential drugs. The life expectancy for a newly diagnosed patient with type 1 diabetes in some parts of Africa may be as short as 1 year. The World Bank has identified 40 highly indebted poor countries (HIPCs) whose national debt substantially exceeds any possibility of repayment without heavy impact on health and social programmes. Incidence and prognosis of type 1 diabetes in HIPCs are lower than in most industrialised countries, and 0.48% of the world's current use of insulin is estimated to be sufficient to treat all type 1 diabetic patients in these countries. A proposal is made for the major insulin manufacturers to donate insulin, at an estimated cost of US$3-5 million per year, as part of a distribution and education initiative for type 1 diabetic patients in the HIPCs. No type 1 diabetic patient in the world's poorest countries need then die because they, or their government, cannot afford insulin.	Royal Free & UCL Sch Med, Whittington Hosp, London N19 3UA, England	University of London; University College London	Yudkin, JS (corresponding author), Royal Free & UCL Sch Med, Whittington Hosp, London N19 3UA, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008					Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Abbasi K, 1999, BRIT MED J, V318, P865, DOI 10.1136/bmj.318.7187.865; Abbasi K, 1999, BMJ-BRIT MED J, V318, P1568, DOI 10.1136/bmj.318.7198.1568; ALBERTI KGM, 1994, WORLD HEALTH FORUM, V15, P6; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; CASTLE WM, 1980, DIABETOLOGIA, V18, P121, DOI 10.1007/BF00290487; CHALE SS, 1992, BRIT MED J, V304, P1215, DOI 10.1136/bmj.304.6836.1215; CHANTELAU E, 1993, LANCET, V342, P620, DOI 10.1016/0140-6736(93)91447-T; Decosas J, 1999, LANCET, V353, P143, DOI 10.1016/S0140-6736(98)11454-X; DEEB LC, 1994, DIABETES CARE, V17, P220, DOI 10.2337/diacare.17.3.220; Gill G. V., 1997, DIABETES AFRICA, P65; MAKAME MH, 1992, DIABETIC MED, V9, P571, DOI 10.1111/j.1464-5491.1992.tb01841.x; McLarty D. G., 1994, International Diabetes Digest, V5, P15; RAAB R, 1999, PRACT DIABETES INT, V16, P58; SAVAGE A, 1994, INT DIABETES DIGEST, V5, P19; United Nations Development Programme, 1997, HUM DEV REP; World Bank, 1993, WORLD DEV REP 1993 I, V1; Yudkin JS, 1999, LANCET, V353, P1519, DOI 10.1016/S0140-6736(98)09440-9; Zaffran M, 1996, DEV BIOL STAND, V87, P9; 1996, JUBILEE 2000 DEBT CU; 1999, LYMPHATIC FILARIASIS	21	45	46	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2000	355	9207					919	+		10.1016/S0140-6736(99)09225-9	http://dx.doi.org/10.1016/S0140-6736(99)09225-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752719				2022-12-01	WOS:000085896000042
J	Cutfield, WS; Wilton, P; Bennmarker, H; Albertsson-Wikland, K; Chatelain, P; Ranke, MB; Price, DA				Cutfield, WS; Wilton, P; Bennmarker, H; Albertsson-Wikland, K; Chatelain, P; Ranke, MB; Price, DA			Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment	LANCET			English	Article							RISING INCIDENCE; INSULIN; IDDM	Background Growth hormone (GH) contributes to insulin resistance, but whether children treated with GH are at increased risk of diabetes has not been established. We undertook a retrospective analysis of data from an international pharmacoepidemiological survey of children treated with GH to find out the incidence of impaired glucose tolerance and types 1 and 2 diabetes mellitus. Methods Reports to the survey of abnormal glucose metabolism were investigated and classified. The incidence and age-distribution of type 1 diabetes were compared with values from a model of reference data. The incidence of type 2 diabetes was compared with data from two reports of children not treated with GH. Findings 85 (0.36%) of 23 333 children were reported with abnormal glucose metabolism. After investigation, 43 had confirmed glucose disorders (11 with type 1 diabetes, 18 with type 2 diabetes, and 14 with impaired glucose tolerance). The incidence and age at diagnosis of type 1 diabetes in children treated with GH did not differ from expected values. The incidence of type 2 diabetes was 34.4 cases per 100 000 years of GH treatment which was six-fold higher than reported in children not treated with GH. Type 2 diabetes did not resolve after GH therapy was stopped. Interpretation GH treatment did not affect the incidence of type 1 diabetes mellitus in any age group. We postulate that the higher than expected incidence of type 2 diabetes mellitus with GH treatment may be an acceleration of the disorder in predisposed individuals.	Univ Auckland, Dept Paediat, Auckland, New Zealand; Pharmacia & Upjohn Inc, Stockholm, Sweden; East Hosp, Dept Paediat, Gothenburg, Sweden; Univ Lyon 1, Serv Pediat Endocrinol & Diabetol Infantiles, Hop Debrousse, F-69365 Lyon, France; Univ Tubingen, Childrens Hosp, Tubingen, Germany; St Marys Hosp, Dept Paediat, Manchester M13 0JH, Lancs, England	University of Auckland; Pfizer; Pharmacia Corporation; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Manchester	Cutfield, WS (corresponding author), Univ Auckland, Dept Paediat, Private Bag 92019, Auckland, New Zealand.	waynec@ahsl.co.nz	Albertsson-Wikland, Kerstin/D-3843-2012					AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402; Blethen SL, 1996, J CLIN ENDOCR METAB, V81, P1704, DOI 10.1210/jc.81.5.1704; BOUGNERES PF, 1990, ACTA PAEDIATR SCAND, P38; CAPRIO S, 1992, HORM RES, V38, P47, DOI 10.1159/000182594; CUTFIELD WS, 1990, J CLIN ENDOCR METAB, V70, P1644, DOI 10.1210/jcem-70-6-1644; CZERNICHOW P, 1993, HORM RES, V39, P102; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; JADRESIC A, 1982, Q J MED, V51, P189; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KITAGAWA T, 1994, DIABETES RES CLIN PR, V24, pS7, DOI 10.1016/0168-8227(94)90221-6; Neu A, 1997, DIABETES CARE, V20, P530, DOI 10.2337/diacare.20.4.530; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rangasami JJ, 1997, ARCH DIS CHILD, V77, P210, DOI 10.1136/adc.77.3.210; REWERS M, 1988, World Health Statistics Quarterly, V41, P179; SHIZUME K, 1984, ENDOCRINOL JAPON, V31, P201; Smith TR, 1997, AM J PHYSIOL-ENDOC M, V272, pE1071, DOI 10.1152/ajpendo.1997.272.6.E1071; VERGE CF, 1994, DIABETES CARE, V17, P693, DOI 10.2337/diacare.17.7.693; WASS JAH, 1980, CLIN ENDOCRINOL, V12, P53, DOI 10.1111/j.1365-2265.1980.tb03132.x	22	211	220	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					610	613		10.1016/S0140-6736(99)04055-6	http://dx.doi.org/10.1016/S0140-6736(99)04055-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696981				2022-12-01	WOS:000085615400012
J	Grosman, C; Zhou, M; Auerbach, A				Grosman, C; Zhou, M; Auerbach, A			Mapping the conformational wave of acetylcholine receptor channel gating	NATURE			English	Article							FREE-ENERGY RELATIONSHIPS; ENGINEERED PROTEINS; MECHANISM; VOLTAGE; ENZYME	Allosteric transitions allow fast regulation of protein function in living systems. Even though the end points of such conformational changes are known for many proteins, the characteristics of the paths connecting these states remain largely unexplored. Rate-equilibrium linear free-energy relationships (LFERs) provide information about such pathways by relating changes in the free energy of the transition state to those of the ground states upon systematic perturbation of the system(1). Here we present an LFER analysis of the gating reaction pathway of the muscle acetylcholine receptor. We studied the closed reversible arrow open conformational change at the single-molecule level following perturbation by series of single-site mutations, agonists and membrane voltages. This method provided a snapshot of several regions of the receptor at the transition state in terms of their approximate positions along the reaction coordinate, on a scale from 0 (closed-like) to 1 (open-like). The resulting map reveals a spatial gradient of positional values, which suggests that the conformational change proceeds in a wave-like manner, with the low-to-high affinity change at the transmitter-binding sites preceding the complete opening of the pore.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Grosman, C (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.			Grosman, Claudio/0000-0001-8093-8362				Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Akk G, 1996, J PHYSIOL-LONDON, V496, P185, DOI 10.1113/jphysiol.1996.sp021676; Auerbach A, 1996, J PHYSIOL-LONDON, V494, P155, DOI 10.1113/jphysiol.1996.sp021482; EATON WA, 1991, P NATL ACAD SCI USA, V88, P4472, DOI 10.1073/pnas.88.10.4472; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; ESTELL DA, 1986, SCIENCE, V233, P659, DOI 10.1126/science.233.4764.659; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FERSHT AR, 1986, NATURE, V322, P284, DOI 10.1038/322284a0; FERSHT AR, 1995, CURR OPIN STRUC BIOL, V5, P79, DOI 10.1016/0959-440X(95)80012-P; Grunwald E., 1989, RATES EQUILIBRIA ORG; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hammett L. P., 1972, ADV LINEAR FREE ENER, pvii; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kirsch JF., 1972, ADV LINEAR FREE ENER, P369, DOI [10.1007/978-1-4615-8660-9_8, DOI 10.1007/978-1-4615-8660-9_8]; KYTE J, 1995, MECHANISM PROTEIN CH, P461; LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; STRAUB JE, 1990, PROTEIN ENG, V3, P673, DOI 10.1093/protein/3.8.673; Sunderman ER, 1999, J GEN PHYSIOL, V113, P621, DOI 10.1085/jgp.113.5.621; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Yifrach O, 1998, J AM CHEM SOC, V120, P13262, DOI 10.1021/ja983136u; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	31	280	282	1	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					773	776		10.1038/35001586	http://dx.doi.org/10.1038/35001586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693806				2022-12-01	WOS:000085423100053
J	Jones, G				Jones, G			Total internal reflection - The secret of the accidental immortals can now be made known.	NATURE			English	Editorial Material																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					707	707		10.1038/35001682	http://dx.doi.org/10.1038/35001682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693780	Bronze			2022-12-01	WOS:000085423100027
J	Molinari, M; Helenius, A				Molinari, M; Helenius, A			Chaperone selection during glycoprotein translocation into the endoplasmic reticulum	SCIENCE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; CHAIN BINDING-PROTEIN; SEQUENTIAL INTERACTION; BIP; ASSOCIATION; CALNEXIN; TRANSPORT; SECRETION; GLYCOSYLATION; MATURATION	A variety of molecular chaperones and folding enzymes assist the folding of newly synthesized proteins in the endoplasmic reticulum. Here we investigated why some glycoproteins interact with the molecular chaperone sip, and others with the calnexin/calreticulin pathway. The folding of Semliki forest virus glycoproteins and influenza hemagglutinin was studied in Living cells. The initial choice of chaperone depended on the Location of N-linked glycans in the growing nascent chain. Direct interaction with calnexin and calreticulin without prior interaction with BiP occurred if glycans were present within about 50 residues of the protein's NH2-terminus.	ETH Zurich, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH Zurich, Univ Str 16, CH-8092 Zurich, Switzerland.		Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829				BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; Knarr G, 1999, J BIOL CHEM, V274, P29850, DOI 10.1074/jbc.274.42.29850; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; PITTMAN DD, 1994, J BIOL CHEM, V269, P17329; SU K, 1993, J BIOL CHEM, V268, P14301; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; ZHANG Y, 1993, BIOCHEM J, V295, P841, DOI 10.1042/bj2950841	21	273	282	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					331	333		10.1126/science.288.5464.331	http://dx.doi.org/10.1126/science.288.5464.331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764645				2022-12-01	WOS:000086454300036
J	Purvis, A; Agapow, PM; Gittleman, JL; Mace, GM				Purvis, A; Agapow, PM; Gittleman, JL; Mace, GM			Nonrandom extinction and the loss of evolutionary history	SCIENCE			English	Article							DIVERSITY; PHYLOGENY; FUTURE	The hierarchical nature of phylogenies means that random extinction of species affects a smaller fraction of higher taxa, and so the total amount of evolutionary history lost may be comparatively slight. However, current extinction risk is not phylogenetically random. We show the potentially severe implications of the clumped nature of threat for the loss of biodiversity. An additional 120 avian and mammalian genera are at risk compared with the number predicted under random extinction. We estimate that the prospective extra Loss of mammalian evolutionary history alone would be equivalent to Losing a monotypic phylum.	Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; University of Virginia; Zoological Society of London	Purvis, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.		Purvis, Andy/A-7529-2008; Mace, Georgina M/I-3072-2016	Purvis, Andy/0000-0002-8609-6204; Mace, Georgina M/0000-0001-8965-5211				AVISE JC, 1982, EVOL BIOL, V15, P151; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Faith Daniel P., 1994, V50, P251; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gaston KJ, 1997, EVOL ECOL, V11, P557, DOI 10.1007/s10682-997-1511-4; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Heywood V. H., 1995, GLOBAL BIODIVERSITY; IUCN, 2021, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; IUCN (International Union for Conservation of Nature), 1994, IUCN RED LIST CAT; MACE GM, 1999, FUTURE PRIORITIES CO; MacPhee R.D.E., 1999, P333; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; May Robert M., 1995, P1; Morony JJ, 1975, REFERENCE LIST BIRDS; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Rylands Anthony B., 1995, Neotropical Primates, V3, P113; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams Paul H., 1996, P261; Williams Paul H., 1996, P54; Wilson DE, 1993, MAMMAL SPECIES WORLD	25	393	400	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					328	330		10.1126/science.288.5464.328	http://dx.doi.org/10.1126/science.288.5464.328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764644				2022-12-01	WOS:000086454300035
J	Yusuf, HR; Akhter, HH; Rahman, MH; Chowdhury, MEEK; Rochat, RW				Yusuf, HR; Akhter, HH; Rahman, MH; Chowdhury, MEEK; Rochat, RW			Injury-related deaths among women aged 10-50 years in Bangladesh, 1996-97	LANCET			English	Article							RURAL BANGLADESH; EPIDEMIOLOGY; DELHI; INDIA	Background Few studies have examined injury-related deaths among women in Bangladesh. We did a case-finding study to identify causes and the impact of intentional and unintentional injury-related deaths among women aged 10-50 years in Bangladesh. Methods Between 1996 and 1997, health care and other service providers at 4751 health facilities throughout Bangladesh were interviewed about their knowledge of deaths among women aged 10-50 years. In addition, at all public facilities providing inpatient service. medical records of women who died during the study period were reviewed. The reported circumstances surrounding each death were carefully reviewed to attribute the most likely cause of death. Findings 28 998 deaths among women aged 10-50 years were identified in our study, and, of these, 6610 (23%) were thought to be caused by intentional or unintentional injuries. About half (3317) of the injury deaths were attributable to suicide, 352 (5%) to homicide, 1100 (17%) to accidental injuries, and the intent was unknown for 1841 (28%) deaths. The unadjusted rate of suicides were higher in the Khulna administrative division (27.0 per 100 000) than the other four administrative divisions of Bangladesh (range 3.5-11.3 per 100 000). Poisoning (n=3971) was the commonest cause of injury-related death-60% of all injury deaths (6610) and 14% of all deaths (28 998). Other common causes of injury deaths in order of frequency were hanging or suffocation, road traffic accidents, bums, drowning, physical assault, firearm or sharp instrument injury, and snake or animal bite. Interpretation Intentional and unintentional injuries are a major cause of death among women aged 10-50 years in Bangladesh. Strategies to reduce injury-related deaths among women need to be devised.	Ctr Dis Control & Prevent, Immunisat Serv Div, Hlth Serv Res & Evaluat Branch, Atlanta, GA 30333 USA; Bangladesh Inst Res & Promot Essential & Reprod H, Dhaka, Bangladesh; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Yusuf, HR (corresponding author), Ctr Dis Control & Prevent, Immunisat Serv Div, Hlth Serv Res & Evaluat Branch, Atlanta, GA 30333 USA.		Rochat, Roger/J-9802-2012					Adityanjee D R, 1986, Int J Soc Psychiatry, V32, P64, DOI 10.1177/002076408603200208; *BANGL BUR STAT, 1994, HDSPUB004 BANGL BUR; *BANGL BUR STAT, 1994, BANGL POP CENS 1991, V1, P98; Bhattacharjee JB, 1996, MED SCI LAW, V36, P194, DOI 10.1177/002580249603600303; FAUVEAU V, 1989, INT J EPIDEMIOL, V18, P139, DOI 10.1093/ije/18.1.139; FAUVEAU V, 1988, B WORLD HEALTH ORGAN, V66, P643; ISLAM S, 1985, WOMEN VICTIMS VIOLEN; KUMAR P, 1994, BURNS, V20, P236, DOI 10.1016/0305-4179(94)90189-9; Latha KS, 1996, ACTA PSYCHIAT SCAND, V94, P26, DOI 10.1111/j.1600-0447.1996.tb09820.x; MAHLER H, 1987, LANCET, V1, P668; MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1, P117; NAGPAUL H, 1985, INT J OFFENDER THER, V29, P147, DOI 10.1177/0306624X8502900207; PANDEY R, 1985, INDIAN J SOC WORK, V45, P429; PANDEY R, 1986, SOCIAL DEFENSE, V21, P5; PRASAD BD, 1994, J COMP FAM STUD, V25, P71, DOI 10.3138/jcfs.25.1.71; ROCHAT R W, 1981, International Journal of Gynecology and Obstetrics, V19, P155, DOI 10.1016/0020-7292(81)90056-4; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SHIQING Z, 1994, CRISIS, V15, P44; SMITH GS, 1991, EPIDEMIOL REV, V13, P228, DOI 10.1093/oxfordjournals.epirev.a036070; STEIN S, 1986, INT J EPIDEMIOL, V15, P303; *WHO, 1978, LAY REP HLTH INF; *WHO, 1993, WHO2 REG OFF SE AS	22	41	42	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1220	1224		10.1016/S0140-6736(00)02088-2	http://dx.doi.org/10.1016/S0140-6736(00)02088-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303VX	10770304				2022-12-01	WOS:000086448000011
J	Chong, L; Culotta, E; Sugden, A				Chong, L; Culotta, E; Sugden, A			On the move	SCIENCE			English	Editorial Material																			0	15	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					79	79		10.1126/science.288.5463.79	http://dx.doi.org/10.1126/science.288.5463.79			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766639				2022-12-01	WOS:000086387700033
J	Lloyd, BW; Brodie, K				Lloyd, BW; Brodie, K			Recognition of television images as a developmental milestone in young children: observational study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine the age at which children with apparently normal development can recognise the television image of a cat, dog, or baby. Design Observational study. Setting District general hospital in north London. Subjects 797 children with apparently normal development aged between 8 and 23 months and 26 children with Down's syndrome aged 18 months. Outcome measures Whether or not the child recognised the television image of a cat, dog, or baby by naming, imitating, or pointing at the image. Results by 18 months of age 96% (95% confidence interval 94% to 98%) of normal children recognised the television image of a cat, dog, or baby compared with 5 of 26 (19%) children with Down's syndrome. Conclusion Recognition of the television image of a cat, dog, or baby is a simple milestone, which may help in the developmental assessment of young children.	N Middlesex Hosp, Childrens Dept, London N18 1QX, England		Lloyd, BW (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.							Baron-Cohen Simon, 1996, British Journal of Psychiatry, V168, P158, DOI 10.1192/bjp.168.2.158; Bayley N., 1993, BAYLEY SCALES INFANT; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; HUNTLEY M, 1996, GRIFFITHMS MENTAL DE; REYNELL J, 1980, LANGUAGE DEV ASSESSM; Sheridan M., 1997, BIRTH 5 YEARS CHILDR	6	2	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					836	838		10.1136/bmj.320.7238.836	http://dx.doi.org/10.1136/bmj.320.7238.836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	299DJ	10731175	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000086180300023
J	Power, C; Li, L				Power, C; Li, L			Cohort study of birthweight, mortality, and disability	BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; INFANTS		Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	University of London; University College London	Power, C (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, 30 Guilford St, London WC1N 1EH, England.							FERRI E, 1993, LIFE 33 5 FOLLOW UP; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P264, DOI 10.1136/adc.70.4.264; STEWART AL, 1981, LANCET, V1, P1038; WEIR W, 1992, ARCH DIS CHILD, V67, P675	5	24	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					840	841		10.1136/bmj.320.7238.840	http://dx.doi.org/10.1136/bmj.320.7238.840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731178	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000086180300026
J	Rubin, GM; Hong, L; Brokstein, P; Evans-Holm, M; Frise, E; Stapleton, M; Harvey, DA				Rubin, GM; Hong, L; Brokstein, P; Evans-Holm, M; Frise, E; Stapleton, M; Harvey, DA			A Drosophila complementary DNA resource	SCIENCE			English	Editorial Material							EXPRESSED SEQUENCE TAGS	Collections of nonredundant, full-length complementary DNA (cDNA) clones for each of the model organisms and humans will be important resources for studies of gene structure and function. We describe a general strategy for producing such collections and its implementation, which so far has generated a set of cDNAs corresponding to over 40% of the genes in the fruit fly Drosophila melanogaster.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rubin, GM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA.			Rubin, Gerald/0000-0001-8762-8703				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; MUNROE DJ, 1995, P NATL ACAD SCI USA, V92, P2209, DOI 10.1073/pnas.92.6.2209; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455	7	289	361	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2222	2224		10.1126/science.287.5461.2222	http://dx.doi.org/10.1126/science.287.5461.2222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731138				2022-12-01	WOS:000086049100039
J	El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS				El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS			Interleukin-1 polymorphisms associated with increased risk of gastric cancer	NATURE			English	Article							HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; DUODENAL-ULCER DISEASE; ACID-SECRETION; RECEPTOR; CELLS; PATHWAYS	Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease(1). The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion(2), whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy(3), which are presumptive precursors of gastric cancer(4). Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are hi near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA-protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine(5) and a powerful inhibitor of gastric acid secretion(6,7). Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.	NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; NCI, Intramural Res Support Program, Sci Applicat Int Corp Frederick, Frederick Canc Res & Dev Ctr, Bethesda, MD 20892 USA; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; NCI, Div Basic Sci, Frederick Canc Res & Dev Ctr, Bethesda, MD 20892 USA; M Sklodowska Curie Inst Oncol, Warsaw, Poland; Ctr Canc, Div Canc Epidemiol & Prevent, Warsaw, Poland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Glasgow; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Maria Sklodowska-Curie National Research Institute of Oncology	El-Omar, EM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	elomare@mail.nih.gov	El-Omar, Emad/AAT-7780-2021; Lissowska, Jolanta/AAH-3252-2020; Garza-González, Elvira/B-7569-2009; Young, Howard/A-6350-2008	Lissowska, Jolanta/0000-0003-2695-5799; El-Omar, Emad/0000-0002-0011-3924; Young, Howard/0000-0002-3118-5111; Bream, Jay/0000-0002-9149-7643	NATIONAL CANCER INSTITUTE [Z01CP010136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; BIDWELL JL, CYTOKINE GENE POLYM; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; CORREA P, 1992, CANCER RES, V52, P6735; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; RUIZ B, 1994, AM J GASTROENTEROL, V89, P533; SANTODONATO J, 1981, J ENVIRON PATHOL TOX, V5, P1; SIPPONEN P, 1994, SCAND J GASTROENTERO, V29, P24, DOI 10.3109/00365529409105356; STOCKBRUEGGER RW, 1984, SCAND J GASTROENTERO, V19, P355, DOI 10.1080/00365521.1984.12005735; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wolfe M M, 1992, Gastroenterology, V102, P2177; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yu CR, 1996, J IMMUNOL, V157, P126	30	1799	1912	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					398	402		10.1038/35006081	http://dx.doi.org/10.1038/35006081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746728	Green Accepted, Green Published			2022-12-01	WOS:000086119000053
J	Gu, L; Tseng, S; Horner, RM; Tam, C; Loda, M; Rollins, BJ				Gu, L; Tseng, S; Horner, RM; Tam, C; Loda, M; Rollins, BJ			Control of T(H)2 polarization by the chemokine monocyte chemoattractant protein-1	NATURE			English	Article							T-LYMPHOCYTES; CHEMOTACTIC RESPONSIVENESS; TRANSGENIC MICE; CELL-LINE; EXPRESSION; RECEPTOR; INDUCTION; CLONING; PURIFICATION; RECRUITMENT	Activated T lymphocytes differentiate into effector cells tailored to meet disparate challenges to host integrity(1). For example, type 1 and type 2 helper (T(H)1 and T(H)2) cells secrete cytokines that enhance cell-mediated and humoral immunity, respectively. The chemokine monocyte chemoattractant protein-1 (MCP-1) can stimulate interleukin-4 production(2) and its overexpression is associated with defects in cell-mediated immunity(3), indicating that it might be involved in T(H)2 polarization. Here we show that MCP-1-deficient mice are unable to mount T(H)2 responses. Lymph node cells from immunized MCP-1(-/-) mice synthesize extremely low levels of interleukin-4, interleukin-5 and interleukin-10, but normal amounts of interferon-gamma and interleukin-2. Consequently, these mice do not accomplish the immunoglobulin subclass switch that is characteristic of T(H)2 responses and are resistant to Leishmania major. These effects are direct rather than due to abnormal cell migration, because the trafficking of naive T cells is undisturbed in MCP-1(-/-) mice despite the presence of MCP-1-expressing cells in secondary lymphoid organs of wild-type mice. Thus, MCP-1 influences both innate immunity, through effects on monocytes, and adaptive immunity, through control of T helper cell polarization.	Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.			Tam-Amersdorfer, Carmen/0000-0003-3123-6342				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALLAVENA P, 1994, EUR J IMMUNOL, V24, P3233, DOI 10.1002/eji.1830241249; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CHENSUE SW, 1995, AM J PATHOL, V146, P130; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Gunn MD, 1997, J IMMUNOL, V158, P376; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Warmington KS, 1999, AM J PATHOL, V154, P1407, DOI 10.1016/S0002-9440(10)65394-1; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449	30	690	717	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					407	411		10.1038/35006097	http://dx.doi.org/10.1038/35006097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746730				2022-12-01	WOS:000086119000055
J	Nolan, TW				Nolan, TW			System changes to improve patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; TASK COMPLEXITY; MEDICINE		Associates Proc Improvement, Silver Spring, MD 20910 USA		Nolan, TW (corresponding author), Associates Proc Improvement, 1110 Bonifant St, Silver Spring, MD 20910 USA.	TNolan@apiweb.org						BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cook RI, 1994, HUMAN ERROR MED, P255; Fraass BA, 1998, INT J RADIAT ONCOL, V42, P651, DOI 10.1016/S0360-3016(98)00244-2; HINCKLEY CM, 1995, J QUAL TECHNOL, V27, P242, DOI 10.1080/00224065.1995.11979596; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEVENSON MD, 1993, SOLID STATE TECHNOL, V36, P18; LEVESON NG, 1993, SAFEWARE SYSTEMS SAF; MAYLOR EA, 1992, Q J EXP PSYCHOL-A, V44, P119, DOI 10.1080/14640749208401286; Murray SA, 1996, HUM FACTORS, V38, P323, DOI 10.1518/001872096779048011; Norman D.A., 1988, PSYCHOL EVERYDAY THI; Norman Donald A., 1993, THINGS MAKE US SMART; Park K, 1997, HDB HUMAN FACTORS ER, P150; Reason J., 1990, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Salvendy G., 2021, HDB HUMAN FACTORS ER; SARTER NB, 1992, INT J AVIAT PSYCHOL, V4, P1; Strong MJ, 1999, NEUROLOGY, V53, pS31; Ushakov IA, 1994, HDB RELIABILITY ENG; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; WICHMAN H, 1983, HUM FACTORS, V25, P583, DOI 10.1177/001872088302500512	22	202	217	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2000	320	7237					771	773		10.1136/bmj.320.7237.771	http://dx.doi.org/10.1136/bmj.320.7237.771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YQ	10720364	Green Published			2022-12-01	WOS:000086054700029
J	Abdurashidova, G; Deganuto, M; Klima, R; Riva, S; Biamonti, G; Giacca, M; Falaschi, A				Abdurashidova, G; Deganuto, M; Klima, R; Riva, S; Biamonti, G; Giacca, M; Falaschi, A			Start sites of bidirectional DNA synthesis at the human lamin B2 origin	SCIENCE			English	Article							REPLICATION ORIGIN; RECOGNITION COMPLEX; IN-VIVO; IDENTIFICATION; PROTEINS; MEMBER	The initiation sites of bidirectional synthesis at the DNA replication origin located at the 3' end of the human lamin B2 gene were investigated. RNA-primed nascent DNA molecules were subjected to second-strand synthesis with appropriate primers, amplified by ligation-mediated polymerase chain reaction, and size fractionated. Evidence for precise start sites was obtained. Exploration of close to 1 kilobase, coupled to inhibition of Okazaki fragment synthesis, demonstrates that the leading strands initiate at precise nucleotides on either helix, overlapping by three base pairs, within the area bound to a protein complex possibly analogous to the prereplicative complex of yeast.	Int Ctr Genet Engn & Biotechnol, Mol Biol Unit, I-34012 Trieste, Italy; Int Ctr Genet Engn & Biotechnol, Mol Med Unit, I-34012 Trieste, Italy; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR)	Falaschi, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Biol Unit, Padriciano 99, I-34012 Trieste, Italy.		Giacca, Mauro/J-9287-2016	Giacca, Mauro/0000-0003-2927-7225; BIAMONTI, GIUSEPPE/0000-0001-6804-4315				Abdurashidova G, 1998, EMBO J, V17, P2961, DOI 10.1093/emboj/17.10.2961; BIAMONTI G, 1992, CHROMOSOMA, V102, pS24, DOI 10.1007/BF02451782; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Dimitrova DS, 1996, P NATL ACAD SCI USA, V93, P1498, DOI 10.1073/pnas.93.4.1498; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Giacca M, 1997, METHODS, V13, P301, DOI 10.1006/meth.1997.0529; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kumar S, 1996, NUCLEIC ACIDS RES, V24, P3289, DOI 10.1093/nar/24.17.3289; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; QUIVY JP, 1993, NUCLEIC ACIDS RES, V21, P2779, DOI 10.1093/nar/21.11.2779; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421	19	148	152	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2023	2026		10.1126/science.287.5460.2023	http://dx.doi.org/10.1126/science.287.5460.2023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720330				2022-12-01	WOS:000085902800064
J	Akashi, K; Traver, D; Miyamoto, T; Weissman, IL				Akashi, K; Traver, D; Miyamoto, T; Weissman, IL			A clonogenic common myeloid progenitor that gives rise to all myeloid lineages	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-1; MICE; GENE; DIFFERENTIATION; LEUKEMIA; SYSTEM; LYMPHOPOIESIS; COMMITMENT; LACKING	Haematopoietic stem cells give rise to progeny that progressively lose self-renewal capacity and become restricted to one lineage(1,2). The points at which haematopoietic stem cell-derived progenitors commit to each of the various lineages remain mostly unknown. We have identified a clonogenic common lymphoid progenitor that can differentiate into T, B and natural killer cells but not myeloid cells(3). Here we report the prospective identification, purification and characterization, using cell-surface markers and flow cytometry, of a complementary clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Common myeloid progenitors give rise to either megakaryocyte/erythrocyte or granulocyte/macrophage progenitors. Purified progenitors were used to provide a first-pass expression profile of various haematopoiesis-related genes. We propose that the common lymphoid progenitor and common myeloid progenitor populations reflect the earliest branch points between the lymphoid and myeloid lineages, and that the commitment of common myeloid progenitors to either the megakaryocyte/erythrocyte or the granulocyte/macrophage lineages are mutually exclusive events.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Akashi, K (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	akashi@leland.stanford.edu						Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; DEXTER TM, 1990, CANCER SURV, V9, P1; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; METCALF D, 1979, J CELL PHYSIOL, V98, P401, DOI 10.1002/jcp.1040980216; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; OGAWA M, 1993, BLOOD, V81, P2844; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; UCHIDA N, 1994, BLOOD, V83, P3758; WEISS TG, 1994, ETHICS INT AFF, V8, P1	30	1830	1890	5	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					193	197		10.1038/35004599	http://dx.doi.org/10.1038/35004599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724173				2022-12-01	WOS:000085870900054
J	Pepin, M; Schwarze, U; Superti-Furga, A; Byers, PH				Pepin, M; Schwarze, U; Superti-Furga, A; Byers, PH			Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIEXON DELETION; III COLLAGEN; COL3A1 GENE; PREGNANCY; COMPLICATIONS; PROCOLLAGEN; MUTATIONS; DNA; SUBSTITUTION; ALLELE	Background: Ehlers-Danlos syndrome type IV, the vascular type, results from mutations in the gene for type III procollagen (COL3A1). Affected patients are at risk for arterial, bowel, and uterine rupture, but the timing of these events, their frequency, and the course of the disease are not well documented. Methods: We reviewed the clinical and family histories of and medical and surgical complications in 220 index patients with biochemically confirmed Ehlers-Danlos syndrome type IV and 199 of their affected relatives. We identified the underlying COL3A1 mutation in 135 index patients. Results: Complications were rare in childhood; 25 percent of the index patients had a first complication by the age of 20 years, and more than 80 percent had had at least one complication by the age of 40. The calculated median survival of the entire cohort was 48 years. Most deaths resulted from arterial rupture. Bowel rupture, which often involved the sigmoid colon, accounted for about a quarter of complications but rarely led to death. Complications of pregnancy led to death in 12 of the 81 women who became pregnant. The types of complications were not associated with specific mutations in COL3A1. Conclusions: Although most affected patients survive the first and second major complications, Ehlers-Danlos syndrome type IV results in premature death. The diagnosis should be considered in young people who come to medical attention because of uterine rupture during pregnancy or arterial or visceral rupture. (N Engl J Med 2000;342:673-80.) (C)2000, Massachusetts Medical Society.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Zurich, Dept Pediat, Div Metab & Mol Dis, Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Zurich	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.	pbyers@u.washington.edu	superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR 21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1993, MCKUSICKS HERITABLE; Bergqvist D, 1996, EUR J SURG, V162, P163; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BRIGHOUSE D, 1992, BRIT J ANAESTH, V69, P517, DOI 10.1093/bja/69.5.517; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; DEPAEPE A, 1989, EUR J OBSTET GYN R B, V33, P189, DOI 10.1016/0028-2243(89)90214-1; Freeman RK, 1996, AM SURGEON, V62, P869; Gilchrist D, 1999, AM J MED GENET, V82, P305, DOI 10.1002/(SICI)1096-8628(19990212)82:4<305::AID-AJMG6>3.3.CO;2-3; JAMES LM, 1993, TERATOLOGY, V48, P707; KONTUSAARI S, 1992, AM J HUM GENET, V51, P497; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; MILEWICZ DM, 1993, AM J HUM GENET, V53, P62; NARCISI P, 1994, HUM MOL GENET, V3, P1617, DOI 10.1093/hmg/3.9.1617; *NAT CTR HLTH STAT, 1998, DHHS PUBL; North KN, 1995, ANN NEUROL, V38, P960, DOI 10.1002/ana.410380620; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PEACEMAN AM, 1987, OBSTET GYNECOL, V69, P428; Pope FM, 1996, BRIT J DERMATOL, V135, P163, DOI 10.1046/j.1365-2133.1996.d01-971.x; POPE FM, 1983, LANCET, V1, P249; RUDD NL, 1983, LANCET, V1, P50; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwarze U, 1997, AM J HUM GENET, V61, P1276, DOI 10.1086/301641; Steinmann Beat, 1993, P351; VENTURA SJ, 1995, MON VITAL STAT REP S, V44, P75; VISSING H, 1991, J BIOL CHEM, V266, P5244; WEINBAUM PJ, 1987, AM J PERINAT, V4, P134, DOI 10.1055/s-2007-999756	30	773	812	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2000	342	10					673	680		10.1056/NEJM200003093421001	http://dx.doi.org/10.1056/NEJM200003093421001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290ZW	10706896	Bronze			2022-12-01	WOS:000085708800001
J	Tosswill, JHC; Taylor, GP; Tedder, RS; Mortimer, PP				Tosswill, JHC; Taylor, GP; Tedder, RS; Mortimer, PP			HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests	BRITISH MEDICAL JOURNAL			English	Article									St Marys Hosp, Imperial Coll Sch Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England; Cent Publ Hlth Lab, Virus Reference Div, London NW9 5HT, England; UCL, Royal Free & Univ Coll Med Sch, Dept Virol, London W1P 6DB, England	Imperial College London; Public Health England; University of London; University College London	Taylor, GP (corresponding author), St Marys Hosp, Imperial Coll Sch Med, Dept Genitourinary Med & Communicable Dis, Praed St, London W2 1PG, England.	g.p.taylor@ic.ac.uk						HASKEY J, 1997, POPULATION TRENDS, V88, P13; *INT AG RES CANC, 1996, IARC MON EV CARC RIS, V67; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Simms I, 1994, Commun Dis Rep CDR Rev, V4, pR65; Tynell E, 1998, BRIT MED J, V316, P1417, DOI 10.1136/bmj.316.7142.1417	5	28	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2000	320	7235					611	612		10.1136/bmj.320.7235.611	http://dx.doi.org/10.1136/bmj.320.7235.611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291NH	10698878	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000085742600024
J	Nakano, S; Chadalavada, DM; Bevilacqua, PC				Nakano, S; Chadalavada, DM; Bevilacqua, PC			General acid-base catalysis in the mechanism of a hepatitis delta virus ribozyme	SCIENCE			English	Article							METAL-ION CATALYSIS; GROUP-I RIBOZYME; ACTIVE-SITE; CRYSTAL-STRUCTURE; RNA; CLEAVAGE; HAIRPIN; HAMMERHEAD; DOMAIN; SPECIFICITY	Many protein enzymes use general acid-base catalysis as a way to increase reaction rates. The amino acid histidine is optimized for this function because it has a pK(a) (where K-a is the acid dissociation constant) near physiological pH. The RNA enzyme (ribozyme) from hepatitis delta virus catalyzes self-cleavage of a phosphodiester bond. Reactivity-pH profiles in monovalent or divalent cations, as well as distance to the Leaving-group oxygen, implicate cytosine 75 (C75) of the ribozyme as the general acid and ribozyme-bound hydrated metal hydroxide as the general base in the self-cleavage reaction. Moreover, C75 has a pK(a) perturbed to neutrality, making it "histidine-like." Anticooperative interaction is observed between protonated C75 and a metal ion, which serves to modulate the pK(a) of C75. General acid-base catalysis expands the catalytic repertoire of RNA and may provide improved rate acceleration.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bevilacqua, PC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.		Chadalavada, Durga/A-5233-2011	Ghosh, Durga/0000-0003-1367-8198; Bevilacqua, Philip/0000-0001-8074-3434	NIGMS NIH HHS [GM58709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASOLO R, 1988, MECHANISMS INORGANIC; Been MD, 1997, EUR J BIOCHEM, V247, P741, DOI 10.1111/j.1432-1033.1997.00741.x; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Cech TR, 1999, RNA WORLD, P321; CHADALAVADA D, UNPUB; CONNELL GJ, 1994, SCIENCE, V264, P1137, DOI 10.1126/science.7513905; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; DASILVA FJJ, 1993, BIOL CHEM ELEMENTS; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Fersht A., 1985, ENZYME STRUCTURE MEC; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; Jencks W. P., 1987, CATALYSIS CHEM ENZYM, P163; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; KIRBY AJ, 1970, J CHEM SOC B, P510, DOI 10.1039/j29700000510; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; MAKINO S, 1987, NATURE, V329, P343, DOI 10.1038/329343a0; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Oivanen M, 1998, CHEM REV, V98, P961, DOI 10.1021/cr960425x; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Pontius BW, 1997, P NATL ACAD SCI USA, V94, P2290, DOI 10.1073/pnas.94.6.2290; Saenger W, 2013, PRINCIPLES NUCL ACID; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Segel I.H, 1993, ENZYME KINETICS; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Shih IH, 1999, RNA, V5, P1140, DOI 10.1017/S1355838299990763; Shim JH, 1999, BIOCHEMISTRY-US, V38, P10024, DOI 10.1021/bi9904609; Suga H, 1998, BIOCHEMISTRY-US, V37, P10118, DOI 10.1021/bi980432a; SUH YA, 1993, NUCLEIC ACIDS RES, V21, P3277, DOI 10.1093/nar/21.14.3277; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; Wadkins TS, 1999, RNA, V5, P720, DOI 10.1017/S1355838299990209; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	48	351	367	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1493	1497		10.1126/science.287.5457.1493	http://dx.doi.org/10.1126/science.287.5457.1493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10688799				2022-12-01	WOS:000085531600053
J	Reed, MB; Saliba, KJ; Caruana, SR; Kirk, K; Cowman, AF				Reed, MB; Saliba, KJ; Caruana, SR; Kirk, K; Cowman, AF			Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum	NATURE			English	Article							CHLOROQUINE RESISTANCE; P-GLYCOPROTEIN; PHYSICOCHEMICAL PROPERTIES; HALOFANTRINE RESISTANCE; MALARIA PARASITES; IN-VITRO; GENE; AMPLIFICATION; DRUG; TRANSFORMATION	Throughout the latter half of this century, the development and spread of resistance to most front-line antimalarial compounds used in the prevention and treatment of the most severe form of human malaria has given cause for grave clinical concern. Polymorphisms in pfmdr1, the gene encoding the P-glycoprotein homologue 1 (Pgh1) protein of Plasmodium falciparum, have been linked to chloroquine resistance(1); Pgh1 has also been implicated in resistance to mefloquine and halofantrine(2-5). However, conclusive evidence of a direct causal association between pfmdr1 and resistance to these antimalarials has remained elusive, and a single genetic cross has suggested that Pgh1 is not involved in resistance to chloroquine and mefloquine(6). Here we provide direct proof that mutations in Pgh1 can confer resistance to mefloquine, quinine and halofantrine. The same mutations influence parasite resistance towards chloroquine in a strain-specific manner and the level of sensitivity to the structurally unrelated compound, artemisinin, This has important implications for the development and efficacy of future antimalarial agents.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Australian Natl Univ, Fac Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Walter & Eliza Hall Institute; Australian National University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	cowman@wehi.edu.au	Saliba, Kevin J/C-9166-2009; Cowman, Alan F/C-7642-2013; Kirk, Kiaran/C-8299-2009	Saliba, Kevin J/0000-0003-3345-8440; Cowman, Alan F/0000-0001-5145-9004; Kirk, Kiaran/0000-0002-5613-2622				Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; Bray PG, 1996, MOL PHARMACOL, V50, P1559; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CREMER G, 1995, EXP PARASITOL, V81, P1, DOI 10.1006/expr.1995.1086; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DOURY JC, 1992, TROP MED PARASITOL, V43, P197; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GEARY TG, 1990, BIOCHEM PHARMACOL, V40, P685, DOI 10.1016/0006-2952(90)90302-2; Hawley SR, 1996, BIOCHEM PHARMACOL, V52, P723, DOI 10.1016/0006-2952(96)00354-1; Kirkman LA, 1996, EXP PARASITOL, V83, P147, DOI 10.1006/expr.1996.0058; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; PEEL SA, 1993, AM J TROP MED HYG, V48, P385, DOI 10.4269/ajtmh.1993.48.385; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; Ritchie GY, 1996, MOL BIOCHEM PARASIT, V83, P35, DOI 10.1016/S0166-6851(96)02746-6; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; WARD SA, 1995, ANN TROP MED PARASIT, V89, P121, DOI 10.1080/00034983.1995.11812942; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	27	681	702	0	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					906	909		10.1038/35002615	http://dx.doi.org/10.1038/35002615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706290				2022-12-01	WOS:000085559200061
J	Averof, M; Rokas, A; Wolfe, KH; Sharp, PM				Averof, M; Rokas, A; Wolfe, KH; Sharp, PM			Evidence for a high frequency of simultaneous double-nucleotide substitutions	SCIENCE			English	Article							NONSYNONYMOUS SUBSTITUTIONS; MOLECULAR EVOLUTION; UBIQUITIN GENES; 2 SERINES; SEQUENCE; DNA; DIVERGENCE; ALIGNMENT; MUTATION; GENOME	Point mutations are generally assumed to involve changes of single nucleotides. Nevertheless, the nature and known mechanisms of mutation do not exclude the possibility that several adjacent nucleotides may change simultaneously in a single mutational event. Two independent approaches are used here to estimate the frequency of simultaneous double-nucleotide substitutions. The first examines switches between TCN and ACY (where N is any nucleotide and Y is a pyrimidine) codons encoding absolutely conserved serine residues in a number of proteins from diverse organisms. The second reveals double-nucleotide substitutions in primate noncoding sequences. These two complementary approaches provide similar high estimates for the rate of doublet substitutions, on the order of 0.1 per site per billion years.	FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	Foundation for Research & Technology - Hellas (FORTH); University of Edinburgh; Trinity College Dublin; University of Nottingham	Averof, M (corresponding author), FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.		Sharp, Paul M/F-5783-2010; Rokas, Antonis/A-9775-2008; Sharp, Paul M/GPX-1497-2022; Wolfe, Kenneth H/B-4653-2009; Sharp, Paul/Y-3787-2019	Sharp, Paul M/0000-0001-9771-543X; Rokas, Antonis/0000-0002-7248-6551; Sharp, Paul M/0000-0001-9771-543X; Wolfe, Kenneth/0000-0003-4992-4979; Averof, Michalis/0000-0002-6803-7251				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; Bailey WJ, 1992, MOL PHYLOGENET EVOL, V1, P97, DOI 10.1016/1055-7903(92)90024-B; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Comeron JM, 1998, GENETICS, V150, P767; DIAZLAZCOZ Y, 1995, J MOL BIOL, V250, P123, DOI 10.1006/jmbi.1995.0363; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gaut BS, 1998, EVOL BIOL, V30, P93; GOLDFARB PS, 1988, NATURE, V336, P429, DOI 10.1038/336429a0; GOLDING GB, 1985, P NATL ACAD SCI USA, V82, P8577, DOI 10.1073/pnas.82.24.8577; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HAMPSEY DM, 1988, J MOL BIOL, V201, P471, DOI 10.1016/0022-2836(88)90629-8; IRWIN DM, 1988, NATURE, V336, P429, DOI 10.1038/336429b0; Kimura M., 1985, POPULATION GENETICS, P19; KOONIN EV, 1989, NATURE, V338, P467, DOI 10.1038/338467b0; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Li W.H., 1997, MOL EVOLUTION; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; MOUCHIROUD D, 1995, J MOL EVOL, V40, P107, DOI 10.1007/BF00166602; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; PALMER JD, 1988, ANN MO BOT GARD, V75, P1180, DOI 10.2307/2399279; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHARP PM, 1987, J MOL EVOL, V25, P58, DOI 10.1007/BF02100041; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHARP PM, 1987, TRENDS ECOL EVOL, V2, P328, DOI 10.1016/0169-5347(87)90108-X; Smith NGC, 1999, GENETICS, V153, P1395; SWOFFORD DL, 1990, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; WOLFE KH, 1993, J MOL EVOL, V37, P441, DOI 10.1007/BF00178874	38	91	96	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1283	1286		10.1126/science.287.5456.1283	http://dx.doi.org/10.1126/science.287.5456.1283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10678838				2022-12-01	WOS:000085444700055
J	Goodson, JL; Bass, AH				Goodson, JL; Bass, AH			Forebrain peptides modulate sexually polymorphic vocal circuitry	NATURE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; TELEOST FISH; VASOTOCIN; VASOPRESSIN; AGGRESSION; OXYTOCIN; NEURONS; BRAIN; RATS; VERTEBRATES	The peptide arginine-vasopressin (mammals) and its evolutionary precursor arginine-vasotocin (non-mammals) modulate reproductive physiology and numerous related social behaviours, as do oxytocin (mammals) and its homologues mesotocin and isotocin (fish)(1). The distributions in the brain and/or the behavioural functions of these peptides often differ between the sexes(2-4), and between species with divergent social structures(3,5,6). Here we present neurophysiological evidence that males with vocal characteristics typical of females share a pattern of neuropeptide function with females rather than conspecific males. The plainfin midshipman fish (Porichthys notatus) has two male morphs with different reproductive tactics and vocalizations (a key species-typical behaviour which varies in its physical attributes and contextual usage, depending on the morph's social strategy)(7,8). Forebrain-evoked, rhythmic vocal-motor activity that precisely mimics natural vocalizations was modulated by arginine-vasotocin, isotocin and their antagonists delivered to the preoptic area-anterior hypothalamus, a primary site for behavioural integration in all vertebrates. Peptides had different effects in males that acoustically court females (arginine-vasotocin-sensitive) than in females and sneak-spawning males (isotocin-sensitive), showing that the neuromodulatory mechanisms that establish reproduction-related behaviour can be dissociated from gonadal sex.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Calif Bodega, Marine Lab, Bodega Bay, CA 94923 USA	Cornell University	Goodson, JL (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jlg14@cornell.edu						Bass AH, 1996, AM SCI, V84, P352; BASS AH, 1990, J NEUROBIOL, V21, P1155, DOI 10.1002/neu.480210802; BASS AH, 1994, J NEUROSCI, V14, P4025; Bass AH, 1997, BRAIN BEHAV EVOLUT, V50, P3, DOI 10.1159/000113351; BATTEN TFC, 1990, J COMP NEUROL, V302, P893, DOI 10.1002/cne.903020416; BLUTHE RM, 1990, BRAIN RES, V535, P301, DOI 10.1016/0006-8993(90)91613-L; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Delville Y, 1998, J NEUROSCI, V18, P2667; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; FINE ML, 1994, J COMP PHYSIOL A, V174, P173; Floody OR, 1998, PEPTIDES, V19, P833, DOI 10.1016/S0196-9781(98)00029-1; Foran CM, 1998, GEN COMP ENDOCR, V111, P271, DOI 10.1006/gcen.1998.7113; Goodson JL, 1998, GEN COMP ENDOCR, V111, P233, DOI 10.1006/gcen.1998.7112; Goodson JL, 1998, HORM BEHAV, V34, P67, DOI 10.1006/hbeh.1998.1467; Grober MS, 1996, NEUROREPORT, V7, P2945, DOI 10.1097/00001756-199611250-00029; HAUSMANN H, 1995, FEBS LETT, V370, P227, DOI 10.1016/0014-5793(95)00832-T; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; MANNING M, 1989, J MED CHEM, V32, P382, DOI 10.1021/jm00122a016; Marler CA, 1999, HORM BEHAV, V36, P53, DOI 10.1006/hbeh.1999.1524; MOORE FL, 1992, ANN NY ACAD SCI, V652, P156, DOI 10.1111/j.1749-6632.1992.tb34352.x; MOORE FL, 1983, PEPTIDES, V4, P97, DOI 10.1016/0196-9781(83)90173-0; Moore FL, 1998, COMP BIOCHEM PHYS C, V119, P251, DOI 10.1016/S0742-8413(98)00014-0; Northcutt RG, 1980, COMP NEUROLOGY TELEN; Ota Y, 1999, GEN COMP ENDOCR, V116, P40, DOI [10.1006/gcen.1999.7344, 10.1006/gcen.1999.7343]; ROSE JD, 1995, NEUROENDOCRINOLOGY, V62, P406, DOI 10.1159/000127030; SWAAB DF, 1990, BRAIN RES, V537, P141, DOI 10.1016/0006-8993(90)90350-K; WINSLOW JT, 1993, EUR J PHARMACOL, V233, P101, DOI 10.1016/0014-2999(93)90354-K; YOUNG DS, 1975, CLIN CHEM, V21, pD1; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475	30	219	222	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2000	403	6771					769	772		10.1038/35001581	http://dx.doi.org/10.1038/35001581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693805				2022-12-01	WOS:000085423100052
J	Groombridge, JJ; Jones, CG; Bruford, MW; Nichols, RA				Groombridge, JJ; Jones, CG; Bruford, MW; Nichols, RA			Conservation biology - 'Ghost' alleles of the Mauritius kestrel	NATURE			English	Article							POPULATIONS; BIRDS		Zool Soc London, Inst Zool, London NW1 4RY, England; Mauritius Wildlife Fdn, Black River, Mauritius; Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England	Zoological Society of London; University of London; Queen Mary University London	Groombridge, JJ (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.		Nichols, Richard/B-7732-2008; Bruford, Michael/Y-7463-2019; Groombridge, Jim/G-8060-2011; Bruford, Michael W/D-3750-2009	Nichols, Richard/0000-0002-4801-9312; Bruford, Michael/0000-0001-6357-6080; Bruford, Michael W/0000-0001-6357-6080				Bataillon T, 2000, GENET RES, V75, P75, DOI 10.1017/S0016672399004048; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Gelman A., 1995, BAYESIAN DATA ANAL; Gilpin M.E., 1986, P19; JOHNSON TH, 1990, IBIS, V132, P167, DOI 10.1111/j.1474-919X.1990.tb01036.x; Jones C. G., 1987, STUDIES MASCARENE IS, P5; JONES CG, 1995, IBIS, V137, pS173, DOI 10.1111/j.1474-919X.1995.tb08439.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; NEI M, 1975, EVOLUTION, V29, P1, DOI [10.1111/j.1558-5646.1975.tb00807.x, 10.2307/2407137]; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; Safford RJ, 1997, BIODIVERS CONSERV, V6, P1445, DOI 10.1023/A:1018350016327	11	131	135	1	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					616	616		10.1038/35001148	http://dx.doi.org/10.1038/35001148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688188	Bronze			2022-12-01	WOS:000085288200040
J	Hou, SB; Larsen, RW; Boudko, D; Riley, CW; Karatan, E; Zimmer, M; Ordal, GW; Alam, M				Hou, SB; Larsen, RW; Boudko, D; Riley, CW; Karatan, E; Zimmer, M; Ordal, GW; Alam, M			Myoglobin-like aerotaxis transducers in Archaea and Bacteria	NATURE			English	Article							AMINO-ACID-SEQUENCES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; HALOBACTERIUM-SALINARIUM; SERINE CHEMORECEPTOR; RHIZOBIUM-MELILOTI; GENE-EXPRESSION; PROTEINS; OXYGEN; METHYLATION	Haem-containing proteins such as haemoglobin and myoglobin play an essential role in oxygen transport and storage. Comparison of the amino-acid sequences of globins from Bacteria and Eukarya suggests that they share an early common ancestor, even though the proteins perform different functions in these two kingdoms(1-6). Until now, no members of the globin family have been found in the third kingdom, Archaea. Recent studies of biological signalling in the Bacteria and Eukarya have revealed a new class of haem-containing proteins that serve as sensors(7). Until now, no haem-based sensor has been described in the Archaea. Here we report the first myoglobin-like, haem-containing protein in the Archaea, and the first haem-based aerotactic transducer in the Bacteria (termed HemAT-Hs for the archaeon Halobacterium salinarum, and HemAT-Bs for Bacillus subtilis). These proteins exhibit spectral properties similar to those of myoglobin and trigger aerotactic responses.	Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Hawaii, Dept Chem, Honolulu, HI 96822 USA	University of Hawaii System; University of Illinois System; University of Illinois Urbana-Champaign; University of Hawaii System	Alam, M (corresponding author), Univ Hawaii, Dept Microbiol, Snyder Hall 207,2538 Mall, Honolulu, HI 96822 USA.			Hou, Shaobin/0000-0003-3467-8242; Boudko, Dmitri/0000-0002-1899-044X				ALAM M, 1991, J BACTERIOL, V173, P5837, DOI 10.1128/jb.173.18.5837-5842.1991; Andersson CR, 1996, P NATL ACAD SCI USA, V93, P5682, DOI 10.1073/pnas.93.12.5682; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; BOYD A, 1983, NATURE, V301, P623, DOI 10.1038/301623a0; Brooun A, 1998, J BACTERIOL, V180, P1642, DOI 10.1128/JB.180.7.1642-1646.1998; BROOUN A, 1997, PRIMARY STRUCTURES F; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Hardison R, 1999, AM SCI, V87, P126, DOI 10.1511/1999.20.809; Hardison R, 1998, J EXP BIOL, V201, P1099; IHARA K, 1991, ARCH BIOCHEM BIOPHYS, V286, P111, DOI 10.1016/0003-9861(91)90015-B; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEONHARDT H, 1988, J GEN MICROBIOL, V134, P605; LINDBECK JC, 1995, MICROBIOL-SGM, V141, P2945, DOI 10.1099/13500872-141-11-2945; MONSON EK, 1992, P NATL ACAD SCI USA, V89, P4280, DOI 10.1073/pnas.89.10.4280; POTTS M, 1992, SCIENCE, V256, P1690, DOI 10.1126/science.256.5064.1690; Rebbapragada A, 1997, P NATL ACAD SCI USA, V94, P10541, DOI 10.1073/pnas.94.20.10541; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VINOGRADOV SN, 1992, COMP BIOCHEM PHYS B, V103, P759, DOI 10.1016/0305-0491(92)90193-U; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; WONG LS, 1995, J BACTERIOL, V177, P3985, DOI 10.1128/jb.177.14.3985-3991.1995; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P4649, DOI 10.1073/pnas.93.10.4649; Zhulin IB, 1998, MOL MICROBIOL, V29, P1522; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	28	229	238	2	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					540	544		10.1038/35000570	http://dx.doi.org/10.1038/35000570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676961				2022-12-01	WOS:000085227300049
J	Costedoat-Chalumeau, N; Amoura, Z; Aymard, G; Sevin, O; Wechsler, B; Cacoub, P; Du, LTH; Diquet, B; Ankri, A; Piette, JC				Costedoat-Chalumeau, N; Amoura, Z; Aymard, G; Sevin, O; Wechsler, B; Cacoub, P; Du, LTH; Diquet, B; Ankri, A; Piette, JC			Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone	ANNALS OF INTERNAL MEDICINE			English	Article							WARFARIN; ANTICOAGULATION; FLUINDIONE; POPULATION; AUDIT	Background: Oral anticoagulants and pulse high-dose intravenous methylprednisolone are often administered concomitantly, but no data on potential interactions are available. Objective: To assess possible potentiation of oral anticoagulation by high-dose intravenous methylprednisolone. Design: Prospective cohort study. Setting: University hospital in Paris, France. Patients: 10 consecutive patients concomitantly receiving methylprednisolone and oral anticoagulants (fluindione and acenocoumarol) and 5 consecutive controls receiving methylprednisolone alone. Measurements: Serial determinations of the international normalized ratio (INR) and clotting factors during administration of pulse methylprednisolone. The total plasma fluindione concentration was determined in 3 patients. Results: The mean INR was 2.75 (range, 2.02 to 3.81) at baseline and increased to 8.04 (range, 5.32 to 20.0) after methylprednisolone administration. Plasma fluindione concentrations and the INR increased after methylprednisolone administration. Methylprednisolone alone did not increase prothrombin time. Conclusions: The action of oral anticoagulants is potentiated by intravenous high-dose methylprednisolone. The INR should be monitored daily during concomitant administration of these medications.	Grp Hosp Univ Pitie Salpetriere, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Costedoat-Chalumeau, N (corresponding author), Hop La Pitie Salpetriere, Serv Med Interne, 47-83 Blvd Hop, F-75013 Paris, France.		Amoura, Zahir/P-5325-2017; AMOURA, Zahir/P-5324-2017	AMOURA, Zahir/0000-0003-0292-9043; , nathalie/0000-0002-1555-9021; Cacoub, Patrice/0000-0002-6727-4992				Aymard G, 1998, J CHROMATOGR B, V707, P169, DOI 10.1016/S0378-4347(97)00587-2; Brigden ML, 1998, AM J HEMATOL, V59, P22, DOI 10.1002/(SICI)1096-8652(199809)59:1<22::AID-AJH5>3.3.CO;2-J; BROZOVIC M, 1973, BRIT J HAEMATOL, V24, P579, DOI 10.1111/j.1365-2141.1973.tb01684.x; CHATTERJEA JB, 1954, BRIT MED J, V2, P790, DOI 10.1136/bmj.2.4891.790; COSGRIFF SW, 1950, AM J MED, V9, P752, DOI 10.1016/0002-9343(50)90290-7; GOODMAN BW, 1979, AM J MED, V67, P839, DOI 10.1016/0002-9343(79)90744-7; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kaufman M, 1997, MULT SCLER, V3, P248, DOI 10.1177/135245859700300406; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Mentre F, 1998, CLIN PHARMACOL THER, V63, P64, DOI 10.1016/S0009-9236(98)90122-9; Murphy PT, 1998, CLIN LAB HAEMATOL, V20, P253, DOI 10.1046/j.1365-2257.1998.00142.x; PATEL PM, 1993, HEMATOL ONCOL, V11, P89, DOI 10.1002/hon.2900110206; PICHARD L, 1990, DRUG METAB DISPOS, V18, P595; Roujeau JC, 1996, ARCH DERMATOL, V132, P1499, DOI 10.1001/archderm.132.12.1499; Wechsler B, 1992, Eur J Med, V1, P387	17	36	39	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					631	635		10.7326/0003-4819-132-8-200004180-00005	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766681				2022-12-01	WOS:000086497500004
J	Canto, JG; Allison, JJ; Kiefe, CI; Fincher, C; Farmer, R; Sekar, P; Person, S; Weissman, NW				Canto, JG; Allison, JJ; Kiefe, CI; Fincher, C; Farmer, R; Sekar, P; Person, S; Weissman, NW			Relation of race and sex to the use of reperfusion therapy in medicare beneficiaries with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOLYTIC THERAPY; NATIONAL REGISTRY; UNITED-STATES; IMMEDIATE ANGIOPLASTY; GENDER DIFFERENCES; MANAGEMENT; WOMEN; PERSPECTIVE; GUIDELINES; MORTALITY	Background: There are few reports describing the combined influence of the race and sex of a patient on the use of reperfusion therapy for acute myocardial infarction. Methods: To determine the relation of race and sex to the receipt of reperfusion therapy for myocardial infarction in the United States, we reviewed the medical records of 234,769 Medicare patients with myocardial infarction. From these records we identified 26,575 white or black patients who met strict eligibility criteria for reperfusion therapy. We then performed bivariate and multivariate analyses of prevalence ratios to determine predictors of the use of reperfusion therapy in four subgroups of patients categorized according to race and sex: white men, white women, black men, and black women. Results: Among eligible patients, white men received reperfusion therapy with the highest frequency (59 percent), followed by white women (56 percent), black men (50 percent), and black women (44 percent). After adjustment for differences in demographic and clinical characteristics, white women were as likely as white men to receive reperfusion therapy (prevalence ratio, 1.00; 95 percent confidence interval, 0.98 to 1.03). Likewise, black women were as likely as black men to receive reperfusion therapy (prevalence ratio, 1.00; 95 percent confidence interval, 0.89 to 1.13). However, black women were significantly less likely to receive reperfusion therapy than white men (prevalence ratio, 0.90; 95 percent confidence interval, 0.82 to 0.98), as were black men (prevalence ratio, 0.85; 95 percent confidence interval, 0.78 to 0.93). Conclusions: After adjustment for differences in clinical and demographic characteristics and clinical presentation, differences according to sex in the use of reperfusion therapy are minimal. However, blacks, regardless of sex, are significantly less likely than whites to receive this potentially lifesaving therapy. (N Engl J Med 2000;342:1094-100.) (C) 2000, Massachusetts Medical Society.	Univ Alabama, Ctr Outcomes & Effect Res & Educ, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Canto, JG (corresponding author), Univ Alabama, Ctr Outcomes & Effect Res & Educ, 363 BDB,1808 7th Ave S, Birmingham, AL 35294 USA.			Allison, Jeroan/0000-0003-4472-2112	AHRQ HHS [HS08843, HS09446] Funding Source: Medline; NCRR NIH HHS [RR00032] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009446, R01HS008843] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Allison JJ, 1996, J GEN INTERN MED, V11, P736, DOI 10.1007/BF02598987; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BEHAR S, 1994, AM J CARDIOL, V73, P438, DOI 10.1016/0002-9149(94)90672-6; Borzak S, 1999, AM HEART J, V137, P338, DOI 10.1053/hj.1999.v137.92523; *CDCP, 1993, CARD DIS SURV ISCH H; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Dellborg M, 1993, Qual Assur Health Care, V5, P261; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; *ICD, 1980, ICD9CM; JOHNSON N, 1988, ENCY STAT, P646; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Lauderdale DS, 1996, AM J PUBLIC HEALTH, V86, P712, DOI 10.2105/AJPH.86.5.712; MAYNARD C, 1991, AM J CARDIOL, V68, P529, DOI 10.1016/0002-9149(91)90791-I; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; MCLAUGHLIN TJ, 1996, ARCH INTERN MED, V156, P1920; *NAT CTR HLTH STAT, 1998, HLTH US 1998 SOC STA; PAGLEY PR, 1993, ARCH INTERN MED, V153, P625, DOI 10.1001/archinte.153.5.625; Pan CX, 1999, J AM GERIATR SOC, V47, P730, DOI 10.1111/j.1532-5415.1999.tb01599.x; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; SCHULMAN K, 1918, NEW ENGL J MED, V340, P1130; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; WEAVER WD, 1991, J AM COLL CARDIOL, V18, P657, DOI 10.1016/0735-1097(91)90784-7; Yarzebski J, 1996, AM HEART J, V131, P43, DOI 10.1016/S0002-8703(96)90049-6; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	32	175	177	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2000	342	15					1094	1100		10.1056/NEJM200004133421505	http://dx.doi.org/10.1056/NEJM200004133421505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303DZ	10760310	Bronze			2022-12-01	WOS:000086406700005
J	Anbar, AD; Roe, JE; Barling, J; Nealson, KH				Anbar, AD; Roe, JE; Barling, J; Nealson, KH			Nonbiological fractionation of iron isotopes	SCIENCE			English	Article							CHLORIDE SOLUTIONS; COMPLEXES	Laboratory experiments demonstrate that iron isotopes can be chemically fractionated in the absence of biology. Isotopic variations comparable to those seen during microbially mediated reduction of ferrihydrite are observed. Fractionation may occur in aqueous solution during equilibration between inorganic iron complexes. These findings provide insight into the mechanisms of iron isotope fractionation and suggest that nonbiological processes may contribute to iron isotope variations observed in sediments.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91106 USA	University of Rochester; University of Rochester; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Anbar, AD (corresponding author), Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA.		Barling, Jane/F-9443-2015	Barling, Jane/0000-0001-8535-5262				ANBAR AD, 1998, MINERAL MAG A, V62, P53; APTED MJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2081, DOI 10.1016/0016-7037(85)90065-1; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; Beard BL, 1999, GEOCHIM COSMOCHIM AC, V63, P1653, DOI 10.1016/S0016-7037(99)00089-7; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; BJERRUM J, 1986, ACTA CHEM SCAND A, V40, P31, DOI 10.3891/acta.chem.scand.40a-0031; Bullen T.D., 1998, MINERAL MAG A, V62, P255; BULLEN TD, 1999, EOS, V80, P479; Criss R. E., 1999, PRINCIPLES STABLE IS; GLUECKAUF E, 1958, T FARADAY SOC, V54, P1203, DOI 10.1039/tf9585401203; HALLIDAY AN, 1995, INT J MASS SPECTROM, V146, P21, DOI 10.1016/0168-1176(95)04200-5; MAGINI M, 1979, J CHEM PHYS, V71, P4255, DOI 10.1063/1.438233; Mandernack KW, 1999, SCIENCE, V285, P1892, DOI 10.1126/science.285.5435.1892; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; MOORE GE, 1959, J AM CHEM SOC, V72, P5792; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; RUSSELL WA, 1978, ANAL CHEM, V50, P1151, DOI 10.1021/ac50030a036; SKOOG DA, 1998, INSTRUMENTAL ANAL, P675; Taylor TI, 1938, J CHEM PHYS, V6, P429, DOI 10.1063/1.1750288; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; VANDERWALT TN, 1985, SOLVENT EXTR ION EXC, V3, P723, DOI 10.1080/07366298508918536; Zhu XK, 2000, CHEM GEOL, V163, P139, DOI 10.1016/S0009-2541(99)00076-5	23	223	247	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					126	128		10.1126/science.288.5463.126	http://dx.doi.org/10.1126/science.288.5463.126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753114				2022-12-01	WOS:000086387700048
J	Smith, O				Smith, O			Nota bene: Development - Awakening aurora	SCIENCE			English	Editorial Material																		Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					69	69		10.1126/science.288.5463.69	http://dx.doi.org/10.1126/science.288.5463.69			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766638				2022-12-01	WOS:000086387700032
J	Battle, M; Bender, ML; Tans, PP; White, JWC; Ellis, JT; Conway, T; Francey, RJ				Battle, M; Bender, ML; Tans, PP; White, JWC; Ellis, JT; Conway, T; Francey, RJ			Global carbon sinks and their variability inferred from atmospheric O-2 and delta C-13	SCIENCE			English	Article							CO2; CYCLE; AIR; DIOXIDE; OXYGEN; RATIO	Recent time-series measurements of atmospheric O-2 show that the land biosphere and world oceans annually sequestered 1.4 +/- 0.8 and 2.0 +/- 0.6 gigatons of carbon, respectively between mid-1991 and mid-1997. The rapid storage of carbon by the Land biosphere from 1991 to 1997 contrasts with the 1980s, when the land biosphere was approximately neutral. Comparison with measurements of delta(13)CO(2) implies an isotopic flux of 89 +/- 21 gigatons of carbon per mil per year, in agreement with model- and inventory-based estimates of this flux. Both the delta(13)C and the O-2 data show significant interannual variability in carbon storage over the period of record. The general agreement of the independent estimates from O-2 and delta(13)C is a robust signal of variable carbon uptake by both the Land biosphere and the oceans.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80303 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; CSIRO, Div Atmospher Res, Mordialloc, Vic 3195, Australia	Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Rhode Island; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Battle, M (corresponding author), Bowdoin Coll, Dept Phys & Astron, 8800 Coll Stn, Brunswick, ME 04011 USA.		Tans, Pieter/AAG-8273-2019; Francey, Roger J/A-2345-2012; White, James W.C./A-7845-2009	Tans, Pieter/0000-0002-9883-0787; White, James W.C./0000-0001-6041-4684				ANDRES R, COMMUNICATION; Battle M, 1996, NATURE, V383, P231, DOI 10.1038/383231a0; Bender M, 1996, GLOBAL BIOGEOCHEM CY, V10, P9, DOI 10.1029/95GB03295; BENDER ML, 1994, GEOCHIM COSMOCHIM AC, V58, P4751, DOI 10.1016/0016-7037(94)90205-4; CIAIS P, 1995, J GEOPHYS RES-ATMOS, V100, P5051, DOI 10.1029/94JD02847; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; FRANCEY R, 1994, 22 NOAA; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; Heimann M, 1996, GLOBAL BIOGEOCHEM CY, V10, P89, DOI 10.1029/95GB03191; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; KEELING CD, 1989, GEOPHYS MONOGR SER, V55, P305, DOI DOI 10.1029/GM055P0305; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; KEELING RF, 1992, NATURE, V358, P723, DOI 10.1038/358723a0; KEELING RF, 1993, GLOBAL BIOGEOCHEM CY, V7, P37, DOI 10.1029/92GB02733; KEELING RF, 1988, THESIS HARVARD U; Langenfelds RL, 1999, GEOPHYS RES LETT, V26, P1897, DOI 10.1029/1999GL900446; MACHTA L, 1970, SCIENCE, V168, P199; MARLAND G, 1997, 5 INT CARB DIOX C CA, P4; MASARIE K, UNPUB; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; SARMIENTO JL, 1992, NATURE, V356, P589, DOI 10.1038/356589a0; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Severinghaus J.P., 1995, THESIS COLUMBIA U; Siegenthaler U., 1981, CARBON CYCLE MODEL, P249; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Trolier M, 1996, J GEOPHYS RES-ATMOS, V101, P25897, DOI 10.1029/96JD02363; WANNINKHOF R, 1985, TELLUS B, V37, P128, DOI 10.1111/j.1600-0889.1985.tb00061.x	29	373	421	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2467	2470		10.1126/science.287.5462.2467	http://dx.doi.org/10.1126/science.287.5462.2467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741962				2022-12-01	WOS:000086202200039
J	Neal, KR; Nguyen-Van-Tam, JS; Jeffrey, N; Slack, RCB; Madeley, RJ; Ait-Tahar, K; Job, K; Wale, MCJ; Ala'Aldeen, DAA				Neal, KR; Nguyen-Van-Tam, JS; Jeffrey, N; Slack, RCB; Madeley, RJ; Ait-Tahar, K; Job, K; Wale, MCJ; Ala'Aldeen, DAA			Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							C MENINGOCOCCAL DISEASE; COAGGLUTINATION; OUTBREAK; ELISA	Objective To determine the rates of, and risk factors for, meningococcal carriage and acquisition among university students. Design Repeated cross sectional study. Participants 2507 students in their first year at university. Main outcome measures Prevalence of carriage of meningococci and risk factors for carriage and acquisition of meningococci. Results Carriage rates for meningoccoci increased rapidly in the first week of term from 6.9% on day 1, to 11.2% on day 2, to 19.0% on day 3, and to 23.1% on day 4. The average carriage rate during the first week of term in October among students living in catered halls was 13.9%. By November this had risen to 31.0% and in December it had reached 34.2%. Independent associations for acquisition of meningococci in the autumn term were frequency of visits to a hall bar (5-7 visits: odds ratio 2.7, 95% confidence interval 1.5 to 4.8), active smoking (1.6, 1.0 to 2.6), being male (1.6, 1.2 to 2.2), visits to night clubs (1.3, 1.0 to 1.6), and intimate kissing (1.4, 1.0 to 1.8). Lower rates of acquisition were found in female only halls (0.5, 0.3 to 0.9). The most commonly acquired meningococcal strain was C2a P1.5 (P1.2), which has been implicated in clusters of invasive meningococcal disease at other UK universities. Conclusions Carriage rates of meningococci among university students increase rapidly in the first week of term, with further increases during the term. The rapid rate of acquisition may explain the increased risk of invasive meningococcal disease and the timing of cases and outbreaks in university students.	Univ Nottingham, Queens Med Ctr, Dept Epidemiol & Publ Hlth Med, Nottingham NG7 2UH, England; Queens Med Ctr, Div Microbiol, Meningococcal Res Grp, Nottingham, England; Queens Med Ctr, Ctr Communicable Dis Surveillance, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Neal, KR (corresponding author), Univ Nottingham, Queens Med Ctr, Dept Epidemiol & Publ Hlth Med, Nottingham NG7 2UH, England.		Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655				ABDILLAHI H, 1988, MICROB PATHOGENESIS, V4, P27, DOI 10.1016/0882-4010(88)90045-9; Andersen J, 1998, EPIDEMIOL INFECT, V121, P85, DOI 10.1017/S0950268898008930; DEVINE LF, 1970, AM J EPIDEMIOL, V92, P25, DOI 10.1093/oxfordjournals.aje.a121176; ELDRIDGE J, 1978, MED LAB SCI, V35, P63; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Hubert B, 1997, Euro Surveill, V2, P69; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; JACKSON LA, 1995, AM J PUBLIC HEALTH, V85, P843, DOI 10.2105/AJPH.85.6.843; Jelfs J, 1998, EPIDEMIOL INFECT, V120, P263, DOI 10.1017/S0950268898008681; Le Saux N, 1992, Can J Infect Dis, V3, P60; MELTON LJ, 1977, AM J EPIDEMIOL, V106, P215, DOI 10.1093/oxfordjournals.aje.a112456; Neal KR, 1999, EPIDEMIOL INFECT, V122, P351, DOI 10.1017/S0950268899002368; Neal KR, 1998, EPIDEMIOL INFECT, V121, P487, DOI 10.1017/S0950268898001502; RONNE T, 1993, SCAND J INFECT DIS, V25, P331, DOI 10.3109/00365549309008507; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390; 1999, FORMIC INTEGRATED QU; 1997, COMMUN DIS REP, V7, P393; 1996, COMMUN DIS REP, V6, P425	21	94	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					846	849		10.1136/bmj.320.7238.846	http://dx.doi.org/10.1136/bmj.320.7238.846			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731181	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000086180300028
J	Scully, RE				Scully, RE			Influence of origin of ovarian cancer on efficacy of screening	LANCET			English	Editorial Material									Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Homer Wright Pathol Labs, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Scully, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Homer Wright Pathol Labs, Boston, MA 02114 USA.							BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L; BELL DA, IN PRESS PATHOLOGY I; BHAN V, 1989, BRIT J OBSTET GYNAEC, V96, P1384, DOI 10.1111/j.1471-0528.1989.tb06299.x; Caduff RF, 1999, AM J SURG PATHOL, V23, P323, DOI 10.1097/00000478-199903000-00012; Deligdisch L, 1997, INT J GYNECOL CANCER, V7, P89, DOI 10.1046/j.1525-1438.1997.00379.x; PECORELLI S, 1998, J EPIDEMIOL BIOSTAT, V3, P1; PULS LE, 1992, GYNECOL ONCOL, V47, P53, DOI 10.1016/0090-8258(92)90075-T; Rosenthal A, 1998, SEMIN ONCOL, V25, P315; RUSSELL P, 1997, SURG PATHOLOGY OVARI; SCULLY R, 1995, OVARIAN CANC, V3, P139; Scully RE, 1998, ATLAS TUMOR PATHOLOG	11	29	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2000	355	9209					1028	1029		10.1016/S0140-6736(00)02026-2	http://dx.doi.org/10.1016/S0140-6736(00)02026-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744081				2022-12-01	WOS:000086380800002
J	Pfister, GC; Puffer, JC; Maron, BJ				Pfister, GC; Puffer, JC; Maron, BJ			Preparticipation cardiovascular screening for US collegiate student-athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; SUDDEN CARDIAC DEATH; HYPERTROPHIC CARDIOMYOPATHY; CLINICAL CARDIOLOGY; YOUNG-ADULTS; DISEASE; PROFESSIONALS; STATEMENT	Context Sudden death in young competitive athletes due to unsuspected cardiovascular disease has heightened interest in preparticipation screening. Objective To assess screening practices for detecting potentially lethal cardiovascular diseases in college-aged student-athletes. Design, Setting, and Participants A total of 1110 National Collegiate Athletic Association member colleges and universities were surveyed between 1995 and 1997, with 879 (79%) responding to the questionnaire, Main Outcome Measures Information on the administration and scope of the preparticipation screening process was obtained from the team physician or athletic director; preparticipation screening forms were evaluated for content and compared with 12 items recommended by the 1996 American Heart Association (AHA) consensus panel screening guidelines. Results Preparticipation screening was a requirement at 855 (97%) of 879 schools, was performed on campus at 713 schools (81%), and was required annually by 446 schools (51%), Team physicians were responsible for examinations at 603 (85%) of 713 schools with on-campus screening, although 135 of these schools (19%) also approved nurse practitioners and 244 schools (34%) allowed athletic trainers to perform examinations. Of the history and physical examination screening forms analyzed from 625 institutions, only 163 schools (26%) had forms that contained at least 9 of the recommended 12 AHA screening guidelines and were judged to be adequate, whereas 150 (24%) contained 4 or fewer of these parameters and were considered to be inadequate. Smaller Division III schools were more likely than larger Division I schools to have inadequate screening forms (30% vs 14%, P<.001). Relevant items that were omitted from more than 40% of the screening forms included history of exertional chest pain, dyspnea, or fatigue; familial heart disease or premature sudden death; and physical stigmata or family history of Marfan syndrome. Conclusion The preparticipation screening process used by many US colleges and universities may have limited potential to detect (or raise the suspicion of) cardiovascular abnormalities capable of causing sudden death in competitive student-athletes.	Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA; Univ Calif Los Angeles, Sch Med, Dept Family Med, Div Sports Med, Los Angeles, CA USA	Minneapolis Heart Institute Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, 920 E 28th St,Suite 40, Minneapolis, MN 55407 USA.							BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; KAPLAN NM, 1994, J AM COLL CARDIOL, V24, P885, DOI 10.1016/0735-1097(94)90845-1; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; Maron BJ, 1998, CIRCULATION, V98, P1460, DOI 10.1161/01.CIR.98.14.1460; Maron BJ, 1998, NEW ENGL J MED, V339, P1632, DOI 10.1056/NEJM199811263392211; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; Maron BJ, 1998, ANN INTERN MED, V129, P379, DOI 10.7326/0003-4819-129-5-199809010-00006; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Maron BJ, 1994, J AM COLL CARDIOL, V24, P845; *NAT COLL ATHL ASS, 1996, 1996 97 NCAA DIR; SMITH DM, 1996, PREPARTICIPATION PHY, P1; Smith J, 1998, MAYO CLIN PROC, V73, P419; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641	19	89	89	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1597	+		10.1001/jama.283.12.1597	http://dx.doi.org/10.1001/jama.283.12.1597			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735397	Bronze			2022-12-01	WOS:000085857300037
J	Thomson, R; Parkin, D; Eccles, M; Sudlow, M; Robinson, A				Thomson, R; Parkin, D; Eccles, M; Sudlow, M; Robinson, A			Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation	LANCET			English	Article							COST-EFFECTIVENESS; MEDICAL LITERATURE; USERS GUIDES; WARFARIN; ASPIRIN; COMMUNITY; COMPLICATIONS; PROPHYLAXIS; POPULATION; PREVALENCE	Background Clinical guidelines are needed on whether or not to use anticoagulant therapy to prevent stroke in patients with non-valvular atrial fibrillation. We did a Markov decision analysis to model decision-making with regard to warfarin treatment in patients with atrial fibrillation, and used the model to develop evaluative guidelines. Methods The decision analysis involved a systematic literature review supplemented by patients' estimates of the quality of life associated with different states of health, secondary analysis of stroke-registry data, and estimation of service costs; it also incorporated a sensitivity analysis. The derived guidelines were subsequently applied to a cohort of patients with atrial fibrillation, Findings We constructed decision tables for 12 age and sex groups. For most risk combinations, warfarin treatment would have decreased healthcare costs and increased quality-of-life years, although the clinical decision was sensitive to patients' preferences and to the estimate of warfarin's effectiveness. 97% of women with atrial fibrillation older than 75 years, and 69% aged 65-74 would have been recommended for treatment; for men, the corresponding figures would have been 75% and 53%, With the upper quartile for the loss of quality of life associated with being on warfarin treatment (1.00), all but two of the 116 patients without contraindications would have been treated, whereas with the lower quartile (0.92), only 27 of 116 would have been treated. Interpretation Decision analysis is useful in the incorporation of complex probabilistic data into informed decision-making, the identification of factors influencing such decisions, and the subsequent development of evaluative guidelines.	Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Thomson, R (corresponding author), Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	richard.thomson@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020					[Anonymous], 1997, ARCH INTERN MED, V157, P1237; *ATR FIBR INV, 1994, ARCH INTERN MED, V15, P1449; BERTAKIS KD, 1977, J FAM PRACTICE, V5, P217; *COCHR COLL, 1997, COCHR STROK GROUP SE; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; *CTR REV DISS, 1996, MAK COST EFF INF ACC; Eccles M, 1996, BMJ-BRIT MED J, V312, P760; ECKMAN MH, 1995, CHEST, V108, pS457, DOI 10.1378/chest.108.4_Supplement.457S; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FORBES JF, 1995, COSTS HLTH OUTCOMES; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; HUTCHINSON A, 1995, DEV IMPLEMENTATION C; ISARD PA, 1992, CEREBROVASC DIS, V2, P47, DOI 10.1159/000108988; KING D, 1995, BRIT J CLIN PRACT, V49, P123; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lilford R, 1998, J Health Serv Res Policy, V3, P159; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; MCCRORY DC, 1995, ARCH INTERN MED, V155, P277, DOI 10.1001/archinte.155.3.277; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; *OFF NAT STAT, 1997, ANN ABSTR STAT; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PETERSEN P, 1989, LANCET, V1, P175; Rodgers H, 1997, BRIT J GEN PRACT, V47, P309; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; Sudlow M, 1997, BRIT MED J, V314, P1529, DOI 10.1136/bmj.314.7093.1529; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; Thomson R, 1998, BRIT MED J, V316, P509, DOI 10.1136/bmj.316.7130.509; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Ubel PA, 1997, SOC SCI MED, V44, P647, DOI 10.1016/S0277-9536(96)00217-1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946; 1994, EFFECTIVE HLTH CARE	45	142	143	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					956	962		10.1016/S0140-6736(00)90012-6	http://dx.doi.org/10.1016/S0140-6736(00)90012-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YH	10768433				2022-12-01	WOS:000086054000009
J	Koster, JC; Marshall, BA; Ensor, N; Corbett, JA; Nichols, CG				Koster, JC; Marshall, BA; Ensor, N; Corbett, JA; Nichols, CG			Targeted overactivity of beta cell K-ATP channels induces profound neonatal diabetes	CELL			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; SENSITIVE POTASSIUM CHANNELS; DEFECTIVE INSULIN-SECRETION; SULFONYLUREA RECEPTOR GENE; PORE-FORMING SUBUNIT; TRANSGENIC MICE; GLUCOKINASE GENE; FAMILIAL HYPERINSULINISM; NONSENSE MUTATION; KIR6.2	A paradigm for control of insulin secretion is that glucose metabolism elevates cytoplasmic [ATP]/[ADP] in beta cells, closing K-ATP channels and causing depolarization, Ca2+ entry, and insulin release. Decreased responsiveness of K-ATP channels to elevated [ATP]/[ADP] should therefore lead to decreased insulin secretion and diabetes. To test this critical prediction, we generated transgenic mice expressing beta cell K-ATP channels with reduced ATP sensitivity. Animals develop severe hyperglycemia, hypoinsulinemia, and ketoacidosis within 2 days and typically die within 5. Nevertheless, islet morphology, insulin localization, and alpha and beta cell distributions were normal (before day 3), pointing to reduced insulin secretion as causal. The data indicate that normal K-ATP channel activity is critical for maintenance of euglycemia and that overactivity can cause diabetes by inhibiting insulin secretion.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Saint Louis University	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.		Nichols, Colin/D-6336-2012		NIDDK NIH HHS [DK20579, DK02339, DK55282] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055282, K08DK002339, P60DK020579] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Aizawa T, 1998, TRENDS PHARMACOL SCI, V19, P496, DOI 10.1016/S0165-6147(98)01273-5; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; ASHCROFT FM, 1990, BIOCHEM SOC T, V18, P109, DOI 10.1042/bst0180109; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BONNERWEIR S, 1983, J CLIN INVEST, V71, P44; Bosch F, 1998, ANNU REV NUTR, V18, P207, DOI 10.1146/annurev.nutr.18.1.207; Branstrom R, 1997, J BIOL CHEM, V272, P17390, DOI 10.1074/jbc.272.28.17390; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; CESAR LA, 1994, VIRCHOWS ARCH, V425, P73; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1988, DIABETES, V37, P495, DOI 10.2337/diabetes.37.5.495; DANDOYDRON F, 1991, NUCLEIC ACIDS RES, V19, P4925, DOI 10.1093/nar/19.18.4925; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Dunne MJ, 1997, NEW ENGL J MED, V336, P703, DOI 10.1056/NEJM199703063361005; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hogan B., 2014, MANIPULATING MOUSE E; HUMASON GL, 1997, HUMASONS ANIMAL TISS, P361; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Kane C, 1996, NAT MED, V2, P1344, DOI 10.1038/nm1296-1344; Kellerer M, 1997, DIABETOLOGIA, V40, P1358, DOI 10.1007/s001250050832; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Lalli MJ, 1998, PFLUG ARCH EUR J PHY, V436, P957, DOI 10.1007/s004240050729; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; MARSHALL BA, 1994, AM J PHYSIOL-ENDOC M, V267, pE738, DOI 10.1152/ajpendo.1994.267.5.E738; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; MISLER S, 1992, DIABETES, V41, P1211; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; OVERBEEK P, 1994, TRANSGENIC ANIMAL TE, P96; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; PRAVTCHEVA DD, 1991, DEVELOPMENT, V111, P1109; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Sakura H, 1998, DIABETOLOGIA, V41, P654, DOI 10.1007/s001250050964; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; ZHOU YP, 1995, ENDOCRINOLOGY, V136, P3546, DOI 10.1210/en.136.8.3546	72	230	240	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					645	654		10.1016/S0092-8674(00)80701-1	http://dx.doi.org/10.1016/S0092-8674(00)80701-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761930	Bronze			2022-12-01	WOS:000085983800007
J	Hammond, SM; Bernstein, E; Beach, D; Hannon, GJ				Hammond, SM; Bernstein, E; Beach, D; Hannon, GJ			An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells	NATURE			English	Article							MESSENGER-RNA; EXPRESSION; PLANTS; VIRUS	In a diverse group of organisms that includes Caenorhabditis elegans, Drosophila, planaria, hydra, trypanosomes, fungi and plants, the introduction of double-stranded RNAs inhibits gene expression in a sequence-specific manner(1-7). These responses, called RNA interference or post-transcriptional gene silencing, may provide anti-viral defence, modulate transposition or regulate gene expression(1,6,8-10). We have taken a biochemical approach towards elucidating the mechanisms underlying this genetic phenomenon. Here we show that 'loss-of-function' phenotypes can be created in cultured Drosophila cells by transfection with specific double-stranded RNAs. This coincides with a marked reduction in the level of cognate cellular messenger RNAs. Extracts of transfected cells contain a nuclease activity that specifically degrades exogenous transcripts homologous to transfected double-stranded RNA. This enzyme contains an essential RNA component. After partial purification, the sequence-specific nuclease co-fractionates with a discrete, similar to 25-nucleotide RNA species which may confer specificity to the enzyme through homology to the substrate mRNAs.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Genet Inc, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; UCL, Wolfson Inst Biol Sci, London WC1E 6BT, England	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of London; University College London	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.org	Hannon, Gregory/AAB-3568-2019					Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Bosher JM, 1999, GENETICS, V153, P1245; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wolf DA, 1998, CURR BIOL, V8, pR636, DOI 10.1016/S0960-9822(07)00410-1	23	2181	2684	9	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					293	296		10.1038/35005107	http://dx.doi.org/10.1038/35005107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749213				2022-12-01	WOS:000086022200051
J	Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB				Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB			Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; HOSPITAL DISCHARGE; MEDICARE PATIENTS; TRIAL; ANGIOPLASTY; QUALITY; CARE; ERA	Background: Reducing the length of hospitalizations can reduce short-term costs, but there are few data on the long-term clinical and economic consequences of early discharge after uncomplicated myocardial infarction. Methods: Using data from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial, we identified 22,361 patients with acute myocardial infarction who had an uncomplicated course for 72 hours after thrombolysis. Then, using a decision-analytic model, we examined the cost effectiveness of an additional day of hospitalization in this group. We defined incremental survival attributable to another day of monitored hospitalization, on the basis of the rate of resuscitation after cardiac arrest between 72 and 96 hours. Lifetime survival curves for each group in the decision-analytic model were estimated from one-year survival data from GUSTO-1. Results: Of the patients with an uncomplicated course within 72 hours after thrombolysis, 16 had ventricular arrhythmias during the next 24 hours; 13 of these patients (81 percent) survived for at least 24 hours. On average, another 0.006 year of life per patient could be saved by keeping patients with an uncomplicated course in the hospital another day. At a cost of $624 for hospital and physicians' services, extending the hospital stay by another day would cost $105,629 per year of life saved. In sensitivity analyses, it was found that a fourth day of hospitalization would be economically attractive only if its cost could be reduced by more than 50 percent or if a high-risk subgroup could be identified in which the estimated survival benefit would be doubled. Conclusions: Hospitalization of patients with uncomplicated myocardial infarction beyond three days after thrombolysis is economically unattractive by conventional standards. (N Engl J Med 2000;342:749-55.) (C)2000, Massachusetts Medical Society.	Duke Clin Res Inst, Durham, NC 27715 USA; Univ Ziekenhuizen Leuven, Louvain, Belgium; Univ Alberta, Edmonton, AB, Canada; Green Lane Hosp, Auckland 3, New Zealand; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; KU Leuven; University Hospital Leuven; University of Alberta; Cleveland Clinic Foundation	Newby, LK (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	newby001@mc.duke.edu	Peterson, Eric David/ABF-5033-2021	Topol, Eric/0000-0002-1478-4729; Armstrong, Paul/0000-0002-0460-3445; Mark, Daniel/0000-0001-6340-8087				EISENBERG MS, 1991, AM J EMERG MED, V9, P544, DOI 10.1016/0735-6757(91)90108-V; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Gold MR., 1996, COST EFFECTIVENESS H; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; JAIN A, 1993, J AM COLL CARDIOL, V22, P1816, DOI 10.1016/0735-1097(93)90763-Q; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krumholz HM, 1997, AM J CARDIOL, V79, P581, DOI 10.1016/S0002-9149(96)00819-3; Krumholz HM, 1999, JAMA-J AM MED ASSOC, V281, P37; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; MADSEN EB, 1983, CIRCULATION, V68, P9, DOI 10.1161/01.CIR.68.1.9; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1991, CIRCULATION, V83, P1186, DOI 10.1161/01.CIR.83.4.1186; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; Mark DB, 1998, CIRCULATION, V97, P1702, DOI 10.1161/01.CIR.97.17.1702; MARK DB, 1995, NEW ENGL J MED, V333, P267; MARK DB, 1997, TXB CARDIOVASCULAR M, P1033; MCNEER JF, 1978, NEW ENGL J MED, V298, P229, DOI 10.1056/NEJM197802022980501; Newby LK, 1996, J AM COLL CARDIOL, V27, P625; Pierard LA, 1999, AM HEART J, V137, P500, DOI 10.1016/S0002-8703(99)70499-0; SANZ G, 1993, J AM COLL CARDIOL, V22, P1795, DOI 10.1016/0735-1097(93)90759-T; Stratmann HG, 1998, AM HEART J, V136, P87, DOI 10.1016/S0002-8703(98)70186-3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1988, NEW ENGL J MED, V318, P1083, DOI 10.1056/NEJM198804283181702; TOPOL EJ, 1987, AM J CARDIOL, V60, P958, DOI 10.1016/0002-9149(87)90332-8; *TREEAG SOFTW, 1996, DATA 3 0 US MAN	27	98	99	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					749	755		10.1056/NEJM200003163421101	http://dx.doi.org/10.1056/NEJM200003163421101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717009				2022-12-01	WOS:000085846900001
J	De Cock, KM; Fowler, MG; Mercier, E; de Vincenzi, I; Saba, J; Hoff, E; Alnwick, DJ; Rogers, M; Shaffer, N				De Cock, KM; Fowler, MG; Mercier, E; de Vincenzi, I; Saba, J; Hoff, E; Alnwick, DJ; Rogers, M; Shaffer, N			Prevention of mother-to-child HIV transmission in resource-poor countries - Translating research into policy and practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERINATAL TRANSMISSION; PREGNANT-WOMEN; CLINICAL-TRIAL; COTE-DIVOIRE; INFANT; TYPE-1; INFECTION; ABIDJAN; AFRICA	Each year, an estimated 590 000 infants acquire human immunodeficiency virus type 1 (HIV) infection from their mothers, mostly in developing countries that are unable to implement interventions now standard in the industrialized world. In resource-poor settings, the HIV pandemic has eroded hard-won gains in infant and child survival. Recent clinical trial results from international settings suggest that short-course antiretroviral regimens could significantly reduce perinatal HIV transmission worldwide if research findings could be translated into practice. This article reviews current knowledge of mother-to-child HIV transmission in developing countries, summarizes key findings from the trials, outlines future research requirements, and describes public health challenges of implementing perinatal HIV prevention interventions in resource-poor settings, Public health efforts must also emphasize primary prevention strategies to reduce incident HIV infections among adolescents and women of childbearing age. Successful implementation of available perinatal HIV interventions could substantially improve global child survival.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; UN Childrens Fund, Programme Div, New York, NY USA; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Policy Strategy & Res, Joint UN Programme HIV AIDS, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization	De Cock, KM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, CDC MS D-21,1600 Clifton Rd, Atlanta, GA 30333 USA.							Ammann AJ, 1996, NAT MED, V2, P490, DOI 10.1038/nm0596-490a; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P313; Beckerman KP, 1999, NEW ENGL J MED, V341, P205; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Biggar RJ, 1996, LANCET, V347, P1647, DOI 10.1016/S0140-6736(96)91486-5; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DECOCK KM, 1997, INT AIDS SOC NEWSLET, V8, P9; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Graham WJ, 1999, LANCET, V353, P836, DOI 10.1016/S0140-6736(98)12374-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; *I MED, 1999, RED ODDS PREV PER TR; *JOINT UN PROGR HI, 1999, PREVENT HIV INFECT; *JOINT UN PROGR HI, 1997, HIV INF FEED POL STA; Kaplan JE, 1996, AM J TROP MED HYG, V55, P1; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Lindegren ML, 1999, JAMA-J AM MED ASSOC, V282, P531, DOI 10.1001/jama.282.6.531; Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Mbidde EK, 1998, NEW ENGL J MED, V338, P837; Minkoff H, 1998, JAMA-J AM MED ASSOC, V279, P1743, DOI 10.1001/jama.279.21.1743; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Mock PA, 1999, AIDS, V13, P407, DOI 10.1097/00002030-199902250-00014; Mofenson LM, 1997, OBSTET GYN CLIN N AM, V24, P759, DOI 10.1016/S0889-8545(05)70343-0; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Msellati P, 1998, AIDS, V12, P1257, DOI 10.1097/00002030-199810000-00026; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NEWELL ML, 1992, LANCET, V339, P1007; Newell ML, 1998, AIDS, V12, P1571, DOI 10.1097/00002030-199813000-00003; NICOLL A, 1995, AIDS, V9, P107, DOI 10.1097/00002030-199509020-00001; SABA J, 1999, 2 C GLOB STRAT PREV; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shaffer N, 1999, J INFECT DIS, V179, P590, DOI 10.1086/314641; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; SMITH M, 1999, 2 C GLOB STRAT PREV; Taha TE, 1997, BRIT MED J, V315, P216, DOI 10.1136/bmj.315.7102.216; *UNAIDS, 2000, GLOB HIV AIDS EP JUN; *UNAIDS, 2000, AIDS EP UPD DEC 1998; *US BUR CENS, 1999, REC HIV SER LEV COUN; VANDEPERRE P, 1991, NEW ENGL J MED, V325, P593, DOI 10.1056/NEJM199108293250901; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; *WHO, 1998, HIV INF FEED GUID DE; Wiktor S Z, 1997, AIDS, V11 Suppl B, pS79; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	56	689	704	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1175	1182		10.1001/jama.283.9.1175	http://dx.doi.org/10.1001/jama.283.9.1175			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703780				2022-12-01	WOS:000085424100027
J	Henney, JE				Henney, JE			New drug for refractory cutaneous T-cell lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	32	32	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1131	1131		10.1001/jama.283.9.1131	http://dx.doi.org/10.1001/jama.283.9.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	286BQ	10703765				2022-12-01	WOS:000085424100005
J	Hatzakis, A; Touloumi, G; Karanicolas, R; Karafoulidou, A; Mandalaki, T; Anastassopoulou, C; Zhang, L; Goedert, JJ; Ho, DD; Kostrikis, LG				Hatzakis, A; Touloumi, G; Karanicolas, R; Karafoulidou, A; Mandalaki, T; Anastassopoulou, C; Zhang, L; Goedert, JJ; Ho, DD; Kostrikis, LG			Effect of recent thymic emigrants on progression of HIV-1 disease	LANCET			English	Article							HEMOPHILIA COHORT; NATURAL-HISTORY; T-CELLS; INFECTION; CCR5; ALLELE; PLASMA; AIDS; GENE; SEROCONVERSION	Background The concentration of T-cell receptor-rearrangement excision DNA circles (TREC) in peripheral-blood T cells is a marker of recent thymic emigrant ap T cells. We studied the predictive ability of measurements of TREC for clinical outcome in HIV-1-infected individuals. Methods We measured TREC in peripheral-blood mononuclear cells with a real-time PCR assay. We studied 131 Greek participants in the Multicenter Hemophilia Cohort Study who had known HIV-1 seroconversion dates. The prognostic value of baseline TREC, CD4 T-cell count, and HIV-1 RNA concentration was assessed by Kaplan-Meier and Cox's regression analysis. Findings Four participants had progressed to AIDS by first blood sampling. Among the remaining 127 individuals, the median value of TREC per 10(6) cells was 6900 (IQR 2370-15 604). Baseline TREC values were lower in the 53 who progressed to AIDS than in those who did not (geometric mean 2843 [95% CI 1468-5504] vs 6560 [4723-9113] per 10(6) cells; p=0.017). The relative hazard of AIDS, adjusted for plasma viral load, CD4 T-cell count, and age at seroconversion was 1.44 (95% CI 1.04-2.01; p=0.031) per ten-fold increase in TREC; that for death was 1.52 (1.12-2.06; p=0.007). The adjusted relative hazards of death were 2.91 (1.91-4.44; p<0.001) per ten-fold increase in plasma HIV-1 RNA load and 1.20 (1.04-1.38; p=0.014) per 100-cell decrease in CD4 T-cell count. Interpretation The concentration of TREC in the peripheral T-cell pool complements HIV-1 RNA load and CD4 T-cell count in predicting the rate of HIV-1 disease progression. Recent thymic emigrants have a role in the pathogenesis of HIV-1 disease.	Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Laikon Gen Hosp, Hemophilia Ctr, Athens, Greece; NCI, Viral Epidemiol Branch, Rockville, MD USA	Rockefeller University; Athens Medical School; National & Kapodistrian University of Athens; Laiko General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kostrikis, LG (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	Ikostrik@adarc.org	KOSTRIKIS, LEONDIOS G/A-5330-2016; Anastassopoulou, Cleo/AAO-8539-2020	KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Anastassopoulou, Cleo/0000-0001-7666-9198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043868, R01AI040387, P30AI042848] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42848, R01 AI40387, R01 AI43868] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; FUJIMOTO S, 1987, NATURE, V327, P242, DOI 10.1038/327242a0; Haynes BF, 1998, IMMUNOL RES, V18, P175, DOI 10.1007/BF02788778; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HENRARD DR, 1995, JAMA-J AM MED ASSOC, V274, P554, DOI 10.1001/jama.274.7.554; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kong FK, 1998, IMMUNITY, V8, P97, DOI 10.1016/S1074-7613(00)80462-8; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Livak F, 1996, MOL CELL BIOL, V16, P609; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OKAZAKI K, 1987, CELL, V49, P477, DOI 10.1016/0092-8674(87)90450-8; Riddler SA, 1997, AIDS, V11, pS141; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Touloumi G, 1998, AIDS, V12, P1691, DOI 10.1097/00002030-199813000-00018; Touloumi G, 1998, J ACQ IMMUN DEF SYND, V19, P89, DOI 10.1097/00042560-199809010-00014; Tyagi S, 1996, NAT BIOTECHNOL, V14, P947, DOI 10.1038/nbt0896-947b; Vigano' A, 1999, AIDS, V13, pF29, DOI 10.1097/00002030-199904010-00001; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	28	83	87	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					599	604		10.1016/S0140-6736(99)10311-8	http://dx.doi.org/10.1016/S0140-6736(99)10311-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696979				2022-12-01	WOS:000085615400010
J	Wilkinson, RJ; Llewelyn, M; Toossi, Z; Patel, P; Pasvol, G; Lalvani, A; Wright, D; Latif, M; Davidson, RN				Wilkinson, RJ; Llewelyn, M; Toossi, Z; Patel, P; Pasvol, G; Lalvani, A; Wright, D; Latif, M; Davidson, RN			Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study	LANCET			English	Article							BONE-MINERAL DENSITY; START CODON POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; GENE; SUSCEPTIBILITY; INTERFERON; WOMEN; SERUM; RISK	Background Susceptibility to disease after infection by Mycobacterium tuberculosis is influenced by environmental and host genetic factors. Vitamin D metabolism leads to activation of macrophages and restricts the intracellular growth of M tuberculosis. This effect may be influenced by polymorphisms at three sites in the Vitamin D receptor (VDR) gene. We investigated the interaction between serum vitamin D (25-hydroxycholecalciferol) concentrations and VDR genotype on susceptibility to tuberculosis. Methods This study was a hospital-based case-control analysis of Asians of Gujarati origin, a mainly vegetarian immigrant population with a high rate of tuberculosis. We typed three VDR polymorphisms (defined by the presence of restriction endonuclease sites for Taq1, Bsm1, and Fok1) in 91 of 126 untreated patients with tuberculosis and 116 healthy contacts who had been sensitised to tuberculosis. Serum 25-hydroxycholecalciferol was recorded in 42 contacts and 103 patients. Findings 25-hydroxycholecalciferol deficiency was associated with active tuberculosis (odds ratio 2.9 [95% CI 1.3-6.5], p=0.008), and undetectable serum 25-hydroxycholecalciferol (<7 nmol/L) carried a higher risk of tuberculosis (9.9 [1.3-76.2], p=0.009). Although there was no significant independent association between VDR genotype and tuberculosis, the combination of genotype TT/Tt and 25-hydroxycholecalciferol deficiency was associated with disease (2.8 [1.2-6.5]) and the presence of genotype ff or undetectable serum 25-hydroxycholecalciferol was strongly associated with disease (5.1[1.4-18.4]). Interpretation 25-hydroxycholecalciferol deficiency may contribute to the high occurrence of tuberculosis in this population. Polymorphisms in the VDR gene also contribute to susceptibility when considered in combination with 25 hydroxycholecalciferol deficiency.	Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England; Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Imperial College London; Case Western Reserve University; University of Oxford	Davidson, RN (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Imperial Coll Sch Med, Wellcome Ctr Clin Trop Med, Harrow HA1 3UJ, Middx, England.	r.n.davidson@ic.ac.uk	Pasvol, Geoffrey/B-7113-2009; Llewelyn, Martin/A-7194-2011; Llewelyn, Martin/Y-1472-2019	Llewelyn, Martin/0000-0002-6811-1124; Wilkinson, Robert/0000-0002-2753-1800; Lalvani, Ajit/0000-0002-2396-246X				Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6; Compston JE, 1998, BRIT MED J, V317, P1466, DOI 10.1136/bmj.317.7171.1466; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cooper GS, 1996, J BONE MINER RES, V11, P1841; DAVIES PDO, 1987, TUBERCLE, V68, P261, DOI 10.1016/0041-3879(87)90066-3; DAVIES PDO, 1985, THORAX, V40, P187, DOI 10.1136/thx.40.3.187; DAVIS P, 1994, HEALTH POLICY, V29, P113, DOI 10.1016/0168-8510(94)90010-8; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; FINCH PJ, 1991, THORAX, V46, P1, DOI 10.1136/thx.46.1.1; GRANGE JM, 1985, TUBERCLE, V66, P187, DOI 10.1016/0041-3879(85)90035-2; Gross C, 1996, J BONE MINER RES, V11, P1850; Gross C, 1998, J BONE MINER RES, V13, P1691, DOI 10.1359/jbmr.1998.13.11.1691; Harris SS, 1997, J BONE MINER RES, V12, P1043, DOI 10.1359/jbmr.1997.12.7.1043; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ormerod LP, 1998, THORAX, V53, P176, DOI 10.1136/thx.53.3.176; PREECE MA, 1974, CLIN CHIM ACTA, V54, P235, DOI 10.1016/0009-8981(74)90241-1; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; SHENDEROVA RJ, 1991, PROBL TUBERK, V3, P54; SINGH SPN, 1983, J INFECT DIS, V148, P676, DOI 10.1093/infdis/148.4.676; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; STRACHAN DP, 1995, THORAX, V50, P175, DOI 10.1136/thx.50.2.175; Verbeek W, 1997, BIOCHEM BIOPH RES CO, V238, P77, DOI 10.1006/bbrc.1997.7239; WILKINSON RJ, 1995, J ROY COLL PHYS LOND, V29, P86; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	32	582	621	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2000	355	9204					618	621		10.1016/S0140-6736(99)02301-6	http://dx.doi.org/10.1016/S0140-6736(99)02301-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289HX	10696983				2022-12-01	WOS:000085615400014
J	Quint, DJ				Quint, DJ			Indications for emergent MRI of the central nervous system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VERTEBRAL ARTERY DISSECTIONS; DIFFUSION-WEIGHTED MR; SUBARACHNOID HEMORRHAGE; ACUTE STROKE; CT; ANGIOGRAPHY; INFARCTION; DIAGNOSIS; THROMBOSIS; ETIOLOGY		Univ Michigan, Med Ctr, Dept Neuroradiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Quint, DJ (corresponding author), Univ Michigan, Med Ctr, Dept Neuroradiol, 1500 E Med Ctr Dr,B1D520,Box 30, Ann Arbor, MI 48109 USA.	djquint@umich.edu						Adams HP, 1996, STROKE, V27, P1711; Adams HP, 1996, NEUROLOGY, V47, P835; Auer F, 1998, J NEUROL NEUROSUR PS, V64, P474, DOI 10.1136/jnnp.64.4.474; BACH F, 1990, ACTA NEUROCHIR, V107, P37, DOI 10.1007/BF01402610; BANNAN PE, 1992, CURR OPIN NEUROL NEU, V5, P540; Beauchamp NJ, 1998, RADIOGRAPHICS, V18, P1269, DOI 10.1148/radiographics.18.5.9747619; Beauchamp NJ, 1998, AM J ROENTGENOL, V171, P73, DOI 10.2214/ajr.171.1.9648768; Burdette JH, 1998, AM J ROENTGENOL, V171, P791, DOI 10.2214/ajr.171.3.9725318; DEMAEREL P, 1992, NEURORADIOLOGY, V34, P490, DOI 10.1007/BF00598957; Desfontaines P, 1995, ACTA NEUROL BELG, V95, P226; ELKHOURY GY, 1995, AM J ROENTGENOL, V164, P43, DOI 10.2214/ajr.164.1.7998567; Ginsberg MD, 1997, AM J NEURORADIOL, V18, P1435; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Haley GH, 1997, ANN EMERG MED, V30, P676, DOI 10.1016/S0196-0644(97)99996-0; HURST RW, 1994, SEMIN NEUROL, V14, P320, DOI 10.1055/s-2008-1041092; Jacobs A, 1997, J NEUROL SCI, V147, P27, DOI 10.1016/S0022-510X(96)05300-2; Kasner SE, 1997, STROKE, V28, P1993, DOI 10.1161/01.STR.28.10.1993; KLUFAS RA, 1995, AM J ROENTGENOL, V164, P673, DOI 10.2214/ajr.164.3.7863892; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; Patel M R, 1996, Top Magn Reson Imaging, V8, P345; Provenzale JM, 1997, AM J ROENTGENOL, V169, P1161, DOI 10.2214/ajr.169.4.9308483; Provenzale JM, 1998, AM J ROENTGENOL, V170, P777, DOI 10.2214/ajr.170.3.9490973; Russell EJ, 1997, RADIOLOGY, V205, P315, DOI 10.1148/radiology.205.2.9356608; Singer MB, 1998, RADIOLOGY, V208, P417, DOI 10.1148/radiology.208.2.9680570; Velthuis BK, 1998, RADIOLOGY, V208, P423, DOI 10.1148/radiology.208.2.9680571; Villringer A, 1997, New Horiz, V5, P332; VILLRINGER A, 1994, J NEURORADIOLOGY, V21, P72	29	18	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2000	283	7					853	855		10.1001/jama.283.7.853	http://dx.doi.org/10.1001/jama.283.7.853			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	281WT	10685696				2022-12-01	WOS:000085185000001
J	Doll, R; Peto, R; Boreham, J; Sutherland, I				Doll, R; Peto, R; Boreham, J; Sutherland, I			Smoking and dementia in male British doctors: prospective study	BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; RISK-FACTORS; POPULATION; COHORT	Objective To assess the possible association between smoking and dementia. Design Prospective study Setting Cohort of British male doctors followed up since 1951. Subjects 34 439 male British doctors, with 24 133 deaths recorded. Results For all types of dementia combined the relative risk was 0.96 (95% confidence interval 0.78 to 1.18), based on 473 deaths at a mean age of 81 years. For probable or definite Alzheimer's disease, the relative risk in continuing smokers was 0.99 (0.78 to 1.25), based on 370 deaths at a mean age of 82 years. In aggregate, however, the other prospective studies indicate a direct, although not clearly significant, association between smoking and the onset of dementia in general and of Alzheimer's disease in particular. Conclusions Contrary to previous suggestions persistent smoking does not substantially reduce the age specific onset rate of Alzheimer's disease or of dementia in general. If anything, it might increase rather than decrease the rate, but any net effect on severe dementia cannot be large in either direction.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	Doll, R (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Baron JA, 1996, BRIT MED BULL, V52, P58, DOI 10.1093/oxfordjournals.bmb.a011533; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; Graves A.B, 1994, J SMOKING RELATED S1, V5, P79; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; Hirayama T, 1992, TOB CONTROL, V1, P176; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Jellinger K. A., 1997, Journal of Neural Transmission Supplement, V51, P57; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LEE PN, 1994, NEUROEPIDEMIOL, V13, P44; McKahnn G., 1984, NEUROLOGY, V34, P939; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; *OFF POP CENS SURV, 1995, 1993 MORT STAT ENGL, pR11; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PRINCE M, 1994, NEUROLOGY, V44, P97; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	19	80	86	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 22	2000	320	7242					1097	1102		10.1136/bmj.320.7242.1097	http://dx.doi.org/10.1136/bmj.320.7242.1097			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	309RJ	10775216	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000086782800014
J	Solomon, T; Dung, NM; Vaughn, DW; Kneen, R; Thao, LTT; Raengsakulrach, B; Loan, HT; Day, NPJ; Farrar, J; Myint, KSA; Warrell, MJ; James, WS; Nisalak, A; White, NJ				Solomon, T; Dung, NM; Vaughn, DW; Kneen, R; Thao, LTT; Raengsakulrach, B; Loan, HT; Day, NPJ; Farrar, J; Myint, KSA; Warrell, MJ; James, WS; Nisalak, A; White, NJ			Neurological manifestations of dengue infection	LANCET			English	Article							JAPANESE ENCEPHALITIS; VIRUSES; FEVER; IDENTIFICATION; CHILDREN; ANTIGEN; TYPE-2; LIVER; PCR	Background Severe forms of dengue, the most important arboviral infection of man, are associated with haemorrhagic disease and a generalised Vascular leak syndrome. The importance of dengue as a cause of neurological disease is uncertain. Methods During 1995, all patients with suspected CNS infections admitted to a referral hospital in southern Vietnam were investigated by culture, PCR, and antibody measurement in serum and CSF for dengue and other viruses. Findings Of 378 patients, 16 (4.2%) were infected with dengue viruses, compared with four (1.4%) of 286 hospital controls (odds ratio [95% CI] 3.1[1.7-5.8]). Five additional dengue positive patients with CNS abnormalities were studied subsequently. No other cause of CNS infection was identified. Seven infections were primary dengue, 13 secondary, and one was not classified. Ten patients had dengue viruses isolated or detected by PCR, and three had dengue antibody in the CSF. 12 of the 21 had no characteristic features of dengue on admission. The most frequent neurological manifestations were reduced consciousness and convulsions. Nine patients had encephalitis. No patient died, but six had neurological sequelae at discharge. Phylogenetic analysis of the four DEN-2 strains isolated mapped them with a DEN-2 strain isolated from a patient with dengue haemorhagic fever, and with other strains previously isolated in southern Vietnam. Interpretation In dengue endemic areas patients with encephalitis and encephalopathy should be investigated for this infection, whether or not they have other features of the disease.	Cho Quan Hosp, Wellcome Trust Clin Res Unit, Ho Chi Minh City, Vietnam; Cho Quan Hosp, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Armed Forces Res Inst Med Sci, USA, Med Component, Dept Virol, Bangkok 10400, Thailand; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Infect Dis, Oxford OX3 9DU, England	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Oxford; University of Oxford	Solomon, T (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Lower Lane, Liverpool L9 7LJ, Merseyside, England.		White, Nick/AAC-6527-2019; james, william/H-4289-2013; White, Nicholas J/I-4629-2012	White, Nick/0000-0002-1897-1978; james, william/0000-0002-2506-1198; Solomon, Tom/0000-0001-7266-6547; Myint, Khin/0000-0002-2087-7331				BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519; BURKE DS, 1985, AM J TROP MED HYG, V34, P1203, DOI 10.4269/ajtmh.1985.34.1203; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; CHEN W-J, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P659; CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157; COYLE PK, 1999, NEUROBASE; DAVIS LE, 1987, INFECTIONS NERVOUS S, P156; Fong MY, 1998, RES VIROLOGY, V149, P457, DOI 10.1016/S0923-2516(99)80014-4; GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; Innis B. L., 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P695; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; IYNGKARAN N, 1992, LANCET, V340, P1466, DOI 10.1016/0140-6736(92)92653-W; KHO LK, 1981, SE ASIAN J TROP MED, V12, P583; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; KUNO G, 1985, J VIROL METHODS, V12, P93, DOI 10.1016/0166-0934(85)90011-4; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Letocart M, 1997, J CLIN MICROBIOL, V35, P248, DOI 10.1128/JCM.35.1.248-253.1997; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; MOLYNEUX ME, 1989, Q J MED, V71, P441; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; NIMMANNITA S, 1987, T R SOC TROP MED HYG, V18, P292; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398; PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793; Plum F, 1982, DIAGNOSIS STUPOR COM, P177; Read SJ, 1997, J CLIN MICROBIOL, V35, P691, DOI 10.1128/JCM.35.3.691-696.1997; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; ROSEN L, 1989, RES VIROLOGY, V140, P351, DOI 10.1016/S0923-2516(89)80115-3; Row D, 1996, AM J TROP MED HYG, V54, P253, DOI 10.4269/ajtmh.1996.54.253; Solomon T, 1998, J CLIN MICROBIOL, V36, P2030, DOI 10.1128/JCM.36.7.2030-2034.1998; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 1996, 7 INT C INF DIS, P132; Solomon T., 1997, NEUROL INFECT EPIDEM, V2, P191; THANH ND, 1994, TROP MED, V36, P177; World Health Organization, 1997, DENG HAEM FEV DIAGN; World Health Organization, 1975, TECHN GUID DIAGN TRE; WULUR HS, 1978, LANCET, V1, P449	39	392	419	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1053	1059		10.1016/S0140-6736(00)02036-5	http://dx.doi.org/10.1016/S0140-6736(00)02036-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744091				2022-12-01	WOS:000086380800012
J	Tchernov, E; Rieppel, O; Zaher, H; Polcyn, MJ; Jacobs, LL				Tchernov, E; Rieppel, O; Zaher, H; Polcyn, MJ; Jacobs, LL			A fossil snake with limbs	SCIENCE			English	Article							PACHYRHACHIS	A 95-million-year-old fossil snake from the Middle East documents the most extreme hindlimb development of any known member of that group, as it preserves the tibia, fibula, tarsals, metatarsals, and phalanges. It is more complete than Pachyrhachis, a second fossil snake with hindlimbs that was recently portrayed to be basal to all other snakes. Phylogenetic analysis of the relationships of the new taxon, as well as reanalysis of Pachyrhachis, shows both to be related to macrostomatans, a group that includes relatively advanced snakes such as pythons, boas, and colubroids to the exclusion of more primitive snakes such as blindsnakes and pipesnakes.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Hebrew Univ Jerusalem, Dept Evolut Syst & Ecol, IL-91904 Jerusalem, Israel; Univ Sao Paulo, Dept Zool, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; So Methodist Univ, Shuler Museum Paleontol, Dallas, TX 75275 USA	Field Museum of Natural History (Chicago); Hebrew University of Jerusalem; Universidade de Sao Paulo; Southern Methodist University	Rieppel, O (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	rieppel@fmnh.org	Zaher, Hussam/ABC-1701-2021; Zaher, Hussam/D-4000-2012	Zaher, Hussam/0000-0002-6994-489X; Zaher, Hussam/0000-0002-6994-489X				BARRIE DJ, 1990, MEMOIRS QUEENSLAND M, V28, P139; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Greene HW., 1997, SNAKES; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Haas G., 1980, P177; HAAS G, 1980, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V2, P87; HAAS G, 1979, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V1, P51; Kluge A.G., 1991, MISCELLANEOUS PUBLIC, V178, P1; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; Lee MSY, 1999, J ZOOL, V248, P509, DOI 10.1017/S0952836999008109; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lee MSY, 1998, PHILOS T ROY SOC B, V353, P1521, DOI 10.1098/rstb.1998.0308; Nopcsa, 1923, PALAEONTOGRAPHICA, V65, P99; Polcyn Michael J., 1999, National Science Museum Monographs, V15, P259; Rage J.C., 1984, ENCY PALEOHERPETOLOG, P1; RAGE JC, 1982, CR ACAD SCI II, V294, P563; RIEPPEL O, IN PRESS ZOOL J LINN; RIEPPEL O, 2000, FIELDIANA GEOL, V43, P1, DOI DOI 10.5962/BHL.TITLE.3584; Scanlon J.D., 1999, Historical Biology, V13, P127; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Zaher H, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011029; Zaher H, 1999, CR ACAD SCI II A, V329, P831, DOI 10.1016/S1251-8050(00)88639-5; Zaher Hussam, 1999, American Museum Novitates, V3271, P1	24	172	176	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2010	2012		10.1126/science.287.5460.2010	http://dx.doi.org/10.1126/science.287.5460.2010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720326				2022-12-01	WOS:000085902800060
J	Dalakas, MC; Park, KY; Semino-Mora, C; Lee, HS; Sivakumar, K; Goldfarb, LG				Dalakas, MC; Park, KY; Semino-Mora, C; Lee, HS; Sivakumar, K; Goldfarb, LG			Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MICE LACKING DESMIN; ALPHA-B-CRYSTALLIN; MYOFIBRILLAR MYOPATHY; INTERMEDIATE FILAMENTS; NULL MUTATION; MUSCLE; POSITIVITY; EXPRESSION; PROTEINS; VACUOLES	Background: Myofibrillar myopathies are a heterogeneous group of inherited or sporadic skeletal myopathies associated with cardiomyopathy. Among the myofibrillar proteins that accumulate within the muscle fibers of affected patients, the one found most consistently is desmin, an intermediate-filament protein responsible for the structural integrity of the myofibrils. Skeletal and cardiac myopathy develops in mice that lack desmin, suggesting that mutations in the desmin gene may be pathogenic. Methods: We examined 22 patients from 8 families with dominantly inherited myofibrillar or desmin-related myopathy and 2 patients with sporadic disease and analyzed the desmin gene for mutations, using complementary DNA (cDNA) amplified from muscle-biopsy specimens and genomic DNA extracted from blood lymphocytes. Restriction-enzyme analysis was used to confirm the mutations. Expression vectors containing normal or mutant desmin cDNA were introduced into cultured cells to determine whether the mutant desmin formed intermediate filaments. Results: Six missense mutations in the coding region of the desmin gene that cause the substitution of an amino acid were identified in 11 patients (10 members of 4 families and 1 patient with sporadic disease); a splicing defect that resulted in the deletion of exon 3 was identified in the other patient with sporadic disease. Mutations were clustered in the carboxy-terminal part of the rod domain, which is critical for filament assembly. In transfected cells, the mutant desmin was unable to form a filamentous network. Seven of the 12 patients with mutations in the desmin gene had cardiomyopathy. Conclusions: Mutations in the desmin gene affecting intermediate filaments cause a distinct myopathy that is often associated with cardiomyopathy and is termed "desmin myopathy.'' The mutant desmin interferes with the normal assembly of intermediate filaments, resulting in fragility of the myofibrils and severe dysfunction of skeletal and cardiac muscles. (N Engl J Med 2000;342:770-80.) (C)2000, Massachusetts Medical Society.	NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA; NINDS, Clin Neurogenet Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Dalakas, MC (corresponding author), NINDS, Neuromuscular Dis Sect, NIH, Bldg 10,Rm 4N248,10 Ctr Dr,MSC 1382, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002038, ZIANS002973, Z01NS002973] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amato AA, 1998, NEUROLOGY, V51, P1646, DOI 10.1212/WNL.51.6.1646; Banwell BL, 1999, J NEUROPATH EXP NEUR, V58, P832, DOI 10.1097/00005072-199908000-00006; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; DALAKAS MC, 1997, SCI AM MED, V3; DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hijikata T, 1999, J CELL SCI, V112, P867; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Nakano S, 1997, J NEUROPATH EXP NEUR, V56, P850, DOI 10.1097/00005072-199708000-00002; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; RAATS JMH, 1991, EUR J CELL BIOL, V56, P84; Raats JMH, 1996, EUR J CELL BIOL, V71, P221; Semino-Mora C, 1998, HUM PATHOL, V29, P1128, DOI 10.1016/S0046-8177(98)90425-7; Sivakumar K, 1996, NEUROLOGY, V46, P1337, DOI 10.1212/WNL.46.5.1337; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191; Sjuve R, 1998, J MUSCLE RES CELL M, V19, P415, DOI 10.1023/A:1005353805699; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vicart P, 1996, HUM GENET, V98, P422, DOI 10.1007/s004390050233; Watson PA, 1996, AM J PHYSIOL-CELL PH, V270, pC1228, DOI 10.1152/ajpcell.1996.270.4.C1228; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070; YU KR, 1994, P NATL ACAD SCI USA, V91, P2497, DOI 10.1073/pnas.91.7.2497	31	323	337	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					770	780		10.1056/NEJM200003163421104	http://dx.doi.org/10.1056/NEJM200003163421104			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717012				2022-12-01	WOS:000085846900004
J	Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J				Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J			Identification of a cellular cofactor required for infection by feline leukemia virus	SCIENCE			English	Article							IMMUNODEFICIENCY DISEASE; RECEPTOR; INTERFERENCE; CELLS; RETROVIRUS; CLONING	Retroviral infection involves continued genetic variation, Leading to phenotypic and immunological selection for more fit virus variants in the host. For retroviruses that cause immunodeficiency, pathogenesis is linked to the emergence of T cell-tropic, cytopathic viruses. Here we show that an immunodeficiency-inducing, T cell-tropic feline Leukemia virus (FeLV) has evolved such that it cannot infect cells unless both a classic multiple membrane-spanning receptor molecule (Pit1) and a second coreceptor or entry factor are present. This second receptor component, which we call FeLIX, was identified as an endogenously expressed protein that is similar to a portion of the FeLV envelope protein. This cellular protein can function either as a transmembrane protein or as a soluble component to facilitate infection.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.							ALLAN JS, 1990, SCIENCE, V247, P1084, DOI 10.1126/science.2309120; Boomer S, 1997, J VIROL, V71, P8116, DOI 10.1128/JVI.71.11.8116-8123.1997; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; DONAHUE PR, 1991, J VIROL, V65, P4461, DOI 10.1128/JVI.65.8.4461-4469.1991; EGLITIS MA, 1993, J VIROL, V67, P5472, DOI 10.1128/JVI.67.9.5472-5477.1993; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KUMAR DV, 1989, J VIROL, V63, P2379, DOI 10.1128/JVI.63.5.2379-2384.1989; MCDOUGALL AS, 1994, J VIROL, V68, P2151, DOI 10.1128/JVI.68.4.2151-2160.1994; Moser M, 1998, VIROLOGY, V242, P366, DOI 10.1006/viro.1997.9008; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; Rohn JL, 1998, J VIROL, V72, P2686, DOI 10.1128/JVI.72.4.2686-2696.1998; SARMA PS, 1971, VIROLOGY, V44, P352, DOI 10.1016/0042-6822(71)90266-2; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Weiss R, 1985, RNA TUMOR VIRUSES; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; [No title captured]	23	95	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1828	1830		10.1126/science.287.5459.1828	http://dx.doi.org/10.1126/science.287.5459.1828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710311				2022-12-01	WOS:000085775300043
J	Fagiolini, M; Hensch, TK				Fagiolini, M; Hensch, TK			Inhibitory threshold for critical-period activation in primary visual cortex	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; ORIENTATION SELECTIVITY; MONOCULAR DEPRIVATION; RAT; MATURATION; DEFICIENT; SYNAPSES; SYSTEM	Neuronal circuits across several systems display remarkable plasticity to sensory input during postnatal development(1-10) Experience-dependent refinements are often restricted to well-defined critical periods in early life, but how these are established remains mostly unknown. A representative example is the loss of responsiveness in neocortex to an eye deprived of vision(2-6). Here we show that the potential for plasticity is retained throughout life until an inhibitory threshold is attained. In mice of all ages lacking an isoform of GABA (gamma-aminobutyric acid) synthetic enzyme (GAD65), as well as in immature wild-type animals before the onset of their natural critical period, benzodiazepines selectively reduced a prolonged discharge phenotype to unmask plasticity. Enhancing GABA-mediated transmission early in life rendered mutant animals insensitive to monocular deprivation as adults, similar to normal wild-type mice. Short-term presynaptic dynamics reflected a synaptic reorganization in GAD65 knockout mice after chronic diazepam treatment. A threshold level of inhibition within the visual cortex may thus trigger, once in life, an experience-dependent critical period for circuit consolidation, which may otherwise lie dormant.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, TK (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Hensch, Takao/L-4182-2019	fagiolini, michela/0000-0003-2807-803X				Bear M F, 1993, Curr Opin Neurobiol, V3, P197, DOI 10.1016/0959-4388(93)90210-P; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DAW N, 1995, VISUAL DEV; DELCERRO S, 1992, NEUROSCIENCE, V49, P1, DOI 10.1016/0306-4522(92)90071-9; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Gordon JA, 1996, J NEUROSCI, V16, P3274; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; Hensch TK, 1998, J NEUROSCI, V18, P2108; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MATAGA N, 1992, NEUROSCI LETT, V142, P115, DOI 10.1016/0304-3940(92)90352-8; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; MOWER GD, 1985, J NEUROPHYSIOL, V53, P572, DOI 10.1152/jn.1985.53.2.572; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; PETTIGREW JD, 1978, NATURE, V271, P761, DOI 10.1038/271761a0; SCOTT JP, 1962, SCIENCE, V138, P949, DOI 10.1126/science.138.3544.949; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1	30	478	489	1	37	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					183	186		10.1038/35004582	http://dx.doi.org/10.1038/35004582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724170				2022-12-01	WOS:000085870900051
J	de Silva, S; Fisher, CA; Premawardhena, A; Lamabadusuriya, SP; Peto, TEA; Perera, G; Old, JM; Clegg, JB; Olivieri, NF; Weatherall, DJ				de Silva, S; Fisher, CA; Premawardhena, A; Lamabadusuriya, SP; Peto, TEA; Perera, G; Old, JM; Clegg, JB; Olivieri, NF; Weatherall, DJ		Sri Lanka Thalassaemia Study Grp	Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations	LANCET			English	Article							THALASSEMIA	Background Thalassaemias pose an increasing problem for the Indian subcontinent and many Asian countries. We analysed the different types of thalassaemia in the Sri Lankan population, surveyed gene frequencies in schoolchildren. and estimated the burden of disease and requirements for its control. Methods We analysed blood samples from patients attending clinics in nine hospitals and defined the different types of beta thalassaemia by high-performance liquid chromatography (HPLC) and DNA analysis. The range of mutations was obtained by analysis of beta-globin genes. Capillary blood was obtained from schoolchildren from different parts of the island and analysed by HPLC to provide an approximate assessment of the carrier frequency of beta thalassaemia and haemoglobin E (HbE). To estimate the frequency of or thalassaemia the cr-globin genotypes were also analysed when it was possible. Findings Blood samples were obtained from 703 patients with beta thalassaemia and from 1600 schoolchildren. The thalassaemia mutations were unevenly spread. Although 23 different beta-thalassaemia mutations were found, three accounted for the thalassaemia phenotype in about 70% of the patients, most whom are homozygotes or compound heterozygotes for IVS1-5 (G-->C) or IVS1-1 (G-->A). The third common mutation, codon 26 (G-->A), which produces HbE, interacts with one or other of these mutations to produce HbE/beta thalassaemia; this comprises 13.0-30.9% of cases in the main centres. Samples from 472 patients were analysed to determine the alpha-globin genotype. Overall, 15.5% patients were carriers for deletion forms of alpha(+) thalassaemia. Average gene frequencies showed that there will be more than 2000 patients requiring treatment at any one time, in the future, of whom those with HbE/beta thalassaemia will account for about 40%. Interpretation In Sri Lanka, interactions of the two common beta-thalassaemia alleles will nearly always result in a transfusion-dependent disorder. However, about 40% of patients will have HbE/beta thalassaemia, which has a variable course. The management of these disorders could require about 5% of the total health budget. We need to learn more about the natural history and appropriate management of HbE/beta thalassaemia if resources are to be used effectively.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Gen Hosp, Thalassaemia Unit, Kurunegala, Sri Lanka; John Radcliffe Hosp, Natl Haemoglobin Reference Lab, Oxford OX3 9DU, England; John Radcliffe Hosp, MRC, Mol Haematol Unit, Oxford OX3 9DU, England; Univ Colombo, Dept Paediat, Colombo, Sri Lanka; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Toronto Gen Hosp, Toronto, ON, Canada	University of Oxford; University of Oxford; University of Oxford; University of Colombo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Weatherall, DJ (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Olivieri, Nancy/AAI-2250-2020; Premawardhena, Anuja/GLN-5388-2022	Premawardhena, Anuja/0000-0003-0605-9081				[Anonymous], 1993, WORLD DEV REPORT; BLACKWELL RQ, 1974, TROP GEOGR MED, V26, P214; Bodmer WalterF., 1976, GENETICS EVOLUTION M; DESILVA CC, 1951, ARCH DIS CHILD, V26, P99; DESILVA CC, 1959, ABNORMAL HAEMOGLOBIN, P340; *EEC, 1999, PREV GEN VAR THAL IN; Ellepola S B, 1980, Ceylon Med J, V25, P29; HIGGS DR, 1993, BAILLIERE CLIN HAEM, V6, P117, DOI 10.1016/S0950-3536(05)80068-X; HUISMAN THJ, 1997, SYLLABUS THALASSAEMI; *MIN HLTH SRI LANK, 1996, ANN HLTH B; NAGARATNAM N, 1989, HEMOGLOBIN, V13, P201, DOI 10.3109/03630268908998074; Old J. M, 1983, METHODS HAEMATOLOGY, P74; OLD JM, 1990, LANCET, V336, P834, DOI 10.1016/0140-6736(90)92338-I; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; WEATHERALL DJ, IN PRESS THALASSAEMI; WICKREMASINGHE RL, 1963, J R ANTHR I, V93, P117; World Health Organization, 1994, GUID CONTR HAEM DIS	18	108	109	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					786	791		10.1016/S0140-6736(99)08246-X	http://dx.doi.org/10.1016/S0140-6736(99)08246-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711926				2022-12-01	WOS:000085766900010
J	Turney, JH				Turney, JH			Renal conservation for gas-forming infections	LANCET			English	Editorial Material							EMPHYSEMATOUS PYELONEPHRITIS		Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary	Turney, JH (corresponding author), Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England.							Best CD, 1999, J UROLOGY, V162, P1273, DOI 10.1016/S0022-5347(05)68263-8; Chen MT, 1997, J UROLOGY, V157, P1569, DOI 10.1016/S0022-5347(01)64797-9; EVANOFF GV, 1987, AM J MED, V83, P149, DOI 10.1016/0002-9343(87)90511-0; Kelly HA, 1898, JAMA-J AM MED ASSOC, V31, P375, DOI [10.1001/jama.1898.92450080001001, DOI 10.1001/JAMA.1898.92450080001001]; MICHAELI J, 1984, J UROLOGY, V131, P203, DOI 10.1016/S0022-5347(17)50309-2; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Wan YL, 1998, J UROLOGY, V159, P369, DOI 10.1016/S0022-5347(01)63919-3; Wan YL, 1996, RADIOLOGY, V198, P433, DOI 10.1148/radiology.198.2.8596845	8	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					770	771		10.1016/S0140-6736(99)00351-7	http://dx.doi.org/10.1016/S0140-6736(99)00351-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711921				2022-12-01	WOS:000085766900005
J	Wuite, GJL; Smith, SB; Young, M; Keller, D; Bustamante, C				Wuite, GJL; Smith, SB; Young, M; Keller, D; Bustamante, C			Single-molecule studies of the effect of template tension on T7 DNA polymerase activity	NATURE			English	Article							BACTERIOPHAGE-T7; EXONUCLEASE; FIDELITY; ENZYME	T7 DNA polymerase(1,2) catalyses DNA replication in vitro at rates of more than 100 bases per second and has a 3'--> 5' exonuclease (nucleotide removing) activity at a separate active site. This enzyme possesses a 'right hand' shape which is common to most polymerases with fingers, palm and thumb domains(3,4). The rate-limiting step for replication is thought to involve a conformational change between an 'open fingers' state in which the active site samples nucleotides, and a 'closed' state in which nucleotide incorporation occurs(3,5). DNA polymerase must function as a molecular motor converting chemical energy into mechanical force as it moves over the template. Here we show, using a single-molecule assay based on the differential elasticity of single-stranded and double-stranded DNA, that mechanical force is generated during the rate-limiting step and that the motor can work against a maximum template tension of similar to 34 pN. Estimates of the mechanical and entropic work done by the enzyme show that T7 DNA polymerase organizes two template bases in the polymerization site during each catalytic cycle. We also find a force-induced 100-fold increase in exonucleolysis above 40pN.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oregon; University of New Mexico	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.			wuite, gijs/0000-0002-5706-043X; Bustamante, Carlos/0000-0002-2970-0073				BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Gurrieri S, 1999, P NATL ACAD SCI USA, V96, P453, DOI 10.1073/pnas.96.2.453; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MODRICH P, 1975, J BIOL CHEM, V250, P5515; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; TABOR S, 1987, J BIOL CHEM, V262, P16212; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0	19	391	407	2	73	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					103	106		10.1038/35003614	http://dx.doi.org/10.1038/35003614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716452				2022-12-01	WOS:000085775100055
J	Dillon, RJ; Vennard, CT; Charnley, AK				Dillon, RJ; Vennard, CT; Charnley, AK			Pheromones - Exploitation of gut bacteria in the locust	NATURE			English	Article							DESERT LOCUST; SCHISTOCERCA-GREGARIA; METARHIZIUM-ANISOPLIAE; INHIBITION; FLORA		Univ Bath, Dept Biol & Biochem, Microbial Pathogen Grp, Bath BA2 7AY, Avon, England	University of Bath	Dillon, RJ (corresponding author), Univ Bath, Dept Biol & Biochem, Microbial Pathogen Grp, Bath BA2 7AY, Avon, England.			Dillon, Rod/0000-0002-3551-0030				BYERS JA, 1991, BIOL REV, V66, P347, DOI 10.1111/j.1469-185X.1991.tb01146.x; CHARNLEY AK, 1985, J INSECT PHYSIOL, V31, P477, DOI 10.1016/0022-1910(85)90096-4; CRAWFORD RL, 1978, APPL ENVIRON MICROB, V36, P539, DOI 10.1128/AEM.36.4.539-543.1978; Dillon R.J., 1991, P129; DILLON RJ, 1988, CAN J MICROBIOL, V34, P1075, DOI 10.1139/m88-189; DILLON RJ, 1986, J INVERTEBR PATHOL, V47, P350, DOI 10.1016/0022-2011(86)90106-0; DILLON RJ, 1995, J INVERTEBR PATHOL, V66, P72, DOI 10.1006/jipa.1995.1063; FUZEAUBRAESCH S, 1988, J CHEM ECOL, V14, P1023, DOI 10.1007/BF01018790; HUNT J, 1981, J INVERTEBR PATHOL, V38, P378, DOI 10.1016/0022-2011(81)90105-1; LYSENKO O, 1985, ANNU REV MICROBIOL, V39, P673; OBENGOFORI D, 1994, J CHEM ECOL, V20, P2077, DOI 10.1007/BF02066244; STEEDMAN A, 1988, LOCUST HDB, P2	12	155	168	2	48	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					851	851		10.1038/35002669	http://dx.doi.org/10.1038/35002669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706273				2022-12-01	WOS:000085559200044
J	Lappe, M; Awater, H; Krekelberg, B				Lappe, M; Awater, H; Krekelberg, B			Postsaccadic visual references generate presaccadic compression of space	NATURE			English	Article							EYE-MOVEMENTS; DISPLACEMENT; LOCALIZATION; SACCADES	With every rapid gaze shift (saccade), our eyes experience a different view of the world. Stable perception of visual space requires that points in the new image are associated with corresponding points in the previous image. The brain may use an extraretinal eye position signal to compensate for gaze changes(1,2), or, alternatively, exploit the image contents to determine associated locations(3,4). Support for a uniform extraretinal signal comes from findings that the apparent position of objects briefly flashed around the time of a saccade is often shifted in the direction of the saccade(5-9). This view is challenged, however, by observations that the magnitude(4,10) and direction(11) of the displacement varies across the visual field. Led by the observation that non-uniform displacements typically occurred in studies conducted in slightly illuminated rooms(4,7,10-13), here we determine the dependence of perisaccadic mislocalization on the availability of visual spatial references at various times around a saccade. We find that presaccadic compression(11) occurs only if visual references are available immediately after, rather than before or during, the saccade. Our findings indicate that the visual processes of transsaccadic spatial localization use mainly postsaccadic visual information.	Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany	Ruhr University Bochum	Lappe, M (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany.		Krekelberg, Bart/N-7938-2019	Krekelberg, Bart/0000-0003-1083-6103				BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Bockisch CJ, 1999, VISION RES, V39, P1025, DOI 10.1016/S0042-6989(98)00205-3; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; DASSONVILLE P, 1995, VISION RES, V35, P2191, DOI 10.1016/0042-6989(94)00317-3; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; MACKAY DM, 1970, NATURE, V227, P731, DOI 10.1038/227731a0; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Miller JM, 1997, NATURE, V386, P550, DOI 10.1038/386550a0; OREGAN JK, 1984, PERCEPT PSYCHOPHYS, V36, P1, DOI 10.3758/BF03206348; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; von Helmholtz H, 1896, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	17	205	205	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					892	895		10.1038/35002588	http://dx.doi.org/10.1038/35002588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706286				2022-12-01	WOS:000085559200057
J	Dahmann, C; Basler, K				Dahmann, C; Basler, K			Opposing transcriptional outputs of hedgehog signaling and engrailed control compartmental cell sorting at the Drosophila A/P boundary	CELL			English	Article							CUBITUS-INTERRUPTUS PROTEIN; KINESIN-RELATED PROTEIN; GENE; EXPRESSION; ADHESION; RECEPTOR; ENCODES; COMPLEX; PATTERN; COSTAL2	The wing imaginal disc is subdivided into two nonintermingling sets of cells, the anterior (A)I and posterior (P) compartments. Anterior cells require reception of the Hedgehog (Hh) signal to segregate from P cells. We provide evidence that Hh signaling controls A/P cell segregation not by directly modifying structural components but by a Cubitus interruptus (Ci)-mediated transcriptional response. A shift in the balance between repressor and activator forms of Ci toward the activator form is necessary and sufficient to define "A-type" cell sorting behavior. Moreover, we show that Engrailed (En), in the absence of Ci, is sufficient to specify "P-type" sorting. We propose that the opposing transcriptional activities of Ci and En control cell segregation at the A/P boundary by regulating a single cell adhesion molecule.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Wintherthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch	Dahmann, Christian/B-5841-2017	Basler, Konrad/0000-0003-3534-1529				Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BLAIR SS, 1992, DEVELOPMENT, V115, P21; BLAIR SS, 1995, BIOESSAYS, V17, P299, DOI 10.1002/bies.950170406; Blair SS, 1997, DEVELOPMENT, V124, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gustavson E, 1996, GENETICS, V142, P893; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LAWRENCE PA, 1982, EMBO J, V1, P827, DOI 10.1002/j.1460-2075.1982.tb01255.x; Lawrence PA, 1997, NATURE, V389, P546, DOI 10.1038/39188; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Pignoni F, 1997, DEVELOPMENT, V124, P271; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Sokal R., 2000, BIOMETRY, V3rd ed., P451; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; TABATA T, 1995, DEVELOPMENT, V121, P3359; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vincent JP, 1998, INT J DEV BIOL, V42, P311; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	50	127	130	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2000	100	4					411	422		10.1016/S0092-8674(00)80677-7	http://dx.doi.org/10.1016/S0092-8674(00)80677-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693758	Bronze, Green Accepted			2022-12-01	WOS:000085446900004
J	Ivessa, AS; Zhou, JQ; Zakian, VA				Ivessa, AS; Zhou, JQ; Zakian, VA			The Saccharomyces Pif1p DNA helicase and the highly related Rrm3p have opposite effects on replication fork progression in ribosomal DNA	CELL			English	Article							TELOMERIC HETEROCHROMATIN; S-CEREVISIAE; GENE-PRODUCT; CELL-CYCLE; YEAST RDNA; RNA GENES; RECOMBINATION; TRANSCRIPTION; ORIGINS; PROTEIN	Replication of Saccharomyces ribosomal DNA (rDNA) proceeds bidirectionally from origins in a subset of the similar to 150 tandem repeats, but the leftward-moving fork stops when it encounters the replication fork barrier (RFB). The Pif1p helicase and the highly related Rrm3p were rDNA associated in vivo. Both proteins affected rDNA replication but had opposing effects on fork progression. Pif1p helped maintain the RFB. Rrm8p appears to be the replicative helicase for rDNA as it acted catalytically to promote fork progression throughout the rDNA. Loss of Rrm3p increased rDNA breakage and accumulation of rDNA circles, whereas breakage and circles were less common in pif1 cells. These data support a model in which replication fork pausing causes breakage and recombination in the rDNA.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Ivessa, Andreas/0000-0002-7578-1337	NIGMS NIH HHS [GM26938] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026938, R01GM026938] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BORST P, 1978, CELL, V15, P705, DOI 10.1016/0092-8674(78)90257-X; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; CHRISTMAN MF, 1993, P NATL ACAD SCI USA, V90, P7637, DOI 10.1073/pnas.90.16.7637; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; CRAMER JH, 1980, MOL GEN GENET, V177, P199; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; Gangloff S, 1996, EMBO J, V15, P1715, DOI 10.1002/j.1460-2075.1996.tb00517.x; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; Gotta M, 1997, EMBO J, V16, P3243, DOI 10.1093/emboj/16.11.3243; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; HARTWELL LH, 1985, GENETICS, V110, P381; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HERNANDEZ P, 1993, EMBO J, V12, P1475, DOI 10.1002/j.1460-2075.1993.tb05791.x; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; KEIL RL, 1993, GENETICS, V135, P711; KIM RA, 1989, CELL, V57, P975, DOI 10.1016/0092-8674(89)90336-X; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LIN YH, 1991, GENETICS, V127, P31; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Lopez-Estrano C, 1998, J MOL BIOL, V277, P249, DOI 10.1006/jmbi.1997.1607; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; ROSE MD, 1990, METHODS YEAST GENETI; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.0.CO;2-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SKRYABIN KG, 1984, NUCLEIC ACIDS RES, V12, P2955, DOI 10.1093/nar/12.6.2955; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; ZAKIAN VA, 1982, PLASMID, V8, P15, DOI 10.1016/0147-619X(82)90037-3	43	216	219	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 18	2000	100	4					479	489		10.1016/S0092-8674(00)80683-2	http://dx.doi.org/10.1016/S0092-8674(00)80683-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	286LF	10693764	Bronze			2022-12-01	WOS:000085446900010
J	Millonig, JH; Millen, KJ; Hatten, ME				Millonig, JH; Millen, KJ; Hatten, ME			The mouse Dreher gene Lmx1a controls formation of the roof plate in the vertebrate CNS	NATURE			English	Article							MUTANT MOUSE; LIM DOMAIN; PROTEIN; CELLS; EXPRESSION	In the vertebrate central nervous system (CNS), a cascade of signals that originates in the ectoderm adjacent to the neural tube is propagated by the roof plate to dorsalize the neural tube(1). Here we report that the phenotype of the spontaneous neurological mutant mouse dreher (dr)(2-5) results from a failure of the roof plate to develop. Dorsalization of the neural tube is consequently affected: dorsal interneurons in the spinal cord and granule neurons in the cerebellar cortex are lost, and the dorsal vertebral neural arches fail to form. Positional cloning of dreher indicates that the LIM homeodomain protein, Lmx1a, is affected in three different alleles of dreher. Lmx1a is expressed in the roof plate dong the neuraxis during development of the CNS. Thus, Lmx1a is required for development of the roof plate and, in turn, for specification of dorsal cell fates in the CNS and developing vertebrae.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.			Millen, Kathleen/0000-0001-9978-675X				Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; ALMASAN A, 1994, GENOMICS, V20, P397, DOI 10.1006/geno.1994.1193; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bergstrom DE, 1999, GENOMICS, V59, P291, DOI 10.1006/geno.1999.5873; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Konrat R, 1997, J BIOL CHEM, V272, P12001, DOI 10.1074/jbc.272.18.12001; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LYONS M, 1996, GENETIC VARIANTS LAB, P195; Millen Kathleen J., 1996, P339; Millonig JH, 1996, MAMM GENOME, V7, P616, DOI 10.1007/s003359900183; PARR BA, 1993, DEVELOPMENT, V119, P247; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; PerezAlvarado GC, 1996, J MOL BIOL, V257, P153, DOI 10.1006/jmbi.1996.0153; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SEKIGUCHI M, 1992, DEV BRAIN RES, V67, P105, DOI 10.1016/0165-3806(92)90030-Z; SEKIGUCHI M, 1994, DEV BRAIN RES, V77, P37, DOI 10.1016/0165-3806(94)90211-9; SIDMAN RL, 1983, GENETICS NEUROLOGICA, P19; WALSTEN D, 1983, J HERED, V74, P421	25	214	221	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					764	769		10.1038/35001573	http://dx.doi.org/10.1038/35001573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693804				2022-12-01	WOS:000085423100051
J	Hak, AE; Pols, HAP; Visser, TJ; Drexhage, HA; Hofman, A; Witteman, JCM				Hak, AE; Pols, HAP; Visser, TJ; Drexhage, HA; Hofman, A; Witteman, JCM			Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study	ANNALS OF INTERNAL MEDICINE			English	Article						hypothyroidism; autoimmune diseases; coronary arteriosclerosis; menopause; myocardial infarction	CORONARY HEART-DISEASE; THYROID-HORMONES; FOLLOW-UP; AUTOIMMUNE-THYROIDITIS; AORTIC ATHEROSCLEROSIS; NONTHYROIDAL ILLNESS; THYROTROPIN; CHOLESTEROL; PROGRESSION; LIPIDS	Background: Overt hypothyroidism has been found to be associated with cardiovascular disease. Whether subclinical hypothyroidism and thyroid autoimmunity are also risk factors for cardiovascular disease is controversial. Objective: To investigate whether subclinical hypothyroidism and thyroid autoimmunity are associated with aortic atherosclerosis and myocardial infarction in postmenopausal women. Design: Population-based cross-sectional study. Setting: A district of Rotterdam, the Netherlands. Participants: Random sample of 1149 women (mean age +/- SD, 69.0 +/- 7.5 years) participating in the Rotterdam Study. Measurements: Data on thyroid status, aortic atherosclerosis, and history of myocardial infarction were obtained at baseline. Subclinical hypothyroidism was defined as an elevated thyroid-stimulating hormone level (>4.0 mU/L) and a normal serum free thyroxine level (11 to 25 pmol/L [0.9 to 1.9 ng/d L]). In tests for antibodies to thyroid peroxidase, a serum level greater than 10 IU/mL was considered a positive result. Results: Subclinical hypothyroidism was present in 10.8% of participants and was associated with a greater age-adjusted prevalence of aortic atherosclerosis (odds ratio, 1.7 [95% CI, 1.1 to 2.6]) and myocardial infarction (odds ratio, 2.3 [CI, 1.3 to 4.0]). Additional adjustment for body mass index, total and high-density lipoprotein cholesterol level, blood pressure, and smoking status, as well as exclusion of women who took p-blockers, did not affect these estimates. Associations were slightly stronger in women who had subclinical hypothyroidism and antibodies to thyroid peroxidase (odds ratio for aortic atherosclerosis, 1.9 [CI, 1.1 to 3.6]; odds ratio for myocardial infarction, 3.1 [CI, 1.5 to 6.3]). No association was found between thyroid autoimmunity itself and cardiovascular disease. The population attributable risk percentage for subclinical hypothyroidism associated with myocardial infarction was within the range of that for known major risk factors for cardiovascular disease. Conclusion: Subclinical hypothyroidism is a strong indicator of risk for atherosclerosis and myocardial infarction in elderly women.	Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Witteman, JCM (corresponding author), Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	witteman@epib.fgg.eur.nl	Visser, Theo J/C-8059-2013	Visser, Theo J/0000-0002-6997-284X				ALTHAUS BU, 1988, CLIN ENDOCRINOL, V28, P157, DOI 10.1111/j.1365-2265.1988.tb03651.x; [Anonymous], 1992, INT STAT CLASS DIS R, V1-3; BASTENIE PA, 1977, LANCET, V2, P155; BASTENIE PA, 1967, LANCET, V2, P1221; BASTENIE PA, 1971, LANCET, V1, P203; BOTS ML, 1993, ATHEROSCLEROSIS, V102, P99, DOI 10.1016/0021-9150(93)90088-C; BRASS EP, 1984, DRUGS, V27, P447, DOI 10.2165/00003495-198427050-00004; BRENT GA, 1986, AM J MED, V81, P463, DOI 10.1016/0002-9343(86)90300-1; CARON P, 1990, CLIN ENDOCRINOL, V33, P519, DOI 10.1111/j.1365-2265.1990.tb03889.x; Chadarevian R, 1998, THROMB HAEMOSTASIS, V79, P99; DEAN JW, 1985, BRIT MED J, V290, P1555, DOI 10.1136/bmj.290.6481.1555; FOWLER PBS, 1970, LANCET, V2, P488; GASPAR IA, 1968, J AM GERIATR SOC, V16, P686, DOI 10.1111/j.1532-5415.1968.tb01278.x; GEUL KW, 1993, CLIN ENDOCRINOL, V39, P275, DOI 10.1111/j.1365-2265.1993.tb02366.x; Harjai KJ, 1997, ANN INTERN MED, V126, P63, DOI 10.7326/0003-4819-126-1-199701010-00009; HEINONEN OP, 1972, LANCET, V1, P785; Helfand M, 1998, ANN INTERN MED, V129, P144, DOI 10.7326/0003-4819-129-2-199807150-00020; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, V1; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; HYMAN JB, 1954, AM HEART J, V48, P540, DOI 10.1016/0002-8703(54)90119-2; ISHIKAWA T, 1989, MOL PHARMACOL, V35, P760; Klein Irwin, 1996, P799; KOLTRINGER P, 1988, J ENDOCRINOL INVEST, V11, P267; KUNG AWC, 1995, CLIN ENDOCRINOL, V43, P445, DOI 10.1111/j.1365-2265.1995.tb02616.x; MAMIYA S, 1989, J BIOL CHEM, V264, P8575; MASAKI H, 1992, J CLIN ENDOCR METAB, V75, P721, DOI 10.1210/jc.75.3.721; MATHEWS JD, 1974, LANCET, V2, P1423; Miura S, 1996, ENDOCR J, V43, P657, DOI 10.1507/endocrj.43.657; Nedrebo BG, 1998, METABOLISM, V47, P89, DOI 10.1016/S0026-0495(98)90198-6; NILSSON G, 1976, ACTA MED SCAND, V200, P63; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; PARLE JV, 1992, CLIN ENDOCRINOL, V37, P411, DOI 10.1111/j.1365-2265.1992.tb02351.x; POWELL J, 1987, BRIT J SURG, V74, P1139, DOI 10.1002/bjs.1800741220; ROBUSCHI G, 1987, ENDOCR REV, V8, P142, DOI 10.1210/edrv-8-2-142; SAWIN CT, 1985, ARCH INTERN MED, V145, P1386, DOI 10.1001/archinte.145.8.1386; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; STEINBERG AD, 1968, ANN INTERN MED, V68, P338, DOI 10.7326/0003-4819-68-2-338; Sundaram V, 1997, J CLIN ENDOCR METAB, V82, P3421, DOI 10.1210/jcem.82.10.4315; TIECHE M, 1981, BRIT HEART J, V46, P202, DOI 10.1136/hrt.46.2.202; TRANTOW T, 1994, METHOD FIND EXP CLIN, V16, P133; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P495, DOI 10.1111/j.1365-2265.1977.tb01341.x; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Vanderpump MPJ, 1996, THYROID, V6, P155; VANGENT CM, 1977, CLIN CHIM ACTA, V75, P243, DOI 10.1016/0009-8981(77)90195-4; VANHAELST L, 1967, LANCET, V2, P800, DOI 10.1016/S0140-6736(67)92235-0; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; WITTEMAN JCM, 1986, LANCET, V2, P1120; WITTEMAN JCM, 1990, AM J CARDIOL, V66, P1060, DOI 10.1016/0002-9149(90)90505-U; WITTEMAN JCM, 1994, LANCET, V343, P504, DOI 10.1016/S0140-6736(94)91459-1; WITTEMAN JCM, 1993, CIRCULATION, V88, P2156, DOI 10.1161/01.CIR.88.5.2156; WONG ET, 1981, ARCH INTERN MED, V141, P873, DOI 10.1001/archinte.141.7.873	52	882	980	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2000	132	4					270	+		10.7326/0003-4819-132-4-200002150-00004	http://dx.doi.org/10.7326/0003-4819-132-4-200002150-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	285CY	10681281	Green Published			2022-12-01	WOS:000085372900003
J	Radajewski, S; Ineson, P; Parekh, NR; Murrell, JC				Radajewski, S; Ineson, P; Parekh, NR; Murrell, JC			Stable-isotope probing as a tool in microbial ecology	NATURE			English	Article							BACTERIA; POPULATIONS; SOIL	Microorganisms are responsible for driving the biogeochemical cycling of elements on Earth. Despite their importance and vast diversity(1), the taxonomic identity of the microorganisms involved in any specific process has usually been confined to that small fraction of the microbiota that has been isolated and cultivated. The recent coupling of molecular biological methods with stable-isotope abundance in biomarkers has provided a cultivation-independent means of linking the identity of bacteria with their function in the environment(2,3). Here we show that C-13-DNA, produced during the growth of metabolically distinct microbial groups on a C-13-enriched carbon source, can be resolved from C-12- DNA by density-gradient centrifugation. DNA isolated from the target group of microorganisms can be characterized taxonomically and functionally by gene probing and sequence analysis. Application of this technique to investigate methanol-utilizing microorganisms in soil demonstrated the involvement of members of two phylogenetically distinct groups of eubacteria; the alpha-proteobacterial and Acidobacterium lineages. Stable-isotope probing thus offers a powerful new technique for identifying microorganisms that are actively involved in specific metabolic processes under conditions which approach those occurring in situ.	Univ Warwick, Dept Sci Biol, Coventry CV4 7AL, W Midlands, England; Inst Terr Ecol, Merlewood Res Stn, Grange Sands LA11 6JU, Cumbria, England	University of Warwick; UK Centre for Ecology & Hydrology (UKCEH)	Murrell, JC (corresponding author), Univ Warwick, Dept Sci Biol, Coventry CV4 7AL, W Midlands, England.		Murrell, John C/B-1443-2012					AMANN RI, 1992, APPL ENVIRON MICROB, V58, P614, DOI 10.1128/AEM.58.2.614-623.1992; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KISHIMOTO N, 1991, CURR MICROBIOL, V22, P1, DOI 10.1007/BF02106205; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Lidstrom M. E., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol.I., P431; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; MOFFAT AJ, 1990, SOIL USE MANAGE, V6, P46, DOI 10.1111/j.1475-2743.1990.tb00797.x; MURRELL JC, 1992, METHANE METHANOL UTI; Nogales B, 1999, ENVIRON MICROBIOL, V1, P199, DOI 10.1046/j.1462-2920.1999.00024.x; Nold SC, 1999, FEMS MICROBIOL ECOL, V29, P81, DOI 10.1111/j.1574-6941.1999.tb00600.x; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; Roslev P, 1999, APPL ENVIRON MICROB, V65, P4064; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sambrook J., 1989, MOL CLONING LAB MANU; Starr M. P., 1981, PROKARYOTES; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yeates C, 1998, LETT APPL MICROBIOL, V27, P49, DOI 10.1046/j.1472-765X.1998.00383.x	26	832	907	15	646	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					646	649		10.1038/35001054	http://dx.doi.org/10.1038/35001054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688198				2022-12-01	WOS:000085288200050
J	Shulz, DE; Sosnik, R; Ego, V; Haidarliu, S; Ahissar, E				Shulz, DE; Sosnik, R; Ego, V; Haidarliu, S; Ahissar, E			A neuronal analogue of state-dependent learning	NATURE			English	Article							LONG-TERM ENHANCEMENT; BASAL FOREBRAIN; AUDITORY-CORTEX; NUCLEUS BASALIS; BARREL CORTEX; CUTANEOUS RECEPTORS; EVOKED-POTENTIALS; GUINEA-PIG; RAT; PLASTICITY	State-dependent learning is a phenomenon in which the retrieval of newly acquired information is possible only if the subject is in the same sensory context and physiological state as during the encoding phase(1). In spite of extensive behavioural and pharmacological characterization(2), no cellular counterpart of this phenomenon has been reported, Here we describe a neuronal analogue of state-dependent learning in which cortical neurons show an acetylcholine-dependent expression of an acetylcholine-induced functional plasticity. This was demonstrated on neurons of rat somatosensory 'barrel' cortex, whose tunings to the temporal frequency of whisker deflections were modified by cellular conditioning. Pairing whisker stimulation with acetylcholine applied iontophoretically yielded selective lasting modification of responses, the expression of which depended on the presence of exogenous acetylcholine. Administration of acetylcholine during testing revealed frequency-specific changes in response that were not expressed when tested without acetylcholine or when the muscarinic antagonist, atropine, was applied concomitantly, Our results suggest that both acquisition and recall can be controlled by the cortical release of acetylcholine.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; CNRS, Inst Alfred Fessard, UNIC, Equipe Cognisci, F-91198 Gif Sur Yvette, France	Weizmann Institute of Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Shulz, DE (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.			Ego-Stengel, Valerie/0000-0002-9099-9051				Ahissar E, 1996, J PHYSIOL-PARIS, V90, P353, DOI 10.1016/S0928-4257(97)87919-3; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; Ahissar Ehud, 1994, Current Opinion in Neurobiology, V4, P580, DOI 10.1016/0959-4388(94)90060-4; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; CARVELL GE, 1990, J NEUROSCI, V10, P2638; DELACOUR J, 1990, NEUROSCIENCE, V34, P1, DOI 10.1016/0306-4522(90)90299-J; Dykes RW, 1997, CAN J PHYSIOL PHARM, V75, P535, DOI 10.1139/cjpp-75-5-535; EDELINE JM, 1994, EXP BRAIN RES, V97, P373; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; GORDON WC, 1994, ANIMAL LEARNING COGN, P255; Haidarliu S, 1997, J COMP NEUROL, V385, P515, DOI 10.1002/(SICI)1096-9861(19970908)385:4<515::AID-CNE3>3.0.CO;2-6; Haidarliu S, 1996, PHYSIOL BEHAV, V60, P111, DOI 10.1016/0031-9384(95)02257-0; HAIDARLIU S, 1995, J NEUROSCI METH, V56, P125, DOI 10.1016/0165-0270(94)00114-V; HOWARD MA, 1994, EXP BRAIN RES, V102, P21; IZQUIERDO I, 1984, NEUROBIOLOGY LEARNIN, P333; JACOBS SE, 1995, J NEUROSCI, V15, P1099; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Maalouf M, 1998, J NEUROPHYSIOL, V80, P529, DOI 10.1152/jn.1998.80.2.529; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; METHERATE R, 1989, BRAIN RES, V480, P372, DOI 10.1016/0006-8993(89)90210-2; RASMUSSON DD, 1988, EXP BRAIN RES, V70, P276; RICHTER LM, 1988, CHILD CARE WORKER, V6, P11; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; Shulz DE, 1997, EUR J NEUROSCI, V9, P396, DOI 10.1111/j.1460-9568.1997.tb01409.x; SINGER W, 1990, BRAIN ORG MEMORY CEL, P211; WEBSTER HH, 1991, BRAIN RES, V545, P292, DOI 10.1016/0006-8993(91)91300-P; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	29	122	126	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2000	403	6769					549	553		10.1038/35000586	http://dx.doi.org/10.1038/35000586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676963				2022-12-01	WOS:000085227300051
J	Sze, JY; Victor, M; Loer, C; Shi, Y; Ruvkun, G				Sze, JY; Victor, M; Loer, C; Shi, Y; Ruvkun, G			Food and metabolic signaling defects in a Caenorhabditis elegans serotonin-synthesis mutant	NATURE			English	Article							C-ELEGANS; PROTEINS; EXPRESSION; LONGEVITY; GENETICS; NEURONS; LONG; PHEROMONE; BEHAVIOR; DAF-2	The functions of serotonin have been assigned through serotonin-receptor-specific drugs and mutants(1,2); however because a constellation of receptors remains when a single receptor subtype is inhibited, the coordinate responses to modulation of serotonin levels may be missed. Here we report the analysis of behavioural and neuroendocrine defects caused by a complete lack of serotonin signalling. Analysis of the C. elegans genome sequence showed that there is a single tryptophan hydroxylase gene (tph-1)-the key enzyme for serotonin biosynthesis. Animals bearing a tph-1 deletion mutation do not synthesize serotonin but are fully viable. The tph-1 mutant shows abnormalities in behaviour and metabolism that are normally coupled with the sensation and ingestion of food: rates of feeding and egg laying are decreased; large amounts of fat are stored; reproductive lifespan is increased; and some animals arrest at the metabolically inactive dauer stage. This metabolic dysregulation is, in part, due to downregulation of tranforming growth factor-beta and insulin-like neuroendocrine signals. The action of the C. elegans serotonergic system in metabolic control is similar to mammalian serotonergic input to metabolism and obesity.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ San Diego, Dept Biol, San Diego, CA 92110 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of San Diego	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@frodo.mgh.harvard.edu						[Anonymous], [No title captured]; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Breum L, 1995, METABOLISM, V44, P1570, DOI 10.1016/0026-0495(95)90077-2; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; DSa CM, 1996, J NEUROCHEM, V67, P917; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348; Gems D, 1998, GENETICS, V150, P129; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Loer CM, 1999, J NEUROGENET, V13, P157, DOI 10.3109/01677069909083472; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Peschke E, 1997, J PINEAL RES, V23, P156, DOI 10.1111/j.1600-079X.1997.tb00349.x; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle D.L., 1997, GENETIC ENV REGULATI, VII, P739; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Zwaal RR, 1997, GENETICS, V145, P715	30	459	481	2	80	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2000	403	6769					560	564		10.1038/35000609	http://dx.doi.org/10.1038/35000609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282PM	10676966				2022-12-01	WOS:000085227300054
J	Harris, J				Harris, J			Essays on science and society - Intimations of immortality	SCIENCE			English	Editorial Material									Univ Manchester, Inst Med Law & Bioeth, Manchester M13 9PL, Lancs, England	University of Manchester	Harris, J (corresponding author), Univ Manchester, Inst Med Law & Bioeth, Manchester M13 9PL, Lancs, England.								0	43	43	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					59	59		10.1126/science.288.5463.59	http://dx.doi.org/10.1126/science.288.5463.59			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766635				2022-12-01	WOS:000086387700025
J	Lim, DS; Kim, ST; Xu, B; Maser, RS; Lin, JY; Petrini, JHJ; Kastan, MB				Lim, DS; Kim, ST; Xu, B; Maser, RS; Lin, JY; Petrini, JHJ; Kastan, MB			ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; IONIZING-RADIATION; PROTEIN-KINASE; REPAIR; P53; LINKAGE	The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation(1-4). The ATM gene encodes a protein kinase that is activated by ionizing radiation or radiomimetic drugs(5,6), whereas p95/nbs1 is part of a protein complex that is involved in responses to DNA double-strand breaks(3,7). Here, because of the similarities between AT and NBS, we evaluated the functional interactions between ATM and p95/nbs1. Activation of the ATM kinase by ionizing radiation and induction of ATM-dependent responses in NBS cells indicated that p95/nbs1 may not be required for signalling to ATM after ionizing radiation. However, p95/nbs1 was phosphorylated on serine 343 in an ATM-dependent manner in vitro and in vivo after ionizing radiation. A p95/nbs1 construct mutated at the ATM phosphorylation site abrogated an S-phase checkpoint induced by ionizing radiation in normal cells and failed to compensate for this functional deficiency in NBS cells. These observations link ATM and p95/nbs1 in a common signalling pathway and provide an explanation for phenotypic similarities in these two diseases.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	St Jude Children's Research Hospital; University of Wisconsin System; University of Wisconsin Madison	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale, Memphis, TN 38105 USA.	Michael.Kastan@stjude.org	Lim, Dae-Sik/C-1599-2011; Kim, Seong-Tae/A-9917-2013; Maser, Richard/B-2970-2012	Lim, Dae-Sik/0000-0003-2356-7555; 				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Featherstone C, 1998, CURR BIOL, V8, pR622, DOI 10.1016/S0960-9822(98)70392-6; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1995, ONCOGENE, V11, P609; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; MASER RS, 1999, MRE11 RAD50 COMPLEX; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Yamazaki V, 1998, CANCER RES, V58, P2316; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	28	644	661	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					613	+		10.1038/35007091	http://dx.doi.org/10.1038/35007091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766245				2022-12-01	WOS:000086400100056
J	Ovchinnikov, IV; Gotherstrom, A; Romanova, GP; Kharitonov, VM; Liden, K; Goodwin, W				Ovchinnikov, IV; Gotherstrom, A; Romanova, GP; Kharitonov, VM; Liden, K; Goodwin, W			Molecular analysis of Neanderthal DNA from the northern Caucasus	NATURE			English	Article							SEQUENCE; HUMANS	The expansion of premodern humans into western and eastern Europe similar to 40,000 years before the present led to the eventual replacement of the Neanderthals by modern humans similar to 28,000 years ago(1). Here we report the second mitochondrial DNA (mtDNA) analysis of a Neanderthal, and the first such analysis on clearly dated Neanderthal remains. The specimen is from one of the eastern-most Neanderthal populations, recovered from Mezmaiskaya Cave in the northern Caucasus(2). Radiocarbon dating estimated the specimen to be similar to 29,000 years old and therefore from one of the latest living Neanderthals(3). The sequence shows 3.48% divergence from the Feldhofer Neanderthal(4). Phylogenetic analysis places the two Neanderthals from the Caucasus and western Germany together in a clade that is distinct from modern humans, suggesting that their mtDNA types have not contributed to the modern human mtDNA pool. Comparison with modern populations provides no evidence for the multiregional hypothesis of modern human evolution.	Univ Glasgow, Human Identificat Ctr, Glasgow G12 8QQ, Lanark, Scotland; Inst Gerontol, Moscow 129226, Russia; Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden; Archaeol Inst, Moscow 117036, Russia; Moscow MV Lomonosov State Univ, Inst Anthropol, Moscow 103009, Russia; Moscow MV Lomonosov State Univ, Museum Anthropol, Moscow 103009, Russia	University of Glasgow; Stockholm University; Lomonosov Moscow State University; Lomonosov Moscow State University	Goodwin, W (corresponding author), Univ Glasgow, Human Identificat Ctr, Glasgow G12 8QQ, Lanark, Scotland.			Gotherstrom, Anders/0000-0001-8579-1304; Liden, Kerstin/0000-0002-5911-9503; Goodwin, William/0000-0002-3632-3552				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; Cooper A, 1997, SCIENCE, V277, P1021; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Gamble C, 1998, PREHISTORIC EURPE, P5; Golovanova LV, 1999, CURR ANTHROPOL, V40, P77, DOI 10.1086/515805; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Kozlowski JK, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P461; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Liden K, 1997, ISKOS, V11, P158; Smith FH, 1999, P NATL ACAD SCI USA, V96, P12281, DOI 10.1073/pnas.96.22.12281; Stringer C., 1996, AFRICAN EXODUS ORIGI; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023	19	327	351	3	67	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					490	493		10.1038/35006625	http://dx.doi.org/10.1038/35006625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761915				2022-12-01	WOS:000086257700046
J	Sharp, D				Sharp, D			Aids to navigation	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), The Lancet, London WC1X 8RR, England.							Clayton NS, 1998, NEUROPHARMACOLOGY, V37, P441, DOI 10.1016/S0028-3908(98)00037-9; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; MAGUIRE EA, 2000, NAVIGATION RELATED S	3	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1034	1034		10.1016/S0140-6736(00)02032-8	http://dx.doi.org/10.1016/S0140-6736(00)02032-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744087				2022-12-01	WOS:000086380800008
J	Gold, JI; Shadlen, MN				Gold, JI; Shadlen, MN			Representation of a perceptual decision in developing oculomotor commands	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; PSYCHOPHYSICAL PERFORMANCE; VISUAL-MOTION; NEURONS; RESPONSES; MONKEY; COMPUTATION; STIMULATION; DISCHARGE	Behaviour often depends on the ability to make categorical judgements about sensory information acquired over time. Such judgements require a comparison of the evidence favouring the alternatives(1-4), but how the brain forms these comparisons is unknown. Here we show that in a visual discrimination task, the accumulating balance of sensory evidence favouring one interpretation over another is evident in the neural circuits that generate the behavioural response. We trained monkeys to make a direction judgement about dynamic random-dot motion(5) and to indicate their judgement with an eye movement to a visual target We interrupted motion viewing with electrical microstimulation of the frontal eye field and analysed the resulting, evoked eye movements for evidence of ongoing activity associated with the oculomotor response(6-10). Evoked eye movements deviated in the direction of the monkey's judgement. The magnitude of the deviation depended on motion strength and viewing time. The oculomotor signals responsible for these deviations reflected the accumulated motion information that informed the monkey's choices on the discrimination task. Thus, for this task, decision formation and motor preparation appear to share a common level of neural organization.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.		Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210				BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Graham N. V., 1989, VISUAL PATTERN ANAL; GREEN DM, 1966, SIGNAL DETECTION THE; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.ne.12.030189.000341; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPARKS DL, 1990, COLD SH Q B, V55, P805; SPARKS DL, 1987, J NEUROPHYSIOL, V58, P300, DOI 10.1152/jn.1987.58.2.300; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Tehovnik EJ, 1999, EUR J NEUROSCI, V11, P2431, DOI 10.1046/j.1460-9568.1999.00665.x; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	30	413	451	1	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					390	394		10.1038/35006062	http://dx.doi.org/10.1038/35006062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746726				2022-12-01	WOS:000086119000051
J	de Man, P; Verhoeven, BAN; Verbrugh, HA; Vos, MC; van den Anker, JN				de Man, P; Verhoeven, BAN; Verbrugh, HA; Vos, MC; van den Anker, JN			An antibiotic policy to prevent emergence of resistant bacilli	LANCET			English	Article							INTENSIVE-CARE-UNIT; ENTEROBACTER-CLOACAE; INFECTION; COLONIZATION; AMPICILLIN; CEFUROXIME; CEFOTAXIME; OUTBREAK; RESTRICTION; IMPACT	Background Fear of infection in neonatal intensive care units (NICUs) often leads to early use of empiric broad-spectrum antibiotics, a strategy that selects for resistant bacteria. We investigated whether the emergence of resistant strains could be halted by modifying the empiric antibiotic regimens to remove the selective pressure that favours resistant bacteria. Methods Two identical NICUs were assigned to different empiric antibiotic regimens. On unit A, penicillin G and tobramycin were used for early-onset septicaemia, flucloxacillin and tobramycin were used for late-onset septicaemia, and no broad-spectrum beta-lactam antibiotics, such as amoxicillin and cefotaxime were used, In unit B, intravenous amoxicillin with cefotaxime was the empiric therapy. After 6 months of the study the units exchanged regimens. Rectal and respiratory cultures were taken on a weekly basis. Findings There were 436 admissions, divided equally between the two regimens (218 in each), Three neonates treated with the penicillin-tobramycin regimen became colonised with bacilli resistant to the empirical therapy used versus 41 neonates on the amoxicillin-cefotaxime regimen (p < 0.001). The relative risk for colonisation with strains resistant to the empirical therapy per 1000 patient days at risk was 18 times higher for the amoxicillin-cefotaxime regimen compared with the penicillin-tobramycin regimen (95% CI 5.6-58.0). Enterobacter cloacae was the predominant bacillus in neonates on the amoxicillin-cefotaxime regimen, whereas Escherichia coli predominated in neonates on the penicillin-tobramycin regimen. These colonisation patterns were also seen when the units exchanged regimens. Interpretation Policies regarding the empiric use of antibiotics do matter in the control of antimicrobial resistance, A regimen avoiding amoxicillin and cefotaxime restricts the resistance problem. of antimicrobial and cefotaxime.	St Franciscus Gasthuis, Dept Med Microbiol & Infect Control, NL-3004 BA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Control, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Sophias Childrens Hosp, Dept Paediat, Rotterdam, Netherlands	Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Man, P (corresponding author), St Franciscus Gasthuis, Dept Med Microbiol & Infect Control, POB 10900, NL-3004 BA Rotterdam, Netherlands.	peter_de_man@franciscus.nl						ACOLET D, 1994, J HOSP INFECT, V28, P273, DOI 10.1016/0195-6701(94)90091-4; ARREDONDO-GARCIA J L, 1992, Revista Latinoamericana de Microbiologia, V34, P11; BERKOWITZ FE, 1995, PEDIATR INFECT DIS J, V14, P97, DOI 10.1097/00006454-199502000-00003; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BRYAN CS, 1985, AM J DIS CHILD, V139, P1086, DOI 10.1001/archpedi.1985.02140130024022; BURMAN LG, 1993, J ANTIMICROB CHEMOTH, V31, P111, DOI 10.1093/jac/31.1.111; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; HAERTL R, 1993, J HOSP INFECT, V25, P109, DOI 10.1016/0195-6701(93)90101-5; HAMMERSCHLAG MR, 1977, NEW ENGL J MED, V296, P1268, DOI 10.1056/NEJM197706022962206; KALENIC S, 1993, J HOSP INFECT, V23, P35, DOI 10.1016/0195-6701(93)90128-M; KAYYALI MZ, 1972, CLIN PEDIATR, V11, P422; KHADILKAR V, 1995, J PAEDIATR CHILD H, V31, P387, DOI 10.1111/j.1440-1754.1995.tb00843.x; LEDINGHAM IM, 1988, LANCET, V1, P785; MARKOWITZ SM, 1980, J INFECT DIS, V142, P106, DOI 10.1093/infdis/142.1.106; MAYHALL CG, 1980, INFECT CONT HOSP EP, V1, P239, DOI 10.1017/S019594170005308X; MODI N, 1987, ARCH DIS CHILD, V62, P148, DOI 10.1136/adc.62.2.148; NOY JH, 1974, J MED MICROBIOL, V7, P509, DOI 10.1099/00222615-7-4-509; PRICE DJE, 1970, LANCET, V2, P1213; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; SPRITZER R, 1990, PEDIATR INFECT DIS J, V9, P92, DOI 10.1097/00006454-199002000-00006; Toltzis P, 1998, CRIT CARE MED, V26, P1893, DOI 10.1097/00003246-199811000-00035; TULLUS K, 1989, LANCET, V1, P1405; TULLUS K, 1990, ANTIMICROB AGENTS CH, V34, P361, DOI 10.1128/AAC.34.2.361; VENEZIA RA, 1995, CLIN INFECT DIS, V21, P915, DOI 10.1093/clinids/21.4.915; VERWEIJ PE, 1995, INFECT CONT HOSP EP, V16, P25; White AC, 1997, CLIN INFECT DIS, V25, P230	27	268	274	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					973	978		10.1016/S0140-6736(00)90015-1	http://dx.doi.org/10.1016/S0140-6736(00)90015-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768436				2022-12-01	WOS:000086054000012
J	Nightingale, PG; Adu, D; Richards, NT; Peters, M				Nightingale, PG; Adu, D; Richards, NT; Peters, M			Implementation of rules based computerised bedside prescribing and administration: intervention study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; DECISION-SUPPORT; MEDICATION ERRORS; PREVENTION; SYSTEMS	Obectives: To Implement and assess a rules based computerised prescribing system with the aim of improving the safety of prescriptions and the administration of drugs. Design: Analysis of performance of computerised system plus questionnaire survey of users. Setting: 64 bed renal unit in a teaching hospital. Intervention: Introduction of the system into routine clinical use. Main outcome measures: Number of attempted prescriptions cancelled by the system; proportion of warning messages overridden; users' comparisons of the system with conventional procedures. Results: Between October 1998 and August 1999 die system cancelled 58 (0.07%) out of 87 789 prescriptions on the grounds of clinical safety. In addition, 427 (57%) attempted prescriptions generating high level warnings and 1257 (8%) generating low level warnings were not completed. In a user survey 82% (31/38) of doctors and nurses considered the system to be an improvement on conventional procedures. Conclusions: The system has contributed to safety and patient care. All prescriptions are complete and legible, and transcription errors have been eliminated. The system assists clinicians when they are writing a prescription by making available information on patients. The system supports clinical decision making and has been well received by doctors, nurses, and pharmacists.	Univ Birmingham, Queen Elizabeth Med Ctr, Dept Med, Wolfson Comp Lab, Birmingham B15 2TH, W Midlands, England; Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Dept Nephrol, Renal Serv, Birmingham B15 2TH, W Midlands, England; Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Dept Nephrol, Urol Serv, Birmingham B15 2TH, W Midlands, England	Birmingham City University; University of Birmingham; University of Birmingham; University of Birmingham	Nightingale, PG (corresponding author), Univ Birmingham, Queen Elizabeth Med Ctr, Dept Med, Wolfson Comp Lab, Birmingham B15 2TH, W Midlands, England.	P.G.Nightingale@bham.ac.uk						Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; FERNER RE, 1992, J MED DEFENCE UNION, V8, P60; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; Purves IN, 1998, BRIT J GEN PRACT, V48, P1552; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; WYATT J, 1995, BRIT MED J, V311, P1181, DOI 10.1136/bmj.311.7014.1181	18	127	128	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2000	320	7237					750	753		10.1136/bmj.320.7237.750	http://dx.doi.org/10.1136/bmj.320.7237.750			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720357	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000086054700022
J	Cynader, M				Cynader, M			Neuroscience - Strengthening visual connections	SCIENCE			English	Editorial Material							CORTEX		Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 3N9, Canada; Vancouver Hosp, Vancouver, BC V5Z 3N9, Canada	University of British Columbia; University of British Columbia	Cynader, M (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 3N9, Canada.							Bruer J. T., 1999, MYTH 1 3 YEARS; CYNADER M, 1977, NATURE, V270, P177, DOI 10.1038/270177a0; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029	5	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1943	1944		10.1126/science.287.5460.1943	http://dx.doi.org/10.1126/science.287.5460.1943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755946				2022-12-01	WOS:000085902800035
J	Odom, AR; Stahlberg, A; Wente, SR; York, JD				Odom, AR; Stahlberg, A; Wente, SR; York, JD			A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control	SCIENCE			English	Article							PHOSPHOLIPASE-C GENE; SACCHAROMYCES-CEREVISIAE; ARGININE METABOLISM; CELL-CYCLE; S-PHASE; YEAST; EXPRESSION; DNA; PHOSPHORYLATION; TRISPHOSPHATE	Phospholipase C and two inositol polyphosphate (IP) kinases constitute a signaling pathway that regulates nuclear messenger RNA export through production of inositol hexakisphosphate (IP6). The inositol 1,4,5-trisphosphate kinase of this pathway in Saccharomyces cerevisiae, designated Ipk2, was found to be identical to Arg82, a regulator of the transcriptional complex ArgR-Mcm1. Synthesis of inositol 1,4,5,6-tetrakisphosphate, but not IP6, was required for gene regulation through ArgR-Mcm1. Thus, the phospholipase C pathway produces multiple IP messengers that modulate distinct nuclear processes. The results reveal a direct mechanism by which activation of IP signaling may control gene expression.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Duke University; Duke University; Washington University (WUSTL)	York, JD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.		John, Audrey Odom/AAF-1300-2019; Pillay, Nischalan/F-9536-2012	John, Audrey Odom/0000-0001-8395-8537; 				BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BERCY J, 1987, GENE, V55, P277, DOI 10.1016/0378-1119(87)90287-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BORONENKOV I, 1998, MOL BIOL CELL, P9; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COMMUNI D, 1995, CELL SIGNAL, V7, P643, DOI 10.1016/0898-6568(95)00035-N; D'Santos CS, 1998, BBA-MOL CELL BIOL L, V1436, P201, DOI 10.1016/S0005-2760(98)00146-5; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; DUBOIS E, 1987, MOL GEN GENET, V207, P142, DOI 10.1007/BF00331501; DUBOIS E, 1991, MOL CELL BIOL, V11, P2162, DOI 10.1128/MCB.11.4.2162; DUBOIS E, 1994, MOL GEN GENET, V243, P315, DOI 10.1007/BF00301067; ESTEVEZ F, 1994, BIOCHEM J, V302, P709, DOI 10.1042/bj3020709; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Hsu AL, 1998, BIOCHEM BIOPH RES CO, V243, P653, DOI 10.1006/bbrc.1998.8161; IRVINE RF, 1988, PHILOS T ROY SOC B, V320, P281, DOI 10.1098/rstb.1988.0077; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MAHER M, 1995, MOL CELL BIOL, V15, P3129; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; RIJCKE MD, 1992, MOL CELL BIOL, V12, P68; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SMITH CD, 1983, J BIOL CHEM, V258, P9368; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; VanderKaay J, 1995, BIOCHEM J, V312, P911, DOI 10.1042/bj3120911; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Yamaga M, 1999, J BIOL CHEM, V274, P28537, DOI 10.1074/jbc.274.40.28537; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; YORK JD, 1994, J BIOL CHEM, V269, P19992; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 1994, J BIOL CHEM, V269, P7847; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	39	313	329	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2026	2029		10.1126/science.287.5460.2026	http://dx.doi.org/10.1126/science.287.5460.2026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720331				2022-12-01	WOS:000085902800065
J	Catalanotto, C; Azzalin, G; Macino, G; Cogoni, C				Catalanotto, C; Azzalin, G; Macino, G; Cogoni, C			Transcription - Gene silencing in worms and fungi	NATURE			English	Article							PLANTS				Catalanotto, C (corresponding author), Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Sez Genet Mol, Viale Regina Elena 324, I-00161 Rome, Italy.	carlo@bce.med.uniroma1.it		CATALANOTTO, Caterina/0000-0001-6583-5170				Benfey PN, 1999, CURR BIOL, V9, pR171, DOI 10.1016/S0960-9822(99)80105-5; Cogoni C, 1997, TRENDS PLANT SCI, V2, P438, DOI 10.1016/S1360-1385(97)90028-5; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	11	191	238	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					245	245		10.1038/35005169	http://dx.doi.org/10.1038/35005169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749199	Bronze			2022-12-01	WOS:000086022200037
J	Packer, A; Clay, K				Packer, A; Clay, K			Soil pathogens and spatial patterns of seedling mortality in a temperate tree	NATURE			English	Article							JANZEN-CONNELL MODEL; RAIN-FOREST TREE; MOIST TROPICAL FOREST; NEOTROPICAL FOREST; SPECIES-DIVERSITY; DISTANCE; DENSITY; RECRUITMENT; MAINTENANCE; FEEDBACK	The Janzen-Connell hypothesis(1,2) proposes that host-specific, distance- and/or density-dependent predators and herbivores maintain high tree diversity in tropical forests. Negative feedback between plant and soil communities could be a more effective mechanism promoting species coexistence because soil pathogens can increase rapidly in the presence of their host(3), causing conditions unfavourable for local conspecific recruitment(4-6). Here we show that a soil pathogen leads to patterns of seedling mortality in a temperate tree (Prunus serotina) as predicted by the Janzen-Connell hypothesis. In the field, the mean distance to parent of seedling cohorts shifted away from maternal trees over a period of 3 years. Seedlings were gown in soil collected 0-5 m or 25-30 m from Prunus trees. Sterilization of soil collected beneath trees improved seedling survival relative to unsterilized soil, whereas sterilization of distant soil did not affect survival. Pythium spp., isolated from roots of dying seedlings and used to inoculate healthy seedlings, decreased survival by 65% relative to controls. Our results provide the most complete evidence that native pathogens influence tree distributions, as predicted by the Janzen-Connell hypothesis, and suggest that similar ecological mechanisms operate in tropical and temperate forests.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Packer, A (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Clay, Keith/C-8730-2012					AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; AUGSPURGER CK, 1983, OIKOS, V40, P189, DOI 10.2307/3544582; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BECKER P, 1985, OIKOS, V44, P382, DOI 10.2307/3565778; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Burdon J.J., 1987, DIS PLANT POPULATION; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; BURKEY TV, 1994, OECOLOGIA, V97, P533, DOI 10.1007/BF00325893; CARLISLE MJ, 1994, FUNGI; CHEN W, 1992, PHYTOPATHOLOGY, V82, P1234, DOI 10.1094/Phyto-82-1234; Cintra R, 1997, J TROP ECOL, V13, P641, DOI 10.1017/S0266467400010841; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; FLORENCE RG, 1965, ECOLOGY, V46, P52, DOI 10.2307/1935257; FOX JF, 1977, AM NAT, V111, P69, DOI 10.1086/283138; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; HUBBELL SP, 1980, OIKOS, V35, P214, DOI 10.2307/3544429; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Notman E, 1996, OECOLOGIA, V106, P221, DOI 10.1007/BF00328602; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WOODS KD, 1979, OIKOS, V33, P31, DOI 10.2307/3544508	29	652	701	20	333	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					278	281		10.1038/35005072	http://dx.doi.org/10.1038/35005072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749209				2022-12-01	WOS:000086022200047
J	Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW				Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW			DNA damage-induced activation of p53 by the checkpoint kinase Chk2	SCIENCE			English	Article							CELL-CYCLE REGULATION; INDUCED APOPTOSIS; RADIATION; ATM; PHOSPHORYLATION; TRANSCRIPTION; LINKAGE; GENE; P21	Chk2 is a protein kinase that is activated in response to DNA damage and may regulate cell cycle arrest. We generated Chk2-deficient mouse cells by gene targeting. Chk2(-/-) embryonic stem cells failed to maintain gamma-irradiation-induced arrest in the Ci phase of the cell cycle. Chk2(-/-) thymocytes were resistant to DNA damage-induced apoptosis. Chk2(-/-) cells were defective for p53 stabilization and for induction of p53-dependent transcripts such as p21 in response to gamma irradiation. Reintroduction of the Chk2 gene restored p53-dependent transcription in response to gamma irradiation. Chk2 directly phosphorylated p53 on serine 20, which is known to interfere with Mdm2 binding. This provides a mechanism for increased stability of p53 by prevention of ubiquitination in response to DNA damage.	Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Baylor Coll Med, Howard Hughes Med Inst, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Mak, TW (corresponding author), Univ Toronto, Ontario Canc Inst, Amgen Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.		Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, R37GM044664] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44664] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARPER JW, 1993, CELL, V75, P805; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIYASHITA T, 1995, CELL, V80, P293; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SANCHEZ Y, UNPUB; Schmidt-Kastner PK, 1998, ONCOGENE, V16, P3003, DOI 10.1038/sj.onc.1201835; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	25	990	1026	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1824	1827		10.1126/science.287.5459.1824	http://dx.doi.org/10.1126/science.287.5459.1824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710310				2022-12-01	WOS:000085775300042
J	Wilson, JA; Hevey, M; Bakken, R; Guest, S; Bray, M; Schmaljohn, AL; Hart, MK				Wilson, JA; Hevey, M; Bakken, R; Guest, S; Bray, M; Schmaljohn, AL; Hart, MK			Epitopes involved in antibody-mediated protection from Ebola virus	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; VIRION GLYCOPROTEINS; PROPHYLAXIS; INFECTION; FEVER	To determine the ability of antibodies to provide protection from Ebola viruses, monoclonal antibodies (mAbs) to the Ebola glycoprotein were generated and evaluated for efficacy. We identified several protective mAbs directed toward five unique epitopes on Ebola glycoprotein. One of the epitopes is conserved among all Ebola viruses that are known to be pathogenic for humans. Some protective mAbs were also effective therapeutically when administered to mice 2 days after exposure to Lethal Ebola virus. The identification of protective mAbs has important implications for developing vaccines and therapies for Ebola virus.	USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, Frederick, MD 21702 USA		Hart, MK (corresponding author), USA, Div Virol, Med Res Inst Infect Dis, Ft Detrick, 1425 Porter St, Frederick, MD 21702 USA.	marykate.hart@amedd.army.mil		Hevey, Michael/0000-0001-7481-1058				Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; *COMM CAR US LAB A, 1996, NIH PUBL; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294; MIKHAILOV VV, 1994, VOP VIRUSOL+, V39, P82; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Peters CJ, 1999, J INFECT DIS, V179, pIX; Pushko P, 1997, VACCINES, P253; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; STILES BG, 1991, TOXICON, V29, P1195, DOI 10.1016/0041-0101(91)90192-T; Volchkov VE, 1998, VIROLOGY, V245, P110, DOI 10.1006/viro.1998.9143; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; WILSON J, UNPUB; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037	19	363	407	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1664	1666		10.1126/science.287.5458.1664	http://dx.doi.org/10.1126/science.287.5458.1664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698744				2022-12-01	WOS:000085628200042
J	Keshavjee, S; Becerra, MC				Keshavjee, S; Becerra, MC			Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: An example of structural violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Stanford Univ, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Cultural & Social Anthropol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School	Keshavjee, S (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.			Keshavjee, Salmaan/0000-0002-6967-3305				Bourdieu P., 1993, MISERE MONDE, P159; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; FARMER P, 1995, DAEDALUS, V125, P261; Harvard Medical School and Open Society Institute, 1999, GLOB IMP DRUG RES TU; KESHAVJEE S, 1998, THESIS HARVARD U BOS; Kim J. Y., 2000, DYING GROWTH GLOBAL; NAJIBULLAH F, 1998, TAJIKISTAN HLTH CARE; SCHEPERHUGHES N, 1992, DEATH WEEPING VIOLEN, P128; *WHO, 1999, TAJ HLTH SECT REP 19; World Health Organization, 1994, WHO TUB PROGR FRAM E	10	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2000	283	9					1201	1201		10.1001/jama.283.9.1201	http://dx.doi.org/10.1001/jama.283.9.1201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	286BQ	10703788	hybrid			2022-12-01	WOS:000085424100035
J	Bruner, SD; Norman, DPG; Verdine, GL				Bruner, SD; Norman, DPG; Verdine, GL			Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; DAMAGED DNA; OGG1 GENE; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; ESCHERICHIA-COLI; HUMAN HOMOLOG; HOGG1 GENE; GLYCOSYLASE; CLONING	Spontaneous oxidation of guanine residues in DNA generates 8-oxoguanine (oxoG), By mispairing with adenine during replication, oxoG gives rise to a G.C --> T.A transversion, a frequent somatic mutation in human cancers. The dedicated repair pathway for oxoG centres on 8-oxoguanine DNA glycosylase (h0GG1), an enzyme that recognizes oxoG.C base pairs, catalysing expulsion of the oxoG and cleavage of the DNA backbone. Here we report the X-ray structure of the catalytic core of h0GG1 bound to oxoG.C-containing DNA at 2.1 Angstrom resolution. The structure reveals the mechanistic basis for the recognition and catalytic excision of DNA damage by h0GG1 and by other members of the enzyme superfamily to which it belongs. The structure also provides a rationale for the biochemical effects of inactivating mutations and polymorphisms in hOGG1. One known mutation, R154H, converts h0GG1 to a promutator by relaxing the specificity of the enzyme for the base opposite oxoG.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Verdine, GL (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	verdine@chemistry.harvard.edu						Aburatani H, 1997, CANCER RES, V57, P2151; Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Blons H, 1999, MOL CARCINOGEN, V26, P254; Bruner SD, 1998, CURR BIOL, V8, P393, DOI 10.1016/S0960-9822(98)70158-7; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Choi JY, 1999, FREE RADICAL BIO MED, V27, P848, DOI 10.1016/S0891-5849(99)00141-0; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; DODSON ML, 1994, J BIOL CHEM, V269, P32709; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kuo FC, 1997, J EXP MED, V186, P1547, DOI 10.1084/jem.186.9.1547; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Shinmura K, 1998, JPN J CANCER RES, V89, P825, DOI 10.1111/j.1349-7006.1998.tb00635.x; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; Yamagata Y, 1996, CELL, V86, P311, DOI 10.1016/S0092-8674(00)80102-6	45	796	820	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2000	403	6772					859	866		10.1038/35002510	http://dx.doi.org/10.1038/35002510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10706276				2022-12-01	WOS:000085559200047
J	Zito, JM; Safer, DJ; dosReis, S; Gardner, JF; Boles, M; Lynch, F				Zito, JM; Safer, DJ; dosReis, S; Gardner, JF; Boles, M; Lynch, F			Trends in the prescribing of psychotropic medications to preschoolers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the American-Psychiatric-Association	MAY 15-19, 1999	WASHINGTON, D.C.	Amer Psychiat Assoc			DEFICIT HYPERACTIVITY DISORDER; STIMULANT MEDICATION; CLONIDINE; CHILDREN; PSYCHOPHARMACOLOGY; METHYLPHENIDATE; ADOLESCENTS; PREVALENCE; QUESTIONS; EFFICACY	Context Recent reports on the use of psychotropic medications for preschool-aged children with behavioral and emotional disorders warrant further examination of trends in the type and extent of drug therapy and sociodemographic correlates. Objectives To determine the prevalence of psychotropic medication use in preschool-aged youths and to show utilization trends across a 5-year span. Design Ambulatory care prescription records from 2 state Medicaid programs and a salaried group-model health maintenance organization (HMO) were used to perform a population - based analysis of three 1-year cross-sectional data sets (for the years 1991, 1993, and 1995). Setting and Participants From 1991 to 1995, the number of enrollees aged 2 through 4 years in a Midwestern state Medicaid (MWM) program ranged from 146 369 to 158 060; in a mid-Atlantic state Medicaid (MAM) program, from 34 842 to 54 237; and in an HMO setting in the Northwest, from 19 107 to 19 322. Main Outcome Measures Total, age-specific, and gender-specific utilization prevalences per 1000 enrollees for 3 major psychotropic drug classes (stimulants, antidepressants, and neuroleptics) and 2 leading psychotherapeutic medications (methylphenidate and clonidine); rates of increased use of these drugs from 1991 to 1995, compared across the 3 sites. Results The 1995 rank order of total prevalence in preschoolers (per 1000) in the MWM program was: stimulants (12.3), 90% of which represents methylphenidate (11.1); anti depressants (3.2); clonidine (2,3); and neuroleptics (0.9), A similar rank order was observed for the MAM program, while the HMO had nearly 3 times more clonidine than antidepressant use (1.9 vs 0.7), Sizable increases in prevalence were noted between 1991 and 1995 across the 3 sites for clonidine, stimulants, and antidepressants, while neuroleptic use increased only slightly. Methylphenidate prevalence in 2- through 4-year-olds increased at each site: MWM, 3-fold; MAM, 1.7-fold; and HMO, 3.1-fold. Decreases occurred in the relative proportions of previously dominant psychotherapeutic agents in the stimulant and antidepressant classes, while increases occurred for newer, less established agents. Conclusions In all 3 data sources, psychotropic medications prescribed for preschoolers increased dramatically between 1991 and 1995. The predominance of medications with off-label (unlabeled) indications calls for prospective community-based, multidimensional outcome studies.	Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Kaiser Permanente, Ctr Hlth Res, Portland, OR USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Kaiser Permanente	Zito, JM (corresponding author), Univ Maryland, Sch Pharm, 100 Greene St,Room 5-13, Baltimore, MD 21201 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055259] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH55259] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHMANN PA, 1993, PEDIATRICS, V91, P1101; Cantwell DP, 1997, J AM ACAD CHILD PSY, V36, P539, DOI 10.1097/00004583-199704000-00017; DAVILLA RR, 1991, CLARIFICATION POLICY; Erickson SJ, 1998, J PAEDIATR CHILD H, V34, P280, DOI 10.1046/j.1440-1754.1998.t01-1-00217.x; Firestone P, 1998, J CHILD ADOL PSYCHOP, V8, P13, DOI 10.1089/cap.1998.8.13; FOXMAN B, 1986, PEDIATRICS, V77, P482; Geller B, 1999, J AM ACAD CHILD PSY, V38, P513, DOI 10.1097/00004583-199905000-00012; Greenhill LL, 1998, CAN J PSYCHIAT, V43, P576, DOI 10.1177/070674379804300604; GRINFELD MJ, 1998, PSYCHIAT TIMES, V15, P69; Hoagwood K, 1996, J AM ACAD CHILD PSY, V35, P1055, DOI 10.1097/00004583-199608000-00017; JENSEN PS, 1994, PSYCHOPHARMACOL BULL, V30, P3; Kappagoda C, 1998, J PAEDIATR CHILD H, V34, P508, DOI 10.1046/j.1440-1754.1998.00301.x; Minde K, 1998, CAN J PSYCHIAT, V43, P571, DOI 10.1177/070674379804300603; PATHIYAL A, 1998, AM SOC CLIN PHARM TH; Perrin JM, 1999, ARCH PEDIAT ADOL MED, V153, P80; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; POPPER CW, 1995, J CHILD ADOL PSYCHOP, V5, P157, DOI 10.1089/cap.1995.5.157; Prince JB, 1996, J AM ACAD CHILD PSY, V35, P599, DOI 10.1097/00004583-199605000-00014; RAPPLEY MD, 1998, PED AC SOC M JOINT S; Safer D.J., 2000, RITALIN THEORY PRACT, P7; Safer DJ, 1996, PEDIATRICS, V98, P1084; Swanson JM, 1995, J CHILD ADOL PSYCHOP, V5, P301, DOI 10.1089/cap.1995.5.301; Traversa G, 1998, J CHILD ADOL PSYCHOP, V8, P175, DOI 10.1089/cap.1998.8.175; Valentine J, 1996, J PAEDIATR CHILD H, V32, P223, DOI 10.1111/j.1440-1754.1996.tb01558.x; Vitiello B, 1997, ARCH GEN PSYCHIAT, V54, P871; Vitiello B, 1998, CAN J PSYCHIAT, V43, P582, DOI 10.1177/070674379804300605; Wilens TE, 1999, J AM ACAD CHILD PSY, V38, P614, DOI 10.1097/00004583-199905000-00025; Zito JM, 1998, J CHILD ADOL PSYCHOP, V8, P99, DOI 10.1089/cap.1998.8.99; ZITO JM, 1998, TRENDS PSYCHOTROPIC	29	634	641	1	35	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2000	283	8					1025	1030		10.1001/jama.283.8.1025	http://dx.doi.org/10.1001/jama.283.8.1025			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	284AM	10697062	Bronze			2022-12-01	WOS:000085308600031
J	Nishita, M; Hashimoto, MK; Ogata, S; Laurent, MN; Ueno, N; Shibuya, H; Cho, KWY				Nishita, M; Hashimoto, MK; Ogata, S; Laurent, MN; Ueno, N; Shibuya, H; Cho, KWY			Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer	NATURE			English	Article							AXIS SPECIFICATION; SIGNALING PATHWAYS; XENOPUS MESODERM; GENE-EXPRESSION; SMAD PROTEINS; WINGLESS; PATTERN; ESTABLISHMENT; ANTAGONISM; INDUCTION	Members of the Wnt and TGF-beta superfamilies regulate both cell fate and proliferation during development and tissue maintenance(1-3). In the early amphibian embryo, the Wnt and TGF-beta superfamily signalling cascades are required for the establishment of a dorsal signalling centre, Spemann's organizer(4-8). Intracellular proteins of both pathways, upon activation, translocate to the nucleus to participate in transcription. Here we show that beta-catenin and Lef1/Tcf, which are downstream components of the Wnt signalling cascade, form a complex with Smad4, an essential mediator of signals initiated by members of the TGF-beta growth factor superfamily. In Xenopus, this interaction directly and synergistically affects expression of the twin (Xtwn) gene during formation of the organizer. This is, to our knowledge, the first demonstration of a physical interaction between TGF-beta and Wnt signalling components in vivo.	Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92617 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of California System; University of California Irvine	Shibuya, H (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan.			Ueno, Naoto/0000-0002-8375-2317				Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Candia AF, 1997, DEVELOPMENT, V124, P4467; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Crease DJ, 1998, P NATL ACAD SCI USA, V95, P4398, DOI 10.1073/pnas.95.8.4398; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; JONES CM, 1992, DEVELOPMENT, V115, P639; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.0.CO;2-I; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Theisen H, 1996, DEVELOPMENT, V122, P3939; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; WATERMAN M L, 1990, New Biologist, V2, P621; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	29	386	399	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					781	785		10.1038/35001602	http://dx.doi.org/10.1038/35001602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693808	Green Submitted			2022-12-01	WOS:000085423100055
J	Willenheimer, R; Erhardt, LR				Willenheimer, R; Erhardt, LR			Value of 6-min-walk test for assessment of severity and prognosis of heart failure	LANCET			English	Editorial Material							LEFT-VENTRICULAR DYSFUNCTION; 6-MINUTE WALK TEST; QUALITY-OF-LIFE; OXYGEN-UPTAKE		Univ Lund, Malmo Univ Hosp, Dept Cardiol, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Willenheimer, R (corresponding author), Univ Lund, Malmo Univ Hosp, Dept Cardiol, SE-20502 Malmo, Sweden.							BENGE W, 1980, CIRCULATION, V61, P955, DOI 10.1161/01.CIR.61.5.955; BITTNER V, 1993, CIRCULATION, V88, P590; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; COHN JN, 1993, CIRCULATION, V87, P1; DRACUP K, 1992, J HEART LUNG TRANSPL, V11, P273; Faggiano P, 1997, AM HEART J, V134, P203, DOI 10.1016/S0002-8703(97)70125-X; GORKIN L, 1993, AM J CARDIOL, V71, P1069, DOI 10.1016/0002-9149(93)90575-W; Lucas C, 1999, AM HEART J, V138, P618, DOI 10.1016/S0002-8703(99)70174-2; RILEY M, 1992, EUR HEART J, V13, P789, DOI 10.1093/oxfordjournals.eurheartj.a060258; Roul G, 1998, AM HEART J, V136, P449, DOI 10.1016/S0002-8703(98)70219-4; Stevenson L., 1996, EXERCISE GAS EXCHANG, P271; Zugck C, 1998, CIRCULATION, V98, P157	13	22	25	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 12	2000	355	9203					515	516		10.1016/S0140-6736(99)00445-6	http://dx.doi.org/10.1016/S0140-6736(99)00445-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287CN	10682999				2022-12-01	WOS:000085487400007
J	Glynne, R; Akkaraju, S; Healy, JI; Rayner, J; Goodnow, CC; Mack, DH				Glynne, R; Akkaraju, S; Healy, JI; Rayner, J; Goodnow, CC; Mack, DH			How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis	NATURE			English	Article							TRANSCRIPTION FACTOR; CYCLOSPORINE-A; LYMPHOCYTES; ACTIVATION; RECEPTOR; PROTEIN; GENE; IMMUNOGLOBULIN; PROLIFERATION; EXPRESSION	Therapy for transplant rejection, autoimmune disease and allergy must target mature lymphocytes that have escaped censoring during their development. FK506 and cyclosporin are immunosuppressants which block three antigen-receptor signalling pathways (NFAT, NF kappa B and JNK), through inhibition of calcineurin(1), and inhibit mature lymphocyte proliferation to antigen(2-4) Neither drug induces long-lived tolerance in vivo, however, necessitating chronic use with adverse side effects. Physiological mechanisms of peripheral tolerance to self-antigens provide an opportunity to emulate these processes pharmacologically. Here we use gene-expression arrays to provide a molecular explanation for the loss of mitogenic response in peripheral B-cell anergy, one aspect of immunological tolerance(5). Self-antigen induces a set of genes that includes negative regulators of signalling and transcription but not genes that promote proliferation. FK506 interferes with calcium-dependent components of the tolerance response and blocks an unexpectedly small fraction of the activation response. Many genes that were not previously connected to self-tolerance are revealed, and our findings provide a molecular fingerprint for the development of improved immunosuppressants that prevent lymphocyte activation without blocking peripheral tolerance.	Stanford Univ, Beckman Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Australian Natl Univ, John Curtin Sch Med Res, Med Genome Ctr, Canberra, ACT 2601, Australia; Eos Biotechnol, S San Francisco, CA 94080 USA	Stanford University; Australian National University; John Curtin School of Medical Research	Goodnow, CC (corresponding author), Stanford Univ, Beckman Ctr, Dept Microbiol & Immunol, Stanford, CA 94305 USA.		Goodnow, Christopher C/V-8108-2018	Goodnow, Christopher C/0000-0001-5296-6155				Adachi T, 1998, J IMMUNOL, V160, P4662; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Grumont RJ, 1996, MOL CELL BIOL, V16, P2913; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Healy JI, 1998, CIBA F SYMP, V215, P137; HONG JX, 1993, J IMMUNOL, V150, P3895; HUO L, 1995, J IMMUNOL, V154, P3300; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; MONROE JG, 1988, J IMMUNOL, V140, P1454; Newton JS, 1996, EUR J IMMUNOL, V26, P811, DOI 10.1002/eji.1830260413; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; Svaren J, 1996, MOL CELL BIOL, V16, P3545; WICKER LS, 1990, EUR J IMMUNOL, V20, P2277, DOI 10.1002/eji.1830201017	30	139	144	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					672	676		10.1038/35001102	http://dx.doi.org/10.1038/35001102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688206				2022-12-01	WOS:000085288200058
J	Ito, K; Uno, M; Nakamura, Y				Ito, K; Uno, M; Nakamura, Y			A tripeptide 'anticodon' deciphers stop codons in messenger RNA	NATURE			English	Article							RELEASE FACTOR-2; AMINO-ACID; ESCHERICHIA-COLI; PEPTIDE; TRANSLATION; SUPPRESSOR; MUTANT	The two translational release factors of prokaryotes, RF1 and RF2, catalyse the termination of polypeptide synthesis at UAG/UAA and UGA/UAA stop codons, respectively(1-3). However, how these polypeptide release factors read both non-identical and identical stop codons is puzzling(4), Here we describe the basis of this recognition. Swaps of each of the conserved domains between RF1 and RF2 in an RF1-RF2. hybrid led to the identification of a domain that could switch recognition specificity. A genetic selection among clones encoding random variants of this domain showed that the tripeptides Pro-Ala-Thr and Ser-Pro-Phe determine release-factor specificity in vivo in RF1 and RF2, respectively. An in vitro release study of tripeptide variants indicated that the first and third amino acids independently discriminate the second and third purine bases, respectively. Analysis with stop codons containing base analogues indicated that the C2 amino group of purine may be the primary target of discrimination of G from A. These findings show that the discriminator tripeptide of bacterial release factors is functionally equivalent to that of the anticodon of transfer RNA, irrespective of the difference between protein and RNA.	Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nak@ims.u-tokyo.ac.jp	Uno, Masatoshi/V-7934-2019	Ito, Koichi/0000-0002-2042-405X				AULD DS, 1995, SCIENCE, V267, P1994, DOI 10.1126/science.7701322; Buckingham RH, 1997, MOL MICROBIOL, V24, P449, DOI 10.1046/j.1365-2958.1997.3711734.x; GRICK FHC, 1966, J MOL BIOL, V19, P548; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; KAWAKAMI K, 1988, J BACTERIOL, V170, P5378, DOI 10.1128/jb.170.11.5378-5381.1988; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Nakamura Y, 1998, GENES CELLS, V3, P265, DOI 10.1046/j.1365-2443.1998.00191.x; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SOLL D, 1967, J MOL BIOL, V29, P113, DOI 10.1016/0022-2836(67)90184-2; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Yoshimura K, 1999, GENES CELLS, V4, P253, DOI 10.1046/j.1365-2443.1999.00260.x	16	218	226	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2000	403	6770					680	684		10.1038/35001115	http://dx.doi.org/10.1038/35001115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688208				2022-12-01	WOS:000085288200060
J	Li, GY; Weis, RM				Li, GY; Weis, RM			Covalent modification regulates ligand binding to receptor complexes in the chemosensory system of Escherichia coli	CELL			English	Article							BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; KINASE CHEA; SERINE CHEMORECEPTOR; CYTOPLASMIC FRAGMENT; RESPONSE REGULATOR; ASPARTATE RECEPTOR; SENSORY RECEPTOR; PROTEIN; METHYLATION	In the Escherichia coli chemosensory pathway, receptor modification mediates adaptation to ligand. Evidence is presented that covalent modification influences ligand binding to receptors in complexes with CheW and the kinase CheA. Kinase inhibition was measured with serine receptor complexes in different modification levels; K-i for serine-mediated inhibition increased 10,000-fold from the lowest to the highest level. Without CheA and CheW, ligand binding is unaffected by covalent modification; thus, the influence of covalent modification is mediated only in the receptor complex, a conclusion supported by an analogy to allosteric enzymes and the observation of cooperative kinase inhibition. Also, the finding that a subsaturating serine concentration accelerates active receptor-kinase complex assembly implies that the assembly/disassembly process may also contribute to kinase regulation.	Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Weis, RM (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	rmweis@chem.umass.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053210] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM53210] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER J, 1969, SCIENCE, V166, P1588, DOI 10.1126/science.166.3913.1588; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; BORKOVICH KA, 1991, METHOD ENZYMOL, V200, P205; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bren A, 1998, J MOL BIOL, V278, P507, DOI 10.1006/jmbi.1998.1730; CONLEY MP, 1989, J BACTERIOL, V171, P5190, DOI 10.1128/jb.171.9.5190-5193.1989; DUNTEN P, 1991, J BIOL CHEM, V266, P1491; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Iwama T, 1997, J BIOL CHEM, V272, P13810, DOI 10.1074/jbc.272.21.13810; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; LeMoual H, 1997, BIOCHEMISTRY-US, V36, P13441, DOI 10.1021/bi9713207; Levit MN, 1998, MOL MICROBIOL, V30, P459, DOI 10.1046/j.1365-2958.1998.01066.x; Levit MN, 1999, BIOCHEMISTRY-US, V38, P6651, DOI 10.1021/bi982839l; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; LI JY, 1995, BIOCHEMISTRY-US, V34, P14626, DOI 10.1021/bi00045a003; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; LONG DG, 1992, BIOCHEMISTRY-US, V31, P9904, DOI 10.1021/bi00156a007; MADDOCK JR, 1993, SCIENCE, V259, P1717; MATSUMURA P, 1984, J BACTERIOL, V160, P36, DOI 10.1128/JB.160.1.36-41.1984; MCNALLY DF, 1991, P NATL ACAD SCI USA, V88, P6269, DOI 10.1073/pnas.88.14.6269; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; NINFA EG, 1991, J BIOL CHEM, V266, P9764; Osborn M J, 1974, Methods Enzymol, V31, P642; RICE MS, 1991, J BIOL CHEM, V266, P9746; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; Seeley SK, 1996, BIOCHEMISTRY-US, V35, P16336, DOI 10.1021/bi961749i; SLOCUM MK, 1983, J BACTERIOL, V155, P565, DOI 10.1128/JB.155.2.565-577.1983; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Wyman J, 1968, Q Rev Biophys, V1, P35; YONEKAWA H, 1986, FEBS LETT, V198, P21, DOI 10.1016/0014-5793(86)81176-0	42	163	165	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2000	100	3					357	365		10.1016/S0092-8674(00)80671-6	http://dx.doi.org/10.1016/S0092-8674(00)80671-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	282ET	10676817	Bronze			2022-12-01	WOS:000085204400009
J	Ratsitorahina, M; Chanteau, S; Rahalison, L; Ratsifasoamanana, L; Boisier, P				Ratsitorahina, M; Chanteau, S; Rahalison, L; Ratsifasoamanana, L; Boisier, P			Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar	LANCET			English	Article							ASSAY	Background Plague is a re-emerging disease and pneumonic plague is the most feared clinical form. We describe a well-documented outbreak of pneumonic plague in Madagascar. Methods Field epidemiological data were collected. Biological tests (microscopy, culture of Yersinia pestis, F1 antigen ELISA and dipstick assays, IgG anti-Fl ELISA) were done on sputum, serum, or necropsy samples. The infection rate among 154 contacts was assessed by anti-Fl serological techniques. Findings The index case was a bubonic patient with a secondary lung infection, who contaminated a traditional healer and his family. Funeral ceremonies and attendance on patients contaminated other villagers. In total 18 cases were recorded, and eight died. F1 antigen could be detected in sputum by ELISA and dipstick tests as early as the second day after the onset of the symptoms and also 48 h after treatment. Among the contact population 13 of 154 (8.4%) have been exposed to the plague bacillus (symptomless or latent infections). Interpretation The F1 dipstick assay on sputum is an invaluable diagnostic tool for pneumonic plague. Treatment of patients and chemoprophylaxis of contacts were efficient in stopping the epidemic.	Inst Pasteur Madagascar, Antananarivo, Madagascar; Minist Hlth, Natl Control Plague Programme, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Chanteau, S (corresponding author), Inst Pasteur Madagascar, POB 1274, Antananarivo, Madagascar.	chanteau@pasteur.mg	BOISIER, PASCAL/A-2922-2009					[Anonymous], 1998, Wkly Epidemiol Rec, V73, P366; BRYGOO E. R., 1958, BULL SOC PATHOL EXOT, V51, P47; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 1998, T ROY SOC TROP MED H, V92, P572, DOI 10.1016/S0035-9203(98)90923-3; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; GIRARD G., 1927, BULL SOC PATH EXOT, V20, P233; POLLITZER R, 1954, WHO MONOGR SER, V22, P533; Rasoamanana B, 1997, CLIN DIAGN LAB IMMUN, V4, P587, DOI 10.1128/CDLI.4.5.587-591.1997; Rasoamanana B, 1996, T ROY SOC TROP MED H, V90, P651, DOI 10.1016/S0035-9203(96)90420-4; THIROUX A, 1920, B SOC PATHOL EXOT, V22, P704; WINTER C C, 1960, Bull World Health Organ, V23, P408; WU LT, 1928, N MANCHURIAN PLAGUE, V6, P55	12	95	100	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2000	355	9198					111	113		10.1016/S0140-6736(99)05163-6	http://dx.doi.org/10.1016/S0140-6736(99)05163-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288HT	10675169				2022-12-01	WOS:000085557200013
J	Dear, P; Newell, S				Dear, P; Newell, S			Establishing probable cause in cerebral palsy - How much certainty is enough?	BRITISH MEDICAL JOURNAL			English	Letter									St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Dear, P (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.							Little WJ., 1861, T OBSTET SOC LOND, P293; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054	2	10	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 15	2000	320	7241					1075	1076						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307VW	10764378				2022-12-01	WOS:000086675700044
J	Williams, TM; Davis, RW; Fuiman, LA; Francis, J; Le Boeuf, BL; Horning, M; Calambokidis, J; Croll, DA				Williams, TM; Davis, RW; Fuiman, LA; Francis, J; Le Boeuf, BL; Horning, M; Calambokidis, J; Croll, DA			Sink or swim: Strategies for cost-efficient diving by marine mammals	SCIENCE			English	Article							CONFLICTING METABOLIC DEMANDS; NORTHERN ELEPHANT SEALS; DOLPHINS; KINEMATICS; EXERCISE; ENERGY; BIRDS	Locomotor activity by diving marine mammals is accomplished while breath-holding and often exceeds predicted aerobic capacities. Video sequences of freely diving seals and whales wearing submersible cameras reveal a behavioral strategy that improves energetic efficiency in these animals. Prolonged gliding (greater than 78% descent duration) occurred during dives exceeding 80 meters in depth. Gliding was attributed to buoyancy changes with Lung compression at depth. By modifying locomotor patterns to take advantage of these physical changes, Weddell seals realized a 9.2 to 59.6% reduction in diving energetic costs. This energy-conserving strategy allows marine mammals to increase aerobic dive duration and achieve remarkable depths despite Limited,oxygen availability when submerged.	Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; Univ Texas, Dept Marine Sci, Port Aransas, TX 78373 USA; Natl Geog Soc, Comm Res & Explorat, Washington, DC 20036 USA; Cascadia Res, Olympia, WA USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Texas A&M University System; University of Texas System; National Geographic Society; University of California System; University of California Santa Cruz	Williams, TM (corresponding author), Univ Calif Santa Cruz, Dept Biol, EMS-A316, Santa Cruz, CA 95064 USA.		Fuiman, Lee A/L-9514-2017; Horning, Markus/I-3019-2015	Fuiman, Lee A/0000-0003-2667-2684; Horning, Markus/0000-0001-6178-4935				AU D, 1980, NATURE, V284, P548, DOI 10.1038/284548a0; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CASTELLINI MA, 1985, J APPL PHYSIOL, V58, P392, DOI 10.1152/jappl.1985.58.2.392; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DAVIS RW, 1985, PHYSIOL ZOOL, V58, P590, DOI 10.1086/physzool.58.5.30158585; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1988, J EXP BIOL, V137, P157; HADRICH Y, 1997, NATURE, V388, P64; HOCHACHKA PW, 1986, FASEB J, V45, P2948; KOOYMAN GL, 1970, SCIENCE, V169, P82, DOI 10.1126/science.169.3940.82; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Lovvorn JR, 1999, J EXP BIOL, V202, P1741; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; PONGANIS PJ, 1990, CAN J ZOOL, V68, P2105, DOI 10.1139/z90-293; RIDGWAY SH, 1969, SCIENCE, V166, P1651, DOI 10.1126/science.166.3913.1651; RIDGWAY SH, 1979, SCIENCE, V206, P1182, DOI 10.1126/science.505001; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Skrovan RC, 1999, J EXP BIOL, V202, P2749; STEPHENSON R, 1994, J EXP BIOL, V190, P155; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; VIDELER J, 1985, J EXP BIOL, V119, P265; Webb PM, 1998, J EXP BIOL, V201, P2349; WEBB PW, 1999, THESIS U CALIFORNIA; WEIHS D, 1974, J THEOR BIOL, V48, P215, DOI 10.1016/0022-5193(74)90192-1; Williams T.M., 1993, Symposia of the Zoological Society of London, V66, P383; Williams TM, 1999, J EXP BIOL, V202, P2739; WILLIAMS TM, 1992, NATURE, V355, P821, DOI 10.1038/355821a0; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371	30	310	318	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					133	136		10.1126/science.288.5463.133	http://dx.doi.org/10.1126/science.288.5463.133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753116				2022-12-01	WOS:000086387700050
J	Zeki, S				Zeki, S			Abstraction and idealism - From Plato to Einstein: how do we acquire knowledge?	NATURE			English	Editorial Material									UCL, Wellcome Dept Cognit Neurol, London WC1E 6BT, England	University of London; University College London	Zeki, S (corresponding author), UCL, Wellcome Dept Cognit Neurol, Gower St, London WC1E 6BT, England.								0	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					547	547		10.1038/35007158	http://dx.doi.org/10.1038/35007158			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	303BC	10766218	Bronze			2022-12-01	WOS:000086400100027
J	Brinsden, PR; Appleton, TC; Murray, E; Hussein, M; Akagbosu, F; Marcus, SF				Brinsden, PR; Appleton, TC; Murray, E; Hussein, M; Akagbosu, F; Marcus, SF			Treatment by in vitro fertilisation with surrogacy: experience of one British centre	BRITISH MEDICAL JOURNAL			English	Article							INVITRO FERTILIZATION		Bourn Hall Clin, Cambridge CB3 7TR, England		Brinsden, PR (corresponding author), Bourn Hall Clin, Cambridge CB3 7TR, England.							*AM COLL OBST GYN, 1990, ETH ISS SURR MOTH; [Anonymous], GENESIS; [Anonymous], GENESIS, V21; [Anonymous], GENESIS; Blyth E., 1994, J REPROD INFANT PSYC, V12, P189, DOI DOI 10.1080/02646839408408885; BRAZIER M, 1998, SURROGACY REV UK HLT; Brinsden PR, 1999, TXB IN VITRO FERTILI, P361; *BRIT MED ASS, 1985, BMJ S, V291; *BRIT MED ASS, 1987, SURR MOTH REP BOARD; *BRIT MED ASS, 1985, BMJ S, V295; British Medical Association, 1996, CHANG CONC MOTH PRAC; British Medical Association, 1990, SURR ETH CONS REP WO; *DEP HLTH, 1997, SURR REV UK HLTH MIN; *ETH COMM AM FERT, 1986, FERTIL STERIL S1, V46, P62; *ETH COMM BOURN HA, GUID TREATM IN VITRO; FISHER S, 1991, PSYCHIATRY, V54, P13; MACNAMEE MC, 1999, TXB IN VITRO FERTILI, P91; MARCUS SF, 1993, HUM REPROD, V8, P238, DOI 10.1093/oxfordjournals.humrep.a138030; MARRS RP, 1993, AM J OBSTET GYNECOL, V168, P1858, DOI 10.1016/0002-9378(93)90702-K; SATHANANDAN M, 1991, HUM REPROD, V5, P1025; UTIAN WH, 1989, FERTIL STERIL, V52, P633	21	16	17	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 1	2000	320	7239					924	928		10.1136/bmj.320.7239.924	http://dx.doi.org/10.1136/bmj.320.7239.924			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10742007	Green Published			2022-12-01	WOS:000086337100033
J	Smith, H; Pickering, RM; Struthers, A; Simpson, I; Mant, D				Smith, H; Pickering, RM; Struthers, A; Simpson, I; Mant, D			Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; CARE	Objective To investigate die usefulness of measuring plasma concentrations of B type natriuretic peptide in the diagnosis of left ventricular systolic dysfunction ill an unselected group of elderly people. Design Observational study. Setting General practice with four centres in Poole, Dorset Participants 155 elderly patients aged 70 to 84 years. Main outcome measures Diagnostic characteristics of plasma B type natriuretic peptide measured by radioimmunoassay as a test for left ventricular systolic dysfunction assessed by echocardiograph): Results The median plasma concentration of B type natriuretic peptide was 39.3 pmol/l in patients with left ventricular systolic dysfunction and 15.8 pmol/l in those with normal function. The proportional area under the receiver operator curve was 0.85. At a cut-off point of 18.7 pmol/l the test sensitivity. was 92% and the predictive value 18%. Conclusions Plasma concentration of B type natriuretic peptide could be used effectively as an initial test in a community screening programme and, possibly, using a low cut-off point, as a means of ruling out left ventricular systolic dysfunction. It is, however, not a good test to "rule in" the diagnosis, and access to echocardiography remains essential for general practitioners to diagnose heart failure early.	Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Dundee DD1 9SY, Scotland; Southampton Gen Hosp, Wessex Cardiothorac Ctr, Dept Cardiol, Southampton, Hants, England; Univ Oxford, Div Publ Hlth & Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England	University of Southampton; University of Southampton; University of Dundee; University of Southampton; University of Oxford	Smith, H (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	hes@soton.ac.uk	Mant, David CA/C-7763-2009; Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124; Struthers, Allan/0000-0002-2926-2528				Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; DAVIDSON NC, 1995, CIRCULATION, V91, P1276; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Omland T, 1998, LANCET, V351, P1063, DOI 10.1016/S0140-6736(05)79035-8; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; STRUTHERS AD, 1994, BMJ-BRIT MED J, V308, P1615, DOI 10.1136/bmj.308.6944.1615; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0	8	75	82	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					906	908		10.1136/bmj.320.7239.906	http://dx.doi.org/10.1136/bmj.320.7239.906			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10741999	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000086337100024
J	Emery, P; Stanewsky, R; Hall, JC; Rosbash, M				Emery, P; Stanewsky, R; Hall, JC; Rosbash, M			Drosophila cryptochromes - A unique circadian-rhythm photoreceptor	NATURE			English	Article							CLOCK; PHOTOSENSITIVITY		Brandeis Univ, NSF Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany	Brandeis University; National Science Foundation (NSF); Brandeis University; Howard Hughes Medical Institute; University of Regensburg	Emery, P (corresponding author), Brandeis Univ, NSF Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA.		Stanewsky, Ralf/ABB-9193-2021	Stanewsky, Ralf/0000-0001-8238-6864				ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; OHATA K, 1999, BIOL CLOCKS MECHANIS, P167; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114	10	196	203	5	38	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					456	457		10.1038/35006558	http://dx.doi.org/10.1038/35006558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761904				2022-12-01	WOS:000086257700035
J	Benos, PV; Gatt, MK; Ashburner, M; Murphy, L; Harris, D; Barrell, B; Ferraz, C; Vidal, S; Brun, C; Demailles, J; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Borkova, D; Minana, B; Kafatos, FC; Louis, C; Siden-Kiamos, I; Bolshakov, S; Papagiannakis, G; Spanos, L; Cox, S; Madueno, E; de Pablos, B; Modolell, J; Peter, A; Schottler, P; Werner, M; Mourkioti, F; Beinert, N; Dowe, G; Schafer, U; Jackle, H; Bucheton, A; Callister, DM; Campbell, LA; Darlamitsou, A; Henderson, NS; McMillan, PJ; Salles, C; Tait, EA; Valenti, P; Saunders, RDC; Glover, DM				Benos, PV; Gatt, MK; Ashburner, M; Murphy, L; Harris, D; Barrell, B; Ferraz, C; Vidal, S; Brun, C; Demailles, J; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Borkova, D; Minana, B; Kafatos, FC; Louis, C; Siden-Kiamos, I; Bolshakov, S; Papagiannakis, G; Spanos, L; Cox, S; Madueno, E; de Pablos, B; Modolell, J; Peter, A; Schottler, P; Werner, M; Mourkioti, F; Beinert, N; Dowe, G; Schafer, U; Jackle, H; Bucheton, A; Callister, DM; Campbell, LA; Darlamitsou, A; Henderson, NS; McMillan, PJ; Salles, C; Tait, EA; Valenti, P; Saunders, RDC; Glover, DM			From sequence to chromosome: The tip of the X chromosome of D. melanogaster	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; PHYSICAL MAP; DNA; POPULATION; NUMBER; GENE	One of the rewards of having a Drosophila melanogaster whole-genome sequence will be the potential to understand the molecular bases for structural features of chromosomes that have been a Long-standing puzzle. Analysis of 2.6 megabases of sequence from the tip of the X chromosome of Drosophila identifies 273 genes. Cloned DNAs from the characteristic bulbous structure at the tip of the X chromosome in the region of the broad complex display an unusual pattern of in situ hybridization. Sequence analysis revealed that this region comprises 154 kilobases of DNA flanked by 1.2-kilobases of inverted repeats, each composed of a 350-base pair satellite related element. Thus, some aspects of chromosome structure appear to be revealed directly within the DNA sequence itself.	European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Sanger Ctr, Cambridge CB10 1SA, England; Univ Montpellier, Sch Med, IGH, CNRS, F-34396 Montpellier 5, France; Fac Med, CNRS, Unite Propre Rech 41, F-35043 Rennes, France; European Mol Biol Lab, Heidelberg, Germany; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Heraklion, Greece; Univ Crete, Dept Biol, Heraklion, Greece; Univ Autonoma Madrid, E-28049 Madrid, Spain; CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37070 Gottingen, Germany; Univ Dundee, Dept Anat & Physiol, Canc Res Campaign, Cell Cycle Genet Grp, Dundee DD1 4HN, Scotland; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England	European Molecular Biology Laboratory (EMBL); University of Cambridge; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; European Molecular Biology Laboratory (EMBL); Foundation for Research & Technology - Hellas (FORTH); University of Crete; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society; University of Dundee; Open University - UK	Benos, PV (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.		McMillan, Paul James/P-6441-2019; Louis, Christos/F-2527-2012; minana, belen/K-5530-2015; McMillan, Paul/B-5081-2008	McMillan, Paul James/0000-0001-5629-1175; minana, belen/0000-0001-7676-5788; Mourkioti, Foteini/0000-0002-7119-6640; Benos, Panayiotis/0000-0003-3172-3132; Glover, David/0000-0003-0956-0103; Murphy, Lee/0000-0001-6467-7449				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 1999, GENETICS, V153, P179; Ashburner M., 1989, DROSOPHILA LAB HDB; BECKER HJ, 1959, CHROMOSOMA, V10, P654, DOI 10.1007/BF00396591; BRIDGES C. B., 1937, Cytologia, P745, DOI 10.1508/cytologia.FujiiJubilaei.745; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Carson Hampton L., 1992, P441; CHARLESWORTH B, 1989, GENET RES, V54, P113, DOI 10.1017/S0016672300028482; DIBARTOLOMEIS SM, 1992, NUCLEIC ACIDS RES, V20, P1113, DOI 10.1093/nar/20.5.1113; GUBB D, 1990, GENETICS, V126, P167; Hoogland C, 1996, GENETICS, V144, P197; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; KASTRITSIS CD, 1986, CHROMOSOMA, V93, P381, DOI 10.1007/BF00327598; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; MADUENO E, 1995, GENETICS, V139, P1631; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; OFFERMANN CA, 1936, J GENET, V32, P102; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; SNIEGOWSKI PD, 1994, GENETICS, V137, P815; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; SORSA V, 1988, CHROMOSOME MAPS DROS, V1; STALKER HD, 1972, GENETICS, V70, P457; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4573; Tzolovsky G, 1999, GENETICS, V153, P1371; WARING GL, 1987, P NATL ACAD SCI USA, V84, P2843, DOI 10.1073/pnas.84.9.2843; ZHIMULEV IF, 1995, EUR J ENTOMOL, V92, P263; [No title captured]	32	22	153	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2220	2222		10.1126/science.287.5461.2220	http://dx.doi.org/10.1126/science.287.5461.2220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731137				2022-12-01	WOS:000086049100038
J	Sun, ZM; Arendt, CW; Ellmeier, W; Schaeffer, EM; Sunshine, MJ; Gandhi, L; Annes, J; Petrzilka, D; Kupfer, A; Schwartzberg, PL; Littman, DR				Sun, ZM; Arendt, CW; Ellmeier, W; Schaeffer, EM; Sunshine, MJ; Gandhi, L; Annes, J; Petrzilka, D; Kupfer, A; Schwartzberg, PL; Littman, DR			PKC-theta is required for TCR-induced NF-kappa B activation in mature but not immature T lymphocytes	NATURE			English	Article							PROTEIN-KINASE-C; CELL ACTIVATION; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; IL-2 PROMOTER; RECEPTOR; INTERLEUKIN-2; VAV; THYMOCYTES; EPSILON	Productive interaction of a T lymphocyte with an antigen-presenting cell results in the clustering of the T-cell antigen receptor (TCR) and the recruitment of a large signalling complex to the site of cell-cell contact(1,2). Subsequent signal transduction resulting in cytokine gene expression requires the activation of one or more of the multiple isoenzymes of serine/threonine-specific protein kinase C (PKC)(3). Among the several PKC isoenzymes expressed in T cells, PKC-theta is unique in being rapidly recruited to the site of TCR clustering(4). Here we show that PKC-theta is essential for TCR-mediated T-cell activation, but is dispensable during TCR-dependent thymocyte development. TCR-initiated NF-kappa B activation was absent from PKC-theta(-/-) mature T lymphocytes, but was intact in thymocytes. Activation of NF-kappa B by tumour-necrosis factor alpha and interleukin-1 was unaffected in the mutant mice. Although studies in T-cell lines had suggested that PKC-B regulates activation of the JNK signalling pathway(5,6), induction of JNK was normal in T cells from mutant mice. These results indicate that PKC-theta functions in a unique pathway that links the TCR signalling, complex to the activation of NF-kappa B in mature T lymphocytes.	NYU, Sch Med, Mol Pathogenesis Program, Sjirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80262 USA	New York University; Howard Hughes Medical Institute; New York University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago; National Jewish Health	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Sjirball Inst Biomol Med, New York, NY 10016 USA.			Sunshine, Mary Jean/0000-0002-2188-7881; Annes, Justin/0000-0001-8431-3589; Ellmeier, Wilfried/0000-0001-8192-8481; Gandhi, Leena/0000-0002-2398-9179				Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Esslinger CW, 1998, MOL IMMUNOL, V35, P847, DOI 10.1016/S0161-5890(98)00071-6; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAMIESON C, 1991, J IMMUNOL, V147, P416; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Zandi E, 1999, MOL CELL BIOL, V19, P4547	28	762	802	0	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					402	407		10.1038/35006090	http://dx.doi.org/10.1038/35006090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746729				2022-12-01	WOS:000086119000054
J	Gebo, DL; Dagosto, M; Beard, KC; Qi, T; Wang, JW				Gebo, DL; Dagosto, M; Beard, KC; Qi, T; Wang, JW			The oldest known anthropoid postcranial fossils and the early evolution of higher primates	NATURE			English	Article							EOCENE FISSURE-FILLINGS; MIDDLE EOCENE; ORIGINS; CHINA; FOOT; MORPHOLOGY; PROVINCE; SKULLS	The middle Eocene primate family Eosimiidae, which is known from sites in central and eastern China(1,2) and Myanmar(3), is central to efforts to reconstruct the origin and early evolution of anthropoid or 'higher' primates (monkeys, apes and humans)(1-6). Previous knowledge of eosimiid anatomy has been restricted to the dentition(3-3,7) and an isolated petrosal bone(5), and this limited anatomical information has led to conflicting interpretations of early anthropoid phylogeny(1-6,8,9). Here we describe foot bones of Eosimias from the same middle Eocene sites in China that yield abundant dental remains of this primate. Tarsals of Eosimias show derived anatomical traits that are otherwise restricted to living and fossil anthropoids. These new fossils substantiate the anthropoid status of Eosimias and clarify the phylogenetic position of anthropoids with respect to other major primate clades. Early anthropoids possessed a mosaic of primitive and derived traits in their postcranial skeletons, reflecting their derivation from haplorhine ancestors that retained marry prosimian-like features.	No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Northern Illinois University; Northwestern University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Gebo, DL (corresponding author), No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA.		Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837				Beard K. Christopher, 1994, P55; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; BEARD KC, 1991, NATURE, V349, P64, DOI 10.1038/349064a0; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Cartmill M., 1980, P243; Cartmill M., 1978, RECENT ADV PRIMATOL, P205; DAGOSTO M, 1992, INT J PRIMATOL, V13, P307, DOI 10.1007/BF02547818; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Dagosto Marian, 1994, P567; Decker R.L., 1974, P261; FLEAGIE JG, 1999, PRIMATE ADAPTATION E; GEBO DL, 1986, J HUM EVOL, V15, P421, DOI 10.1016/S0047-2484(86)80025-2; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; Gingerich P.D., 1980, P123; Godinot Marc, 1994, P235; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; LEWIS OJ, 1980, J ANAT, V131, P275; MacPhee RDE, 1995, J HUM EVOL, V29, P501, DOI 10.1006/jhev.1995.1073; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Rasmussen D. Tab, 1994, P335; RASMUSSEN DT, 1990, INT J PRIMATOL, V11, P439, DOI 10.1007/BF02196131; Rosenberger A.L., 1980, P139; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; Ross Callum, 1994, P469; SIMONS EL, 1989, AM J PHYS ANTHROPOL, V79, P1, DOI 10.1002/ajpa.1330790103; SIMONS EL, 1995, SCIENCE, V268, P1885, DOI 10.1126/science.7604261; Swofford DL, 1998, PHYLOGENETIC ANAL US; TONG Y, 1997, PALEONTOLOGIA SINICA, V26, P1	30	54	57	2	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					276	278		10.1038/35005066	http://dx.doi.org/10.1038/35005066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	296JX	10749208				2022-12-01	WOS:000086022200046
J	Vazquez-Torres, A; Xu, YS; Jones-Carson, J; Holden, DW; Lucia, SM; Dinauer, MC; Mastroeni, P; Fang, FC				Vazquez-Torres, A; Xu, YS; Jones-Carson, J; Holden, DW; Lucia, SM; Dinauer, MC; Mastroeni, P; Fang, FC			Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase	SCIENCE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; III SECRETION SYSTEM; NITRIC-OXIDE; MYCOBACTERIUM-TUBERCULOSIS; SUPEROXIDE PRODUCTION; BACTERIAL VIRULENCE; RADICAL PRODUCTION; RESPIRATORY BURST; HOST-CELLS; TYPHIMURIUM	A type III protein secretion system encoded by Salmonella pathogenicity island 2 (SPI2) has been found to be required for virulence and survival within macrophages. Here, SPI2 was shown to allow Salmonella typhimurium to avoid NADPH oxidase-dependent killing by macrophages. The ability of SPI2-mutant bacteria to survive in macrophages and to cause Lethal infection in mice was restored by abrogation of the NADPH oxidase-dependent respiratory burst. Ultrastructural and immunofluorescence microscopy demonstrated efficient Localization of the NADPH oxidase in the proximity of vacuoles containing SPI2-mutant but not wild-type bacteria, suggesting that SPI2 interferes with trafficking of oxidase-containing vesicles to the phagosome.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA; Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis, London W12 0NN, England; Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2BZ, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Imperial College London; Indiana University System; Indiana University-Purdue University Indianapolis; Imperial College London	Fang, FC (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA.		Timms, Andrew/K-2380-2019	Timms, Andrew/0000-0001-7439-1073; Fang, Ferric/0000-0002-3243-110X; Mastroeni, Pietro/0000-0003-3838-4962	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R01AI044486, R21AI039557] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44486, AI39557] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CURNUTTE JT, 1989, J CLIN INVEST, V83, P1236, DOI 10.1172/JCI114006; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Dusi S, 1996, J IMMUNOL, V157, P4615; Fang FC, 1997, INFECT IMMUN, V65, P5371, DOI 10.1128/IAI.65.12.5371-5375.1997; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509; Kobayashi T, 1998, J CELL SCI, V111, P81; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MASTROENI P, UNPUB; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; OBRIEN S, 1991, MICROB PATHOGENESIS, V10, P199, DOI 10.1016/0882-4010(91)90054-E; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Taylor PD, 1998, INFECT IMMUN, V66, P3208, DOI 10.1128/IAI.66.7.3208-3217.1998; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; VAZQUEZTORRES A, UNPUB; WILES ME, 1995, LIFE SCI, V57, P1533, DOI 10.1016/0024-3205(95)02114-X; WOLFF DJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P290, DOI 10.1006/abbi.1995.1040; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	45	432	441	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 3	2000	287	5458					1655	1658		10.1126/science.287.5458.1655	http://dx.doi.org/10.1126/science.287.5458.1655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289NE	10698741				2022-12-01	WOS:000085628200039
J	Hoffman, GR; Nassar, N; Cerione, RA				Hoffman, GR; Nassar, N; Cerione, RA			Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI	CELL			English	Article							GDP-DISSOCIATION INHIBITOR; GUANINE-NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; RAS; GTPASES; PROGRAM; DOMAIN; CYTOSKELETON; ACTIVATION; ANALOG	The RhoGDI proteins serve as key multifunctional regulators of Rho family GTP-binding proteins. The 2.6 Angstrom X-ray crystallographic structure of the Cdc42/RhoGDI complex reveals two important sites of interaction between GDI and Cdc42. First, the amino-terminal regulatory arm of the GDI binds to the switch I and II domains of Cdc42 leading to the inhibition of both GDP dissociation and GTP hydrolysis. Second, the geranylgeranyl moiety of Cdc42 inserts into a hydrophobic pocket within the immunoglobulin-like domain of the GDI molecule leading to membrane release. The structural data demonstrate how GDIs serve as negative regulators of small GTP-binding proteins and how the isoprenoid moeity is utilized in this critical regulatory interaction.	Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-01646] Funding Source: Medline; NEI NIH HHS [EY-06429] Funding Source: Medline; NIGMS NIH HHS [GM-47458] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gillilan R. E., 1995, Computer Graphics, V29, P55, DOI 10.1145/204362.204376; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; HORI Y, 1991, ONCOGENE, V6, P515; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keep NH, 1997, STRUCTURE, V5, P623, DOI 10.1016/S0969-2126(97)00218-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Longenecker K, 1999, ACTA CRYSTALLOGR D, V55, P1503, DOI 10.1107/S090744499900801X; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nomanbhoy TK, 1999, BIOCHEMISTRY-US, V38, P1744, DOI 10.1021/bi982198u; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; PLATKO JV, 1995, P NATL ACAD SCI USA, V92, P2974, DOI 10.1073/pnas.92.7.2974; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153	40	409	418	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2000	100	3					345	356		10.1016/S0092-8674(00)80670-4	http://dx.doi.org/10.1016/S0092-8674(00)80670-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	282ET	10676816	Bronze			2022-12-01	WOS:000085204400008
J	Morris, AAM; Lightowlers, RN				Morris, AAM; Lightowlers, RN			Can paternal mtDNA be inherited?	LANCET			English	Editorial Material							MITOCHONDRIAL-DNA; RECOMBINATION		Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Newcastle Univ, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Morris, AAM (corresponding author), Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.							Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663; KAMIMURA N, 1989, J MOL BIOL, V210, P703, DOI 10.1016/0022-2836(89)90103-4; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Macaulay V, 1999, P ROY SOC B-BIOL SCI, V266, P2037, DOI 10.1098/rspb.1999.0883; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536	9	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2000	355	9212					1290	1291						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LJ	10776737				2022-12-01	WOS:000086829400004
J	Li, MW; Ona, VO; Guegan, C; Chen, MH; Jackson-Lewis, V; Andrews, LJ; Olszewski, AJ; Stieg, PE; Lee, JP; Przedborski, S; Friedlander, RM				Li, MW; Ona, VO; Guegan, C; Chen, MH; Jackson-Lewis, V; Andrews, LJ; Olszewski, AJ; Stieg, PE; Lee, JP; Przedborski, S; Friedlander, RM			Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CU,ZN SUPEROXIDE-DISMUTASE; TROPHIC FACTOR WITHDRAWAL; MEDIATED APOPTOSIS; NEURONAL APOPTOSIS; FAMILY PROTEASES; BRAIN INJURY; CELL-DEATH; MICE	Mutations in the copper/zinc superoxide dismutase (SOD1) gene produce an animal model of familiar amyotrophic Lateral sclerosis (ALS), a fatal neurodegenerative disorder., To test a new therapeutic strategy for ALS, we examined the effect of caspase inhibition in transgenic mice expressing mutant human SOD1 with a substitution of glycine to alanine in position 93 (mSOD1(G93A)). Intracerebroventricular administration of zVAD-fmk, a broad caspase inhibitor. delays disease onset and mortality. Moreover, zVAD-fmk inhibits caspase-1 activity as well as caspase-1 and caspase-3 mRNA up-regulation, providing evidence for a non-cell-autonomous pathway regulating caspase expression. Caspases play an instrumental role in neurodegeneration in transgenic mSOD1(G93A) mice, which suggests that caspase inhibition may have a protective role in ALS.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neuroapoptosis Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neurosurg Serv, Boston, MA 02115 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; Columbia University; University of Chicago	Friedlander, RM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neuroapoptosis Lab, Boston, MA 02115 USA.		Guegan, Christelle/AAD-5377-2020; Friedlander, Robert M/A-2845-2016; Olszewski, Adam J/F-8449-2013	Friedlander, Robert M/0000-0003-4423-9219; Olszewski, Adam J/0000-0002-6472-6658	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370, R29NS037345, R01NS038586] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS38370, R29 NS37345, R01 NS38586] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali A, 1999, J HEMATOTH STEM CELL, V8, P343, DOI 10.1089/152581699320108; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Liberatore GT, 1999, NAT MED, V5, P1403; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Martin LJ, 2000, INT J MOL MED, V5, P3; Namura S, 1998, J NEUROSCI, V18, P3659; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland L. P., 1995, MERRITTS TXB NEUROLO, P742; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Vukosavic Slobodanka, 1999, Society for Neuroscience Abstracts, V25, P1304; WILLIAMS DB, 1993, PERIPHERAL NEUROPATH; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	30	576	602	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					335	339		10.1126/science.288.5464.335	http://dx.doi.org/10.1126/science.288.5464.335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764647				2022-12-01	WOS:000086454300038
J	Felker, GM; Thompson, RE; Hare, JM; Hruban, RH; Clemetson, DE; Howard, DL; Baughman, KL; Kasper, EK				Felker, GM; Thompson, RE; Hare, JM; Hruban, RH; Clemetson, DE; Howard, DL; Baughman, KL; Kasper, EK			Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; PERIPARTUM CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MORTALITY; MORBIDITY	Background: Previous studies of the prognosis of patients with heart failure due to cardiomyopathy categorized patients according to whether they had ischemic or nonischemic disease. The prognostic value of identifying more specific underlying causes of cardiomyopathy is unknown. Methods: We evaluated the outcomes of 1230 patients with cardiomyopathy. The patients were grouped into the following categories according to underlying cause: idiopathic cardiomyopathy (616 patients); peripartum cardiomyopathy (51); and cardiomyopathy due to myocarditis (111), ischemic heart disease (91), infiltrative myocardial disease (59), hypertension (49), human immunodeficiency virus (HIV) infection (45), connective-tissue disease (39), substance abuse (37), therapy with doxorubicin (15), and other causes (117). Cox proportional-hazards analysis was used to assess the association between the underlying cause of cardiomyopathy and survival. Results: During a mean follow-up of 4.4 years, 417 patients died and 57 underwent cardiac transplantation. As compared with the patients with idiopathic cardiomyopathy, the patients with peripartum cardiomyopathy had better survival (adjusted hazard ratio for death, 0.31; 95 percent confidence interval, 0.09 to 0.98), and survival was significantly worse among the patients with cardiomyopathy due to infiltrative myocardial disease (adjusted hazard ratio, 4.40; 95 percent confidence interval, 3.04 to 6.39), HIV infection (adjusted hazard ratio, 5.86; 95 percent confidence interval, 3.92 to 8.77), therapy with doxorubicin (adjusted hazard ratio, 3.46; 95 percent confidence interval, 1.67 to 7.18), and ischemic heart disease (adjusted hazard ratio, 1.52; 95 percent confidence interval, 1.07 to 2.17). Conclusions: The underlying cause of heart failure has prognostic value in patients with unexplained cardiomyopathy. Patients with peripartum cardiomyopathy appear to have a better prognosis than those with other forms of cardiomyopathy. Patients with cardiomyopathy due to infiltrative myocardial diseases, HIV infection, or doxorubicin therapy have an especially poor prognosis. (N Engl J Med 2000;342:1077-84.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kasper, EK (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	ekasper@jhmi.edu	Howard, David L/H-8288-2019; Felker, Michael/AAX-2288-2021	Howard, David L/0000-0002-4907-4292; Felker, Gary/0000-0002-5931-1239				Adams KF, 1999, CIRCULATION, V99, P1816, DOI 10.1161/01.CIR.99.14.1816; Adams KF, 1996, J AM COLL CARDIOL, V28, P1781, DOI 10.1016/S0735-1097(96)00380-4; *AM COLL CARD AM H, 1995, CIRCULATION, V92, P2794; BILGRAD R, 1995, NATL DEATH INDEX USE; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; Felker GM, 1999, MEDICINE, V78, P270, DOI 10.1097/00005792-199907000-00005; FRANCIOSA JA, 1983, AM J CARDIOL, V51, P831, DOI 10.1016/S0002-9149(83)80141-6; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; HOMANS DC, 1985, NEW ENGL J MED, V312, P1432, DOI 10.1056/NEJM198505303122206; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; OAKLEY CM, 1980, BRIT HEART J, V44, P672; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 1999, AM J CARDIOL, V83, p1A; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4	26	1047	1093	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2000	342	15					1077	1084		10.1056/NEJM200004133421502	http://dx.doi.org/10.1056/NEJM200004133421502			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303DZ	10760308				2022-12-01	WOS:000086406700002
J	Rocheville, M; Lange, DC; Kumar, U; Patel, SC; Patel, RC; Patel, YC				Rocheville, M; Lange, DC; Kumar, U; Patel, SC; Patel, RC; Patel, YC			Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity	SCIENCE			English	Article							ADENYLYL-CYCLASE; RAT-BRAIN; INTERNALIZATION; SYSTEM; CELLS; D1	Somatostatin and dopamine are two major neurotransmitter systems that share a number of structural and functional characteristics. Somatostatin receptors and dopamine receptors are colocalized in neuronal subgroups, and somatostatin is involved in modulating dopamine-mediated control of motor activity. However, the molecular basis for such interaction between the two systems is unclear. Here, we show that dopamine receptor D2R and somatostatin receptor SSTR5 interact physically through hetero-oligomerization to create a novel receptor with enhanced functional activity. Our results provide evidence that receptors from different G protein (heterotrimeric guanine nucleotide binding protein)-coupled receptor families interact through oligomerization. Such direct intramembrane association defines a new level of molecular crosstalk between related G protein-coupled receptor subfamilies.	McGill Univ, Dept Med, Fraser Labs, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Pharmacol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Therapeut, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 1A1, Canada; Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; Clarkson Univ, Dept Phys, Potsdam, NY 13699 USA; Clarkson Univ, Dept Chem, Potsdam, NY 13699 USA; VA Connecticut Healthcare Syst, Newington, CT 06111 USA; New England Biomed Res Ctr, Newington, CT 06111 USA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Royal Victoria Hospital; Clarkson University; Clarkson University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Patel, YC (corresponding author), McGill Univ, Dept Med, Fraser Labs, Montreal, PQ H3A 1A1, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034339, R01NS032160] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34339, NS32160-05] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHNEIWEISS H, 1985, J NEUROCHEM, V44, P1825, DOI 10.1111/j.1471-4159.1985.tb07175.x; Clegg R.M., 1996, FLUORESCENCE IMAGING; COHN L, 1975, BRAIN RES, V96, P138; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Forster T, 1948, NATURWISSENSCHAFTEN, V6, P166; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; HAVLICEK V, 1976, PHARMACOL BIOCHEM BE, V4, P455, DOI 10.1016/0091-3057(76)90063-0; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; HOYER D, 1994, ARCH PHARM, V350, P1; Hukovic N, 1998, J BIOL CHEM, V273, P21416, DOI 10.1074/jbc.273.33.21416; IzquierdoClaros RM, 1997, MOL BRAIN RES, V47, P99, DOI 10.1016/S0169-328X(97)00063-6; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; JOVIN TM, 1989, CELL STRUCTURE FUNCT; KASTIN AJ, 1978, METABOLISM, V27, P1247, DOI 10.1016/0026-0495(78)90053-7; Kumar U, 1999, DIABETES, V48, P77, DOI 10.2337/diabetes.48.1.77; LEBLANC R, 1988, NEUROLOGY, V38, P1887, DOI 10.1212/WNL.38.12.1887; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; MARTINIVERSON MT, 1986, PHARM BIOCH BEHAV, V24, P17; Marzullo P, 1999, Pituitary, V1, P115, DOI 10.1023/A:1009932521242; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1992, BASIC CLIN ASPECTS N, V4, P1; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; RodriguezSanchez MN, 1997, J NEUROSCI RES, V48, P238, DOI 10.1002/(SICI)1097-4547(19970501)48:3<238::AID-JNR6>3.0.CO;2-G; SRIKANT CB, 1981, P NATL ACAD SCI-BIOL, V78, P3930, DOI 10.1073/pnas.78.6.3930; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	31	703	723	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					154	157		10.1126/science.288.5463.154	http://dx.doi.org/10.1126/science.288.5463.154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753124				2022-12-01	WOS:000086387700056
J	de Waal, FBM; Berger, ML				de Waal, FBM; Berger, ML			Payment for labour in monkeys	NATURE			English	Article							FOOD; CHIMPANZEES; CEBUS		Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Dept Psychol, Atlanta, GA 30329 USA	Emory University; Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA.			Berger, Michelle/0000-0002-6679-6756				BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Crawford M.P., 1937, COMP PSYCHOL MONOGR, V14, P1; De Waal F., 1996, GOOD NATURED; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL FBM, IN PRESS ANIM BEHAV; Dugatkin LA., 1997, COOPERATION ANIMALS; Goodall J., 1965, P425; PERRY S, 1994, PRIMATES, V35, P409, DOI 10.1007/BF02381950; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Stanford CB, 1999, HUNTING APES; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; [No title captured]	13	144	149	1	46	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					563	563		10.1038/35007138	http://dx.doi.org/10.1038/35007138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766228	Bronze			2022-12-01	WOS:000086400100039
J	Polleux, F; Morrow, T; Ghosh, A				Polleux, F; Morrow, T; Ghosh, A			Semaphorin 3A is a chemoattractant for cortical apical dendrites	NATURE			English	Article							VISUAL-CORTEX; GROWTH; PROJECTIONS; EXPRESSION; NEUROPILIN; RECEPTOR; CELLS; IV	The apical dendrites of pyramidal neurons integrate inputs from various cortical layers and are central to information processing. Here we show that the growth of apical dendrites towards the pial surface is regulated by a diffusible chemoattractant present at high levels near the marginal zone. A major component of this signal is semaphorin 3A (Sema3A), which was previously characterized as a chemorepellant for cortical axons. Soluble guanylate cyclase is asymmetrically localized to the developing apical dendrite, and is required for the chemoattractive effect of Sema3A. Thus the asymmetric localization of soluble guanylate cyclase confers distinct Sema3A responses to axons and dendrites. These observations reveal a mechanism by which a single chemotropic signal can pattern both axons and dendrites during development.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481				Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BUTTS NK, 1994, J STRENGTH COND RES, V8, P265; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Chedotal A, 1998, DEVELOPMENT, V125, P4313; FISHELL G, 1995, DEVELOPMENT, V121, P803; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MILLER MW, 1988, CEREB CORTEX, V7, P133; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Robinson KR, 1997, DEV BIOL, V187, P125, DOI 10.1006/dbio.1997.8600; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	30	553	565	0	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					567	573		10.1038/35007001	http://dx.doi.org/10.1038/35007001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766232				2022-12-01	WOS:000086400100043
J	Walker, RG; Willingham, AT; Zuker, CS				Walker, RG; Willingham, AT; Zuker, CS			A Drosophila mechanosensory transduction channel	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; ADAPTATION; MUTATIONS; RECEPTOR; GENETICS; NEURONS; EAR	Mechanosensory transduction underlies a wide range of senses, including proprioception, touch, balance, and hearing. The pivotal element of these senses is a mechanically gated ion channel that transduces sound, pressure, or movement into changes in excitability of specialized sensory cells. Despite the prevalence of mechanosensory systems, Little is known about the molecular nature of the transduction channels. To identify such a channel, we analyzed Drosophila melanogaster mechanoreceptive mutants for defects in mechanosensory physiology, Loss-of-function mutations in the no mechanoreceptor potential C (nompC) gene virtually abolished mechanosensory signaling. nompC encodes a new ion channel that is essential for mechanosensory transduction. As expected for a transduction channel, D, melanogaster NOMPC and a Caenorhabditis elegans homolog were selectively expressed in mechanosensory organs.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu			NIGMS NIH HHS [5T32GM08107] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008107] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Colbert HA, 1997, J NEUROSCI, V17, P8259; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; CORFAS G, 1990, J NEUROSCI, V10, P491; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; George H, 1997, GENETICS, V146, P1345; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; KERNAN M, UNPUB; Luna EJ, 1991, CURR OPIN CELL BIOL, V3, P120, DOI 10.1016/0955-0674(91)90174-W; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; SAIMI Y, 1987, ANNU REV GENET, V21, P47, DOI 10.1146/annurev.genet.21.1.47; Sawin E.R., 1996, SELECTED WORKS MAO T, V151, P135; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; THURM U, 1965, COLD SPRING HARB SYM, V30, P75, DOI 10.1101/SQB.1965.030.01.011; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WALKER RB, UNPUB; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0	35	489	529	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2229	2234		10.1126/science.287.5461.2229	http://dx.doi.org/10.1126/science.287.5461.2229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744543				2022-12-01	WOS:000086049100041
J	Raber, J; Wong, D; Yu, GQ; Buttini, M; Mahley, RW; Pitas, RE; Mucke, L				Raber, J; Wong, D; Yu, GQ; Buttini, M; Mahley, RW; Pitas, RE; Mucke, L			Alzheimer's disease - Apolipoprotein E and cognitive performance	NATURE			English	Article									Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Neurol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Pathol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Program Neurosci, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Raber, J (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.			Buttini, Manuel/0000-0003-1805-0279				Buttini M, 1999, J NEUROSCI, V19, P4867; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001	13	189	199	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					352	354		10.1038/35006165	http://dx.doi.org/10.1038/35006165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746713				2022-12-01	WOS:000086119000038
J	Weingart, SN; Wilson, RM; Gibberd, RW; Harrison, B				Weingart, SN; Wilson, RM; Gibberd, RW; Harrison, B			Epidemiology of medical error	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; INTENSIVE-CARE UNIT; HOSPITALIZED-PATIENTS; QUALITY; PREVENTION; MORTALITY; MISTAKES; COSTS		Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Royal N Shore Hosp, Qual Assurance Royal N Shore, St Leonards, NSW 2065, Australia; Univ Newcastle, Dept Stat, Newcastle, NSW 2308, Australia	Harvard University; Beth Israel Deaconess Medical Center; Royal North Shore Hospital; University of Newcastle	Weingart, SN (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.							Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bhasale AL, 1998, MED J AUSTRALIA, V169, P73, DOI 10.5694/j.1326-5377.1998.tb140186.x; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; BURNUM JF, 1976, ANN INTERN MED, V85, P80, DOI 10.7326/0003-4819-85-1-80; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COOK RI, 1998, TALE I STORIES CONTR; COOPER JB, 1984, ANESTHESIOLOGY, V60, P34, DOI 10.1097/00000542-198401000-00008; Darchy B, 1999, ARCH INTERN MED, V159, P71, DOI 10.1001/archinte.159.1.71; DONCHIN Y, 1995, CRIT CARE MED, V23, P294, DOI 10.1097/00003246-199502000-00015; GANDHI TK, IN PRESS J GEN INTER; Garcia-Martin M, 1997, J CLIN EPIDEMIOL, V50, P1319, DOI 10.1016/S0895-4356(97)00219-9; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Johnson JA, 1997, AM J HEALTH-SYST PH, V54, P554, DOI 10.1093/ajhp/54.5.554; Kohn L., 1999, ERR IS HUMAN BUILDIN; LANSHMANAN MC, 1986, ARCH INTERN MED, V146, P1931; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lundberg GD, 1998, JAMA-J AM MED ASSOC, V280, P1273, DOI 10.1001/jama.280.14.1273; Macklis RM, 1998, J CLIN ONCOL, V16, P551, DOI 10.1200/JCO.1998.16.2.551; MARTINEZ JVB, 1998, AN MED INTERNA, V15, P179; MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Plebani M, 1997, CLIN CHEM, V43, P1348; SHIMMEL EM, 1964, ANN INTERN MED, V60, P100; Stambouly JJ, 1996, INTENS CARE MED, V22, P1098, DOI 10.1007/BF01699236; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; TRUNET P, 1980, JAMA-J AM MED ASSOC, V244, P2617, DOI 10.1001/jama.244.23.2617; Wilson DG, 1998, EUR J PEDIATR, V157, P769, DOI 10.1007/s004310050932; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Windsor JA, 1998, AUST NZ J SURG, V68, P186, DOI 10.1111/j.1445-2197.1998.tb04742.x; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	39	351	376	0	32	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					774	777		10.1136/bmj.320.7237.774	http://dx.doi.org/10.1136/bmj.320.7237.774			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720365	Green Published			2022-12-01	WOS:000086054700030
J	Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G				Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G			Correlates of sleep and waking in Drosophila melanogaster	SCIENCE			English	Article							RATS; EXPRESSION; LOCUS; DEPRIVATION; COCKROACH; NEURONS; LESIONS; CYCLE	Drosophila exhibits a circadian rest-activity cycle, but it is not known whether fly rest constitutes sleep or is mere inactivity. it is shown here that, like mammalian sleep, rest in Drosophila is characterized by an increased arousal threshold and is homeostatically regulated independently of the circadian clock. As in mammals, rest is abundant in young flies, is reduced in older flies, and is modulated by stimulants and hypnotics. Several molecular markers modulated by sleep and waking in mammals are modulated by rest and activity in Drosophila, including cytochrome oxidase C, the endoplasmic reticulum chaperone protein BiP, and enzymes implicated in the catabolism of monoamines. Flies Lacking one such enzyme, arylalkylamine N-acetyltransferase, show increased rest after rest deprivation. These results implicate the catabolism of monoamines in the regulation of sleep and waking in the fly and suggest that Drosophila may serve as a model system for the genetic dissection of sleep.	Inst Neurosci, San Diego, CA 92121 USA		Tononi, G (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BRIDGES C. B., 1937, Cytologia, P745, DOI 10.1508/cytologia.FujiiJubilaei.745; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cirelli C, 1998, MOL BRAIN RES, V56, P293, DOI 10.1016/S0169-328X(98)00057-6; CIRELLI C, 1999, SLEEP S, V22, P113; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Dunkov BC, 1996, MOL GEN GENET, V251, P290, DOI 10.1007/s004380050169; EDGAR DM, 1993, J NEUROSCI, V13, P1065; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hartmann E.L., 1973, FUNCTIONS SLEEP; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RUBIN DM, 1993, GENE, V128, P155, DOI 10.1016/0378-1119(93)90558-K; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; Stone W S, 1989, Clin Geriatr Med, V5, P363; TOBLER I, 1992, J SLEEP RES, V1, P231, DOI 10.1111/j.1365-2869.1992.tb00044.x; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TOBLER I, 1988, J COMP PHYSIOL A, V163, P227, DOI 10.1007/BF00612431; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; YANIK G, 1987, BRAIN RES, V403, P177, DOI 10.1016/0006-8993(87)90141-7; Yehuda S, 1998, PEPTIDES, V19, P407, DOI 10.1016/S0196-9781(97)00295-7; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330	29	807	829	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1834	1837		10.1126/science.287.5459.1834	http://dx.doi.org/10.1126/science.287.5459.1834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710313				2022-12-01	WOS:000085775300045
J	Bida, TA; Killen, RM; Morgan, TH				Bida, TA; Killen, RM; Morgan, TH			Discovery of calcium in Mercury's atmosphere	NATURE			English	Article							SURFACE; SODIUM; MOON	The composition and evolutionary history of Mercury's crust are not well determined(1,2). The planet as a whole has been predicted(3) to have a refractory, anhydrous composition: rich in Ca, Al, Mg and Fe, but poor in Na, K, OH, and S. Its atmosphere is believed to be derived in large part from the surface materials. A combination of effects that include impact vaporization (from infalling material), volatile evaporation, photon-stimulated desorption and sputtering releases material from the surface to form the atmosphere. Sodium and potassium have already been observed in Mercury's atmosphere(4-6), with abundances that require a volatile-rich crust(7). The sodium probably results from photon-stimulated desorption(8,9), and has a temperature of 1,500 K (ref. 10). Here we report the discovery of calcium in the atmosphere near Mercury's poles. The column density is very low and the temperature is apparently very high (12,000 K). The localized distribution and high temperature, if confirmed, suggest that the atmospheric calcium may arise from surface sputtering by ions, which enter Mercury's auroral zone. The low abundance of atmospheric Ca may indicate that the regolith is rarefied in calcium.	CARA, WM Keck Observ, Kamuela, HI 96743 USA; SW Res Inst, San Antonio, TX 78228 USA; NASA Headquarters, Washington, DC 20546 USA	Southwest Research Institute; National Aeronautics & Space Administration (NASA)	Bida, TA (corresponding author), CARA, WM Keck Observ, 65-1120 Mamalahoa Highway, Kamuela, HI 96743 USA.		Killen, Rosemary M/E-7127-2012; Morgan, Thomas/I-5943-2013					Chamberlain J. W., 1987, THEORY PLANETARY ATM; CHAMBERLAIN JW, 1976, J GEOPHYS RES-SPACE, V81, P1774, DOI 10.1029/JA081i010p01774; CHENG AF, 1987, ICARUS, V71, P430, DOI 10.1016/0019-1035(87)90038-8; ELPHIC RC, 1991, GEOPHYS RES LETT, V18, P2165, DOI 10.1029/91GL02669; Goettel K.A., 1988, MERCURY, P613; JEANLOZ R, 1995, SCIENCE, V268, P1455, DOI 10.1126/science.7770770; KIILEN RM, 1993, ICARUS, V101, P293; Killen RM, 1999, PLANET SPACE SCI, V47, P1449, DOI 10.1016/S0032-0633(99)00071-9; Kurucz R. L., 1984, Solar flux atlas from 296 to 1300 nm; Lewis J.S., 1988, MERCURY, P651; LEWIS JS, 1972, EARTH PLANET SC LETT, V15, P286, DOI 10.1016/0012-821X(72)90174-4; Madey TE, 1998, J GEOPHYS RES-PLANET, V103, P5873, DOI 10.1029/98JE00230; MCGRATH MA, 1986, NATURE, V323, P694, DOI 10.1038/323694a0; Morgan TH, 1997, PLANET SPACE SCI, V45, P81, DOI 10.1016/S0032-0633(96)00099-2; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Sprague AL, 1998, ICARUS, V136, P60, DOI 10.1006/icar.1998.6009; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; Sprague AL, 1997, ADV SPACE RES-SERIES, V19, P1507, DOI 10.1016/S0273-1177(97)00363-3; SPRAGUE AL, 1993, ICARUS, V104, P33, DOI 10.1006/icar.1993.1080; SUGITA S, 1997, P LUNAR PLANET SCI C, V28, P1393; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Yakshinskiy BV, 1999, NATURE, V400, P642, DOI 10.1038/23204	23	135	135	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					159	161		10.1038/35004521	http://dx.doi.org/10.1038/35004521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724161				2022-12-01	WOS:000085870900042
J	Cocheo, V; Sacco, P; Boaretto, C; De Saeger, E; Ballesta, PP; Skov, H; Goelen, E; Gonzalez, N; Caracena, AB				Cocheo, V; Sacco, P; Boaretto, C; De Saeger, E; Ballesta, PP; Skov, H; Goelen, E; Gonzalez, N; Caracena, AB			Urban benzene and population exposure	NATURE			English	Article									IRCCS, Fdn Salvatore Maugeri, I-35127 Padua, Italy; Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; Natl Environm Res Inst, DK-4000 Roskilde, Denmark; Vlaamse Instelling Technol Onderzoek, B-2400 Mol, Belgium; Inst Natl Environm Ind & Risques, F-60550 Verneuil En Halatte, France; Univ Murcia, Dept Ingn Quim Murcia, E-30071 Murcia, Spain	Istituti Clinici Scientifici Maugeri IRCCS; European Commission Joint Research Centre; EC JRC ISPRA Site; Aarhus University; VITO; Institut National de l'Environnement Industriel et des Risques (INERIS); University of Murcia	Cocheo, V (corresponding author), IRCCS, Fdn Salvatore Maugeri, Via Svizzera 16, I-35127 Padua, Italy.		Caracena, Antonia Baeza/L-7529-2014	Caracena, Antonia Baeza/0000-0002-8207-0453; Skov, Henrik/0000-0003-1167-8696				BOND GG, 1986, BRIT J IND MED, V43, P685; Cocheo V, 1996, AM IND HYG ASSOC J, V57, P897, DOI 10.1202/0002-8894(1996)057<0897:HURRDS>2.0.CO;2; Kumar N, 1996, ATMOS ENVIRON, V30, P1099, DOI 10.1016/1352-2310(95)00317-7; Rinsky R A, 1981, Am J Ind Med, V2, P217, DOI 10.1002/ajim.4700020305; SNYDER R, 1993, ENVIRON HEALTH PERSP, V100, P293, DOI 10.2307/3431535; VIGLIANI EC, 1964, NEW ENGL J MED, V271, P872, DOI 10.1056/NEJM196410222711703; WARD JB, 1992, MUTAT RES, V268, P49, DOI 10.1016/0027-5107(92)90082-D; *WHO, 1996, EURICPEHAZ9405MT12 R	8	99	101	1	32	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					141	142		10.1038/35004651	http://dx.doi.org/10.1038/35004651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724154				2022-12-01	WOS:000085870900034
J	Steinmetz, PN; Roy, A; Fitzgerald, PJ; Hsiao, SS; Johnson, KO; Niebur, E				Steinmetz, PN; Roy, A; Fitzgerald, PJ; Hsiao, SS; Johnson, KO; Niebur, E			Attention modulates synchronized neuronal firing in primate somatosensory cortex	NATURE			English	Article							CORTICAL ACTIVITY; MONKEYS; OSCILLATIONS; PATTERNS	A potentially powerful information processing strategy in the brain is to take advantage of the;temporal structure of neuronal spike trains. An increase in synchrony within the neural representation of an object or location increases the efficacy of that neural representation at the next synaptic stage in the brain; thus, increasing synchrony is a candidate for the neural correlate of attentional selection(1). We investigated the synchronous firing of pairs of neurons in the secondary somatosensory cortex (SII) of three monkeys trained to switch attention between a visual task and a tactile discrimination task. We found that most neuron pairs in SII cortex fired synchronously and, furthermore, that the degree of synchrony was affected by the monkey's attentional state. In the monkey performing the most difficult task, 35% of neuron pairs that fired synchronously changed their degree of synchrony when the monkey switched attention between the tactile and visual tasks. Synchrony increased in 80% and decreased in 20% of neuron pairs affected by attention.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Niebur, E (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	niebur@jhu.edu	Steinmetz, Peter/H-3151-2011					ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M., 1982, LOCAL CORTICAL CIRCU; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; Burton H, 1997, SOMATOSENS MOT RES, V14, P237, DOI 10.1080/08990229770971; Craig JC, 1996, SOMATOSENS MOT RES, V13, P199, DOI 10.3109/08990229609052576; Crick F., 1990, Seminars in the Neurosciences, V2, P263; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Haalman I, 1998, Z NATURFORSCH C, V53, P657; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; POGGIO GF, 1964, J NEUROPHYSIOL, V27, P517, DOI 10.1152/jn.1964.27.4.517; PORANEN A, 1982, ELECTROEN CLIN NEURO, V53, P525, DOI 10.1016/0013-4694(82)90065-7; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; ROY A, IN PRESS NEUROCOMPUT; Roy S, 1999, J NEUROPHYSIOL, V81, P999, DOI 10.1152/jn.1999.81.3.999; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.ph.55.030193.002025; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0	25	556	576	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					187	190		10.1038/35004588	http://dx.doi.org/10.1038/35004588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724171				2022-12-01	WOS:000085870900052
J	Thompson, PM; Giedd, JN; Woods, RP; MacDonald, D; Evans, AC; Toga, AW				Thompson, PM; Giedd, JN; Woods, RP; MacDonald, D; Evans, AC; Toga, AW			Growth patterns in the developing brain detected by using continuum mechanical tensor maps	NATURE			English	Article							ALZHEIMERS-DISEASE; IMAGES	The dynamic nature of growth and degenerative disease processes requires the design of sensitive strategies to detect, track and quantify structural change in the brain in its full spatial and temporal complexity(1). Although volumes of brain substructures are known to change during development(2), detailed maps of these dynamic growth processes have been unavailable. Here we report the creation of spatially complex, four-dimensional quantitative maps of growth patterns in the developing human brain, detected using a tensor mapping strategy with greater spatial detail and sensitivity than previously obtainable. By repeatedly scanning children (aged 3-15 years) across time spans of up to four years, a rostro-caudal wave of growth was detected at the corpus callosum, a fibre system that relays information between brain hemispheres. Peak growth rates, in fibres innervating association and language cortices, were attenuated after puberty, and contrasted sharply with a severe, spatially localized loss of subcortical grey matter. Conversely, at ages 3-6 years, the fastest growth rates occurred in frontal networks that regulate the planning of new actions. Local rates, profiles, and principal directions of growth were visualized in each individual child.	Univ Calif Los Angeles, Sch Med, Div Brain Mapping, Dept Neurol,Lab Neuroimaging, Los Angeles, CA 90095 USA; NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); McGill University	Thompson, PM (corresponding author), Univ Calif Los Angeles, Sch Med, Div Brain Mapping, Dept Neurol,Lab Neuroimaging, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	thompson@loni.ucla.edu	Giedd, Jay N./A-3080-2008; Thompson, Paul M/C-4194-2018; Giedd, Jay/J-9644-2015; Giedd, Jay N/B-7302-2012	Thompson, Paul M/0000-0002-4720-8867; Giedd, Jay/0000-0003-2002-8978; Giedd, Jay N/0000-0003-0827-3460				CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Davatzikos C, 1996, J COMPUT ASSIST TOMO, V20, P656, DOI 10.1097/00004728-199607000-00031; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Grimshaw GM, 1998, BRAIN LANG, V63, P237, DOI 10.1006/brln.1997.1943; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Thomas HC, 1996, J VIRAL HEPATITIS, V3, P1; Thompson JS, 1996, IEEE PERS COMMUN, V3, P16, DOI 10.1109/98.542234; Thompson P M, 1997, Med Image Anal, V1, P271; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Thompson PM, 1998, CEREB CORTEX, V8, P492, DOI 10.1093/cercor/8.6.492; THOMPSON PM, 1998, BRAIN WARPING, P311; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yakovlev P., 1967, REGIONAL DEV BRAIN E, P3; Zijdenbos Alex P., 1994, Critical Reviews in Biomedical Engineering, V22, P401	18	647	650	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					190	193		10.1038/35004593	http://dx.doi.org/10.1038/35004593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724172				2022-12-01	WOS:000085870900053
J	Yan, H; Papadopoulos, N; Marra, G; Perrera, C; Jiricny, J; Boland, CR; Lynch, HT; Chadwick, RB; de la Chapelle, A; Berg, K; Eshleman, JR; Yuan, WS; Markowitz, S; Laken, SJ; Lengauer, C; Kinzler, KW; Vogelstein, B				Yan, H; Papadopoulos, N; Marra, G; Perrera, C; Jiricny, J; Boland, CR; Lynch, HT; Chadwick, RB; de la Chapelle, A; Berg, K; Eshleman, JR; Yuan, WS; Markowitz, S; Laken, SJ; Lengauer, C; Kinzler, KW; Vogelstein, B			Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily.	NATURE			English	Article							MONOALLELIC MUTATION ANALYSIS; HYBRIDS; GENES; MICE		Johns Hopkins Univ, Howard Hughes Med Inst, Ctr Oncol, Dept Math Sci, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Univ Calif San Diego, La Jolla, CA 92093 USA; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Case Western Reserve Univ, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Columbia University; University of California System; University of California San Diego; Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Yan, H (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Ctr Oncol, Dept Math Sci, Baltimore, MD 21231 USA.		Papadopoulos, Nickolas/K-7272-2012					ANDERSON MJ, 1993, FASEB J, V7, P826, DOI 10.1096/fasebj.7.10.8344482; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HARRIS H, 1985, J CELL SCI, V79, P83; IMREH S, 1994, GENE CHROMOSOME CANC, V11, P237, DOI 10.1002/gcc.2870110406; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Lynch HT, 1999, J MED GENET, V36, P801; McDaniel LD, 1997, HUM MUTAT, V10, P317, DOI 10.1002/(SICI)1098-1004(1997)10:4<317::AID-HUMU8>3.3.CO;2-J; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PATERSON D, 1982, ANN NY ACAD SCI, V396, P69; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; SCHULTZ RA, 1987, P NATL ACAD SCI USA, V84, P4176, DOI 10.1073/pnas.84.12.4176; Warthin AS, 1913, ARCH INTERN MED, V12, P546; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Yuan ZQ, 1999, J MED GENET, V36, P790	15	209	222	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					723	724		10.1038/35001659	http://dx.doi.org/10.1038/35001659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10693791				2022-12-01	WOS:000085423100038
J	Bilder, D; Perrimon, N				Bilder, D; Perrimon, N			Localization of apical epithelial determinants by the basolateral PDZ protein Scribble	NATURE			English	Article							LEUCINE-RICH REPEATS; TIGHT JUNCTIONS; PLASMA-MEMBRANE; DROSOPHILA; CRUMBS; DOMAINS; CELLS; EXPRESSION; ENCODES; FAMILY	The generation of membrane domains with distinct protein constituents is a hallmark of cell polarization. In epithelia, segregation of membrane proteins into epical and basolateral compartments is critical for cell morphology, tissue physiology and cell signalling. Drosophila proteins that confer apical membrane identity have been found(1,2), but the mechanisms that restrict these determinants to the apical cell surface are unknown. Here we show that a laterally localized protein is required for the apical confinement of polarity determinants. Mutations in Drosophila scribble (scrib), which encodes a multi-PDZ (PSD-95, Discs-large and ZO-1) and leucine-rich-repeat protein, cause aberrant cell shapes and loss of the monolayer organization of embryonic epithelia. Scrib is localized to the epithelial septate junction, the analogue of the vertebrate tight junction(3), at the boundary of the apical and basolateral cell surfaces. Loss of scrib function results in the misdistribution of apical proteins and adherens junctions to the basolateral cell surface, but basolateral protein localization remains intact. These phenotypes can be accounted for by mislocalization of the apical determinant Crumbs. Ow results show that the lateral domain of epithelia, particularly the septate junction, functions in restricting apical membrane identity and correctly placing adherens junctions.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Bilder, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.			Perrimon, Norbert/0000-0001-7542-472X; Bilder, David/0000-0002-1842-4966				Apperson ML, 1996, J NEUROSCI, V16, P6839; Balda MS, 1998, J CELL SCI, V111, P541; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 1998, DEVELOPMENT, V125, P1781; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; CAMPOSORGEGA JA, 1997, EMBRYONIC DEV DROSOP; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; DRAGSTEN PR, 1981, NATURE, V294, P718, DOI 10.1038/294718a0; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Grawe F, 1996, DEVELOPMENT, V122, P951; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Salzberg A, 1997, GENETICS, V147, P1723; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Spradling AC, 1999, GENETICS, V153, P135; SUZUKI N, 1990, P NATL ACAD SCI USA, V87, P8711, DOI 10.1073/pnas.87.22.8711; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	29	545	554	2	34	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2000	403	6770					676	680		10.1038/35001108	http://dx.doi.org/10.1038/35001108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	283RD	10688207				2022-12-01	WOS:000085288200059
J	Rabow, MW; Hardie, GE; Fair, JM; McPhee, SJ				Rabow, MW; Hardie, GE; Fair, JM; McPhee, SJ			End-of-life care content in 50 textbooks from multiple specialties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Conference on Improving End-of-Life Care - A Conference of Nursing and Medical Textbook Publishers	MAR 12, 1999	OPEN SOC INST, NEW YORK, NY	Robert Wood Johnson Fdn, Last Acts Program	OPEN SOC INST		MEDICAL-EDUCATION; PALLIATIVE CARE; DYING PATIENTS; CHALLENGE; MODEL	Context Prior reviews of small numbers of medical textbooks suggest that end-of-life care is not well covered in textbooks. No broad study of end-of-life care content analysis has been performed on textbooks across a wide range of medical, pediatric, psychiatric, and surgical specialties. Objective To determine the quantity and rate the adequacy of information on end-of-life care in textbooks from multiple medical disciplines. Design and Sources A 1998 review of 50 top-selling textbooks from multiple specialties (cardiology, emergency medicine, family and primary care medicine, geriatrics, infectious disease and acquired immunodeficiency syndrome [AIDS], internal medicine, neurology, oncology and hematology, pediatrics, psychiatry, pulmonary medicine, and surgery) for the presence and adequacy of content in 13 end-of-life care domains. Main Outcome Measures Chapters on diseases commonly causing death and those devoted to end-of-life care were identified, read, rated, and compared by textbook specialty, chapter, and domain for the presence of helpful information in the 13 domains. Content for each domain was rated as absent, minimally present, or helpful. Textbook indexes were analyzed for the number of pages relevant to end-of-life care. Results Overall, helpful information was provided in 24.1% (range, 8.7%-44.2%) of the expected end-of-life content domains; in 19.1% (range, 6.2%-38.5%), expected content received minimal attention; and in 56.9% (range, 23.1%-77.9%), expected content was absent. As a group, the textbooks with the highest percentages of absent content were in surgery (71.8%), infectious diseases and AIDS (70%), and oncology and hematology (61.9%). Textbooks with the highest percentage of helpful end-of-life care content were in family medicine (34.4%), geriatrics (34.4%), and psychiatry (29.6%), In internal medicine textbooks, the content domains with the greatest amount of helpful information were epidemiology and natural history. Content domains covered least well were social, spiritual, ethical, and family issues, as well as physician after-death responsibilities. On average, textbook indexes cited 2% of their total pages as pertinent to end-of-life care. Conclusion Top-selling textbooks generally offered little helpful information on caring for patients at the end of life. Most disease-oriented chapters had no or minimal end-of-life care content. Specialty textbooks with information about particular diseases often did not contain helpful information on caring for patients dying from those diseases.	Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rabow, MW (corresponding author), Univ Calif San Francisco, Mt Zion, 1701 Divisadero St,5th Floor, San Francisco, CA 94115 USA.	mrabow@medicine.ucsf.edu						American Board of Internal Medicine, 1996, CAR DYING ID PROM PH; Billings JA, 1997, JAMA-J AM MED ASSOC, V278, P733, DOI 10.1001/jama.278.9.733; BLANCHARD CG, 1981, CANCER, V47, P2756, DOI 10.1002/1097-0142(19810601)47:11<2756::AID-CNCR2820471135>3.0.CO;2-G; Block S D, 1998, J Palliat Med, V1, P347, DOI 10.1089/jpm.1998.1.347; Carron A T, 1999, Ann Intern Med, V130, P82; *CDCP, 1998, 10 LEAD CAUS DEATH U; Emanuel EJ, 1997, LANCET, V349, P1714, DOI 10.1016/S0140-6736(05)62952-2; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ferrell B R, 1999, J Palliat Med, V2, P161, DOI 10.1089/jpm.1999.2.161; GIBSON R, 1998, J PALLIAT MED, V1, P415; HILL TP, 1995, ARCH INTERN MED, V155, P1265, DOI 10.1001/archinte.155.12.1265; Hill Wendy C., 1998, Pediatric Research, V43, p111A; HOLLEMAN WL, 1994, TEACH LEARN MED, V6, P260; *I MED COMM CAR EN, 1997, APPR DEATH IMPR CAR; Kaye J M, 1991, J Cancer Educ, V6, P21; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; *LOG BROTH CO INC, 1997, ORD FORM MOST POP TI; Lynn J, 1997, J AM GERIATR SOC, V45, P526; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MACDONALD N, 1991, CANADIAN PALLIATIVE; MCWHINNEY IR, 1994, CAN FAM PHYSICIAN, V40, P240; MERMANN AC, 1991, ACAD MED, V66, P35, DOI 10.1097/00001888-199101000-00010; Plumb J D, 1992, Am J Hosp Palliat Care, V9, P32, DOI 10.1177/104990919200900311; Quill TE, 1998, ANN INTERN MED, V129, P590, DOI 10.7326/0003-4819-129-7-199810010-00026; Rabow M W, 1999, J Palliat Med, V2, P153, DOI 10.1089/jpm.1999.2.153; RAPPAPORT W, 1993, SURGERY, V113, P163; *RW JOHNS FDN LAST, 1999, C NURS MED TXB PUBL; SCHEIDERMAMN LJ, 1997, J FAM PRACTICE, V45, P259; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinmetz D, 1993, Arch Fam Med, V2, P753, DOI 10.1001/archfami.2.7.753; The SUPPORT Principal Investigators, 1995, J AMER MED ASSOC, V274, P1591; von Gunten C F, 1995, Am J Hosp Palliat Care, V12, P38, DOI 10.1177/104990919501200413; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; Woods NF., 1988, NURSING RES THEORY P	34	125	126	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2000	283	6					771	778		10.1001/jama.283.6.771	http://dx.doi.org/10.1001/jama.283.6.771			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	280XL	10683056				2022-12-01	WOS:000085129000029
